{"data": [{"Element": "<div class=\"WordSection1\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"17\" id=\"Picture 1\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. \u00a0This\nwill allow quick identification of new safety information. \u00a0Healthcare\nprofessionals are asked to report any suspected adverse reactions. \u00a0See\nsection\u00a04.8 for how to report adverse reactions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated tablets.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir</span><span lang=\"EN-GB\">.</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list\nof excipients, see section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Film\u2011coated\ntablet.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pink, diamond\u2011shaped,\nfilm\u2011coated tablet of dimensions 20\u00a0mm\u00a0x\u00a010\u00a0mm,\ndebossed on one side with \u201cGSI\u201d and \u201c7916\u201d on the other\nside.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">is indicated for the treatment of chronic\nhepatitis\u00a0C virus (HCV) infection in adults </span><span lang=\"EN-GB\">(see\nsections\u00a04.2,\u00a04.4 and\u00a05.1).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa\ntreatment should be initiated and monitored by a physician experienced in the\nmanagement of patients with HCV infection.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended\ndose of Epclusa is one tablet, taken orally, once daily with or without food\n(see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoCaption\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a01: Recommended treatment and duration\nfor all HCV genotypes</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Includes\npatients co\u2011infected with human immunodeficiency virus (HIV) and patients\nwith recurrent HCV post-liver transplant (see section\u00a04.4.).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">When used in\ncombination with ribavirin, refer also to the Summary of Product\nCharacteristics of the medicinal product containing ribavirin.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The following dosing is recommended where ribavirin is divided in\ntwo daily doses and given with food:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a02: Guidance for ribavirin dosing when administered with Epclusa\nto patients with decompensated cirrhosis</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>\n</td>\n<td style=\"width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If ribavirin is\nused in genotype\u00a03 infected patients with compensated cirrhosis (pre- or\npost-transplant) the recommended dose of ribavirin is 1,000/1,200</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">mg (</span><span lang=\"EN-GB\">1,000\u00a0mg\nfor patients weighing &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients\nweighing \u2265\u00a075\u00a0kg</span><span lang=\"EN-GB\">).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For ribavirin\ndose modifications, refer to the Summary of Product Characteristics of the\nmedicinal product containing ribavirin.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients should\nbe instructed that if vomiting occurs within 3\u00a0hours of dosing an\nadditional tablet of Epclusa should be taken.\u00a0 If vomiting occurs more\nthan 3\u00a0hours after dosing, no further dose of Epclusa is needed (see\nsection\u00a05.1).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If a dose of Epclusa\nis missed and it is within 18\u00a0hours of the normal time, patients should be\ninstructed to take the tablet as soon as possible and then patients should take\nthe next dose at the usual time.\u00a0 If it is after 18\u00a0hours then\npatients should be instructed to wait and take the next dose of Epclusa at the\nusual time.\u00a0 Patients should be instructed not to take a double dose of Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa +\nribavirin for 24\u00a0weeks may be considered (see section\u00a04.4).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment is warranted for elderly patients (see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> is\nrequired for patients with mild or moderate renal impairment. \u00a0The safety\nand efficacy of Epclusa has not been assessed in patients with severe renal impairment\n(estimated glomerular filtration rate\n[eGFR]\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>) or end stage\nrenal disease (ESRD) requiring haemodialysis (see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">is required for patients with mild, moderate, or severe hepatic\nimpairment (CPT Class\u00a0A, B, or C) (see section\u00a05.2). \u00a0Safety and\nefficacy of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> have been assessed\nin patients with CPT Class\u00a0B cirrhosis, but not in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.4,\u00a04.8 and\u00a05.1).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Epclusa in children and adolescents aged less\nthan 18\u00a0years have not yet been established. \u00a0No data are available.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Patients should be instructed to swallow the tablet whole with or\nwithout food (see section\u00a05.2). \u00a0Due to the bitter taste, it is\nrecommended that the film\u2011coated tablet is not chewed or crushed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\nto the active substances or to any of the excipients listed in section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with potent P\u2011gp and potent CYP inducers</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproducts that are potent P\u2011glycoprotein (P\u2011gp) or potent cytochrome\nP450 (CYP) inducers (rifampicin, rifabutin, St.\u00a0John\u2019s wort\n[Hypericum perforatum], carbamazepine, phenobarbital and phenytoin).\u00a0 Co\u2011administration\nwill significantly decrease sofosbuvir or velpatasvir plasma concentrations and\ncould result in loss of efficacy of Epclusa (see section\u00a04.5).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special\nwarnings and precautions for use</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> should not be administered concurrently with other medicinal\nproducts containing sofosbuvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Severe bradycardia and heart block</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone with or without other medicinal\nproducts that lower heart rate.\u00a0 The mechanism is not established.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The concomitant\nuse of amiodarone was limited through the clinical development of sofosbuvir.\u00a0\nCases are potentially life threatening, therefore amiodarone should only be\nused in patients on Epclusa when other alternative anti-arrhythmic treatments\nare not tolerated or are contraindicated.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Should\nconcomitant use of amiodarone be considered necessary, it is recommended that\npatients are closely monitored when initiating Epclusa.\u00a0 Patients who are\nidentified as being at high risk of bradyarrhythmia should be continuously\nmonitored for 48\u00a0hours in an appropriate clinical setting.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to the long\nhalf-life of amiodarone, appropriate monitoring should also be carried out for\npatients who have discontinued amiodarone within the past few months and are to\nbe initiated on Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">All patients\nreceiving Epclusa in combination with amiodarone with or without other medicinal\nproducts that lower heart rate should also be warned of the symptoms of\nbradycardia and heart block and should be advised to seek medical advice\nurgently should they experience them.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\nclinical data to support the efficacy of sofosbuvir/velpatasvir for the\ntreatment of patients who have failed treatment with a regimen containing\nanother NS5A inhibitor.\u00a0 However, on the basis of NS5A resistance\nassociated variants (RAVs) typically seen in patients who have failed therapy\nwith other NS5A inhibitor containing regimens, the <i>in\u00a0vitro</i>\npharmacology of velpatasvir, and the outcomes of sofosbuvir/velpatasvir\ntreatment in NS5A-na\u00efve patients with baseline NS5A RAVs enrolled into the\nASTRAL-studies, treatment with Epclusa + RBV for 24\u00a0weeks can be\nconsidered for patients who have failed therapy on an NS5A-containing regimen\nand who are deemed at high risk for clinical disease progression and who do not\nhave alternative treatment options.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Renal impairment</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of Epclusa is required for patients with mild or moderate renal\nimpairment.\u00a0 </span><span lang=\"EN-GB\">The safety of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> has not been assessed in patients\nwith severe renal impairment (eGFR\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nor ESRD requiring haemodialysis.\u00a0 When </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> is used in combination with ribavirin refer also to the Summary of\nProduct Characteristics for ribavirin for patients with creatinine clearance\n&lt;\u00a050\u00a0mL/min (see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with moderate P\u2011gp inducers or moderate CYP inducers</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproducts that are moderate P\u2011gp or moderate CYP inducers (e.g. oxcarbazepine,\nmodafinil or efavirenz) may decrease sofosbuvir or velpatasvir plasma\nconcentrations leading to reduced therapeutic effect of Epclusa. \u00a0Co-administration\nof such medicinal products with Epclusa is not recommended (see\nsection\u00a04.5).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with certain HIV antiretroviral regimens</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa has been\nshown to increase tenofovir exposure, especially when used together with an HIV\nregimen containing tenofovir disoproxil fumarate and a pharmacokinetic enhancer\n(ritonavir or cobicistat).\u00a0 The safety of tenofovir disoproxil fumarate in\nthe setting of Epclusa and a pharmacokinetic enhancer has not been\nestablished.\u00a0 The potential risks and benefits associated with co\u2011administration\nof Epclusa with the fixed-dose combination tablet containing\nelvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate or\ntenofovir disoproxil fumarate given in conjunction with a boosted HIV protease\ninhibitor (e.g. atazanavir or darunavir) should be considered, particularly in\npatients at increased risk of renal dysfunction. \u00a0Patients receiving Epclusa\nconcomitantly with elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil\nfumarate or with tenofovir disoproxil fumarate and a boosted HIV protease\ninhibitor should be monitored for tenofovir\u2011associated adverse reactions.\n\u00a0Refer to tenofovir disoproxil fumarate, emtricitabine/tenofovir\ndisoproxil fumarate, or elvitegravir/cobicistat/emtricitabine/tenofovir\ndisoproxil fumarate Summary of Product Characteristics for recommendations on\nrenal monitoring.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Use in\ndiabetic patients </span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diabetics may\nexperience improved glucose control, potentially resulting in symptomatic\nhypoglycaemia, after initiating HCV direct-acting antiviral treatment. Glucose\nlevels of diabetic patients initiating direct-acting antiviral therapy should\nbe closely monitored, particularly within the first 3 months, and their\ndiabetic medication modified when necessary. The physician in charge of the\ndiabetic care of the patient should be informed when direct-acting antiviral\ntherapy is initiated.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">HCV/HBV (hepatitis\u00a0B virus) co\u2011infection</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of\nhepatitis B\u00a0virus (HBV) reactivation, some of them fatal, have been\nreported during or after treatment with direct-acting antiviral agents. \u00a0HBV\nscreening should be performed in all patients before initiation of treatment. \u00a0HBV/HCV\nco-infected patients are at risk of HBV reactivation, and should therefore be\nmonitored and managed according to current clinical guidelines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">CPT Class\u00a0C cirrhosis</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Safety and\nefficacy of Epclusa has not been assessed in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.8 and\u00a05.1).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Liver transplant patients</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and\nefficacy of Epclusa in the treatment of HCV infection in patients who are post\u2011liver\ntransplant have not been assessed.\u00a0 Treatment with Epclusa in accordance\nwith the recommended posology (see section\u00a04.2) should be guided by an\nassessment of the potential benefits and risks for the individual patient.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction\nwith other medicinal products and other forms of interaction</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As</span><span lang=\"EN-GB\"> Epclusa </span><span lang=\"EN-GB\">contains\nsofosbuvir and velpatasvir, any interactions that have been identified with\nthese active substances individually may occur with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Potential for Epclusa to affect other medicinal products</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Velpatasvir is an inhibitor of drug transporter P\u2011gp, breast\ncancer resistance protein (BCRP), organic anion\u2011transporting polypeptide\n(OATP)\u00a01B1 and OATP1B3. \u00a0Co\u2011administration of Epclusa with\nmedicinal products that are substrates of these transporters may increase the\nexposure of such medicinal products. \u00a0See Table\u00a03 for examples of\ninteractions with sensitive substrates of P\u2011gp (digoxin), BCRP\n(rosuvastatin), and OATP (pravastatin).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Potential for other medicinal products to affect Epclusa</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP.\u00a0 Velpatasvir\nis also a substrate of drug transporter OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8 and CYP3A4 was\nobserved. \u00a0Medicinal products that are potent inducers of P\u2011gp or potent\ninducers of CYP2B6, CYP2C8, or CYP3A4 (e.g. rifampicin, rifabutin, St.\u00a0John\u2019s\nwort, carbamazepine, phenobarbital and phenytoin) may decrease plasma\nconcentrations of sofosbuvir or velpatasvir leading to reduced therapeutic\neffect of sofosbuvir/velpatasvir.\u00a0 The use of such medicinal products with\nEpclusa is contraindicated (see section\u00a04.3).\u00a0 Medicinal products\nthat are moderate P\u2011gp\u00a0inducers or moderate CYP inducers (e.g.\noxcarbazepine, modafinil or efavirenz) may decrease sofosbuvir or velpatasvir\nplasma concentration leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\nwith such medicinal products is not recommended with Epclusa (see\nsection\u00a04.4).\u00a0 Co\u2011administration with medicinal products that\ninhibit P\u2011gp or BCRP may increase sofosbuvir or velpatasvir plasma\nconcentrations.\u00a0 Medicinal products that inhibit OATP, CYP2B6, CYP2C8, or\nCYP3A4 may increase plasma concentration of velpatasvir. \u00a0Clinically\nsignificant medicinal product interactions with Epclusa mediated by P\u2011gp,\nBCRP, OATP, or CYP450 inhibitors are not expected; Epclusa may be co\u2011administered\nwith P\u2011gp, BCRP, OATP and CYP\u00a0inhibitors.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients treated with vitamin\u00a0K antagonists</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">As liver\nfunction may change during treatment with Epclusa, a close monitoring of\nInternational Normalised Ratio (INR) values is recommended.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Interactions between Epclusa and other medicinal products</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">3 provides a listing of established or\npotentially clinically significant medicinal product interactions (where 90%\nconfidence interval [CI] of the geometric least\u2011squares mean [GLSM] ratio\nwere within \u201c\u2194\u201d, extended above \u201c\u2191\u201d, or\nextended below \u201c\u2193\u201d the predetermined interaction boundaries).\u00a0\nThe medicinal product interactions described are based on studies conducted\nwith either </span><span lang=\"EN-GB\">sofosbuvir/velpatasvir or velpatasvir and\nsofosbuvir as individual agents, or are predicted medicinal product\ninteractions that may occur with sofosbuvir/velpatasvir.\u00a0 The table is not\nall\u2011inclusive.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a03: Interactions between </span></b><b><span lang=\"EN-GB\">Epclusa</span></b><span lang=\"EN-GB\"> <b>and other medicinal products</b></span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:61.0pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:72.55pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:57.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:41.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:65.6pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:83.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:70.95pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:20.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"margin-left:-.45pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:75.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:38.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:58.15pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span></p>\n</td>\n<td colspan=\"5\" style=\"width:72.88%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"72%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:20.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:37.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"5\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"5\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:14.8pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:17.95pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:26.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:\n  avoid !msorm;height:7.25pt !msorm\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;border:solid windowtext 1.0pt !msorm;\n  border-top:none !msorm;padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:91.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:11.75pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:11.75pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:70.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"6\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean\nratio (90%\u00a0CI) of co\u2011administered drug pharmacokinetics of study\nmedicinal products alone or in combination.\u00a0 No effect\u00a0=\u00a01.00.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 All\ninteraction studies conducted in healthy volunteers.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Administered\nas Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Lack\nof pharmacokinetics interaction bounds 70\u2011143%.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">e\u00a0\u00a0\u00a0\u00a0 These\nare medicinal products within class where similar interactions could be\npredicted.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">f\u00a0\u00a0\u00a0\u00a0 Bioequivalence/Equivalence\nboundary 80\u2011125%.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">g\u00a0\u00a0\u00a0 Lack of\npharmacokinetics interaction bounds 50\u2011200%.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no or\nlimited amount of data (less than 300\u00a0pregnancy outcomes) from the use of\nsofosbuvir, velpatasvir or Epclusa in pregnant women.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Sofosbuvir</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies\ndo not indicate direct or indirect harmful effects with respect to reproductive\ntoxicity (see section\u00a05.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It has not been\npossible to fully estimate exposure margins achieved for sofosbuvir in the rat\nrelative to the exposure in humans at the recommended clinical dose (see\nsection\u00a05.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Velpatasvir</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies have\nshown a possible link to reproductive toxicity (see section\u00a05.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As a precautionary measure, Epclusa use is not recommended during\npregnancy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether sofosbuvir, metabolites of sofosbuvir or velpatasvir are excreted in\nhuman milk.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Available\npharmacokinetic data in animals have shown excretion of velpatasvir and\nmetabolites of sofosbuvir in milk.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">A risk to the newborns/infants cannot\nbe excluded.\u00a0 Therefore, </span><span lang=\"EN-GB\">Epclusa<span style=\"layout-grid-mode:line\"> should not be used during breast\u2011feeding.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No human data on\nthe effect of Epclusa on fertility are available.\u00a0 Animal studies do not\nindicate harmful effects of sofosbuvir or velpatasvir on fertility.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If ribavirin is\nco\u2011administered with </span><span lang=\"EN-GB\">Epclusa, refer to the\nSummary of Product Characterisitics for ribavirin for detailed recommendations\nregarding pregnancy, contraception, and breast\u2011feeding.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects\non ability to drive and use machines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa has no\nor negligible influence on the ability to drive and use machines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable\neffects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Summary of the safety\nprofile</span></u></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nsafety assessment of </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> was based on pooled Phase\u00a03 clinical study data from patients\nwith genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection (with or without compensated\ncirrhosis) including 1,035 patients who received Epclusa for 12\u00a0weeks.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The proportion of </span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who permanently discontinued treatment due to\nadverse events was 0.2% and the proportion of patients who experienced any\nsevere adverse events was 3.2% for </span>patients<span style=\"layout-grid-mode:\nline\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> for\n12\u00a0weeks. \u00a0In clinical studies, headache, fatigue and nausea were the\nmost common (incidence \u2265\u00a010%) treatment emergent adverse events\nreported in </span>patients<span style=\"layout-grid-mode:line\"> treated with\n12\u00a0weeks of </span>Epclusa<span style=\"layout-grid-mode:line\">.\u00a0\nThese and other adverse events were reported at a similar frequency in placebo\ntreated patients compared with Epclusa treated patients.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients<span style=\"layout-grid-mode:line\"> with decompensated cirrhosis</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The safety profile of Epclusa has been evaluated\nin one open\u2011label study in which </span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> with CPT Class\u00a0B cirrhosis received </span>Epclusa<span style=\"layout-grid-mode:line\"> for 12\u00a0weeks (n\u00a0=\u00a090), </span>Epclusa\n<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks (n\u00a0=\u00a087)\nor </span>Epclusa<span style=\"layout-grid-mode:line\"> for 24\u00a0weeks (n\u00a0=\u00a090).\n\u00a0The adverse events observed were consistent with expected clinical\nsequelae of decompensated liver disease, or the known toxicity profile of\nribavirin for </span>patients<span style=\"layout-grid-mode:line\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> in combination with ribavirin.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">Among the 87\u00a0</span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who were treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks, decreases in haemoglobin\nto less than 10\u00a0g/dL and 8.5\u00a0g/dL during treatment were experienced\nby 23% and 7%\u00a0</span>patients, respectively.<span style=\"layout-grid-mode:\nline\">\u00a0 Ribavirin was discontinued in 15% of </span>patients<span style=\"layout-grid-mode:line\"> treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks due to adverse events.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Cardiac arrhythmias</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone and/or other medicinal\nproducts that lower heart rate (see sections\u00a04.4 and\u00a04.5).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Skin disorders</span></i></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">Frequency Not known: Stevens-Johnson\nsyndrome</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Reporting\nsuspected adverse reactions after authorisation of the medicinal product is\nimportant.\u00a0 It allows continued monitoring of the benefit/risk balance of\nthe medicinal product.\u00a0 Healthcare professionals are asked to report any\nsuspected adverse reactions via <span style=\"color:black;background:#BFBFBF\">the\nnational reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The highest documented\ndoses of sofosbuvir and velpatasvir were a single dose of 1,200\u00a0mg and a\nsingle dose of 500\u00a0mg, respectively.\u00a0 In these healthy volunteer\nstudies, there were no untoward effects observed at these dose levels, and\nadverse events were similar in frequency and severity to those reported in the\nplacebo groups.\u00a0 The effects of higher doses/exposures are not known.</span></p>\n<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No specific\nantidote is available for overdose with Epclusa. \u00a0If overdose occurs the\npatient must be monitored for evidence of toxicity. \u00a0Treatment of overdose\nwith Epclusa consists of general supportive measures including monitoring of\nvital signs, as well as observation of the clinical status of the patient. \u00a0Haemodialysis\ncan efficiently remove the predominant circulating metabolite of sofosbuvir, GS\u2011331007,\nwith an extraction ratio of 53%.\u00a0 Haemodialysis is unlikely to result in\nsignificant removal of velpatasvir, since velpatasvir is highly bound to plasma\nprotein.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: </span><span lang=\"EN-GB\">Direct acting antiviral</span><span lang=\"EN-GB\">,\nATC code: </span><span lang=\"EN-GB\">J05AP55</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is a\npan\u2011genotypic inhibitor of the HCV NS5B RNA\u2011dependent\nRNA\u00a0polymerase, which is essential for viral replication.\u00a0 Sofosbuvir\nis a nucleotide prodrug that undergoes intracellular metabolism to form the\npharmacologically active uridine analogue triphosphate (GS\u2011461203), which\ncan be incorporated into HCV\u00a0RNA by the NS5B\u00a0polymerase and acts as a\nchain terminator.\u00a0 GS\u2011461203 (the active metabolite of sofosbuvir)\nis neither an inhibitor of human DNA and RNA\u00a0polymerases nor an inhibitor\nof mitochondrial RNA\u00a0polymerase.</span></p>\n<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir is a HCV\ninhibitor targeting the HCV\u00a0NS5A protein, which is essential for both RNA\nreplication and the assembly of HCV virions. \u00a0<i>In\u00a0vitro</i>\nresistance selection and cross-resistance studies indicate velpatasvir targets\nNS5A as its mode of action.</span></p>\n<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Antiviral activity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The 50% effective concentration (EC<sub>50</sub>) values of sofosbuvir\nand velpatasvir against full\u2011length or chimeric replicons encoding NS5B\nand NS5A sequences from the laboratory strains are presented in Table\u00a04. \u00a0The\nEC<sub>50</sub> values of sofosbuvir and velpatasvir against clinical isolates\nare presented in Table\u00a05.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a04: Activity of sofosbuvir and velpatasvir\nagainst full\u2011length or chimeric laboratory replicons</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:23.7pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td style=\"width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean value from multiple\nexperiments of same laboratory replicon.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 Stable chimeric 1b replicons\ncarrying NS5B genes from genotype\u00a02b, 5a or 6a were used for testing.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Data from various strains of\nfull length NS5A replicons or chimeric NS5A replicons carrying full\u2011length\nNS5A genes that contain L31 or M31 polymorphisms.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Data\nfrom a chimeric NS5A replicon carrying NS5A amino acids 9\u2011184.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a05: Activity of sofosbuvir and velpatasvir against\ntransient replicons containing NS5A or NS5B from clinical isolates</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The presence of\n40% human serum had no effect on the anti\u2011HCV activity of sofosbuvir but\nreduced the anti\u2011HCV activity of velpatasvir by 13\u2011fold against\ngenotype\u00a01a HCV replicons.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Evaluation of\nsofosbuvir in combination with velpatasvir showed no antagonistic effect in\nreducing HCV\u00a0RNA levels in replicon cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Resistance</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">In cell culture</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">HCV replicons\nwith reduced susceptibility to sofosbuvir have been selected in cell culture\nfor multiple genotypes including 1b, 2a, 2b, 3a, 4a, 5a and 6a.\u00a0 Reduced\nsusceptibility to sofosbuvir was associated with the primary NS5B substitution\nS282T in all replicon genotypes examined.\u00a0 Site-directed mutagenesis of\nthe S282T substitution in replicons of genotype\u00a01 to 6 conferred 2\u2011\nto 18\u2011fold reduced susceptibility to sofosbuvir and reduced the\nreplication viral capacity by 89% to 99% compared to the corresponding\nwild-type.\u00a0 In biochemical assays, the ability of the active triphosphate\nof sofosbuvir (GS\u2011461203) to inhibit recombinant NS5B polymerase from\ngenotypes\u00a01b, 2a, 3a and 4a expressing the S282T substitution was reduced\ncompared to its ability to inhibit wild-type recombinant NS5B polymerase, as\nindicated by a 8.5\u2011 to 24\u2011fold increase in the 50% inhibitory\nconcentration (IC<sub>50</sub>).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In\u00a0vitro</span></i><span lang=\"EN-GB\"> selection of HCV replicons with reduced susceptibility to\nvelpatasvir was performed in cell culture for multiple genotypes including 1a,\n1b, 2a, 3a, 4a, 5a and 6a.\u00a0 Variants were selected at NS5A resistance\nassociated positions 24, 28, 30, 31, 32, 58, 92 and 93. \u00a0The resistance\nassociated variants (RAVs) selected in 2 or more genotypes were F28S, L31I/V\nand Y93H.\u00a0 Site-directed mutagenesis of known NS5A\u00a0RAVs showed that\nsubstitutions conferring a &gt;\u00a0100\u2011fold reduction in velpatasvir\nsusceptibility are M28G, A92K and Y93H/N/R/W in genotype\u00a01a, A92K in\ngenotype\u00a01b, C92T and Y93H/N in genotype\u00a02b, Y93H in genotype\u00a03,\nand L31V and P32A/L/Q/R in genotype\u00a06.\u00a0 No individual substitutions\ntested in genotypes\u00a02a, 4a, or 5a conferred a &gt;\u00a0100\u2011fold\nreduction in velpatasvir susceptibility. \u00a0Combinations of these variants\noften showed greater reductions in susceptibility to velpatasvir than single\nRAVs alone.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">In clinical studies</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a pooled\nanalysis of patients without cirrhosis or with compensated cirrhosis who\nreceived Epclusa for 12\u00a0weeks in three Phase\u00a03 studies, 12\u00a0patients\n(2 with genotype\u00a01 and 10 with genotype\u00a03) qualified for resistance\nanalysis due to virologic failure.\u00a0 One additional patient with genotype\u00a03\nHCV infection at baseline was reinfected with genotype\u00a01a HCV at virologic\nfailure and was excluded from the virological analysis.\u00a0 No patients with\ngenotype\u00a02, 4, 5, or 6 HCV infection experienced virologic failure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 2\ngenotype\u00a01 virologic failure patients, one patient had virus with emergent\nNS5A\u00a0RAV Y93N and the other patient had virus with emergent NS5A\u00a0RAVs\nL31I/V and Y93H at virologic failure. \u00a0Both patients had virus at baseline\nharboring NS5A\u00a0RAVs.\u00a0 No NS5B nucleoside inhibitor (NI) RAVs were\nobserved at failure in the 2\u00a0patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 10\ngenotype\u00a03 virologic failure patients, Y93H was observed in all 10\u00a0patients\nat failure (6 had Y93H emerge post-treatment and 4\u00a0patients had Y93H at\nbaseline and post-treatment).\u00a0 No NS5B\u00a0NI\u00a0RAVs were observed at\nfailure in the 10\u00a0patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In one Phase\u00a03\nstudy in patients with decompensated cirrhosis who received Epclusa + RBV for\n12\u00a0weeks, 3\u00a0patients (1 with genotype\u00a01 and 2 with\ngenotype\u00a03) qualified for resistance analysis due to virologic\nfailure.\u00a0 No patients with genotype\u00a02 or 4 HCV infection in the Epclusa\n+ RBV 12\u00a0weeks group experienced virologic failure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The 1 virologic\nfailure patient with genotype\u00a01 HCV had no NS5A or NS5B\u00a0RAVs at\nfailure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 2 genotype\u00a03\nvirologic failure patients, one had NS5A\u00a0RAV Y93H emerge at failure.\u00a0\nAnother patient had virus with Y93H at baseline and virologic failure and also\ndeveloped low levels (&lt;\u00a05%) of NS5B\u00a0NI\u00a0RAVs N142T and E237G\nat failure.\u00a0 Pharmacokinetic data from this patient was consistent with\nnon-adherence to treatment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In this study,\n2\u00a0patients treated with Epclusa for 12 or 24\u00a0weeks without ribavirin\nhad emergent NS5B S282T at low levels (&lt;\u00a05%) along with L159F.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Effect of baseline HCV resistance-associated variants on treatment outcome</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients without cirrhosis or with compensated\ncirrhosis in three Phase\u00a03 clinical studies (ASTRAL\u20111, ASTRAL\u20112\nand ASTRAL\u20113).\u00a0 Of the 1,035\u00a0patients treated with\nsofosbuvir/velpatasvir in the three Phase\u00a03 clinical studies, 1,023\u00a0patients\nwere included in the analysis of NS5A\u00a0RAVs; 7\u00a0patients were excluded\nas they neither achieved sustained virologic response (SVR12) nor had virologic\nfailure and 5\u00a0additional patients were excluded as NS5A gene sequencing\nfailed.\u00a0 In the pooled analysis of the Phase\u00a03 studies, 380/1,023\n(37%) patients\u2019 virus had baseline NS5A\u00a0RAVs.\u00a0 Genotype\u00a02,\n4, and 6 HCV\u2011infected patients had a higher prevalence of NS5A\u00a0RAVs\n(70%, 63% and 52%, respectively) compared to genotype\u00a01 (23%), genotype\u00a03\n(16%), and genotype\u00a05 (18%) HCV\u2011infected patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Baseline RAVs\nhad no relevant impact on SVR12 rates in patients infected with genotype\u00a01,\n2, 4, 5 and 6 HCV, as summarised in Table\u00a06. \u00a0Genotype\u00a03\ninfected patients with the NS5A RAV Y93H at baseline had a lower SVR12 rate\nthan patients without Y93H after treatment with Epclusa for </span><span lang=\"EN-GB\">12\u00a0weeks</span><span lang=\"EN-GB\">, as summarised in Table\u00a07.\n\u00a0In the ASTRAL\u20113 study, the Y93H RAV was detected at baseline in 9%\nof patients treated with Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a06: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (studies ASTRAL\u20111, ASTRAL\u20112 and\nASTRAL\u20113)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a07: SVR12 in patients with and without baseline Y93H, 1%\nCut-off (Resistance Analysis Population Set) ASTRAL 3</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:455.7pt;border-collapse:collapse;border:none\" width=\"608\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" rowspan=\"2\" style=\"width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" valign=\"bottom\" width=\"192\"></td>\n<td colspan=\"3\" nowrap=\"\" style=\"width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"415\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:30.65pt\">\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The NS5B NI RAV\nS282T was not detected in the baseline NS5B sequence of any patient in Phase\u00a03\nstudies.\u00a0 SVR12 was achieved in all 77\u00a0patients who had baseline NS5B\u00a0NI\u00a0RAVs\nincluding N142T, L159F, E/N237G, C/M289L/I, L320F/I/V, V321A/I, and\nS282G+V321I.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis (CPT Class\u00a0B)</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients with decompensated cirrhosis in one Phase\u00a03\nstudy (ASTRAL\u20114).\u00a0 Of the 87\u00a0patients treated with Epclusa + RBV,\n85\u00a0patients were included in the analysis of NS5A\u00a0RAVs; 2\u00a0patients\nwere excluded as they neither achieved SVR12 nor had virologic failure.\u00a0\nAmong the patients who received treatment with Epclusa + RBV for 12\u00a0weeks,\n29% (25/85) of patients had baseline virus with NS5A\u00a0RAVs: 29% (19/66),\n75% (3/4), 15% (2/13), and 50% (1/2) for patients with genotype\u00a01, 2, 3\nand 4 HCV, respectively.</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\">SVR12 in patients with or without baseline NS5A\u00a0RAVs in the Epclusa\n+ RBV 12\u00a0week group for this study is shown in Table\u00a08.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a08: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (study ASTRAL\u20114)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The single\ngenotype\u00a03 patient who had baseline NS5A\u00a0RAVs and failed to achieve\nSVR12 had NS5A substitution Y93H at baseline; pharmacokinetic data from this\npatient was consistent with non\u2011adherence to treatment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Three patients\nin the Epclusa + RBV 12\u00a0week group had baseline NS5B\u00a0NI\u00a0RAVs\n(N142T and L159F) and all three patients achieved SVR12.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cross\u2011resistance</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In\u00a0vitro</span></i><span lang=\"EN-GB\"> data suggests that the majority of NS5A\u00a0RAVs that confer\nresistance to ledipasvir and daclatasvir remained susceptible to\nvelpatasvir.\u00a0 Velpatasvir was fully active against the sofosbuvir\nresistance-associated substitution S282T in NS5B while all velpatasvir resistance-associated\nsubstitutions in NS5A were fully susceptible to sofosbuvir.\u00a0 Both\nsofosbuvir and velpatasvir were fully active against substitutions associated\nwith resistance to other classes of direct-acting antivirals with different\nmechanisms of actions, such as NS5B non\u2011nucleoside inhibitors and NS3\nprotease inhibitors.\u00a0 The efficacy of Epclusa has not been assessed in\npatients who have previously failed treatment with other regimens that include\nan NS5A inhibitor.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nefficacy of </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> was evaluated in three\nPhase\u00a03 studies in patients with genotype\u00a01 to 6 HCV infection with\nor without compensated cirrhosis, one Phase\u00a03 study in patients with\ngenotype\u00a01 to 6 HCV infection with decompensated cirrhosis, and one\nPhase\u00a03 study in HCV/HIV\u20111 co-infected patients with genotype\u00a01\nto 6 HCV infection, as summarised in Table\u00a09.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a09: Studies conducted with Epclusa in patients with genotype\u00a01,\n2, 3, 4, 5 or 6 HCV infection</span></b></p>\n<div align=\"center\">\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:25.45pt\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>\n<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>\n<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>\n</td>\n</tr>\n</table>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">TN\u00a0=\u00a0treatment-na\u00efve patients; TE\u00a0=\u00a0treatment-experienced\npatients (including those who have failed a peginterferon alfa + ribavirin\nbased regimen with or without an HCV protease inhibitor)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The ribavirin dose\nwas weight-based (1,000\u00a0mg daily administered in two divided doses for\npatients &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those \u2265\u00a075\u00a0kg)\nand administered in two divided doses when used in combination with sofosbuvir\nin the ASTRAL\u20112 and ASTRAL\u20113 studies or in combination with Epclusa\nin the ASTRAL\u20114 study. \u00a0Ribavirin dose adjustments were performed\naccording to the ribavirin prescribing information.\u00a0 Serum HCV\u00a0RNA\nvalues were measured during the clinical studies using the COBAS\nAmpliPrep/COBAS Taqman HCV test (version\u00a02.0) with a lower limit of\nquantification (LLOQ) of 15\u00a0IU/mL. \u00a0Sustained virologic response\n(SVR12), defined as HCV\u00a0RNA less than LLOQ at 12\u00a0weeks after the\ncessation of treatment, was the primary endpoint to determine the HCV cure\nrate.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a01, 2, 4, 5 and 6 HCV\u2011infected adults <b>\u2013</b>\nASTRAL\u20111 (study\u00a01138)</span></i></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20111\nwas a randomised, double-blind, placebo-controlled study that evaluated\n12\u00a0weeks of treatment with </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">compared with 12\u00a0weeks of placebo in patients with\ngenotype\u00a01, 2, 4, 5, or 6 HCV infection.\u00a0 Patients with genotype\u00a01,\n2, 4 or 6 HCV infection were randomised in a 5:1 ratio to treatment with </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks or\nplacebo for 12\u00a0weeks. \u00a0Patients with genotype\u00a05 HCV infection\nwere enrolled to the </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">group.\u00a0 Randomisation was stratified by HCV genotype (1,\n2, 4, 6, and indeterminate) and the presence or absence of cirrhosis.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced between the Epclusa and placebo\ngroup. \u00a0Of the 740\u00a0treated patients, the median age was 56\u00a0years\n(range: 18 to 82); 60% of the patients were male; 79% were White, 9% were\nBlack; 21% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\nthe proportions of patients with genotype\u00a01, 2, 4, 5, or 6 HCV infection\nwere 53%, 17%, 19%, 5% and 7%, respectively; 69% had non\u2011CC IL28B alleles\n(CT or TT); 74% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL;\n19% had compensated cirrhosis; and 32% were treatment-experienced.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Table\u00a010\npresents the SVR12 for the ASTRAL\u20111 study by HCV genotypes. \u00a0No\npatients in the placebo group achieved SVR12.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a010: SVR12 in study ASTRAL\u20111 by HCV genotype</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"631\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:27.0pt\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"8\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td rowspan=\"2\" style=\"width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"211\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td style=\"width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td colspan=\"9\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:50.25pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.5pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:white\">GT\u00a0=\u00a0genotype</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a02 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20112\n(study\u00a01139)</span></i></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20112\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 12\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a02 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n12\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00ef</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ve <i>versus</i> treatment\u2011experienced).</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced across the two treatment\ngroups.\u00a0 Of the 266 treated patients, the median age was 58\u00a0years\n(range: 23 to 81); 59% of the patients were male; 88% were White, 7% were\nBlack; 33% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n62% had non\u2011CC IL28B alleles (CT or TT); 80% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL; 14% had compensated cirrhosis and 15%\nwere treatment-experienced.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a011 presents\nthe SVR12 for the ASTRAL\u20112 study.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a011: SVR12 in study ASTRAL\u20112 (HCV genotype\u00a02)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment\nwith </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks\ndemonstrated the statistical superiority (p\u00a0=\u00a00.018) over treatment\nwith SOF+RBV for 12\u00a0weeks (treatment difference +5.2%; 95% confidence\ninterval: +0.2% to +10.3%).</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a03 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20113\n(study\u00a01140)</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20113\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 24\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a03 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n24\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na\u00efve <i>versus</i>\ntreatment\u2011experienced).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the two treatment groups.\u00a0\nOf the 552 treated patients, the median age was 52\u00a0years (range: 19 to\n76); 62% of the patients were male; 89% were White, 9% were Asian; 1% were\nBlack; 20% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n61% had non\u2011CC IL28B alleles (CT or TT); 70% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL, 30% had compensated cirrhosis and 26%\nwere treatment-experienced.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a012\npresents the SVR12 for the ASTRAL\u20113 study.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a012: SVR12 in study ASTRAL\u20113 (HCV genotype\u00a03)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment with Epclusa\nfor 12\u00a0weeks demonstrated the statistical superiority (p\u00a0&lt;\u00a00.001)\ncompared to treatment with SOF+RBV for 24\u00a0weeks (treatment difference +14.8%;\n95% confidence interval: +9.6% to +20.0%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SVR12 for\nselected subgroups are presented in Table\u00a013.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a013: SVR12 for selected subgroups in study ASTRAL\u20113\n(HCV genotype\u00a03)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 Five\npatients with missing cirrhosis status in the SOF+RBV 24\u00a0week group were\nexcluded from this subgroup analysis.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients with decompensated cirrhosis <b>\u2013</b>\nASTRAL\u20114 (study\u00a01137)</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20114\nwas a randomised, open-label study in patients with genotype\u00a01, 2, 3, 4, 5\nor 6 HCV infection and CPT Class\u00a0B cirrhosis.\u00a0 Patients were randomised\nin a 1:1:1 ratio to treatment with Epclusa for 12\u00a0weeks, Epclusa + RBV for\n12\u00a0weeks or Epclusa for 24\u00a0weeks.\u00a0 Randomisation was stratified\nby HCV genotype (1, 2, 3, 4, 5, 6 and indeterminate).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the treatment groups.\u00a0 Of\nthe 267 treated patients, the median age was 59\u00a0years (range: 40 to 73);\n70% of the patients were male; 90% were White, 6% were Black; 42% had a\nbaseline body mass index of at least 30\u00a0kg/m<sup>2</sup>.\u00a0 The\nproportions of patients with genotype\u00a01, 2, 3, 4 or 6 HCV were 78%, 4%,\n15%, 3%, and &lt;\u00a01% (1\u00a0patient), respectively.\u00a0 No patients\nwith genotype\u00a05 HCV infection were enrolled.\u00a0 76% of the patients had\nnon\u2011CC IL28B alleles (CT or TT); 56% had baseline HCV\u00a0RNA levels of at\nleast 800,000\u00a0IU/mL, 55% were treatment-experienced; 90% and 95% of\npatients had CPT Class\u00a0B cirrhosis and Model for End Stage Liver Disease\n(MELD) score \u2264\u00a015 at baseline, respectively.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a014 presents\nthe SVR12 for the ASTRAL\u20114 study by HCV genotype.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a014: SVR12 in study ASTRAL\u20114 by HCV genotype</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"621\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a04 for genotype\u00a04.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a02 for genotype\u00a04.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02, n\u00a0=\u00a02 for genotype\u00a04 and n\u00a0=\u00a01\nfor genotype\u00a06.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a015\npresents the virologic outcome for patients with genotype\u00a01 or 3 HCV\ninfection in the ASTRAL\u20114 study.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No patients with\ngenotype\u00a02, 4 or 6 HCV infection experienced virologic failure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a015: Virologic outcome for patients with genotype\u00a01 and\n3 HCV infection in study ASTRAL\u20114</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:466.1pt;border-collapse:collapse;border:none\" width=\"621\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"4\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 No\npatients with genotype\u00a01 HCV had on-treatment virologic failure.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure; pharmacokinetic data from this\npatient was consistent with non-adherence to treatment.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">c\u00a0\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">d\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Changes in the\nparameters found in the CPT score system in patients achieving SVR12 in ASTRAL\u20114\n(all 3 regimens) are shown in Table\u00a016.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a016: Changes in CPT score parameters from baseline to week\u00a012\nand 24 post\u2011treatment in patients achieving SVR12, ASTRAL\u20114</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>\n</td>\n<td style=\"width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;\n  border-left:solid windowtext 1.0pt;border-bottom:solid black 1.0pt;\n  border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:\n  solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">Note:\u00a0\u00a0\u00a0 Baseline\nfrequency of ascites was: 20% none, 77% mild/moderate, 3% severe</span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Baseline\nfrequency of encephalopathy was: 38% none, 62% grade\u00a01\u20112.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients with HCV/HIV\u20111 Co-infection <b>\u2013</b>\nASTRAL\u20115 (study\u00a01202)</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20115\nevaluated 12\u00a0weeks of treatment with Epclusa in patients with genotype\u00a01,\n2, 3, or 4 HCV infection who were co-infected with HIV\u20111 (HCV genotype\u00a05\nand 6 allowed, but no such patients were included).\u00a0 Patients were on a\nstable HIV\u20111 antiretroviral therapy that included emtricitabine/tenofovir\ndisoproxil fumarate or abacavir/lamivudine administered with a ritonavir boosted\nprotease inhibitor (atazanavir, darunavir, or lopinavir), rilpivirine,\nraltegravir or emtricitabine/tenofovir disoproxil fumarate /elvitegravir/cobicistat.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 106\ntreated patients, the median age was 57\u00a0years (range: 25 to 72); 86% of\nthe patients were male; 51% were white; 45% were black; 22% had a baseline body\nmass index \u2265\u00a030\u00a0kg/m<sup>2</sup>; 19 patients (18%) had\ncompensated cirrhosis; and 29% were treatment experienced.\u00a0 The overall\nmean CD4+ count was 598\u00a0cells/\u00b5L (range: 183\u22121513\u00a0cells/\u00b5L).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a017\npresents the SVR12 for the ASTRAL\u20115 study by HCV genotype.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a017: SVR12 in study ASTRAL\u20115 by HCV genotype</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"631\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"7\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"246\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"8\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n</table>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">GT\u00a0=\u00a0genotype</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA\n&lt;\u00a0LLOQ at their last on-treatment assessment.</span></p>\n<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SVR12 was achieved\nby 19/19 patients with cirrhosis. \u00a0No patient had HIV\u20111 rebound\nduring the study, and CD4+ counts were stable during treatment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Epclusa in one or more subsets of the paediatric population in the\ntreatment of chronic hepatitis\u00a0C (see section\u00a04.2 for information on\npaediatric use).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clinical studies\nof Epclusa included 156\u00a0patients aged\u00a065 and over (12% of total number\nof patients in the Phase\u00a03 clinical studies).\u00a0 The response rates\nobserved for patients \u2265\u00a065\u00a0years of age were similar to that of\npatients &lt;\u00a065\u00a0years of age, across treatment groups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetic properties of sofosbuvir, GS\u2011331007 and velpatasvir have\nbeen evaluated in healthy adult subjects and in patients with chronic\nhepatitis\u00a0C.\u00a0 Following oral administration of Epclusa, sofosbuvir\nwas absorbed quickly and the peak median plasma concentration was observed\n1\u00a0hour post\u2011dose.\u00a0 Median peak plasma concentration of GS\u2011331007\nwas observed 3\u00a0hours post\u2011dose.\u00a0 Velpatasvir median peak\nconcentrations were observed at 3\u00a0hours post\u2011dose.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the\npopulation pharmacokinetic analysis in HCV\u2011infected patients, mean steady\u2011state\nAUC<sub>0\u201124</sub> for sofosbuvir (n\u00a0=\u00a0982), GS\u2011331007 (n\u00a0=\u00a01,428)\nand velpatasvir (n\u00a0=\u00a01,425) were 1,260, 13,970 and 2,970\u00a0ng\u2022h/mL,\nrespectively.\u00a0 Steady-state C<sub>max</sub> for sofosbuvir, GS\u2011331007\nand velpatasvir were 566, 868 and 259\u00a0ng/mL, respectively.\u00a0\nSofosbuvir and GS\u2011331007 AUC<sub>0\u201124</sub> and C<sub>max</sub>\nwere similar in healthy adult subjects and patients with HCV infection.\u00a0\nRelative to healthy subjects (n\u00a0=\u00a0331), velpatasvir AUC<sub>0\u201124</sub>\nand C<sub>max</sub> were 37% lower and 41% lower, respectively in HCV\u2011infected\npatients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Effects of food</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Relative to\nfasting conditions, the administration of a single dose of Epclusa with a\nmoderate fat (~600\u00a0kcal, 30% fat) or high fat (~800\u00a0kcal, 50% fat)\nmeal resulted in a 34% and 21% increase in velpatasvir AUC<sub>0\u2011inf</sub>,\nrespectively, and a 31% and 5% increase in velpatasvir C<sub>max</sub>, respectively.\u00a0\nThe moderate or high fat meal increased sofosbuvir AUC<sub>0\u2011inf</sub> by\n60% and 78%, respectively, but did not substantially affect the sofosbuvir C<sub>max</sub>.\n\u00a0The moderate or high fat meal did not alter GS\u2011331007 AUC<sub>0\u2011inf</sub>,\nbut resulted in a 25% and 37% decrease in its C<sub>max</sub>, respectively. \u00a0The\nresponse rates in Phase\u00a03 studies were similar in HCV\u2011infected patients\nwho received Epclusa with food or without food. \u00a0Epclusa can be\nadministered without regard to food.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is\napproximately 61\u201165% bound to human plasma proteins and the binding is\nindependent of drug concentration over the range of 1\u00a0\u00b5g/mL to\n20\u00a0\u00b5g/mL.\u00a0 Protein binding of GS\u2011331007 was minimal in\nhuman plasma.\u00a0 After a single 400\u00a0mg dose of [<sup>14</sup>C]\u2011sofosbuvir\nin healthy subjects, the blood to plasma ratio of [<sup>14</sup>C]\u2011radioactivity\nwas approximately 0.7.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nis &gt;\u00a099.5% bound to human plasma proteins and binding is independent of\ndrug concentration over the range of 0.09</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">to 1.8</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. \u00a0After a single 100\u00a0mg\ndose of [<sup>14</sup>C]\u2011velpatasvir in healthy subjects, the blood to\nplasma ratio of [<sup>14</sup>C]\u2011radioactivity ranged between 0.52 and\n0.67.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is\nextensively metabolised in the liver to form the pharmacologically active\nnucleoside analog triphosphate GS\u2011461203. \u00a0The metabolic activation\npathway involves sequential hydrolysis of the carboxyl ester moiety catalysed\nby human cathepsin\u00a0A (CatA) or carboxylesterase\u00a01 (CES1) and\nphosphoramidate cleavage by histidine triad nucleotide-binding protein\u00a01\n(HINT1) followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.\u00a0\nDephosphorylation results in the formation of nucleoside metabolite GS\u2011331007\nthat cannot be efficiently rephosphorylated and lacks anti-HCV activity <i>in\u00a0vitro.</i>\n\u00a0Sofosbuvir and GS\u2011331007 are not substrates or inhibitors of UGT1A1\nor CYP3A4, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 enzymes.\u00a0 After\na single 400\u00a0mg oral dose of [<sup>14</sup>C]-sofosbuvir, GS\u2011331007\naccounted for approximately &gt;\u00a090% of total systemic exposure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir is a\nsubstrate of CYP2B6, CYP2C8, and CYP3A4 with slow turnover. \u00a0Following a\nsingle dose of 100\u00a0mg [<sup>14</sup>C]\u2011velpatasvir, the majority\n(&gt;\u00a098%) of radioactivity in plasma was parent drug.\u00a0 The\nmonohydroxylated and desmethylated velpatasvir were the metabolites identified\nin human plasma.\u00a0 Unchanged velpatasvir is the major species present in\nfaeces.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following a\nsingle 400\u00a0mg oral dose of [<sup>14</sup>C]\u2011sofosbuvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was greater than 92%,\nconsisting of approximately 80%, 14%, and 2.5% recovered in urine, faeces, and\nexpired air, respectively.\u00a0 The majority of the sofosbuvir dose recovered\nin urine was GS\u2011331007 (78%) while 3.5% was recovered as\nsofosbuvir.\u00a0 These data indicate that renal clearance is the major\nelimination pathway for GS\u2011331007.\u00a0 The median terminal half\u2011lives\nof sofosbuvir and GS\u2011331007 following administration of Epclusa were 0.5\nand 25\u00a0hours, respectively.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following a\nsingle 100\u00a0mg oral dose of [<sup>14</sup>C]\u2011velpatasvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was 95%, consisting of\napproximately 94% and 0.4% recovered from the faeces and urine,\nrespectively.\u00a0 Unchanged velpatasvir was the major species in faeces\naccounting for a mean of 77% of the administered dose, followed by\nmonohydroxylated velpatasvir (5.9%) and desmethylated velpatasvir (3.0%).\u00a0\nThese data indicate that biliary excretion of parent drug was a major route of\nelimination for velpatasvir. \u00a0The median terminal half-life of velpatasvir\nfollowing administration of Epclusa was approximately 15\u00a0hours.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non-linearity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir AUC\nincreases in a nearly dose proportional manner over the dose range of\n25\u00a0mg to 150\u00a0mg.\u00a0 Sofosbuvir and GS\u2011331007 AUCs are near\ndose\u2011proportional over the dose range of 200\u00a0mg to 1,200\u00a0mg.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">In\u00a0vitro</span></u></i><u><span lang=\"EN-GB\"> potential for\nsofosbuvir/velpatasvir drug-drug interactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP while GS\u2011331007\nis not.\u00a0 Velpatasvir is also a substrate of OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8, and CYP3A4 was\nobserved.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir is\nan inhibitor of drug transporter P\u2011gp, BCRP, OATP1B1 and OATP1B3 and its\ninvolvement in drug interactions with these transporters is primarily limited\nto the process of absorption.\u00a0 At clinically relevant plasma concentration,\nvelpatasvir is not an inhibitor of hepatic transporters bile salt export pump\n(BSEP), sodium taurocholate cotransporter protein (NTCP), OATP2B1, OATP1A2 or organic\ncation transporter (OCT)\u00a01, renal transporters OCT2, OAT1, OAT3, multidrug\nresistance-associated protein\u00a02 (MRP2) or multidrug and toxin extrusion\nprotein (MATE)\u00a01, or CYP or uridine glucuronosyltransferase (UGT)\u00a01A1\nenzymes.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nGS\u2011331007 are not inhibitors of drug transporters P\u2011gp, BCRP, MRP2,\nBSEP, OATP1B1, OATP1B3 and OCT1. \u00a0GS\u2011331007 is not an inhibitor of\nOAT1, OCT2, and MATE1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pharmacokinetics in special populations</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Race and gender</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No clinically\nrelevant pharmacokinetic differences due to race or gender have been identified\nfor sofosbuvir, GS\u2011331007 or velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Population\npharmacokinetic analysis in HCV\u2011infected patients showed that within the\nage range (18 to 82\u00a0years) analysed, age did not have a clinically\nrelevant effect on the exposure to sofosbuvir, GS\u2011331007, or velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied in HCV negative patients with mild\n(eGFR \u2265\u00a050 and &lt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nmoderate (eGFR \u2265\u00a030 and &lt;\u00a050\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nsevere renal impairment (eGFR &lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nand patients with ESRD requiring haemodialysis following a single 400\u00a0mg\ndose of sofosbuvir.\u00a0 Relative to patients with normal renal function (eGFR\n&gt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>), the sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 61%, 107% and 171% higher in mild, moderate and severe renal impairment,\nwhile the GS\u2011331007 AUC<sub>0\u2011inf</sub> was 55%, 88% and 451%\nhigher, respectively.\u00a0 In patients with ESRD, sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 28% higher when sofosbuvir was dosed 1\u00a0hour before haemodialysis\ncompared with 60% higher when dosed 1\u00a0hour after haemodialysis,\nrespectively.\u00a0 The AUC<sub>0\u2011inf</sub> of GS\u2011331007 in\npatients with ESRD administered with sofosbuvir 1\u00a0hour before or\n1\u00a0hour after haemodialysis was at least 10\u2011fold and 20\u2011fold\nhigher, respectively.\u00a0 GS\u2011331007 is efficiently removed by haemodialysis\nwith an extraction coefficient of approximately 53%.\u00a0 Following a single\n400\u00a0mg dose of sofosbuvir, a 4\u00a0hour haemodialysis removed 18% of\nadministered dose (see section\u00a04.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with severe renal impairment (eGFR\n&lt;\u00a030\u00a0mL/min by Cockcroft-Gault).\u00a0 Relative to subjects with\nnormal renal function, velpatasvir AUC<sub>inf</sub> was 50% higher in subjects\nwith severe renal impairment (see section\u00a04.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied following 7\u2011day dosing of\n400\u00a0mg sofosbuvir in HCV\u2011infected patients with moderate and severe\nhepatic impairment (CPT Class\u00a0B and C).\u00a0 Relative to patients with\nnormal hepatic function, the sofosbuvir AUC<sub>0\u201124</sub> was 126% and\n143% higher in moderate and severe hepatic impairment, while the GS\u2011331007\nAUC<sub>0\u201124</sub> was 18% and 9% higher, respectively.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to sofosbuvir and GS\u2011331007.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with moderate and severe hepatic\nimpairment (CPT Class\u00a0B and C).\u00a0 Compared to subjects with normal\nhepatic function velpatasvir total plasma exposure (AUC<sub>inf</sub>) was\nsimilar in patients with moderate or severe hepatic impairment.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to velpatasvir (see section\u00a04.2). </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Body weight</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Body weight did\nnot have a clinically significant effect on sofosbuvir or velpatasvir exposure\naccording to a population pharmacokinetic analysis.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The pharmacokinetics of sofosbuvir, GS\u2011331007 and velpatasvir\nin paediatric patients have not been established </span><span lang=\"EN-GB\">(see\nsection\u00a04.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical\nsafety data</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Sofosbuvir</span></u></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Exposure\nto sofosbuvir in rodent studies could not be detected likely due to high\nesterase activity and exposure to the major metabolite GS\u2011331007 was\ninstead used to estimate exposure margins.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> mouse micronucleus\nassays.\u00a0 No teratogenic effects were observed in the rat and rabbit\ndevelopmental toxicity studies with sofosbuvir.\u00a0 Sofosbuvir had no adverse\neffects on behaviour, reproduction, or development of the offspring in the rat pre\u2011\nand post\u2011natal development study.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not a carcinogen in the 2\u2011year mouse and rat carcinogenicity studies\nat GS\u2011331007 exposures up to 15 and 9\u00a0times, respectively, higher\nthan human exposure.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Velpatasvir</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir was\nnot genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> rat micronucleus assays.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nwas not carcinogenic in the 6\u2011month rasH2 transgenic mouse and 2\u2011year\nrat carcinogenicity studies at exposures at least 50-times and 5-times higher\nthan human exposure, respectively.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir had\nno adverse effects on mating and fertility.\u00a0 </span><span lang=\"EN-GB\">No\nteratogenic effects were observed in the mouse and rat developmental toxicity\nstudies with velpatasvir at AUC exposures approximately 31\u2011 and 6\u2011fold\nhigher, respectively, than the human exposure at the recommended clinical\ndose.\u00a0 However, a possible teratogenic effect was indicated in rabbits\nwhere an increase in total visceral malformations was seen in exposed animals\nat AUC exposures up to 0.7 fold the human exposure at recommended clinical\ndose.\u00a0 The human relevance of this finding is not known.</span><span lang=\"EN-GB\">\u00a0 Velpatasvir had no adverse effects on behaviour,\nreproduction, or development of the offspring in the rat pre\u2011 and post\u2011natal\ndevelopment study at AUC exposures approximately 5\u2011fold higher than the\nhuman exposure at the recommended clinical dose.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List\nof excipients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Tablet core</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Copovidone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Croscarmellose sodium</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Magnesium\nstearate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Film\u2011coating</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polyvinyl alcohol</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Titanium dioxide</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polyethylene glycol</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talc</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide red</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf\nlife</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4\u00a0years.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for storage</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa tablets\nare supplied in high density polyethylene (HDPE) bottle with a polypropylene\nchild\u2011resistant closure containing 28\u00a0film\u2011coated tablets with\npolyester coil.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The following\npack sizes are available: outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal</span></b></a></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1116/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE\nOF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of first authorisation:\n06 July 2016</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE\nOF REVISION OF THE TEXT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency http://www.ema.europa.eu.</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-right:-.1pt;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE\nFOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"TitleB\"><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Name and address of the manufacturer responsible for\nbatch release</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">IDA Business &amp; Technology Park</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Carrigtohill</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">County Cork</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">IRELAND</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex\u00a0I: Summary\nof Product Characteristics, section\u00a04.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The requirements\nfor submission of periodic safety update reports for this medicinal product are\nset out in the list of Union reference dates (EURD list) provided for under\nArticle\u00a0107c(7) of Directive\u00a02001/83/EC and any subsequent updates\npublished on the European medicines web-portal.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder shall submit the first periodic safety update report for\nthis product within 6\u00a0months following authorisation.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\"><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The MAH shall\nperform the required pharmacovigilance activities and interventions detailed in\nthe agreed RMP presented in Module\u00a01.8.2 of the marketing authorisation\nand any agreed subsequent updates of the RMP.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post-authorisation\nmeasures</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.0%;border-collapse:collapse;border:none\" width=\"98%\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span></p>\n</td>\n<td style=\"width:16.38%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Q2 2021</span></p>\n</td>\n</tr>\n</table>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE\nPACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BOTTLE AND CARTON LABELLING</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Epclusa 400\u00a0mg/100\u00a0mg film\u2011coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">sofosbuvir/</span><span lang=\"EN-GB\">velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg </span><span lang=\"EN-GB\">velpatasvir</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">28\u00a0film\u2011coated\ntablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1116/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa <span style=\"color:black;background:#BFBFBF\">[Outer packaging only]</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">2D barcode carrying the unique\nidentifier included.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">PC: </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">SN: </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN: </span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the user</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Epclusa</span></b><b><span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated\ntablets</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">sofosbuvir/velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"><img border=\"0\" height=\"17\" id=\"Picture 2\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicine\nis subject to additional monitoring.\u00a0 This will allow quick identification\nof new safety information.\u00a0 You can help by reporting any side effects you\nmay get.\u00a0 See the end of section\u00a04 for how to report side effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains important information for you.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Keep this\nleaflet.\u00a0 You may need to read it again.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you\nhave any further questions, ask your doctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only.\u00a0 Do not pass it on to\nothers.\u00a0 It may harm them, even if their signs of illness are the same as\nyours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you get\nany side effects talk to your doctor or pharmacist.\u00a0 This includes any\npossible side effects not listed in this leaflet.\u00a0 See section\u00a04.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Epclusa is\nand what it is used for</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Epclusa</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Epclusa</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Epclusa</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nEpclusa is and what it is used for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">is a medicine that contains the active substances sofosbuvir and\nvelpatasvir in a single tablet.\u00a0 It is given to treat a chronic\n(long-term) viral infection of the liver called hepatitis\u00a0C in adults of\n18\u00a0years and older.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The active\nsubstances in this medicine work together by blocking two different proteins\nthat the virus needs to grow and reproduce itself, allowing the infection to be\npermanently eliminated from the body.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">is sometimes taken with another medicine, ribavirin.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is very\nimportant that you also read the leaflets for the other medicines that you will\nbe taking with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.\u00a0\nIf you have any questions about your medicines, please ask your doctor or\npharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nyou need to know before you take Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not take Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK2\"></a><a name=\"OLE_LINK3\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you are allergic</span></b><span lang=\"EN-GB\"> to sofosbuvir, velpatasvir or any of the other ingredients of this\nmedicine (listed in section\u00a06 of this leaflet).</span></a></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span><span lang=\"EN-GB\"> </span></b><span lang=\"EN-GB\">If this applies to you, <b>do not take Epclusa\nand tell your doctor immediately.</b></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you are currently taking any of the\nfollowing medicines:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rifampicin</span></b><span lang=\"EN-GB\"> and <b>rifabutin</b>\n(antibiotics used to treat infections, including tuberculosis);</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">St.\u00a0John\u2019s wort</span></b><span lang=\"EN-GB\"> (<i>Hypericum perforatum</i> \u2013 herbal medicine used to treat\ndepression);</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">carbamazepine, phenobarbital</span></b><span lang=\"EN-GB\"> and <b>phenytoin</b> (medicines used to treat epilepsy and prevent\nseizures);</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor if you:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">have liver problems</span></b><span lang=\"EN-GB\"> other than from hepatitis\u00a0C, for instance</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">if you have</span></b><span lang=\"EN-GB\"> a\ncurrent or previous infection with the <b>hepatitis\u00a0B</b> virus</span><span lang=\"EN-GB\">, since your doctor may want to monitor you more closely;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">if you have had a liver transplant</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">have kidney problems,</span></b><span lang=\"EN-GB\"> since </span><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">has\nnot been fully tested in patients with some severe kidney problems;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">are taking treatment for human\nimmunodeficiency virus (HIV) infection,</span></b><span lang=\"EN-GB\"> since your\ndoctor may want to monitor you more closely.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor or pharmacist before taking </span><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">if:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you currently take, or have taken in the last\nfew months, the medicine amiodarone to treat irregular heartbeats (your doctor\nmay consider alternative treatments if you have taken this medicine).</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have diabetes. You may need closer\nmonitoring of your blood glucose levels and/or adjustment of your diabetes\nmedication after starting Epclusa. Some diabetic patients have experienced low\nsugar levels in the blood (hypoglycaemia) after starting treatment with\nmedicines like Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor immediately</span></b><span lang=\"EN-GB\"> if you are\ntaking any medicines for heart problems and during treatment you experience:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">shortness of breath</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">light-headedness</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">palpitations</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">fainting</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood tests</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Your doctor will test your blood before, during and after your\ntreatment with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.\u00a0\nThis is so that:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor can decide if you should take Epclusa\nand for how long;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor can confirm that your treatment has\nworked and you are free of the hepatitis\u00a0C virus.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not give this\nmedicine to children and adolescents under 18\u00a0years of age.\u00a0 The use\nof Epclusa in children and adolescents has not yet been studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Tell your\ndoctor or pharmacist</span></b><span lang=\"EN-GB\"> if you are taking, have\nrecently taken or might take any other medicines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Warfarin and\nother similar medicines called vitamin\u00a0K antagonists used to thin the\nblood.\u00a0 Your doctor may need to increase the frequency of your blood tests\nto check how well your blood can clot.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are not sure\ntalk to your doctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Some medicines should not be taken with Epclusa.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Do not take any other medicine that contains\nsofosbuvir, one of the active substances in Epclusa.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or pharmacist</span></b><span lang=\"EN-GB\"> if you\nare taking any of the medicines below:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">amiodarone</span></b><span lang=\"EN-GB\"> used\nto treat irregular heartbeats;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rifapentine</span></b><span lang=\"EN-GB\">\n(antibiotic used to treat infections, including tuberculosis);</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">oxcarbazepine</span></b><span lang=\"EN-GB\">\n(medicine used to treat epilepsy and prevent seizures)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">tenofovir disoproxil fumarate</span></b><span lang=\"EN-GB\"> or any medicine containing tenofovir disoproxil fumarate, used to\ntreat HIV infection;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">efavirenz</span></b><span lang=\"EN-GB\"> used to\ntreat HIV infection;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">digoxin</span></b><span lang=\"EN-GB\"> used to\ntreat heart conditions;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">dabigatran</span></b><span lang=\"EN-GB\"> used\nto thin the blood;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">modafinil</span></b><span lang=\"EN-GB\"> used to\ntreat sleep disorders;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rosuvastatin</span></b><span lang=\"EN-GB\"> or <b>other\nstatins</b> used to treat high cholesterol.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Taking Epclusa with\nany of these may stop your medicines from working properly, or make any side\neffects worse.\u00a0 Your doctor may need to give you a different medicine or\nadjust the dose of medicine you are taking.\u00a0 This change could be to\nEpclusa or another medicine you are taking.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Get advice from a doctor or pharmacist</span></b><span lang=\"EN-GB\"> if you take medicines used to treat <b>stomach ulcers, heartburn or\nacid reflux</b> as they </span><span lang=\"EN-GB\">can decrease the amount of\nvelpatasvir in your blood.\u00a0 These medicines include:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">antacids (such as aluminium/magnesium hydroxide\nor calcium carbonate).\u00a0 These should be taken at least 4\u00a0hours before\nor 4\u00a0hours after Epclusa;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">proton pump inhibitors (such as omeprazole,\nlansoprazole, rabeprazole, pantoprazole and esomeprazole).\u00a0 Epclusa should\nbe taken with food 4\u00a0hours before using a proton pump inhibitor.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">H<sub>2</sub>\u2011receptor antagonists (such\nas famotidine, cimetidine, nizatidine or ranitidine).\u00a0 If you need high\ndoses of these medicines your doctor may give you a different medicine instead\nor adjust the dose of the medicine you are taking.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">These medicines\ncan decrease the amount of velpatasvir in your blood.\u00a0 If you are taking\none of these medicines your doctor will either give you a different medicine\nfor stomach ulcers, heartburn or acid reflux, or recommend how and when you\ntake that medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and contraception</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The effects of Epclusa\nduring pregnancy are not known.\u00a0 If you are pregnant, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before taking\nthis medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa is\nsometimes used together with ribavirin.\u00a0 Ribavirin can harm your unborn\nbaby.\u00a0 It is therefore very important that you (or your partner) do not\nbecome pregnant during this treatment or for a period of time after completing\ntreatment.\u00a0 You must read the \u201cPregnancy\u201d section in the\nribavirin package leaflet very carefully. \u00a0Ask your doctor for effective\ncontraception method suitable for you and your partner.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Breast\u2011feeding</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Do not breast\u2011feed\nduring treatment with Epclusa.</span></b><span lang=\"EN-GB\">\u00a0 It is not\nknown whether sofosbuvir or velpatasvir, the two active substances of Epclusa,\npass into human breast milk.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa should\nnot affect your ability to drive or use any tools or machinery.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto take Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you.\u00a0\nCheck with your doctor or pharmacist if you are not sure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Recommended dose</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended\ndose is <b>one\u00a0tablet once\u00a0a\u00a0day for 12\u00a0weeks.</b></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Swallow the\ntablet whole with or without food.\u00a0 Do not chew, crush or split the tablet\nas it has a very bitter taste.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you are\ntaking an antacid,</span></b><span lang=\"EN-GB\"> take it at least 4\u00a0hours\nbefore or at least 4\u00a0hours after Epclusa.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you are\ntaking a proton pump inhibitor,</span></b><span lang=\"EN-GB\"> take Epclusa with\nfood 4\u00a0hours before using a proton pump inhibitor.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you are sick (vomit) after taking Epclusa</span></b><span lang=\"EN-GB\"> it may affect the amount of Epclusa in your blood.\u00a0 This may\nmake Epclusa work less well.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you are sick (vomit) <b>less than 3\u00a0hours\nafter</b> taking Epclusa, take another tablet.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you are sick (vomit) <b>more than 3\u00a0hours\nafter</b> taking Epclusa, you do not need to take another tablet until your\nnext scheduled tablet.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you take more Epclusa than you should</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you\naccidentally take more than the recommended dose you should contact your doctor\nor nearest emergency department immediately for advice.\u00a0 Keep the tablet\nbottle with you so that you can easily describe what you have taken.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you forget to take Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is important\nnot to miss a dose of this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If you do miss a dose, work out how long it is since you last took\nyour Epclusa:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you notice within 18\u00a0hours</span></b><span lang=\"EN-GB\"> of the time you usually take Epclusa, you must take the tablet as\nsoon as possible.\u00a0 Then take the next dose at your usual time.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If it\u2019s 18\u00a0hours or more</span></b><span lang=\"EN-GB\"> after the time you usually take Epclusa, wait and take the next\ndose at your usual time.\u00a0 Do not take a double dose (two doses close\ntogether).</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not stop taking Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop\ntaking this medicine unless your doctor tells you to.\u00a0 It is very\nimportant that you complete the full course of treatment to give the medicine\nthe best chance to treat your hepatitis\u00a0C virus infection.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any\nfurther questions on the use of this medicine, ask your doctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Like all medicines, this medicine may cause side effects, although\nnot everybody gets them.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other effects that may be seen during treatment with sofosbuvir:</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The frequency of the following side effects is not known (frequency\ncannot be estimated from the available data).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a wide\nspread severe rash with peeling skin which may be accompanied by fever, flu\nlike symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson\nsyndrome).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span></b><b><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">If you get any side effects tell your\ndoctor.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you get\nany side effects, talk to your doctor or pharmacist.</span></b><span lang=\"EN-GB\">\u00a0 This includes any possible side effects not listed in this\nleaflet.\u00a0 You can also report side effects directly via </span><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">the national reporting system\nlisted in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">.</span><span lang=\"EN-GB\">\u00a0\nBy reporting side effects you can help provide more information on the safety\nof this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto store Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the bottle and carton after\n\u201cEXP\u201d.\u00a0 The expiry date refers to the last day of that month.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine\ndoes not require any special storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste.\u00a0 Ask your pharmacist\nhow to throw away medicines you no longer use.\u00a0 These measures will help\nprotect the environment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Epclusa contains</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">The active substances are</span></b><span lang=\"EN-GB\"> sofosbuvir and velpatasvir.\u00a0 Each film\u2011coated tablet\ncontains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">The other ingredients are</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:\navoid\"><i><span lang=\"EN-GB\">Tablet core:</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">Copovidone, microcrystalline cellulose, croscarmellose sodium,\nmagnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:\navoid\"><i><span lang=\"EN-GB\">Film\u2011coating:</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">Polyvinyl alcohol, titanium dioxide, p</span><span lang=\"EN-GB\">olyethylene\nglycol, talc, iron oxide red</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Epclusa looks like and contents of the pack</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The film\u2011coated\ntablets are pink, diamond\u2011shaped tablets debossed with \u201cGSI\u201d\non one side and \u201c7916\u201d on the other side.\u00a0 The tablet is 20\u00a0mm\nlong and 10\u00a0mm wide.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The following pack sizes are available:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">IDA Business &amp; Technology Park</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 39 02\n  439201</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\"><span style=\"color:windowtext;\ntext-decoration:none\">http://www.ema.europa.eu</span></a>.</span></p>\n</div>", "ID": "ebce45a2-df8a-4783-898d-96fb3461993e", "Styles": "None", "Classes": "['WordSection1']", "Text": "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ", "ParentId": "af650045-9d03-4795-88ee-dd4e5c9a2f51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f14d84b7-c6f9-4819-8bd2-3cc75ed42476", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8e1d3d99-fe22-4d10-b8d4-a81dd00cc4ae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f14d84b7-c6f9-4819-8bd2-3cc75ed42476"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "418d35a6-ce63-4263-bc2f-20ae919ed6a2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae43de30-42e3-4353-b78f-39bea9c9cdc6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "418d35a6-ce63-4263-bc2f-20ae919ed6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba922120-bc00-48d0-8950-6408ad537f8b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05b65b9c-1801-46c7-84e8-ec5dc65a1c89", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba922120-bc00-48d0-8950-6408ad537f8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "865c0e05-ca48-4459-8e23-95f5475e4a3f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e3d9e368-7fe9-4250-a660-f8c1b76e2e76", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "865c0e05-ca48-4459-8e23-95f5475e4a3f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4981f1cb-e9b8-4040-953d-0c6e33669343", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3fb1308a-efe6-45a8-b131-e0cfcd741c3a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4981f1cb-e9b8-4040-953d-0c6e33669343"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d62e8eea-d7da-498c-86d0-ee75d93d9ab3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "07799a00-155e-4403-9641-8ad15aa840c1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d62e8eea-d7da-498c-86d0-ee75d93d9ab3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "47230a66-5d04-4a05-9451-fc4acef85ced", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "179e293f-eceb-465e-a8e0-9aa4602f6c72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47230a66-5d04-4a05-9451-fc4acef85ced"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98457368-61cc-4b05-a88b-17f491df08c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c8439374-3e3c-4c50-8694-8cf34d9cc329", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98457368-61cc-4b05-a88b-17f491df08c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "71a83902-2b57-4454-84fe-db75f69142dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "98b32ed0-2fa8-4724-af16-0267fc263e8a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "71a83902-2b57-4454-84fe-db75f69142dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7076db28-d7bc-4cfb-92e5-65bac932cb7a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eba44cdc-e0cc-4cc5-a778-d8f8d5be8325", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7076db28-d7bc-4cfb-92e5-65bac932cb7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7617bfb4-100b-4c07-b2cb-958408b64f1c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ecaf5c2-dc3a-4ea6-b642-6159bcc6d6d4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7617bfb4-100b-4c07-b2cb-958408b64f1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "984934d6-773a-4830-8dec-480c61a0725e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9f52b6e-34ad-40b2-93b3-cc41d4929e87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "984934d6-773a-4830-8dec-480c61a0725e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f79dac17-65b3-434a-b908-de294b242bbc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7276cad-48f5-4711-9b38-04349ce94077", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f79dac17-65b3-434a-b908-de294b242bbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5f149da8-816a-4e99-b07e-3abcc2321210", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05046140-122d-4290-bfee-b6592ef08ef8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5f149da8-816a-4e99-b07e-3abcc2321210"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "18393302-eeb9-4b17-8923-66224b9beec8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "536c2510-3f41-4a7d-ad51-9b2cbfec3bdb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "18393302-eeb9-4b17-8923-66224b9beec8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ffbbf131-16be-4251-ab59-e33720089172", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fff1c908-4f82-40ea-941c-d54a1e12a8e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ffbbf131-16be-4251-ab59-e33720089172"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7238a238-6d87-4ece-aa81-967d18111238", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "468df60a-002f-47c0-aed5-b1d7c62b27ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7238a238-6d87-4ece-aa81-967d18111238"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7986b68e-8f92-4682-ad95-0daa1de2026a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2d96c5f-f260-42d4-aba7-1d23b8131a11", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7986b68e-8f92-4682-ad95-0daa1de2026a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bb60e2bd-bd22-4cb2-ba05-db4137237fef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ab503b76-4904-42e4-b9c2-0b37a8cf5c8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb60e2bd-bd22-4cb2-ba05-db4137237fef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eb65c111-7248-44f7-8cc8-1114cdb145e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59170e4c-09d1-4320-b7e7-9e14414e9640", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eb65c111-7248-44f7-8cc8-1114cdb145e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "466c0a3e-65a3-445f-a074-f7eb889a12f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c114adcd-22ae-4309-808d-5d7232fdb4e1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "466c0a3e-65a3-445f-a074-f7eb889a12f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "848b16ff-7a8b-49ba-9f79-a84d8a2c6216", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9af9fad-2f8d-4a2d-b24f-291587205946", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "848b16ff-7a8b-49ba-9f79-a84d8a2c6216"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2cdf607-6c85-4cf6-a186-a94b6956dd3a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c18747cd-714f-4dc7-b2fb-fa5e79762ae9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2cdf607-6c85-4cf6-a186-a94b6956dd3a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>", "ID": "69948c88-538f-4170-89a7-047323b5b1bf", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX I</span></b>", "ID": "b205fd77-f592-4a37-85bb-63c0cea24ebc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69948c88-538f-4170-89a7-047323b5b1bf"}, {"Element": "<span lang=\"EN-GB\">ANNEX I</span>", "ID": "9e68958c-322e-479a-a1f2-f71dda4ea3ff", "Styles": "None", "Classes": "None", "Text": "ANNEX I", "ParentId": "b205fd77-f592-4a37-85bb-63c0cea24ebc"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1ec36ea-eb20-4c11-80ae-78739c5650ce", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "db68ba45-30bc-46a7-b42b-2d2844dec08a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1ec36ea-eb20-4c11-80ae-78739c5650ce"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>", "ID": "0507347e-620e-4a18-b445-0df096620d06", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span>", "ID": "30f96a5d-cb08-4948-939e-5e35d5a2b9dc", "Styles": "None", "Classes": "None", "Text": "SUMMARY OF PRODUCT CHARACTERISTICS", "ParentId": "0507347e-620e-4a18-b445-0df096620d06"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "431f5228-ee0b-417d-a14b-7c64657bb671", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "4d537b59-3dac-4ac3-80b0-9aa6242f087b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "431f5228-ee0b-417d-a14b-7c64657bb671"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"17\" id=\"Picture 1\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. \u00a0This\nwill allow quick identification of new safety information. \u00a0Healthcare\nprofessionals are asked to report any suspected adverse reactions. \u00a0See\nsection\u00a04.8 for how to report adverse reactions.</span></p>", "ID": "d31e81ff-16c8-43bb-9067-57d4bc157e2f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"17\" id=\"Picture 1\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span>", "ID": "248eac80-0ce8-4dbf-b55b-d38f3bfe08cd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d31e81ff-16c8-43bb-9067-57d4bc157e2f"}, {"Element": "<img alt=\"BT_1000x858px\" height=\"17\" id=\"Picture 1\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/>", "ID": "69fea899-bbba-498f-9f7a-e69c7570fff6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "248eac80-0ce8-4dbf-b55b-d38f3bfe08cd"}, {"Element": "<span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. \u00a0This\nwill allow quick identification of new safety information. \u00a0Healthcare\nprofessionals are asked to report any suspected adverse reactions. \u00a0See\nsection\u00a04.8 for how to report adverse reactions.</span>", "ID": "48d51341-3e14-4d37-b8b2-27e9fd8250f0", "Styles": "None", "Classes": "None", "Text": "This medicinal product is subject to additional monitoring. \u00a0This will allow quick identification of new safety information. \u00a0Healthcare professionals are asked to report any suspected adverse reactions. \u00a0See section\u00a04.8 for how to report adverse reactions.", "ParentId": "d31e81ff-16c8-43bb-9067-57d4bc157e2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2bea7fad-7e2f-4ead-b3c8-7e1d9cff313b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48ba59ca-9a50-4e85-96a3-f208b00b5cbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bea7fad-7e2f-4ead-b3c8-7e1d9cff313b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7fdfe9cc-414d-4497-97b1-25b5476b8bfa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f09733cb-5944-48d5-a7f4-5f41f238b509", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7fdfe9cc-414d-4497-97b1-25b5476b8bfa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>", "ID": "b75fe150-6441-43de-ac33-1ac4610aabdb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF </span></b>", "ID": "1bd3af04-12d6-4b4f-ad6d-685b35310eb9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b75fe150-6441-43de-ac33-1ac4610aabdb"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF </span>", "ID": "9ae93456-3f4d-41d4-b00e-1cc33ea15711", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF ", "ParentId": "1bd3af04-12d6-4b4f-ad6d-685b35310eb9"}, {"Element": "<b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b>", "ID": "7f8c1ac6-4c89-47da-865d-482634d3e708", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b75fe150-6441-43de-ac33-1ac4610aabdb"}, {"Element": "<span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span>", "ID": "253d0410-e213-418a-a531-808629bc1640", "Styles": "None", "Classes": "None", "Text": "THE MEDICINAL PRODUCT", "ParentId": "7f8c1ac6-4c89-47da-865d-482634d3e708"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b8e7a795-7032-4938-8d91-29883d3f38ac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7adf64bf-d4d6-4344-99c8-fb34016bf136", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8e7a795-7032-4938-8d91-29883d3f38ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated tablets.</span></p>", "ID": "76541c81-418d-4fd9-ae96-0706fc720d8d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "d13e41d8-2b54-42f9-b286-5473c4e680e7", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "76541c81-418d-4fd9-ae96-0706fc720d8d"}, {"Element": "<span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated tablets.</span>", "ID": "3cd70758-569f-4b47-8a06-4c8f32df1ecf", "Styles": "None", "Classes": "None", "Text": " 400\u00a0mg/100\u00a0mg film\u2011coated tablets.", "ParentId": "76541c81-418d-4fd9-ae96-0706fc720d8d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e55070e-09de-47fc-b448-9a6eaf5d2b58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb3940a5-ba87-4aba-a8ba-4d435db1650b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e55070e-09de-47fc-b448-9a6eaf5d2b58"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "03d4d6be-2754-45cf-81c8-feec7db07238", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "32b07fbe-6cb5-4c50-a4b8-480a2a7c0ab5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03d4d6be-2754-45cf-81c8-feec7db07238"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b></p>", "ID": "be4ee74f-b639-4580-8e83-76132b78564e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span></b>", "ID": "d4601f66-1fe3-45fb-8df4-2cd6ef989c7d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be4ee74f-b639-4580-8e83-76132b78564e"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE\nAND QUANTITATIVE COMPOSITION</span>", "ID": "efe924b5-ac0e-4db9-97b4-69a5bf18a5ad", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "d4601f66-1fe3-45fb-8df4-2cd6ef989c7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4956f69f-6cdd-4164-8fb2-b8254af5ff6e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "97f21a2e-b1e2-428d-b234-527540a4c8e1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4956f69f-6cdd-4164-8fb2-b8254af5ff6e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir</span><span lang=\"EN-GB\">.</span></p>", "ID": "a2eee766-6dd3-44ff-b989-aceb07c6688b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir</span>", "ID": "8f7baff2-9fa3-4755-bc64-fa5bf5bdc859", "Styles": "None", "Classes": "None", "Text": "Each film\u2011coated tablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir", "ParentId": "a2eee766-6dd3-44ff-b989-aceb07c6688b"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "f3a69fbe-23be-429e-b906-80946577eadf", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "a2eee766-6dd3-44ff-b989-aceb07c6688b"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc431d2e-d1c1-4f56-bdd5-60e143c6a59f", "Styles": "margin:0in;text-align:left;\ntext-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d6840409-d7b1-421d-94c0-8f2888b917c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc431d2e-d1c1-4f56-bdd5-60e143c6a59f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list\nof excipients, see section\u00a06.1.</span></p>", "ID": "68fea14a-834c-41db-a8c4-aeceac2550f0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">For the full list\nof excipients, see section\u00a06.1.</span>", "ID": "9172157c-7a54-4ec1-ada7-61cc086041e4", "Styles": "None", "Classes": "None", "Text": "For the full list of excipients, see section\u00a06.1.", "ParentId": "68fea14a-834c-41db-a8c4-aeceac2550f0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df83b6bd-28bd-4994-b9a7-f74d6cfe3a23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7835644f-3622-4bf8-9f63-f6798b07cf95", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df83b6bd-28bd-4994-b9a7-f74d6cfe3a23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a9c35ed9-3418-459e-b1b8-6a333adaa63e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5008f532-163f-4f94-92ca-08ed53e37a0b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a9c35ed9-3418-459e-b1b8-6a333adaa63e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM</span></b></p>", "ID": "b0684327-dd59-4dcf-9bf7-a2cf5c1d8ec6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM</span></b>", "ID": "143ffff4-c32f-49f7-bc4c-def7f18b9132", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0684327-dd59-4dcf-9bf7-a2cf5c1d8ec6"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM</span>", "ID": "1b6f2f07-89d2-4c9d-8f44-4b1ff079d4a8", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM", "ParentId": "143ffff4-c32f-49f7-bc4c-def7f18b9132"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "744b5c7b-5ac5-4a99-a8d1-04e36022cf90", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efd9fa77-f3b9-4c64-9227-c902b2099860", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "744b5c7b-5ac5-4a99-a8d1-04e36022cf90"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Film\u2011coated\ntablet.</span></p>", "ID": "cafc58ff-29f2-4f5f-9459-db444c95e13f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Film\u2011coated\ntablet.</span>", "ID": "ac814d08-36e7-4cee-91c4-067d7eb93a99", "Styles": "None", "Classes": "None", "Text": "Film\u2011coated tablet.", "ParentId": "cafc58ff-29f2-4f5f-9459-db444c95e13f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83c4ce6a-6d00-4ecd-bb7a-e1cf5d88b940", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4da80296-6e74-4f70-bb99-57a36304e75c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83c4ce6a-6d00-4ecd-bb7a-e1cf5d88b940"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pink, diamond\u2011shaped,\nfilm\u2011coated tablet of dimensions 20\u00a0mm\u00a0x\u00a010\u00a0mm,\ndebossed on one side with \u201cGSI\u201d and \u201c7916\u201d on the other\nside.</span></p>", "ID": "0c6f7689-17c7-400c-bfdc-e86467c5d907", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Pink, diamond\u2011shaped,\nfilm\u2011coated tablet of dimensions 20\u00a0mm\u00a0x\u00a010\u00a0mm,\ndebossed on one side with \u201cGSI\u201d and \u201c7916\u201d on the other\nside.</span>", "ID": "35e6deed-012e-4709-b417-b6f14fa055a9", "Styles": "None", "Classes": "None", "Text": "Pink, diamond\u2011shaped, film\u2011coated tablet of dimensions 20\u00a0mm\u00a0x\u00a010\u00a0mm, debossed on one side with \u201cGSI\u201d and \u201c7916\u201d on the other side.", "ParentId": "0c6f7689-17c7-400c-bfdc-e86467c5d907"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "716a80c6-4f3e-4b2b-afba-a34a79c9efc7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9ef7df48-b897-458d-bfbc-077d1a62b2fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "716a80c6-4f3e-4b2b-afba-a34a79c9efc7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f111b861-f82d-4de2-924c-b4db1d08f8ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d4c5a94-3ac7-4128-965c-70e67ee8f245", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f111b861-f82d-4de2-924c-b4db1d08f8ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b></p>", "ID": "d333d4b4-9094-47ff-83f3-3267e71557ad", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "68aa7787-c7b9-4e2f-b3fa-eabd6f277cc0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d333d4b4-9094-47ff-83f3-3267e71557ad"}, {"Element": "<span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "76c75359-34c0-426f-9a65-369dff1dd64d", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "68aa7787-c7b9-4e2f-b3fa-eabd6f277cc0"}, {"Element": "<b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b>", "ID": "abbdde56-f4a0-429b-8d5d-7dbef18c3e35", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d333d4b4-9094-47ff-83f3-3267e71557ad"}, {"Element": "<span lang=\"EN-GB\">CLINICAL PARTICULARS</span>", "ID": "b6b43438-1474-4815-8358-157c841cbd46", "Styles": "None", "Classes": "None", "Text": "CLINICAL PARTICULARS", "ParentId": "abbdde56-f4a0-429b-8d5d-7dbef18c3e35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "62d1f221-550e-497d-b5cb-ea565ab6f935", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f23d7030-a3e0-4529-b412-04cd2002e035", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62d1f221-550e-497d-b5cb-ea565ab6f935"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b></p>", "ID": "fbf5c212-d593-4434-805a-fcef50bbde31", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b>", "ID": "b578e5dc-7a16-45b2-a31c-c0196500bbbd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbf5c212-d593-4434-805a-fcef50bbde31"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span>", "ID": "509fe552-64c4-4087-a58e-94a875380eba", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "b578e5dc-7a16-45b2-a31c-c0196500bbbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c0f2a5f8-5a3c-47a0-8a8a-ac89b2fc4cb3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c054941-fd84-4463-9c8d-60f7379b0790", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c0f2a5f8-5a3c-47a0-8a8a-ac89b2fc4cb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">is indicated for the treatment of chronic\nhepatitis\u00a0C virus (HCV) infection in adults </span><span lang=\"EN-GB\">(see\nsections\u00a04.2,\u00a04.4 and\u00a05.1).</span></p>", "ID": "b81bf68a-205e-4e8d-99ee-d43f99c47628", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "1569b8ea-69ea-4a95-b6c3-b5b32abab608", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "b81bf68a-205e-4e8d-99ee-d43f99c47628"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "7eff8d41-90d8-456f-9c27-297984d6f563", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "b81bf68a-205e-4e8d-99ee-d43f99c47628"}, {"Element": "<span lang=\"EN-GB\">is indicated for the treatment of chronic\nhepatitis\u00a0C virus (HCV) infection in adults </span>", "ID": "a02b2f52-fa3d-4bf0-b1bd-b319c2de1ecc", "Styles": "None", "Classes": "None", "Text": "is indicated for the treatment of chronic hepatitis\u00a0C virus (HCV) infection in adults ", "ParentId": "b81bf68a-205e-4e8d-99ee-d43f99c47628"}, {"Element": "<span lang=\"EN-GB\">(see\nsections\u00a04.2,\u00a04.4 and\u00a05.1).</span>", "ID": "99ccb112-414b-4702-b565-c660d41f677e", "Styles": "None", "Classes": "None", "Text": "(see sections\u00a04.2,\u00a04.4 and\u00a05.1).", "ParentId": "b81bf68a-205e-4e8d-99ee-d43f99c47628"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1efddfe1-e74c-45f1-bc3c-7aea20527d11", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2877588-4fea-4ba9-8eb0-676fc7e53762", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1efddfe1-e74c-45f1-bc3c-7aea20527d11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b></p>", "ID": "c4d17542-2956-436d-9f66-98df3ed6785a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b>", "ID": "fbf31453-7a14-4175-909c-5f7072ed7a79", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c4d17542-2956-436d-9f66-98df3ed6785a"}, {"Element": "<span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span>", "ID": "59964843-3694-4d0c-b1c0-c395456081cc", "Styles": "None", "Classes": "None", "Text": "4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration", "ParentId": "fbf31453-7a14-4175-909c-5f7072ed7a79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9185ef22-9698-41b8-8cca-c68fc2e1125c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "918a01e4-0a9a-45ba-b162-04f0a33619e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9185ef22-9698-41b8-8cca-c68fc2e1125c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa\ntreatment should be initiated and monitored by a physician experienced in the\nmanagement of patients with HCV infection.</span></p>", "ID": "73b6e35c-86c9-4739-91fc-6546dad59766", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa\ntreatment should be initiated and monitored by a physician experienced in the\nmanagement of patients with HCV infection.</span>", "ID": "aa995d52-36e1-48f3-b40a-f51bb76f7dda", "Styles": "None", "Classes": "None", "Text": "Epclusa treatment should be initiated and monitored by a physician experienced in the management of patients with HCV infection.", "ParentId": "73b6e35c-86c9-4739-91fc-6546dad59766"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fcdbd832-3cae-44f2-9b16-9a3a15383385", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6a0d76c-42c8-45b6-9c56-e54f00ad281e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fcdbd832-3cae-44f2-9b16-9a3a15383385"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>", "ID": "eecbe80e-a563-4f65-befe-f6b5436892de", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Posology</span></u>", "ID": "7e9b0550-89c9-43de-83bb-15d724ab3cdd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eecbe80e-a563-4f65-befe-f6b5436892de"}, {"Element": "<span lang=\"EN-GB\">Posology</span>", "ID": "bf52efcd-4da8-413a-bbc9-747f7147eaf8", "Styles": "None", "Classes": "None", "Text": "Posology", "ParentId": "7e9b0550-89c9-43de-83bb-15d724ab3cdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended\ndose of Epclusa is one tablet, taken orally, once daily with or without food\n(see section\u00a05.2).</span></p>", "ID": "86117027-75b2-480d-951e-7b7a46cb1843", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The recommended\ndose of Epclusa is one tablet, taken orally, once daily with or without food\n(see section\u00a05.2).</span>", "ID": "20ac100b-0906-45b7-8acc-879fad75955b", "Styles": "None", "Classes": "None", "Text": "The recommended dose of Epclusa is one tablet, taken orally, once daily with or without food (see section\u00a05.2).", "ParentId": "86117027-75b2-480d-951e-7b7a46cb1843"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f89037ac-3bb8-4cb9-91a3-622d1d37237b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7050108-2791-4976-84fe-df39e02c9a0f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f89037ac-3bb8-4cb9-91a3-622d1d37237b"}, {"Element": "<p class=\"MsoCaption\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a01: Recommended treatment and duration\nfor all HCV genotypes</span></p>", "ID": "3927daf3-d4ac-4dc9-b989-63eed5511a38", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCaption']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a01: Recommended treatment and duration\nfor all HCV genotypes</span>", "ID": "a8cf83af-4f46-4570-b176-1b4119b6ef71", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Table\u00a01: Recommended treatment and duration for all HCV genotypes", "ParentId": "3927daf3-d4ac-4dc9-b989-63eed5511a38"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n</td>\n</tr>\n</table>", "ID": "a6e30039-bcaa-4741-80f7-977ad5d2defd", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "    ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "2542c212-ea14-447d-bcf3-77f03baf63a8", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "a6e30039-bcaa-4741-80f7-977ad5d2defd"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>\n</td>\n</tr>", "ID": "209f42fa-ce75-4a24-9f97-473372acdbea", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "2542c212-ea14-447d-bcf3-77f03baf63a8"}, {"Element": "<td style=\"width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>\n</td>", "ID": "1b3cc0ae-13f1-46f4-a50a-8be284cacc8e", "Styles": "width:189.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "209f42fa-ce75-4a24-9f97-473372acdbea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b></p>", "ID": "336a846f-b882-45f1-82a8-66e87132ecc6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b3cc0ae-13f1-46f4-a50a-8be284cacc8e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span></b>", "ID": "aaf6d790-f71e-4885-bf4e-8876a6f5286c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "336a846f-b882-45f1-82a8-66e87132ecc6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient population<sup>a</sup></span>", "ID": "50dc1f51-6f21-409e-bdad-2579c50f9bfd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Patient population", "ParentId": "aaf6d790-f71e-4885-bf4e-8876a6f5286c"}, {"Element": "<sup>a</sup>", "ID": "c831c749-d85a-4a5a-8bf2-1b687b9a441b", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "50dc1f51-6f21-409e-bdad-2579c50f9bfd"}, {"Element": "<td style=\"width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>\n</td>", "ID": "f99bca30-a7ed-4ea4-8cce-272e6f363817", "Styles": "width:274.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "209f42fa-ce75-4a24-9f97-473372acdbea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b></p>", "ID": "821db8b6-57bd-4757-b992-dda972706125", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f99bca30-a7ed-4ea4-8cce-272e6f363817"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span></b>", "ID": "60786b27-a707-4bb4-b4ac-91c3292b8d8c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "821db8b6-57bd-4757-b992-dda972706125"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment and duration</span>", "ID": "a197224c-25d3-4792-b40a-05e750ef5199", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Treatment and duration", "ParentId": "60786b27-a707-4bb4-b4ac-91c3292b8d8c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span></p>\n</td>\n</tr>", "ID": "6b520018-1134-4fde-b07c-5c079378030f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "a6e30039-bcaa-4741-80f7-977ad5d2defd"}, {"Element": "<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span></p>\n</td>", "ID": "e1110cfd-d38f-46f7-88ec-93faf3254a53", "Styles": "width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6b520018-1134-4fde-b07c-5c079378030f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span></p>", "ID": "2ac58850-0493-4500-a6c4-622a632c9437", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e1110cfd-d38f-46f7-88ec-93faf3254a53"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients without cirrhosis and patients\n  with compensated cirrhosis</span>", "ID": "f6e6b8be-c8a8-4bf7-aa04-4846caab057b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Patients without cirrhosis and patients   with compensated cirrhosis", "ParentId": "2ac58850-0493-4500-a6c4-622a632c9437"}, {"Element": "<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span></p>\n</td>", "ID": "3f29981b-244c-499f-8104-29c934541b24", "Styles": "width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "6b520018-1134-4fde-b07c-5c079378030f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>", "ID": "467ed805-5ab5-4ab5-83d3-8d5377aece0d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f29981b-244c-499f-8104-29c934541b24"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "10d09f0c-6020-4b81-9c64-15b3ac97db9f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "467ed805-5ab5-4ab5-83d3-8d5377aece0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> for </span>", "ID": "8d93fcbd-cc36-4ab0-a1a1-b4297c16d8de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " for ", "ParentId": "467ed805-5ab5-4ab5-83d3-8d5377aece0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "c79f90c8-d4d6-4a8e-ac83-1ec6d5596b2f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "467ed805-5ab5-4ab5-83d3-8d5377aece0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "c60efc45-388b-4283-a909-a7437df1d0a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f29981b-244c-499f-8104-29c934541b24"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "ec44bc73-5515-4fdd-ba60-01c0edf9e245", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "c60efc45-388b-4283-a909-a7437df1d0a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span></p>", "ID": "46bfa357-6bc8-44aa-89fc-08ea3802f163", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f29981b-244c-499f-8104-29c934541b24"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Addition of ribavirin may be considered\n  for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)</span>", "ID": "a0944aa9-3aca-4969-92e8-3f47e7cbe3c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Addition of ribavirin may be considered   for genotype\u00a03 infected patients with compensated cirrhosis (see section\u00a05.1.)", "ParentId": "46bfa357-6bc8-44aa-89fc-08ea3802f163"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span></p>\n</td>\n<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n</td>\n</tr>", "ID": "38f58ab9-532b-4249-8af9-6aeb970065de", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "a6e30039-bcaa-4741-80f7-977ad5d2defd"}, {"Element": "<td style=\"width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"253\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span></p>\n</td>", "ID": "bea33528-7adb-4028-b57b-2da069b31540", "Styles": "width:189.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "38f58ab9-532b-4249-8af9-6aeb970065de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span></p>", "ID": "7cbeef9d-2e70-499c-9001-c7045623f9be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bea33528-7adb-4028-b57b-2da069b31540"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients with decompensated cirrhosis</span>", "ID": "4a0daa14-5278-43ac-8cf5-635f3e711f4b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Patients with decompensated cirrhosis", "ParentId": "7cbeef9d-2e70-499c-9001-c7045623f9be"}, {"Element": "<td style=\"width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"366\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>\n</td>", "ID": "ed34f3bc-0a83-471e-aecd-079febb64717", "Styles": "width:274.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "38f58ab9-532b-4249-8af9-6aeb970065de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></p>", "ID": "9c645528-5af5-4db7-a52f-8a368f6b0b1b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ed34f3bc-0a83-471e-aecd-079febb64717"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa </span>", "ID": "3a8c04d9-8a12-4fb8-98f6-734e1694cd08", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa ", "ParentId": "9c645528-5af5-4db7-a52f-8a368f6b0b1b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">+ ribavirin for </span>", "ID": "ef4bc98d-ed57-4ebc-8766-490c4313a36d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "+ ribavirin for ", "ParentId": "9c645528-5af5-4db7-a52f-8a368f6b0b1b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "e2572ebe-4537-416c-86e4-33ecd70c0975", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "9c645528-5af5-4db7-a52f-8a368f6b0b1b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Includes\npatients co\u2011infected with human immunodeficiency virus (HIV) and patients\nwith recurrent HCV post-liver transplant (see section\u00a04.4.).</span></p>", "ID": "01b888c9-e74e-4af7-b961-46b6d9701541", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Includes\npatients co\u2011infected with human immunodeficiency virus (HIV) and patients\nwith recurrent HCV post-liver transplant (see section\u00a04.4.).</span>", "ID": "2c75f8a7-d454-470e-830e-0703115fddf5", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 Includes patients co\u2011infected with human immunodeficiency virus (HIV) and patients with recurrent HCV post-liver transplant (see section\u00a04.4.).", "ParentId": "01b888c9-e74e-4af7-b961-46b6d9701541"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bca87228-6f07-405b-a2b9-35e084ad72ec", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c434baef-632c-4503-b0d8-4cb5fd7fec2c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bca87228-6f07-405b-a2b9-35e084ad72ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">When used in\ncombination with ribavirin, refer also to the Summary of Product\nCharacteristics of the medicinal product containing ribavirin.</span></p>", "ID": "839a7863-da01-4c36-a7fb-714145d72a79", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">When used in\ncombination with ribavirin, refer also to the Summary of Product\nCharacteristics of the medicinal product containing ribavirin.</span>", "ID": "c5e7e4cf-c679-43d7-8b09-66daad3a5aa3", "Styles": "None", "Classes": "None", "Text": "When used in combination with ribavirin, refer also to the Summary of Product Characteristics of the medicinal product containing ribavirin.", "ParentId": "839a7863-da01-4c36-a7fb-714145d72a79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9626ddd-ccc6-4345-8a86-56fd44d319f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "212aaade-4649-4a28-a4a2-4c4b1bc5b517", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9626ddd-ccc6-4345-8a86-56fd44d319f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The following dosing is recommended where ribavirin is divided in\ntwo daily doses and given with food:</span></p>", "ID": "2f3ac99c-40c4-4740-bdaa-63d3c8d0bb45", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The following dosing is recommended where ribavirin is divided in\ntwo daily doses and given with food:</span>", "ID": "d3f8167c-a8b2-4142-9139-79c1648c570f", "Styles": "None", "Classes": "None", "Text": "The following dosing is recommended where ribavirin is divided in two daily doses and given with food:", "ParentId": "2f3ac99c-40c4-4740-bdaa-63d3c8d0bb45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b4683ce-921a-4b33-b95b-2200d8e1fd7b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4dd9ce8-6775-4db8-988f-e212aad28b3f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b4683ce-921a-4b33-b95b-2200d8e1fd7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a02: Guidance for ribavirin dosing when administered with Epclusa\nto patients with decompensated cirrhosis</span></b></p>", "ID": "f2784c95-5741-41a6-9c8d-e7d1bb4ed8fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a02: Guidance for ribavirin dosing when administered with Epclusa\nto patients with decompensated cirrhosis</span></b>", "ID": "d399a3f4-0a71-42ca-a3d4-66f77d2fc3e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2784c95-5741-41a6-9c8d-e7d1bb4ed8fe"}, {"Element": "<span lang=\"EN-GB\">Table\u00a02: Guidance for ribavirin dosing when administered with Epclusa\nto patients with decompensated cirrhosis</span>", "ID": "26d64858-a796-4dfc-b344-91071d026183", "Styles": "None", "Classes": "None", "Text": "Table\u00a02: Guidance for ribavirin dosing when administered with Epclusa to patients with decompensated cirrhosis", "ParentId": "d399a3f4-0a71-42ca-a3d4-66f77d2fc3e2"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>\n</td>\n<td style=\"width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span></p>\n</td>\n</tr>\n</table>", "ID": "6b49a32a-f46f-458b-be07-533578f67c40", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "    ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>\n</td>\n<td style=\"width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "6b16dc04-34b3-498b-b872-b6b0e47e8c65", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6b49a32a-f46f-458b-be07-533578f67c40"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>\n</td>\n<td style=\"width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>\n</td>\n</tr>", "ID": "c7f2d16f-8186-437d-b424-1caac3ad32c5", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "6b16dc04-34b3-498b-b872-b6b0e47e8c65"}, {"Element": "<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>\n</td>", "ID": "bd985f68-2031-4268-bfe9-8206e2a287a4", "Styles": "width:168.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c7f2d16f-8186-437d-b424-1caac3ad32c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b></p>", "ID": "02869289-8d0b-4476-b2d3-f986894baf7a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bd985f68-2031-4268-bfe9-8206e2a287a4"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span></b>", "ID": "3800f6d5-ae39-4ad6-bd4c-80650ba6fc88", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "02869289-8d0b-4476-b2d3-f986894baf7a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patient</span>", "ID": "a238c83e-4dae-40e0-96ab-a5757f0c8310", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Patient", "ParentId": "3800f6d5-ae39-4ad6-bd4c-80650ba6fc88"}, {"Element": "<td style=\"width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>\n</td>", "ID": "c44b6a28-6175-4696-ada4-e80f2144a773", "Styles": "width:292.1pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c7f2d16f-8186-437d-b424-1caac3ad32c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b></p>", "ID": "3c1c49d4-bbfa-47d1-a696-66c55e9e3029", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c44b6a28-6175-4696-ada4-e80f2144a773"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span></b>", "ID": "3fdc7949-addd-4dc0-8a7e-06ab58551848", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c1c49d4-bbfa-47d1-a696-66c55e9e3029"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ribavirin Dose</span>", "ID": "6afc16e1-9309-4030-a3b1-b64da31e42bb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ribavirin Dose", "ParentId": "3fdc7949-addd-4dc0-8a7e-06ab58551848"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span></p>\n</td>\n</tr>", "ID": "5a1c3355-ee5c-42f6-80ad-a53db9beec6f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "6b49a32a-f46f-458b-be07-533578f67c40"}, {"Element": "<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span></p>\n</td>", "ID": "98b5bffb-3c83-41b8-9741-29eec55cef1f", "Styles": "width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5a1c3355-ee5c-42f6-80ad-a53db9beec6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span></p>", "ID": "a7527065-93ea-4c01-815f-86eba16e53a6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "98b5bffb-3c83-41b8-9741-29eec55cef1f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Child\u2011Pugh\u2011Turcotte (CPT) </span>", "ID": "469334a8-cc79-4320-a317-e78ed76f8ddb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Child\u2011Pugh\u2011Turcotte (CPT) ", "ParentId": "a7527065-93ea-4c01-815f-86eba16e53a6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Class\u00a0B cirrhosis pre-transplant</span>", "ID": "163dc63d-075d-4b04-89be-6b14673e8f6f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Class\u00a0B cirrhosis pre-transplant", "ParentId": "a7527065-93ea-4c01-815f-86eba16e53a6"}, {"Element": "<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span></p>\n</td>", "ID": "59b95cb0-b047-41f3-89f7-77a693cee52c", "Styles": "width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5a1c3355-ee5c-42f6-80ad-a53db9beec6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span></p>", "ID": "ea6c3711-d4a7-443b-8097-fd4cdd88d2e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59b95cb0-b047-41f3-89f7-77a693cee52c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1,000\u00a0mg per day for patients\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those weighing\n  \u2265\u00a075\u00a0kg</span>", "ID": "81d6b0e1-dd56-460e-8f42-f80242a906b8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1,000\u00a0mg per day for patients   <\u00a075\u00a0kg and 1,200\u00a0mg for those weighing   \u2265\u00a075\u00a0kg", "ParentId": "ea6c3711-d4a7-443b-8097-fd4cdd88d2e0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span></p>\n</td>\n<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span></p>\n</td>\n</tr>", "ID": "d677bbaa-8a22-4492-b203-d618b032bdb5", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "6b49a32a-f46f-458b-be07-533578f67c40"}, {"Element": "<td style=\"width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span></p>\n</td>", "ID": "61ccbade-849c-4373-875e-d7449ef19dda", "Styles": "width:168.45pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "d677bbaa-8a22-4492-b203-d618b032bdb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span></p>", "ID": "5d62d48a-239d-4692-bf39-c160de388ee4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "61ccbade-849c-4373-875e-d7449ef19dda"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0C cirrhosis pre-transplant</span>", "ID": "8db177f5-74e6-46fa-81a1-c8c004e7f5b6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "CPT Class\u00a0C cirrhosis pre-transplant", "ParentId": "5d62d48a-239d-4692-bf39-c160de388ee4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0451763c-5917-4e74-b420-272a15fe55d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "61ccbade-849c-4373-875e-d7449ef19dda"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "9ca03a7e-ee9a-41f8-9357-53e87c32023e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0451763c-5917-4e74-b420-272a15fe55d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span></p>", "ID": "1d6df837-5b3f-49d0-88f2-715ce1952675", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "61ccbade-849c-4373-875e-d7449ef19dda"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">CPT Class\u00a0B or C post-transplant</span>", "ID": "1b202460-cc85-462b-967a-c28a6259e3ba", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "CPT Class\u00a0B or C post-transplant", "ParentId": "1d6df837-5b3f-49d0-88f2-715ce1952675"}, {"Element": "<td style=\"width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"389\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span></p>\n</td>", "ID": "5d0aa71a-f776-42da-a7a6-d9e8835d58c1", "Styles": "width:292.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d677bbaa-8a22-4492-b203-d618b032bdb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span></p>", "ID": "c062d1ea-6753-46e7-81a3-a996b4cf9fe1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5d0aa71a-f776-42da-a7a6-d9e8835d58c1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Starting dose of 600\u00a0mg, which can be titrated\n  up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing\n  &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing\n  \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not\n  well tolerated, the dose should be reduced as clinically indicated based on\n  haemoglobin levels</span>", "ID": "5b1e5c67-03ff-4613-97df-b4b62e85801a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Starting dose of 600\u00a0mg, which can be titrated   up to a maximum of 1,000/1,200\u00a0mg (1,000\u00a0mg for patients weighing   <\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing   \u2265\u00a075\u00a0kg) if well tolerated.\u00a0 If the starting dose is not   well tolerated, the dose should be reduced as clinically indicated based on   haemoglobin levels", "ParentId": "c062d1ea-6753-46e7-81a3-a996b4cf9fe1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc601540-a554-4601-adee-3595bcb14a60", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4b1d699-48ef-4cb3-ba3c-bd0cef098cfe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc601540-a554-4601-adee-3595bcb14a60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If ribavirin is\nused in genotype\u00a03 infected patients with compensated cirrhosis (pre- or\npost-transplant) the recommended dose of ribavirin is 1,000/1,200</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">mg (</span><span lang=\"EN-GB\">1,000\u00a0mg\nfor patients weighing &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients\nweighing \u2265\u00a075\u00a0kg</span><span lang=\"EN-GB\">).</span></p>", "ID": "186536e7-7ac8-40ee-a169-590254031989", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If ribavirin is\nused in genotype\u00a03 infected patients with compensated cirrhosis (pre- or\npost-transplant) the recommended dose of ribavirin is 1,000/1,200</span>", "ID": "bc4a8039-9391-4254-bc45-2a52ea087f30", "Styles": "None", "Classes": "None", "Text": "If ribavirin is used in genotype\u00a03 infected patients with compensated cirrhosis (pre- or post-transplant) the recommended dose of ribavirin is 1,000/1,200", "ParentId": "186536e7-7ac8-40ee-a169-590254031989"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9f198592-1a63-4b7b-afa8-d52145e531a3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "186536e7-7ac8-40ee-a169-590254031989"}, {"Element": "<span lang=\"EN-GB\">mg (</span>", "ID": "38f2790d-6a3f-4670-959b-3319c2dc46e5", "Styles": "None", "Classes": "None", "Text": "mg (", "ParentId": "186536e7-7ac8-40ee-a169-590254031989"}, {"Element": "<span lang=\"EN-GB\">1,000\u00a0mg\nfor patients weighing &lt;\u00a075\u00a0kg and 1,200\u00a0mg for patients\nweighing \u2265\u00a075\u00a0kg</span>", "ID": "3c5c2cb4-32ca-4183-b65b-07cf3cd6525a", "Styles": "None", "Classes": "None", "Text": "1,000\u00a0mg for patients weighing <\u00a075\u00a0kg and 1,200\u00a0mg for patients weighing \u2265\u00a075\u00a0kg", "ParentId": "186536e7-7ac8-40ee-a169-590254031989"}, {"Element": "<span lang=\"EN-GB\">).</span>", "ID": "dd6e9007-5a46-4d10-b24b-e43db4411a5d", "Styles": "None", "Classes": "None", "Text": ").", "ParentId": "186536e7-7ac8-40ee-a169-590254031989"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d6e873e9-868f-4107-b87c-d02081d8ad14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "19e7f5e7-c2ac-4a52-8594-2320bd3f7587", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6e873e9-868f-4107-b87c-d02081d8ad14"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For ribavirin\ndose modifications, refer to the Summary of Product Characteristics of the\nmedicinal product containing ribavirin.</span></p>", "ID": "7e4564c0-d163-483a-8de7-dac236df440e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">For ribavirin\ndose modifications, refer to the Summary of Product Characteristics of the\nmedicinal product containing ribavirin.</span>", "ID": "34f3f8a9-8d40-4852-9d27-90adac06aeb7", "Styles": "None", "Classes": "None", "Text": "For ribavirin dose modifications, refer to the Summary of Product Characteristics of the medicinal product containing ribavirin.", "ParentId": "7e4564c0-d163-483a-8de7-dac236df440e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a893706a-434a-4304-8369-1946c372e99a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ef183dd1-520b-49c0-a2c4-c1276a2249e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a893706a-434a-4304-8369-1946c372e99a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients should\nbe instructed that if vomiting occurs within 3\u00a0hours of dosing an\nadditional tablet of Epclusa should be taken.\u00a0 If vomiting occurs more\nthan 3\u00a0hours after dosing, no further dose of Epclusa is needed (see\nsection\u00a05.1).</span></p>", "ID": "28093dbb-dedd-4337-8f82-bd4f7e12d232", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Patients should\nbe instructed that if vomiting occurs within 3\u00a0hours of dosing an\nadditional tablet of Epclusa should be taken.\u00a0 If vomiting occurs more\nthan 3\u00a0hours after dosing, no further dose of Epclusa is needed (see\nsection\u00a05.1).</span>", "ID": "fbfc44c5-3231-4f81-8367-039286188bb7", "Styles": "None", "Classes": "None", "Text": "Patients should be instructed that if vomiting occurs within 3\u00a0hours of dosing an additional tablet of Epclusa should be taken.\u00a0 If vomiting occurs more than 3\u00a0hours after dosing, no further dose of Epclusa is needed (see section\u00a05.1).", "ParentId": "28093dbb-dedd-4337-8f82-bd4f7e12d232"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b726aa6e-ec6a-421d-9532-d5da1587648f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da8db38f-9083-4a93-9436-750bc435f76f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b726aa6e-ec6a-421d-9532-d5da1587648f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If a dose of Epclusa\nis missed and it is within 18\u00a0hours of the normal time, patients should be\ninstructed to take the tablet as soon as possible and then patients should take\nthe next dose at the usual time.\u00a0 If it is after 18\u00a0hours then\npatients should be instructed to wait and take the next dose of Epclusa at the\nusual time.\u00a0 Patients should be instructed not to take a double dose of Epclusa.</span></p>", "ID": "912b6c4f-3763-41cb-bac3-544b874a444a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If a dose of Epclusa\nis missed and it is within 18\u00a0hours of the normal time, patients should be\ninstructed to take the tablet as soon as possible and then patients should take\nthe next dose at the usual time.\u00a0 If it is after 18\u00a0hours then\npatients should be instructed to wait and take the next dose of Epclusa at the\nusual time.\u00a0 Patients should be instructed not to take a double dose of Epclusa.</span>", "ID": "b0457ff1-7737-41ae-8d60-24e3d14a00be", "Styles": "None", "Classes": "None", "Text": "If a dose of Epclusa is missed and it is within 18\u00a0hours of the normal time, patients should be instructed to take the tablet as soon as possible and then patients should take the next dose at the usual time.\u00a0 If it is after 18\u00a0hours then patients should be instructed to wait and take the next dose of Epclusa at the usual time.\u00a0 Patients should be instructed not to take a double dose of Epclusa.", "ParentId": "912b6c4f-3763-41cb-bac3-544b874a444a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4e34d85f-9920-4f8e-ba21-58465fe22d6d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2892ddc4-c770-4ebf-9aa8-28a09915c97f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4e34d85f-9920-4f8e-ba21-58465fe22d6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></i></p>", "ID": "3347a5b8-6a30-4dec-8ce8-9e8048e09441", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></i>", "ID": "bc84f049-a370-41b4-aa78-593fe291752e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3347a5b8-6a30-4dec-8ce8-9e8048e09441"}, {"Element": "<span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span>", "ID": "da4ea32a-c957-4803-831f-3159cf9ff2c2", "Styles": "None", "Classes": "None", "Text": "Patients who have previously failed therapy with an NS5A-containing regimen", "ParentId": "bc84f049-a370-41b4-aa78-593fe291752e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa +\nribavirin for 24\u00a0weeks may be considered (see section\u00a04.4).</span></p>", "ID": "44a52f8d-c427-4619-8b1b-c2ce2af2a73b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa +\nribavirin for 24\u00a0weeks may be considered (see section\u00a04.4).</span>", "ID": "3b896154-1752-4d5f-abbd-a5e0d800962a", "Styles": "None", "Classes": "None", "Text": "Epclusa + ribavirin for 24\u00a0weeks may be considered (see section\u00a04.4).", "ParentId": "44a52f8d-c427-4619-8b1b-c2ce2af2a73b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6e49bf24-510f-4f75-a217-6ca923c1d988", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d215b3f-dc82-4afc-9401-4eee75f450ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6e49bf24-510f-4f75-a217-6ca923c1d988"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>", "ID": "aac378e7-911e-4dd4-be94-3e7c936d6aa8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Elderly</span></i>", "ID": "7ba9dbec-72bf-4877-9c4d-fe3ad4715309", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aac378e7-911e-4dd4-be94-3e7c936d6aa8"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "c3d81435-0e90-4ebe-831d-070c1c8ca6ab", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "7ba9dbec-72bf-4877-9c4d-fe3ad4715309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment is warranted for elderly patients (see section\u00a05.2).</span></p>", "ID": "e978037a-38e2-4ae3-8d88-0d31287a2dbc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment is warranted for elderly patients (see section\u00a05.2).</span>", "ID": "34e62a98-f96b-4f9f-8388-2567e07b0ea6", "Styles": "None", "Classes": "None", "Text": "No dose adjustment is warranted for elderly patients (see section\u00a05.2).", "ParentId": "e978037a-38e2-4ae3-8d88-0d31287a2dbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e599407b-fd08-4575-bb26-3bf679d626fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01f7f20c-4389-489d-9309-bee50e8e0818", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e599407b-fd08-4575-bb26-3bf679d626fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>", "ID": "c160a273-cc69-4967-ad59-4299283b50e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Renal impairment</span></i>", "ID": "080b3e25-dd1d-4269-bfd3-2b5b300ca1e7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c160a273-cc69-4967-ad59-4299283b50e3"}, {"Element": "<span lang=\"EN-GB\">Renal impairment</span>", "ID": "558208cd-2286-4c46-8f3d-0c6b951edb3f", "Styles": "None", "Classes": "None", "Text": "Renal impairment", "ParentId": "080b3e25-dd1d-4269-bfd3-2b5b300ca1e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> is\nrequired for patients with mild or moderate renal impairment. \u00a0The safety\nand efficacy of Epclusa has not been assessed in patients with severe renal impairment\n(estimated glomerular filtration rate\n[eGFR]\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>) or end stage\nrenal disease (ESRD) requiring haemodialysis (see section\u00a05.2).</span></p>", "ID": "161606b0-ba43-4f52-b82c-874d2afd10ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment of </span>", "ID": "0e50a3c2-7ca1-4e36-952a-f8f183cdaba6", "Styles": "None", "Classes": "None", "Text": "No dose adjustment of ", "ParentId": "161606b0-ba43-4f52-b82c-874d2afd10ae"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "855b0e68-3e8c-4327-ad5e-adca8f6143bf", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "161606b0-ba43-4f52-b82c-874d2afd10ae"}, {"Element": "<span lang=\"EN-GB\"> is\nrequired for patients with mild or moderate renal impairment. \u00a0The safety\nand efficacy of Epclusa has not been assessed in patients with severe renal impairment\n(estimated glomerular filtration rate\n[eGFR]\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>) or end stage\nrenal disease (ESRD) requiring haemodialysis (see section\u00a05.2).</span>", "ID": "640f337e-17a0-4028-9a81-173283c38bcd", "Styles": "None", "Classes": "None", "Text": " is required for patients with mild or moderate renal impairment. \u00a0The safety and efficacy of Epclusa has not been assessed in patients with severe renal impairment (estimated glomerular filtration rate [eGFR]\u00a0<\u00a030\u00a0mL/min/1.73\u00a0m) or end stage renal disease (ESRD) requiring haemodialysis (see section\u00a05.2).", "ParentId": "161606b0-ba43-4f52-b82c-874d2afd10ae"}, {"Element": "<sup>2</sup>", "ID": "074c737d-910a-4963-b3dd-478635ce842a", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "640f337e-17a0-4028-9a81-173283c38bcd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4834f009-33fc-488b-a88f-c3645333457c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aae4bda5-915a-4c16-8783-82d604997b19", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4834f009-33fc-488b-a88f-c3645333457c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>", "ID": "11de35af-3afe-427c-9add-95342d5c902f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Hepatic impairment</span></i>", "ID": "8aed3f30-fc2c-43a4-a5f5-04979185d56e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "11de35af-3afe-427c-9add-95342d5c902f"}, {"Element": "<span lang=\"EN-GB\">Hepatic impairment</span>", "ID": "b6a5fad3-3606-4caa-9e0a-0e93312dce74", "Styles": "None", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "8aed3f30-fc2c-43a4-a5f5-04979185d56e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">is required for patients with mild, moderate, or severe hepatic\nimpairment (CPT Class\u00a0A, B, or C) (see section\u00a05.2). \u00a0Safety and\nefficacy of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> have been assessed\nin patients with CPT Class\u00a0B cirrhosis, but not in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.4,\u00a04.8 and\u00a05.1).</span></p>", "ID": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment of </span>", "ID": "40126a52-0343-4ad3-9b72-ba8cde092170", "Styles": "None", "Classes": "None", "Text": "No dose adjustment of ", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "aed4b64c-fd58-4af0-8e40-a54b29e45572", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "565ecc54-84bc-4c69-80cf-e0c828092ecd", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<span lang=\"EN-GB\">is required for patients with mild, moderate, or severe hepatic\nimpairment (CPT Class\u00a0A, B, or C) (see section\u00a05.2). \u00a0Safety and\nefficacy of </span>", "ID": "7c3422fa-51b9-4112-8675-a06c6d50d82f", "Styles": "None", "Classes": "None", "Text": "is required for patients with mild, moderate, or severe hepatic impairment (CPT Class\u00a0A, B, or C) (see section\u00a05.2). \u00a0Safety and efficacy of ", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "101815d2-3c9e-4d80-b1a0-069171dd79cd", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<span lang=\"EN-GB\"> have been assessed\nin patients with CPT Class\u00a0B cirrhosis, but not in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.4,\u00a04.8 and\u00a05.1).</span>", "ID": "ec84dd50-bc3c-4da1-b290-fd912ac66f97", "Styles": "None", "Classes": "None", "Text": " have been assessed in patients with CPT Class\u00a0B cirrhosis, but not in patients with CPT Class\u00a0C cirrhosis (see sections\u00a04.4,\u00a04.8 and\u00a05.1).", "ParentId": "7edf8246-53e7-4ff6-b23d-f4995d36e4ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "54f8f295-11ea-489a-9e44-b9b3811fe12e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "99b33c40-be4a-44e0-af7a-6b50233e27be", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54f8f295-11ea-489a-9e44-b9b3811fe12e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>", "ID": "4f9fbcac-9233-4ac9-b006-c36755e98308", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Paediatric population</span></i>", "ID": "66cee33c-0122-4591-b099-8ba3eb08832a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f9fbcac-9233-4ac9-b006-c36755e98308"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "c3076f67-cff1-40ef-a4e7-3dfca7447c71", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "66cee33c-0122-4591-b099-8ba3eb08832a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Epclusa in children and adolescents aged less\nthan 18\u00a0years have not yet been established. \u00a0No data are available.</span></p>", "ID": "4714388b-1e6d-4577-80a3-4cb880033ea5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The safety and efficacy of Epclusa in children and adolescents aged less\nthan 18\u00a0years have not yet been established. \u00a0No data are available.</span>", "ID": "386c6c31-61fb-4274-8716-924b4b896dc5", "Styles": "None", "Classes": "None", "Text": "The safety and efficacy of Epclusa in children and adolescents aged less than 18\u00a0years have not yet been established. \u00a0No data are available.", "ParentId": "4714388b-1e6d-4577-80a3-4cb880033ea5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3072d4e7-2722-4079-a624-a97da782d78e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "516d513c-ade2-4888-9c69-0690acc7ca22", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3072d4e7-2722-4079-a624-a97da782d78e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>", "ID": "bf1fcd13-49f4-41cf-a6f9-99f2d5be560f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Method of administration</span></u>", "ID": "ba9847f2-4d0c-4da2-9abc-022aa7d9007c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf1fcd13-49f4-41cf-a6f9-99f2d5be560f"}, {"Element": "<span lang=\"EN-GB\">Method of administration</span>", "ID": "122d32f0-c713-4740-8c66-537a6dee589c", "Styles": "None", "Classes": "None", "Text": "Method of administration", "ParentId": "ba9847f2-4d0c-4da2-9abc-022aa7d9007c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For oral use.</span></p>", "ID": "d2c79a56-54cf-4879-a327-83888b48e1ee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">For oral use.</span>", "ID": "23bb5c99-7c6f-4ea7-b84a-522d89b34481", "Styles": "None", "Classes": "None", "Text": "For oral use.", "ParentId": "d2c79a56-54cf-4879-a327-83888b48e1ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "07b47dd3-f76f-4983-85f8-6eadb0e04930", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae7b1a99-3be4-487f-8e99-6199d9f6ea23", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "07b47dd3-f76f-4983-85f8-6eadb0e04930"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Patients should be instructed to swallow the tablet whole with or\nwithout food (see section\u00a05.2). \u00a0Due to the bitter taste, it is\nrecommended that the film\u2011coated tablet is not chewed or crushed.</span></p>", "ID": "e84da740-52d8-47d9-b225-99b9329d3afa", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Patients should be instructed to swallow the tablet whole with or\nwithout food (see section\u00a05.2). \u00a0Due to the bitter taste, it is\nrecommended that the film\u2011coated tablet is not chewed or crushed.</span>", "ID": "491d7cda-59dd-4bd0-b25c-e47d743335f1", "Styles": "None", "Classes": "None", "Text": "Patients should be instructed to swallow the tablet whole with or without food (see section\u00a05.2). \u00a0Due to the bitter taste, it is recommended that the film\u2011coated tablet is not chewed or crushed.", "ParentId": "e84da740-52d8-47d9-b225-99b9329d3afa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2c840a87-3007-4b11-a4d4-f5d6646ba684", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0badc8c7-182b-41f7-af6b-c25140dae41e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2c840a87-3007-4b11-a4d4-f5d6646ba684"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>", "ID": "9bedd403-80c5-4b8b-bebc-af2495d51ae3", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b>", "ID": "7cefae05-92af-4613-a642-eb1f62fbccd2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9bedd403-80c5-4b8b-bebc-af2495d51ae3"}, {"Element": "<span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span>", "ID": "6ae9b362-5c3b-45a5-b565-e8988faecbf4", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "7cefae05-92af-4613-a642-eb1f62fbccd2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64327e6a-1111-4c5c-aa67-1d135d613c87", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e3516b5b-8c60-4112-bfaf-66ae330ed3b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64327e6a-1111-4c5c-aa67-1d135d613c87"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\nto the active substances or to any of the excipients listed in section\u00a06.1.</span></p>", "ID": "00a2f4b2-bc52-4f49-8d5d-c268efbaf59f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Hypersensitivity\nto the active substances or to any of the excipients listed in section\u00a06.1.</span>", "ID": "270111c5-3147-45b2-8814-11c81dfdf542", "Styles": "None", "Classes": "None", "Text": "Hypersensitivity to the active substances or to any of the excipients listed in section\u00a06.1.", "ParentId": "00a2f4b2-bc52-4f49-8d5d-c268efbaf59f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e2921f5d-8f33-4d6f-9881-8e8f089bb479", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b2a95e12-ec79-4f24-a85f-48a6a701e44b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e2921f5d-8f33-4d6f-9881-8e8f089bb479"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with potent P\u2011gp and potent CYP inducers</span></u></p>", "ID": "c60b8068-eda0-4fcc-994c-6d2c0dc5664b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Use with potent P\u2011gp and potent CYP inducers</span></u>", "ID": "6b2f0e21-898d-41cb-b365-fa5f7cdbb4a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c60b8068-eda0-4fcc-994c-6d2c0dc5664b"}, {"Element": "<span lang=\"EN-GB\">Use with potent P\u2011gp and potent CYP inducers</span>", "ID": "983792de-6a57-44df-b209-2599f88f2d48", "Styles": "None", "Classes": "None", "Text": "Use with potent P\u2011gp and potent CYP inducers", "ParentId": "6b2f0e21-898d-41cb-b365-fa5f7cdbb4a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproducts that are potent P\u2011glycoprotein (P\u2011gp) or potent cytochrome\nP450 (CYP) inducers (rifampicin, rifabutin, St.\u00a0John\u2019s wort\n[Hypericum perforatum], carbamazepine, phenobarbital and phenytoin).\u00a0 Co\u2011administration\nwill significantly decrease sofosbuvir or velpatasvir plasma concentrations and\ncould result in loss of efficacy of Epclusa (see section\u00a04.5).</span></p>", "ID": "afccd247-223c-4b36-9899-b9d746d5ba2f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Medicinal\nproducts that are potent P\u2011glycoprotein (P\u2011gp) or potent cytochrome\nP450 (CYP) inducers (rifampicin, rifabutin, St.\u00a0John\u2019s wort\n[Hypericum perforatum], carbamazepine, phenobarbital and phenytoin).\u00a0 Co\u2011administration\nwill significantly decrease sofosbuvir or velpatasvir plasma concentrations and\ncould result in loss of efficacy of Epclusa (see section\u00a04.5).</span>", "ID": "a729800b-b57b-40b1-9fb3-a47f5f425f59", "Styles": "None", "Classes": "None", "Text": "Medicinal products that are potent P\u2011glycoprotein (P\u2011gp) or potent cytochrome P450 (CYP) inducers (rifampicin, rifabutin, St.\u00a0John\u2019s wort [Hypericum perforatum], carbamazepine, phenobarbital and phenytoin).\u00a0 Co\u2011administration will significantly decrease sofosbuvir or velpatasvir plasma concentrations and could result in loss of efficacy of Epclusa (see section\u00a04.5).", "ParentId": "afccd247-223c-4b36-9899-b9d746d5ba2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "965645d6-4422-4f92-9aa7-3cdb3b5120b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f265d90c-0093-444e-aaf9-f9c68a257586", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "965645d6-4422-4f92-9aa7-3cdb3b5120b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special\nwarnings and precautions for use</span></b></p>", "ID": "4ad99c43-e8f3-484f-94df-9d718edffc7c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special\nwarnings and precautions for use</span></b>", "ID": "32161ec9-cbfd-4c94-981e-fc5a53d627a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ad99c43-e8f3-484f-94df-9d718edffc7c"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special\nwarnings and precautions for use</span>", "ID": "b4fdcd12-635c-4132-a813-c284816d8e47", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "32161ec9-cbfd-4c94-981e-fc5a53d627a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "3b398dae-3952-4262-8df7-7fd3d9a08a76", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f28a426a-e037-4675-a280-8f2d67aae9d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b398dae-3952-4262-8df7-7fd3d9a08a76"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e0d29a0-c4c6-44b5-94a0-7f73f3dd0e2d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f28a426a-e037-4675-a280-8f2d67aae9d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> should not be administered concurrently with other medicinal\nproducts containing sofosbuvir.</span></p>", "ID": "2c519603-696f-42f1-bb46-1bd41f322eed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "9d8f8c8b-3bf0-423c-9c91-9a6da40b6f21", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "2c519603-696f-42f1-bb46-1bd41f322eed"}, {"Element": "<span lang=\"EN-GB\"> should not be administered concurrently with other medicinal\nproducts containing sofosbuvir.</span>", "ID": "6e5b66c7-4691-46c6-b4b1-e21cd1265f8b", "Styles": "None", "Classes": "None", "Text": " should not be administered concurrently with other medicinal products containing sofosbuvir.", "ParentId": "2c519603-696f-42f1-bb46-1bd41f322eed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ab636c4-f172-4fdc-b016-98c539737528", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4b3ee1fe-5a50-4325-b4a7-f268f50c94a3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ab636c4-f172-4fdc-b016-98c539737528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Severe bradycardia and heart block</span></u></p>", "ID": "34b23878-5f8c-4826-9aef-03c119e50fba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Severe bradycardia and heart block</span></u>", "ID": "79de9acc-ddda-4d07-bb22-06dba10290c8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "34b23878-5f8c-4826-9aef-03c119e50fba"}, {"Element": "<span lang=\"EN-GB\">Severe bradycardia and heart block</span>", "ID": "1672b00f-22be-4790-9bb5-a2975827e470", "Styles": "None", "Classes": "None", "Text": "Severe bradycardia and heart block", "ParentId": "79de9acc-ddda-4d07-bb22-06dba10290c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone with or without other medicinal\nproducts that lower heart rate.\u00a0 The mechanism is not established.</span></p>", "ID": "264a7056-cd58-43a1-9c58-37d7c64b50e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone with or without other medicinal\nproducts that lower heart rate.\u00a0 The mechanism is not established.</span>", "ID": "fb18cd43-97ec-425d-8230-38e7c5be21c7", "Styles": "None", "Classes": "None", "Text": "Cases of severe bradycardia and heart block have been observed when sofosbuvir-containing regimens are used in combination with amiodarone with or without other medicinal products that lower heart rate.\u00a0 The mechanism is not established.", "ParentId": "264a7056-cd58-43a1-9c58-37d7c64b50e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "43bc5622-819c-4e6d-858f-690503e9f212", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efc62f94-55cf-41ad-a9e2-06cd2c392143", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "43bc5622-819c-4e6d-858f-690503e9f212"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The concomitant\nuse of amiodarone was limited through the clinical development of sofosbuvir.\u00a0\nCases are potentially life threatening, therefore amiodarone should only be\nused in patients on Epclusa when other alternative anti-arrhythmic treatments\nare not tolerated or are contraindicated.</span></p>", "ID": "08ebd3d8-babb-4a6a-836e-18480f14f5e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The concomitant\nuse of amiodarone was limited through the clinical development of sofosbuvir.\u00a0\nCases are potentially life threatening, therefore amiodarone should only be\nused in patients on Epclusa when other alternative anti-arrhythmic treatments\nare not tolerated or are contraindicated.</span>", "ID": "83251238-d46c-4863-aea2-455f1854ec92", "Styles": "None", "Classes": "None", "Text": "The concomitant use of amiodarone was limited through the clinical development of sofosbuvir.\u00a0 Cases are potentially life threatening, therefore amiodarone should only be used in patients on Epclusa when other alternative anti-arrhythmic treatments are not tolerated or are contraindicated.", "ParentId": "08ebd3d8-babb-4a6a-836e-18480f14f5e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c83a7752-55a2-450b-af90-68336b4fac51", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2bd0d01f-638d-4d40-a011-0f484398e4e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c83a7752-55a2-450b-af90-68336b4fac51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Should\nconcomitant use of amiodarone be considered necessary, it is recommended that\npatients are closely monitored when initiating Epclusa.\u00a0 Patients who are\nidentified as being at high risk of bradyarrhythmia should be continuously\nmonitored for 48\u00a0hours in an appropriate clinical setting.</span></p>", "ID": "1b22c3c4-947a-4fc2-9251-de54639e0415", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Should\nconcomitant use of amiodarone be considered necessary, it is recommended that\npatients are closely monitored when initiating Epclusa.\u00a0 Patients who are\nidentified as being at high risk of bradyarrhythmia should be continuously\nmonitored for 48\u00a0hours in an appropriate clinical setting.</span>", "ID": "0dbc3c92-1a2c-4674-91ff-9a97e1e479d7", "Styles": "None", "Classes": "None", "Text": "Should concomitant use of amiodarone be considered necessary, it is recommended that patients are closely monitored when initiating Epclusa.\u00a0 Patients who are identified as being at high risk of bradyarrhythmia should be continuously monitored for 48\u00a0hours in an appropriate clinical setting.", "ParentId": "1b22c3c4-947a-4fc2-9251-de54639e0415"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9a6dbb4b-9325-454b-b31c-5ff930b38230", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd9701d2-a27a-4ecc-a00e-88386e0af44a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a6dbb4b-9325-454b-b31c-5ff930b38230"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to the long\nhalf-life of amiodarone, appropriate monitoring should also be carried out for\npatients who have discontinued amiodarone within the past few months and are to\nbe initiated on Epclusa.</span></p>", "ID": "3cc294ad-b619-46e1-b76d-7272e6dbf96f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Due to the long\nhalf-life of amiodarone, appropriate monitoring should also be carried out for\npatients who have discontinued amiodarone within the past few months and are to\nbe initiated on Epclusa.</span>", "ID": "1396ce1e-180e-4031-b59e-7e861a37337e", "Styles": "None", "Classes": "None", "Text": "Due to the long half-life of amiodarone, appropriate monitoring should also be carried out for patients who have discontinued amiodarone within the past few months and are to be initiated on Epclusa.", "ParentId": "3cc294ad-b619-46e1-b76d-7272e6dbf96f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bced9cbe-8519-4bf6-8bd1-199cb076c1b7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "000f8c7f-b1d0-4cea-851f-47636caa7e7f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bced9cbe-8519-4bf6-8bd1-199cb076c1b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">All patients\nreceiving Epclusa in combination with amiodarone with or without other medicinal\nproducts that lower heart rate should also be warned of the symptoms of\nbradycardia and heart block and should be advised to seek medical advice\nurgently should they experience them.</span></p>", "ID": "4484dfd7-4d90-405e-b4f8-6c257d94014a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">All patients\nreceiving Epclusa in combination with amiodarone with or without other medicinal\nproducts that lower heart rate should also be warned of the symptoms of\nbradycardia and heart block and should be advised to seek medical advice\nurgently should they experience them.</span>", "ID": "bb8bb335-cc91-496e-946c-f4ea472e2dba", "Styles": "None", "Classes": "None", "Text": "All patients receiving Epclusa in combination with amiodarone with or without other medicinal products that lower heart rate should also be warned of the symptoms of bradycardia and heart block and should be advised to seek medical advice urgently should they experience them.", "ParentId": "4484dfd7-4d90-405e-b4f8-6c257d94014a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "699df074-1860-4b25-aed0-dc35e8f46c13", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dcfc7611-69d8-45f1-89c7-d4b53711183c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "699df074-1860-4b25-aed0-dc35e8f46c13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></u></p>", "ID": "5585ad81-9229-40c9-a8a1-7ede6f681176", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span></u>", "ID": "f891c3f3-ba07-45a1-ab5c-2f2ac3a548b9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5585ad81-9229-40c9-a8a1-7ede6f681176"}, {"Element": "<span lang=\"EN-GB\">Patients who have previously failed therapy with an NS5A-containing\nregimen</span>", "ID": "15a51cfc-7ffe-46e9-94b8-2597a1c6838b", "Styles": "None", "Classes": "None", "Text": "Patients who have previously failed therapy with an NS5A-containing regimen", "ParentId": "f891c3f3-ba07-45a1-ab5c-2f2ac3a548b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\nclinical data to support the efficacy of sofosbuvir/velpatasvir for the\ntreatment of patients who have failed treatment with a regimen containing\nanother NS5A inhibitor.\u00a0 However, on the basis of NS5A resistance\nassociated variants (RAVs) typically seen in patients who have failed therapy\nwith other NS5A inhibitor containing regimens, the <i>in\u00a0vitro</i>\npharmacology of velpatasvir, and the outcomes of sofosbuvir/velpatasvir\ntreatment in NS5A-na\u00efve patients with baseline NS5A RAVs enrolled into the\nASTRAL-studies, treatment with Epclusa + RBV for 24\u00a0weeks can be\nconsidered for patients who have failed therapy on an NS5A-containing regimen\nand who are deemed at high risk for clinical disease progression and who do not\nhave alternative treatment options.</span></p>", "ID": "4f5f6cd5-707f-423c-87c1-d440a6cd3629", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">There are no\nclinical data to support the efficacy of sofosbuvir/velpatasvir for the\ntreatment of patients who have failed treatment with a regimen containing\nanother NS5A inhibitor.\u00a0 However, on the basis of NS5A resistance\nassociated variants (RAVs) typically seen in patients who have failed therapy\nwith other NS5A inhibitor containing regimens, the <i>in\u00a0vitro</i>\npharmacology of velpatasvir, and the outcomes of sofosbuvir/velpatasvir\ntreatment in NS5A-na\u00efve patients with baseline NS5A RAVs enrolled into the\nASTRAL-studies, treatment with Epclusa + RBV for 24\u00a0weeks can be\nconsidered for patients who have failed therapy on an NS5A-containing regimen\nand who are deemed at high risk for clinical disease progression and who do not\nhave alternative treatment options.</span>", "ID": "5835d65c-de29-4504-a9de-201a2d8937f2", "Styles": "None", "Classes": "None", "Text": "There are no clinical data to support the efficacy of sofosbuvir/velpatasvir for the treatment of patients who have failed treatment with a regimen containing another NS5A inhibitor.\u00a0 However, on the basis of NS5A resistance associated variants (RAVs) typically seen in patients who have failed therapy with other NS5A inhibitor containing regimens, the  pharmacology of velpatasvir, and the outcomes of sofosbuvir/velpatasvir treatment in NS5A-na\u00efve patients with baseline NS5A RAVs enrolled into the ASTRAL-studies, treatment with Epclusa + RBV for 24\u00a0weeks can be considered for patients who have failed therapy on an NS5A-containing regimen and who are deemed at high risk for clinical disease progression and who do not have alternative treatment options.", "ParentId": "4f5f6cd5-707f-423c-87c1-d440a6cd3629"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "69f540a8-ecc0-4e93-a7ca-07c1585f42de", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "5835d65c-de29-4504-a9de-201a2d8937f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "455ca86c-27bc-47af-9c62-ad7e8f6313df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "593d19c4-5ad2-4bb3-bf86-c55fcfdb2198", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "455ca86c-27bc-47af-9c62-ad7e8f6313df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Renal impairment</span></u></p>", "ID": "9e29b6c7-7a07-440c-864b-9658730c0732", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Renal impairment</span></u>", "ID": "098a1cd0-faa3-405a-b326-30157ebfdd56", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e29b6c7-7a07-440c-864b-9658730c0732"}, {"Element": "<span lang=\"EN-GB\">Renal impairment</span>", "ID": "8a324c84-9270-4439-93bc-1250bdf99f70", "Styles": "None", "Classes": "None", "Text": "Renal impairment", "ParentId": "098a1cd0-faa3-405a-b326-30157ebfdd56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of Epclusa is required for patients with mild or moderate renal\nimpairment.\u00a0 </span><span lang=\"EN-GB\">The safety of </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> has not been assessed in patients\nwith severe renal impairment (eGFR\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nor ESRD requiring haemodialysis.\u00a0 When </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\"> is used in combination with ribavirin refer also to the Summary of\nProduct Characteristics for ribavirin for patients with creatinine clearance\n&lt;\u00a050\u00a0mL/min (see section\u00a05.2).</span></p>", "ID": "b87884bb-677f-45fe-865a-f75676b34601", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment of Epclusa is required for patients with mild or moderate renal\nimpairment.\u00a0 </span>", "ID": "6ce13de7-0d96-4d89-be8f-fd48db0da0b0", "Styles": "None", "Classes": "None", "Text": "No dose adjustment of Epclusa is required for patients with mild or moderate renal impairment.\u00a0 ", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<span lang=\"EN-GB\">The safety of </span>", "ID": "c717a4b6-15f3-4df9-b093-c117e85af0c1", "Styles": "None", "Classes": "None", "Text": "The safety of ", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "31b6e821-563e-4087-9316-1e3370a5ada1", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<span lang=\"EN-GB\"> has not been assessed in patients\nwith severe renal impairment (eGFR\u00a0&lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nor ESRD requiring haemodialysis.\u00a0 When </span>", "ID": "65938739-0f7d-46db-b885-f1512ba7f718", "Styles": "None", "Classes": "None", "Text": " has not been assessed in patients with severe renal impairment (eGFR\u00a0<\u00a030\u00a0mL/min/1.73\u00a0m) or ESRD requiring haemodialysis.\u00a0 When ", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<sup>2</sup>", "ID": "3bf1359e-ea55-4dce-961c-4f9b1f1e5d71", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "65938739-0f7d-46db-b885-f1512ba7f718"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "d41be581-532d-4063-b054-a1789e45ea18", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<span lang=\"EN-GB\"> is used in combination with ribavirin refer also to the Summary of\nProduct Characteristics for ribavirin for patients with creatinine clearance\n&lt;\u00a050\u00a0mL/min (see section\u00a05.2).</span>", "ID": "f10ad541-2a10-4369-a947-d50347292508", "Styles": "None", "Classes": "None", "Text": " is used in combination with ribavirin refer also to the Summary of Product Characteristics for ribavirin for patients with creatinine clearance <\u00a050\u00a0mL/min (see section\u00a05.2).", "ParentId": "b87884bb-677f-45fe-865a-f75676b34601"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ee16153-70aa-43aa-b65f-7ae93e5a6a68", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a85bf792-4a82-4d61-8f0a-52b23d12b440", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ee16153-70aa-43aa-b65f-7ae93e5a6a68"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with moderate P\u2011gp inducers or moderate CYP inducers</span></u></p>", "ID": "64579caf-7bb4-418a-a7d7-74ea0e609d87", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Use with moderate P\u2011gp inducers or moderate CYP inducers</span></u>", "ID": "9ea2f9f7-57c0-41a8-8e5c-ec01bc933935", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64579caf-7bb4-418a-a7d7-74ea0e609d87"}, {"Element": "<span lang=\"EN-GB\">Use with moderate P\u2011gp inducers or moderate CYP inducers</span>", "ID": "c7ec993a-125c-4b87-aac3-6accb081eb5a", "Styles": "None", "Classes": "None", "Text": "Use with moderate P\u2011gp inducers or moderate CYP inducers", "ParentId": "9ea2f9f7-57c0-41a8-8e5c-ec01bc933935"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproducts that are moderate P\u2011gp or moderate CYP inducers (e.g. oxcarbazepine,\nmodafinil or efavirenz) may decrease sofosbuvir or velpatasvir plasma\nconcentrations leading to reduced therapeutic effect of Epclusa. \u00a0Co-administration\nof such medicinal products with Epclusa is not recommended (see\nsection\u00a04.5).</span></p>", "ID": "b120f6e9-5c76-4aab-9a12-ad445cba534f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Medicinal\nproducts that are moderate P\u2011gp or moderate CYP inducers (e.g. oxcarbazepine,\nmodafinil or efavirenz) may decrease sofosbuvir or velpatasvir plasma\nconcentrations leading to reduced therapeutic effect of Epclusa. \u00a0Co-administration\nof such medicinal products with Epclusa is not recommended (see\nsection\u00a04.5).</span>", "ID": "3fdada9d-8f04-4149-a265-b086edc4d6fc", "Styles": "None", "Classes": "None", "Text": "Medicinal products that are moderate P\u2011gp or moderate CYP inducers (e.g. oxcarbazepine, modafinil or efavirenz) may decrease sofosbuvir or velpatasvir plasma concentrations leading to reduced therapeutic effect of Epclusa. \u00a0Co-administration of such medicinal products with Epclusa is not recommended (see section\u00a04.5).", "ParentId": "b120f6e9-5c76-4aab-9a12-ad445cba534f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "29de8baf-dbc2-4628-9598-cfcb66f02839", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a073866-9bb2-448d-affd-f63cc339d770", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "29de8baf-dbc2-4628-9598-cfcb66f02839"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Use with certain HIV antiretroviral regimens</span></u></p>", "ID": "6d27a954-9930-41bb-acbf-dbe936c97140", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Use with certain HIV antiretroviral regimens</span></u>", "ID": "3427fc8d-7fad-44b3-a758-657ced7d1d10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6d27a954-9930-41bb-acbf-dbe936c97140"}, {"Element": "<span lang=\"EN-GB\">Use with certain HIV antiretroviral regimens</span>", "ID": "cb5ceb45-ef6b-4b94-af2f-9e621ef4420b", "Styles": "None", "Classes": "None", "Text": "Use with certain HIV antiretroviral regimens", "ParentId": "3427fc8d-7fad-44b3-a758-657ced7d1d10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa has been\nshown to increase tenofovir exposure, especially when used together with an HIV\nregimen containing tenofovir disoproxil fumarate and a pharmacokinetic enhancer\n(ritonavir or cobicistat).\u00a0 The safety of tenofovir disoproxil fumarate in\nthe setting of Epclusa and a pharmacokinetic enhancer has not been\nestablished.\u00a0 The potential risks and benefits associated with co\u2011administration\nof Epclusa with the fixed-dose combination tablet containing\nelvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate or\ntenofovir disoproxil fumarate given in conjunction with a boosted HIV protease\ninhibitor (e.g. atazanavir or darunavir) should be considered, particularly in\npatients at increased risk of renal dysfunction. \u00a0Patients receiving Epclusa\nconcomitantly with elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil\nfumarate or with tenofovir disoproxil fumarate and a boosted HIV protease\ninhibitor should be monitored for tenofovir\u2011associated adverse reactions.\n\u00a0Refer to tenofovir disoproxil fumarate, emtricitabine/tenofovir\ndisoproxil fumarate, or elvitegravir/cobicistat/emtricitabine/tenofovir\ndisoproxil fumarate Summary of Product Characteristics for recommendations on\nrenal monitoring.</span></p>", "ID": "482e66f7-20f8-45bd-a311-18947e717573", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa has been\nshown to increase tenofovir exposure, especially when used together with an HIV\nregimen containing tenofovir disoproxil fumarate and a pharmacokinetic enhancer\n(ritonavir or cobicistat).\u00a0 The safety of tenofovir disoproxil fumarate in\nthe setting of Epclusa and a pharmacokinetic enhancer has not been\nestablished.\u00a0 The potential risks and benefits associated with co\u2011administration\nof Epclusa with the fixed-dose combination tablet containing\nelvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate or\ntenofovir disoproxil fumarate given in conjunction with a boosted HIV protease\ninhibitor (e.g. atazanavir or darunavir) should be considered, particularly in\npatients at increased risk of renal dysfunction. \u00a0Patients receiving Epclusa\nconcomitantly with elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil\nfumarate or with tenofovir disoproxil fumarate and a boosted HIV protease\ninhibitor should be monitored for tenofovir\u2011associated adverse reactions.\n\u00a0Refer to tenofovir disoproxil fumarate, emtricitabine/tenofovir\ndisoproxil fumarate, or elvitegravir/cobicistat/emtricitabine/tenofovir\ndisoproxil fumarate Summary of Product Characteristics for recommendations on\nrenal monitoring.</span>", "ID": "40a4459e-7e95-4b95-a73a-cbc0063dc493", "Styles": "None", "Classes": "None", "Text": "Epclusa has been shown to increase tenofovir exposure, especially when used together with an HIV regimen containing tenofovir disoproxil fumarate and a pharmacokinetic enhancer (ritonavir or cobicistat).\u00a0 The safety of tenofovir disoproxil fumarate in the setting of Epclusa and a pharmacokinetic enhancer has not been established.\u00a0 The potential risks and benefits associated with co\u2011administration of Epclusa with the fixed-dose combination tablet containing elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate or tenofovir disoproxil fumarate given in conjunction with a boosted HIV protease inhibitor (e.g. atazanavir or darunavir) should be considered, particularly in patients at increased risk of renal dysfunction. \u00a0Patients receiving Epclusa concomitantly with elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate or with tenofovir disoproxil fumarate and a boosted HIV protease inhibitor should be monitored for tenofovir\u2011associated adverse reactions. \u00a0Refer to tenofovir disoproxil fumarate, emtricitabine/tenofovir disoproxil fumarate, or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Summary of Product Characteristics for recommendations on renal monitoring.", "ParentId": "482e66f7-20f8-45bd-a311-18947e717573"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "18f2c893-260d-4f36-a3ba-ba92d7c351d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "76f86670-56e4-461a-a909-4b208b133991", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "18f2c893-260d-4f36-a3ba-ba92d7c351d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Use in\ndiabetic patients </span></u></p>", "ID": "b5213055-c7f7-4ba0-b963-7edd915071d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Use in\ndiabetic patients </span></u>", "ID": "177cbd03-b004-40a9-a738-adc33eb3fd24", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5213055-c7f7-4ba0-b963-7edd915071d7"}, {"Element": "<span lang=\"EN-GB\">Use in\ndiabetic patients </span>", "ID": "6dffaa2b-1c57-43de-9c87-ed20099781b7", "Styles": "None", "Classes": "None", "Text": "Use in diabetic patients ", "ParentId": "177cbd03-b004-40a9-a738-adc33eb3fd24"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diabetics may\nexperience improved glucose control, potentially resulting in symptomatic\nhypoglycaemia, after initiating HCV direct-acting antiviral treatment. Glucose\nlevels of diabetic patients initiating direct-acting antiviral therapy should\nbe closely monitored, particularly within the first 3 months, and their\ndiabetic medication modified when necessary. The physician in charge of the\ndiabetic care of the patient should be informed when direct-acting antiviral\ntherapy is initiated.</span></p>", "ID": "aad6c397-22d7-4a67-a502-1fbe80205cb5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Diabetics may\nexperience improved glucose control, potentially resulting in symptomatic\nhypoglycaemia, after initiating HCV direct-acting antiviral treatment. Glucose\nlevels of diabetic patients initiating direct-acting antiviral therapy should\nbe closely monitored, particularly within the first 3 months, and their\ndiabetic medication modified when necessary. The physician in charge of the\ndiabetic care of the patient should be informed when direct-acting antiviral\ntherapy is initiated.</span>", "ID": "d8910d90-d2d9-4a42-9041-5857750920fb", "Styles": "None", "Classes": "None", "Text": "Diabetics may experience improved glucose control, potentially resulting in symptomatic hypoglycaemia, after initiating HCV direct-acting antiviral treatment. Glucose levels of diabetic patients initiating direct-acting antiviral therapy should be closely monitored, particularly within the first 3 months, and their diabetic medication modified when necessary. The physician in charge of the diabetic care of the patient should be informed when direct-acting antiviral therapy is initiated.", "ParentId": "aad6c397-22d7-4a67-a502-1fbe80205cb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "c172f47f-896a-496d-8253-a8986af2cf40", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "34ae390e-7c91-4bab-8153-e6af1da58dc0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c172f47f-896a-496d-8253-a8986af2cf40"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "43f31b12-9e8d-4d12-9594-b2c9d4764bfb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "34ae390e-7c91-4bab-8153-e6af1da58dc0"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "9d961c88-f14e-4a45-909d-ab2c29ce17d7", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "43f31b12-9e8d-4d12-9594-b2c9d4764bfb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">HCV/HBV (hepatitis\u00a0B virus) co\u2011infection</span></u></p>", "ID": "328ee8f5-eae3-4162-8753-ec091df8a09f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">HCV/HBV (hepatitis\u00a0B virus) co\u2011infection</span></u>", "ID": "ba3ad5fa-232d-4471-a0af-3ec7395f2db4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "328ee8f5-eae3-4162-8753-ec091df8a09f"}, {"Element": "<span lang=\"EN-GB\">HCV/HBV (hepatitis\u00a0B virus) co\u2011infection</span>", "ID": "a5e43390-b2db-44f4-b819-67c4af4993d5", "Styles": "None", "Classes": "None", "Text": "HCV/HBV (hepatitis\u00a0B virus) co\u2011infection", "ParentId": "ba3ad5fa-232d-4471-a0af-3ec7395f2db4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of\nhepatitis B\u00a0virus (HBV) reactivation, some of them fatal, have been\nreported during or after treatment with direct-acting antiviral agents. \u00a0HBV\nscreening should be performed in all patients before initiation of treatment. \u00a0HBV/HCV\nco-infected patients are at risk of HBV reactivation, and should therefore be\nmonitored and managed according to current clinical guidelines.</span></p>", "ID": "b4107c4b-05ab-45b6-b6d8-6759ddf978cd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Cases of\nhepatitis B\u00a0virus (HBV) reactivation, some of them fatal, have been\nreported during or after treatment with direct-acting antiviral agents. \u00a0HBV\nscreening should be performed in all patients before initiation of treatment. \u00a0HBV/HCV\nco-infected patients are at risk of HBV reactivation, and should therefore be\nmonitored and managed according to current clinical guidelines.</span>", "ID": "b8a7af39-80a6-4c63-8d31-eaece84730f7", "Styles": "None", "Classes": "None", "Text": "Cases of hepatitis B\u00a0virus (HBV) reactivation, some of them fatal, have been reported during or after treatment with direct-acting antiviral agents. \u00a0HBV screening should be performed in all patients before initiation of treatment. \u00a0HBV/HCV co-infected patients are at risk of HBV reactivation, and should therefore be monitored and managed according to current clinical guidelines.", "ParentId": "b4107c4b-05ab-45b6-b6d8-6759ddf978cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4df5b13e-474f-4c0c-95a5-12ac667af551", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65a3de3f-b51a-4cf7-b2db-427bad9157c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4df5b13e-474f-4c0c-95a5-12ac667af551"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">CPT Class\u00a0C cirrhosis</span></u></p>", "ID": "a5fb962e-fae0-4391-89a3-60253e4b4211", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">CPT Class\u00a0C cirrhosis</span></u>", "ID": "3637ff51-bcf1-468d-9760-0e50b1e53783", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a5fb962e-fae0-4391-89a3-60253e4b4211"}, {"Element": "<span lang=\"EN-GB\">CPT Class\u00a0C cirrhosis</span>", "ID": "7e36d4f1-d2ce-4061-a1f2-7f71b73de336", "Styles": "None", "Classes": "None", "Text": "CPT Class\u00a0C cirrhosis", "ParentId": "3637ff51-bcf1-468d-9760-0e50b1e53783"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Safety and\nefficacy of Epclusa has not been assessed in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.8 and\u00a05.1).</span></p>", "ID": "890fe9c8-0a70-4812-af50-48c7173308a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Safety and\nefficacy of Epclusa has not been assessed in patients with CPT Class\u00a0C\ncirrhosis (see sections\u00a04.8 and\u00a05.1).</span>", "ID": "6351802a-4a68-49f4-90d2-7dfeb773fc20", "Styles": "None", "Classes": "None", "Text": "Safety and efficacy of Epclusa has not been assessed in patients with CPT Class\u00a0C cirrhosis (see sections\u00a04.8 and\u00a05.1).", "ParentId": "890fe9c8-0a70-4812-af50-48c7173308a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b9207d15-d5ed-4102-9dd5-5fcfc32c52f9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d26a0cbd-5009-42ee-8d82-6bf3c5bc79db", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9207d15-d5ed-4102-9dd5-5fcfc32c52f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Liver transplant patients</span></u></p>", "ID": "43f91314-2018-4497-8baf-def1d44d25f7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Liver transplant patients</span></u>", "ID": "ccfb850b-8401-403a-a27b-240718f0c4e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43f91314-2018-4497-8baf-def1d44d25f7"}, {"Element": "<span lang=\"EN-GB\">Liver transplant patients</span>", "ID": "a8d63ec5-24a0-467e-a63f-74ba9b83166d", "Styles": "None", "Classes": "None", "Text": "Liver transplant patients", "ParentId": "ccfb850b-8401-403a-a27b-240718f0c4e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and\nefficacy of Epclusa in the treatment of HCV infection in patients who are post\u2011liver\ntransplant have not been assessed.\u00a0 Treatment with Epclusa in accordance\nwith the recommended posology (see section\u00a04.2) should be guided by an\nassessment of the potential benefits and risks for the individual patient.</span></p>", "ID": "5d4ef3f1-20c1-47b1-91fc-32dfc1955700", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The safety and\nefficacy of Epclusa in the treatment of HCV infection in patients who are post\u2011liver\ntransplant have not been assessed.\u00a0 Treatment with Epclusa in accordance\nwith the recommended posology (see section\u00a04.2) should be guided by an\nassessment of the potential benefits and risks for the individual patient.</span>", "ID": "0126cb81-a446-40d5-8042-f32ab5f683be", "Styles": "None", "Classes": "None", "Text": "The safety and efficacy of Epclusa in the treatment of HCV infection in patients who are post\u2011liver transplant have not been assessed.\u00a0 Treatment with Epclusa in accordance with the recommended posology (see section\u00a04.2) should be guided by an assessment of the potential benefits and risks for the individual patient.", "ParentId": "5d4ef3f1-20c1-47b1-91fc-32dfc1955700"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6abbcc74-2414-4f8b-86e9-98a14610720a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ea93364-f797-43f4-bcb2-47da0ed7c62b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6abbcc74-2414-4f8b-86e9-98a14610720a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction\nwith other medicinal products and other forms of interaction</span></b></p>", "ID": "fb2472e9-9e78-4308-9755-11c6931502f4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction\nwith other medicinal products and other forms of interaction</span></b>", "ID": "dce3e9df-e43b-4ac3-b73c-1e7b4d255626", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb2472e9-9e78-4308-9755-11c6931502f4"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction\nwith other medicinal products and other forms of interaction</span>", "ID": "74743c79-ab53-412a-94c5-ad1400b3d5a0", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "dce3e9df-e43b-4ac3-b73c-1e7b4d255626"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "66a1fb8f-68ae-496d-b9f0-3d064e77e957", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f4d7d2b-8f16-4e21-871b-c6f598fcdd93", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "66a1fb8f-68ae-496d-b9f0-3d064e77e957"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As</span><span lang=\"EN-GB\"> Epclusa </span><span lang=\"EN-GB\">contains\nsofosbuvir and velpatasvir, any interactions that have been identified with\nthese active substances individually may occur with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.</span></p>", "ID": "9e9756bc-11f2-4655-a5f1-67c60c1507fe", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">As</span>", "ID": "c2117d2c-022f-44e5-888f-3b185eea392f", "Styles": "None", "Classes": "None", "Text": "As", "ParentId": "9e9756bc-11f2-4655-a5f1-67c60c1507fe"}, {"Element": "<span lang=\"EN-GB\"> Epclusa </span>", "ID": "f1bff3e1-e52b-4122-ab15-b91a60cfb3de", "Styles": "None", "Classes": "None", "Text": " Epclusa ", "ParentId": "9e9756bc-11f2-4655-a5f1-67c60c1507fe"}, {"Element": "<span lang=\"EN-GB\">contains\nsofosbuvir and velpatasvir, any interactions that have been identified with\nthese active substances individually may occur with </span>", "ID": "ffbe632a-e95a-47b7-bdd2-5c12250991c7", "Styles": "None", "Classes": "None", "Text": "contains sofosbuvir and velpatasvir, any interactions that have been identified with these active substances individually may occur with ", "ParentId": "9e9756bc-11f2-4655-a5f1-67c60c1507fe"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "82e77263-003b-4997-bc28-c3a6ec4db844", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "9e9756bc-11f2-4655-a5f1-67c60c1507fe"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "0334498e-d1e1-4c43-b518-9bb54c6ff47c", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "9e9756bc-11f2-4655-a5f1-67c60c1507fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a99768ae-613d-4fa5-8ad2-6c57ae69ebd4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fa9ee3a3-c6e8-4ddc-a977-f10f1ebf813c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a99768ae-613d-4fa5-8ad2-6c57ae69ebd4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Potential for Epclusa to affect other medicinal products</span></u></p>", "ID": "ce40728e-8267-4c55-9367-d1b34a9bbb57", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Potential for Epclusa to affect other medicinal products</span></u>", "ID": "8b864547-6e09-4d6f-8967-0ef6069c9437", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce40728e-8267-4c55-9367-d1b34a9bbb57"}, {"Element": "<span lang=\"EN-GB\">Potential for Epclusa to affect other medicinal products</span>", "ID": "d0ffb680-c148-42ef-9bf4-e1cbab2b631e", "Styles": "None", "Classes": "None", "Text": "Potential for Epclusa to affect other medicinal products", "ParentId": "8b864547-6e09-4d6f-8967-0ef6069c9437"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Velpatasvir is an inhibitor of drug transporter P\u2011gp, breast\ncancer resistance protein (BCRP), organic anion\u2011transporting polypeptide\n(OATP)\u00a01B1 and OATP1B3. \u00a0Co\u2011administration of Epclusa with\nmedicinal products that are substrates of these transporters may increase the\nexposure of such medicinal products. \u00a0See Table\u00a03 for examples of\ninteractions with sensitive substrates of P\u2011gp (digoxin), BCRP\n(rosuvastatin), and OATP (pravastatin).</span></p>", "ID": "a84cb3fb-75d3-4eb8-8708-21159cf14c46", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir is an inhibitor of drug transporter P\u2011gp, breast\ncancer resistance protein (BCRP), organic anion\u2011transporting polypeptide\n(OATP)\u00a01B1 and OATP1B3. \u00a0Co\u2011administration of Epclusa with\nmedicinal products that are substrates of these transporters may increase the\nexposure of such medicinal products. \u00a0See Table\u00a03 for examples of\ninteractions with sensitive substrates of P\u2011gp (digoxin), BCRP\n(rosuvastatin), and OATP (pravastatin).</span>", "ID": "defb286e-d854-4a32-a058-239741dfea93", "Styles": "None", "Classes": "None", "Text": "Velpatasvir is an inhibitor of drug transporter P\u2011gp, breast cancer resistance protein (BCRP), organic anion\u2011transporting polypeptide (OATP)\u00a01B1 and OATP1B3. \u00a0Co\u2011administration of Epclusa with medicinal products that are substrates of these transporters may increase the exposure of such medicinal products. \u00a0See Table\u00a03 for examples of interactions with sensitive substrates of P\u2011gp (digoxin), BCRP (rosuvastatin), and OATP (pravastatin).", "ParentId": "a84cb3fb-75d3-4eb8-8708-21159cf14c46"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "38bc4ff5-1dd8-4fbb-bb59-18b06cb3b04e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "63663cb2-606e-403d-8b98-5b76d8d750e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38bc4ff5-1dd8-4fbb-bb59-18b06cb3b04e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Potential for other medicinal products to affect Epclusa</span></u></p>", "ID": "87627288-599d-4b22-a22c-8cbc1c63b9a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Potential for other medicinal products to affect Epclusa</span></u>", "ID": "7c38d572-af16-48fd-a5d4-8afcedd4663e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87627288-599d-4b22-a22c-8cbc1c63b9a5"}, {"Element": "<span lang=\"EN-GB\">Potential for other medicinal products to affect Epclusa</span>", "ID": "5a3b9e2a-937f-402c-a4b5-643554ca7a39", "Styles": "None", "Classes": "None", "Text": "Potential for other medicinal products to affect Epclusa", "ParentId": "7c38d572-af16-48fd-a5d4-8afcedd4663e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP.\u00a0 Velpatasvir\nis also a substrate of drug transporter OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8 and CYP3A4 was\nobserved. \u00a0Medicinal products that are potent inducers of P\u2011gp or potent\ninducers of CYP2B6, CYP2C8, or CYP3A4 (e.g. rifampicin, rifabutin, St.\u00a0John\u2019s\nwort, carbamazepine, phenobarbital and phenytoin) may decrease plasma\nconcentrations of sofosbuvir or velpatasvir leading to reduced therapeutic\neffect of sofosbuvir/velpatasvir.\u00a0 The use of such medicinal products with\nEpclusa is contraindicated (see section\u00a04.3).\u00a0 Medicinal products\nthat are moderate P\u2011gp\u00a0inducers or moderate CYP inducers (e.g.\noxcarbazepine, modafinil or efavirenz) may decrease sofosbuvir or velpatasvir\nplasma concentration leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\nwith such medicinal products is not recommended with Epclusa (see\nsection\u00a04.4).\u00a0 Co\u2011administration with medicinal products that\ninhibit P\u2011gp or BCRP may increase sofosbuvir or velpatasvir plasma\nconcentrations.\u00a0 Medicinal products that inhibit OATP, CYP2B6, CYP2C8, or\nCYP3A4 may increase plasma concentration of velpatasvir. \u00a0Clinically\nsignificant medicinal product interactions with Epclusa mediated by P\u2011gp,\nBCRP, OATP, or CYP450 inhibitors are not expected; Epclusa may be co\u2011administered\nwith P\u2011gp, BCRP, OATP and CYP\u00a0inhibitors.</span></p>", "ID": "9dc8366e-96dc-4c73-8bae-a4a3cef77cb5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP.\u00a0 Velpatasvir\nis also a substrate of drug transporter OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8 and CYP3A4 was\nobserved. \u00a0Medicinal products that are potent inducers of P\u2011gp or potent\ninducers of CYP2B6, CYP2C8, or CYP3A4 (e.g. rifampicin, rifabutin, St.\u00a0John\u2019s\nwort, carbamazepine, phenobarbital and phenytoin) may decrease plasma\nconcentrations of sofosbuvir or velpatasvir leading to reduced therapeutic\neffect of sofosbuvir/velpatasvir.\u00a0 The use of such medicinal products with\nEpclusa is contraindicated (see section\u00a04.3).\u00a0 Medicinal products\nthat are moderate P\u2011gp\u00a0inducers or moderate CYP inducers (e.g.\noxcarbazepine, modafinil or efavirenz) may decrease sofosbuvir or velpatasvir\nplasma concentration leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\nwith such medicinal products is not recommended with Epclusa (see\nsection\u00a04.4).\u00a0 Co\u2011administration with medicinal products that\ninhibit P\u2011gp or BCRP may increase sofosbuvir or velpatasvir plasma\nconcentrations.\u00a0 Medicinal products that inhibit OATP, CYP2B6, CYP2C8, or\nCYP3A4 may increase plasma concentration of velpatasvir. \u00a0Clinically\nsignificant medicinal product interactions with Epclusa mediated by P\u2011gp,\nBCRP, OATP, or CYP450 inhibitors are not expected; Epclusa may be co\u2011administered\nwith P\u2011gp, BCRP, OATP and CYP\u00a0inhibitors.</span>", "ID": "35a2311b-8d5b-4646-9fd1-143316608184", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir and velpatasvir are substrates of drug transporters P\u2011gp and BCRP.\u00a0 Velpatasvir is also a substrate of drug transporter OATP1B.\u00a0  slow metabolic turnover of velpatasvir by CYP2B6, CYP2C8 and CYP3A4 was observed. \u00a0Medicinal products that are potent inducers of P\u2011gp or potent inducers of CYP2B6, CYP2C8, or CYP3A4 (e.g. rifampicin, rifabutin, St.\u00a0John\u2019s wort, carbamazepine, phenobarbital and phenytoin) may decrease plasma concentrations of sofosbuvir or velpatasvir leading to reduced therapeutic effect of sofosbuvir/velpatasvir.\u00a0 The use of such medicinal products with Epclusa is contraindicated (see section\u00a04.3).\u00a0 Medicinal products that are moderate P\u2011gp\u00a0inducers or moderate CYP inducers (e.g. oxcarbazepine, modafinil or efavirenz) may decrease sofosbuvir or velpatasvir plasma concentration leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration with such medicinal products is not recommended with Epclusa (see section\u00a04.4).\u00a0 Co\u2011administration with medicinal products that inhibit P\u2011gp or BCRP may increase sofosbuvir or velpatasvir plasma concentrations.\u00a0 Medicinal products that inhibit OATP, CYP2B6, CYP2C8, or CYP3A4 may increase plasma concentration of velpatasvir. \u00a0Clinically significant medicinal product interactions with Epclusa mediated by P\u2011gp, BCRP, OATP, or CYP450 inhibitors are not expected; Epclusa may be co\u2011administered with P\u2011gp, BCRP, OATP and CYP\u00a0inhibitors.", "ParentId": "9dc8366e-96dc-4c73-8bae-a4a3cef77cb5"}, {"Element": "<i>In\u00a0vitro,</i>", "ID": "def47bee-2a1d-4eee-ad51-17ccb2920501", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro,", "ParentId": "35a2311b-8d5b-4646-9fd1-143316608184"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4076fe7-180a-4a7d-9876-023cd1a5c9da", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a306554-099e-4152-b6bd-8bbe8e1a9df6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4076fe7-180a-4a7d-9876-023cd1a5c9da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients treated with vitamin\u00a0K antagonists</span></u></p>", "ID": "9a249cca-9d49-455b-b75a-8c623bbeec02", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Patients treated with vitamin\u00a0K antagonists</span></u>", "ID": "bafed165-bac4-45e8-a3d3-a7b043e720ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a249cca-9d49-455b-b75a-8c623bbeec02"}, {"Element": "<span lang=\"EN-GB\">Patients treated with vitamin\u00a0K antagonists</span>", "ID": "ab92b06d-f2cb-41e0-abc7-f7f6e4fdc4b0", "Styles": "None", "Classes": "None", "Text": "Patients treated with vitamin\u00a0K antagonists", "ParentId": "bafed165-bac4-45e8-a3d3-a7b043e720ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">As liver\nfunction may change during treatment with Epclusa, a close monitoring of\nInternational Normalised Ratio (INR) values is recommended.</span></p>", "ID": "a91dccf3-c126-4450-9f04-3fbbcc220f22", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">As liver\nfunction may change during treatment with Epclusa, a close monitoring of\nInternational Normalised Ratio (INR) values is recommended.</span>", "ID": "a320c2c9-6850-4e92-aff0-06acd3ee0441", "Styles": "None", "Classes": "None", "Text": "As liver function may change during treatment with Epclusa, a close monitoring of International Normalised Ratio (INR) values is recommended.", "ParentId": "a91dccf3-c126-4450-9f04-3fbbcc220f22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b6c13a1-3760-4006-b12c-29c8e742e794", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d3ca7ea-02d1-44b6-9ecd-acfef94d75c9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b6c13a1-3760-4006-b12c-29c8e742e794"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Interactions between Epclusa and other medicinal products</span></u></p>", "ID": "b08bcb19-c76d-4265-9037-9cb84c56bdd5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Interactions between Epclusa and other medicinal products</span></u>", "ID": "9ff0403c-b9d4-431c-af44-5662425a2d65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b08bcb19-c76d-4265-9037-9cb84c56bdd5"}, {"Element": "<span lang=\"EN-GB\">Interactions between Epclusa and other medicinal products</span>", "ID": "c796e9cb-222a-48f8-b920-68988bd6c1dc", "Styles": "None", "Classes": "None", "Text": "Interactions between Epclusa and other medicinal products", "ParentId": "9ff0403c-b9d4-431c-af44-5662425a2d65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">3 provides a listing of established or\npotentially clinically significant medicinal product interactions (where 90%\nconfidence interval [CI] of the geometric least\u2011squares mean [GLSM] ratio\nwere within \u201c\u2194\u201d, extended above \u201c\u2191\u201d, or\nextended below \u201c\u2193\u201d the predetermined interaction boundaries).\u00a0\nThe medicinal product interactions described are based on studies conducted\nwith either </span><span lang=\"EN-GB\">sofosbuvir/velpatasvir or velpatasvir and\nsofosbuvir as individual agents, or are predicted medicinal product\ninteractions that may occur with sofosbuvir/velpatasvir.\u00a0 The table is not\nall\u2011inclusive.</span></p>", "ID": "fa943ca4-ad53-4b1e-90cd-9f084a09d404", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table</span>", "ID": "5e4f2370-988b-4171-bfc7-60264705a054", "Styles": "None", "Classes": "None", "Text": "Table", "ParentId": "fa943ca4-ad53-4b1e-90cd-9f084a09d404"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ab742672-845f-4138-8b0c-99282260612e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa943ca4-ad53-4b1e-90cd-9f084a09d404"}, {"Element": "<span lang=\"EN-GB\">3 provides a listing of established or\npotentially clinically significant medicinal product interactions (where 90%\nconfidence interval [CI] of the geometric least\u2011squares mean [GLSM] ratio\nwere within \u201c\u2194\u201d, extended above \u201c\u2191\u201d, or\nextended below \u201c\u2193\u201d the predetermined interaction boundaries).\u00a0\nThe medicinal product interactions described are based on studies conducted\nwith either </span>", "ID": "54974f5c-858d-4496-8bc1-926e7234fc5b", "Styles": "None", "Classes": "None", "Text": "3 provides a listing of established or potentially clinically significant medicinal product interactions (where 90% confidence interval [CI] of the geometric least\u2011squares mean [GLSM] ratio were within \u201c\u2194\u201d, extended above \u201c\u2191\u201d, or extended below \u201c\u2193\u201d the predetermined interaction boundaries).\u00a0 The medicinal product interactions described are based on studies conducted with either ", "ParentId": "fa943ca4-ad53-4b1e-90cd-9f084a09d404"}, {"Element": "<span lang=\"EN-GB\">sofosbuvir/velpatasvir or velpatasvir and\nsofosbuvir as individual agents, or are predicted medicinal product\ninteractions that may occur with sofosbuvir/velpatasvir.\u00a0 The table is not\nall\u2011inclusive.</span>", "ID": "b724cbad-00fc-4fcd-9f6c-0bfd8f6bddf4", "Styles": "None", "Classes": "None", "Text": "sofosbuvir/velpatasvir or velpatasvir and sofosbuvir as individual agents, or are predicted medicinal product interactions that may occur with sofosbuvir/velpatasvir.\u00a0 The table is not all\u2011inclusive.", "ParentId": "fa943ca4-ad53-4b1e-90cd-9f084a09d404"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a745d11e-4087-463c-8453-ca1eeca6161e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2bddef10-89ea-468e-a9dd-612abd14eff0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a745d11e-4087-463c-8453-ca1eeca6161e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a03: Interactions between </span></b><b><span lang=\"EN-GB\">Epclusa</span></b><span lang=\"EN-GB\"> <b>and other medicinal products</b></span></p>", "ID": "d0630865-b174-48f0-b6ba-b1c001ad3777", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a03: Interactions between </span></b>", "ID": "7cf1c9b4-fde3-4250-9140-3d30ec9d88dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0630865-b174-48f0-b6ba-b1c001ad3777"}, {"Element": "<span lang=\"EN-GB\">Table\u00a03: Interactions between </span>", "ID": "5496413a-a8d9-41f5-b719-6aae71fbb13f", "Styles": "None", "Classes": "None", "Text": "Table\u00a03: Interactions between ", "ParentId": "7cf1c9b4-fde3-4250-9140-3d30ec9d88dd"}, {"Element": "<b><span lang=\"EN-GB\">Epclusa</span></b>", "ID": "4017aa34-09cc-4d47-b09c-2e652adf3b7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0630865-b174-48f0-b6ba-b1c001ad3777"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "ee30331a-b123-4312-83ea-7bdfe4dc52b0", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "4017aa34-09cc-4d47-b09c-2e652adf3b7e"}, {"Element": "<span lang=\"EN-GB\"> <b>and other medicinal products</b></span>", "ID": "2acb7ddd-4464-43a2-8418-a0750f4c5e34", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "d0630865-b174-48f0-b6ba-b1c001ad3777"}, {"Element": "<b>and other medicinal products</b>", "ID": "88d56e79-2c73-419d-a6d9-90f1b2c68c2d", "Styles": "None", "Classes": "None", "Text": "and other medicinal products", "ParentId": "2acb7ddd-4464-43a2-8418-a0750f4c5e34"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:61.0pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:72.55pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:57.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:41.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:65.6pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:83.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:70.95pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:20.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"margin-left:-.45pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:75.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:38.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:58.15pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span></p>\n</td>\n<td colspan=\"5\" style=\"width:72.88%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"72%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:20.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:37.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"5\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"5\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:14.8pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:17.95pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:26.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:\n  avoid !msorm;height:7.25pt !msorm\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;border:solid windowtext 1.0pt !msorm;\n  border-top:none !msorm;padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:91.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:11.75pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:11.75pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:70.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"6\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span></p>\n</td>\n</tr>\n</table>", "ID": "4317317e-2e1a-417c-9a01-7ea58f79b4ef", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                                                                                                        ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>\n</td>\n</tr>\n</thead>", "ID": "c26b7b2e-539d-4f22-938f-2c77b3e92125", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>\n</td>\n</tr>", "ID": "bd6c834f-4f93-4735-8ab9-114a50fa99c1", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "c26b7b2e-539d-4f22-938f-2c77b3e92125"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>\n</td>", "ID": "46da64ea-d121-42e6-9af2-5549b60fb908", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd6c834f-4f93-4735-8ab9-114a50fa99c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b></p>", "ID": "98ac1a58-419d-4c0d-b1c1-34eea4a0b8d1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46da64ea-d121-42e6-9af2-5549b60fb908"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span></b>", "ID": "4989c7ff-bab2-45eb-ae08-3a5aedeb4c1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "98ac1a58-419d-4c0d-b1c1-34eea4a0b8d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Medicinal product by therapeutic\n   areas/Possible Mechanism of Interaction</span>", "ID": "936c3a5f-e331-4335-b534-e76effa7b0ac", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Medicinal product by therapeutic    areas/Possible Mechanism of Interaction", "ParentId": "4989c7ff-bab2-45eb-ae08-3a5aedeb4c1f"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>\n</td>", "ID": "ebdb6d15-0df1-44cd-995f-cb1e48ac6d39", "Styles": "width:39.72%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "bd6c834f-4f93-4735-8ab9-114a50fa99c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b></p>", "ID": "86f610ae-6ff9-4ed1-8893-a220789da9ba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebdb6d15-0df1-44cd-995f-cb1e48ac6d39"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span></b>", "ID": "ab4d70c6-33cd-4882-9e8d-f96b46df14ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "86f610ae-6ff9-4ed1-8893-a220789da9ba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effects on medicinal product levels.</span>", "ID": "22b7d3d4-b450-4e8b-a320-e2835bf2343c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effects on medicinal product levels.", "ParentId": "ab4d70c6-33cd-4882-9e8d-f96b46df14ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b></p>", "ID": "033d2139-56c2-496f-aee0-7d38aea6b6ad", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebdb6d15-0df1-44cd-995f-cb1e48ac6d39"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span></b>", "ID": "80ee4a21-1fa0-4b39-8015-e66a2cdd46a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "033d2139-56c2-496f-aee0-7d38aea6b6ad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Mean ratio (90% confidence interval)<sup>a,b</sup></span>", "ID": "17942e00-afe1-4fff-86dd-5c6b88dc7d01", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Mean ratio (90% confidence interval)", "ParentId": "80ee4a21-1fa0-4b39-8015-e66a2cdd46a3"}, {"Element": "<sup>a,b</sup>", "ID": "97ff481e-f6e8-4489-b04b-e0afa89d9056", "Styles": "None", "Classes": "None", "Text": "a,b", "ParentId": "17942e00-afe1-4fff-86dd-5c6b88dc7d01"}, {"Element": "<td rowspan=\"2\" style=\"width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>\n</td>", "ID": "34c35adb-30a1-4da3-9c33-d2825c7eabcc", "Styles": "width:33.16%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd6c834f-4f93-4735-8ab9-114a50fa99c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b></p>", "ID": "938768d5-f339-4a15-93f2-5728c944175b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34c35adb-30a1-4da3-9c33-d2825c7eabcc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span></b>", "ID": "1a7e1a89-4152-44a8-9669-de1ae8e6ddf6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "938768d5-f339-4a15-93f2-5728c944175b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Recommendation concerning co\u2011administration\n   with Epclusa</span>", "ID": "b4b65f4d-e082-4d7d-a6ef-2b09cb4675b1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Recommendation concerning co\u2011administration    with Epclusa", "ParentId": "1a7e1a89-4152-44a8-9669-de1ae8e6ddf6"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>\n</td>\n</tr>", "ID": "12c995a8-5798-4b34-b301-8ffaea5162fc", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "c26b7b2e-539d-4f22-938f-2c77b3e92125"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>\n</td>", "ID": "c3119f8b-a36d-4541-b05f-cb9d2f6cd8c0", "Styles": "width:14.1%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "12c995a8-5798-4b34-b301-8ffaea5162fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b></p>", "ID": "069e13f5-cd77-453c-aa6d-ce3de244582b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3119f8b-a36d-4541-b05f-cb9d2f6cd8c0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span></b>", "ID": "965488b2-53a7-4993-bd1c-cde29073e58c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "069e13f5-cd77-453c-aa6d-ce3de244582b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Active</span>", "ID": "96f6ce2c-2dc3-49fe-aa83-420f9c8cb584", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Active", "ParentId": "965488b2-53a7-4993-bd1c-cde29073e58c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>\n</td>", "ID": "dc56a7f4-9466-4d71-9076-833dabed5259", "Styles": "width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "12c995a8-5798-4b34-b301-8ffaea5162fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b></p>", "ID": "d30c9c27-e438-46ae-a6e6-d4710031732a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dc56a7f4-9466-4d71-9076-833dabed5259"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span></b>", "ID": "d9ac2b83-b93a-40a5-912e-aabf02a6eff1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d30c9c27-e438-46ae-a6e6-d4710031732a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>max</sub></span>", "ID": "c36e5546-a1aa-4e11-8802-379cfea33b04", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "C", "ParentId": "d9ac2b83-b93a-40a5-912e-aabf02a6eff1"}, {"Element": "<sub>max</sub>", "ID": "5509a737-914a-4264-b921-8d41e4765e53", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "c36e5546-a1aa-4e11-8802-379cfea33b04"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>\n</td>", "ID": "2b203c54-7ab8-48f7-9662-49f1829613f1", "Styles": "width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "12c995a8-5798-4b34-b301-8ffaea5162fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b></p>", "ID": "9037c9c2-877d-468d-829a-7be995984b25", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b203c54-7ab8-48f7-9662-49f1829613f1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span></b>", "ID": "2b1eb4ce-0192-4383-a887-46bb6b81f255", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9037c9c2-877d-468d-829a-7be995984b25"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">AUC</span>", "ID": "dc81723b-e570-4704-9ceb-2af82e264084", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "AUC", "ParentId": "2b1eb4ce-0192-4383-a887-46bb6b81f255"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"bottom\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>\n</td>", "ID": "07a9efda-b3d5-4bb3-aa90-7bed76d9d4c3", "Styles": "width:8.54%;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "12c995a8-5798-4b34-b301-8ffaea5162fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b></p>", "ID": "ee2aaac0-2f6f-4545-9d08-071a0f8fb9a8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "07a9efda-b3d5-4bb3-aa90-7bed76d9d4c3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span></b>", "ID": "753626b8-062f-474e-84ce-32d8d9044538", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee2aaac0-2f6f-4545-9d08-071a0f8fb9a8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">C<sub>min</sub></span>", "ID": "6cebed8b-8f19-49b6-b1b2-dce98e511b29", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "C", "ParentId": "753626b8-062f-474e-84ce-32d8d9044538"}, {"Element": "<sub>min</sub>", "ID": "500e2235-732d-4491-8ccf-cfc6746e3a12", "Styles": "None", "Classes": "None", "Text": "min", "ParentId": "6cebed8b-8f19-49b6-b1b2-dce98e511b29"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b></p>\n</td>\n</tr>", "ID": "d80c88f4-a6bc-41f6-a7d5-7b6b47863a3c", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b></p>\n</td>", "ID": "dba10a7d-2dd4-4658-a4fe-e6e2e759a301", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d80c88f4-a6bc-41f6-a7d5-7b6b47863a3c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b></p>", "ID": "5bf83668-bd1d-4321-b27b-e20784429219", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dba10a7d-2dd4-4658-a4fe-e6e2e759a301"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i></b>", "ID": "57f8b052-bb99-4dca-abd3-b3d079e2b8a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5bf83668-bd1d-4321-b27b-e20784429219"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span></i>", "ID": "4992928b-08fb-4fb9-8ec2-a5bc84e176d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57f8b052-bb99-4dca-abd3-b3d079e2b8a1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ACID REDUCING AGENTS</span>", "ID": "16727638-6443-494a-9d64-3e128bdd3f7a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ACID REDUCING AGENTS", "ParentId": "4992928b-08fb-4fb9-8ec2-a5bc84e176d4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span></p>\n</td>\n</tr>", "ID": "01b9b806-f060-422b-a958-f176cc4b8391", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b></p>\n</td>", "ID": "03baa308-f30d-41e1-9bb0-661bcc17a93c", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "01b9b806-f060-422b-a958-f176cc4b8391"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b></p>", "ID": "68d53391-4d5b-47fe-a73d-58a24d38e559", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "03baa308-f30d-41e1-9bb0-661bcc17a93c"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i></b>", "ID": "04b3b2b3-79a4-4d5d-b996-0600ef51e6dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68d53391-4d5b-47fe-a73d-58a24d38e559"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></i>", "ID": "3c84d855-39c1-4dd3-9624-09920e9e13f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04b3b2b3-79a4-4d5d-b996-0600ef51e6dc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "12a8b103-401e-4405-9778-9a5ecb04f4a3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3c84d855-39c1-4dd3-9624-09920e9e13f6"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "29d23a38-8ec1-4b81-a09d-b91d37a13a97", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "01b9b806-f060-422b-a958-f176cc4b8391"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "f9d1fbc6-1603-45a2-9cd5-6eb838167540", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "29d23a38-8ec1-4b81-a09d-b91d37a13a97"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "ab6bc6bb-cca5-4872-bfdc-a2f4c61949d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9d1fbc6-1603-45a2-9cd5-6eb838167540"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b991fb84-5582-4a43-a422-3bf70f7d897e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ab6bc6bb-cca5-4872-bfdc-a2f4c61949d1"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span></p>\n</td>", "ID": "f8e17653-c828-4163-8148-8c74eed7fde2", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "01b9b806-f060-422b-a958-f176cc4b8391"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span></p>", "ID": "a3137ff4-2067-4925-8ac1-d00028b801c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8e17653-c828-4163-8148-8c74eed7fde2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir solubility decreases as pH\n  increases.\u00a0 Medicinal products that increase gastric pH are expected to\n  decrease the concentration of velpatasvir.</span>", "ID": "029fddfd-77a6-4132-a237-332b3aaf361d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir solubility decreases as pH   increases.\u00a0 Medicinal products that increase gastric pH are expected to   decrease the concentration of velpatasvir.", "ParentId": "a3137ff4-2067-4925-8ac1-d00028b801c2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i></p>\n</td>\n</tr>", "ID": "13802347-4b75-4901-839f-7266b04e1575", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i></p>\n</td>", "ID": "0060ed32-2693-435c-a018-1a7fecb5b410", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "13802347-4b75-4901-839f-7266b04e1575"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i></p>", "ID": "284ac85f-0674-435b-a3b6-a2327fe93cb3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0060ed32-2693-435c-a018-1a7fecb5b410"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span></i>", "ID": "0dcee369-de94-4ac8-bc41-09961bf2a626", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "284ac85f-0674-435b-a3b6-a2327fe93cb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Antacids</span>", "ID": "cbfe563b-5d32-4e7d-85b0-e6a4edbfea29", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Antacids", "ParentId": "0dcee369-de94-4ac8-bc41-09961bf2a626"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span></p>\n</td>\n</tr>", "ID": "743a0967-dd48-4420-99ca-170b245075c2", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>", "ID": "ee110285-43a1-4649-9b50-60357d7befce", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "743a0967-dd48-4420-99ca-170b245075c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span></p>", "ID": "92aa2b80-0403-4ee1-a950-925bc09dafc1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee110285-43a1-4649-9b50-60357d7befce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">e.g. Aluminium or magnesium hydroxide; calcium\n  carbonate</span>", "ID": "791914d6-4493-4f4d-8513-0f4d22826ff1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "e.g. Aluminium or magnesium hydroxide; calcium   carbonate", "ParentId": "92aa2b80-0403-4ee1-a950-925bc09dafc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "bdae2ff9-a15a-4434-92f6-03408dbb33e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee110285-43a1-4649-9b50-60357d7befce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "bb269858-939f-42a8-bba2-0d3e75c014cc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "bdae2ff9-a15a-4434-92f6-03408dbb33e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>", "ID": "c1e2f5c1-5f86-4f04-8d5d-c9873105e381", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee110285-43a1-4649-9b50-60357d7befce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span>", "ID": "5332d53f-74e6-4046-b61d-1fc7141e7706", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Increase in gastric pH)", "ParentId": "c1e2f5c1-5f86-4f04-8d5d-c9873105e381"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>", "ID": "d94d94d4-54f8-4b42-b783-58ce8f6ba123", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "743a0967-dd48-4420-99ca-170b245075c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "16667eb0-3f91-432d-b3eb-c644fa3e87dd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d94d94d4-54f8-4b42-b783-58ce8f6ba123"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "58e16134-a863-4075-afc6-f419a11d73d3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "16667eb0-3f91-432d-b3eb-c644fa3e87dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i></p>", "ID": "feb16292-23fd-4292-89f7-756347d2e929", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d94d94d4-54f8-4b42-b783-58ce8f6ba123"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span></i>", "ID": "738e4618-d227-4bfd-a77b-e9c7535d2cf3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "feb16292-23fd-4292-89f7-756347d2e929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected.</span>", "ID": "6b1e3ef0-f368-4d51-9dc0-f5b874a58e45", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected.", "ParentId": "738e4618-d227-4bfd-a77b-e9c7535d2cf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "b766751e-3fa2-41a1-9123-2276f3fc6ab4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d94d94d4-54f8-4b42-b783-58ce8f6ba123"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "765a7c8c-376c-476a-8da6-d4efd35f4243", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "b766751e-3fa2-41a1-9123-2276f3fc6ab4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>", "ID": "3ded6758-ff92-4f31-a582-75a6c403002b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d94d94d4-54f8-4b42-b783-58ce8f6ba123"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span>", "ID": "9390731c-6271-4e2a-9c4f-0c18628d1bea", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Velpatasvir", "ParentId": "3ded6758-ff92-4f31-a582-75a6c403002b"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span></p>\n</td>", "ID": "10a9c976-5925-450b-a6bd-cc27ade7e9d7", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "743a0967-dd48-4420-99ca-170b245075c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span></p>", "ID": "af084db8-600a-43bd-b675-f7f7728e18bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10a9c976-5925-450b-a6bd-cc27ade7e9d7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">It is recommended to separate antacid and Epclusa\n  administration by 4\u00a0hours.</span>", "ID": "512facdd-2954-4b70-a82a-e795cc2c183d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "It is recommended to separate antacid and Epclusa   administration by 4\u00a0hours.", "ParentId": "af084db8-600a-43bd-b675-f7f7728e18bc"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i></p>\n</td>\n</tr>", "ID": "3f8d7436-ce9a-4a20-9093-b658b4e5f1a6", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i></p>\n</td>", "ID": "bb173d7f-6385-4ff5-8ebc-c357f92440e4", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3f8d7436-ce9a-4a20-9093-b658b4e5f1a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i></p>", "ID": "33d8e972-e614-4807-8187-211054bf021b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb173d7f-6385-4ff5-8ebc-c357f92440e4"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span></i>", "ID": "46caa499-b8b6-4b7a-899f-bd8dd7d46508", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33d8e972-e614-4807-8187-211054bf021b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists</span>", "ID": "c6b33815-d51d-464a-9831-71f213f936b2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "H\u2011receptor antagonists", "ParentId": "46caa499-b8b6-4b7a-899f-bd8dd7d46508"}, {"Element": "<sub>2</sub>", "ID": "473ee492-ea83-4032-bf8f-23cb854e12ce", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "c6b33815-d51d-464a-9831-71f213f936b2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:61.0pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span></p>\n</td>\n</tr>", "ID": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94", "Styles": "page-break-inside:avoid;height:61.0pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>", "ID": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "           ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>", "ID": "36ccbbdc-6834-4f07-94c0-3d991de8a89b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span>", "ID": "dfa525a7-5aee-4cf5-8541-cafaa24237ce", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Famotidine", "ParentId": "36ccbbdc-6834-4f07-94c0-3d991de8a89b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>", "ID": "32aeedd2-f25e-42d8-8bc5-c031543808af", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span>", "ID": "33326180-73c1-46b5-aee3-0415fb1f64d1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(40\u00a0mg single dose)/ sofosbuvir/   velpatasvir (400/ 100\u00a0mg single dose)", "ParentId": "32aeedd2-f25e-42d8-8bc5-c031543808af"}, {"Element": "<sup>c</sup>", "ID": "70369d93-a7be-4a20-a2cb-5188cbe00eda", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "33326180-73c1-46b5-aee3-0415fb1f64d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "f04fc3b0-f2bb-41fe-9e6d-53a75e51dccc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6958154c-7750-44e4-843f-d166f68ad8ab", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f04fc3b0-f2bb-41fe-9e6d-53a75e51dccc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span></p>", "ID": "5f26ce5a-d1ca-452f-aa4f-98c550c58407", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed simultaneously with Epclusa<sup>d</sup></span>", "ID": "a3a73529-e2ea-4d2d-94b3-905cf3b6343f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Famotidine dosed simultaneously with Epclusa", "ParentId": "5f26ce5a-d1ca-452f-aa4f-98c550c58407"}, {"Element": "<sup>d</sup>", "ID": "78ef3dc7-0b30-43fb-b1f1-f843dfb24b78", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "a3a73529-e2ea-4d2d-94b3-905cf3b6343f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "da695e7e-e265-49a8-93a7-48dd94fbb956", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "91dad8dd-258c-4ab0-9845-75945e16d8c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "da695e7e-e265-49a8-93a7-48dd94fbb956"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span></p>", "ID": "aedadd9c-295e-474e-bfaa-dc6b0027a9f5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cimetidine<sup>e</sup></span>", "ID": "e7e81138-d94f-4641-b8fc-9458124f5f76", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Cimetidine", "ParentId": "aedadd9c-295e-474e-bfaa-dc6b0027a9f5"}, {"Element": "<sup>e</sup>", "ID": "ee77ff1e-825e-4e3c-ae1f-41b8c555d75c", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "e7e81138-d94f-4641-b8fc-9458124f5f76"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span></p>", "ID": "4118d152-434a-42c4-94ab-c7c5a7ba0cc7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Nizatidine<sup>e</sup></span>", "ID": "73c6c4d3-b193-4e25-bdc9-ed4ed1c98baf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Nizatidine", "ParentId": "4118d152-434a-42c4-94ab-c7c5a7ba0cc7"}, {"Element": "<sup>e</sup>", "ID": "55d1beb9-cee9-48ff-9e8e-7ae517a6cb46", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "73c6c4d3-b193-4e25-bdc9-ed4ed1c98baf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span></p>", "ID": "adc943cd-7340-4ad1-b050-4e82778c5938", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ranitidine<sup>e</sup></span>", "ID": "18a4bdd8-7c41-464a-a55c-764fb8233458", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ranitidine", "ParentId": "adc943cd-7340-4ad1-b050-4e82778c5938"}, {"Element": "<sup>e</sup>", "ID": "0bd80c29-d375-4b9f-bc9a-1bd63f0de3d0", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "18a4bdd8-7c41-464a-a55c-764fb8233458"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "6f91d335-3036-4457-a8ca-1f3e62078289", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "a5d5c069-bb3e-433b-b4f0-ccec993cdad3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6f91d335-3036-4457-a8ca-1f3e62078289"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>", "ID": "2e444987-6776-411c-9011-85d69888919d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7322d69-e3ab-4f45-b9ad-a809045a8ddd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span>", "ID": "4ca6ff74-74df-4966-becd-8dcef805db7e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Increase in gastric pH)", "ParentId": "2e444987-6776-411c-9011-85d69888919d"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "a7f0e432-bc0f-4376-a35a-94152ec91be8", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "  ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "b931d8da-0239-46d7-b521-cc7750fd6ded", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7f0e432-bc0f-4376-a35a-94152ec91be8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "0d7a7d75-e9dd-4c35-b795-14f00500990e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "b931d8da-0239-46d7-b521-cc7750fd6ded"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "8cf7d047-ddcb-4e9b-9aff-38890890028d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "  ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "9a6faea8-e285-41bd-b537-2849ed317dff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8cf7d047-ddcb-4e9b-9aff-38890890028d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "1495803e-f502-479b-a13e-d837581d5d4f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "9a6faea8-e285-41bd-b537-2849ed317dff"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "903191ba-6381-481a-86e4-ed4251966c46", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "  ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "aa9c459e-21c8-4efe-830b-633fd0cb0b78", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "903191ba-6381-481a-86e4-ed4251966c46"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "ce75c54c-38af-4a79-bc0b-f44065eb32d5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "aa9c459e-21c8-4efe-830b-633fd0cb0b78"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "65b0e9a8-6f3c-4374-9315-a7175db03a47", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "  ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "6757aed3-3541-4088-8d3c-f339a26334a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65b0e9a8-6f3c-4374-9315-a7175db03a47"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "186761f0-1534-4b92-9a26-2e51744e1304", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6757aed3-3541-4088-8d3c-f339a26334a5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6945c02e-71d0-4249-84d8-2b5f8df81491", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "186761f0-1534-4b92-9a26-2e51744e1304"}, {"Element": "<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span></p>\n</td>", "ID": "9141696e-64df-420e-b4e9-5b6f7650a7c4", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:61.0pt", "Classes": "None", "Text": "  ", "ParentId": "52ebf8d8-faac-4d2f-bcc5-0c56ac6c3e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span></p>", "ID": "6f849bb0-c9a5-416f-9ade-38cfd3d34fdd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9141696e-64df-420e-b4e9-5b6f7650a7c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">H<sub>2</sub>\u2011receptor antagonists\n  may be administered simultaneously with or staggered from Epclusa at a dose\n  that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.</span>", "ID": "f40c9d03-5584-402e-b53e-05e93ce71c1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "H\u2011receptor antagonists   may be administered simultaneously with or staggered from Epclusa at a dose   that does not exceed doses comparable to famotidine 40\u00a0mg twice daily.", "ParentId": "6f849bb0-c9a5-416f-9ade-38cfd3d34fdd"}, {"Element": "<sub>2</sub>", "ID": "18765200-65de-4df8-9670-7615d90d921e", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "f40c9d03-5584-402e-b53e-05e93ce71c1f"}, {"Element": "<tr style=\"page-break-inside:avoid;height:72.55pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "15ce0665-1aa4-42c4-b5d8-317025ecfcfa", "Styles": "page-break-inside:avoid;height:72.55pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "188dc639-41fa-4f62-a66d-1e67c075f689", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt", "Classes": "None", "Text": "  ", "ParentId": "15ce0665-1aa4-42c4-b5d8-317025ecfcfa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "0eaa6567-b2d3-4d33-94cf-c3bc190ff0f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "188dc639-41fa-4f62-a66d-1e67c075f689"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "8f747f61-bb2e-4f25-aa0c-8a4a56634a7b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "0eaa6567-b2d3-4d33-94cf-c3bc190ff0f2"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span></p>\n</td>", "ID": "fac52278-4d44-421e-8aaa-606480fac73c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt", "Classes": "None", "Text": "   ", "ParentId": "15ce0665-1aa4-42c4-b5d8-317025ecfcfa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "1228cbbf-8a28-48a5-8e00-99a1a20aecaa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fac52278-4d44-421e-8aaa-606480fac73c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "ecba2c38-77d5-4335-a172-e976f8d7bf08", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "1228cbbf-8a28-48a5-8e00-99a1a20aecaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span></p>", "ID": "1ab42d1a-1fc0-42bb-85ba-326481d628bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fac52278-4d44-421e-8aaa-606480fac73c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.70, 0.91)</span>", "ID": "89af3773-0de5-46e4-b8fe-d26bb0386a96", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.80 (0.70, 0.91)", "ParentId": "1ab42d1a-1fc0-42bb-85ba-326481d628bf"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span></p>\n</td>", "ID": "290fba42-2c30-4736-bb9e-1c11c5aecfa1", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt", "Classes": "None", "Text": "   ", "ParentId": "15ce0665-1aa4-42c4-b5d8-317025ecfcfa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "d9b675a3-f687-4789-a34d-21c7e5f332fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "290fba42-2c30-4736-bb9e-1c11c5aecfa1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "ef484ecd-3253-4953-9001-9a9821bdd467", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "d9b675a3-f687-4789-a34d-21c7e5f332fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span></p>", "ID": "59749328-08cc-452e-abef-3f3719033ef0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "290fba42-2c30-4736-bb9e-1c11c5aecfa1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.81 (0.71, 0.91)</span>", "ID": "07e5dc59-d1df-44e4-bc96-e4dcfa48b8b7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.81 (0.71, 0.91)", "ParentId": "59749328-08cc-452e-abef-3f3719033ef0"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "e667a986-7f73-4ab4-a212-a19749682e46", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:72.55pt", "Classes": "None", "Text": "  ", "ParentId": "15ce0665-1aa4-42c4-b5d8-317025ecfcfa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "e40e6ce2-bcf0-4c2a-bbe2-8dafa2a48296", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e667a986-7f73-4ab4-a212-a19749682e46"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "3250ab63-a389-4792-af38-ea71cd79a2cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e40e6ce2-bcf0-4c2a-bbe2-8dafa2a48296"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6dc017f5-9f93-444a-a437-69c54cbc7f0e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3250ab63-a389-4792-af38-ea71cd79a2cf"}, {"Element": "<tr style=\"page-break-inside:avoid;height:57.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "bd8133c3-de80-4b94-892e-25a304db88af", "Styles": "page-break-inside:avoid;height:57.8pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>", "ID": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "       ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span></p>", "ID": "80ab1666-5155-45d6-ac51-f2809e767e53", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">Famotidine</span>", "ID": "366609a1-9938-44f3-9b04-964a7ca210e9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Famotidine", "ParentId": "80ab1666-5155-45d6-ac51-f2809e767e53"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span></p>", "ID": "8e785864-e0a6-482a-81ff-72d6bec6125e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">(40\u00a0mg single dose)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose)<sup>c</sup></span>", "ID": "27925c2e-2250-403d-9f43-867dfff5f525", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(40\u00a0mg single dose)/ sofosbuvir/   velpatasvir (400/ 100\u00a0mg single dose)", "ParentId": "8e785864-e0a6-482a-81ff-72d6bec6125e"}, {"Element": "<sup>c</sup>", "ID": "16749883-ab70-4385-8ea3-29374a5cc508", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "27925c2e-2250-403d-9f43-867dfff5f525"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2d347a39-1f0a-47c9-b159-c6c9998bbc34", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "954e86d4-2bdc-445b-b2ab-bd8746f66612", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2d347a39-1f0a-47c9-b159-c6c9998bbc34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span></p>", "ID": "29f0ee0d-4565-4e15-8b66-8a411c15c7c8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Famotidine dosed 12\u00a0hours prior to Epclusa<sup>d</sup></span>", "ID": "5f97357a-a268-49f9-9a0f-85db93b6efa4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Famotidine dosed 12\u00a0hours prior to Epclusa", "ParentId": "29f0ee0d-4565-4e15-8b66-8a411c15c7c8"}, {"Element": "<sup>d</sup>", "ID": "4afc3d1f-6444-481c-a99e-b75bfb263579", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "5f97357a-a268-49f9-9a0f-85db93b6efa4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "77c1389a-ef98-41cb-8840-6c3d464b67be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "95cc2a93-e276-4b5f-9d5b-007c25cf6456", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "77c1389a-ef98-41cb-8840-6c3d464b67be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>", "ID": "8553da0c-6100-4a60-b7f6-596d61b80f5d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bafbcff-c5c1-49a7-82de-d21aefd7e23d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span>", "ID": "c5125089-5c8f-4b68-b2ce-2b0f9a2eb957", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Increase in gastric pH)", "ParentId": "8553da0c-6100-4a60-b7f6-596d61b80f5d"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "2a30df92-2926-4de8-bae5-37932b8a4db8", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "  ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "ad928b21-833c-48ed-887a-a2ee9c5125c1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a30df92-2926-4de8-bae5-37932b8a4db8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "7a1c5f1e-9f9c-4000-9ba0-860745d96a42", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "ad928b21-833c-48ed-887a-a2ee9c5125c1"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span></p>\n</td>", "ID": "08a9aa6a-258f-41b8-8c72-80a406d2a7f9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "   ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "94f19e85-1828-4ff7-a735-d12f7f68432e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08a9aa6a-258f-41b8-8c72-80a406d2a7f9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "f5a58a22-a906-4995-891c-c4de19bde90b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "94f19e85-1828-4ff7-a735-d12f7f68432e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span></p>", "ID": "945dbf4d-6b19-4d63-b587-fc776d19e6dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08a9aa6a-258f-41b8-8c72-80a406d2a7f9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.77 (0.68, 0.87)</span>", "ID": "15e178cc-5c12-487e-bae3-0c7d759678ea", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.77 (0.68, 0.87)", "ParentId": "945dbf4d-6b19-4d63-b587-fc776d19e6dd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span></p>\n</td>", "ID": "ae5763f7-0605-4958-8a61-e4bff78daee9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "   ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "735ed003-455f-437b-986e-af94e641cfba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae5763f7-0605-4958-8a61-e4bff78daee9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "5a9a6938-74d6-4b88-8eef-00a00d6b0ccc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "735ed003-455f-437b-986e-af94e641cfba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span></p>", "ID": "076bbe4f-a0c1-4925-87e0-4c79b5cd51ed", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae5763f7-0605-4958-8a61-e4bff78daee9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.80 (0.73, 0.88)</span>", "ID": "6ce442cb-b87f-4217-8273-253f7bfd5991", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.80 (0.73, 0.88)", "ParentId": "076bbe4f-a0c1-4925-87e0-4c79b5cd51ed"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "fe7f3df6-fc24-4983-a5eb-23360b627319", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "  ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "58ecf708-9397-4209-9de1-d0605928f1ee", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe7f3df6-fc24-4983-a5eb-23360b627319"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "7ad0c9ac-c511-466a-a87e-23f8e03a3c03", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58ecf708-9397-4209-9de1-d0605928f1ee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "226bec10-98a8-4d59-82e1-eee9d41540f4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "7ad0c9ac-c511-466a-a87e-23f8e03a3c03"}, {"Element": "<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "7cc3d1fb-b3d5-4503-a8e1-64c1316f7799", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:57.8pt", "Classes": "None", "Text": "  ", "ParentId": "bd8133c3-de80-4b94-892e-25a304db88af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "0f00e284-0fe3-4084-bc4a-82e282c6877b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7cc3d1fb-b3d5-4503-a8e1-64c1316f7799"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "0b7b4ea8-2121-498c-b1e8-fc32985694d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f00e284-0fe3-4084-bc4a-82e282c6877b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "cdeb71af-117d-421b-9d1a-d105bacdaa40", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0b7b4ea8-2121-498c-b1e8-fc32985694d0"}, {"Element": "<tr style=\"page-break-inside:avoid;height:41.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c840b6c5-af8c-4752-947d-b84be38498d1", "Styles": "page-break-inside:avoid;height:41.9pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "05508fa4-a6bf-48fb-ad56-8f80d1ec8dfd", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt", "Classes": "None", "Text": "  ", "ParentId": "c840b6c5-af8c-4752-947d-b84be38498d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "914a43dc-daea-41ee-a503-9f2aee7ade14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "05508fa4-a6bf-48fb-ad56-8f80d1ec8dfd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "fc710bf1-6474-46fa-8e7c-67d28e67fb73", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "914a43dc-daea-41ee-a503-9f2aee7ade14"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "b7ab69f2-6996-4071-a032-011ee9a1f6dd", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt", "Classes": "None", "Text": "  ", "ParentId": "c840b6c5-af8c-4752-947d-b84be38498d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "3334216c-47d8-4288-8cd7-a657a7d880cd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7ab69f2-6996-4071-a032-011ee9a1f6dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "44375c76-d4f4-4cb6-a532-33fda7d1a386", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "3334216c-47d8-4288-8cd7-a657a7d880cd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "488e7980-8c01-4d99-9126-024f2624c99d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt", "Classes": "None", "Text": "  ", "ParentId": "c840b6c5-af8c-4752-947d-b84be38498d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "c4d87ae8-a094-4364-a3e0-fe3835ef1fa6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "488e7980-8c01-4d99-9126-024f2624c99d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "ba89a507-8b8e-4912-9f29-757c03de6cad", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "c4d87ae8-a094-4364-a3e0-fe3835ef1fa6"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "6d240466-32f7-467e-a6f1-83ec808a94dc", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:41.9pt", "Classes": "None", "Text": "  ", "ParentId": "c840b6c5-af8c-4752-947d-b84be38498d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "3446a173-d36e-46b7-ae66-e3339432438c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d240466-32f7-467e-a6f1-83ec808a94dc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "98a1c0c5-5da3-4937-9da4-c0bde013358f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3446a173-d36e-46b7-ae66-e3339432438c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6f4a444a-3a6d-4875-9266-3fa57ecebd33", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "98a1c0c5-5da3-4937-9da4-c0bde013358f"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i></p>\n</td>\n</tr>", "ID": "7e0033ff-16b3-4eff-a8c7-c80f3d1f0764", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i></p>\n</td>", "ID": "e992934d-3ec1-41b6-b408-c7487fe6648d", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "7e0033ff-16b3-4eff-a8c7-c80f3d1f0764"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i></p>", "ID": "dce1b489-f3c2-4774-aff5-bccda7f34b65", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e992934d-3ec1-41b6-b408-c7487fe6648d"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span></i>", "ID": "ddaa750c-c7be-45b4-a136-9abf9be6532e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dce1b489-f3c2-4774-aff5-bccda7f34b65"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Proton pump inhibitors</span>", "ID": "b0a5dce5-b337-4262-a270-26c376e5ba36", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Proton pump inhibitors", "ParentId": "ddaa750c-c7be-45b4-a136-9abf9be6532e"}, {"Element": "<tr style=\"page-break-inside:avoid;height:65.6pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span></p>\n</td>\n</tr>", "ID": "52887b58-701c-4c1d-9cc1-f6b1a259d361", "Styles": "page-break-inside:avoid;height:65.6pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>", "ID": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "            ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>", "ID": "54d8cc11-4dde-41c4-acb5-e291b96bc28b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span>", "ID": "9fa6c605-938d-4a00-9304-69d871546a6a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Omeprazole", "ParentId": "54d8cc11-4dde-41c4-acb5-e291b96bc28b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span></p>", "ID": "1bab5edf-db79-4f11-beaa-ef3d0026847c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fasted)<sup>c</sup></span>", "ID": "0427ccd3-d684-445a-9913-ea20c0157f5c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(20\u00a0mg once daily)/ sofosbuvir/   velpatasvir (400/ 100\u00a0mg single dose fasted)", "ParentId": "1bab5edf-db79-4f11-beaa-ef3d0026847c"}, {"Element": "<sup>c</sup>", "ID": "bb58f700-7cfc-475a-bb75-fb289905ac87", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "0427ccd3-d684-445a-9913-ea20c0157f5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "23a670cf-9e3c-476c-9c6a-0010ca5eb0e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "d7e5306f-26c4-4d90-824d-2265b4c759d1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "23a670cf-9e3c-476c-9c6a-0010ca5eb0e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span></p>", "ID": "b474d46a-865c-4897-b18e-ea7f69c49004", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed simultaneously with Epclusa<sup>d</sup></span>", "ID": "f4fd9587-ab31-448f-aade-d900267d32d4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Omeprazole dosed simultaneously with Epclusa", "ParentId": "b474d46a-865c-4897-b18e-ea7f69c49004"}, {"Element": "<sup>d</sup>", "ID": "d04b1031-58b5-4b92-ae4f-88f66c6d0762", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "f4fd9587-ab31-448f-aade-d900267d32d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "897d3bd7-6d98-4686-9b81-552d62d412aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "e58773b4-8d7e-4ab3-bce3-4275ac6040c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "897d3bd7-6d98-4686-9b81-552d62d412aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span></p>", "ID": "98d622c4-f07b-45ea-9927-11ac749f0602", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lansoprazole<sup>e</sup></span>", "ID": "e75231d2-b7b4-4b3d-ad16-252e9333d3dd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Lansoprazole", "ParentId": "98d622c4-f07b-45ea-9927-11ac749f0602"}, {"Element": "<sup>e</sup>", "ID": "b77a798e-7ae8-4536-be0e-1b801c2184c2", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "e75231d2-b7b4-4b3d-ad16-252e9333d3dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span></p>", "ID": "7769e36d-d905-429f-98fb-e85734b75204", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rabeprazole<sup>e</sup></span>", "ID": "8dc71d28-4763-43cc-b726-f167d6406988", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rabeprazole", "ParentId": "7769e36d-d905-429f-98fb-e85734b75204"}, {"Element": "<sup>e</sup>", "ID": "a365a9d6-5e7c-4900-8082-f95d3c77eb3f", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "8dc71d28-4763-43cc-b726-f167d6406988"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span></p>", "ID": "1f2a83f8-7af1-4c72-aa10-8d9116be03fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pantoprazole<sup>e</sup></span>", "ID": "4c4f43ad-c446-427b-b519-8627841a1e4f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Pantoprazole", "ParentId": "1f2a83f8-7af1-4c72-aa10-8d9116be03fe"}, {"Element": "<sup>e</sup>", "ID": "a00bbf89-966d-40a7-bf88-3dcc7be27e0e", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "4c4f43ad-c446-427b-b519-8627841a1e4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span></p>", "ID": "a93c6891-5911-4c84-94ad-bb4e22c2cb0e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Esomeprazole<sup>e</sup></span>", "ID": "b37b6e3d-fa89-4c7d-b829-d4cba3b933cd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Esomeprazole", "ParentId": "a93c6891-5911-4c84-94ad-bb4e22c2cb0e"}, {"Element": "<sup>e</sup>", "ID": "a113e6aa-d33b-4087-8749-de8299485764", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "b37b6e3d-fa89-4c7d-b829-d4cba3b933cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "edaa7a8b-cc17-4969-830d-6164f70db745", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "4512b50e-d38b-4d74-9a8b-d29699bd3e57", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "edaa7a8b-cc17-4969-830d-6164f70db745"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>", "ID": "cfdb7ff9-fb66-4113-8561-52a24479c11e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd0be0d7-e9e5-4c69-9912-f6caa218bcc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span>", "ID": "124ad2e7-cdd7-406e-aac8-f256e1f413ef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Increase in gastric pH)", "ParentId": "cfdb7ff9-fb66-4113-8561-52a24479c11e"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "a570eaea-4b6d-45d9-b106-1bbf01a0411b", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "  ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "28fb3ce4-e34a-4312-bc40-852ad6821093", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a570eaea-4b6d-45d9-b106-1bbf01a0411b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "069bf87d-f03d-4b70-8d69-370027563a88", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "28fb3ce4-e34a-4312-bc40-852ad6821093"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span></p>\n</td>", "ID": "55298b1e-925c-4921-a173-5b6b81eaafee", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "   ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "1ad0e371-01bb-4aa0-a709-f446a6727d78", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "55298b1e-925c-4921-a173-5b6b81eaafee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "7f232c4e-9d0b-441c-8c2e-211f0dfd7266", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "1ad0e371-01bb-4aa0-a709-f446a6727d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span></p>", "ID": "d9bca6a9-3b6a-4b0e-8164-7fc87cfc5911", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "55298b1e-925c-4921-a173-5b6b81eaafee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.66 (0.55, 0.78)</span>", "ID": "896c704f-fcc4-4ad7-810e-e564db89efd2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.66 (0.55, 0.78)", "ParentId": "d9bca6a9-3b6a-4b0e-8164-7fc87cfc5911"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span></p>\n</td>", "ID": "df3ce1b8-5611-4520-a06e-450e9576c391", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "   ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "c06e6ac7-5248-414a-90cd-a07cd9e4b2c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df3ce1b8-5611-4520-a06e-450e9576c391"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "4657fec5-b54d-4f5e-a3cf-85bcce38769f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "c06e6ac7-5248-414a-90cd-a07cd9e4b2c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span></p>", "ID": "17802662-55f0-4977-b2cf-189315ef3e7e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df3ce1b8-5611-4520-a06e-450e9576c391"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.71 (0.60, 0.83)</span>", "ID": "9f2a5774-74b6-4566-a9d6-6640e0839c44", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.71 (0.60, 0.83)", "ParentId": "17802662-55f0-4977-b2cf-189315ef3e7e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "e41f6295-cf7b-4afa-8bfe-64df94e4cf4e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "  ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "240dc3fe-240d-433a-8022-a44eeda80e56", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e41f6295-cf7b-4afa-8bfe-64df94e4cf4e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "0c51fbd8-4414-4385-87b3-065afcf2039a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "240dc3fe-240d-433a-8022-a44eeda80e56"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "83e5df6d-120c-4cf8-8773-0668c82a03ca", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0c51fbd8-4414-4385-87b3-065afcf2039a"}, {"Element": "<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span></p>\n</td>", "ID": "9933963e-0b5e-4443-9804-3da24fd5da7a", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:65.6pt", "Classes": "None", "Text": "  ", "ParentId": "52887b58-701c-4c1d-9cc1-f6b1a259d361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span></p>", "ID": "505b8267-7409-4f4b-863e-946b0ea29fe6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9933963e-0b5e-4443-9804-3da24fd5da7a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co-administration with proton pump\n  inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,\n  then Epclusa should be administered with food and taken 4\u00a0hours before\n  proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.</span>", "ID": "c9bfceed-8a78-4729-a92f-084f60a9714a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co-administration with proton pump   inhibitors is not recommended. \u00a0If it is considered necessary to co\u2011administer,   then Epclusa should be administered with food and taken 4\u00a0hours before   proton pump inhibitor at max doses comparable to omeprazole 20\u00a0mg.", "ParentId": "505b8267-7409-4f4b-863e-946b0ea29fe6"}, {"Element": "<tr style=\"page-break-inside:avoid;height:83.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "3e7d9102-7281-4775-b27a-c21cab419cae", "Styles": "page-break-inside:avoid;height:83.8pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "1bb4bd3e-79a9-4a8c-bbc7-d385658e3632", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt", "Classes": "None", "Text": "  ", "ParentId": "3e7d9102-7281-4775-b27a-c21cab419cae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "922be9b6-5057-4043-af83-391c8947c0b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1bb4bd3e-79a9-4a8c-bbc7-d385658e3632"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "5f864bca-907a-4d93-9d92-8aed80fadf9a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "922be9b6-5057-4043-af83-391c8947c0b8"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span></p>\n</td>", "ID": "e0e2b0ed-f593-41e5-9f72-a1203bb6aa09", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt", "Classes": "None", "Text": "   ", "ParentId": "3e7d9102-7281-4775-b27a-c21cab419cae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "91224ada-5692-4d77-afec-aad83848d4bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0e2b0ed-f593-41e5-9f72-a1203bb6aa09"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "13b38243-4e88-41be-b89c-7dabeb540ec8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "91224ada-5692-4d77-afec-aad83848d4bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span></p>", "ID": "ef6b3a49-10ae-4198-81a9-09de013ca5e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0e2b0ed-f593-41e5-9f72-a1203bb6aa09"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.63 (0.50, 0.78)</span>", "ID": "5b3ff82f-4857-48c2-bd65-27a537cfa9e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.63 (0.50, 0.78)", "ParentId": "ef6b3a49-10ae-4198-81a9-09de013ca5e0"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span></p>\n</td>", "ID": "38dca2b5-53f4-41d0-b9f4-5e028232b97a", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt", "Classes": "None", "Text": "   ", "ParentId": "3e7d9102-7281-4775-b27a-c21cab419cae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "7a3a9b65-55ee-4639-b3b9-bb395309d3c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "38dca2b5-53f4-41d0-b9f4-5e028232b97a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "0e8de2b3-f3e8-4f07-9969-3911d01f4628", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "7a3a9b65-55ee-4639-b3b9-bb395309d3c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span></p>", "ID": "ab30e8b6-657b-4f7a-968c-2fcea6e52fa1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "38dca2b5-53f4-41d0-b9f4-5e028232b97a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.64 (0.52, 0.79)</span>", "ID": "74a52ab8-7d7a-4f64-85af-5a70796f3948", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.64 (0.52, 0.79)", "ParentId": "ab30e8b6-657b-4f7a-968c-2fcea6e52fa1"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "f5559c9c-faae-4848-a36e-af5e419f574d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:83.8pt", "Classes": "None", "Text": "  ", "ParentId": "3e7d9102-7281-4775-b27a-c21cab419cae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "bc404c87-e943-41e6-a11c-876e5a8cbc3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5559c9c-faae-4848-a36e-af5e419f574d"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "02ab7b17-c783-4bf5-b0e4-bd825cb52d65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc404c87-e943-41e6-a11c-876e5a8cbc3b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "5e9e0f99-0f0d-4388-b94a-e857d0ca83e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "02ab7b17-c783-4bf5-b0e4-bd825cb52d65"}, {"Element": "<tr style=\"page-break-inside:avoid;height:70.95pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c14bb4ed-01a2-4299-8a3f-78908d5810ac", "Styles": "page-break-inside:avoid;height:70.95pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>\n</td>", "ID": "ac6f49ce-fc83-4893-820f-b7b021b03b54", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "       ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span></p>", "ID": "d322b7dc-34c4-4e8d-a5c3-3a9f7780f067", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole</span>", "ID": "e50bf94c-e008-4933-9b56-9cdccdf64234", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Omeprazole", "ParentId": "d322b7dc-34c4-4e8d-a5c3-3a9f7780f067"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span></p>", "ID": "e36db676-bee9-4f64-a9bd-c223a48f719d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(20\u00a0mg once daily)/ sofosbuvir/\n  velpatasvir (400/ 100\u00a0mg single dose fed)<sup>c</sup></span>", "ID": "873c3bba-61d0-47af-a827-b4c499fdf1eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(20\u00a0mg once daily)/ sofosbuvir/   velpatasvir (400/ 100\u00a0mg single dose fed)", "ParentId": "e36db676-bee9-4f64-a9bd-c223a48f719d"}, {"Element": "<sup>c</sup>", "ID": "53806f05-7f65-4894-83ac-05a44e0b0d80", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "873c3bba-61d0-47af-a827-b4c499fdf1eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "874c327c-7de1-4059-a4ab-30d89e1983ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "ac14e671-3d6b-41e2-8515-b16f0a31553c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "874c327c-7de1-4059-a4ab-30d89e1983ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span></p>", "ID": "64fa22d0-2766-47a0-9b9c-13f369225971", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Omeprazole dosed 4\u00a0hours after Epclusa<sup>d</sup></span>", "ID": "5e29e8bf-b385-45fa-93d4-2412195551c7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Omeprazole dosed 4\u00a0hours after Epclusa", "ParentId": "64fa22d0-2766-47a0-9b9c-13f369225971"}, {"Element": "<sup>d</sup>", "ID": "68d7c87a-00cc-46cb-be13-d90f5096ec5d", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "5e29e8bf-b385-45fa-93d4-2412195551c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "75ae10a4-3f51-44a4-a08f-6b202f2dedc8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "8782c3db-dbad-4684-9e11-39be4c870578", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "75ae10a4-3f51-44a4-a08f-6b202f2dedc8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span></p>", "ID": "5353aafe-4b4b-4391-9338-961e1fa45baa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ac6f49ce-fc83-4893-820f-b7b021b03b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Increase in gastric pH)</span>", "ID": "7d5d6542-7b87-459a-b824-281ec6840c79", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Increase in gastric pH)", "ParentId": "5353aafe-4b4b-4391-9338-961e1fa45baa"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "decccb45-6eb3-44cf-9cb8-fb97100c27d6", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "  ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "0abebbb8-38e4-4f7b-85d5-caf22bc84b11", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "decccb45-6eb3-44cf-9cb8-fb97100c27d6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "d6626413-49da-458c-8a18-0739fa66915b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "0abebbb8-38e4-4f7b-85d5-caf22bc84b11"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span></p>\n</td>", "ID": "d02124a1-eddc-4488-979b-64664caa2244", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "   ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "6d93b544-2246-43f6-afb2-e1f987acc478", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d02124a1-eddc-4488-979b-64664caa2244"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "615564c4-5633-45d5-a42d-435eed7f5443", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "6d93b544-2246-43f6-afb2-e1f987acc478"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span></p>", "ID": "b7afc767-e2cb-4600-b688-cbf748ab9348", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d02124a1-eddc-4488-979b-64664caa2244"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.68, 0.92)</span>", "ID": "82fa5803-49a5-4cdb-b295-16828cef1818", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.79 (0.68, 0.92)", "ParentId": "b7afc767-e2cb-4600-b688-cbf748ab9348"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "20a8c6f1-e2da-4917-b68a-4c3e76d8e92e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "  ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7b206190-a38e-49a1-a8e0-4153af551b94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "20a8c6f1-e2da-4917-b68a-4c3e76d8e92e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "721162f1-e362-4a56-b26b-92b52e6679d0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7b206190-a38e-49a1-a8e0-4153af551b94"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "b119f053-cb06-418a-a97c-9a74d8c9a747", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "  ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "9a5f13bc-ec90-4d76-889b-e411fab14976", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b119f053-cb06-418a-a97c-9a74d8c9a747"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "e5869bd4-97ab-4024-826c-08ae48bd77e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a5f13bc-ec90-4d76-889b-e411fab14976"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "e6dc2fe9-8bdc-487a-9f18-43939e89dc83", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "e5869bd4-97ab-4024-826c-08ae48bd77e8"}, {"Element": "<td rowspan=\"2\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "77a3c694-5b80-4854-9aeb-5029348266a5", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.95pt", "Classes": "None", "Text": "  ", "ParentId": "c14bb4ed-01a2-4299-8a3f-78908d5810ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "bbea6c3e-52fb-4000-abbb-ac7e7a1d61f8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "77a3c694-5b80-4854-9aeb-5029348266a5"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "1b921488-807a-4df3-95bd-cbb49a77acf7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bbea6c3e-52fb-4000-abbb-ac7e7a1d61f8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "1898102d-7026-493e-a655-cf789b07e70b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "1b921488-807a-4df3-95bd-cbb49a77acf7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:20.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "5feb544b-d30f-48dc-a12f-8f41552dcd74", "Styles": "page-break-inside:avoid;height:20.9pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "034f70bb-596e-4d08-bef9-12ecab70ada5", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt", "Classes": "None", "Text": "  ", "ParentId": "5feb544b-d30f-48dc-a12f-8f41552dcd74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "c938d656-7d26-4378-9fc2-548d5345e724", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "034f70bb-596e-4d08-bef9-12ecab70ada5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "a593e8c6-8bb1-4456-8a97-2ec862245c09", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "c938d656-7d26-4378-9fc2-548d5345e724"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span></p>\n</td>", "ID": "c133d78a-6e1c-424f-9185-860acf861852", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt", "Classes": "None", "Text": "   ", "ParentId": "5feb544b-d30f-48dc-a12f-8f41552dcd74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "c94d14e6-53a3-4931-9556-850918092a10", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c133d78a-6e1c-424f-9185-860acf861852"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "3894f338-3a52-4803-9043-4161b5e00b55", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "c94d14e6-53a3-4931-9556-850918092a10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span></p>", "ID": "42742fad-f0f5-4b44-8b89-618615befb94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c133d78a-6e1c-424f-9185-860acf861852"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.67 (0.58, 0.78)</span>", "ID": "bfea5c30-e0eb-441e-b01c-8131f1159654", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.67 (0.58, 0.78)", "ParentId": "42742fad-f0f5-4b44-8b89-618615befb94"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span></p>\n</td>", "ID": "0c5e0968-6151-4b0b-abd8-679a28f07053", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt", "Classes": "None", "Text": "   ", "ParentId": "5feb544b-d30f-48dc-a12f-8f41552dcd74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "8d5c8a7c-d51f-4afb-94c2-608fad0514ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c5e0968-6151-4b0b-abd8-679a28f07053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "f2e9d699-e159-47b3-a520-ff48aa75b60d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "8d5c8a7c-d51f-4afb-94c2-608fad0514ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span></p>", "ID": "94dd92aa-2881-427c-b1ae-8d18ea2312eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c5e0968-6151-4b0b-abd8-679a28f07053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.74 (0.63, 0.86)</span>", "ID": "3578ebfb-83c9-44a3-a624-2e53156d29de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.74 (0.63, 0.86)", "ParentId": "94dd92aa-2881-427c-b1ae-8d18ea2312eb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "d16fd9ff-3c18-4488-97bb-41bd67cb74aa", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.9pt", "Classes": "None", "Text": "  ", "ParentId": "5feb544b-d30f-48dc-a12f-8f41552dcd74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "60f2e65b-4e09-4ade-81ad-0013eadc777b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d16fd9ff-3c18-4488-97bb-41bd67cb74aa"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "7c857aaf-7daf-4ab7-8a0a-092c06def76c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "60f2e65b-4e09-4ade-81ad-0013eadc777b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "bc3028cc-88bb-4098-9580-b65c4c4d00c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "7c857aaf-7daf-4ab7-8a0a-092c06def76c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b></p>\n</td>\n</tr>", "ID": "1dee35a2-d938-4196-b282-25129542315e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b></p>\n</td>", "ID": "f79191c0-a8c4-48dc-96f4-2102bc8603fa", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "1dee35a2-d938-4196-b282-25129542315e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b></p>", "ID": "ac8401db-2898-46c2-80c5-8216da7d5e1d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f79191c0-a8c4-48dc-96f4-2102bc8603fa"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i></b>", "ID": "c60dc2e6-1767-4dcd-aa2d-8f39e15f737c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac8401db-2898-46c2-80c5-8216da7d5e1d"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span></i>", "ID": "4c9842d8-62c7-4700-9741-d22fc9245dca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c60dc2e6-1767-4dcd-aa2d-8f39e15f737c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIARRHYTHMICS</span>", "ID": "61ba7350-dd0e-4e17-b19b-867772e44878", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ANTIARRHYTHMICS", "ParentId": "4c9842d8-62c7-4700-9741-d22fc9245dca"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span></p>\n</td>\n</tr>", "ID": "7d816e60-ebe0-4cc1-bde1-c9c57b06e6a2", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span></p>\n</td>", "ID": "92f0b6ae-2349-40d5-bb62-2d10ad885776", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "7d816e60-ebe0-4cc1-bde1-c9c57b06e6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span></p>", "ID": "de3966a1-444b-4521-b9be-e53253170d98", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92f0b6ae-2349-40d5-bb62-2d10ad885776"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Amiodarone</span>", "ID": "89ee997e-c2d4-4854-bc15-e79a8e87e8bd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Amiodarone", "ParentId": "de3966a1-444b-4521-b9be-e53253170d98"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span></p>\n</td>", "ID": "cc22043d-1ddd-4479-9c08-27137ff430e1", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "7d816e60-ebe0-4cc1-bde1-c9c57b06e6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "addf5085-7165-4432-b3c1-45201fa8cbf5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc22043d-1ddd-4479-9c08-27137ff430e1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "5cffaecf-e59b-475b-b2dd-63d78405dc9f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "addf5085-7165-4432-b3c1-45201fa8cbf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span></p>", "ID": "3d911073-e16e-4cd2-a8bf-123f24689a4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc22043d-1ddd-4479-9c08-27137ff430e1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on amiodarone, velpatasvir, and sofosbuvir\n  concentrations unknown.</span>", "ID": "996b1e5a-311b-49ae-a901-772c5825887b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on amiodarone, velpatasvir, and sofosbuvir   concentrations unknown.", "ParentId": "3d911073-e16e-4cd2-a8bf-123f24689a4e"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span></p>\n</td>", "ID": "59bdb1bf-bee1-4e3b-b386-a229f56e4db4", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "7d816e60-ebe0-4cc1-bde1-c9c57b06e6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span></p>", "ID": "2d0fedef-5548-459f-9748-341c195514c7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59bdb1bf-bee1-4e3b-b386-a229f56e4db4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Use only if no other alternative is available. \u00a0Close\n  monitoring is recommended if this medicinal product is administered with Epclusa\n  (see sections\u00a04.4 and 4.8).</span>", "ID": "5804ae25-be52-4e8b-96dc-59fda859ad1a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Use only if no other alternative is available. \u00a0Close   monitoring is recommended if this medicinal product is administered with Epclusa   (see sections\u00a04.4 and 4.8).", "ParentId": "2d0fedef-5548-459f-9748-341c195514c7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span></p>\n</td>\n</tr>", "ID": "704001fc-22af-4652-836f-645297adb1b5", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>", "ID": "c2cdc6ed-460c-4f01-98e4-294df5bfad8f", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "704001fc-22af-4652-836f-645297adb1b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>", "ID": "af65365a-31b0-467e-84b3-53074a7c1090", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c2cdc6ed-460c-4f01-98e4-294df5bfad8f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span>", "ID": "77660442-846e-4ddb-82aa-86de98a402b3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Digoxin", "ParentId": "af65365a-31b0-467e-84b3-53074a7c1090"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>", "ID": "648aea96-0975-47cd-a2f1-949efc41abf7", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "704001fc-22af-4652-836f-645297adb1b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span></p>", "ID": "f0fba52b-51f9-49e9-90c9-929a76ef1e45", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "648aea96-0975-47cd-a2f1-949efc41abf7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with\n  velpatasvir.</span>", "ID": "52a8b0e2-29ae-4aff-844b-a63f927d068f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction only studied with   velpatasvir.", "ParentId": "f0fba52b-51f9-49e9-90c9-929a76ef1e45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "08d3bc47-6f23-48a1-aa7b-3bb0af0dba27", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "648aea96-0975-47cd-a2f1-949efc41abf7"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "d90243c2-092c-4591-9709-0c9bb39fd2bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08d3bc47-6f23-48a1-aa7b-3bb0af0dba27"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "f2e471a5-0940-4f0f-a230-4d6d9cd7b79f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "d90243c2-092c-4591-9709-0c9bb39fd2bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "8145fcf9-6250-46c7-ac86-bceb9bad2ece", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "648aea96-0975-47cd-a2f1-949efc41abf7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "c8d41fd2-aeff-424c-aeb7-3f889f837a95", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "8145fcf9-6250-46c7-ac86-bceb9bad2ece"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span></p>\n</td>", "ID": "a8bd1243-b9ad-4221-8833-a8055ef665e3", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "704001fc-22af-4652-836f-645297adb1b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span></p>", "ID": "6bdca92d-f00a-432e-87ae-28e44bc1196a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8bd1243-b9ad-4221-8833-a8055ef665e3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  digoxin may increase the concentration of digoxin. \u00a0Caution is warranted\n  and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered\n  with Epclusa.</span>", "ID": "07e5a6e3-d957-41aa-9fd9-b2dd74a103cc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co\u2011administration of Epclusa with   digoxin may increase the concentration of digoxin. \u00a0Caution is warranted   and therapeutic concentration monitoring of digoxin is recommended when co\u2011administered   with Epclusa.", "ParentId": "6bdca92d-f00a-432e-87ae-28e44bc1196a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>", "ID": "bb79d7e6-8c71-4538-b613-0253960c5321", "Styles": "page-break-inside:avoid;height:51.8pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>", "ID": "4d77e699-b8b3-4c83-a5b9-98912afeba78", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "    ", "ParentId": "bb79d7e6-8c71-4538-b613-0253960c5321"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span></p>", "ID": "8093bf9d-2035-44d3-8220-e4a5e14fb4b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d77e699-b8b3-4c83-a5b9-98912afeba78"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">Digoxin (0.25\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)</span>", "ID": "fbaecaf9-7c8f-4b30-a10c-e5aea5993270", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Digoxin (0.25\u00a0mg single dose)/   velpatasvir (100\u00a0mg single dose)", "ParentId": "8093bf9d-2035-44d3-8220-e4a5e14fb4b1"}, {"Element": "<sup>f</sup>", "ID": "bf1abdc6-ce03-47a1-ab82-cfd7dd3df357", "Styles": "None", "Classes": "None", "Text": "f", "ParentId": "fbaecaf9-7c8f-4b30-a10c-e5aea5993270"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0942888b-bf5c-464e-9465-9cdb0338fa22", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d77e699-b8b3-4c83-a5b9-98912afeba78"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "da25c4e2-ff7b-4899-8a81-331ec873b886", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0942888b-bf5c-464e-9465-9cdb0338fa22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>", "ID": "f10a77b5-6536-4594-86c6-55f6d906e3a4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d77e699-b8b3-4c83-a5b9-98912afeba78"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span>", "ID": "d64b1ccc-af3f-4496-8303-c9c72512e2b3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Inhibition of P\u2011gp)", "ParentId": "f10a77b5-6536-4594-86c6-55f6d906e3a4"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "34ca66a7-32f4-4fac-8f7c-3ddf804fc7dc", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "    ", "ParentId": "bb79d7e6-8c71-4538-b613-0253960c5321"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span></p>", "ID": "c4ef6a7d-3d2a-4fa0-ba86-27207fc5c68f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34ca66a7-32f4-4fac-8f7c-3ddf804fc7dc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not\n  studied</span>", "ID": "0aaeecd2-1596-4993-83d6-b543dcc480ff", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on velpatasvir exposure not   studied", "ParentId": "c4ef6a7d-3d2a-4fa0-ba86-27207fc5c68f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "5246580d-aeaa-4be0-a860-24a2ca79df6f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34ca66a7-32f4-4fac-8f7c-3ddf804fc7dc"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "fa53b402-e970-4026-8ee5-f8321ae0c10f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5246580d-aeaa-4be0-a860-24a2ca79df6f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "457726b6-66ad-4302-98a1-a8ccc3cb3e60", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "fa53b402-e970-4026-8ee5-f8321ae0c10f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "16ace170-30a2-47dd-9067-42c776baccd9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34ca66a7-32f4-4fac-8f7c-3ddf804fc7dc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "575e0c9c-c1af-43ee-ab0e-6e29470f0a77", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "16ace170-30a2-47dd-9067-42c776baccd9"}, {"Element": "<tr style=\"page-break-inside:avoid;height:51.8pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "f71b4c86-f039-4e17-94cc-13f45df05a59", "Styles": "page-break-inside:avoid;height:51.8pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>\n</td>", "ID": "9720b9aa-a1d7-4a97-b055-bb994008ed31", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "   ", "ParentId": "f71b4c86-f039-4e17-94cc-13f45df05a59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "959dcff2-6e2e-417a-948e-02bca25cdb60", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9720b9aa-a1d7-4a97-b055-bb994008ed31"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "51826911-207c-474d-a5bf-2ef3c4b14a41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "959dcff2-6e2e-417a-948e-02bca25cdb60"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "e62d82d3-2067-4f49-a75a-e464878b47f5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "51826911-207c-474d-a5bf-2ef3c4b14a41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span></p>", "ID": "a3979636-99dd-4e19-87ea-7f39b95ea634", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9720b9aa-a1d7-4a97-b055-bb994008ed31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Digoxin</span>", "ID": "c0adaf09-6155-4369-b08a-2a64893d942d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Digoxin", "ParentId": "a3979636-99dd-4e19-87ea-7f39b95ea634"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span></p>\n</td>", "ID": "f086b440-df69-4bdd-9a28-49edaffa17f4", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "    ", "ParentId": "f71b4c86-f039-4e17-94cc-13f45df05a59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "48c2fb8f-0dbd-429a-bf54-3590ac3861ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f086b440-df69-4bdd-9a28-49edaffa17f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "51af3fa3-cef1-4814-a14c-9bfc1e1259e7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "48c2fb8f-0dbd-429a-bf54-3590ac3861ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "47c45686-ebeb-4c78-a291-4d8008bab7b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f086b440-df69-4bdd-9a28-49edaffa17f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "c2e349ca-6930-4ae9-b1bf-ff619316ce8f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "47c45686-ebeb-4c78-a291-4d8008bab7b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span></p>", "ID": "dd93319e-e4ba-4ddc-bbda-e6c5301cf2bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f086b440-df69-4bdd-9a28-49edaffa17f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.9 (1.7, 2.1)</span>", "ID": "7be439aa-348b-4d78-b4dc-c5f9fa40e1d0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.9 (1.7, 2.1)", "ParentId": "dd93319e-e4ba-4ddc-bbda-e6c5301cf2bb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span></p>\n</td>", "ID": "f207b20f-dd14-476a-9521-fc05f1bc3925", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "    ", "ParentId": "f71b4c86-f039-4e17-94cc-13f45df05a59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5570ada8-e8e7-4f90-8c27-e5cd71507f36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f207b20f-dd14-476a-9521-fc05f1bc3925"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "bd45ef7a-ea5e-42be-a353-cd9da6af465c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5570ada8-e8e7-4f90-8c27-e5cd71507f36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "f2429022-e9c1-4e8a-b552-27f2c4d320aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f207b20f-dd14-476a-9521-fc05f1bc3925"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "e76f6c27-2521-4fd6-b5b8-ec810df92ddc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "f2429022-e9c1-4e8a-b552-27f2c4d320aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span></p>", "ID": "0ab60aee-666a-4518-a910-ebecf5d2b11a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f207b20f-dd14-476a-9521-fc05f1bc3925"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.6)</span>", "ID": "abffed0d-8590-42c3-912d-b5336f6e749f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.1, 1.6)", "ParentId": "0ab60aee-666a-4518-a910-ebecf5d2b11a"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "89e1fb87-3193-4554-93ad-645021e89ce8", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:51.8pt", "Classes": "None", "Text": "  ", "ParentId": "f71b4c86-f039-4e17-94cc-13f45df05a59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "3f3b33a6-2908-4b13-ab84-b43eba3cdf5e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89e1fb87-3193-4554-93ad-645021e89ce8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "652c7d39-080e-49ad-b1ab-1b3927ebe24e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3f3b33a6-2908-4b13-ab84-b43eba3cdf5e"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b></p>\n</td>\n</tr>", "ID": "514bcd7b-8df2-434e-a0eb-984464de78c1", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b></p>\n</td>", "ID": "15c17d3c-f964-4f31-90d1-a1bba24d0ff9", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "514bcd7b-8df2-434e-a0eb-984464de78c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b></p>", "ID": "3bbec598-1fd8-4ce1-9efc-6f90e70e2616", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15c17d3c-f964-4f31-90d1-a1bba24d0ff9"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i></b>", "ID": "d3157411-6e5c-4cd6-9a8c-614d6d36d627", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3bbec598-1fd8-4ce1-9efc-6f90e70e2616"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span></i>", "ID": "52c2aab9-ee13-423a-a853-e54c68f1f38d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d3157411-6e5c-4cd6-9a8c-614d6d36d627"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICOAGULANTS</span>", "ID": "b63514e3-3ce0-4d9d-a0ce-efc873ab8657", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ANTICOAGULANTS", "ParentId": "52c2aab9-ee13-423a-a853-e54c68f1f38d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span></p>\n</td>\n</tr>", "ID": "6012e9b8-a198-432e-a129-164aa0fe4377", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>\n</td>", "ID": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "6012e9b8-a198-432e-a129-164aa0fe4377"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span></p>", "ID": "9f2c56bf-b447-434f-88ef-6b1b38fea2b1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dabigatran etexilate</span>", "ID": "07219bea-5583-458b-b611-0a53a866c76e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Dabigatran etexilate", "ParentId": "9f2c56bf-b447-434f-88ef-6b1b38fea2b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0a8b32cd-8334-4523-aac3-c0cd1721a411", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "f4e4176d-a8a2-41f9-b403-7f1509431b31", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0a8b32cd-8334-4523-aac3-c0cd1721a411"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "cf181a1a-e228-4cf6-adc1-a3cf2d7d8f7e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "20a3b6af-0c48-4b9b-bc69-fb746489b72e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "cf181a1a-e228-4cf6-adc1-a3cf2d7d8f7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "50b3182b-283d-4ba6-bc8f-a3bb8d43ef00", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "db97faf0-4175-4abb-8a86-3b6ad373dde2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "50b3182b-283d-4ba6-bc8f-a3bb8d43ef00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "3e597477-d4d3-4eb5-bcf7-e222afd2b25e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "51cc3420-04dd-442e-a488-1e9734ab2f54", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3e597477-d4d3-4eb5-bcf7-e222afd2b25e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span></p>", "ID": "9a5c5b03-795a-46b0-9443-98fb49a28495", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39edb3c3-4f6b-4a89-adc3-aa80f2c77597"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp)</span>", "ID": "b6b5a272-4633-40bb-85b4-0ecd887d7852", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Inhibition of P\u2011gp)", "ParentId": "9a5c5b03-795a-46b0-9443-98fb49a28495"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "      ", "ParentId": "6012e9b8-a198-432e-a129-164aa0fe4377"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "eee1e3e8-f329-4819-961c-ab03f2bc5086", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "5aa67bc9-3efa-48f5-8309-82bd6a2c55d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "eee1e3e8-f329-4819-961c-ab03f2bc5086"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "d59f5925-efe7-4bc3-91ec-36a2734806d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "9dbf71df-362d-4b56-ae6a-a712426c586f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d59f5925-efe7-4bc3-91ec-36a2734806d5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "9a7e76df-c287-4033-89cb-5860d40cee08", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "9dbf71df-362d-4b56-ae6a-a712426c586f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span></p>", "ID": "08182fad-8ce5-41cc-be96-4914a6ef0290", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Dabigatran</span>", "ID": "f386f8ae-7fff-4b8c-9800-739e82e372a3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191 Dabigatran", "ParentId": "08182fad-8ce5-41cc-be96-4914a6ef0290"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "0ac1499d-668a-41d5-85a8-23d10da1c466", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "aa69ac18-f1e5-4ce9-a785-919fa0e74b5f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "0ac1499d-668a-41d5-85a8-23d10da1c466"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "d69da223-d86a-4abd-9714-43071ae0aa0f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c6a7542-dcd9-4b63-856e-8fe88c2b1857"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "4db013d9-768b-4dd4-bbd8-feb7a4ea59dc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "d69da223-d86a-4abd-9714-43071ae0aa0f"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span></p>\n</td>", "ID": "a78314c3-9158-452a-9337-daead1700196", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "6012e9b8-a198-432e-a129-164aa0fe4377"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span></p>", "ID": "c8560c4c-781e-46d0-a7f6-241e9da9990d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a78314c3-9158-452a-9337-daead1700196"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Clinical monitoring, looking for signs of bleeding\n  and anaemia, is recommended when dabigatran etexilate is co-administered with\n  Epclusa.\u00a0 A coagulation test helps to identify patients with an\n  increased bleeding risk due to increased dabigatran exposure.</span>", "ID": "a48faee6-5bca-4a28-a299-d0bafee03328", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Clinical monitoring, looking for signs of bleeding   and anaemia, is recommended when dabigatran etexilate is co-administered with   Epclusa.\u00a0 A coagulation test helps to identify patients with an   increased bleeding risk due to increased dabigatran exposure.", "ParentId": "c8560c4c-781e-46d0-a7f6-241e9da9990d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span></p>\n</td>\n</tr>", "ID": "627e8831-b318-4f6c-bc9f-b13e46ca901c", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span></p>\n</td>", "ID": "f5f395c7-6755-4570-8683-df2c32a24ad3", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "627e8831-b318-4f6c-bc9f-b13e46ca901c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span></p>", "ID": "ebb779a0-1658-47d1-9c4a-060d1cd0676d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5f395c7-6755-4570-8683-df2c32a24ad3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Vitamin\u00a0K antagonists</span>", "ID": "db3cfded-502c-444a-b0be-6bbea0873e1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Vitamin\u00a0K antagonists", "ParentId": "ebb779a0-1658-47d1-9c4a-060d1cd0676d"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span></p>\n</td>", "ID": "d3954241-6caa-4f76-a0b5-d302b7b9b1f0", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "627e8831-b318-4f6c-bc9f-b13e46ca901c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span></p>", "ID": "e134a33a-6c8f-45de-b369-eb7c7a13df7c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d3954241-6caa-4f76-a0b5-d302b7b9b1f0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied</span>", "ID": "044f9089-d999-42d2-a6b2-36f3588f612a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied", "ParentId": "e134a33a-6c8f-45de-b369-eb7c7a13df7c"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span></p>\n</td>", "ID": "db6e3d29-6558-4a33-b5ad-8562750c2607", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "627e8831-b318-4f6c-bc9f-b13e46ca901c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span></p>", "ID": "10c467c3-c299-48da-9477-c42cb872bf67", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db6e3d29-6558-4a33-b5ad-8562750c2607"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Close monitoring of INR is recommended with all\n  vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes\n  during treatment with Epclusa.</span>", "ID": "b6bea80f-3df5-4b81-a744-41c823fa6268", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Close monitoring of INR is recommended with all   vitamin\u00a0K antagonists.\u00a0 This is due to liver function changes   during treatment with Epclusa.", "ParentId": "10c467c3-c299-48da-9477-c42cb872bf67"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b></p>\n</td>\n</tr>", "ID": "b8186ac6-4057-4a79-ab14-20544c73a334", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b></p>\n</td>", "ID": "90802dc6-fa92-476a-be05-a9c99b04d2cf", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "b8186ac6-4057-4a79-ab14-20544c73a334"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b></p>", "ID": "ba5ea9e6-94b9-412d-b62c-529639d13918", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "90802dc6-fa92-476a-be05-a9c99b04d2cf"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i></b>", "ID": "aae0c008-1f20-4c86-b1a7-d91b4c23d57a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ba5ea9e6-94b9-412d-b62c-529639d13918"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span></i>", "ID": "2699f708-c137-4540-8302-6f6bd455f822", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aae0c008-1f20-4c86-b1a7-d91b4c23d57a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTICONVULSANTS</span>", "ID": "a542a44d-7c43-441a-b30f-ab6ea42c9d4b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ANTICONVULSANTS", "ParentId": "2699f708-c137-4540-8302-6f6bd455f822"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"margin-left:-.45pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span></p>\n</td>\n</tr>", "ID": "6571c40b-9bac-474c-88ce-b4b2bd2385b4", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span></p>\n</td>", "ID": "fb08e856-23f9-47de-8fc2-7289c5c8acaf", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "      ", "ParentId": "6571c40b-9bac-474c-88ce-b4b2bd2385b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span></p>", "ID": "92aace2a-4153-46b0-9871-90e27b8fe7cd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb08e856-23f9-47de-8fc2-7289c5c8acaf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Carbamazepine</span>", "ID": "aaae0158-3198-45fe-a138-11759ed7cadd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Carbamazepine", "ParentId": "92aace2a-4153-46b0-9871-90e27b8fe7cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span></p>", "ID": "dba2909f-37c3-40a7-88a0-c447294cefce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb08e856-23f9-47de-8fc2-7289c5c8acaf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenytoin</span>", "ID": "e10a120d-d25a-41b2-a0b5-5afaae84f272", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Phenytoin", "ParentId": "dba2909f-37c3-40a7-88a0-c447294cefce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span></p>", "ID": "e99be1a2-112c-4bb4-90dc-f16119070941", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb08e856-23f9-47de-8fc2-7289c5c8acaf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Phenobarbital</span>", "ID": "2b002a84-8aa3-41f8-80b9-5d3aabc7738c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Phenobarbital", "ParentId": "e99be1a2-112c-4bb4-90dc-f16119070941"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "d82cbeb7-dea0-48b8-90af-f0de222df18d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb08e856-23f9-47de-8fc2-7289c5c8acaf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "93966edb-b8dd-4045-9b7b-b57d81078e1e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d82cbeb7-dea0-48b8-90af-f0de222df18d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span></p>", "ID": "db1682bc-e8ae-4781-881b-f92bc9b08df6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb08e856-23f9-47de-8fc2-7289c5c8acaf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp </span>", "ID": "7306e44e-7207-4dec-86b2-ab79b27f49d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp ", "ParentId": "db1682bc-e8ae-4781-881b-f92bc9b08df6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">and CYPs</span>", "ID": "f856d726-c817-46ff-b84b-59886a201e15", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "and CYPs", "ParentId": "db1682bc-e8ae-4781-881b-f92bc9b08df6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\">)</span>", "ID": "f5705a16-9cdf-427a-9fcb-d19fadcee2be", "Styles": "font-size:\n  10.0pt", "Classes": "None", "Text": ")", "ParentId": "db1682bc-e8ae-4781-881b-f92bc9b08df6"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>", "ID": "4489adca-751a-4f7c-93b6-df829c0ec945", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "6571c40b-9bac-474c-88ce-b4b2bd2385b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "43d29f27-027c-4204-9e84-91d8137aced0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4489adca-751a-4f7c-93b6-df829c0ec945"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "f359c01a-f2ad-42fe-9483-4bb8b74d714f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "43d29f27-027c-4204-9e84-91d8137aced0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "17c0ebf0-ca49-4fa8-9f93-ea0a67bca951", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4489adca-751a-4f7c-93b6-df829c0ec945"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "d2556e3e-3717-4d73-a890-9ee8f77c39ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17c0ebf0-ca49-4fa8-9f93-ea0a67bca951"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "041cb629-a1bc-4d6d-8394-662e662f3eb2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "d2556e3e-3717-4d73-a890-9ee8f77c39ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>", "ID": "e555765b-81df-416b-8c4c-cd0e9486421e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4489adca-751a-4f7c-93b6-df829c0ec945"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span>", "ID": "b32c4aaf-98e7-4eda-854d-0125f8934cde", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Sofosbuvir", "ParentId": "e555765b-81df-416b-8c4c-cd0e9486421e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>", "ID": "40e28904-905c-4649-a39a-f8397bfa7cee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4489adca-751a-4f7c-93b6-df829c0ec945"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span>", "ID": "b680ca9f-e382-4ee1-88c4-edd7c858777d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Velpatasvir", "ParentId": "40e28904-905c-4649-a39a-f8397bfa7cee"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"margin-left:-.45pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span></p>\n</td>", "ID": "8cbbd131-3b86-4b00-8857-bf0e20a8d9ae", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "6571c40b-9bac-474c-88ce-b4b2bd2385b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:-.45pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span></p>", "ID": "c81cc280-ebcb-4aae-ad1b-f7dd8dde89c2", "Styles": "margin-left:-.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8cbbd131-3b86-4b00-8857-bf0e20a8d9ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "c84bb038-291a-412c-aa7c-5e62ed9859dd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "c81cc280-ebcb-4aae-ad1b-f7dd8dde89c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with carbamazepine,\n  phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see\n  section\u00a04.3).</span>", "ID": "f7d71846-1af4-4af2-8194-a94b7b078e0a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " is contraindicated with carbamazepine,   phenobarbital and phenytoin, potent P\u2011gp and CYP\u00a0inducers (see   section\u00a04.3).", "ParentId": "c81cc280-ebcb-4aae-ad1b-f7dd8dde89c2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:75.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>", "ID": "71e77260-2115-42d8-83f5-6c1603b84f82", "Styles": "page-break-inside:avoid;height:75.75pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>", "ID": "0b63337c-1926-4812-9677-7d472e415f40", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:75.75pt", "Classes": "None", "Text": "     ", "ParentId": "71e77260-2115-42d8-83f5-6c1603b84f82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span></p>", "ID": "1a233f92-0711-49e3-ba09-3e00cb8b84c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b63337c-1926-4812-9677-7d472e415f40"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Oxcarbazepine</span>", "ID": "d656d22e-114b-4a1c-a10e-a9718b6d89ef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Oxcarbazepine", "ParentId": "1a233f92-0711-49e3-ba09-3e00cb8b84c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "6ecb5aa1-42a3-4e08-9181-83ad89cea1d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b63337c-1926-4812-9677-7d472e415f40"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "c85c8b53-dbed-4fed-a923-15d15532a28a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6ecb5aa1-42a3-4e08-9181-83ad89cea1d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "c16376b2-8af4-4fe2-b159-f177fca7b94f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b63337c-1926-4812-9677-7d472e415f40"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "94344fbc-0b5d-4273-ad55-9fbbf8640933", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "c16376b2-8af4-4fe2-b159-f177fca7b94f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>", "ID": "31e27dd9-dc97-4629-838d-90264592133b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b63337c-1926-4812-9677-7d472e415f40"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span>", "ID": "4925f50b-43bd-44ef-b1e8-8979579ab9cc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp and CYPs)", "ParentId": "31e27dd9-dc97-4629-838d-90264592133b"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>", "ID": "e9e34ce3-46fb-4122-b2b4-5628fe4ca208", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt", "Classes": "None", "Text": "     ", "ParentId": "71e77260-2115-42d8-83f5-6c1603b84f82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "0410a910-a8ae-42c4-836f-4057fe6a7610", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9e34ce3-46fb-4122-b2b4-5628fe4ca208"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "6f2fcee1-b5f9-45c7-a324-cda550b855d0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "0410a910-a8ae-42c4-836f-4057fe6a7610"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "37f584ba-8cbe-404b-a222-95e6a2b85db4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9e34ce3-46fb-4122-b2b4-5628fe4ca208"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "c328a3aa-1157-4efd-9240-353d3fa45e04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37f584ba-8cbe-404b-a222-95e6a2b85db4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "654121e7-c1c8-4ba9-a84c-99339ccf1f59", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "c328a3aa-1157-4efd-9240-353d3fa45e04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>", "ID": "b22bef6d-b79e-4a0b-b439-3f8b91b3e54b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9e34ce3-46fb-4122-b2b4-5628fe4ca208"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span>", "ID": "50beef6e-7afc-4781-857a-1793b95a40e3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Sofosbuvir", "ParentId": "b22bef6d-b79e-4a0b-b439-3f8b91b3e54b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>", "ID": "0cc95d8d-28da-494d-9ee2-7f0d0e8903a0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9e34ce3-46fb-4122-b2b4-5628fe4ca208"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span>", "ID": "7ff59534-c568-405e-a237-851e53f15268", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Velpatasvir", "ParentId": "0cc95d8d-28da-494d-9ee2-7f0d0e8903a0"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>", "ID": "a69c5770-3894-45fa-84df-d1058f038f46", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:75.75pt", "Classes": "None", "Text": "  ", "ParentId": "71e77260-2115-42d8-83f5-6c1603b84f82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>", "ID": "220a4d3c-6fd6-4d74-9ab0-51ce81038ace", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a69c5770-3894-45fa-84df-d1058f038f46"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  oxcarbazepine is expected to decrease the concentration of sofosbuvir and\n  velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span>", "ID": "8e0306ba-dd6b-404e-9b6b-bbc37a6e22c2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co\u2011administration of Epclusa with   oxcarbazepine is expected to decrease the concentration of sofosbuvir and   velpatasvir, leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration   is not recommended (see section\u00a04.4).", "ParentId": "220a4d3c-6fd6-4d74-9ab0-51ce81038ace"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b></p>\n</td>\n</tr>", "ID": "be3323cb-5fdd-4f2d-baef-a35743b69a3e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b></p>\n</td>", "ID": "806b2a2a-1d57-419f-bc4c-e8d1781ed4a8", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "be3323cb-5fdd-4f2d-baef-a35743b69a3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b></p>", "ID": "4ff3b005-0205-4685-950c-738a0443daba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "806b2a2a-1d57-419f-bc4c-e8d1781ed4a8"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i></b>", "ID": "ff0e6522-b387-47cb-89d6-d3fcb8140491", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ff3b005-0205-4685-950c-738a0443daba"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span></i>", "ID": "017d2c80-567d-4f7a-af92-4b2f9c3297d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff0e6522-b387-47cb-89d6-d3fcb8140491"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIFUNGALS</span>", "ID": "6400926d-f717-4600-b2d5-4b2024b2cd81", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ANTIFUNGALS", "ParentId": "017d2c80-567d-4f7a-af92-4b2f9c3297d2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span></p>\n</td>\n</tr>", "ID": "689156cc-d599-4183-98df-335985b50d56", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span></p>\n</td>", "ID": "6869aa60-18f6-4e29-8a04-372c0124fb7c", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "689156cc-d599-4183-98df-335985b50d56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span></p>", "ID": "d2a4a18a-0a84-43c3-be84-5b63f39c81fd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6869aa60-18f6-4e29-8a04-372c0124fb7c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole</span>", "ID": "836d0cb7-67e3-463c-88f9-a101d7e5a7c6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ketoconazole", "ParentId": "d2a4a18a-0a84-43c3-be84-5b63f39c81fd"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>", "ID": "94c7d227-0009-47da-8122-1a456d37bda0", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "689156cc-d599-4183-98df-335985b50d56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>", "ID": "192e3fc7-bb1c-4170-83f0-5f64a9c7477e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c7d227-0009-47da-8122-1a456d37bda0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span>", "ID": "f6629bb4-5381-4873-8e04-a02d63848237", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction only studied with velpatasvir", "ParentId": "192e3fc7-bb1c-4170-83f0-5f64a9c7477e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "b9f8932a-f632-49d9-8c3a-c5e8d09a6ccc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c7d227-0009-47da-8122-1a456d37bda0"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "282fd1ea-ef09-4299-935c-ef593e76a487", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9f8932a-f632-49d9-8c3a-c5e8d09a6ccc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "38cd68ba-2385-4296-b2fd-8c5d70810365", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "282fd1ea-ef09-4299-935c-ef593e76a487"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "f246080d-b7f9-49d9-8a3e-a9c7a1702d17", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c7d227-0009-47da-8122-1a456d37bda0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "a32ddb70-c1fe-40ea-8694-db8bd8a78ebe", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "f246080d-b7f9-49d9-8a3e-a9c7a1702d17"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span></p>\n</td>", "ID": "6b4597c9-d058-4fab-8c78-af999a39c5ec", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "689156cc-d599-4183-98df-335985b50d56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span></p>", "ID": "f441b134-ea71-45f4-b841-02c3bd2fa314", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b4597c9-d058-4fab-8c78-af999a39c5ec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ketoconazole is required.</span>", "ID": "2a7e80a3-b154-4c3f-9f53-7bfec113c6f0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   ketoconazole is required.", "ParentId": "f441b134-ea71-45f4-b841-02c3bd2fa314"}, {"Element": "<tr style=\"page-break-inside:avoid;height:25.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span></p>\n</td>\n</tr>", "ID": "3857fb51-f53b-48c8-8502-dc3223cc60bb", "Styles": "page-break-inside:avoid;height:25.7pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span></p>\n</td>", "ID": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:25.7pt", "Classes": "None", "Text": "           ", "ParentId": "3857fb51-f53b-48c8-8502-dc3223cc60bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>", "ID": "212a17c9-e4c6-4abe-84e8-f78fc8d5dd09", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ketoconazole (200\u00a0mg twice daily)/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span>", "ID": "560fd832-f3b1-47f3-a2d9-d7edec195d19", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ketoconazole (200\u00a0mg twice daily)/   velpatasvir (100\u00a0mg single dose)", "ParentId": "212a17c9-e4c6-4abe-84e8-f78fc8d5dd09"}, {"Element": "<sup>d</sup>", "ID": "17f4f990-f9bf-4fd1-b8a5-a00d4321b4aa", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "560fd832-f3b1-47f3-a2d9-d7edec195d19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "6f0cd75b-1f02-4eca-a0c1-ab90b4253fac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "184dc022-c14c-4fd9-bab7-74287bf2fb91", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6f0cd75b-1f02-4eca-a0c1-ab90b4253fac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "28e18d99-744b-472a-8496-9054bc232f9b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "bc515d77-22ed-4e33-bdeb-c8c6d075fb4f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "28e18d99-744b-472a-8496-9054bc232f9b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "438d2e8b-6a30-4f44-8f63-1b84dc310a29", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "be029596-02bf-4ee4-994d-8c49b69d8e1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "438d2e8b-6a30-4f44-8f63-1b84dc310a29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span></p>", "ID": "0ee305c3-baef-4bca-8c9a-73e06036a981", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of P\u2011gp and CYPs)</span>", "ID": "51b00b2e-85a1-44fb-8baa-10061882f084", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Inhibition of P\u2011gp and CYPs)", "ParentId": "0ee305c3-baef-4bca-8c9a-73e06036a981"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2ec5cc6a-fe4f-409f-a282-dcc5235030db", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "2b2c1340-87e7-419e-a3df-c8e41ec1a3b9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2ec5cc6a-fe4f-409f-a282-dcc5235030db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span></p>", "ID": "834ef398-0cfd-4fbf-93d5-3660c77fbdfc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Itraconazole<sup>e</sup></span>", "ID": "76e43f4b-e6e9-4e6d-9266-adb23ff48074", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Itraconazole", "ParentId": "834ef398-0cfd-4fbf-93d5-3660c77fbdfc"}, {"Element": "<sup>e</sup>", "ID": "f9aba364-0164-413f-912e-d666f2227932", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "76e43f4b-e6e9-4e6d-9266-adb23ff48074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span></p>", "ID": "603630d8-8eb7-4365-beba-b07a8396afc9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Voriconazole<sup>e</sup></span>", "ID": "afbf46c4-10cf-4653-8c13-c280073e46aa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Voriconazole", "ParentId": "603630d8-8eb7-4365-beba-b07a8396afc9"}, {"Element": "<sup>e</sup>", "ID": "4eb54d5d-3868-4253-a2b3-2e0ef97a4cc9", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "afbf46c4-10cf-4653-8c13-c280073e46aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span></p>", "ID": "55af42e8-c2bb-41cb-89c6-70ee5537d023", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Posaconazole<sup>e</sup></span>", "ID": "f22a6bd4-51b0-4fba-a032-dd2823ff5a22", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Posaconazole", "ParentId": "55af42e8-c2bb-41cb-89c6-70ee5537d023"}, {"Element": "<sup>e</sup>", "ID": "750b9ce0-b229-4a48-8f6f-8514e8e9f39b", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "f22a6bd4-51b0-4fba-a032-dd2823ff5a22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span></p>", "ID": "4adb6988-b61d-4858-b338-06085b8e46e2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ef5c9a4-a190-4b49-a659-5dfac6beb98d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Isavuconazole<sup>e</sup></span>", "ID": "8a52a084-96d1-46e4-9a3d-5b07779bf895", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Isavuconazole", "ParentId": "4adb6988-b61d-4858-b338-06085b8e46e2"}, {"Element": "<sup>e</sup>", "ID": "596c4746-6548-4e6c-8124-c50fc43bae14", "Styles": "None", "Classes": "None", "Text": "e", "ParentId": "8a52a084-96d1-46e4-9a3d-5b07779bf895"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span></p>\n</td>", "ID": "c47c8a87-349d-4cf4-9cca-6f87bd72e75e", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.7pt", "Classes": "None", "Text": "    ", "ParentId": "3857fb51-f53b-48c8-8502-dc3223cc60bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span></p>", "ID": "9a1f8c93-8801-4375-a028-ca33c2687cda", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c47c8a87-349d-4cf4-9cca-6f87bd72e75e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on ketoconazole exposure not\n  studied.</span>", "ID": "64a625e2-01c9-4608-97fc-3b00406b01cd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on ketoconazole exposure not   studied.", "ParentId": "9a1f8c93-8801-4375-a028-ca33c2687cda"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "7285583f-9b6f-436a-add2-150b47c5de89", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c47c8a87-349d-4cf4-9cca-6f87bd72e75e"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "efe38732-5916-4135-be4f-b4f9f5decef2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7285583f-9b6f-436a-add2-150b47c5de89"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "4ee1e034-1b6e-4195-955a-11fb5ae63104", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "efe38732-5916-4135-be4f-b4f9f5decef2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span></p>", "ID": "e1fec1d2-01a5-4e57-810f-a78cce37ec8c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c47c8a87-349d-4cf4-9cca-6f87bd72e75e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Ketoconazole</span>", "ID": "133c0ae8-caa9-46c5-ab52-bd5c390ccc30", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Ketoconazole", "ParentId": "e1fec1d2-01a5-4e57-810f-a78cce37ec8c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:25.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "74a6b3ba-29ca-4c71-9bca-cd386e84418a", "Styles": "page-break-inside:avoid;height:25.65pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "53e53c9d-c59e-4371-8882-d6193dddd89a", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt", "Classes": "None", "Text": "   ", "ParentId": "74a6b3ba-29ca-4c71-9bca-cd386e84418a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "c477f29b-8a51-41a6-8b42-3025c2c4b811", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "53e53c9d-c59e-4371-8882-d6193dddd89a"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "c8da6c0d-2189-4306-9bfa-27b7ba6a13d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c477f29b-8a51-41a6-8b42-3025c2c4b811"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "ab8e952b-b273-470f-9ff4-79b6c0a6c716", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "c8da6c0d-2189-4306-9bfa-27b7ba6a13d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "8f9d4198-76cc-4512-9e10-7848e4aed1ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "53e53c9d-c59e-4371-8882-d6193dddd89a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "b10fad10-ad33-4456-8703-4c5b26f49b8f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "8f9d4198-76cc-4512-9e10-7848e4aed1ac"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span></p>\n</td>", "ID": "5902b965-d3b3-47a2-97e7-902621523b72", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt", "Classes": "None", "Text": "    ", "ParentId": "74a6b3ba-29ca-4c71-9bca-cd386e84418a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "474fc5b9-f302-41a9-a18d-f7c8305269cd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5902b965-d3b3-47a2-97e7-902621523b72"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "8178736d-4b93-47a4-89e1-d0d352245830", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "474fc5b9-f302-41a9-a18d-f7c8305269cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "81ac8314-60ff-4fe5-959e-0b52ecce58c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5902b965-d3b3-47a2-97e7-902621523b72"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "46013e1e-270d-4748-bc75-f06d8a1f6815", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "81ac8314-60ff-4fe5-959e-0b52ecce58c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span></p>", "ID": "de2c3d5b-98a6-478f-bedf-8d0b08a37c91", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5902b965-d3b3-47a2-97e7-902621523b72"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.6)</span>", "ID": "81abe763-dcc9-4a77-b556-0102cd4ba664", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.0, 1.6)", "ParentId": "de2c3d5b-98a6-478f-bedf-8d0b08a37c91"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span></p>\n</td>", "ID": "eadefb79-d3f0-46f0-9e3f-d9e3e68f9980", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt", "Classes": "None", "Text": "    ", "ParentId": "74a6b3ba-29ca-4c71-9bca-cd386e84418a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "08d2058e-7bc8-4269-b622-b0bcc00d436b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eadefb79-d3f0-46f0-9e3f-d9e3e68f9980"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "e9ce95ad-23e6-4e8b-b756-9234a8dc82d3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "08d2058e-7bc8-4269-b622-b0bcc00d436b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "d335d377-ddd5-4104-b2b4-394131a5784f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eadefb79-d3f0-46f0-9e3f-d9e3e68f9980"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "37c38acc-e813-4c70-ac2d-2c55f4a659f3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "d335d377-ddd5-4104-b2b4-394131a5784f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span></p>", "ID": "cdaf35e3-b97d-484c-bf8d-3f3cf3de4aeb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eadefb79-d3f0-46f0-9e3f-d9e3e68f9980"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.4, 2.2)</span>", "ID": "f72d8b37-d020-4156-86c5-2126684dd1cb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.7 (1.4, 2.2)", "ParentId": "cdaf35e3-b97d-484c-bf8d-3f3cf3de4aeb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "bef8ceac-4b48-42cd-8462-4d644fafc8c0", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:25.65pt", "Classes": "None", "Text": "  ", "ParentId": "74a6b3ba-29ca-4c71-9bca-cd386e84418a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "ad7d66f8-01c9-4932-947a-e04595e77798", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bef8ceac-4b48-42cd-8462-4d644fafc8c0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "5dd70f27-01e4-4e8c-92c4-f2cb274c3a63", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ad7d66f8-01c9-4932-947a-e04595e77798"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b></p>\n</td>\n</tr>", "ID": "0f73f421-d3bf-4f26-949d-d8dc4e4ff5ee", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b></p>\n</td>", "ID": "a79150b8-fcd9-4409-bb00-7febea321574", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0f73f421-d3bf-4f26-949d-d8dc4e4ff5ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b></p>", "ID": "74b4a9d1-0e08-4a47-ba29-dcd4ea20418c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a79150b8-fcd9-4409-bb00-7febea321574"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i></b>", "ID": "6a3548ca-1fd7-4bab-b9d5-94d75d5782b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74b4a9d1-0e08-4a47-ba29-dcd4ea20418c"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span></i>", "ID": "6384f478-26ec-4a45-97eb-9583ca4839fe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a3548ca-1fd7-4bab-b9d5-94d75d5782b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ANTIMYCOBACTERIALS</span>", "ID": "fbb290bf-ed0a-4edc-805d-07adbc7baf7b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ANTIMYCOBACTERIALS", "ParentId": "6384f478-26ec-4a45-97eb-9583ca4839fe"}, {"Element": "<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>", "ID": "fec0dae8-a9a5-4f1f-a8bd-268ee15edc57", "Styles": "page-break-inside:avoid;height:45.05pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>", "ID": "ec98f2a1-9db4-44aa-8b83-20d2f17a9114", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "     ", "ParentId": "fec0dae8-a9a5-4f1f-a8bd-268ee15edc57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>", "ID": "3c7d6838-7ccc-4db6-a530-a3d49c66f65a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec98f2a1-9db4-44aa-8b83-20d2f17a9114"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span>", "ID": "5c34a17c-2935-4c96-afc9-f30ddde24c7e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rifampicin (600\u00a0mg once daily)/   sofosbuvir (400\u00a0mg single dose)", "ParentId": "3c7d6838-7ccc-4db6-a530-a3d49c66f65a"}, {"Element": "<sup>d</sup>", "ID": "2cc3b1a0-91a7-406c-a951-5399f5d19c64", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "5c34a17c-2935-4c96-afc9-f30ddde24c7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "76217f08-69c2-41e4-9c81-9dd8338d0abc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec98f2a1-9db4-44aa-8b83-20d2f17a9114"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6758b7d8-170c-41d9-bf01-abad6238ed80", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "76217f08-69c2-41e4-9c81-9dd8338d0abc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "4d9e2d7a-31e7-427e-b225-c4d6a632e85a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec98f2a1-9db4-44aa-8b83-20d2f17a9114"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "ed0d3aef-dc67-4818-9ead-7d1cf8dc5e49", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "4d9e2d7a-31e7-427e-b225-c4d6a632e85a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>", "ID": "ab76a5fb-8951-4d45-88fa-28e9806cdab3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec98f2a1-9db4-44aa-8b83-20d2f17a9114"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span>", "ID": "37410e40-b527-443c-b34e-5cdc537f69f1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp and CYPs)", "ParentId": "ab76a5fb-8951-4d45-88fa-28e9806cdab3"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>", "ID": "b40b31fb-15ce-4014-bf17-42aff5df336c", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "     ", "ParentId": "fec0dae8-a9a5-4f1f-a8bd-268ee15edc57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>", "ID": "33a8fb5b-43dd-479b-a274-a22ef0382fd8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b40b31fb-15ce-4014-bf17-42aff5df336c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span>", "ID": "06c3786c-c5a5-4d07-817f-d90e131d4512", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on rifampicin exposure not   studied.", "ParentId": "33a8fb5b-43dd-479b-a274-a22ef0382fd8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "74456360-2f95-4aa8-9a48-af3dafa9f6fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b40b31fb-15ce-4014-bf17-42aff5df336c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "caa7f51b-f1a1-49cb-99ac-5921f80f423d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "74456360-2f95-4aa8-9a48-af3dafa9f6fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "218e4f38-1e35-4f42-8e05-f3f8381d6cff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b40b31fb-15ce-4014-bf17-42aff5df336c"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "4ed3958e-3777-4be4-b686-942f4f4db323", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "218e4f38-1e35-4f42-8e05-f3f8381d6cff"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "bc1c9395-13ff-408b-98ce-907d41f7be18", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "4ed3958e-3777-4be4-b686-942f4f4db323"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>", "ID": "81d14501-1d33-4807-9b88-765e52054d4e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b40b31fb-15ce-4014-bf17-42aff5df336c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span>", "ID": "413dae0d-5db1-4957-983c-f887b51e6478", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Rifampicin", "ParentId": "81d14501-1d33-4807-9b88-765e52054d4e"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>", "ID": "6c082487-b8a5-4cf5-914e-26c7e9d94bde", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "  ", "ParentId": "fec0dae8-a9a5-4f1f-a8bd-268ee15edc57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>", "ID": "9d06c37e-e810-497c-ae0e-7bba30ea24d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c082487-b8a5-4cf5-914e-26c7e9d94bde"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "7f037457-3ce3-43fa-ae06-42619c793f5a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "9d06c37e-e810-497c-ae0e-7bba30ea24d0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> is contraindicated with rifampicin, a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span>", "ID": "df41ee07-8d9b-4f03-b7af-952a0b07dab4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " is contraindicated with rifampicin, a potent P\u2011gp   and CYP inducer (see section\u00a04.3).", "ParentId": "9d06c37e-e810-497c-ae0e-7bba30ea24d0"}, {"Element": "<tr style=\"page-break-inside:avoid;height:45.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "289dc379-f36f-450a-a5f9-8d6b5a9f46bb", "Styles": "page-break-inside:avoid;height:45.05pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "d8d71afa-cb3c-4822-84a5-52d608f93d44", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "   ", "ParentId": "289dc379-f36f-450a-a5f9-8d6b5a9f46bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "cdafa2b4-1922-4b94-9cbd-b3b2d015523c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8d71afa-cb3c-4822-84a5-52d608f93d44"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "3ad2abe8-282e-4301-802c-c755431fb41e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cdafa2b4-1922-4b94-9cbd-b3b2d015523c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "ce82ead1-38cd-4819-8cfd-71228e4942de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "3ad2abe8-282e-4301-802c-c755431fb41e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "3c1be255-42f0-43cf-a3ca-3adb66013bd6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8d71afa-cb3c-4822-84a5-52d608f93d44"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "ff8720ed-e931-4005-bbe4-01511da42f6c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "3c1be255-42f0-43cf-a3ca-3adb66013bd6"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span></p>\n</td>", "ID": "f1a9bd51-a512-4a4b-8520-d3b72df61447", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "    ", "ParentId": "289dc379-f36f-450a-a5f9-8d6b5a9f46bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "1a981636-6e82-4164-96e1-d8af9f394a4d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1a9bd51-a512-4a4b-8520-d3b72df61447"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "c5778b35-8949-4b98-93dd-8d59f580da26", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "1a981636-6e82-4164-96e1-d8af9f394a4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "0ece0f91-d793-4f00-96ba-502621f20833", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1a9bd51-a512-4a4b-8520-d3b72df61447"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "815b7176-3557-4485-97c3-1e3532886958", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "0ece0f91-d793-4f00-96ba-502621f20833"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span></p>", "ID": "b837b437-a4ba-4fad-b2e2-925bf3ae6662", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1a9bd51-a512-4a4b-8520-d3b72df61447"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.23 (0.19, 0.29)</span>", "ID": "6a2924d4-36ab-4da7-a7a7-067239092a98", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.23 (0.19, 0.29)", "ParentId": "b837b437-a4ba-4fad-b2e2-925bf3ae6662"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span></p>\n</td>", "ID": "ba1d6f29-1ec1-4bb6-bfbf-db0076c3d13b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "    ", "ParentId": "289dc379-f36f-450a-a5f9-8d6b5a9f46bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "539964cc-37b0-48cf-9e7b-77479c9ed967", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba1d6f29-1ec1-4bb6-bfbf-db0076c3d13b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "23971bcc-7e62-4f36-a685-d8d0aa06af78", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "539964cc-37b0-48cf-9e7b-77479c9ed967"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "0afa9c07-c53c-454e-bc60-d5a55c8fa3e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba1d6f29-1ec1-4bb6-bfbf-db0076c3d13b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "483fa0f2-4bc3-46af-a19b-eefa906bf922", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "0afa9c07-c53c-454e-bc60-d5a55c8fa3e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span></p>", "ID": "866f10dc-16ed-4963-8dae-23fd8ce3ab0d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba1d6f29-1ec1-4bb6-bfbf-db0076c3d13b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.28 (0.24, 0.32)</span>", "ID": "3b54244b-b339-41ed-b12e-c810b7309758", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.28 (0.24, 0.32)", "ParentId": "866f10dc-16ed-4963-8dae-23fd8ce3ab0d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "903124ac-13b3-4721-b8a5-533706092bcc", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:45.05pt", "Classes": "None", "Text": "  ", "ParentId": "289dc379-f36f-450a-a5f9-8d6b5a9f46bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "0f1ff51b-705d-4f96-82f2-ec008b8ae61c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "903124ac-13b3-4721-b8a5-533706092bcc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "d676588d-3313-46b0-8406-0cf667a6a8ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f1ff51b-705d-4f96-82f2-ec008b8ae61c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "acbd1f10-6910-4794-a0e7-6cc62543cda4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d676588d-3313-46b0-8406-0cf667a6a8ad"}, {"Element": "<tr style=\"page-break-inside:avoid;height:38.7pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>\n</tr>", "ID": "11633ea9-4607-41de-b6f7-ca3e712277c5", "Styles": "page-break-inside:avoid;height:38.7pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>", "ID": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:38.7pt", "Classes": "None", "Text": "       ", "ParentId": "11633ea9-4607-41de-b6f7-ca3e712277c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span></p>", "ID": "13af0b38-8a5d-4e0f-aa64-c56c5466db57", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifampicin (600\u00a0mg once daily)/\n  velpatasvir (100\u00a0mg single dose)</span>", "ID": "922792f4-f18d-43df-932e-b691734b68f4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rifampicin (600\u00a0mg once daily)/   velpatasvir (100\u00a0mg single dose)", "ParentId": "13af0b38-8a5d-4e0f-aa64-c56c5466db57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "49dedaaf-5022-4a2b-83d0-d9d53feed4d6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "915f6807-8c25-4979-a62b-6cf0b0dbaa7d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "49dedaaf-5022-4a2b-83d0-d9d53feed4d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5135ce41-7010-4ba4-9984-4dd59e22c0f2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "cba9af36-9e92-4cc9-a2f4-bf404c046291", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5135ce41-7010-4ba4-9984-4dd59e22c0f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5bf1a1cd-d91f-42a7-be3e-aed986f9fc7d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "cea2891f-2a16-4d2c-8266-05dd8ccda917", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5bf1a1cd-d91f-42a7-be3e-aed986f9fc7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5c13344c-13a8-4956-a381-729ac2140dbb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "d0251454-9133-40f3-99ed-a770a78082db", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5c13344c-13a8-4956-a381-729ac2140dbb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>", "ID": "1f4074dd-3782-446b-be69-82e3a4b75b5d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c00baa-3d6e-4b5d-9e94-4b50e3b1da1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span>", "ID": "6438b84d-31b6-46c8-80e3-84bb16fe380c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp and CYPs)", "ParentId": "1f4074dd-3782-446b-be69-82e3a4b75b5d"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:38.7pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>\n</td>", "ID": "5eef62f8-c96b-4702-b8bc-b4ac32c57553", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:38.7pt", "Classes": "None", "Text": "     ", "ParentId": "11633ea9-4607-41de-b6f7-ca3e712277c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span></p>", "ID": "e9f97e37-004c-4718-91e1-2e16365a1697", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5eef62f8-c96b-4702-b8bc-b4ac32c57553"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on rifampicin exposure not\n  studied.</span>", "ID": "3fa57ef3-cc32-440f-9ab2-696bbd4126c5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on rifampicin exposure not   studied.", "ParentId": "e9f97e37-004c-4718-91e1-2e16365a1697"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "e1ac4056-a811-43cd-967f-902ec84f9482", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5eef62f8-c96b-4702-b8bc-b4ac32c57553"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "a15aa532-0cd9-4d07-8c9a-7f961159f741", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "e1ac4056-a811-43cd-967f-902ec84f9482"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "7fd16ef3-4066-4c07-96b1-aa812c4d54c8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5eef62f8-c96b-4702-b8bc-b4ac32c57553"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "fcdf4674-056b-4aa5-8f38-c5bcf3e2ac32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fd16ef3-4066-4c07-96b1-aa812c4d54c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "d67af98b-7ea3-458d-bb7f-4ac1066d9dce", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "fcdf4674-056b-4aa5-8f38-c5bcf3e2ac32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span></p>", "ID": "3aa3ae6f-c9cf-43e3-89e3-60d515dca735", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5eef62f8-c96b-4702-b8bc-b4ac32c57553"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Rifampicin</span>", "ID": "789ee16e-596a-4d94-ab2b-4c53d2f83fe8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Rifampicin", "ParentId": "3aa3ae6f-c9cf-43e3-89e3-60d515dca735"}, {"Element": "<tr style=\"page-break-inside:avoid;height:58.15pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "6ff519ed-e141-4d58-98ae-bc4a112dd89a", "Styles": "page-break-inside:avoid;height:58.15pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "fcf79a69-ffce-4e50-aa6c-3f6f3b1894de", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt", "Classes": "None", "Text": "   ", "ParentId": "6ff519ed-e141-4d58-98ae-bc4a112dd89a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "a25e30cc-051c-4fda-88cd-b24db131face", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fcf79a69-ffce-4e50-aa6c-3f6f3b1894de"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "8d111bec-fb0e-4483-92f4-cb0c4816d319", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a25e30cc-051c-4fda-88cd-b24db131face"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "f5e062d3-b889-49d3-8ac1-ccddf9ba2bd8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "8d111bec-fb0e-4483-92f4-cb0c4816d319"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "aa503fa5-4585-49fc-8996-33bac056e32d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fcf79a69-ffce-4e50-aa6c-3f6f3b1894de"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "d0ca6be4-6e7d-48bc-aa8c-d2595bd6cf52", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "aa503fa5-4585-49fc-8996-33bac056e32d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span></p>\n</td>", "ID": "a6bc1ef3-b770-41df-b7b6-10cad40d8405", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt", "Classes": "None", "Text": "    ", "ParentId": "6ff519ed-e141-4d58-98ae-bc4a112dd89a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2a567922-51a3-44d1-9c8c-0baaa422d86b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a6bc1ef3-b770-41df-b7b6-10cad40d8405"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "da37add2-b4bc-445a-b145-01dcc619cea9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2a567922-51a3-44d1-9c8c-0baaa422d86b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "004bca72-d993-47ed-a5a6-5fded346510c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a6bc1ef3-b770-41df-b7b6-10cad40d8405"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "591f6e9b-4778-4ef2-b13f-1de54eb43600", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "004bca72-d993-47ed-a5a6-5fded346510c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span></p>", "ID": "37ac59b1-f3bd-43f7-ad21-7123f59b0b87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a6bc1ef3-b770-41df-b7b6-10cad40d8405"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.29 (0.23, 0.37)</span>", "ID": "42f8ff0c-ba90-46e9-b7a8-236b65ebd158", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.29 (0.23, 0.37)", "ParentId": "37ac59b1-f3bd-43f7-ad21-7123f59b0b87"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span></p>\n</td>", "ID": "dca5bd33-9a24-4fe5-9719-cdd77ee173ef", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt", "Classes": "None", "Text": "    ", "ParentId": "6ff519ed-e141-4d58-98ae-bc4a112dd89a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "e549717d-319c-476a-b9fe-6b5a5d5700aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dca5bd33-9a24-4fe5-9719-cdd77ee173ef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "4cf52fd3-0c35-4270-a1b2-43663f56c020", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "e549717d-319c-476a-b9fe-6b5a5d5700aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "4daf13e8-bd72-4d87-a9d4-84df3927edb6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dca5bd33-9a24-4fe5-9719-cdd77ee173ef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "834dbb98-547d-4be9-a70f-411d8e3e3117", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "4daf13e8-bd72-4d87-a9d4-84df3927edb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span></p>", "ID": "fd728d09-6108-43d3-afd3-86be6e666f6d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dca5bd33-9a24-4fe5-9719-cdd77ee173ef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.18 (0.15, 0.22)</span>", "ID": "7dd065da-6b88-4ecc-a274-d4afccadda8a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.18 (0.15, 0.22)", "ParentId": "fd728d09-6108-43d3-afd3-86be6e666f6d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "0e7e0d97-2494-4172-8e0c-cefcacb87300", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:58.15pt", "Classes": "None", "Text": "  ", "ParentId": "6ff519ed-e141-4d58-98ae-bc4a112dd89a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "54b93137-5c85-475f-94e6-ab30226e0e01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e7e0d97-2494-4172-8e0c-cefcacb87300"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "db49018c-5cef-40b1-9536-b503508e7492", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54b93137-5c85-475f-94e6-ab30226e0e01"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "4eace131-817e-4da7-9bef-090436f7587f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "db49018c-5cef-40b1-9536-b503508e7492"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>\n</tr>", "ID": "b955789b-00f9-4016-81fa-09e25a3d1ae7", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>", "ID": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "b955789b-00f9-4016-81fa-09e25a3d1ae7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span></p>", "ID": "1254244f-4317-4c41-9cc4-c97fefeea250", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifabutin</span>", "ID": "5ebaa9cd-702a-4257-9a99-cf2397d00619", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rifabutin", "ParentId": "1254244f-4317-4c41-9cc4-c97fefeea250"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span></p>", "ID": "138771e0-869c-4159-a883-22277bec3fe5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rifapentine</span>", "ID": "773fad4e-c082-4201-9282-096271b1810a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rifapentine", "ParentId": "138771e0-869c-4159-a883-22277bec3fe5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "703ba1b2-609c-45fa-932e-91cbe9ebaeff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "03ef27eb-5977-48e0-b718-c867f6cefcd6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "703ba1b2-609c-45fa-932e-91cbe9ebaeff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "33746c02-4cac-4770-a714-8f27abf15b57", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "184470eb-057a-45fc-9094-e69f874598c4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "33746c02-4cac-4770-a714-8f27abf15b57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "c181e183-dad3-4bd9-ba79-b5ff4d7ca795", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "81cab1a5-d3b3-4045-9620-388b46530ef1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "c181e183-dad3-4bd9-ba79-b5ff4d7ca795"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>", "ID": "e000114f-53b7-48c4-b589-f2c0f71b4294", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba5f6fa7-a0fc-4b69-9c56-ba06eb0e6fbd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span>", "ID": "bc46907c-088a-424e-8021-4182e30900cf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp and CYPs)", "ParentId": "e000114f-53b7-48c4-b589-f2c0f71b4294"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>", "ID": "267e4eef-b2b7-4cd8-91c0-b42ff27f09f7", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "b955789b-00f9-4016-81fa-09e25a3d1ae7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "e72e97a1-06b7-4d71-8530-4958f8bd5768", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "267e4eef-b2b7-4cd8-91c0-b42ff27f09f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "62c96119-f66f-445a-ada6-3ee1e0063a26", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "e72e97a1-06b7-4d71-8530-4958f8bd5768"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "bbd4e4f6-38b6-4b74-b801-81e3b8f57ccc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "267e4eef-b2b7-4cd8-91c0-b42ff27f09f7"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "634e9793-36c5-46e9-bcfa-1f0c0d380a89", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bbd4e4f6-38b6-4b74-b801-81e3b8f57ccc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "afa72678-0ef1-48b7-98d7-e9272ab26b65", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "634e9793-36c5-46e9-bcfa-1f0c0d380a89"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>", "ID": "93e74552-f0cb-43c3-8ecd-46b8eff724eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "267e4eef-b2b7-4cd8-91c0-b42ff27f09f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span>", "ID": "1d5933ea-081a-4a43-8269-f9cc671174eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Sofosbuvir", "ParentId": "93e74552-f0cb-43c3-8ecd-46b8eff724eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>", "ID": "3e6afe91-c66b-4c6c-80d0-e0623df925ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "267e4eef-b2b7-4cd8-91c0-b42ff27f09f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span>", "ID": "ed3255bc-06a1-46cf-adc3-3bd4b1446005", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Velpatasvir", "ParentId": "3e6afe91-c66b-4c6c-80d0-e0623df925ba"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>\n</td>", "ID": "482e7e16-d0f2-4071-8aa7-064b6a9bfcfb", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "b955789b-00f9-4016-81fa-09e25a3d1ae7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span></p>", "ID": "2dee9989-3872-46c9-a9df-ce7f4c7f146d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "482e7e16-d0f2-4071-8aa7-064b6a9bfcfb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "faefa67e-b105-4e2c-8c97-ffd38f0a09c2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "2dee9989-3872-46c9-a9df-ce7f4c7f146d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with rifabutin, a potent P\u2011gp and CYP\n  inducer (see section\u00a04.3).</span>", "ID": "f8dc8378-0556-4027-8e7e-444e526b38be", "Styles": "font-size:\n  10.0pt", "Classes": "None", "Text": " is contraindicated with rifabutin, a potent P\u2011gp and CYP   inducer (see section\u00a04.3).", "ParentId": "2dee9989-3872-46c9-a9df-ce7f4c7f146d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "3b7201bc-a8e1-4ff1-b7ea-ad1854da5fdd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "482e7e16-d0f2-4071-8aa7-064b6a9bfcfb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "27b249bb-1215-4746-ae9d-2ff80bb05f8e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3b7201bc-a8e1-4ff1-b7ea-ad1854da5fdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span></p>", "ID": "820261af-af7e-4005-b1f5-c73a6ef82434", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "482e7e16-d0f2-4071-8aa7-064b6a9bfcfb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with rifapentine\n  is expected to decrease the concentration of sofosbuvir and velpatasvir,\n  leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration\n  is not recommended (see section\u00a04.4).</span>", "ID": "7d1b5c5e-307c-4f10-b622-5837afb82e7e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co\u2011administration of Epclusa with rifapentine   is expected to decrease the concentration of sofosbuvir and velpatasvir,   leading to reduced therapeutic effect of Epclusa.\u00a0 Co\u2011administration   is not recommended (see section\u00a04.4).", "ParentId": "820261af-af7e-4005-b1f5-c73a6ef82434"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>", "ID": "1e54a18a-cb2e-40e4-abeb-8d052ed0dc8a", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b></p>\n</td>", "ID": "cb340ffe-2c38-4367-9ee3-1adf53afed0f", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "1e54a18a-cb2e-40e4-abeb-8d052ed0dc8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b></p>", "ID": "58212a56-3d97-4c8a-8f75-21fb29a7c0e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb340ffe-2c38-4367-9ee3-1adf53afed0f"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i></b>", "ID": "e8c63740-6910-486c-a96d-f624c63627e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58212a56-3d97-4c8a-8f75-21fb29a7c0e0"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span></i>", "ID": "0b8753d5-297e-4200-a07d-08b581c44c7c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8c63740-6910-486c-a96d-f624c63627e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: REVERSE\n  TRANSCRIPTASE INHIBITORS</span>", "ID": "64169e1f-214f-48c7-b03a-f403d1d62bc8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "HIV ANTIVIRAL AGENTS: REVERSE   TRANSCRIPTASE INHIBITORS", "ParentId": "0b8753d5-297e-4200-a07d-08b581c44c7c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span></p>\n</td>\n<td colspan=\"5\" style=\"width:72.88%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"72%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span></p>\n</td>\n</tr>", "ID": "41e69c2e-0f9d-4dc0-af77-9a9de659664e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span></p>\n</td>", "ID": "3d6f8129-81db-4155-bf85-f7ec4cf97d3e", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "41e69c2e-0f9d-4dc0-af77-9a9de659664e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span></p>", "ID": "1c971f20-7cc7-4251-b46d-d186b76e121b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3d6f8129-81db-4155-bf85-f7ec4cf97d3e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir disoproxil fumarate</span>", "ID": "9b1c29b8-1cfe-4a74-b816-afe49c4cd114", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Tenofovir disoproxil fumarate", "ParentId": "1c971f20-7cc7-4251-b46d-d186b76e121b"}, {"Element": "<td colspan=\"5\" style=\"width:72.88%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"72%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span></p>\n</td>", "ID": "92150da4-f3a4-4199-b4fe-d2403ef0c4a2", "Styles": "width:72.88%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "41e69c2e-0f9d-4dc0-af77-9a9de659664e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span></p>", "ID": "1ac28960-505d-49f4-a36f-f6f44ea02fa1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92150da4-f3a4-4199-b4fe-d2403ef0c4a2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "b66d652e-0c4a-4642-af4b-30bd86ba657f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "1ac28960-505d-49f4-a36f-f6f44ea02fa1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0\n  The increase in tenofovir exposure (AUC and C<sub>max</sub>) was around 40\u201180%\n  during co-treatment with Epclusa and tenofovir disoproxil\n  fumarate/emtricitabine as part of various HIV regimens.</span>", "ID": "f1981877-a655-48c4-b87d-2deddf59fa8b", "Styles": "font-size:\n  10.0pt", "Classes": "None", "Text": " has been shown to increase tenofovir exposure (P\u2011gp-inhibition).\u00a0   The increase in tenofovir exposure (AUC and C) was around 40\u201180%   during co-treatment with Epclusa and tenofovir disoproxil   fumarate/emtricitabine as part of various HIV regimens.", "ParentId": "1ac28960-505d-49f4-a36f-f6f44ea02fa1"}, {"Element": "<sub>max</sub>", "ID": "25ebf34f-cb59-492a-9aea-21bbb8d3d1de", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "f1981877-a655-48c4-b87d-2deddf59fa8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5c8b2836-8ee7-4506-b82c-cfb1fd98f2e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92150da4-f3a4-4199-b4fe-d2403ef0c4a2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "70d22e65-41f9-4ec1-87eb-d951ecaa04e6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5c8b2836-8ee7-4506-b82c-cfb1fd98f2e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span></p>", "ID": "54a8afe8-aec8-487a-b0cb-76d2c7596b52", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92150da4-f3a4-4199-b4fe-d2403ef0c4a2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Patients receiving tenofovir disoproxil fumarate and\n  Epclusa concomitantly should be monitored for adverse reactions associated\n  with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil\n  fumarate-containing product\u2019s Summary of Product Characteristics for\n  recommendations on renal monitoring (see section\u00a04.4).</span>", "ID": "52b607c8-9fca-4b7c-90f5-5b8d361a8774", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Patients receiving tenofovir disoproxil fumarate and   Epclusa concomitantly should be monitored for adverse reactions associated   with tenofovir disoproxil fumarate. \u00a0Refer to the tenofovir disoproxil   fumarate-containing product\u2019s Summary of Product Characteristics for   recommendations on renal monitoring (see section\u00a04.4).", "ParentId": "54a8afe8-aec8-487a-b0cb-76d2c7596b52"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span></p>\n</td>\n</tr>", "ID": "4d121220-1546-47e5-ae68-f53c65374842", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "e9cda479-ff53-47ba-833d-1dd8eeb9def3", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span></p>", "ID": "d074f4f1-ac05-48d5-bddb-602aaff648b4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9cda479-ff53-47ba-833d-1dd8eeb9def3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz/ emtricitabine/ tenofovir\n  disoproxil fumarate</span>", "ID": "d0ff69f3-adf4-4bb1-b95d-cadefbba719f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Efavirenz/ emtricitabine/ tenofovir   disoproxil fumarate", "ParentId": "d074f4f1-ac05-48d5-bddb-602aaff648b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "0f2ec646-824d-4adc-9845-1b35d524df30", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9cda479-ff53-47ba-833d-1dd8eeb9def3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(600/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "c5ebfdf0-529c-456b-a145-b28d451c12d0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(600/ 200/ 300\u00a0mg once daily)/   sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "0f2ec646-824d-4adc-9845-1b35d524df30"}, {"Element": "<sup>c, d</sup>", "ID": "0610ff7f-56f0-4c89-b9e4-d23b7bc04370", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "c5ebfdf0-529c-456b-a145-b28d451c12d0"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span></p>\n</td>", "ID": "9381a7e4-b049-4df3-a69a-1a11e6a2fe96", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span></p>", "ID": "ec706f7c-e225-4448-a835-5bae3f41253f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9381a7e4-b049-4df3-a69a-1a11e6a2fe96"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Efavirenz</span>", "ID": "ceb12c35-14f4-4ea4-8706-edef2e7354fa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Efavirenz", "ParentId": "ec706f7c-e225-4448-a835-5bae3f41253f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "08944cc6-85ee-4121-8b19-8a5ccfdd44bb", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "0664eccc-e31c-43a2-9971-94ff43936667", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "08944cc6-85ee-4121-8b19-8a5ccfdd44bb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "04c148e9-8675-4aae-9fd7-cf5ed3c35ecd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "0664eccc-e31c-43a2-9971-94ff43936667"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "2377506b-a7a9-47ea-809b-63e7b4e42de1", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "c403e6ca-6932-41de-8af7-125fcba9433b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2377506b-a7a9-47ea-809b-63e7b4e42de1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "7238a2d2-9b0f-424a-809b-00baf8d2c63e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "c403e6ca-6932-41de-8af7-125fcba9433b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "55eb4e7e-4687-4309-a395-1eb6dbbd306c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "1abd858c-b7db-40e4-9452-816bd94494bd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "55eb4e7e-4687-4309-a395-1eb6dbbd306c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "3045e1fc-c878-4925-86c5-96850139c541", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "1abd858c-b7db-40e4-9452-816bd94494bd"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span></p>\n</td>", "ID": "2a7280ac-6881-451d-95b5-6e18d722bdc2", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4d121220-1546-47e5-ae68-f53c65374842"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span></p>", "ID": "f59b3fed-2e48-40b8-88e0-5c4b72c94d6c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a7280ac-6881-451d-95b5-6e18d722bdc2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to\n  decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa\n  with efavirenz\u2011containing regimens is not recommended (see\n  section\u00a04.4).</span>", "ID": "6b0dc38c-3097-435f-8aa6-a78e0583dda0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co\u2011administration of Epclusa with   efavirenz/ emtricitabine/ tenofovir disoproxil fumarate is expected to   decrease the concentration of velpatasvir.\u00a0 Co\u2011administration of Epclusa   with efavirenz\u2011containing regimens is not recommended (see   section\u00a04.4).", "ParentId": "f59b3fed-2e48-40b8-88e0-5c4b72c94d6c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "85448273-84d6-4b91-8aa4-b0a3d8e30d78", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "962835a8-e28e-47f7-b7b0-11596af087e8", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "85448273-84d6-4b91-8aa4-b0a3d8e30d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "0cadbc36-3788-4731-b254-dd4c8fe5a218", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "962835a8-e28e-47f7-b7b0-11596af087e8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "766f5019-ab8f-4386-8e53-79b6e3ce2bf0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "0cadbc36-3788-4731-b254-dd4c8fe5a218"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span></p>\n</td>", "ID": "e950e655-61db-425b-b858-f72ab0c075c5", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "85448273-84d6-4b91-8aa4-b0a3d8e30d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "dfa7df64-03bb-471a-8d73-d48b486bf7a3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e950e655-61db-425b-b858-f72ab0c075c5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "15161d79-f8a7-43f7-8c81-d49f1db0a610", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "dfa7df64-03bb-471a-8d73-d48b486bf7a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span></p>", "ID": "f863ba7c-a4e8-45f2-a1c0-07c5854251aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e950e655-61db-425b-b858-f72ab0c075c5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.1, 1.7)</span>", "ID": "3032e916-c636-4992-be0e-41b3671166ab", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.1, 1.7)", "ParentId": "f863ba7c-a4e8-45f2-a1c0-07c5854251aa"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "f0b7e866-02f5-4235-a7fa-2b9f8ffa339f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "85448273-84d6-4b91-8aa4-b0a3d8e30d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "8d64b58f-6bdb-44ed-936f-bd55b60b54f3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0b7e866-02f5-4235-a7fa-2b9f8ffa339f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "510ea7a4-da99-4886-871e-3a6341234e56", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "8d64b58f-6bdb-44ed-936f-bd55b60b54f3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "3a85af1e-e850-4cdd-afe2-6b3777181978", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "85448273-84d6-4b91-8aa4-b0a3d8e30d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "4ffb15e6-8daa-4059-a8f6-c42b0497cf21", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a85af1e-e850-4cdd-afe2-6b3777181978"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "9f8f5e06-aad7-4a3b-b119-3652d8e96acb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ffb15e6-8daa-4059-a8f6-c42b0497cf21"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "1e74102d-decf-4f12-9f5d-9e746d84896e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "9f8f5e06-aad7-4a3b-b119-3652d8e96acb"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span></p>\n</td>\n</tr>", "ID": "d4299c90-abc2-4dc4-a8e1-9bd177fb5177", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "ae2d7195-d171-46ff-8d2b-6bf602692a1c", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d4299c90-abc2-4dc4-a8e1-9bd177fb5177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "b14a64da-9466-45ab-9b87-0e3e657968bd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae2d7195-d171-46ff-8d2b-6bf602692a1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "5f7db9b5-a915-42d4-bbdb-dd3d0c6150bc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "b14a64da-9466-45ab-9b87-0e3e657968bd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span></p>\n</td>", "ID": "f00177b4-5fbd-472b-bc64-4f55ee5c85c8", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "d4299c90-abc2-4dc4-a8e1-9bd177fb5177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "fe0c4744-7d50-45c5-920f-c4757b3c222f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f00177b4-5fbd-472b-bc64-4f55ee5c85c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "793eeeda-6599-43a6-a051-53cc6b4fa346", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "fe0c4744-7d50-45c5-920f-c4757b3c222f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span></p>", "ID": "0125aef3-741b-4ef8-983a-348f7f0ac923", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f00177b4-5fbd-472b-bc64-4f55ee5c85c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.53 (0.43, 0.64)</span>", "ID": "3b9d5761-6fae-4159-bd0e-ae08519883da", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.53 (0.43, 0.64)", "ParentId": "0125aef3-741b-4ef8-983a-348f7f0ac923"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span></p>\n</td>", "ID": "1790a171-3cb7-40c2-a89d-b51c5237fb5c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "d4299c90-abc2-4dc4-a8e1-9bd177fb5177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "de911c24-edda-4c5d-b2e5-005bd0fac69d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1790a171-3cb7-40c2-a89d-b51c5237fb5c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "a3b694a6-4f08-4e09-8d27-3a6a87af79f9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "de911c24-edda-4c5d-b2e5-005bd0fac69d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span></p>", "ID": "bdb17aed-3eea-4bff-ac8e-f4b926a1b896", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1790a171-3cb7-40c2-a89d-b51c5237fb5c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.47 (0.39, 0.57)</span>", "ID": "531c2b1e-7ca5-4ba7-967b-8795c74342ac", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.47 (0.39, 0.57)", "ParentId": "bdb17aed-3eea-4bff-ac8e-f4b926a1b896"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span></p>\n</td>", "ID": "5683c342-bbcb-444d-ad40-fabb1754a77f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "d4299c90-abc2-4dc4-a8e1-9bd177fb5177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "7d7b90a7-637c-4fa7-8583-2b361ae7a113", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5683c342-bbcb-444d-ad40-fabb1754a77f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "6bae6d9e-db34-4029-95ed-6850a9f7f3a8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "7d7b90a7-637c-4fa7-8583-2b361ae7a113"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span></p>", "ID": "a6b5f117-1e90-4e17-9610-0437d8f59f74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5683c342-bbcb-444d-ad40-fabb1754a77f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.43 (0.36, 0.52)</span>", "ID": "9ca742bd-2795-4119-9653-726881271c33", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.43 (0.36, 0.52)", "ParentId": "a6b5f117-1e90-4e17-9610-0437d8f59f74"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>", "ID": "45b7351b-1c72-4754-a006-fe212e24c41b", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "df4d94ca-0c8a-4e27-b5d1-53713275f9f3", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span></p>", "ID": "2a5da047-3496-4970-b5cd-b2066b27dedf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df4d94ca-0c8a-4e27-b5d1-53713275f9f3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Emtricitabine/ <b>rilpivirine</b>/\n  tenofovir disoproxil fumarate</span>", "ID": "016742c5-b088-4822-9066-d547189cf203", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Emtricitabine/ /   tenofovir disoproxil fumarate", "ParentId": "2a5da047-3496-4970-b5cd-b2066b27dedf"}, {"Element": "<b>rilpivirine</b>", "ID": "c34722f2-9b19-4f3c-a816-21141f55e162", "Styles": "None", "Classes": "None", "Text": "rilpivirine", "ParentId": "016742c5-b088-4822-9066-d547189cf203"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "9bef6874-7ec4-4868-b0ef-cd979b514fe5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df4d94ca-0c8a-4e27-b5d1-53713275f9f3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(200/ 25/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "3d404e3a-745c-4ad7-86e8-18f3fe31b933", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(200/ 25/ 300\u00a0mg once daily)/   sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "9bef6874-7ec4-4868-b0ef-cd979b514fe5"}, {"Element": "<sup>c, d</sup>", "ID": "371493f7-64d8-4b66-857b-4293c612907c", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "3d404e3a-745c-4ad7-86e8-18f3fe31b933"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span></p>\n</td>", "ID": "db0b09bf-f305-499b-89e8-5f281ff99ab0", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span></p>", "ID": "10ceee3e-0b63-4ab9-a57a-cc8c7ca064a2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db0b09bf-f305-499b-89e8-5f281ff99ab0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rilpivirine</span>", "ID": "f26014ac-7ce4-4157-8067-22ac9a27789b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rilpivirine", "ParentId": "10ceee3e-0b63-4ab9-a57a-cc8c7ca064a2"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "036877c7-f3ce-4c1f-aab5-e21facc6d88d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "34e4058b-3ca4-4bb8-83d5-a4c7654b4f4f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "036877c7-f3ce-4c1f-aab5-e21facc6d88d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c1709d7b-d064-4a96-969a-8b1701114d21", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "34e4058b-3ca4-4bb8-83d5-a4c7654b4f4f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "0ae7df3e-10df-470e-8831-8ec530fb3b06", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "0c494900-63b3-46e7-b90d-8286cf09d618", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ae7df3e-10df-470e-8831-8ec530fb3b06"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c44478e7-762b-4d6b-8f3e-26240c07cec5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "0c494900-63b3-46e7-b90d-8286cf09d618"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "1abbe9c0-9802-466d-a1f9-167f7a494087", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "47b72b88-561e-496f-a103-38c363dfeab7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1abbe9c0-9802-466d-a1f9-167f7a494087"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "8494dc17-58fa-4d82-ad72-bda3756c74cd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "47b72b88-561e-496f-a103-38c363dfeab7"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>", "ID": "d541de7e-e65d-4738-a369-445e082c657e", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "45b7351b-1c72-4754-a006-fe212e24c41b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span></p>", "ID": "e044dcf0-6f52-43cb-ba84-b686bb5dc64b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d541de7e-e65d-4738-a369-445e082c657e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.</span>", "ID": "9702f124-9b2f-43f1-b7ff-d725c46a36a1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate is required.", "ParentId": "e044dcf0-6f52-43cb-ba84-b686bb5dc64b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "0e8ac9c6-3af0-4288-8327-fe8a31d7963e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "6a209e09-9f87-4787-a9b3-6334322dcdac", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0e8ac9c6-3af0-4288-8327-fe8a31d7963e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "c964bfe1-c81c-4f3a-947e-2f8579bb7077", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6a209e09-9f87-4787-a9b3-6334322dcdac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "1bbce0c4-175e-43eb-8b17-be0f152e05c8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "c964bfe1-c81c-4f3a-947e-2f8579bb7077"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "8571807f-28f3-48dd-82c2-3886f043b7df", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0e8ac9c6-3af0-4288-8327-fe8a31d7963e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "a594800f-76cb-4ac4-87af-f44289fa636c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8571807f-28f3-48dd-82c2-3886f043b7df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "1de72a8a-8507-41e8-9705-56b05c6079da", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "a594800f-76cb-4ac4-87af-f44289fa636c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "60dab86d-d2a5-4bbf-be5f-d3906e2c1d9e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0e8ac9c6-3af0-4288-8327-fe8a31d7963e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "ad2e3b86-94ac-49b8-9e62-f07c899eb196", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60dab86d-d2a5-4bbf-be5f-d3906e2c1d9e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fbc53994-cfc6-4526-b531-70caab5a97a8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "ad2e3b86-94ac-49b8-9e62-f07c899eb196"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "f389a344-372b-4f4a-82db-3a5eeba83c47", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0e8ac9c6-3af0-4288-8327-fe8a31d7963e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "9aa0dfb9-317c-4713-96ca-e64d86ef0ed9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f389a344-372b-4f4a-82db-3a5eeba83c47"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "b04f7793-f00f-4f44-8eac-96ae4d493bdd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9aa0dfb9-317c-4713-96ca-e64d86ef0ed9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "9054174c-4d34-4bec-a596-cc75613bae07", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b04f7793-f00f-4f44-8eac-96ae4d493bdd"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "824d1066-1678-402b-87c3-499f81d0fd81", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "81fd84a2-1df7-415f-bef6-7c747b7293d9", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "824d1066-1678-402b-87c3-499f81d0fd81"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "8d1e029c-047a-48c7-81c5-2f149a973443", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81fd84a2-1df7-415f-bef6-7c747b7293d9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "0977d3e7-6fe4-49fc-becd-dfab70e0bb69", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "8d1e029c-047a-48c7-81c5-2f149a973443"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "eb9ac8df-84c9-4c84-b20b-1f466f401625", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "824d1066-1678-402b-87c3-499f81d0fd81"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "920dea8d-ef59-4d91-b90a-075b6f07d94f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb9ac8df-84c9-4c84-b20b-1f466f401625"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "e32d9632-519b-4098-bc85-8bc718c73529", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "920dea8d-ef59-4d91-b90a-075b6f07d94f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "e5279497-8c86-4392-b34d-2df760813a89", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "824d1066-1678-402b-87c3-499f81d0fd81"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "575b9efb-6d79-4131-9311-382c73bff65b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e5279497-8c86-4392-b34d-2df760813a89"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "8cd67063-4315-45a2-ab36-0eb8e4f20dad", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "575b9efb-6d79-4131-9311-382c73bff65b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "5fb764e4-c5d4-451b-a567-108e3266b1b9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "824d1066-1678-402b-87c3-499f81d0fd81"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "c82baf53-dea7-40cc-b5c1-d44f29b04f3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5fb764e4-c5d4-451b-a567-108e3266b1b9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "46814fd6-5912-43ba-85f9-c36cba0f9947", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "c82baf53-dea7-40cc-b5c1-d44f29b04f3c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>", "ID": "e0ac2147-5e4f-4489-9b05-7ffcf148b02e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b></p>\n</td>", "ID": "3fcba16f-7421-44ee-b6ed-03e42b9e2ce4", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "e0ac2147-5e4f-4489-9b05-7ffcf148b02e"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b></p>", "ID": "832d2c29-10eb-4065-a381-1d6da34623a2", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "3fcba16f-7421-44ee-b6ed-03e42b9e2ce4"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i></b>", "ID": "bd8f8dcd-9cbc-4784-bdce-b2245fb85573", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "832d2c29-10eb-4065-a381-1d6da34623a2"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span></i>", "ID": "81b55e48-f3e7-4b48-ae3b-daaf9039550c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd8f8dcd-9cbc-4784-bdce-b2245fb85573"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;color:windowtext\">HIV ANTIVIRAL AGENTS: HIV PROTEASE\n  INHIBITORS</span>", "ID": "fdf2f3ce-93dd-47b5-8c07-d6b3b9e4f8e4", "Styles": "font-size:10.0pt;color:windowtext", "Classes": "None", "Text": "HIV ANTIVIRAL AGENTS: HIV PROTEASE   INHIBITORS", "ParentId": "81b55e48-f3e7-4b48-ae3b-daaf9039550c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>", "ID": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>", "ID": "9b624adf-e97a-4cfb-abb0-38401bbc1be0", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>", "ID": "d7e380d6-d56d-493f-a22e-e6b598390e6c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b624adf-e97a-4cfb-abb0-38401bbc1be0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></b>", "ID": "c84e0b2a-8d60-4b21-acbb-087b2a4cd881", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7e380d6-d56d-493f-a22e-e6b598390e6c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span>", "ID": "55e48845-664a-4d4a-959d-0cb981d3a97c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Atazanavir", "ParentId": "c84e0b2a-8d60-4b21-acbb-087b2a4cd881"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (300/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span>", "ID": "fa1a5669-9c11-4f0c-822c-42d3bc406f3d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " boosted with ritonavir (300/ 100\u00a0mg once   daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/   300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once   daily)", "ParentId": "d7e380d6-d56d-493f-a22e-e6b598390e6c"}, {"Element": "<sup>c, d</sup>", "ID": "211c7932-e7e4-4b7d-b1f2-4fb81a8c0c73", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "fa1a5669-9c11-4f0c-822c-42d3bc406f3d"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></p>\n</td>", "ID": "0460dd5c-a8a9-4059-83bd-3e4da9f16367", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span></p>", "ID": "fc1904a3-c618-4081-b497-ae9d1053d63e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0460dd5c-a8a9-4059-83bd-3e4da9f16367"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Atazanavir</span>", "ID": "7901bc8d-9106-4991-b188-c64ed4c6bd2c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Atazanavir", "ParentId": "fc1904a3-c618-4081-b497-ae9d1053d63e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "ab86089f-5aa5-4f7f-8b26-b7034e77bb4e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "d3733c49-f85d-4922-bb3c-7e8276a6c607", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab86089f-5aa5-4f7f-8b26-b7034e77bb4e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fb462ac3-3936-4992-9f3a-1ddbe0d866ae", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "d3733c49-f85d-4922-bb3c-7e8276a6c607"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "d98f4acf-2310-44c4-818d-4fffdae16f31", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "07c6854e-2f15-402c-b932-a912bd6e8b90", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d98f4acf-2310-44c4-818d-4fffdae16f31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "871eb944-2c21-46d3-9fc8-24521f9190c5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "07c6854e-2f15-402c-b932-a912bd6e8b90"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span></p>\n</td>", "ID": "0f2a06f3-7e8c-4fe9-9fb2-8d881706c660", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "947f3a6f-aa1c-4a85-8eb9-fe92f203dc7b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f2a06f3-7e8c-4fe9-9fb2-8d881706c660"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "9a074b0f-f8bc-4ab0-9659-8127c3dd6ee0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "947f3a6f-aa1c-4a85-8eb9-fe92f203dc7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span></p>", "ID": "35442276-c428-4272-9d57-4946502796f7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f2a06f3-7e8c-4fe9-9fb2-8d881706c660"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.6)</span>", "ID": "53468f37-c2b0-4902-8916-8dc248a0af94", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.2, 1.6)", "ParentId": "35442276-c428-4272-9d57-4946502796f7"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>", "ID": "a8138e25-7d36-4dfe-9382-1ed7ba3abf9d", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bca1dbe8-8650-4118-8e4f-4fe4b1b4e3ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>", "ID": "a3381099-9509-4927-b500-a8f3394471e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8138e25-7d36-4dfe-9382-1ed7ba3abf9d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, atazanavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span>", "ID": "7dfa473c-814f-42cd-a0cd-e620a8741923", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa, atazanavir   (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is   required.", "ParentId": "a3381099-9509-4927-b500-a8f3394471e0"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span></p>\n</td>\n</tr>", "ID": "53310d00-7272-4007-b9b3-ec38e56e969c", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>", "ID": "172bf323-3eb3-4838-ba0f-d7e1e0333946", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "53310d00-7272-4007-b9b3-ec38e56e969c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>", "ID": "d6a84e7d-cd15-4f9e-9424-b64dcf6bf5de", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "172bf323-3eb3-4838-ba0f-d7e1e0333946"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span>", "ID": "415f2cae-229f-4082-93f8-75f0f45a6ceb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ritonavir", "ParentId": "d6a84e7d-cd15-4f9e-9424-b64dcf6bf5de"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "24d753ab-7cc3-4464-a86b-58b06a9df4fc", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "53310d00-7272-4007-b9b3-ec38e56e969c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "2dce9da8-0559-424f-a5da-65e0e20d610d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "24d753ab-7cc3-4464-a86b-58b06a9df4fc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "15f8a080-acd0-4c28-9a41-4528bbed8086", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "2dce9da8-0559-424f-a5da-65e0e20d610d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "c3d3a63b-b3c2-4935-8f69-fc883a342a7f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "53310d00-7272-4007-b9b3-ec38e56e969c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "695b0044-b4c5-4981-8053-9c88162cc6d3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3d3a63b-b3c2-4935-8f69-fc883a342a7f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6f5d6612-6461-4f1a-8f37-26cdd962e5de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "695b0044-b4c5-4981-8053-9c88162cc6d3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span></p>\n</td>", "ID": "5cb25417-1eb2-4031-9a3f-fcc32d1d5e15", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "53310d00-7272-4007-b9b3-ec38e56e969c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "1990a9fd-5c5b-4516-8064-e69973881686", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5cb25417-1eb2-4031-9a3f-fcc32d1d5e15"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "13a7fe31-3c3a-4754-9b80-999993f7b126", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "1990a9fd-5c5b-4516-8064-e69973881686"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span></p>", "ID": "7fd8a23d-0488-4c40-946c-1972b73d4358", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5cb25417-1eb2-4031-9a3f-fcc32d1d5e15"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.5, 1.4)</span>", "ID": "55fc43bf-a6eb-47cf-b3ab-325f74f7ad27", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.5, 1.4)", "ParentId": "7fd8a23d-0488-4c40-946c-1972b73d4358"}, {"Element": "<tr style=\"page-break-inside:avoid;height:20.65pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "d430f68a-14a0-4479-a34c-1ed58c436059", "Styles": "page-break-inside:avoid;height:20.65pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "daeef37f-5434-4829-be0c-c76d8a1d15a7", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt", "Classes": "None", "Text": "  ", "ParentId": "d430f68a-14a0-4479-a34c-1ed58c436059"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "7b687e2d-332b-42fd-9bac-ce65237fe14b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "daeef37f-5434-4829-be0c-c76d8a1d15a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "24217728-3aa6-4922-9424-e8a72277a5fc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "7b687e2d-332b-42fd-9bac-ce65237fe14b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "b8090080-44b6-486c-ad1d-89bb1a5657d9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt", "Classes": "None", "Text": "  ", "ParentId": "d430f68a-14a0-4479-a34c-1ed58c436059"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7e89420d-83a5-46cb-86bd-b6df02b04181", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8090080-44b6-486c-ad1d-89bb1a5657d9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "dc6a3020-93bd-49b2-9d54-528a5720d551", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7e89420d-83a5-46cb-86bd-b6df02b04181"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "875590b8-b343-45fa-ab01-1ca7c56860bf", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt", "Classes": "None", "Text": "  ", "ParentId": "d430f68a-14a0-4479-a34c-1ed58c436059"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "8bf81f28-c67d-40b4-8241-b248e0502ba6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "875590b8-b343-45fa-ab01-1ca7c56860bf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "970c673a-2599-4415-af70-fbad65827a97", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "8bf81f28-c67d-40b4-8241-b248e0502ba6"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "9d9593e6-49e8-4493-866c-0113768044ca", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:20.65pt", "Classes": "None", "Text": "  ", "ParentId": "d430f68a-14a0-4479-a34c-1ed58c436059"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "ea48364f-ec0d-49fd-9f11-343905a07982", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9d9593e6-49e8-4493-866c-0113768044ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "2e694fed-bb14-4d39-a357-9c1db5d0154e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ea48364f-ec0d-49fd-9f11-343905a07982"}, {"Element": "<tr style=\"page-break-inside:avoid;height:37.9pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span></p>\n</td>\n</tr>", "ID": "375e299c-a7f3-45d5-a651-3a5e64dbe049", "Styles": "page-break-inside:avoid;height:37.9pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "1a85f506-dd76-47fb-abea-bf3198803a16", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt", "Classes": "None", "Text": "  ", "ParentId": "375e299c-a7f3-45d5-a651-3a5e64dbe049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "85f8955f-53ac-4409-998d-cd7487192539", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1a85f506-dd76-47fb-abea-bf3198803a16"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "8ea5e2e1-015c-47a3-aca9-947df5759b77", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "85f8955f-53ac-4409-998d-cd7487192539"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span></p>\n</td>", "ID": "ff35edb5-9e0e-4f34-be01-21bef4468c95", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt", "Classes": "None", "Text": "   ", "ParentId": "375e299c-a7f3-45d5-a651-3a5e64dbe049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "65421e6b-1231-4070-bcaa-4f35d7e2aeaa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff35edb5-9e0e-4f34-be01-21bef4468c95"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "aedbb3c3-307d-425c-a949-62875877cea4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "65421e6b-1231-4070-bcaa-4f35d7e2aeaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span></p>", "ID": "e65d15dc-feab-44fa-b73a-6d698878a374", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff35edb5-9e0e-4f34-be01-21bef4468c95"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.7)</span>", "ID": "5b19b89f-5368-4e62-89b2-965abac2f99a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.6 (1.4, 1.7)", "ParentId": "e65d15dc-feab-44fa-b73a-6d698878a374"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span></p>\n</td>", "ID": "3b6b2135-c2c8-4ba2-a7ca-ac45dbe0ba3b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt", "Classes": "None", "Text": "   ", "ParentId": "375e299c-a7f3-45d5-a651-3a5e64dbe049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "fe1a0dd5-1d97-4733-ab66-e59e87d1d7b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b6b2135-c2c8-4ba2-a7ca-ac45dbe0ba3b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "bf2724bd-7eb3-4301-88a7-f7b79e571b1c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "fe1a0dd5-1d97-4733-ab66-e59e87d1d7b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span></p>", "ID": "7c003e60-f576-4ccb-b26e-c2e35dbc4c52", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b6b2135-c2c8-4ba2-a7ca-ac45dbe0ba3b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.4 (2.2, 2.6)</span>", "ID": "eb414b48-6674-4fcf-8c22-b4590b8443da", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.4 (2.2, 2.6)", "ParentId": "7c003e60-f576-4ccb-b26e-c2e35dbc4c52"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span></p>\n</td>", "ID": "f7f27d8e-21bd-4de6-8a18-ceab57d3cebc", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:37.9pt", "Classes": "None", "Text": "   ", "ParentId": "375e299c-a7f3-45d5-a651-3a5e64dbe049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "73d28cdd-e40e-4023-a42c-4020c62664d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7f27d8e-21bd-4de6-8a18-ceab57d3cebc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "42f97a76-b5a5-4a19-b72c-dd2ce34861f0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "73d28cdd-e40e-4023-a42c-4020c62664d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span></p>", "ID": "b9563dea-447f-4df5-a068-51e44b5703db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7f27d8e-21bd-4de6-8a18-ceab57d3cebc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.0 (3.6, 4.5)</span>", "ID": "d948d017-eb2b-440c-83bb-6b0918072e4a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4.0 (3.6, 4.5)", "ParentId": "b9563dea-447f-4df5-a068-51e44b5703db"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>", "ID": "0272aba1-8343-4d9b-a875-5babab72a10e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>\n</td>", "ID": "b583f172-9ca8-4a33-8b40-5ffd747140a2", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span></p>", "ID": "f035ef43-cbce-47c8-a901-efe05f9ac3ca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b583f172-9ca8-4a33-8b40-5ffd747140a2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></b>", "ID": "d3b3c68b-91b2-45f7-a42b-7a5cfc8fa294", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f035ef43-cbce-47c8-a901-efe05f9ac3ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span>", "ID": "d5256947-0cc5-4917-9bfb-a3b90113fa8a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Darunavir", "ParentId": "d3b3c68b-91b2-45f7-a42b-7a5cfc8fa294"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir (800/ 100\u00a0mg once\n  daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/\n  300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once\n  daily)<sup>c, d</sup></span>", "ID": "d7a797c4-155c-42f0-957b-dbe4679594bd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " boosted with ritonavir (800/ 100\u00a0mg once   daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/   300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once   daily)", "ParentId": "f035ef43-cbce-47c8-a901-efe05f9ac3ca"}, {"Element": "<sup>c, d</sup>", "ID": "1e80ad13-a39b-42fa-b297-182303afd935", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "d7a797c4-155c-42f0-957b-dbe4679594bd"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></p>\n</td>", "ID": "c76f7e18-e97d-429f-a818-13ea71fdb98f", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span></p>", "ID": "3094fbad-e913-45a7-92dd-86caa62542dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c76f7e18-e97d-429f-a818-13ea71fdb98f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Darunavir</span>", "ID": "67adf527-019d-4d74-ad40-588f4d3eb979", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Darunavir", "ParentId": "3094fbad-e913-45a7-92dd-86caa62542dc"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "c64dc9bb-2109-47eb-b1ca-35432e2016b1", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "4c9e8dff-313e-4229-bda3-0039b3c460d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c64dc9bb-2109-47eb-b1ca-35432e2016b1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "048ef01c-fcb7-442e-a339-23761a002d43", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "4c9e8dff-313e-4229-bda3-0039b3c460d2"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "aa2cf9a0-c605-46dd-8b19-ca58dc277a62", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "e27d4db0-0437-4f4f-9f78-082702d5307e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aa2cf9a0-c605-46dd-8b19-ca58dc277a62"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "1acbae56-e3cf-42a2-b45e-b0be41c40cb1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "e27d4db0-0437-4f4f-9f78-082702d5307e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "44643c92-c985-46a6-981e-d8326a3e588c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "57a728af-f862-4fca-9f07-50566401d28b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44643c92-c985-46a6-981e-d8326a3e588c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "a49768f9-e539-41d8-bd8e-e189724d021a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "57a728af-f862-4fca-9f07-50566401d28b"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>", "ID": "95c49819-8e0b-4951-b1ac-9f37f9cbb56f", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0272aba1-8343-4d9b-a875-5babab72a10e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>", "ID": "cbb18e7d-8967-4b44-8228-f73b5db1608b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "95c49819-8e0b-4951-b1ac-9f37f9cbb56f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, darunavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span>", "ID": "23fbe409-aacc-4482-8165-fa369ddad8c9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa, darunavir   (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is   required.", "ParentId": "cbb18e7d-8967-4b44-8228-f73b5db1608b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "da3b6f2c-6b5b-4671-a02b-f7625551699d", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>", "ID": "111c8e51-703d-43be-9779-e18ee2e56a0d", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "da3b6f2c-6b5b-4671-a02b-f7625551699d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>", "ID": "38bb65d0-cc48-4953-b591-6cc0bb8a8b0b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "111c8e51-703d-43be-9779-e18ee2e56a0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span>", "ID": "c4cd9141-d8cd-4a70-9313-801d2f3e91f6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ritonavir", "ParentId": "38bb65d0-cc48-4953-b591-6cc0bb8a8b0b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "8baae77b-54de-43c2-9a71-d4d659c2718c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "da3b6f2c-6b5b-4671-a02b-f7625551699d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "17bc60c8-d03d-426a-b103-bce1342e6675", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8baae77b-54de-43c2-9a71-d4d659c2718c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "82d38723-6835-40d5-97fd-bd0294b02b2d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "17bc60c8-d03d-426a-b103-bce1342e6675"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "99959bed-3a43-45fc-a28f-3ae948b3d8da", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "da3b6f2c-6b5b-4671-a02b-f7625551699d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "6836339f-58d3-4e1e-b16e-050eeceed7d9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "99959bed-3a43-45fc-a28f-3ae948b3d8da"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "332d91fa-9c96-4aaa-851a-bb012b449869", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "6836339f-58d3-4e1e-b16e-050eeceed7d9"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "876fb1f9-b54e-49b3-8745-493fb7a60760", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "da3b6f2c-6b5b-4671-a02b-f7625551699d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "37a46523-059d-478b-b792-5508d2e63208", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "876fb1f9-b54e-49b3-8745-493fb7a60760"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "0b3f1feb-e83c-4149-bb99-ad2b413f4788", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "37a46523-059d-478b-b792-5508d2e63208"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "fae3120c-4a31-444c-9aab-92475c735924", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "36cc311f-8116-4c8f-97b4-2743b29c78ad", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "fae3120c-4a31-444c-9aab-92475c735924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "3406be57-57da-471d-a8e8-866a2c21f99f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "36cc311f-8116-4c8f-97b4-2743b29c78ad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "3ebdbd1e-d9da-4181-bd2a-6e72a25c675c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "3406be57-57da-471d-a8e8-866a2c21f99f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span></p>\n</td>", "ID": "d814caf2-ba5f-41e9-a785-254efe5636d9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "fae3120c-4a31-444c-9aab-92475c735924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "739aac72-9fd4-411e-a0e2-9a1916b74a33", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d814caf2-ba5f-41e9-a785-254efe5636d9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "aed7d16b-6d47-4f15-b9ef-aab271f2da7b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "739aac72-9fd4-411e-a0e2-9a1916b74a33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span></p>", "ID": "f2dd6af0-2b33-4425-aa4a-44b17293d7af", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d814caf2-ba5f-41e9-a785-254efe5636d9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.62 (0.54, 0.71)</span>", "ID": "fc1f6888-d696-4306-a3b6-f02231a22caa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.62 (0.54, 0.71)", "ParentId": "f2dd6af0-2b33-4425-aa4a-44b17293d7af"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span></p>\n</td>", "ID": "2c4eb371-1c9b-4e60-891c-fd1bd1f86158", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "fae3120c-4a31-444c-9aab-92475c735924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "72730cc5-11ad-4b58-a435-7f31445ca6a2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2c4eb371-1c9b-4e60-891c-fd1bd1f86158"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "c1eb6c58-8350-40ba-8fba-c61464c92f6a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "72730cc5-11ad-4b58-a435-7f31445ca6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span></p>", "ID": "4c806f8e-82ec-443b-b613-152b7ff66fef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2c4eb371-1c9b-4e60-891c-fd1bd1f86158"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.72 (0.66, 0.80)</span>", "ID": "635c8f55-bf00-4bdc-a437-d4053ce1a0df", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.72 (0.66, 0.80)", "ParentId": "4c806f8e-82ec-443b-b613-152b7ff66fef"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "2847a572-e01a-415e-b7e7-3b5042d1b798", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "fae3120c-4a31-444c-9aab-92475c735924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "3445f4ea-048d-408f-8692-f0a178fdc33a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2847a572-e01a-415e-b7e7-3b5042d1b798"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b63a5ad2-8e67-45a7-a7de-3501927310cf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3445f4ea-048d-408f-8692-f0a178fdc33a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "0c759c7d-48d4-4dd2-bc69-8f422596c368", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "191062d4-0ed9-49d8-844e-e8e635f05256", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0c759c7d-48d4-4dd2-bc69-8f422596c368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "76c70fe6-36f7-40ae-87da-532bb9c3251a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "191062d4-0ed9-49d8-844e-e8e635f05256"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "5e6f2eec-1766-434c-b50b-ec7c789ffc28", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "76c70fe6-36f7-40ae-87da-532bb9c3251a"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span></p>\n</td>", "ID": "8a5f6a5b-3950-4305-b14f-3969e63e36b7", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "0c759c7d-48d4-4dd2-bc69-8f422596c368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "62d2022f-46f0-4b57-9f83-f553be21e1b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a5f6a5b-3950-4305-b14f-3969e63e36b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "90c6159c-5494-495c-b134-277b85df8f61", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "62d2022f-46f0-4b57-9f83-f553be21e1b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span></p>", "ID": "597cf1c2-1b5f-42fe-8d28-38ad8e30f715", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a5f6a5b-3950-4305-b14f-3969e63e36b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.76 (0.65, 0.89)</span>", "ID": "10c443b4-2138-45ff-92cd-e624a86d156e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.76 (0.65, 0.89)", "ParentId": "597cf1c2-1b5f-42fe-8d28-38ad8e30f715"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "c3aeec56-d3d2-487e-b114-9f7afeae6125", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0c759c7d-48d4-4dd2-bc69-8f422596c368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "fb8f7f64-d4f0-4c0a-90d7-0a6035f09ef5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3aeec56-d3d2-487e-b114-9f7afeae6125"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "2db00f6e-4711-4887-8d1d-4af648ce1ad3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "fb8f7f64-d4f0-4c0a-90d7-0a6035f09ef5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "35c03f68-742f-442f-804e-8a9db2dceedd", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "0c759c7d-48d4-4dd2-bc69-8f422596c368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "218d8d52-26fa-4cfe-8ca3-9c848f0b39eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "35c03f68-742f-442f-804e-8a9db2dceedd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "162ad0c6-0197-4b57-9dbd-3166f0344408", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "218d8d52-26fa-4cfe-8ca3-9c848f0b39eb"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>", "ID": "86d769dc-0494-47a8-acf7-15dced7b7734", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "fb76c7e0-ff61-4cba-aba2-685f67d4c1b5", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "46fcb9d6-93eb-4cf6-8149-f83fbc082a42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb76c7e0-ff61-4cba-aba2-685f67d4c1b5"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></b>", "ID": "ade83b57-6481-4839-b126-c7bca0c0a765", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46fcb9d6-93eb-4cf6-8149-f83fbc082a42"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span>", "ID": "0a8c4eab-c47c-4ec6-b26b-2e679708481c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Lopinavir", "ParentId": "ade83b57-6481-4839-b126-c7bca0c0a765"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\"> boosted with ritonavir\u00a0(4x200\u00a0mg/\n  50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil\n  fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/\n  100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "0a65d5ce-b392-479f-976d-2b2b32138f9b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": " boosted with ritonavir\u00a0(4x200\u00a0mg/   50\u00a0mg once daily)\u00a0+\u00a0emtricitabine/ tenofovir disoproxil   fumarate (200/ 300\u00a0mg once daily)/ sofosbuvir/ velpatasvir (400/   100\u00a0mg once daily)", "ParentId": "46fcb9d6-93eb-4cf6-8149-f83fbc082a42"}, {"Element": "<sup>c, d</sup>", "ID": "0b018abe-4026-4895-ac27-20ec83f1cff2", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "0a65d5ce-b392-479f-976d-2b2b32138f9b"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></p>\n</td>", "ID": "18342114-fee8-4f94-9260-8570e1093405", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span></p>", "ID": "e735abfa-b28e-4533-8a8a-df921c22a6a1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18342114-fee8-4f94-9260-8570e1093405"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Lopinavir</span>", "ID": "980010b7-8de5-4cb5-8906-16dace79a142", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Lopinavir", "ParentId": "e735abfa-b28e-4533-8a8a-df921c22a6a1"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "0cd67e56-37b8-4dcc-bba6-94fac8459106", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "1cd8525c-5b4f-4cfa-a7eb-ad637a3b3031", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0cd67e56-37b8-4dcc-bba6-94fac8459106"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "582bb4de-b038-45e2-86dd-ccf72bebe756", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "1cd8525c-5b4f-4cfa-a7eb-ad637a3b3031"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "28c51c6b-7aa9-45bf-960d-d2af8b0c2522", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "f2077257-3346-44f0-9f96-d7216874737d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "28c51c6b-7aa9-45bf-960d-d2af8b0c2522"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "e8e42743-fd61-4121-b60d-8309fc7b8b98", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "f2077257-3346-44f0-9f96-d7216874737d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "aba1c629-b790-4970-bff1-4533aaf47c84", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "45a19520-960d-40f2-b1e8-9804e3171717", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aba1c629-b790-4970-bff1-4533aaf47c84"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "b9b952c6-aa0a-4c0e-afea-545fa475d701", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "45a19520-960d-40f2-b1e8-9804e3171717"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>", "ID": "da31c90d-52f7-40f8-bd22-543f1daea231", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "86d769dc-0494-47a8-acf7-15dced7b7734"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>", "ID": "b2b3140a-cbd5-4db3-9072-97af5b10f149", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da31c90d-52f7-40f8-bd22-543f1daea231"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa, lopinavir\n  (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span>", "ID": "fb77bdf0-4c9a-48aa-a083-c2eb2e5b92e4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa, lopinavir   (ritonavir boosted) or emtricitabine/ tenofovir disoproxil fumarate is   required.", "ParentId": "b2b3140a-cbd5-4db3-9072-97af5b10f149"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "bd3cfedf-5a12-48ae-881d-345553cd58e0", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>\n</td>", "ID": "3bde783a-4798-4753-b990-628171f2a2ee", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd3cfedf-5a12-48ae-881d-345553cd58e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span></p>", "ID": "4a16c25d-eb6a-486b-ac76-24f93d400c7b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3bde783a-4798-4753-b990-628171f2a2ee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ritonavir</span>", "ID": "5f6bc360-ad2d-48ff-8c02-914b1ee577ad", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ritonavir", "ParentId": "4a16c25d-eb6a-486b-ac76-24f93d400c7b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "b5f15662-34d1-4fa3-bfe1-4866d2a01a8b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd3cfedf-5a12-48ae-881d-345553cd58e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7a757633-0689-41a0-8852-2aa2abc6c9bc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5f15662-34d1-4fa3-bfe1-4866d2a01a8b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fa401531-f17a-4c7b-aac7-2df4922b20ed", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7a757633-0689-41a0-8852-2aa2abc6c9bc"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "73f7f1f5-1605-4d4a-89a0-141e57b31811", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd3cfedf-5a12-48ae-881d-345553cd58e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "51674e3e-76ed-4122-8ad8-647753d7b51e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73f7f1f5-1605-4d4a-89a0-141e57b31811"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "efccac6a-9ec8-40d4-92d1-e03d3d627ea5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "51674e3e-76ed-4122-8ad8-647753d7b51e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "0d4f26f0-bde1-4181-96ec-5749ac6da70b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "bd3cfedf-5a12-48ae-881d-345553cd58e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "53eae1ae-e962-4a25-bb6c-f6c7db4078c2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d4f26f0-bde1-4181-96ec-5749ac6da70b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "767eb359-d9cf-4491-97d4-0156b9745b18", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "53eae1ae-e962-4a25-bb6c-f6c7db4078c2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "2deb53e7-02ef-492d-99f5-ab161d6828cc", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "ded36023-f04f-491b-896a-bd81c58cee0d", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "2deb53e7-02ef-492d-99f5-ab161d6828cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "e4343d65-fbb6-4e5c-9673-601def0edc23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ded36023-f04f-491b-896a-bd81c58cee0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "9c275535-710e-45f9-b8bf-ca30ae40e9d3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "e4343d65-fbb6-4e5c-9673-601def0edc23"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span></p>\n</td>", "ID": "69bf808d-1a3e-4130-9bc5-9a51bd7c679f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "2deb53e7-02ef-492d-99f5-ab161d6828cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "970611a5-562b-41e8-9b3c-2b0734e8239e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69bf808d-1a3e-4130-9bc5-9a51bd7c679f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "52618c5c-84db-45b1-8e46-c8bc7c97f047", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "970611a5-562b-41e8-9b3c-2b0734e8239e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span></p>", "ID": "aaa6c374-884a-4129-8cf0-aa232934da13", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69bf808d-1a3e-4130-9bc5-9a51bd7c679f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.59 (0.49 0.71)</span>", "ID": "1424e4c9-64b2-4407-b94e-9fb6879802df", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.59 (0.49 0.71)", "ParentId": "aaa6c374-884a-4129-8cf0-aa232934da13"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span></p>\n</td>", "ID": "849bb874-e206-4ea6-a72b-79d06147848a", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "2deb53e7-02ef-492d-99f5-ab161d6828cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "18d41ad9-9657-45a9-ae9e-b6cbe2db201b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "849bb874-e206-4ea6-a72b-79d06147848a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "fa065225-a53d-48de-877b-c760b52a4496", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "18d41ad9-9657-45a9-ae9e-b6cbe2db201b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span></p>", "ID": "81c3758a-96c1-403f-8466-50ec3b7d54e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "849bb874-e206-4ea6-a72b-79d06147848a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.7 (0.6, 0.8)</span>", "ID": "987b5f59-a995-4985-a085-ea75508aea46", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.7 (0.6, 0.8)", "ParentId": "81c3758a-96c1-403f-8466-50ec3b7d54e3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "37f5abd0-2ea8-45af-93a6-b196578009c1", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "2deb53e7-02ef-492d-99f5-ab161d6828cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "1bfa10d0-91cc-4cda-962e-432f5be3675a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37f5abd0-2ea8-45af-93a6-b196578009c1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "00ed5cae-ac7a-429b-93d7-c7275c89ba47", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "1bfa10d0-91cc-4cda-962e-432f5be3675a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span></p>\n</td>\n</tr>", "ID": "25082b7c-3c46-4f52-a489-01d1f5780e0c", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "9eb28aa0-def8-45dc-b497-7d874f4c47ac", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25082b7c-3c46-4f52-a489-01d1f5780e0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "b75b5b42-c6ea-4835-84c1-4d2dfdb80b5e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9eb28aa0-def8-45dc-b497-7d874f4c47ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "0ca8b007-cad8-406e-b95b-a570fcb08db3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "b75b5b42-c6ea-4835-84c1-4d2dfdb80b5e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span></p>\n</td>", "ID": "2e27ba08-fefb-4f7e-9994-5f9ba210ce5b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "25082b7c-3c46-4f52-a489-01d1f5780e0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "28da8a91-e106-4f2c-8b87-6886f9b85997", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e27ba08-fefb-4f7e-9994-5f9ba210ce5b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "14e5e985-323b-4be0-976a-c6cc1896af0d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "28da8a91-e106-4f2c-8b87-6886f9b85997"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span></p>", "ID": "590b40bb-0583-4b64-8bc7-ff4882ecf838", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e27ba08-fefb-4f7e-9994-5f9ba210ce5b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.70 (0.59, 0.83)</span>", "ID": "d48e0bd3-c215-4109-a51d-fa3c6a753d36", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.70 (0.59, 0.83)", "ParentId": "590b40bb-0583-4b64-8bc7-ff4882ecf838"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "766a6f5b-79f3-442f-afee-c7fde5dd05d3", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25082b7c-3c46-4f52-a489-01d1f5780e0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "40d8c5f0-9434-4b70-abbc-9e28bc007f2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "766a6f5b-79f3-442f-afee-c7fde5dd05d3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "90fd814f-aa3a-4a53-997a-0e4e9762f80c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "40d8c5f0-9434-4b70-abbc-9e28bc007f2d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span></p>\n</td>", "ID": "fc432d3e-8b1c-4085-abc4-9c6bb0843e10", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "25082b7c-3c46-4f52-a489-01d1f5780e0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "01d1c44f-2c9d-473c-b129-a80cc0d48c6d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc432d3e-8b1c-4085-abc4-9c6bb0843e10"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "c362ca18-2264-4e57-a817-0cc6a0878644", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "01d1c44f-2c9d-473c-b129-a80cc0d48c6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span></p>", "ID": "cc9c3de2-a969-4cbe-9dbd-97b191d814a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc432d3e-8b1c-4085-abc4-9c6bb0843e10"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.9)</span>", "ID": "264f8d12-fd8f-416e-a8b9-a4a76d4d01a1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.6 (1.4, 1.9)", "ParentId": "cc9c3de2-a969-4cbe-9dbd-97b191d814a4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b></p>\n</td>\n</tr>", "ID": "055c8287-9bb4-4ea3-b994-8cb3c5ee8cd8", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b></p>\n</td>", "ID": "0c93328f-4d2e-4538-8484-9611e01219fd", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "055c8287-9bb4-4ea3-b994-8cb3c5ee8cd8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b></p>", "ID": "fa2d0279-657f-4f79-868b-3634ecf56e87", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c93328f-4d2e-4538-8484-9611e01219fd"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i></b>", "ID": "b8f0ce2f-5ecc-45a9-b6d8-dd14e0344839", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa2d0279-657f-4f79-868b-3634ecf56e87"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span></i>", "ID": "42cb0dd4-072e-46b1-aeab-8db0e81bf185", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8f0ce2f-5ecc-45a9-b6d8-dd14e0344839"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">HIV ANTIVIRAL AGENTS: INTEGRASE\n  INHIBITORS</span>", "ID": "6fd5bc50-053b-4753-877d-bd1d345871e3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "HIV ANTIVIRAL AGENTS: INTEGRASE   INHIBITORS", "ParentId": "42cb0dd4-072e-46b1-aeab-8db0e81bf185"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>\n</tr>", "ID": "d0947fd8-564f-4751-94f3-6365ad49d19a", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "411fc127-33d0-4374-ad3b-5fb205b06076", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "7cdb2935-b135-4f83-b635-ec287a8b2a96", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "411fc127-33d0-4374-ad3b-5fb205b06076"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span></b>", "ID": "d51dc543-2905-4153-8725-81a7f1397aad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7cdb2935-b135-4f83-b635-ec287a8b2a96"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir </span>", "ID": "a5c6d270-79d5-467a-8d7b-30626d8bf256", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Raltegravir ", "ParentId": "d51dc543-2905-4153-8725-81a7f1397aad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(400\u00a0mg twice daily)<sup>g</sup>\n  +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once\n  daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "a1e976b9-d38e-4ecc-8542-d59eebe58421", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(400\u00a0mg twice daily)   +\u00a0emtricitabine/ tenofovir disoproxil fumarate (200/ 300\u00a0mg once   daily)/ sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "7cdb2935-b135-4f83-b635-ec287a8b2a96"}, {"Element": "<sup>g</sup>", "ID": "36b755f7-aecf-4f1d-a5b8-effd9955a424", "Styles": "None", "Classes": "None", "Text": "g", "ParentId": "a1e976b9-d38e-4ecc-8542-d59eebe58421"}, {"Element": "<sup>c, d</sup>", "ID": "ad7bbb75-5aff-4cf9-af3e-8239203d21a9", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "a1e976b9-d38e-4ecc-8542-d59eebe58421"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span></p>\n</td>", "ID": "2205506b-b1b3-4fc4-92e0-84128db52c32", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span></p>", "ID": "6883a492-8874-49b6-8704-6fac403d6748", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2205506b-b1b3-4fc4-92e0-84128db52c32"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Raltegravir</span>", "ID": "b704558e-49fc-49c3-8b20-04ef297b04f4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Raltegravir", "ParentId": "6883a492-8874-49b6-8704-6fac403d6748"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "eac8ad3d-d5d3-4808-82db-6d1b9bbd1795", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "649aad8b-e222-4a09-a4ec-ec929c965715", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eac8ad3d-d5d3-4808-82db-6d1b9bbd1795"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "2f7a240a-7c05-4e7b-bc45-f96862140edd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "649aad8b-e222-4a09-a4ec-ec929c965715"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "69dfe0cf-96e4-4d74-80a7-8f0d2cf24e6d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "b7593abf-8066-4af8-86e8-ff14a5390533", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69dfe0cf-96e4-4d74-80a7-8f0d2cf24e6d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "aeb60527-220c-4c6d-a45e-7666009915f9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "b7593abf-8066-4af8-86e8-ff14a5390533"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span></p>\n</td>", "ID": "16d062af-1876-4e3c-bdc7-47f03162fc91", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "74692552-e305-4563-9497-e8837da3dcd5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16d062af-1876-4e3c-bdc7-47f03162fc91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "abbe21c3-4e96-4f29-b13f-3ed006fcac81", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "74692552-e305-4563-9497-e8837da3dcd5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span></p>", "ID": "bb3766d5-8dad-41c3-8cef-955354529854", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16d062af-1876-4e3c-bdc7-47f03162fc91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.79 (0.42, 1.5)</span>", "ID": "79489bdf-47f0-457f-9bad-42f7f69ebbe2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.79 (0.42, 1.5)", "ParentId": "bb3766d5-8dad-41c3-8cef-955354529854"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span></p>\n</td>", "ID": "60501554-c25f-4968-bf2c-c41ac415952c", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "d0947fd8-564f-4751-94f3-6365ad49d19a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span></p>", "ID": "831c3744-2cb4-4b31-9d5d-9c3fadf9d1a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60501554-c25f-4968-bf2c-c41ac415952c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa,\n  raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.</span>", "ID": "f6b9bf9b-a8b9-4174-856f-614dd76e259a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa,   raltegravir or emtricitabine/ tenofovir disoproxil fumarate is required.", "ParentId": "831c3744-2cb4-4b31-9d5d-9c3fadf9d1a5"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "186a7be1-e796-42e7-8ec6-0eb2541750b0", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "ece00436-27b8-4fe9-8940-03abf75740ca", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "186a7be1-e796-42e7-8ec6-0eb2541750b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "2e507794-9802-4ce9-87bc-259f78763971", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ece00436-27b8-4fe9-8940-03abf75740ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "198bad28-d7f4-4124-ba5f-ea8e5846df84", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "2e507794-9802-4ce9-87bc-259f78763971"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "913acd76-04af-458d-823d-359bc0039c4c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "186a7be1-e796-42e7-8ec6-0eb2541750b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "3c87c4cb-830d-4780-b582-99c8d6cc64c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "913acd76-04af-458d-823d-359bc0039c4c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "950f6564-eead-40df-bc61-58db8bf68a5a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "3c87c4cb-830d-4780-b582-99c8d6cc64c4"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "d96eed72-5e7d-4fb3-a0ff-72b175931bcc", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "186a7be1-e796-42e7-8ec6-0eb2541750b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "ac0781ce-53dc-43b8-a1ec-2807485e2ef6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d96eed72-5e7d-4fb3-a0ff-72b175931bcc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "798e06be-d684-4c52-ade2-dccdbd04379e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "ac0781ce-53dc-43b8-a1ec-2807485e2ef6"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "edcb9cc4-b85b-45c8-88d0-1011adbd607d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "186a7be1-e796-42e7-8ec6-0eb2541750b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0f38dd7f-3597-4dce-a5b8-0c2f17748394", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "edcb9cc4-b85b-45c8-88d0-1011adbd607d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "ba1be027-168f-48ff-b4ac-eaccfdccddb2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0f38dd7f-3597-4dce-a5b8-0c2f17748394"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "a4c8caa9-577f-4aff-8416-6a57f3d68b01", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "1ad8c3a5-21fd-4bc8-8660-913df0a7bf6f", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a4c8caa9-577f-4aff-8416-6a57f3d68b01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "9d8abc2a-839e-418e-8298-dc56b17cb02c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ad8c3a5-21fd-4bc8-8660-913df0a7bf6f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "4a3e91d0-89a6-4d1a-9ba4-542140337601", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "9d8abc2a-839e-418e-8298-dc56b17cb02c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "26c024d9-658f-47b8-86f5-9dc5101b9029", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a4c8caa9-577f-4aff-8416-6a57f3d68b01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "1821d09d-c3a3-47f1-b6e1-7ae94e473379", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "26c024d9-658f-47b8-86f5-9dc5101b9029"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "7bdabcbc-9953-4ed8-928b-009615b88a40", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "1821d09d-c3a3-47f1-b6e1-7ae94e473379"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "5c195ae4-77b8-410e-9e7e-22cb11167b8f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a4c8caa9-577f-4aff-8416-6a57f3d68b01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "e8681ccd-4068-40bd-bc43-42e4b2d6c74a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c195ae4-77b8-410e-9e7e-22cb11167b8f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "1f343368-a95f-4d32-891f-3c7726905add", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "e8681ccd-4068-40bd-bc43-42e4b2d6c74a"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "c8ac33fa-813a-4705-bcdc-d6b89297027e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a4c8caa9-577f-4aff-8416-6a57f3d68b01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "d782033e-8065-4e32-a325-5a3077d69943", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c8ac33fa-813a-4705-bcdc-d6b89297027e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "dea05e89-4b2e-4780-95d3-0f2481c8b11d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "d782033e-8065-4e32-a325-5a3077d69943"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"5\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"5\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span></p>\n</td>\n</tr>", "ID": "4a4d3879-8aff-47a7-8635-25d6a02482b4", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"5\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "cfae734d-0463-40a3-8af7-eff217360a9b", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span></p>", "ID": "84d2fa04-09b5-4dd7-8446-ba2dbab85149", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cfae734d-0463-40a3-8af7-eff217360a9b"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b>", "ID": "126c55ad-c6c8-4951-a1fb-697acaca357f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84d2fa04-09b5-4dd7-8446-ba2dbab85149"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span>", "ID": "f25dfbf0-6d68-42ac-99e9-e1e88802f071", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Elvitegravir", "ParentId": "126c55ad-c6c8-4951-a1fb-697acaca357f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir alafenamide\n  fumarate</span>", "ID": "887c5254-90d1-429a-ab54-a68847248355", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "/ cobicistat/ emtricitabine/ tenofovir alafenamide   fumarate", "ParentId": "84d2fa04-09b5-4dd7-8446-ba2dbab85149"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "e2a7f34e-140e-4948-8b66-4d1f9b628fa0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cfae734d-0463-40a3-8af7-eff217360a9b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 10\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "1a9aa019-a94e-4783-a18d-67a1219d02c8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(150/ 150/ 200/ 10\u00a0mg once daily)/   sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "e2a7f34e-140e-4948-8b66-4d1f9b628fa0"}, {"Element": "<sup>c, d</sup>", "ID": "5d7a857f-56be-4d17-96ec-9431a49c077b", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "1a9aa019-a94e-4783-a18d-67a1219d02c8"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>", "ID": "60e773c4-edcf-4d85-b45a-ddd69c3caf57", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>", "ID": "be3f06ab-acc2-4577-b777-4a869684f212", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60e773c4-edcf-4d85-b45a-ddd69c3caf57"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span>", "ID": "83b8eb74-c81b-484d-9aec-de57f7dc20c8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Elvitegravir", "ParentId": "be3f06ab-acc2-4577-b777-4a869684f212"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "ec185e9b-38c1-4496-bf80-d17016e6eb4c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "dc8e7d60-0d5a-480f-8bb4-21270aa6f63d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec185e9b-38c1-4496-bf80-d17016e6eb4c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "45582444-0124-41e3-a516-0ffc61dd7b0e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "dc8e7d60-0d5a-480f-8bb4-21270aa6f63d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "947ea241-66b5-4a91-86e7-b42551c8bc73", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "812ab957-e749-4ad2-83f9-fe556977d1dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "947ea241-66b5-4a91-86e7-b42551c8bc73"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "7a424244-5bed-4b01-9b2e-7a509e1176a7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "812ab957-e749-4ad2-83f9-fe556977d1dc"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "bf354e6f-a314-42f1-b296-84191a759eab", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "e0ecea3e-b994-45d6-a413-43bf0b448df4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf354e6f-a314-42f1-b296-84191a759eab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "928ea454-53c1-4ab9-b41c-f00b859212bc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "e0ecea3e-b994-45d6-a413-43bf0b448df4"}, {"Element": "<td rowspan=\"5\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span></p>\n</td>", "ID": "a4bec244-e346-472b-9642-fa9e622a992e", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4a4d3879-8aff-47a7-8635-25d6a02482b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span></p>", "ID": "e652d9ab-72cf-4527-b714-297b68268c4b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4bec244-e346-472b-9642-fa9e622a992e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is\n  required.</span>", "ID": "a616eace-f42d-41ec-925e-2c8b1e1017aa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   elvitegravir/ cobicistat/ emtricitabine/ tenofovir alafenamide fumarate is   required.", "ParentId": "e652d9ab-72cf-4527-b714-297b68268c4b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span></p>\n</td>\n</tr>", "ID": "754c1a9b-103c-478e-bf0c-7988e6d5a841", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>", "ID": "9c36c4db-c011-458d-892c-62e90329d8a0", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "754c1a9b-103c-478e-bf0c-7988e6d5a841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>", "ID": "0510a3dd-1cde-4143-a7a5-9697773f78dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c36c4db-c011-458d-892c-62e90329d8a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span>", "ID": "9be1b53e-8956-4d08-ab33-5abbd78e91ba", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Cobicistat", "ParentId": "0510a3dd-1cde-4143-a7a5-9697773f78dd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "7011654f-5640-4264-ba50-b789e3a19220", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "754c1a9b-103c-478e-bf0c-7988e6d5a841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "41daf389-6312-4c64-ab33-8fd3c029f947", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7011654f-5640-4264-ba50-b789e3a19220"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c30ed1ed-a688-48f2-9ef1-73fa06837189", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "41daf389-6312-4c64-ab33-8fd3c029f947"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "1169fc73-846e-4053-8e71-e392ae850e60", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "754c1a9b-103c-478e-bf0c-7988e6d5a841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "11c1c0b7-1bcc-4c6d-9c6d-6dcd40c062eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1169fc73-846e-4053-8e71-e392ae850e60"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c71d0eef-7ffd-414f-9e42-62b1d7a0f6ad", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "11c1c0b7-1bcc-4c6d-9c6d-6dcd40c062eb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span></p>\n</td>", "ID": "23586912-390e-4ba5-8425-1fea16d548b6", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "754c1a9b-103c-478e-bf0c-7988e6d5a841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "11dc8f7c-ea00-4a21-89d8-be1e451c2347", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23586912-390e-4ba5-8425-1fea16d548b6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "048920d9-0d9e-49b1-8c93-1dc10fd3c000", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "11dc8f7c-ea00-4a21-89d8-be1e451c2347"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span></p>", "ID": "265a3029-d55a-4bad-9a45-0039d63698d4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "23586912-390e-4ba5-8425-1fea16d548b6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.7, 2.5)</span>", "ID": "b5d4be4c-1674-478c-8c66-7a9584505a93", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.0 (1.7, 2.5)", "ParentId": "265a3029-d55a-4bad-9a45-0039d63698d4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "36c6d156-9311-4659-bf6d-d6dbcbce4488", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span></p>\n</td>", "ID": "700a2d10-90ac-459d-8dd4-1e9ef250d242", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "36c6d156-9311-4659-bf6d-d6dbcbce4488"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span></p>", "ID": "99afd6f0-231a-417f-987e-3de205b5d3a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "700a2d10-90ac-459d-8dd4-1e9ef250d242"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tenofovir alafenamide</span>", "ID": "2a8d55fd-f0d7-42ca-b1fe-49365314a92c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Tenofovir alafenamide", "ParentId": "99afd6f0-231a-417f-987e-3de205b5d3a5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "ae8f4a86-d448-4d24-9646-5521902b0e1c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "36c6d156-9311-4659-bf6d-d6dbcbce4488"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "4b73abf6-9a4d-42f7-88a0-f55016af15d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae8f4a86-d448-4d24-9646-5521902b0e1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "787744bf-aef8-4fa4-9a09-6a6db7f1f548", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "4b73abf6-9a4d-42f7-88a0-f55016af15d8"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "94bf112f-eb6a-4847-a4ae-404d812a07cb", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "36c6d156-9311-4659-bf6d-d6dbcbce4488"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "9aedc216-575b-476c-923e-d3a2931e8831", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94bf112f-eb6a-4847-a4ae-404d812a07cb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "50ccc98c-b4a6-4884-93ba-a3aa62adcb4d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "9aedc216-575b-476c-923e-d3a2931e8831"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "7d0c7a7f-ee94-4c19-843a-8e0156ec1e58", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "36c6d156-9311-4659-bf6d-d6dbcbce4488"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5c81d278-d6fb-42eb-95d9-5a9b562e5d3d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d0c7a7f-ee94-4c19-843a-8e0156ec1e58"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "33695a18-01d9-49fd-8da3-5b19c43c4d35", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5c81d278-d6fb-42eb-95d9-5a9b562e5d3d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "58c568b4-311f-4003-94fa-e92702cd6c97", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "48a5728e-d303-4c87-a555-d27ce163f482", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "58c568b4-311f-4003-94fa-e92702cd6c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "7d5e294a-c394-4ffe-bbc9-01f2a43767e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48a5728e-d303-4c87-a555-d27ce163f482"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "9785c606-3e40-4424-b1cb-636d9015c576", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "7d5e294a-c394-4ffe-bbc9-01f2a43767e3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "f43a1b2b-5392-439e-98a8-8c1600f94284", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "58c568b4-311f-4003-94fa-e92702cd6c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "39055cd4-cbba-43d9-ba91-ed3026bdcd76", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f43a1b2b-5392-439e-98a8-8c1600f94284"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "78deb64d-fbe8-4e10-be72-425721a9f967", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "39055cd4-cbba-43d9-ba91-ed3026bdcd76"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>", "ID": "c8e4d243-22c9-4b0a-a54c-add1f80822d0", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "58c568b4-311f-4003-94fa-e92702cd6c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "956394d6-f34e-47cf-beeb-06a5568bdcbd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c8e4d243-22c9-4b0a-a54c-add1f80822d0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "d2849bb9-2d00-4cf2-924f-e912a5ed457e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "956394d6-f34e-47cf-beeb-06a5568bdcbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>", "ID": "90487f14-789e-4c85-bb1f-36b199e37aac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c8e4d243-22c9-4b0a-a54c-add1f80822d0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span>", "ID": "ff74f22a-8499-4aa2-8394-b06b273cdf05", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.2, 1.5)", "ParentId": "90487f14-789e-4c85-bb1f-36b199e37aac"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "a4313296-ad61-4d32-b948-650fa05ae3e2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "58c568b4-311f-4003-94fa-e92702cd6c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "5b696b8d-1f1d-40b4-89cd-e94fa8a78aa6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4313296-ad61-4d32-b948-650fa05ae3e2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "0c8be520-1b97-4d36-87ed-f3a2ada48293", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "5b696b8d-1f1d-40b4-89cd-e94fa8a78aa6"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span></p>\n</td>\n</tr>", "ID": "a690879e-a4a7-47e2-9cb0-57ab8a0c405b", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "a953b47f-5649-44a3-b0de-e3239a8f4b7d", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a690879e-a4a7-47e2-9cb0-57ab8a0c405b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "a3ab30f7-f1bd-46b3-b613-0604bbc9b4d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a953b47f-5649-44a3-b0de-e3239a8f4b7d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "3489341a-6860-4859-827c-92a80cee384c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "a3ab30f7-f1bd-46b3-b613-0604bbc9b4d8"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span></p>\n</td>", "ID": "868d2807-1693-4704-a2a6-9c7590d193a7", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "a690879e-a4a7-47e2-9cb0-57ab8a0c405b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "be9cd8e2-b815-4a87-aa5c-c20c9891466f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "868d2807-1693-4704-a2a6-9c7590d193a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "a2aec931-fd68-49aa-a8c8-9f99499c9e68", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "be9cd8e2-b815-4a87-aa5c-c20c9891466f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span></p>", "ID": "2a23c9fc-7279-4471-b164-6608887d001c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "868d2807-1693-4704-a2a6-9c7590d193a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.2, 1.5)</span>", "ID": "36ba6238-9a96-4b4b-b81f-3aba305b1aca", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.2, 1.5)", "ParentId": "2a23c9fc-7279-4471-b164-6608887d001c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span></p>\n</td>", "ID": "57730ec9-8a54-4f86-a66f-d8e6ea00cab8", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "a690879e-a4a7-47e2-9cb0-57ab8a0c405b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "3880a0bc-d2b8-497c-bb5a-aebc606046ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "57730ec9-8a54-4f86-a66f-d8e6ea00cab8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "e0bc27ec-00e8-49f7-953b-412ca2dd5403", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "3880a0bc-d2b8-497c-bb5a-aebc606046ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span></p>", "ID": "f0e71a04-7651-45aa-8679-6813bb8d1eb3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "57730ec9-8a54-4f86-a66f-d8e6ea00cab8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.5 (1.4, 1.7)</span>", "ID": "ad5df1d3-16f3-4727-9692-e5fc0abd8cef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.5 (1.4, 1.7)", "ParentId": "f0e71a04-7651-45aa-8679-6813bb8d1eb3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span></p>\n</td>", "ID": "43224713-9e26-4776-8b1e-5aab2963c74e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "a690879e-a4a7-47e2-9cb0-57ab8a0c405b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "4eaafc58-a077-4ad3-8fb2-52690603bf91", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43224713-9e26-4776-8b1e-5aab2963c74e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "025cce0a-cba5-4e98-a566-f91854e8d7eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "4eaafc58-a077-4ad3-8fb2-52690603bf91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span></p>", "ID": "f9ef8696-14a3-4979-a446-61b69e6c4ca7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43224713-9e26-4776-8b1e-5aab2963c74e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.4, 1.8)</span>", "ID": "906e9037-edbd-4368-bbf6-6531488cf124", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.6 (1.4, 1.8)", "ParentId": "f9ef8696-14a3-4979-a446-61b69e6c4ca7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>\n</tr>", "ID": "3e30f2f3-ef03-4cc0-b358-554806d8eec9", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"4\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>\n</td>", "ID": "df9cd51c-f003-4d38-87fe-e87cbdb326e8", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span></p>", "ID": "332bedc0-326b-4233-b1bb-2e9038461934", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df9cd51c-f003-4d38-87fe-e87cbdb326e8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></b>", "ID": "1500b89c-2555-41e6-9893-c6ea2de8876a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "332bedc0-326b-4233-b1bb-2e9038461934"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span>", "ID": "d95c1231-be3a-494c-80e7-55dafcf7207f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Elvitegravir", "ParentId": "1500b89c-2555-41e6-9893-c6ea2de8876a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">/ cobicistat/ emtricitabine/ tenofovir disoproxil\n  fumarate</span>", "ID": "b24e5e0d-8da2-45d1-b84f-ae5723c5f495", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "/ cobicistat/ emtricitabine/ tenofovir disoproxil   fumarate", "ParentId": "332bedc0-326b-4233-b1bb-2e9038461934"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span></p>", "ID": "314a2a02-863d-438f-a45e-25a081f6864b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df9cd51c-f003-4d38-87fe-e87cbdb326e8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(150/ 150/ 200/ 300\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)<sup>c, d</sup></span>", "ID": "c2c32641-7d13-4511-ac43-b03a18b77216", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(150/ 150/ 200/ 300\u00a0mg once daily)/   sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "314a2a02-863d-438f-a45e-25a081f6864b"}, {"Element": "<sup>c, d</sup>", "ID": "72da7958-e6f2-44bd-a6d5-da4d0c672d88", "Styles": "None", "Classes": "None", "Text": "c, d", "ParentId": "c2c32641-7d13-4511-ac43-b03a18b77216"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>\n</td>", "ID": "3f340cdc-8dd7-41df-bfab-de6cad1ba028", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span></p>", "ID": "8553dfc8-30c3-4d1e-9bc4-f59da486d009", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f340cdc-8dd7-41df-bfab-de6cad1ba028"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Elvitegravir</span>", "ID": "351e4732-9cda-4370-a76f-128801152bb9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Elvitegravir", "ParentId": "8553dfc8-30c3-4d1e-9bc4-f59da486d009"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "2dfb04b9-b7be-419c-a4b5-403fdfbf3917", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "575aacd7-3be0-454d-8c76-c1c7e9512b79", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2dfb04b9-b7be-419c-a4b5-403fdfbf3917"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "ca4b531c-666c-44e4-a61e-73bb78b7ef6d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "575aacd7-3be0-454d-8c76-c1c7e9512b79"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "fbaae926-cbac-4edd-a1db-ce1ccaedb2d2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "a15f6a4b-2f4a-4326-b5e8-c362a417468b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fbaae926-cbac-4edd-a1db-ce1ccaedb2d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "78ddf190-d8f6-4ca8-b593-546284073790", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "a15f6a4b-2f4a-4326-b5e8-c362a417468b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "fd42d6a0-2b4d-4e2e-85db-f7ba04479e5b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "55c7cfa0-536b-404e-96da-3fc679fede55", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd42d6a0-2b4d-4e2e-85db-f7ba04479e5b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "01b9d1b6-8672-4aff-9bf5-db1105e08686", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "55c7cfa0-536b-404e-96da-3fc679fede55"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>\n</td>", "ID": "5879cf70-728b-422d-8fbf-e0b932b73acf", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "3e30f2f3-ef03-4cc0-b358-554806d8eec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span></p>", "ID": "f5930080-242b-4fb0-9e42-b6f8dd126525", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5879cf70-728b-422d-8fbf-e0b932b73acf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is\n  required.</span>", "ID": "024fb391-76da-4e4d-9e7b-ad42a4d5ad42", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil fumarate is   required.", "ParentId": "f5930080-242b-4fb0-9e42-b6f8dd126525"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span></p>\n</td>\n</tr>", "ID": "61f64e7b-2d7d-4529-9de1-d5e2869a1bdd", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>\n</td>", "ID": "10ef2252-57cc-4b7b-b2dc-005fa9dd47da", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "61f64e7b-2d7d-4529-9de1-d5e2869a1bdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span></p>", "ID": "eeebdbfe-e914-489a-83c3-25a2793a9f08", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10ef2252-57cc-4b7b-b2dc-005fa9dd47da"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cobicistat</span>", "ID": "56ebf54f-5492-44b2-8ef4-b8169c47baff", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Cobicistat", "ParentId": "eeebdbfe-e914-489a-83c3-25a2793a9f08"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "71d145c6-c148-4aae-9d72-a44b3d6951c8", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "61f64e7b-2d7d-4529-9de1-d5e2869a1bdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "19bd93d5-60f9-4236-8c4b-aed9f7fbb59c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71d145c6-c148-4aae-9d72-a44b3d6951c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "3438c8ad-640e-490d-80ed-9c9c5460c492", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "19bd93d5-60f9-4236-8c4b-aed9f7fbb59c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "703803d6-a7bb-4623-b4cd-13d2182a45b4", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "61f64e7b-2d7d-4529-9de1-d5e2869a1bdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "6268b3bd-9044-4dbe-af7b-ff18c262be89", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "703803d6-a7bb-4623-b4cd-13d2182a45b4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "bb005048-c0f3-4c6b-8d48-c85162ef4661", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "6268b3bd-9044-4dbe-af7b-ff18c262be89"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span></p>\n</td>", "ID": "b196575c-8544-41d0-b935-6e672831c001", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "61f64e7b-2d7d-4529-9de1-d5e2869a1bdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "33df1914-1c50-4d9a-b940-a616e6168f70", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b196575c-8544-41d0-b935-6e672831c001"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "16843c15-0778-4760-892a-c3404d66618b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "33df1914-1c50-4d9a-b940-a616e6168f70"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span></p>", "ID": "a21fbfbf-fd8e-45da-bafe-f7e85d9d8dc0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b196575c-8544-41d0-b935-6e672831c001"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.7 (1.5, 1.9)</span>", "ID": "198cf251-7b4e-4af0-9cb2-dd4e440acd60", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.7 (1.5, 1.9)", "ParentId": "a21fbfbf-fd8e-45da-bafe-f7e85d9d8dc0"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "25d6b869-a391-4734-9113-7abd0fdaaff3", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "5d15d3a2-e0b2-429e-bce5-65a935c05141", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25d6b869-a391-4734-9113-7abd0fdaaff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "11a6ef2a-f9ef-4174-9465-1e3acb1d634e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5d15d3a2-e0b2-429e-bce5-65a935c05141"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "4ecf0e66-b084-4adc-ab48-799a83f019f6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "11a6ef2a-f9ef-4174-9465-1e3acb1d634e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "042a8b81-a84b-4ede-9ba0-b96317e08988", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25d6b869-a391-4734-9113-7abd0fdaaff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "5c1d98ec-71f4-438c-b99e-5f76182c93ea", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "042a8b81-a84b-4ede-9ba0-b96317e08988"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "446a2424-fa0f-42fb-9797-afe7a249492a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "5c1d98ec-71f4-438c-b99e-5f76182c93ea"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "9450f3ba-3b18-45d9-8e06-808647335a43", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25d6b869-a391-4734-9113-7abd0fdaaff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "17bcd877-e5eb-4585-bdbf-0ec56d31fd3a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9450f3ba-3b18-45d9-8e06-808647335a43"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "d3303940-d15e-4ce2-bd8e-6c5bab6f3b29", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "17bcd877-e5eb-4585-bdbf-0ec56d31fd3a"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "3f444054-16d5-4ee1-9b1d-0d40e0a0389b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "25d6b869-a391-4734-9113-7abd0fdaaff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "754701be-970e-4277-a25a-1adbb8d70a44", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f444054-16d5-4ee1-9b1d-0d40e0a0389b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "49f144ef-b483-4555-8d5e-597dedf0dcac", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "754701be-970e-4277-a25a-1adbb8d70a44"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n</tr>", "ID": "ed4f0fcc-72ff-4c7e-86f8-372027e15955", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "6849b8c2-8a44-4db5-80b2-6c6c4ba93a7b", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ed4f0fcc-72ff-4c7e-86f8-372027e15955"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "b4e2f2ab-21af-44ea-ac59-416e851131a5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6849b8c2-8a44-4db5-80b2-6c6c4ba93a7b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "57a335bb-c225-42e3-b9d7-7d7730d71ae6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "b4e2f2ab-21af-44ea-ac59-416e851131a5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "589d78f1-3538-4df7-b88e-d1a14823aa74", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ed4f0fcc-72ff-4c7e-86f8-372027e15955"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "9c5f4b94-6e15-435f-8a94-0bad284695df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "589d78f1-3538-4df7-b88e-d1a14823aa74"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "a085d2ef-212b-4a00-8810-b94cc05def46", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "9c5f4b94-6e15-435f-8a94-0bad284695df"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "f029626c-5d6f-4217-9d36-1e33c36b45ad", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ed4f0fcc-72ff-4c7e-86f8-372027e15955"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "805ccfa8-abf3-47e5-914a-fd7b55805abb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f029626c-5d6f-4217-9d36-1e33c36b45ad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "9a94f3c5-af6f-4314-8028-a8ab26342b5e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "805ccfa8-abf3-47e5-914a-fd7b55805abb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>", "ID": "3a62c3c9-66bb-480d-b521-47ff8a334de2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ed4f0fcc-72ff-4c7e-86f8-372027e15955"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "82d1e12c-5c8b-4f9a-82ee-ae2de65d9852", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a62c3c9-66bb-480d-b521-47ff8a334de2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "d38d0d6c-d652-458e-b2d6-ab3d49533682", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "82d1e12c-5c8b-4f9a-82ee-ae2de65d9852"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>", "ID": "fe2ca3f0-f6d9-40a1-bf07-a811c36a5cef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a62c3c9-66bb-480d-b521-47ff8a334de2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span>", "ID": "f33b088a-1bc3-41f8-ae34-d98591dd1393", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.2, 1.5)", "ParentId": "fe2ca3f0-f6d9-40a1-bf07-a811c36a5cef"}, {"Element": "<tr style=\"page-break-inside:avoid;height:14.8pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span></p>\n</td>\n</tr>", "ID": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92", "Styles": "page-break-inside:avoid;height:14.8pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span></p>\n</td>", "ID": "4ed12cdf-9ba2-4b94-bb45-03950280ab76", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span></p>", "ID": "31c4963b-1504-4c44-ad80-56ba521ce96b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ed12cdf-9ba2-4b94-bb45-03950280ab76"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir (50\u00a0mg once daily)/\n  sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)</span>", "ID": "e6fc679e-5915-42f6-a4fa-403712a6db20", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Dolutegravir (50\u00a0mg once daily)/   sofosbuvir/ velpatasvir (400/ 100\u00a0mg once daily)", "ParentId": "31c4963b-1504-4c44-ad80-56ba521ce96b"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span></p>\n</td>", "ID": "75bd123f-182e-4233-b1f6-ad5c2fbdf619", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span></p>", "ID": "09d62e54-e1c3-4113-99ef-9463b8f21b42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75bd123f-182e-4233-b1f6-ad5c2fbdf619"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Dolutegravir</span>", "ID": "172b4bcc-2cf2-489e-aa49-4c6430d90f05", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Dolutegravir", "ParentId": "09d62e54-e1c3-4113-99ef-9463b8f21b42"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "268c166b-6e22-49d4-bd39-1a5448241a88", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "fb24f83b-525c-47d8-8b7c-31f98b8a9860", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "268c166b-6e22-49d4-bd39-1a5448241a88"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "24a65b40-e728-4b34-bfd0-c2bc7b30fd4e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "fb24f83b-525c-47d8-8b7c-31f98b8a9860"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "3e842070-0f92-45da-8de7-caf4b2e9304f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "80bd60b7-c149-4497-8239-9466ad9875e5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3e842070-0f92-45da-8de7-caf4b2e9304f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "044cce40-c048-481b-80de-28611462c80a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "80bd60b7-c149-4497-8239-9466ad9875e5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "fbc3f86c-d499-441a-8cb1-e08a86c5d8ff", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "27a5c3c7-609b-43d5-b68e-affa8ad8661d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fbc3f86c-d499-441a-8cb1-e08a86c5d8ff"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "30172ea6-f62a-4a78-9806-944d1f0481a1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "27a5c3c7-609b-43d5-b68e-affa8ad8661d"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span></p>\n</td>", "ID": "eedf571c-1193-45a9-9dab-f487412a5638", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:14.8pt", "Classes": "None", "Text": "  ", "ParentId": "fbe7091d-262a-4a0f-b9bc-7ae4df225d92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span></p>", "ID": "f280d2b3-c52e-434c-b390-9d6085b5105c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eedf571c-1193-45a9-9dab-f487412a5638"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  dolutegravir is required.</span>", "ID": "7877b395-8629-4d2b-8bc3-3bde04eb489b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   dolutegravir is required.", "ParentId": "f280d2b3-c52e-434c-b390-9d6085b5105c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:17.95pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c554c1e7-8c59-4b5a-9145-6379ecc5f90c", "Styles": "page-break-inside:avoid;height:17.95pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "0f2b65d1-ff0e-4d87-a922-3561adf7c620", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt", "Classes": "None", "Text": "  ", "ParentId": "c554c1e7-8c59-4b5a-9145-6379ecc5f90c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "e3421906-b788-41e2-8878-1ee1c1a31753", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f2b65d1-ff0e-4d87-a922-3561adf7c620"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "3ca848d7-0043-4c6b-bd48-b321c54b3911", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "e3421906-b788-41e2-8878-1ee1c1a31753"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "5bc42d0d-042e-4266-8b90-b45355ce27aa", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt", "Classes": "None", "Text": "  ", "ParentId": "c554c1e7-8c59-4b5a-9145-6379ecc5f90c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "f3967978-56b8-4fa7-a661-4874a48eb6b2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5bc42d0d-042e-4266-8b90-b45355ce27aa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "09952abf-3757-408e-a2ec-b481fa1191f1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "f3967978-56b8-4fa7-a661-4874a48eb6b2"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "60a38d9c-2d77-46c0-93c7-8fc12355ee41", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt", "Classes": "None", "Text": "  ", "ParentId": "c554c1e7-8c59-4b5a-9145-6379ecc5f90c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "3686391d-f3f9-465d-aca4-21eb71228e3f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60a38d9c-2d77-46c0-93c7-8fc12355ee41"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "d1b4e6c7-b756-403a-b2b4-9d3dca4c584e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "3686391d-f3f9-465d-aca4-21eb71228e3f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "5febd489-559d-456a-9d6e-9a52a732db95", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:17.95pt", "Classes": "None", "Text": "  ", "ParentId": "c554c1e7-8c59-4b5a-9145-6379ecc5f90c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "1f753cc0-142a-426b-8811-401c4022e22e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5febd489-559d-456a-9d6e-9a52a732db95"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "9bef1c60-36ea-460b-8e49-1c1c250ec4b5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "1f753cc0-142a-426b-8811-401c4022e22e"}, {"Element": "<tr style=\"page-break-inside:avoid;height:26.05pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n</tr>", "ID": "465eedc5-e48b-4158-ad31-caf370c2f0b7", "Styles": "page-break-inside:avoid;height:26.05pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "9c7e579f-e6fc-490a-ae49-037a732f350e", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt", "Classes": "None", "Text": "  ", "ParentId": "465eedc5-e48b-4158-ad31-caf370c2f0b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "cb651688-cc02-4f46-89d3-c1e320dac9f0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c7e579f-e6fc-490a-ae49-037a732f350e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "6329dded-dff5-4b61-8a83-9bde79f2ee56", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "cb651688-cc02-4f46-89d3-c1e320dac9f0"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "873f300a-e19b-4688-bb72-bf211a11fd9a", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt", "Classes": "None", "Text": "  ", "ParentId": "465eedc5-e48b-4158-ad31-caf370c2f0b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "17a32799-ae73-43b7-ab67-9025c98050e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "873f300a-e19b-4688-bb72-bf211a11fd9a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "2ca5cce2-02c2-497f-9d9a-206ae9fdd2fb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "17a32799-ae73-43b7-ab67-9025c98050e3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "819fc16c-539b-432a-8cf7-4345ee703ad3", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt", "Classes": "None", "Text": "  ", "ParentId": "465eedc5-e48b-4158-ad31-caf370c2f0b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7c2d6b3f-48bc-44f9-8632-148a8cbcc619", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "819fc16c-539b-432a-8cf7-4345ee703ad3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "27a6d208-3da0-455f-b325-2ada3add63aa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7c2d6b3f-48bc-44f9-8632-148a8cbcc619"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "a21ad153-12e9-4e36-a50b-0a8be70ba793", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:26.05pt", "Classes": "None", "Text": "  ", "ParentId": "465eedc5-e48b-4158-ad31-caf370c2f0b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "36e6a1b5-44fb-4fa8-a1ed-077ef8815d4d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a21ad153-12e9-4e36-a50b-0a8be70ba793"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "d8d23bad-922a-4132-9e6b-a5224f9b3ab2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "36e6a1b5-44fb-4fa8-a1ed-077ef8815d4d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b></p>\n</td>\n</tr>", "ID": "181b5fc5-8877-489c-b404-8675ff427add", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b></p>\n</td>", "ID": "3ecb7d79-745f-4abe-9f33-38c889a2a523", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "181b5fc5-8877-489c-b404-8675ff427add"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b></p>", "ID": "0c0dbc2e-58db-4fd2-a40a-fc4c2e45c3ee", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ecb7d79-745f-4abe-9f33-38c889a2a523"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i></b>", "ID": "06ae1f9b-a950-4b01-aaa0-fea225993752", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c0dbc2e-58db-4fd2-a40a-fc4c2e45c3ee"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span></i>", "ID": "9b8c5c69-101a-45e4-89fa-e7d2cbbfcbf1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06ae1f9b-a950-4b01-aaa0-fea225993752"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">HERBAL SUPPLEMENTS</span>", "ID": "9a8ec3a7-480c-4f4f-9c93-4795a7b3840a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "HERBAL SUPPLEMENTS", "ParentId": "9b8c5c69-101a-45e4-89fa-e7d2cbbfcbf1"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>\n</tr>", "ID": "f1dc0bff-98ac-4929-b5ca-c152256f0bed", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>\n</td>", "ID": "81897970-be91-4a58-8fd4-2e57e968733a", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "      ", "ParentId": "f1dc0bff-98ac-4929-b5ca-c152256f0bed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span></p>", "ID": "b191a94f-e3fd-4874-bbda-d3854dc5dd93", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81897970-be91-4a58-8fd4-2e57e968733a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">St.\u00a0John\u2019s wort</span>", "ID": "6f0f5b6c-5d74-450c-91e0-f02bacf3ac0b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "St.\u00a0John\u2019s wort", "ParentId": "b191a94f-e3fd-4874-bbda-d3854dc5dd93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2b309ffd-5655-4e06-a7ce-cb0d9421dce3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81897970-be91-4a58-8fd4-2e57e968733a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "f36d0e98-14ae-422b-ada6-3bd1f7511a64", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2b309ffd-5655-4e06-a7ce-cb0d9421dce3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "b1bcade7-0a3a-4a1b-8cdf-2e3ebdddc823", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81897970-be91-4a58-8fd4-2e57e968733a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "77502a95-402c-4ee3-82c9-a5e5ed5b7141", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b1bcade7-0a3a-4a1b-8cdf-2e3ebdddc823"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2613e3f2-e497-4621-8033-055255518971", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81897970-be91-4a58-8fd4-2e57e968733a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "13d0a1cd-57e9-4bf8-98c6-07f95db20a78", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2613e3f2-e497-4621-8033-055255518971"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span></p>", "ID": "d2bc25e7-461f-4229-ac99-adba40087525", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81897970-be91-4a58-8fd4-2e57e968733a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Induction of P\u2011gp and CYPs)</span>", "ID": "9444bb22-5e8e-40bc-b73e-a46f49500986", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Induction of P\u2011gp and CYPs)", "ParentId": "d2bc25e7-461f-4229-ac99-adba40087525"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>\n</td>", "ID": "64eeb594-f95a-4415-87af-70a1773a664f", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "f1dc0bff-98ac-4929-b5ca-c152256f0bed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span></p>", "ID": "59f4dddf-9a98-404d-b02b-84cf3225d2e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "64eeb594-f95a-4415-87af-70a1773a664f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction not studied.</span>", "ID": "6bb88433-5c37-4138-885c-dce6c7d06dd5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction not studied.", "ParentId": "59f4dddf-9a98-404d-b02b-84cf3225d2e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "a22b0bed-a9a3-4005-a166-c95b41fae980", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "64eeb594-f95a-4415-87af-70a1773a664f"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "9c301b61-6826-443f-a874-7638deb5ea1c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a22b0bed-a9a3-4005-a166-c95b41fae980"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "f3b0cb56-8785-4c68-9d06-490cd61193cf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "9c301b61-6826-443f-a874-7638deb5ea1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span></p>", "ID": "80ee74d2-edca-4074-85a8-671ae4e1bea1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "64eeb594-f95a-4415-87af-70a1773a664f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Sofosbuvir</span>", "ID": "0dcf56b7-0c78-456d-8b74-f4f3257a6e03", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Sofosbuvir", "ParentId": "80ee74d2-edca-4074-85a8-671ae4e1bea1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span></p>", "ID": "230502ed-c520-46a8-b5db-c4272c009357", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "64eeb594-f95a-4415-87af-70a1773a664f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193 Velpatasvir</span>", "ID": "3aea944c-3f04-407c-b1eb-05777f57c5d1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193 Velpatasvir", "ParentId": "230502ed-c520-46a8-b5db-c4272c009357"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>\n</td>", "ID": "8127a949-9684-405b-ad2a-04515d759531", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "f1dc0bff-98ac-4929-b5ca-c152256f0bed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span></p>", "ID": "7b147129-81f7-4219-815e-b68f81909d52", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8127a949-9684-405b-ad2a-04515d759531"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "2f311006-388f-4e87-a4cd-df8c7b4ed867", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "7b147129-81f7-4219-815e-b68f81909d52"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n  10.0pt\"> is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp\n  and CYP inducer (see section\u00a04.3).</span>", "ID": "ae4b603b-1371-44e0-9460-cc380bc9e337", "Styles": "font-size:\n  10.0pt", "Classes": "None", "Text": " is contraindicated with St.\u00a0John\u2019s wort a potent P\u2011gp   and CYP inducer (see section\u00a04.3).", "ParentId": "7b147129-81f7-4219-815e-b68f81909d52"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b></p>\n</td>\n</tr>", "ID": "13f7fc3b-62b4-4cc6-9188-1e9c1a4927e1", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b></p>\n</td>", "ID": "b065bd7e-9d3e-4357-90aa-b383048f387e", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "13f7fc3b-62b4-4cc6-9188-1e9c1a4927e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b></p>", "ID": "ce971bc2-893d-4f50-ac36-fc2fd00e5a04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b065bd7e-9d3e-4357-90aa-b383048f387e"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i></b>", "ID": "767cb75e-d3b1-4671-8585-9e133fbc41c8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce971bc2-893d-4f50-ac36-fc2fd00e5a04"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span></i>", "ID": "f2887cc9-e29f-45e2-8baa-b41ca128eee6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "767cb75e-d3b1-4671-8585-9e133fbc41c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">HMG\u2011CoA REDUCTASE INHIBITORS</span>", "ID": "547f8718-b890-4bf5-b970-3dcba5870dc6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "HMG\u2011CoA REDUCTASE INHIBITORS", "ParentId": "f2887cc9-e29f-45e2-8baa-b41ca128eee6"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span></p>\n</td>\n</tr>", "ID": "fb618d62-f0e4-4dd5-b83c-5bfe180d6612", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>", "ID": "566c55ab-5b9c-4421-824d-6530b99e96c8", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "fb618d62-f0e4-4dd5-b83c-5bfe180d6612"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>", "ID": "5c54a171-96d0-429f-b580-27427bbc773c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "566c55ab-5b9c-4421-824d-6530b99e96c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span>", "ID": "478937fa-c89f-44e7-8d07-f303a41f9fe7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rosuvastatin", "ParentId": "5c54a171-96d0-429f-b580-27427bbc773c"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>", "ID": "c00f00bf-1957-4d10-bf56-9e99592b5d9d", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "fb618d62-f0e4-4dd5-b83c-5bfe180d6612"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>", "ID": "0ea89561-cc49-49ef-b320-544f5558a4bf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c00f00bf-1957-4d10-bf56-9e99592b5d9d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span>", "ID": "01d51c4f-0559-4759-9e26-671311b29e30", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction only studied with velpatasvir", "ParentId": "0ea89561-cc49-49ef-b320-544f5558a4bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "4b1fe5b3-9aea-42b0-9303-7be0f4570a47", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c00f00bf-1957-4d10-bf56-9e99592b5d9d"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "f1cbb1e7-107a-458e-9bb7-f7894f35b540", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b1fe5b3-9aea-42b0-9303-7be0f4570a47"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "484b984b-8394-4a4d-8547-b0e2d332c9d5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "f1cbb1e7-107a-458e-9bb7-f7894f35b540"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "f1bb8ee3-139f-432a-b849-27ea62edeb37", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c00f00bf-1957-4d10-bf56-9e99592b5d9d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "760f9c99-cb43-4e17-aa61-6da9ba81bc00", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "f1bb8ee3-139f-432a-b849-27ea62edeb37"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span></p>\n</td>", "ID": "449a331a-7b0b-45af-94ca-4aa53be2cc7b", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "fb618d62-f0e4-4dd5-b83c-5bfe180d6612"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span></p>", "ID": "8b17d028-1388-4168-b191-b37adbf1f539", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "449a331a-7b0b-45af-94ca-4aa53be2cc7b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Co\u2011administration of Epclusa with\n  rosuvastatin increases the concentration of rosuvastatin, which is associated\n  with increased risk of myopathy, including rhabdomyolysis.\u00a0\n  Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered\n  with Epclusa.</span>", "ID": "b1a2cb07-678b-498a-be69-ca8987759cc6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Co\u2011administration of Epclusa with   rosuvastatin increases the concentration of rosuvastatin, which is associated   with increased risk of myopathy, including rhabdomyolysis.\u00a0   Rosuvastatin, at a dose that does not exceed 10\u00a0mg, may be administered   with Epclusa.", "ParentId": "8b17d028-1388-4168-b191-b37adbf1f539"}, {"Element": "<tr style=\"page-break-inside:\n  avoid !msorm;height:7.25pt !msorm\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;border:solid windowtext 1.0pt !msorm;\n  border-top:none !msorm;padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "4b29fd11-bf0f-4f87-822a-8b632dbfb545", "Styles": "page-break-inside:\n  avoid !msorm;height:7.25pt !msorm", "Classes": "None", "Text": "      ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;border:solid windowtext 1.0pt !msorm;\n  border-top:none !msorm;padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span></p>\n</td>", "ID": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;border:solid windowtext 1.0pt !msorm;\n  border-top:none !msorm;padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt", "Classes": "None", "Text": "      ", "ParentId": "4b29fd11-bf0f-4f87-822a-8b632dbfb545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>", "ID": "f12dae82-43c5-4034-a8d6-0263d2418b04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin (10\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span>", "ID": "8ffedde7-4033-4719-9049-c9f45a05b4b7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rosuvastatin (10\u00a0mg single dose)/   velpatasvir (100\u00a0mg once daily)", "ParentId": "f12dae82-43c5-4034-a8d6-0263d2418b04"}, {"Element": "<sup>d</sup>", "ID": "062d7dce-729c-443b-b359-e8812ebe8841", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "8ffedde7-4033-4719-9049-c9f45a05b4b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "02408d4d-2e18-486a-9686-883dd1610d7e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "bf02d827-86b3-4c48-9e4c-6df9d61cc881", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "02408d4d-2e18-486a-9686-883dd1610d7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "952469a5-d5ad-4954-8a12-78c70537b393", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "93af5cea-07a7-4f23-a976-12932aed4e3f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "952469a5-d5ad-4954-8a12-78c70537b393"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "d50fd384-d4e5-4ae3-811d-f4ba6ed06e4d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b4617e81-e940-477f-8c97-ed93dbaf6487", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d50fd384-d4e5-4ae3-811d-f4ba6ed06e4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span></p>", "ID": "f39697bd-4a06-4fe9-bf8e-5a5080e76788", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e2583c-ab1f-4a25-9f8f-593b8456c0dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B and BCRP)</span>", "ID": "eaf8035c-eeec-4d6f-b809-8d17be335063", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Inhibition of OATP1B and BCRP)", "ParentId": "f39697bd-4a06-4fe9-bf8e-5a5080e76788"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>\n</td>", "ID": "5ae96056-62ba-49e9-af2e-0bc1a912092c", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4b29fd11-bf0f-4f87-822a-8b632dbfb545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "adc64afd-debb-4437-a4af-32d694e6b5d9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ae96056-62ba-49e9-af2e-0bc1a912092c"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "32a83a2e-cdbb-4051-9d5a-9af987068e78", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "adc64afd-debb-4437-a4af-32d694e6b5d9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "c360740b-aefc-44ca-82f4-9b8ebb2c0d8a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "32a83a2e-cdbb-4051-9d5a-9af987068e78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span></p>", "ID": "9c54075e-f7af-4d9b-8f8c-8f1c0b41483f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ae96056-62ba-49e9-af2e-0bc1a912092c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Rosuvastatin</span>", "ID": "3e8eb747-9eb3-4131-9d83-17bfffa91b50", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Rosuvastatin", "ParentId": "9c54075e-f7af-4d9b-8f8c-8f1c0b41483f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span></p>\n</td>", "ID": "839d31fc-45e4-41ea-ad90-38a7d5dfd958", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4b29fd11-bf0f-4f87-822a-8b632dbfb545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0638605d-132a-475b-86c7-7ae7d0eb4d91", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "839d31fc-45e4-41ea-ad90-38a7d5dfd958"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "0206ff3d-e9f7-46f7-a7c2-2b5f47ce2444", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0638605d-132a-475b-86c7-7ae7d0eb4d91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "873559d3-65b4-4275-9e45-7b4766dc204e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "839d31fc-45e4-41ea-ad90-38a7d5dfd958"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "74a4759e-3b61-4b99-b12b-c42785de7210", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "873559d3-65b4-4275-9e45-7b4766dc204e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span></p>", "ID": "c5cb1ed7-522e-405f-8f12-94dd2972c89f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "839d31fc-45e4-41ea-ad90-38a7d5dfd958"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.6 (2.3, 2.9)</span>", "ID": "c1aba148-8ce4-4905-a619-88b199cdb67b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.6 (2.3, 2.9)", "ParentId": "c5cb1ed7-522e-405f-8f12-94dd2972c89f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span></p>\n</td>", "ID": "5aedb4c7-766f-4fc7-a2e2-263558a666d1", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4b29fd11-bf0f-4f87-822a-8b632dbfb545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "40920bad-8254-498b-b51d-ecd0f5738a50", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5aedb4c7-766f-4fc7-a2e2-263558a666d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "730edcf8-cf04-4e96-a863-6c894d1712e0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "40920bad-8254-498b-b51d-ecd0f5738a50"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "cbe157b6-ba7a-4819-ab4f-63845705c23b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5aedb4c7-766f-4fc7-a2e2-263558a666d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "396f34a7-93f9-4890-a36c-29751292d497", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "cbe157b6-ba7a-4819-ab4f-63845705c23b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span></p>", "ID": "a77ffb58-4d69-4706-bf16-cfaa1de9670d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5aedb4c7-766f-4fc7-a2e2-263558a666d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.7 (2.5, 2.9)</span>", "ID": "4e6b9fc2-1fe3-4712-b577-ffb98d32b180", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.7 (2.5, 2.9)", "ParentId": "a77ffb58-4d69-4706-bf16-cfaa1de9670d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "e1a0b8f5-edd6-4ac7-8f9e-f4b911e6c69b", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;border-top:none !msorm;border-left:none !msorm;\n  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;\n  padding:0in 5.75pt 0in 5.75pt !msorm;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4b29fd11-bf0f-4f87-822a-8b632dbfb545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "66d837e9-e345-4d5b-964b-f27b9b8db60d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e1a0b8f5-edd6-4ac7-8f9e-f4b911e6c69b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "291b487d-a043-4b9d-b1fa-95a7d5fe4097", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "66d837e9-e345-4d5b-964b-f27b9b8db60d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>", "ID": "c8b2c5cd-b018-41c7-99a5-66ea896986a3", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "a0311a95-e948-4cdd-bd3a-05adc2de410b", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "c8b2c5cd-b018-41c7-99a5-66ea896986a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>", "ID": "6bec0780-b30c-47fc-b3c3-4451e588423f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0311a95-e948-4cdd-bd3a-05adc2de410b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span>", "ID": "e06a1035-7fbe-45ab-9da1-91effe469395", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on velpatasvir exposure not studied", "ParentId": "6bec0780-b30c-47fc-b3c3-4451e588423f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "577ee471-3db7-424f-9796-0727768bcb14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0311a95-e948-4cdd-bd3a-05adc2de410b"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "080d8821-4c19-4372-bd29-14f8c09a24f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "577ee471-3db7-424f-9796-0727768bcb14"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "b4674753-6eda-4312-9a29-c1cb1085ce97", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "080d8821-4c19-4372-bd29-14f8c09a24f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "9f9ea445-eb5c-4935-a06e-afceb7a5fd8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0311a95-e948-4cdd-bd3a-05adc2de410b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "c34ed51a-2cc7-4979-864f-6e28a3b0a4d7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "9f9ea445-eb5c-4935-a06e-afceb7a5fd8e"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span></p>\n</td>\n</tr>", "ID": "504665c6-eb2c-4098-8c19-1c20d3bd4cce", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>", "ID": "11cb6b9a-969d-4dcd-9e10-c89834fe0f9f", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "504665c6-eb2c-4098-8c19-1c20d3bd4cce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>", "ID": "08846975-e534-4f02-bdc5-3a04f3dd3259", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11cb6b9a-969d-4dcd-9e10-c89834fe0f9f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span>", "ID": "e697e532-1e0f-4223-8cc5-b2f4020661f0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Pravastatin", "ParentId": "08846975-e534-4f02-bdc5-3a04f3dd3259"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>\n</td>", "ID": "31f48590-1dfb-4cfd-9cd4-6dfc5c33a524", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "504665c6-eb2c-4098-8c19-1c20d3bd4cce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span></p>", "ID": "7edef3be-5a78-40cd-a664-f4d0f4ce1a1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31f48590-1dfb-4cfd-9cd4-6dfc5c33a524"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with velpatasvir</span>", "ID": "23a7b462-b18e-40ab-b157-8f70b9d021e7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction only studied with velpatasvir", "ParentId": "7edef3be-5a78-40cd-a664-f4d0f4ce1a1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "9174a99b-28f4-4bf1-ae88-09ab67a65005", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31f48590-1dfb-4cfd-9cd4-6dfc5c33a524"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "96537327-fbb5-46c8-b743-b9a190f98e45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9174a99b-28f4-4bf1-ae88-09ab67a65005"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "8d0d4996-7bc3-44fc-aada-6965413d378a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "96537327-fbb5-46c8-b743-b9a190f98e45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span></p>", "ID": "5bca802a-2ec2-4530-bf7c-abd1a69923f3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31f48590-1dfb-4cfd-9cd4-6dfc5c33a524"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Sofosbuvir</span>", "ID": "8ee3dc02-83e1-4891-91b4-562fcd622614", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Sofosbuvir", "ParentId": "5bca802a-2ec2-4530-bf7c-abd1a69923f3"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span></p>\n</td>", "ID": "11b94ece-e8d5-4e62-82d1-c754875da769", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "504665c6-eb2c-4098-8c19-1c20d3bd4cce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span></p>", "ID": "b5b5d1c3-f706-49d1-a738-019ec3617f88", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11b94ece-e8d5-4e62-82d1-c754875da769"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  pravastatin is required.</span>", "ID": "ea976d41-6bdb-44c6-b5ce-e55e5ac53396", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   pravastatin is required.", "ParentId": "b5b5d1c3-f706-49d1-a738-019ec3617f88"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "      ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span></p>\n</td>", "ID": "11237e74-494b-4918-8005-dcf341a89ea5", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>", "ID": "ee1071a2-be43-4677-b8e0-6c3172a92a6b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11237e74-494b-4918-8005-dcf341a89ea5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin (40\u00a0mg single dose)/\n  velpatasvir (100\u00a0mg once daily)<sup>d</sup></span>", "ID": "db6ebffd-afc0-433b-9cf6-b66f68bf6076", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Pravastatin (40\u00a0mg single dose)/   velpatasvir (100\u00a0mg once daily)", "ParentId": "ee1071a2-be43-4677-b8e0-6c3172a92a6b"}, {"Element": "<sup>d</sup>", "ID": "746b5a33-a1f9-4747-b9bf-18d02c344cbf", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "db6ebffd-afc0-433b-9cf6-b66f68bf6076"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "12b9298b-d2ba-481b-a6b2-c12564ce030e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11237e74-494b-4918-8005-dcf341a89ea5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "3a8b2b10-92d8-4442-a0ef-8fbd3bf73a5d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "12b9298b-d2ba-481b-a6b2-c12564ce030e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "4bca9d05-0ac2-4fdb-ac15-ccbca88af93f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11237e74-494b-4918-8005-dcf341a89ea5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "0d671dd0-b266-4417-98d9-7d24a0b54e58", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "4bca9d05-0ac2-4fdb-ac15-ccbca88af93f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span></p>", "ID": "e4924936-d794-4786-b49b-251b7f1abc22", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11237e74-494b-4918-8005-dcf341a89ea5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Inhibition of OATP1B)</span>", "ID": "115e4dd1-68a9-49ef-bc38-0cda0ca2e1b5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Inhibition of OATP1B)", "ParentId": "e4924936-d794-4786-b49b-251b7f1abc22"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>\n</td>", "ID": "d0564f29-98fa-403a-8b84-39c4c3a532e9", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i></p>", "ID": "3af91a7a-632f-4067-a489-ae9e9448f35a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0564f29-98fa-403a-8b84-39c4c3a532e9"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span></i>", "ID": "a204913f-51f7-4086-8b1d-be993dfae7ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3af91a7a-632f-4067-a489-ae9e9448f35a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Observed:</span>", "ID": "63e5a7a7-42a8-42ba-9d3d-43e0b6de5950", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Observed:", "ParentId": "a204913f-51f7-4086-8b1d-be993dfae7ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span></p>", "ID": "21c2def0-2ee5-4cc0-b639-067223fa2d4c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0564f29-98fa-403a-8b84-39c4c3a532e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Pravastatin</span>", "ID": "045d2962-f120-4d2a-b0d7-9590a20a3dce", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Pravastatin", "ParentId": "21c2def0-2ee5-4cc0-b639-067223fa2d4c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span></p>\n</td>", "ID": "f1b3b269-d9de-48d1-bf29-6cba34916246", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "eefb4494-ab82-401b-a0b9-accaded48320", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1b3b269-d9de-48d1-bf29-6cba34916246"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "1a4a628a-4eca-4c12-85f0-d43f1f229ba7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "eefb4494-ab82-401b-a0b9-accaded48320"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "f4bf8933-2823-4b55-bc04-88d37a107908", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1b3b269-d9de-48d1-bf29-6cba34916246"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "a4d43aaf-50d2-4e87-ad43-9ac27adad5b1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "f4bf8933-2823-4b55-bc04-88d37a107908"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span></p>", "ID": "ec2ef55f-89be-4bb5-8be7-c1a46462efc8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1b3b269-d9de-48d1-bf29-6cba34916246"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.1, 1.5)</span>", "ID": "aa163546-74a0-43a1-978f-320ab9ab1bc2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.1, 1.5)", "ParentId": "ec2ef55f-89be-4bb5-8be7-c1a46462efc8"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>\n</td>", "ID": "71994fc8-a265-47ab-8730-29063e36bf8c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "56280530-85df-43c0-bc8e-fa0cc5399d8f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71994fc8-a265-47ab-8730-29063e36bf8c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "cb8b8db0-2dde-4fa7-b0ee-275359381611", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "56280530-85df-43c0-bc8e-fa0cc5399d8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "1f01a4f2-140a-4ad7-a435-f97b01e10084", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71994fc8-a265-47ab-8730-29063e36bf8c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "a43e1384-ef97-4e63-9c42-4f9e3ff61a08", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "1f01a4f2-140a-4ad7-a435-f97b01e10084"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span></p>", "ID": "1d139c14-b27a-44ba-8c4a-5bd783c58601", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71994fc8-a265-47ab-8730-29063e36bf8c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.5)</span>", "ID": "a6231dd9-a1ef-4570-a2a7-6cca76c68a5d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.2, 1.5)", "ParentId": "1d139c14-b27a-44ba-8c4a-5bd783c58601"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "0fafe31f-87a8-4946-aede-d8e62afc6be2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4ab47eb6-d671-4bc0-941a-868cf9c0d2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "27ec9f54-36ec-4604-a5a8-f8f6938872b5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0fafe31f-87a8-4946-aede-d8e62afc6be2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "534881f4-e681-432e-ba2e-a1842d7c4ccd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "27ec9f54-36ec-4604-a5a8-f8f6938872b5"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>", "ID": "cd4ab758-f47c-4551-80a6-d167a889fb09", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "cd1d784e-555b-4092-94d9-2205e7d41ba1", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "    ", "ParentId": "cd4ab758-f47c-4551-80a6-d167a889fb09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span></p>", "ID": "3dd7e70c-87e5-4695-9599-56647ce8f756", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd1d784e-555b-4092-94d9-2205e7d41ba1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied</span>", "ID": "945b796c-927a-4b65-979f-159a8a1e556e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on velpatasvir exposure not studied", "ParentId": "3dd7e70c-87e5-4695-9599-56647ce8f756"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "a22a334e-8355-4e20-b306-b497ac0a7ad7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd1d784e-555b-4092-94d9-2205e7d41ba1"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "9412e10e-453c-4f91-8cf0-8d0b03263969", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a22a334e-8355-4e20-b306-b497ac0a7ad7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "5654f087-2035-42e5-9912-9c9302aa2bd4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "9412e10e-453c-4f91-8cf0-8d0b03263969"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "12636492-0529-441d-98fc-e6f4038ff9fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd1d784e-555b-4092-94d9-2205e7d41ba1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "b0083f74-d26d-42ab-be12-efa1a884666b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "12636492-0529-441d-98fc-e6f4038ff9fc"}, {"Element": "<tr style=\"page-break-inside:avoid;height:91.75pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span></p>\n</td>\n<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span></p>\n</td>\n</tr>", "ID": "4ba925db-ee1c-4ee7-b0a9-57b22b39e8e1", "Styles": "page-break-inside:avoid;height:91.75pt", "Classes": "None", "Text": "    ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span></p>\n</td>", "ID": "409ec82d-e150-4732-ab0a-d31227e68047", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:91.75pt", "Classes": "None", "Text": "  ", "ParentId": "4ba925db-ee1c-4ee7-b0a9-57b22b39e8e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span></p>", "ID": "0b42a014-90b0-48c8-b0e9-b259fb68981a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409ec82d-e150-4732-ab0a-d31227e68047"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other statins</span>", "ID": "e524ff93-fa30-4f86-9933-19b17044141c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other statins", "ParentId": "0b42a014-90b0-48c8-b0e9-b259fb68981a"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span></p>\n</td>", "ID": "b85da34f-1129-42e3-bbdb-9024c2dd5c60", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt", "Classes": "None", "Text": "   ", "ParentId": "4ba925db-ee1c-4ee7-b0a9-57b22b39e8e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "7b28c27a-c07c-4fa4-9d8e-51c0ef5af3bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b85da34f-1129-42e3-bbdb-9024c2dd5c60"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "76d06ec5-e87d-4975-84e9-b49d8368ee10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b28c27a-c07c-4fa4-9d8e-51c0ef5af3bb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "53e1367f-f0cb-4854-b645-f004695e1183", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "76d06ec5-e87d-4975-84e9-b49d8368ee10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span></p>", "ID": "5624d707-c182-43f5-8e98-7bba516b3025", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b85da34f-1129-42e3-bbdb-9024c2dd5c60"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191 Statins</span>", "ID": "4154d930-fa29-4e2d-bb64-9c1d50c680f8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191 Statins", "ParentId": "5624d707-c182-43f5-8e98-7bba516b3025"}, {"Element": "<td style=\"width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span></p>\n</td>", "ID": "b9d7033c-8fee-4c27-8285-29ce96d4092d", "Styles": "width:33.16%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:91.75pt", "Classes": "None", "Text": "  ", "ParentId": "4ba925db-ee1c-4ee7-b0a9-57b22b39e8e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span></p>", "ID": "f54052aa-93b0-4ff9-9ff4-6776b61d052d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b9d7033c-8fee-4c27-8285-29ce96d4092d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interactions cannot be excluded with other HMG\u2011CoA\n  reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful\n  monitoring for statin adverse reactions should be undertaken and a reduced\n  dose of statins should be considered if required.</span>", "ID": "6cf31914-fcba-4e7a-912c-6a34297ff4b4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interactions cannot be excluded with other HMG\u2011CoA   reductase inhibitors. \u00a0When co\u2011administered with Epclusa, careful   monitoring for statin adverse reactions should be undertaken and a reduced   dose of statins should be considered if required.", "ParentId": "f54052aa-93b0-4ff9-9ff4-6776b61d052d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:11.75pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:11.75pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b></p>\n</td>\n</tr>", "ID": "0a66db02-c19e-41db-b6d3-c82862015c7c", "Styles": "page-break-inside:avoid;height:11.75pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:11.75pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b></p>\n</td>", "ID": "cc1ffd5c-bbe5-49f5-90fa-d795ddcba2f5", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:11.75pt", "Classes": "None", "Text": "  ", "ParentId": "0a66db02-c19e-41db-b6d3-c82862015c7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b></p>", "ID": "ddfdb4ee-c3ba-4baa-a4ce-e67a6ed7f30e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc1ffd5c-bbe5-49f5-90fa-d795ddcba2f5"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i></b>", "ID": "1faa0a5b-1a69-4821-9710-a38928dd5a9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ddfdb4ee-c3ba-4baa-a4ce-e67a6ed7f30e"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span></i>", "ID": "1e339c9c-9604-4516-b0ba-ce6e7b91de09", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1faa0a5b-1a69-4821-9710-a38928dd5a9e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NARCOTIC ANALGESICS</span>", "ID": "0f354c87-0b4e-41de-9460-6689805d85c2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NARCOTIC ANALGESICS", "ParentId": "1e339c9c-9604-4516-b0ba-ce6e7b91de09"}, {"Element": "<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span></p>\n</td>\n</tr>", "ID": "1221080a-dd41-4c4c-a763-c21b16c803df", "Styles": "page-break-inside:avoid;height:22.75pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>", "ID": "835ae58b-232f-4757-a059-0d5c06ed5e15", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>", "ID": "559acb25-0bc4-486f-a9cd-93435aae6843", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "835ae58b-232f-4757-a059-0d5c06ed5e15"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span>", "ID": "ed554cf0-a32e-442a-8998-5f05996069eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Methadone", "ParentId": "559acb25-0bc4-486f-a9cd-93435aae6843"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>", "ID": "4bf81d29-047b-4523-8b30-df15277d5c73", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "835ae58b-232f-4757-a059-0d5c06ed5e15"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Methadone maintenance therapy [30 to\n  130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span>", "ID": "ac9684c2-6ce6-4953-baac-1abe97d16989", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Methadone maintenance therapy [30 to   130\u00a0mg daily])/ sofosbuvir (400\u00a0mg once daily)", "ParentId": "4bf81d29-047b-4523-8b30-df15277d5c73"}, {"Element": "<sup>d</sup>", "ID": "6f895f4a-c6b8-45da-a79a-69b15c670857", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "ac9684c2-6ce6-4953-baac-1abe97d16989"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "3c8300f6-3259-4d77-8ff9-ca0cc29a8778", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span></p>", "ID": "761c4b72-f924-4cfe-a59a-a102b4534fe2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c8300f6-3259-4d77-8ff9-ca0cc29a8778"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">R\u2011methadone</span>", "ID": "626e0a7a-3ea0-4d13-8f97-9940f16fcee5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "R\u2011methadone", "ParentId": "761c4b72-f924-4cfe-a59a-a102b4534fe2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "145a6708-46bf-47c3-b1c5-6e19587cedbe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c8300f6-3259-4d77-8ff9-ca0cc29a8778"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "d5504969-e8ba-4f23-ad51-155a2859487a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "145a6708-46bf-47c3-b1c5-6e19587cedbe"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "6733e48d-7017-43e2-b4fa-d25ff361075c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "a706030e-0a8a-4ad0-aefe-ede0f3b668ac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6733e48d-7017-43e2-b4fa-d25ff361075c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "3ac2392c-5136-42c6-88a9-12fa9610f4e3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "a706030e-0a8a-4ad0-aefe-ede0f3b668ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "75d313bd-6e42-4128-8ebf-2e4681c78180", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6733e48d-7017-43e2-b4fa-d25ff361075c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "9ff9d020-3c1f-4779-bb3f-40780bd485f7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "75d313bd-6e42-4128-8ebf-2e4681c78180"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "8210ae9f-5df1-49d5-a805-3f2726ca30e4", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "241e2d9e-89c5-4400-975f-fc3bb040faf7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8210ae9f-5df1-49d5-a805-3f2726ca30e4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "499144a0-563f-4716-8c81-7fc13b68be1c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "241e2d9e-89c5-4400-975f-fc3bb040faf7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2f7496a3-5e06-4bde-b836-0b105ca1d4c9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8210ae9f-5df1-49d5-a805-3f2726ca30e4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "7ce4a88d-0879-4010-9199-d6d2badc7135", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2f7496a3-5e06-4bde-b836-0b105ca1d4c9"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "fa713578-09f8-464f-895b-a1661b50a98a", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "95881b43-775d-40d3-a877-ef330d8b61c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa713578-09f8-464f-895b-a1661b50a98a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "49eb8b6e-de77-43cd-96b9-b9ab808c11e2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "95881b43-775d-40d3-a877-ef330d8b61c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "2e298b83-07c0-4dab-bc21-1689daf1ed14", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa713578-09f8-464f-895b-a1661b50a98a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "91e0d5bc-c543-4202-a90a-d79a5e202d79", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "2e298b83-07c0-4dab-bc21-1689daf1ed14"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span></p>\n</td>", "ID": "c96c1ac1-8115-4870-aa15-de7811748eea", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "1221080a-dd41-4c4c-a763-c21b16c803df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span></p>", "ID": "dc1e88d3-fc0c-417b-b0fe-5afb42ca4498", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c96c1ac1-8115-4870-aa15-de7811748eea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  methadone is required.</span>", "ID": "306dfba7-a4ea-45cc-b091-bb3b1d25835d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   methadone is required.", "ParentId": "dc1e88d3-fc0c-417b-b0fe-5afb42ca4498"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "1695264f-014c-43c2-bb6f-6e3299e67193", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "d16001d3-74be-42c2-ac21-622b5a700dab", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "1695264f-014c-43c2-bb6f-6e3299e67193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span></p>", "ID": "cdb5e670-0a0e-4bc2-ab59-dcf1dbdb3c61", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d16001d3-74be-42c2-ac21-622b5a700dab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">S\u2011methadone</span>", "ID": "9efaddec-76e0-418a-b2a3-98929ea8a4a4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "S\u2011methadone", "ParentId": "cdb5e670-0a0e-4bc2-ab59-dcf1dbdb3c61"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "e908d6b5-4717-411a-8ba3-70a091a32c91", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d16001d3-74be-42c2-ac21-622b5a700dab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "e68e3a22-e957-4b8c-b353-3c4e4d6d4a41", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "e908d6b5-4717-411a-8ba3-70a091a32c91"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "0aab0b47-65a3-416f-b9e6-1a101bb4289e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "1695264f-014c-43c2-bb6f-6e3299e67193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "81c94819-896e-410e-9207-3e78ed351077", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0aab0b47-65a3-416f-b9e6-1a101bb4289e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "ccaf31db-9654-4555-a60f-496d43e26227", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "81c94819-896e-410e-9207-3e78ed351077"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "a37d8a39-6d15-466b-a750-19735d009abd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0aab0b47-65a3-416f-b9e6-1a101bb4289e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "65860ac4-4069-49e1-ae37-75827e3b3b4e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "a37d8a39-6d15-466b-a750-19735d009abd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "d84007da-23be-4e41-9554-9b3beb575899", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "1695264f-014c-43c2-bb6f-6e3299e67193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "24712385-5255-46b0-b551-6bfb8fc2c385", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d84007da-23be-4e41-9554-9b3beb575899"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "02ba8910-0ee5-4544-8ed2-4c06814c4a94", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "24712385-5255-46b0-b551-6bfb8fc2c385"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "30692ee7-d791-4b0a-ae6a-999220098af9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d84007da-23be-4e41-9554-9b3beb575899"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "87a7f548-0410-44ab-ab1f-546f8743639c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "30692ee7-d791-4b0a-ae6a-999220098af9"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "77e388d8-ad7d-4d8f-af8d-4404e3828426", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "1695264f-014c-43c2-bb6f-6e3299e67193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "30128cfb-f9c7-4b06-ba60-d7c3aa612acb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "77e388d8-ad7d-4d8f-af8d-4404e3828426"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "66e36492-f646-4aba-a55f-2f25c7f32fd9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "30128cfb-f9c7-4b06-ba60-d7c3aa612acb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "7b2ee72d-a7cb-4b52-a6b1-dc7c1eb4fcf7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "77e388d8-ad7d-4d8f-af8d-4404e3828426"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "8e1acb64-62f7-4680-80ba-93ebb76581d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "7b2ee72d-a7cb-4b52-a6b1-dc7c1eb4fcf7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "6a7a2164-c55c-44ff-a83e-dd3c6e258ef4", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "a2cac3fd-537a-4bdc-b16b-604a3e7ce6df", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "6a7a2164-c55c-44ff-a83e-dd3c6e258ef4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "f0d244d9-8bf3-4fb6-b3b0-acbe6609fbf7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2cac3fd-537a-4bdc-b16b-604a3e7ce6df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "9f771eff-4bab-4c9a-9090-d9abc3178685", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "f0d244d9-8bf3-4fb6-b3b0-acbe6609fbf7"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "978802ef-ac5a-446b-8cf0-d5187aff43f0", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "6a7a2164-c55c-44ff-a83e-dd3c6e258ef4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7abb1b4b-f58d-4d89-a185-1065c4b72dfb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "978802ef-ac5a-446b-8cf0-d5187aff43f0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "832ea5d6-bc05-4c0f-a1e0-6c30ecb396d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7abb1b4b-f58d-4d89-a185-1065c4b72dfb"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span></p>\n</td>", "ID": "5f2afd8a-a2f3-453f-86a5-a6a2ef2e3730", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "6a7a2164-c55c-44ff-a83e-dd3c6e258ef4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "4ef94b95-5be4-445f-b442-9af0b1588712", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f2afd8a-a2f3-453f-86a5-a6a2ef2e3730"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "9993f033-7226-4c4b-9cb5-2fcae66e7f39", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "4ef94b95-5be4-445f-b442-9af0b1588712"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span></p>", "ID": "59a2c886-2d3e-4b63-bf1c-eb5fb9e994d4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f2afd8a-a2f3-453f-86a5-a6a2ef2e3730"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.3 (1.0, 1.7)</span>", "ID": "aa7442a0-432d-4168-8c00-403b2a5e2727", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.3 (1.0, 1.7)", "ParentId": "59a2c886-2d3e-4b63-bf1c-eb5fb9e994d4"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "3bdd0c00-166e-4b0c-b463-993b653c9f83", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "6a7a2164-c55c-44ff-a83e-dd3c6e258ef4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "3f175350-07da-4bcf-b6b7-cfe780ee2f03", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3bdd0c00-166e-4b0c-b463-993b653c9f83"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "034622cc-33cd-4232-888e-070613f247f0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3f175350-07da-4bcf-b6b7-cfe780ee2f03"}, {"Element": "<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>", "ID": "46fb4b7b-ab03-45d0-8e7e-a4ce90b3f5ba", "Styles": "page-break-inside:avoid;height:34.55pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>\n</td>", "ID": "303a43ee-c03f-464b-a031-98e8b68092a9", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "  ", "ParentId": "46fb4b7b-ab03-45d0-8e7e-a4ce90b3f5ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span></p>", "ID": "eead3e2c-b85a-4ee4-8352-aa3b1ed82e71", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "303a43ee-c03f-464b-a031-98e8b68092a9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Methadone</span>", "ID": "bc725e55-1db8-4cf5-8da0-0a544129309f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Methadone", "ParentId": "eead3e2c-b85a-4ee4-8352-aa3b1ed82e71"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "d7557d16-64e8-4b2d-9a7d-33bc377dc7d8", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "    ", "ParentId": "46fb4b7b-ab03-45d0-8e7e-a4ce90b3f5ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span></p>", "ID": "714c9de1-14cf-4e13-8db8-bb23169cb888", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7557d16-64e8-4b2d-9a7d-33bc377dc7d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Interaction only studied with sofosbuvir</span>", "ID": "8e27d109-d589-4882-b50c-ff985aa3e8b8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Interaction only studied with sofosbuvir", "ParentId": "714c9de1-14cf-4e13-8db8-bb23169cb888"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "ed5fd814-d803-4c68-87c9-8360b017c9ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7557d16-64e8-4b2d-9a7d-33bc377dc7d8"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "4f05eeb5-944c-453c-b460-f51b6035322e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed5fd814-d803-4c68-87c9-8360b017c9ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "9b37406b-802a-4a42-a131-2e7086bfada2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "4f05eeb5-944c-453c-b460-f51b6035322e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "e338e874-5406-4104-8d62-e87fa742fd0a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7557d16-64e8-4b2d-9a7d-33bc377dc7d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "1a7114dc-f337-4d84-a09b-7010f6787561", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "e338e874-5406-4104-8d62-e87fa742fd0a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b></p>\n</td>\n</tr>", "ID": "cedcf634-caba-4664-bd25-babb6e28b75e", "Styles": "page-break-inside:avoid;height:10.95pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b></p>\n</td>", "ID": "ad00f4bd-7dcc-4a73-b81a-2c9afa2790c5", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt", "Classes": "None", "Text": "  ", "ParentId": "cedcf634-caba-4664-bd25-babb6e28b75e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b></p>", "ID": "0b652623-730a-47db-a0ff-5a6a6237f307", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad00f4bd-7dcc-4a73-b81a-2c9afa2790c5"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i></b>", "ID": "7d572a54-8484-4f6f-81b8-34b5e75904ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b652623-730a-47db-a0ff-5a6a6237f307"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span></i>", "ID": "711451fc-217f-4f1b-91c7-f4f9f422dd45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7d572a54-8484-4f6f-81b8-34b5e75904ec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">IMMUNOSUPPRESSANTS</span>", "ID": "180a0633-d38e-4ea7-bd71-ea152f49a553", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "IMMUNOSUPPRESSANTS", "ParentId": "711451fc-217f-4f1b-91c7-f4f9f422dd45"}, {"Element": "<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span></p>\n</td>\n</tr>", "ID": "0e85ecfa-ff60-42cb-996d-7c81801c4a30", "Styles": "page-break-inside:avoid;height:22.75pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span></p>\n</td>", "ID": "0c0dfdf4-7f9f-4518-91f8-9745f717ba01", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>", "ID": "70745548-c751-4fe3-89c8-ef359f8375fc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c0dfdf4-7f9f-4518-91f8-9745f717ba01"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span>", "ID": "852b5852-e93c-4de7-a9a6-46924b3f7f95", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ciclosporin", "ParentId": "70745548-c751-4fe3-89c8-ef359f8375fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span></p>", "ID": "6f844fd9-1b85-448b-85c8-164c6482b2f6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c0dfdf4-7f9f-4518-91f8-9745f717ba01"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)/ sofosbuvir\n  (400\u00a0mg single dose)<sup>f</sup></span>", "ID": "65250aa8-bdbf-481a-85c2-c4f174857518", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(600\u00a0mg single dose)/ sofosbuvir   (400\u00a0mg single dose)", "ParentId": "6f844fd9-1b85-448b-85c8-164c6482b2f6"}, {"Element": "<sup>f</sup>", "ID": "d1b398ae-c655-43a6-a4cb-15e970769741", "Styles": "None", "Classes": "None", "Text": "f", "ParentId": "65250aa8-bdbf-481a-85c2-c4f174857518"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>", "ID": "40f51d6c-fe56-4726-8ae5-454e0dbd5636", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>", "ID": "e3d4c6c0-09b5-40d2-92e7-11d888495c89", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "40f51d6c-fe56-4726-8ae5-454e0dbd5636"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span>", "ID": "f86eb4ac-73ab-4dc8-b055-4d6bec863ffa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ciclosporin", "ParentId": "e3d4c6c0-09b5-40d2-92e7-11d888495c89"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "e8656a17-4ca8-497b-9ddd-fe032b6d7f0c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "cfc2c286-3419-48f7-a13e-a9120d118af2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e8656a17-4ca8-497b-9ddd-fe032b6d7f0c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fbd905a2-9902-4e35-98b1-d8a6dceb0670", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "cfc2c286-3419-48f7-a13e-a9120d118af2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "b892f02f-dbb1-4339-b4dd-c4227d42497c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e8656a17-4ca8-497b-9ddd-fe032b6d7f0c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "c248da53-d277-4c06-b9e1-9b3559c65ab4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b892f02f-dbb1-4339-b4dd-c4227d42497c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "69c63802-01c3-464f-a4b1-ee9c33ede81f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "6311310c-0837-47a4-befe-656c161bc892", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69c63802-01c3-464f-a4b1-ee9c33ede81f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fee49ed2-7671-423e-afb4-7562543df76e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "6311310c-0837-47a4-befe-656c161bc892"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "b008cd07-3a94-434e-80bd-4af4f4742b92", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69c63802-01c3-464f-a4b1-ee9c33ede81f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b3a13ed2-af1b-441e-8bca-eb6c05f73e2a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b008cd07-3a94-434e-80bd-4af4f4742b92"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "15d112f2-9469-4629-9b14-4739540fae3a", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "bd4b161e-472d-4451-88b3-edeb9be28f40", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15d112f2-9469-4629-9b14-4739540fae3a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "cb577b94-3013-491a-9674-d81957c38f17", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "bd4b161e-472d-4451-88b3-edeb9be28f40"}, {"Element": "<td rowspan=\"4\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span></p>\n</td>", "ID": "19bd204b-23ff-4094-97a4-1a3c6d31dd30", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "0e85ecfa-ff60-42cb-996d-7c81801c4a30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span></p>", "ID": "a5b2b673-2c52-4a52-9b0b-235e491838ae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19bd204b-23ff-4094-97a4-1a3c6d31dd30"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  ciclosporin is required.</span>", "ID": "75d7a1d4-1545-4a70-868f-909fdc193ddf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   ciclosporin is required.", "ParentId": "a5b2b673-2c52-4a52-9b0b-235e491838ae"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "88808f75-4bd4-463c-9707-6291cd0b4435", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "4e8a96bc-ff7c-4d47-bef9-b6b64564705c", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "88808f75-4bd4-463c-9707-6291cd0b4435"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "4cbe21cb-ed4b-4e49-bdac-4621746d0b50", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e8a96bc-ff7c-4d47-bef9-b6b64564705c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "26dc7233-eaed-4368-86d3-b77f8d441ad5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "4cbe21cb-ed4b-4e49-bdac-4621746d0b50"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span></p>\n</td>", "ID": "120e7641-5cc4-43cc-b17d-e0e549eb9bed", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "88808f75-4bd4-463c-9707-6291cd0b4435"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "77e2e29c-7a0b-484d-b2c0-9c63d4436178", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "120e7641-5cc4-43cc-b17d-e0e549eb9bed"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "c5e512b8-a0ca-4b82-bc03-60597fb04b2b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "77e2e29c-7a0b-484d-b2c0-9c63d4436178"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span></p>", "ID": "49bab50c-e1d0-4f4d-8773-4f5c54a68aed", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "120e7641-5cc4-43cc-b17d-e0e549eb9bed"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.5 (1.9, 3.5)</span>", "ID": "e0e656b2-67d9-401d-ae30-df672121f023", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.5 (1.9, 3.5)", "ParentId": "49bab50c-e1d0-4f4d-8773-4f5c54a68aed"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span></p>\n</td>", "ID": "8f8baa1a-1c98-4a37-a59e-87cc43843f1f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "88808f75-4bd4-463c-9707-6291cd0b4435"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "a45c14f3-c597-4819-bb44-bec94e26d706", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f8baa1a-1c98-4a37-a59e-87cc43843f1f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "701abab3-b75e-44c2-828c-79d865d4319e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "a45c14f3-c597-4819-bb44-bec94e26d706"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span></p>", "ID": "f0d81e2f-8d9f-47ff-a453-7551e160a6ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f8baa1a-1c98-4a37-a59e-87cc43843f1f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4.5 (3.3, 6.3)</span>", "ID": "d601c83c-8d0b-43da-b19f-b79056539354", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4.5 (3.3, 6.3)", "ParentId": "f0d81e2f-8d9f-47ff-a453-7551e160a6ef"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "be7e44a5-7865-4c92-9118-3e04b2a8a16f", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "88808f75-4bd4-463c-9707-6291cd0b4435"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "44dbf176-2c64-45ea-9a89-4b5bad468aac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be7e44a5-7865-4c92-9118-3e04b2a8a16f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "c2d39b2f-2690-4456-9cf6-ef65048407e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "44dbf176-2c64-45ea-9a89-4b5bad468aac"}, {"Element": "<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "8eea3def-7fcc-4ccf-9233-2ba413457c0a", "Styles": "page-break-inside:avoid;height:22.75pt", "Classes": "None", "Text": "      ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>\n</td>", "ID": "4325a736-27c1-46ef-903f-e125d6b34cc1", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "8eea3def-7fcc-4ccf-9233-2ba413457c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span></p>", "ID": "6ab971fd-5362-4daf-a80e-26aeace883a7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4325a736-27c1-46ef-903f-e125d6b34cc1"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">Ciclosporin</span>", "ID": "10fd0be5-2214-410f-ae96-a22237a842ac", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ciclosporin", "ParentId": "6ab971fd-5362-4daf-a80e-26aeace883a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span></p>", "ID": "c5e8752d-a2d4-4ff4-b5cc-b3b71c410549", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4325a736-27c1-46ef-903f-e125d6b34cc1"}, {"Element": "<span lang=\"IT-CH\" style=\"font-size:10.0pt\">(600\u00a0mg single dose)<sup>f</sup>/\n  velpatasvir (100\u00a0mg single dose)<sup>d</sup></span>", "ID": "9b16998b-5b67-4199-935a-da0ab03e45b2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(600\u00a0mg single dose)/   velpatasvir (100\u00a0mg single dose)", "ParentId": "c5e8752d-a2d4-4ff4-b5cc-b3b71c410549"}, {"Element": "<sup>f</sup>", "ID": "a9705d22-8578-4be1-97f6-004d201e383a", "Styles": "None", "Classes": "None", "Text": "f", "ParentId": "9b16998b-5b67-4199-935a-da0ab03e45b2"}, {"Element": "<sup>d</sup>", "ID": "b5daf0f9-9424-411e-8e8e-ccfaff07c13f", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "9b16998b-5b67-4199-935a-da0ab03e45b2"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>\n</td>", "ID": "382d046e-7125-43e5-9d80-f9e858de5b50", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "8eea3def-7fcc-4ccf-9233-2ba413457c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span></p>", "ID": "d1896d68-ea72-4b55-bbe8-f2e33ba3d455", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "382d046e-7125-43e5-9d80-f9e858de5b50"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ciclosporin</span>", "ID": "91a6ce4e-5509-4550-b9b0-e5c3a29403e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ciclosporin", "ParentId": "d1896d68-ea72-4b55-bbe8-f2e33ba3d455"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "6ec4edb8-a117-466b-9b70-36a825e19454", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "8eea3def-7fcc-4ccf-9233-2ba413457c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "eb5572cf-f32a-4a96-b1cd-730e05d0bd56", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ec4edb8-a117-466b-9b70-36a825e19454"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "ca57dbe4-7f51-4cce-80e8-ab7263f496d8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "eb5572cf-f32a-4a96-b1cd-730e05d0bd56"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span></p>\n</td>", "ID": "0912543e-7c3e-44b8-92c4-0e8ebd6f685d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "8eea3def-7fcc-4ccf-9233-2ba413457c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "9c51e3c4-02ea-4d46-85ca-b3ac8fc8d69e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0912543e-7c3e-44b8-92c4-0e8ebd6f685d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "9b77b1de-dcde-4ae3-8cf8-016d03514a73", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "9c51e3c4-02ea-4d46-85ca-b3ac8fc8d69e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span></p>", "ID": "30ae6560-988d-4872-912f-cad4ba31fb6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0912543e-7c3e-44b8-92c4-0e8ebd6f685d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.88 (0.78, 1.0)</span>", "ID": "ca052606-d3c5-41ad-bd7e-66db5b2623c5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.88 (0.78, 1.0)", "ParentId": "30ae6560-988d-4872-912f-cad4ba31fb6d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "18d50fe6-d145-4bec-9b2b-ee374bfc1281", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "8eea3def-7fcc-4ccf-9233-2ba413457c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "d7af5bc5-1ac5-45e2-8f4c-7e3d3d7109be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18d50fe6-d145-4bec-9b2b-ee374bfc1281"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "99696655-ec6c-4aa5-a6a8-25745773d9f7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d7af5bc5-1ac5-45e2-8f4c-7e3d3d7109be"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "4dcee263-b224-420f-ad8e-f016aafcbb32", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>\n</td>", "ID": "e117aab7-a644-49cd-81ba-fb56d0c55f94", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4dcee263-b224-420f-ad8e-f016aafcbb32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span></p>", "ID": "6dc1a3e4-d57e-42f4-9dab-f59105292788", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e117aab7-a644-49cd-81ba-fb56d0c55f94"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir</span>", "ID": "805fa39e-7b53-4200-9f18-145994143cd6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir", "ParentId": "6dc1a3e4-d57e-42f4-9dab-f59105292788"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span></p>\n</td>", "ID": "06a6870e-ed45-4f76-bf64-eb636836df11", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4dcee263-b224-420f-ad8e-f016aafcbb32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "5971fd32-2bc7-4cbb-8109-9d636822fd42", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "06a6870e-ed45-4f76-bf64-eb636836df11"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "5aae76bf-b70e-4f7a-a8b8-1f2fb686332b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "5971fd32-2bc7-4cbb-8109-9d636822fd42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span></p>", "ID": "69c2cdf2-fad0-4e27-a02e-321547be0e69", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "06a6870e-ed45-4f76-bf64-eb636836df11"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.6 (1.2, 2.0)</span>", "ID": "e627cdff-2487-4cc2-adb7-28497c327d30", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.6 (1.2, 2.0)", "ParentId": "69c2cdf2-fad0-4e27-a02e-321547be0e69"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span></p>\n</td>", "ID": "d10d402c-af6d-4d99-86c9-9807f389345c", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "4dcee263-b224-420f-ad8e-f016aafcbb32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "eecaf9e4-69a4-425d-a603-92e57f05bac2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d10d402c-af6d-4d99-86c9-9807f389345c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "ec559583-e44e-4b78-88ac-38ee53294aa8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "eecaf9e4-69a4-425d-a603-92e57f05bac2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span></p>", "ID": "5e9d857c-eca8-498a-a960-ba1399b4e981", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d10d402c-af6d-4d99-86c9-9807f389345c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2.0 (1.5, 2.7)</span>", "ID": "c2028639-613c-40b5-81b4-14efe2ec99ae", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2.0 (1.5, 2.7)", "ParentId": "5e9d857c-eca8-498a-a960-ba1399b4e981"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "86ea858d-6266-439f-a869-14965b0c1126", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "4dcee263-b224-420f-ad8e-f016aafcbb32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "04b8e023-7781-4ebc-b5e9-e77d832d5336", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86ea858d-6266-439f-a869-14965b0c1126"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "df99f8c1-540d-424a-b92c-bb05fa398f7c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "04b8e023-7781-4ebc-b5e9-e77d832d5336"}, {"Element": "<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span></p>\n</td>\n</tr>", "ID": "fe99c5c3-6525-4e41-9179-27bc34c93667", "Styles": "page-break-inside:avoid;height:34.55pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"2\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>\n</td>", "ID": "36cab306-9a03-4506-af2e-ae9fe94013c2", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "   ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>", "ID": "6de94ccf-c106-4802-8fe8-90dd777426ab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "36cab306-9a03-4506-af2e-ae9fe94013c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span>", "ID": "406acc91-e625-4363-b257-cdfd142f20cb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Tacrolimus", "ParentId": "6de94ccf-c106-4802-8fe8-90dd777426ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span></p>", "ID": "086ac211-226c-41a6-ac6f-d65db99b237b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "36cab306-9a03-4506-af2e-ae9fe94013c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5\u00a0mg single dose)<sup>f</sup>/\n  sofosbuvir (400\u00a0mg single dose)<sup>d</sup></span>", "ID": "f3cf7f24-ff59-4551-a583-66d41f884f19", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(5\u00a0mg single dose)/   sofosbuvir (400\u00a0mg single dose)", "ParentId": "086ac211-226c-41a6-ac6f-d65db99b237b"}, {"Element": "<sup>f</sup>", "ID": "f1fa487b-5d8d-4832-9266-bec3ecedda13", "Styles": "None", "Classes": "None", "Text": "f", "ParentId": "f3cf7f24-ff59-4551-a583-66d41f884f19"}, {"Element": "<sup>d</sup>", "ID": "769f58fb-f5ef-4dd7-8c0c-a3d47780fbe6", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "f3cf7f24-ff59-4551-a583-66d41f884f19"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>", "ID": "7c26894a-d5c7-4584-891f-69d8e29d4767", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "  ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>", "ID": "dc5b66f3-6264-4486-9877-bee4f643f85d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7c26894a-d5c7-4584-891f-69d8e29d4767"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span>", "ID": "4529a85f-21a3-40b5-9cb6-f36eeb4f1e9d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Tacrolimus", "ParentId": "dc5b66f3-6264-4486-9877-bee4f643f85d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span></p>\n</td>", "ID": "729a5ec5-0d06-4032-acd7-88bc09ef4b54", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "   ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "55a4a55d-b2ec-4df2-91e8-3f23826bb138", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "729a5ec5-0d06-4032-acd7-88bc09ef4b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "e57ad6de-3b0d-44d2-9986-df9a849dbaf5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "55a4a55d-b2ec-4df2-91e8-3f23826bb138"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span></p>", "ID": "be95f98e-73e9-4312-9bc7-e43ac65e79c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "729a5ec5-0d06-4032-acd7-88bc09ef4b54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.73 (0.59, 0.90)</span>", "ID": "f123f883-38ad-46c9-897e-90b3ac151e7c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.73 (0.59, 0.90)", "ParentId": "be95f98e-73e9-4312-9bc7-e43ac65e79c0"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span></p>\n</td>", "ID": "d36b6a8c-fde6-4b35-8d8c-a2016c90777e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "   ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "049fa0d2-2b77-4db8-a822-a8e5da3954de", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d36b6a8c-fde6-4b35-8d8c-a2016c90777e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "796a3d7f-d265-49d7-ae03-00efa6eb983e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "049fa0d2-2b77-4db8-a822-a8e5da3954de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span></p>", "ID": "3eb71d3a-31ee-4520-a61e-5660b5d94127", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d36b6a8c-fde6-4b35-8d8c-a2016c90777e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.84, 1.4)</span>", "ID": "c3d4bf2c-89ed-4f7d-94bf-e1d7ecb9db3b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.1 (0.84, 1.4)", "ParentId": "3eb71d3a-31ee-4520-a61e-5660b5d94127"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "7e5925a3-9452-4e56-92ba-255139b1b602", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "  ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "9fd1c5cf-5301-4ca5-9fd1-cdb17e58aaaf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e5925a3-9452-4e56-92ba-255139b1b602"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b07d3746-244f-463d-8bfa-cba2ac897d25", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "9fd1c5cf-5301-4ca5-9fd1-cdb17e58aaaf"}, {"Element": "<td rowspan=\"3\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span></p>\n</td>", "ID": "a5823b4e-c058-40d7-af74-4bfed7c6d01d", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "  ", "ParentId": "fe99c5c3-6525-4e41-9179-27bc34c93667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span></p>", "ID": "3cc86fce-1514-49d1-ab4d-28c95b09fdce", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5823b4e-c058-40d7-af74-4bfed7c6d01d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of Epclusa or\n  tacrolimus is required.</span>", "ID": "6cb04e6e-ff23-4d21-b8c8-36bbaaf0402e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of Epclusa or   tacrolimus is required.", "ParentId": "3cc86fce-1514-49d1-ab4d-28c95b09fdce"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "5d4ecd15-1f35-46ca-bdee-359274cb4a36", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>\n</td>", "ID": "eb94ea65-ebf1-48ce-8af3-1a5f9152787c", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "5d4ecd15-1f35-46ca-bdee-359274cb4a36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span></p>", "ID": "76c95db8-af51-48c5-a97c-1412138ef806", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb94ea65-ebf1-48ce-8af3-1a5f9152787c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir</span>", "ID": "50cec76a-2e24-4455-85d8-b5674cbdb10f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "76c95db8-af51-48c5-a97c-1412138ef806"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span></p>\n</td>", "ID": "601dec03-dfff-4935-bcdf-e24cefebb8f5", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "5d4ecd15-1f35-46ca-bdee-359274cb4a36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "daa9f026-c912-40a1-91da-a88ca8ec3e60", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "601dec03-dfff-4935-bcdf-e24cefebb8f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "6a93727d-909d-491b-8b70-f4f1f4bebb31", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "daa9f026-c912-40a1-91da-a88ca8ec3e60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span></p>", "ID": "af2b40f5-e975-4481-86ad-2a7931c4e3e5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "601dec03-dfff-4935-bcdf-e24cefebb8f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.97 (0.65, 1.4)</span>", "ID": "479d336f-e550-4d15-bbee-c6a02072d672", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.97 (0.65, 1.4)", "ParentId": "af2b40f5-e975-4481-86ad-2a7931c4e3e5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span></p>\n</td>", "ID": "6a4143d2-28e5-4cf6-bedc-b57c657feaaa", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "5d4ecd15-1f35-46ca-bdee-359274cb4a36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "152e88b0-d8c8-44dc-bd37-6cdbe20f69d1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6a4143d2-28e5-4cf6-bedc-b57c657feaaa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "c79b7e6c-88af-4b49-9108-6a732e18bf0c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "152e88b0-d8c8-44dc-bd37-6cdbe20f69d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span></p>", "ID": "265d80c1-31cc-40c8-af63-e57b1c2db002", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6a4143d2-28e5-4cf6-bedc-b57c657feaaa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.1 (0.81, 1.6)</span>", "ID": "2a07cd90-2fc5-428f-b940-5942f24f6f78", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.1 (0.81, 1.6)", "ParentId": "265d80c1-31cc-40c8-af63-e57b1c2db002"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "3697c172-8c36-48e7-932a-0391c1d16cde", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "5d4ecd15-1f35-46ca-bdee-359274cb4a36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "a9d475f9-0dc5-4f71-994f-7de07a0327f2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3697c172-8c36-48e7-932a-0391c1d16cde"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "8cc70d7f-2ecb-4e1a-a8cd-7c14d6e7b6c6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "a9d475f9-0dc5-4f71-994f-7de07a0327f2"}, {"Element": "<tr style=\"page-break-inside:avoid;height:34.55pt\">\n<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>\n<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>\n</tr>", "ID": "25dc194e-a7cc-48df-9fa2-04370ac45556", "Styles": "page-break-inside:avoid;height:34.55pt", "Classes": "None", "Text": "   ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>\n</td>", "ID": "71d27c4b-ab56-4c56-bfeb-7d936004b493", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "  ", "ParentId": "25dc194e-a7cc-48df-9fa2-04370ac45556"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span></p>", "ID": "e6ef98ea-80c1-436f-9019-d77dd01b1aaf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71d27c4b-ab56-4c56-bfeb-7d936004b493"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Tacrolimus</span>", "ID": "b6e495b6-1470-4c29-bb8a-713336d7fc65", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Tacrolimus", "ParentId": "e6ef98ea-80c1-436f-9019-d77dd01b1aaf"}, {"Element": "<td colspan=\"4\" style=\"width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt\" valign=\"top\" width=\"39%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>\n</td>", "ID": "f88dc5c9-0994-4170-a4ab-507444671729", "Styles": "width:39.72%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:34.55pt", "Classes": "None", "Text": "    ", "ParentId": "25dc194e-a7cc-48df-9fa2-04370ac45556"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span></p>", "ID": "51b8fd2e-c28c-4323-a081-06613bdf5408", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f88dc5c9-0994-4170-a4ab-507444671729"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Effect on velpatasvir exposure not studied.</span>", "ID": "0188a576-ea47-4eb8-9203-94af22efb6c6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Effect on velpatasvir exposure not studied.", "ParentId": "51b8fd2e-c28c-4323-a081-06613bdf5408"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i></p>", "ID": "4a947c56-fc51-4906-9778-94ca99ead860", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f88dc5c9-0994-4170-a4ab-507444671729"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span></i>", "ID": "511a99a9-1740-4678-a48c-5685e6128e3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4a947c56-fc51-4906-9778-94ca99ead860"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Expected:</span>", "ID": "b4aadad0-6dfb-4ce1-89fe-23dba7c97eb2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Expected:", "ParentId": "511a99a9-1740-4678-a48c-5685e6128e3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span></p>", "ID": "6b01e9ed-3c50-4721-9918-e79cea18bdf7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f88dc5c9-0994-4170-a4ab-507444671729"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194 Velpatasvir</span>", "ID": "4187e42a-005c-41bc-b5a3-1cf2cf1b5333", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194 Velpatasvir", "ParentId": "6b01e9ed-3c50-4721-9918-e79cea18bdf7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:10.95pt\">\n<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b></p>\n</td>\n</tr>", "ID": "08d5448c-e306-4829-8e9f-006542acd077", "Styles": "page-break-inside:avoid;height:10.95pt", "Classes": "None", "Text": "  ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td colspan=\"6\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b></p>\n</td>", "ID": "413ee3f4-589a-4123-9208-404afa5619b3", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:10.95pt", "Classes": "None", "Text": "  ", "ParentId": "08d5448c-e306-4829-8e9f-006542acd077"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b></p>", "ID": "9e98aab9-6747-4a52-a3b4-0537ef913cbb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "413ee3f4-589a-4123-9208-404afa5619b3"}, {"Element": "<b><i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i></b>", "ID": "b4e763f1-fde0-47fb-8e15-3e8b8b78ddba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e98aab9-6747-4a52-a3b4-0537ef913cbb"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span></i>", "ID": "b1358b50-5d4a-40eb-9edf-28db55e170d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b4e763f1-fde0-47fb-8e15-3e8b8b78ddba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORAL CONTRACEPTIVES</span>", "ID": "e67567eb-1afb-40ec-98a8-ef0b23171bc1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ORAL CONTRACEPTIVES", "ParentId": "b1358b50-5d4a-40eb-9edf-28db55e170d4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:70.25pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td rowspan=\"6\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span></p>\n</td>\n</tr>", "ID": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03", "Styles": "page-break-inside:avoid;height:70.25pt", "Classes": "None", "Text": "       ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>\n</td>", "ID": "5fd1937c-db3e-4820-ad67-b535588ecb28", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "  ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span></p>", "ID": "6d369b7e-0e41-4f29-a4d8-3656569a1ee4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5fd1937c-db3e-4820-ad67-b535588ecb28"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)<sup>d</sup></span>", "ID": "a6411512-c493-4352-bcaa-96710af4396e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norgestimate/ ethinyl estradiol   (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol   0.025\u00a0mg)/ sofosbuvir (400\u00a0mg once daily)", "ParentId": "6d369b7e-0e41-4f29-a4d8-3656569a1ee4"}, {"Element": "<sup>d</sup>", "ID": "9ee9f521-1c2e-42fe-8f6c-a785b855040f", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "a6411512-c493-4352-bcaa-96710af4396e"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>", "ID": "5e8413ee-19ec-4f45-834c-531bfa438a22", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "  ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>", "ID": "5c2dc6d6-5804-465c-8dda-6b95cf8cbee7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e8413ee-19ec-4f45-834c-531bfa438a22"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span>", "ID": "b613db0a-8661-4b11-bbf2-f6d51ab3c82f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norel-gestromin", "ParentId": "5c2dc6d6-5804-465c-8dda-6b95cf8cbee7"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "bb204577-f15f-4507-b137-4407888def9e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "   ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "61dd853d-c846-4f99-8036-a4e3a6332a39", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb204577-f15f-4507-b137-4407888def9e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "29ea1325-b60d-4aa1-878e-dd1cdaadd158", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "61dd853d-c846-4f99-8036-a4e3a6332a39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "86a61b93-3ba2-4c4c-a7dd-f5fcf37721ad", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb204577-f15f-4507-b137-4407888def9e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "63c68e7f-743f-4f5d-af7d-ea7471d54f05", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "86a61b93-3ba2-4c4c-a7dd-f5fcf37721ad"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "aaf22712-07be-4b97-9776-ebeeda050794", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "   ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "31c9cfd2-0ccc-46ae-8b5b-f7c1e63f27a0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf22712-07be-4b97-9776-ebeeda050794"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "cb1351aa-1efa-469c-b4ee-25a3da035b81", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "31c9cfd2-0ccc-46ae-8b5b-f7c1e63f27a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "4528bfb2-02dd-49e6-a990-c586914e977d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf22712-07be-4b97-9776-ebeeda050794"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "9362f3ce-2a2a-48b7-99ec-7d790d5c6cf2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "4528bfb2-02dd-49e6-a990-c586914e977d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "af922fda-8176-468d-acf2-590fa7415e80", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "   ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "373924d0-cf6d-4a24-9254-96dd599b1a76", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af922fda-8176-468d-acf2-590fa7415e80"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "1fe12c7e-d430-44b6-aab1-b806e1f5d46f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "373924d0-cf6d-4a24-9254-96dd599b1a76"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "ee3750a6-0dde-4eff-bdab-3d66f918e4b6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af922fda-8176-468d-acf2-590fa7415e80"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "2ae4798d-e895-4929-8723-90b13ebed2fe", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ee3750a6-0dde-4eff-bdab-3d66f918e4b6"}, {"Element": "<td rowspan=\"6\" style=\"width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt\" valign=\"top\" width=\"33%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span></p>\n</td>", "ID": "6eba5a88-8fd3-49fa-acb9-801682261db3", "Styles": "width:33.16%;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:70.25pt", "Classes": "None", "Text": "  ", "ParentId": "2a5ca19a-8a35-403c-bb9b-47a5bd21bc03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span></p>", "ID": "d7d60c94-8605-4498-9c5f-7aaee10e995f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6eba5a88-8fd3-49fa-acb9-801682261db3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No dose adjustment of oral contraceptives\n  is required.</span>", "ID": "faefa852-95da-4a99-bd97-2ca771f47053", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "No dose adjustment of oral contraceptives   is required.", "ParentId": "d7d60c94-8605-4498-9c5f-7aaee10e995f"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span></p>\n</td>\n</tr>", "ID": "a2137e91-7034-4692-b6c2-e7b365416bfe", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>", "ID": "d42d5f5a-ba98-46ee-85dc-d0b23696df5d", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a2137e91-7034-4692-b6c2-e7b365416bfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>", "ID": "8a5326fb-572f-404f-ba3d-6b481d884325", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d42d5f5a-ba98-46ee-85dc-d0b23696df5d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span>", "ID": "4b0d0052-c4db-4f04-9281-01447caa0b2d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norgestrel", "ParentId": "8a5326fb-572f-404f-ba3d-6b481d884325"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "58f2ae80-0a1a-4055-b134-b2c5153ab6ba", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "a2137e91-7034-4692-b6c2-e7b365416bfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7278575e-5df3-4e01-be76-6b5d32439a62", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "58f2ae80-0a1a-4055-b134-b2c5153ab6ba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c873696a-4001-484d-81fa-51a4f6dcebb1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7278575e-5df3-4e01-be76-6b5d32439a62"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span></p>\n</td>", "ID": "c24d9546-e8c4-4e31-b267-f54e3a6ceab2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "a2137e91-7034-4692-b6c2-e7b365416bfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "934e9e4d-6b42-4495-bcd2-43163e92ce83", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c24d9546-e8c4-4e31-b267-f54e3a6ceab2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "ea4e722f-291c-4d35-a2dd-317a0d36bb59", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "934e9e4d-6b42-4495-bcd2-43163e92ce83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span></p>", "ID": "2736ae78-7ef7-4209-83c3-4e56e87e959b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c24d9546-e8c4-4e31-b267-f54e3a6ceab2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (0.98, 1.5)</span>", "ID": "35b68398-6330-45e3-85d5-cd4466da07b4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.2 (0.98, 1.5)", "ParentId": "2736ae78-7ef7-4209-83c3-4e56e87e959b"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span></p>\n</td>", "ID": "0f68d4c1-755d-48ee-9b36-14b009968091", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "a2137e91-7034-4692-b6c2-e7b365416bfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "9380cf26-b72c-4736-9a2f-28b12f008d78", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f68d4c1-755d-48ee-9b36-14b009968091"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "fc7cd055-980e-4297-8303-8c9159de0bfa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "9380cf26-b72c-4736-9a2f-28b12f008d78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span></p>", "ID": "5c7ba647-1751-43e3-9fcb-563c39fd8141", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f68d4c1-755d-48ee-9b36-14b009968091"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.2 (1.0, 1.5)</span>", "ID": "934c6e81-e32d-45dc-9767-784cabc760b5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.2 (1.0, 1.5)", "ParentId": "5c7ba647-1751-43e3-9fcb-563c39fd8141"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "dce3519d-e627-4d1a-9758-61544b22cb4e", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>", "ID": "2b859a3c-5b69-4bd3-959b-97e0b482dbc7", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "dce3519d-e627-4d1a-9758-61544b22cb4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>", "ID": "5897c1da-cc06-4fc6-81d8-1bf44b015e05", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b859a3c-5b69-4bd3-959b-97e0b482dbc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span>", "ID": "e1f3c5e1-8534-4ada-8e24-66b247b63525", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ethinyl estradiol", "ParentId": "5897c1da-cc06-4fc6-81d8-1bf44b015e05"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "7c2e4018-77cc-4a3b-a3fa-a599eebe35d3", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "dce3519d-e627-4d1a-9758-61544b22cb4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "bfd85f24-ee76-457c-9d79-81accc39aaf0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7c2e4018-77cc-4a3b-a3fa-a599eebe35d3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "c55e1274-9387-40a8-ab5c-09688c93692a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "bfd85f24-ee76-457c-9d79-81accc39aaf0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "953ca24d-4414-4c4f-8d0f-aef7f73e428d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7c2e4018-77cc-4a3b-a3fa-a599eebe35d3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "a8bf4d0a-722c-400f-ab5f-2d8507e29161", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "953ca24d-4414-4c4f-8d0f-aef7f73e428d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "a13dbc25-e545-4615-911d-b0e50c9468ca", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "dce3519d-e627-4d1a-9758-61544b22cb4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "7d719ad5-2732-4311-ba39-6d87956f5b0a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a13dbc25-e545-4615-911d-b0e50c9468ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "f85c0b82-1369-45ae-a7b4-ebd9c747a354", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "7d719ad5-2732-4311-ba39-6d87956f5b0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "d91977aa-03df-41bc-b30c-1e82603a522f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a13dbc25-e545-4615-911d-b0e50c9468ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b2d90bca-a7d0-41fb-bc87-54d12acd64fe", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d91977aa-03df-41bc-b30c-1e82603a522f"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "4fe6344f-ba98-4823-8197-4a63deae9d61", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "dce3519d-e627-4d1a-9758-61544b22cb4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "4afa7335-620c-404c-842e-f23e2bd3033c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe6344f-ba98-4823-8197-4a63deae9d61"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "f7d625de-6e40-449e-a0e2-c438bd32cc55", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "4afa7335-620c-404c-842e-f23e2bd3033c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "f388cf7a-ac86-4920-9b86-e1e604b9bf23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe6344f-ba98-4823-8197-4a63deae9d61"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "35ed96be-b4d0-40d2-964f-3d0239d64a9a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f388cf7a-ac86-4920-9b86-e1e604b9bf23"}, {"Element": "<tr style=\"page-break-inside:avoid;height:22.75pt\">\n<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n</td>\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "4ed983fa-bc63-4cbe-bba9-b7d428562528", "Styles": "page-break-inside:avoid;height:22.75pt", "Classes": "None", "Text": "      ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td rowspan=\"3\" style=\"width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"27%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>\n</td>", "ID": "0d8756e3-1c59-4309-a92a-a0c1f129846c", "Styles": "width:27.12%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "4ed983fa-bc63-4cbe-bba9-b7d428562528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span></p>", "ID": "0675c704-84fb-4793-abe7-7c8139f6ba88", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d8756e3-1c59-4309-a92a-a0c1f129846c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestimate/ ethinyl estradiol\n  (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol\n  0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)<sup>d</sup></span>", "ID": "c8e0a7c0-217e-4f9e-98dd-4def46c683af", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norgestimate/ ethinyl estradiol   (norgestimate 0.180\u00a0mg/ 0.215\u00a0mg/ 0.25\u00a0mg/ ethinyl estradiol   0.025\u00a0mg)/ velpatasvir (100\u00a0mg once daily)", "ParentId": "0675c704-84fb-4793-abe7-7c8139f6ba88"}, {"Element": "<sup>d</sup>", "ID": "3fb8021b-88ae-4c19-beb6-bf82b9d9f697", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "c8e0a7c0-217e-4f9e-98dd-4def46c683af"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>\n</td>", "ID": "20aadb80-d6ca-4278-90ae-badc2e8ea08f", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "  ", "ParentId": "4ed983fa-bc63-4cbe-bba9-b7d428562528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span></p>", "ID": "578118ed-ff7c-451c-b0c6-f3884a184ddf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "20aadb80-d6ca-4278-90ae-badc2e8ea08f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norel-gestromin</span>", "ID": "fd7fbe84-4bc7-41d8-80ae-82a647ce6da0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norel-gestromin", "ParentId": "578118ed-ff7c-451c-b0c6-f3884a184ddf"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "a835722e-4626-4a0e-b69e-7912de76dfa9", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "4ed983fa-bc63-4cbe-bba9-b7d428562528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "ea443a62-58f0-4072-9884-f44e54adf5e1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a835722e-4626-4a0e-b69e-7912de76dfa9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "5022d796-36f2-4a10-baab-ec5da94c6fdc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "ea443a62-58f0-4072-9884-f44e54adf5e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "b0a353cc-e3ec-4440-a091-26845a54694c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a835722e-4626-4a0e-b69e-7912de76dfa9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "fd24fe29-501a-4484-b915-22aeb2117d3f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b0a353cc-e3ec-4440-a091-26845a54694c"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "809407d8-2f78-418b-b94a-dfbf02df1a32", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "4ed983fa-bc63-4cbe-bba9-b7d428562528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "10f1ba46-38e3-4a14-ab7c-12d36d523580", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "809407d8-2f78-418b-b94a-dfbf02df1a32"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "9f4b4dfe-a289-4599-9a30-7ab2054855ee", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "10f1ba46-38e3-4a14-ab7c-12d36d523580"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "60e62d8a-8497-456f-a0bc-2c38b05453b6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "809407d8-2f78-418b-b94a-dfbf02df1a32"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "7293093a-acaa-48bd-9cd8-7e60493f3ab3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "60e62d8a-8497-456f-a0bc-2c38b05453b6"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "479035ef-60f3-4243-8f87-efc487d3e01d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:22.75pt", "Classes": "None", "Text": "   ", "ParentId": "4ed983fa-bc63-4cbe-bba9-b7d428562528"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "e3509c35-a748-4079-8a59-a44885be7366", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "479035ef-60f3-4243-8f87-efc487d3e01d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "2d9405f1-4044-4c69-90b8-57049fd03c77", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "e3509c35-a748-4079-8a59-a44885be7366"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "0e6ef1b7-06fc-4f14-9a12-7bc06603af65", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "479035ef-60f3-4243-8f87-efc487d3e01d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "a2554109-794e-4392-b199-e76cc3317e87", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0e6ef1b7-06fc-4f14-9a12-7bc06603af65"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "ae2d0e23-bb3f-49fd-8b5a-b853cc2f2481", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>\n</td>", "ID": "eaa1d6f2-044c-42a0-829b-2f7e622116ed", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ae2d0e23-bb3f-49fd-8b5a-b853cc2f2481"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span></p>", "ID": "980e8ae4-b97f-4fcb-8ce3-1bb1589df31d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eaa1d6f2-044c-42a0-829b-2f7e622116ed"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Norgestrel</span>", "ID": "bfa579be-b6a8-461d-9f5d-9c19e87796a3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Norgestrel", "ParentId": "980e8ae4-b97f-4fcb-8ce3-1bb1589df31d"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "d32f1495-2191-44a9-8d70-63a71163ebc6", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ae2d0e23-bb3f-49fd-8b5a-b853cc2f2481"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "33c952e3-50f0-4e8b-9d96-2a8612da419b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d32f1495-2191-44a9-8d70-63a71163ebc6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "bfac136d-b15d-4821-b42e-293e9fc9ec21", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "33c952e3-50f0-4e8b-9d96-2a8612da419b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "ff15210c-9f52-441b-8bd8-a07938cd2a7e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d32f1495-2191-44a9-8d70-63a71163ebc6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "6b00564f-0277-46bd-99f6-3ab5230619fd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ff15210c-9f52-441b-8bd8-a07938cd2a7e"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "b159d48d-5f28-40b0-83b1-7c4f8c15f57d", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ae2d0e23-bb3f-49fd-8b5a-b853cc2f2481"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "dd550678-f704-483f-8b54-2c7a1f2ed90d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b159d48d-5f28-40b0-83b1-7c4f8c15f57d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "fd57e73b-068a-4aaf-a7c6-d619b69cd42d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "dd550678-f704-483f-8b54-2c7a1f2ed90d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "7c6af406-8609-4f4c-a263-48b3684586cd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b159d48d-5f28-40b0-83b1-7c4f8c15f57d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "8f32092e-aa5c-4b87-a67b-ba8e7efb9340", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "7c6af406-8609-4f4c-a263-48b3684586cd"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "d5f5d693-8c8a-4f14-afa8-16727a6300d2", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ae2d0e23-bb3f-49fd-8b5a-b853cc2f2481"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "3912b199-1c20-45ff-b3fa-3588e862aeca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5f5d693-8c8a-4f14-afa8-16727a6300d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "4328e07c-d49e-4326-b507-47df832eba00", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "3912b199-1c20-45ff-b3fa-3588e862aeca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "6508765a-0dcb-4992-92ea-364a9d74a58f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5f5d693-8c8a-4f14-afa8-16727a6300d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "595a9d7f-a7c4-41fe-af34-54935b4d2884", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6508765a-0dcb-4992-92ea-364a9d74a58f"}, {"Element": "<tr style=\"page-break-inside:avoid;height:7.25pt\">\n<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>\n<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span></p>\n</td>\n</tr>", "ID": "ca6af9a2-36c7-46f1-8979-776e39fd5211", "Styles": "page-break-inside:avoid;height:7.25pt", "Classes": "None", "Text": "     ", "ParentId": "4317317e-2e1a-417c-9a01-7ea58f79b4ef"}, {"Element": "<td style=\"width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"14%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>\n</td>", "ID": "1bb1b5cf-69c4-48cb-9af1-aa87eeed6c3d", "Styles": "width:14.1%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ca6af9a2-36c7-46f1-8979-776e39fd5211"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span></p>", "ID": "a963a9e4-cb1a-42ab-b20a-7e267dc70fb5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1bb1b5cf-69c4-48cb-9af1-aa87eeed6c3d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Ethinyl estradiol</span>", "ID": "4704e065-d78c-4e5f-a78b-27d3e6809c4e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Ethinyl estradiol", "ParentId": "a963a9e4-cb1a-42ab-b20a-7e267dc70fb5"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span></p>\n</td>", "ID": "ba0575f8-fc31-4ad3-8718-6dd2ba36008e", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ca6af9a2-36c7-46f1-8979-776e39fd5211"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span></p>", "ID": "46cd6fa1-e595-4ece-a86d-5100f76bdcda", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba0575f8-fc31-4ad3-8718-6dd2ba36008e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2191</span>", "ID": "c50ab5da-684d-4a24-8136-0c8f694cbccf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2191", "ParentId": "46cd6fa1-e595-4ece-a86d-5100f76bdcda"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span></p>", "ID": "bdd817c9-f595-4651-a020-2f7c59e5cde3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba0575f8-fc31-4ad3-8718-6dd2ba36008e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1.4 (1.2, 1.7)</span>", "ID": "a240aa02-c787-45e9-87f5-ce8951d7d5a4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1.4 (1.2, 1.7)", "ParentId": "bdd817c9-f595-4651-a020-2f7c59e5cde3"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>\n</td>", "ID": "b61de810-39e7-47d3-8d7a-1f8df805bf98", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "  ", "ParentId": "ca6af9a2-36c7-46f1-8979-776e39fd5211"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span></p>", "ID": "ebdd5ad7-5405-4692-9be7-d384bd48b228", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b61de810-39e7-47d3-8d7a-1f8df805bf98"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2194</span>", "ID": "2385f127-e38f-4240-9856-8e2074aa4a6c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2194", "ParentId": "ebdd5ad7-5405-4692-9be7-d384bd48b228"}, {"Element": "<td style=\"width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt\" valign=\"top\" width=\"8%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span></p>\n</td>", "ID": "b8a3de75-a79d-43b2-bf18-dbc023ac31a7", "Styles": "width:8.54%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.75pt 0in 5.75pt;height:7.25pt", "Classes": "None", "Text": "   ", "ParentId": "ca6af9a2-36c7-46f1-8979-776e39fd5211"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span></p>", "ID": "37db19a3-a5a8-4a67-a90f-0dfb1a3a8cff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8a3de75-a79d-43b2-bf18-dbc023ac31a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2193</span>", "ID": "8c81dbaf-e986-4b62-bf16-fdd09792cb96", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2193", "ParentId": "37db19a3-a5a8-4a67-a90f-0dfb1a3a8cff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span></p>", "ID": "ae5be425-366a-4d61-85a0-557d4c43d244", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8a3de75-a79d-43b2-bf18-dbc023ac31a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.83 (0.65, 1.1)</span>", "ID": "400ae63a-0353-439d-a2ce-046b05704ea3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.83 (0.65, 1.1)", "ParentId": "ae5be425-366a-4d61-85a0-557d4c43d244"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean\nratio (90%\u00a0CI) of co\u2011administered drug pharmacokinetics of study\nmedicinal products alone or in combination.\u00a0 No effect\u00a0=\u00a01.00.</span></p>", "ID": "1b93b0fc-1465-43f8-96ea-b222d9faff19", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean\nratio (90%\u00a0CI) of co\u2011administered drug pharmacokinetics of study\nmedicinal products alone or in combination.\u00a0 No effect\u00a0=\u00a01.00.</span>", "ID": "dc53d8de-ba23-4183-a412-85e08c1c4401", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 Mean ratio (90%\u00a0CI) of co\u2011administered drug pharmacokinetics of study medicinal products alone or in combination.\u00a0 No effect\u00a0=\u00a01.00.", "ParentId": "1b93b0fc-1465-43f8-96ea-b222d9faff19"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 All\ninteraction studies conducted in healthy volunteers.</span></p>", "ID": "805398bc-f9ae-4833-b5ec-481727b146ff", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 All\ninteraction studies conducted in healthy volunteers.</span>", "ID": "8d359328-fc4c-4302-ba77-29a684a414e5", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 All interaction studies conducted in healthy volunteers.", "ParentId": "805398bc-f9ae-4833-b5ec-481727b146ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Administered\nas Epclusa.</span></p>", "ID": "6939bcce-adda-4a9a-bee0-68453a4be046", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Administered\nas Epclusa.</span>", "ID": "6f01f655-bd40-4948-8734-49e1eda6041f", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "c\u00a0\u00a0\u00a0\u00a0 Administered as Epclusa.", "ParentId": "6939bcce-adda-4a9a-bee0-68453a4be046"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Lack\nof pharmacokinetics interaction bounds 70\u2011143%.</span></p>", "ID": "44648e28-fe03-4df6-98ed-5ebf2e283a71", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Lack\nof pharmacokinetics interaction bounds 70\u2011143%.</span>", "ID": "cf952c88-65e2-493b-89d9-0c3938601af2", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "d\u00a0\u00a0\u00a0 Lack of pharmacokinetics interaction bounds 70\u2011143%.", "ParentId": "44648e28-fe03-4df6-98ed-5ebf2e283a71"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">e\u00a0\u00a0\u00a0\u00a0 These\nare medicinal products within class where similar interactions could be\npredicted.</span></p>", "ID": "cbfdcc1b-d1cc-415f-bfc1-622fe14771e0", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">e\u00a0\u00a0\u00a0\u00a0 These\nare medicinal products within class where similar interactions could be\npredicted.</span>", "ID": "241b54a5-eb86-4ffd-bf53-2c5f56fcce79", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "e\u00a0\u00a0\u00a0\u00a0 These are medicinal products within class where similar interactions could be predicted.", "ParentId": "cbfdcc1b-d1cc-415f-bfc1-622fe14771e0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">f\u00a0\u00a0\u00a0\u00a0 Bioequivalence/Equivalence\nboundary 80\u2011125%.</span></p>", "ID": "8109de9b-2ca6-464f-947d-04ad7d9133ee", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">f\u00a0\u00a0\u00a0\u00a0 Bioequivalence/Equivalence\nboundary 80\u2011125%.</span>", "ID": "7e4927d4-4d23-4995-a304-4065e117ef70", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "f\u00a0\u00a0\u00a0\u00a0 Bioequivalence/Equivalence boundary 80\u2011125%.", "ParentId": "8109de9b-2ca6-464f-947d-04ad7d9133ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">g\u00a0\u00a0\u00a0 Lack of\npharmacokinetics interaction bounds 50\u2011200%.</span></p>", "ID": "005fc61a-0df8-4a97-919a-5081bce9f2c9", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">g\u00a0\u00a0\u00a0 Lack of\npharmacokinetics interaction bounds 50\u2011200%.</span>", "ID": "e3eeebe0-dde5-49d7-87e0-2ab048f7b69d", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "g\u00a0\u00a0\u00a0 Lack of pharmacokinetics interaction bounds 50\u2011200%.", "ParentId": "005fc61a-0df8-4a97-919a-5081bce9f2c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "457404d0-a783-4239-85a8-aab748190a26", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "787024b1-98cb-43ff-b80c-3e3118c58b75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "457404d0-a783-4239-85a8-aab748190a26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>", "ID": "06745a7f-22a6-494a-bc46-a6820f8d9a9d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "d44a95a0-71dd-4606-9ec4-b911d8cf9ded", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06745a7f-22a6-494a-bc46-a6820f8d9a9d"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "0e569fca-64cb-4f47-95da-b7949f0de6cf", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d44a95a0-71dd-4606-9ec4-b911d8cf9ded"}, {"Element": "<b><span lang=\"EN-GB\">Fertility, p</span></b>", "ID": "c2f0fee3-8263-4b04-9a46-da8811b9f9b3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06745a7f-22a6-494a-bc46-a6820f8d9a9d"}, {"Element": "<span lang=\"EN-GB\">Fertility, p</span>", "ID": "12fbe6e9-467f-4ebe-83fb-03ee83b42263", "Styles": "None", "Classes": "None", "Text": "Fertility, p", "ParentId": "c2f0fee3-8263-4b04-9a46-da8811b9f9b3"}, {"Element": "<b><span lang=\"EN-GB\">regnancy and lactation</span></b>", "ID": "cdf2dddf-e904-4e1f-b98d-f06109a88ce9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06745a7f-22a6-494a-bc46-a6820f8d9a9d"}, {"Element": "<span lang=\"EN-GB\">regnancy and lactation</span>", "ID": "bd9aa46b-72a6-45c0-b8b5-8f75a98a81b6", "Styles": "None", "Classes": "None", "Text": "regnancy and lactation", "ParentId": "cdf2dddf-e904-4e1f-b98d-f06109a88ce9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "81502e6c-d452-44a2-ae84-4bb00aecfe9d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3e46ba43-1e9e-4c65-92de-c8522f9dc25f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "81502e6c-d452-44a2-ae84-4bb00aecfe9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>", "ID": "6344fc9e-1c68-40b3-9b1f-cfdd2d996e64", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Pregnancy</span></u>", "ID": "34068e4f-562d-4419-a3a1-436f41986fcf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6344fc9e-1c68-40b3-9b1f-cfdd2d996e64"}, {"Element": "<span lang=\"EN-GB\">Pregnancy</span>", "ID": "3b1610f2-336c-4443-9467-e54611e6f4b9", "Styles": "None", "Classes": "None", "Text": "Pregnancy", "ParentId": "34068e4f-562d-4419-a3a1-436f41986fcf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no or\nlimited amount of data (less than 300\u00a0pregnancy outcomes) from the use of\nsofosbuvir, velpatasvir or Epclusa in pregnant women.</span></p>", "ID": "63f54255-e13f-43c2-beaf-3c8a1678cae3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">There are no or\nlimited amount of data (less than 300\u00a0pregnancy outcomes) from the use of\nsofosbuvir, velpatasvir or Epclusa in pregnant women.</span>", "ID": "6424a410-3155-45ae-9429-f94db35c7c55", "Styles": "None", "Classes": "None", "Text": "There are no or limited amount of data (less than 300\u00a0pregnancy outcomes) from the use of sofosbuvir, velpatasvir or Epclusa in pregnant women.", "ParentId": "63f54255-e13f-43c2-beaf-3c8a1678cae3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b8fc7321-0a6b-4e7b-9846-3e57642b16ee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2da221d-d38e-4c8f-8a1c-f915a86a175e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8fc7321-0a6b-4e7b-9846-3e57642b16ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Sofosbuvir</span></u></p>", "ID": "37708e70-a28e-4e62-a477-cdee2f5aad87", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Sofosbuvir</span></u>", "ID": "1745442c-64ec-4f3f-ac76-6f33b2623257", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37708e70-a28e-4e62-a477-cdee2f5aad87"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir</span>", "ID": "b51adeef-5f25-412f-b24b-6ebb62ce3b8a", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "1745442c-64ec-4f3f-ac76-6f33b2623257"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies\ndo not indicate direct or indirect harmful effects with respect to reproductive\ntoxicity (see section\u00a05.3).</span></p>", "ID": "08d3378d-fb8e-4d8c-898d-feb1989146b9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Animal studies\ndo not indicate direct or indirect harmful effects with respect to reproductive\ntoxicity (see section\u00a05.3).</span>", "ID": "86d7827d-69a3-4eaa-88b8-cca95bc4cab4", "Styles": "None", "Classes": "None", "Text": "Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section\u00a05.3).", "ParentId": "08d3378d-fb8e-4d8c-898d-feb1989146b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7aa307ec-5f22-4051-a9ce-883379e08193", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4472aaf1-0706-45d7-95d0-5c7f9b01a503", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7aa307ec-5f22-4051-a9ce-883379e08193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It has not been\npossible to fully estimate exposure margins achieved for sofosbuvir in the rat\nrelative to the exposure in humans at the recommended clinical dose (see\nsection\u00a05.3).</span></p>", "ID": "855e7b22-62d1-4bb7-a819-f5d933e8eed9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">It has not been\npossible to fully estimate exposure margins achieved for sofosbuvir in the rat\nrelative to the exposure in humans at the recommended clinical dose (see\nsection\u00a05.3).</span>", "ID": "074a7415-1b5d-4102-a9c4-695384b2e1a7", "Styles": "None", "Classes": "None", "Text": "It has not been possible to fully estimate exposure margins achieved for sofosbuvir in the rat relative to the exposure in humans at the recommended clinical dose (see section\u00a05.3).", "ParentId": "855e7b22-62d1-4bb7-a819-f5d933e8eed9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "934e4392-0392-4410-ae58-22b9c10bdab7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb9ff513-e995-4d94-8ef3-c8f8253b077f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "934e4392-0392-4410-ae58-22b9c10bdab7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Velpatasvir</span></u></p>", "ID": "dc5224cf-e260-430d-b924-ce87306d89e8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Velpatasvir</span></u>", "ID": "91ab180a-bfdc-4973-bfac-0193f5b6f465", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc5224cf-e260-430d-b924-ce87306d89e8"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir</span>", "ID": "f0223e40-3a64-46b0-86e0-cfc6ff5ec20a", "Styles": "None", "Classes": "None", "Text": "Velpatasvir", "ParentId": "91ab180a-bfdc-4973-bfac-0193f5b6f465"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies have\nshown a possible link to reproductive toxicity (see section\u00a05.3).</span></p>", "ID": "cd6845af-ed05-439a-b53f-1dd936b61924", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Animal studies have\nshown a possible link to reproductive toxicity (see section\u00a05.3).</span>", "ID": "5ed8653c-b7d4-4019-9c21-43b2c1b85491", "Styles": "None", "Classes": "None", "Text": "Animal studies have shown a possible link to reproductive toxicity (see section\u00a05.3).", "ParentId": "cd6845af-ed05-439a-b53f-1dd936b61924"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7dac203d-5af1-46c7-9a7f-79e0abded66b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80aa7666-8165-46f4-8dd2-93cc0e63a464", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7dac203d-5af1-46c7-9a7f-79e0abded66b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As a precautionary measure, Epclusa use is not recommended during\npregnancy.</span></p>", "ID": "39dab5e7-2f2e-41ef-bec9-b76e278de519", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">As a precautionary measure, Epclusa use is not recommended during\npregnancy.</span>", "ID": "de8eb1a1-05ab-4e1d-9013-2d744776d8f5", "Styles": "None", "Classes": "None", "Text": "As a precautionary measure, Epclusa use is not recommended during pregnancy.", "ParentId": "39dab5e7-2f2e-41ef-bec9-b76e278de519"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "93822584-d3cf-44bd-9d83-d87251c2d317", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca3073bc-0c75-4508-9bcf-cc077e5794f4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "93822584-d3cf-44bd-9d83-d87251c2d317"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>", "ID": "4600d16c-be9b-4a75-9152-8d9d492042c6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Breast\u2011feeding</span></u>", "ID": "058e60fe-ec18-4e5c-9bb6-ea6684648677", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4600d16c-be9b-4a75-9152-8d9d492042c6"}, {"Element": "<span lang=\"EN-GB\">Breast\u2011feeding</span>", "ID": "af313cc5-3dcf-4051-b674-2ab5f3c5d156", "Styles": "None", "Classes": "None", "Text": "Breast\u2011feeding", "ParentId": "058e60fe-ec18-4e5c-9bb6-ea6684648677"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether sofosbuvir, metabolites of sofosbuvir or velpatasvir are excreted in\nhuman milk.</span></p>", "ID": "777679cd-b417-48d6-8fd2-09395211acff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">It is unknown\nwhether sofosbuvir, metabolites of sofosbuvir or velpatasvir are excreted in\nhuman milk.</span>", "ID": "7a0a92dc-efe5-40da-a5a4-b651d25006ff", "Styles": "None", "Classes": "None", "Text": "It is unknown whether sofosbuvir, metabolites of sofosbuvir or velpatasvir are excreted in human milk.", "ParentId": "777679cd-b417-48d6-8fd2-09395211acff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1f144108-63fb-4319-993a-0062398953f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a95f9f19-b96f-44e5-b13f-90883fe81576", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1f144108-63fb-4319-993a-0062398953f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Available\npharmacokinetic data in animals have shown excretion of velpatasvir and\nmetabolites of sofosbuvir in milk.</span></p>", "ID": "ff2e406a-98f5-468d-bcfd-dfb4452e61ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Available\npharmacokinetic data in animals have shown excretion of velpatasvir and\nmetabolites of sofosbuvir in milk.</span>", "ID": "f5ec0431-063d-4836-bf08-4062f389e799", "Styles": "None", "Classes": "None", "Text": "Available pharmacokinetic data in animals have shown excretion of velpatasvir and metabolites of sofosbuvir in milk.", "ParentId": "ff2e406a-98f5-468d-bcfd-dfb4452e61ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "bae0f7b9-e9e0-49f2-bf03-ad9114df8d7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "1930a055-8bef-4cb4-beea-7ef4798c1921", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "bae0f7b9-e9e0-49f2-bf03-ad9114df8d7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">A risk to the newborns/infants cannot\nbe excluded.\u00a0 Therefore, </span><span lang=\"EN-GB\">Epclusa<span style=\"layout-grid-mode:line\"> should not be used during breast\u2011feeding.</span></span></p>", "ID": "7517ff31-2d62-475a-a69c-843cec27cc6a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">A risk to the newborns/infants cannot\nbe excluded.\u00a0 Therefore, </span>", "ID": "6e68cc74-fb1e-4021-815f-d820ab75ea7a", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "A risk to the newborns/infants cannot be excluded.\u00a0 Therefore, ", "ParentId": "7517ff31-2d62-475a-a69c-843cec27cc6a"}, {"Element": "<span lang=\"EN-GB\">Epclusa<span style=\"layout-grid-mode:line\"> should not be used during breast\u2011feeding.</span></span>", "ID": "6263ee80-b319-4990-909e-8822c8f0197f", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "7517ff31-2d62-475a-a69c-843cec27cc6a"}, {"Element": "<span style=\"layout-grid-mode:line\"> should not be used during breast\u2011feeding.</span>", "ID": "bd759a24-bba8-4708-af36-409ec1518b1f", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " should not be used during breast\u2011feeding.", "ParentId": "6263ee80-b319-4990-909e-8822c8f0197f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "cec8d798-baa8-4cc2-939c-12790da7d50a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "bccb9156-985a-45ed-9f06-10c10e481364", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "cec8d798-baa8-4cc2-939c-12790da7d50a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>", "ID": "56a5c4c6-ab34-4b35-b7c5-7dd22bd1ef00", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Fertility</span></u>", "ID": "e8706c31-f0eb-4692-b505-1a850d6620a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56a5c4c6-ab34-4b35-b7c5-7dd22bd1ef00"}, {"Element": "<span lang=\"EN-GB\">Fertility</span>", "ID": "fd7d3bbe-7c42-4c83-83f8-4793ac850cc5", "Styles": "None", "Classes": "None", "Text": "Fertility", "ParentId": "e8706c31-f0eb-4692-b505-1a850d6620a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No human data on\nthe effect of Epclusa on fertility are available.\u00a0 Animal studies do not\nindicate harmful effects of sofosbuvir or velpatasvir on fertility.</span></p>", "ID": "75e2af5c-9a8e-43a7-b943-74138225f5f0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No human data on\nthe effect of Epclusa on fertility are available.\u00a0 Animal studies do not\nindicate harmful effects of sofosbuvir or velpatasvir on fertility.</span>", "ID": "c07b4c9b-db3b-45f2-a5c9-d1365f501ce2", "Styles": "None", "Classes": "None", "Text": "No human data on the effect of Epclusa on fertility are available.\u00a0 Animal studies do not indicate harmful effects of sofosbuvir or velpatasvir on fertility.", "ParentId": "75e2af5c-9a8e-43a7-b943-74138225f5f0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e475fd3f-83fb-4d90-90d6-03d4dcef85dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88b3a2f3-a537-4c78-9e5f-737fe8767e73", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e475fd3f-83fb-4d90-90d6-03d4dcef85dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If ribavirin is\nco\u2011administered with </span><span lang=\"EN-GB\">Epclusa, refer to the\nSummary of Product Characterisitics for ribavirin for detailed recommendations\nregarding pregnancy, contraception, and breast\u2011feeding.</span></p>", "ID": "0074eb61-3273-4f4f-a24e-3ea06e2d340c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If ribavirin is\nco\u2011administered with </span>", "ID": "a2adaf61-3252-4ee3-ba4a-4d508840d272", "Styles": "None", "Classes": "None", "Text": "If ribavirin is co\u2011administered with ", "ParentId": "0074eb61-3273-4f4f-a24e-3ea06e2d340c"}, {"Element": "<span lang=\"EN-GB\">Epclusa, refer to the\nSummary of Product Characterisitics for ribavirin for detailed recommendations\nregarding pregnancy, contraception, and breast\u2011feeding.</span>", "ID": "ff2e79c5-c188-44c7-8550-083302560b47", "Styles": "None", "Classes": "None", "Text": "Epclusa, refer to the Summary of Product Characterisitics for ribavirin for detailed recommendations regarding pregnancy, contraception, and breast\u2011feeding.", "ParentId": "0074eb61-3273-4f4f-a24e-3ea06e2d340c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d9364b5-13c0-47ff-be88-d33302847975", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "08e480a6-5325-47ad-a37a-fbc5d5606de3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d9364b5-13c0-47ff-be88-d33302847975"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects\non ability to drive and use machines</span></b></p>", "ID": "bd7f644b-7e22-471c-92c0-ff9072cbd8d2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects\non ability to drive and use machines</span></b>", "ID": "69904555-04fd-4c13-8f97-95c1a6e22253", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd7f644b-7e22-471c-92c0-ff9072cbd8d2"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects\non ability to drive and use machines</span>", "ID": "b93835a2-cc9b-4cf7-91e6-62286e3e1afa", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "69904555-04fd-4c13-8f97-95c1a6e22253"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b2225f8-0319-44d2-ba12-78ce5855de82", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b1ed6c6-ddbd-46b2-bd49-0b5a9a04304f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b2225f8-0319-44d2-ba12-78ce5855de82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa has no\nor negligible influence on the ability to drive and use machines.</span></p>", "ID": "7dd6b822-2172-4052-b67e-0984d2e18388", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa has no\nor negligible influence on the ability to drive and use machines.</span>", "ID": "5b78a317-d688-4540-b366-bc855ca849ad", "Styles": "None", "Classes": "None", "Text": "Epclusa has no or negligible influence on the ability to drive and use machines.", "ParentId": "7dd6b822-2172-4052-b67e-0984d2e18388"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3d8a5679-93ec-4da2-abd4-c546a9daaa2a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ebc8ac1b-544f-43d6-8af5-6ef5ab1e257a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3d8a5679-93ec-4da2-abd4-c546a9daaa2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable\neffects</span></b></p>", "ID": "7454a9f7-5a5c-44ae-9485-d5d7adaff468", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable\neffects</span></b>", "ID": "72c667bf-4892-4923-8c82-c35f92175837", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7454a9f7-5a5c-44ae-9485-d5d7adaff468"}, {"Element": "<span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable\neffects</span>", "ID": "f551ac7d-0e8a-4bc8-9cb5-e9f29c4b6e65", "Styles": "None", "Classes": "None", "Text": "4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects", "ParentId": "72c667bf-4892-4923-8c82-c35f92175837"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b963f545-e587-49b5-ba1f-9b3e881397b6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d92d7fdc-1454-464d-b4a9-338cccb4268d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b963f545-e587-49b5-ba1f-9b3e881397b6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Summary of the safety\nprofile</span></u></p>", "ID": "294e460a-a103-4085-bc08-11fa4cec23e8", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Summary of the safety\nprofile</span></u>", "ID": "eaa2c6cf-85f8-4228-a81e-6af5538354ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "294e460a-a103-4085-bc08-11fa4cec23e8"}, {"Element": "<span lang=\"EN-GB\">Summary of the safety\nprofile</span>", "ID": "a3fd79c9-6ae5-42bd-9566-a595446daeb4", "Styles": "None", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "eaa2c6cf-85f8-4228-a81e-6af5538354ac"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nsafety assessment of </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> was based on pooled Phase\u00a03 clinical study data from patients\nwith genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection (with or without compensated\ncirrhosis) including 1,035 patients who received Epclusa for 12\u00a0weeks.</span></p>", "ID": "12c774ed-a16b-441d-9536-fa3c0472e06d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nsafety assessment of </span>", "ID": "b1c23a67-f4f3-4c59-85e8-7c725cb8590b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "The safety assessment of ", "ParentId": "12c774ed-a16b-441d-9536-fa3c0472e06d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa</span>", "ID": "6f03b867-ceb0-466f-a203-047b0064c16a", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": "Epclusa", "ParentId": "12c774ed-a16b-441d-9536-fa3c0472e06d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> was based on pooled Phase\u00a03 clinical study data from patients\nwith genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection (with or without compensated\ncirrhosis) including 1,035 patients who received Epclusa for 12\u00a0weeks.</span>", "ID": "e283d738-6c9f-403a-86da-fa7ce4134a99", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": " was based on pooled Phase\u00a03 clinical study data from patients with genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection (with or without compensated cirrhosis) including 1,035 patients who received Epclusa for 12\u00a0weeks.", "ParentId": "12c774ed-a16b-441d-9536-fa3c0472e06d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "3356fb29-fb29-4da2-a2af-60a6d6ab83d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "0b2aacf9-0b76-46ee-99d5-b8dba18a6aab", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "3356fb29-fb29-4da2-a2af-60a6d6ab83d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The proportion of </span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who permanently discontinued treatment due to\nadverse events was 0.2% and the proportion of patients who experienced any\nsevere adverse events was 3.2% for </span>patients<span style=\"layout-grid-mode:\nline\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> for\n12\u00a0weeks. \u00a0In clinical studies, headache, fatigue and nausea were the\nmost common (incidence \u2265\u00a010%) treatment emergent adverse events\nreported in </span>patients<span style=\"layout-grid-mode:line\"> treated with\n12\u00a0weeks of </span>Epclusa<span style=\"layout-grid-mode:line\">.\u00a0\nThese and other adverse events were reported at a similar frequency in placebo\ntreated patients compared with Epclusa treated patients.</span></span></p>", "ID": "5ae40893-67f4-4a20-905b-b084ca6c6941", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The proportion of </span>", "ID": "ca556a34-8a15-4d56-b822-33142323c8e4", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "The proportion of ", "ParentId": "5ae40893-67f4-4a20-905b-b084ca6c6941"}, {"Element": "<span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who permanently discontinued treatment due to\nadverse events was 0.2% and the proportion of patients who experienced any\nsevere adverse events was 3.2% for </span>patients<span style=\"layout-grid-mode:\nline\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> for\n12\u00a0weeks. \u00a0In clinical studies, headache, fatigue and nausea were the\nmost common (incidence \u2265\u00a010%) treatment emergent adverse events\nreported in </span>patients<span style=\"layout-grid-mode:line\"> treated with\n12\u00a0weeks of </span>Epclusa<span style=\"layout-grid-mode:line\">.\u00a0\nThese and other adverse events were reported at a similar frequency in placebo\ntreated patients compared with Epclusa treated patients.</span></span>", "ID": "82851b2e-a92a-4cd2-81da-de9089c0401b", "Styles": "None", "Classes": "None", "Text": "patientspatientsEpclusapatientsEpclusa", "ParentId": "5ae40893-67f4-4a20-905b-b084ca6c6941"}, {"Element": "<span style=\"layout-grid-mode:line\"> who permanently discontinued treatment due to\nadverse events was 0.2% and the proportion of patients who experienced any\nsevere adverse events was 3.2% for </span>", "ID": "081999ff-36b1-4a2a-818a-8d7e723bc8ea", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " who permanently discontinued treatment due to adverse events was 0.2% and the proportion of patients who experienced any severe adverse events was 3.2% for ", "ParentId": "82851b2e-a92a-4cd2-81da-de9089c0401b"}, {"Element": "<span style=\"layout-grid-mode:\nline\"> receiving </span>", "ID": "0b669ad0-0898-4ac0-902b-fc4b72a3a74a", "Styles": "layout-grid-mode:\nline", "Classes": "None", "Text": " receiving ", "ParentId": "82851b2e-a92a-4cd2-81da-de9089c0401b"}, {"Element": "<span style=\"layout-grid-mode:line\"> for\n12\u00a0weeks. \u00a0In clinical studies, headache, fatigue and nausea were the\nmost common (incidence \u2265\u00a010%) treatment emergent adverse events\nreported in </span>", "ID": "e3ea6235-048e-4e7f-ad93-b4ece0754a0b", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " for 12\u00a0weeks. \u00a0In clinical studies, headache, fatigue and nausea were the most common (incidence \u2265\u00a010%) treatment emergent adverse events reported in ", "ParentId": "82851b2e-a92a-4cd2-81da-de9089c0401b"}, {"Element": "<span style=\"layout-grid-mode:line\"> treated with\n12\u00a0weeks of </span>", "ID": "8890eaae-d529-4460-ae76-09f9a7e65ff9", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " treated with 12\u00a0weeks of ", "ParentId": "82851b2e-a92a-4cd2-81da-de9089c0401b"}, {"Element": "<span style=\"layout-grid-mode:line\">.\u00a0\nThese and other adverse events were reported at a similar frequency in placebo\ntreated patients compared with Epclusa treated patients.</span>", "ID": "7bfc2479-78db-4c7d-a0b7-1d0b382f604d", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": ".\u00a0 These and other adverse events were reported at a similar frequency in placebo treated patients compared with Epclusa treated patients.", "ParentId": "82851b2e-a92a-4cd2-81da-de9089c0401b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "372a6a67-3ff9-4a1a-8289-8033dea8bd1c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "aff8a350-48c2-4172-9de5-32ebcc5e38bb", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "372a6a67-3ff9-4a1a-8289-8033dea8bd1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Patients<span style=\"layout-grid-mode:line\"> with decompensated cirrhosis</span></span></u></p>", "ID": "c1a03e86-0ca4-4da8-949b-d59c5115a045", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Patients<span style=\"layout-grid-mode:line\"> with decompensated cirrhosis</span></span></u>", "ID": "c4f450c1-8e3f-4e9b-a67f-04ae685319a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c1a03e86-0ca4-4da8-949b-d59c5115a045"}, {"Element": "<span lang=\"EN-GB\">Patients<span style=\"layout-grid-mode:line\"> with decompensated cirrhosis</span></span>", "ID": "f04d5fdb-1c68-45fc-8c41-ea2abf2301e9", "Styles": "None", "Classes": "None", "Text": "Patients", "ParentId": "c4f450c1-8e3f-4e9b-a67f-04ae685319a0"}, {"Element": "<span style=\"layout-grid-mode:line\"> with decompensated cirrhosis</span>", "ID": "0c763629-9038-4463-af9c-dc77c924194f", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " with decompensated cirrhosis", "ParentId": "f04d5fdb-1c68-45fc-8c41-ea2abf2301e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The safety profile of Epclusa has been evaluated\nin one open\u2011label study in which </span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> with CPT Class\u00a0B cirrhosis received </span>Epclusa<span style=\"layout-grid-mode:line\"> for 12\u00a0weeks (n\u00a0=\u00a090), </span>Epclusa\n<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks (n\u00a0=\u00a087)\nor </span>Epclusa<span style=\"layout-grid-mode:line\"> for 24\u00a0weeks (n\u00a0=\u00a090).\n\u00a0The adverse events observed were consistent with expected clinical\nsequelae of decompensated liver disease, or the known toxicity profile of\nribavirin for </span>patients<span style=\"layout-grid-mode:line\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> in combination with ribavirin.</span></span></p>", "ID": "4ecd4795-cb7d-4d41-90f8-10df278afe5f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">The safety profile of Epclusa has been evaluated\nin one open\u2011label study in which </span>", "ID": "43997288-918d-48d5-889e-89f23b7eac60", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "The safety profile of Epclusa has been evaluated in one open\u2011label study in which ", "ParentId": "4ecd4795-cb7d-4d41-90f8-10df278afe5f"}, {"Element": "<span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> with CPT Class\u00a0B cirrhosis received </span>Epclusa<span style=\"layout-grid-mode:line\"> for 12\u00a0weeks (n\u00a0=\u00a090), </span>Epclusa\n<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks (n\u00a0=\u00a087)\nor </span>Epclusa<span style=\"layout-grid-mode:line\"> for 24\u00a0weeks (n\u00a0=\u00a090).\n\u00a0The adverse events observed were consistent with expected clinical\nsequelae of decompensated liver disease, or the known toxicity profile of\nribavirin for </span>patients<span style=\"layout-grid-mode:line\"> receiving </span>Epclusa<span style=\"layout-grid-mode:line\"> in combination with ribavirin.</span></span>", "ID": "1e883808-c35c-477a-b565-8b31e25e0c68", "Styles": "None", "Classes": "None", "Text": "patientsEpclusaEpclusa EpclusapatientsEpclusa", "ParentId": "4ecd4795-cb7d-4d41-90f8-10df278afe5f"}, {"Element": "<span style=\"layout-grid-mode:line\"> with CPT Class\u00a0B cirrhosis received </span>", "ID": "45f1ebea-c185-4004-8191-6e8a265d2c5d", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " with CPT Class\u00a0B cirrhosis received ", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<span style=\"layout-grid-mode:line\"> for 12\u00a0weeks (n\u00a0=\u00a090), </span>", "ID": "fb6cfbfb-126f-46cb-bb9f-aad33be65d6b", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " for 12\u00a0weeks (n\u00a0=\u00a090), ", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks (n\u00a0=\u00a087)\nor </span>", "ID": "1d5b6ca8-e209-40e6-8e7e-83474db6f9d2", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "+ RBV for 12\u00a0weeks (n\u00a0=\u00a087) or ", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<span style=\"layout-grid-mode:line\"> for 24\u00a0weeks (n\u00a0=\u00a090).\n\u00a0The adverse events observed were consistent with expected clinical\nsequelae of decompensated liver disease, or the known toxicity profile of\nribavirin for </span>", "ID": "b7b001a5-eb33-48ab-9bca-e1b0da8258f5", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " for 24\u00a0weeks (n\u00a0=\u00a090). \u00a0The adverse events observed were consistent with expected clinical sequelae of decompensated liver disease, or the known toxicity profile of ribavirin for ", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<span style=\"layout-grid-mode:line\"> receiving </span>", "ID": "3cc9fd89-1c22-4e69-baa3-e1ce21b40a6c", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " receiving ", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<span style=\"layout-grid-mode:line\"> in combination with ribavirin.</span>", "ID": "2e5fd056-f901-4472-a03c-99b2446eb62f", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " in combination with ribavirin.", "ParentId": "1e883808-c35c-477a-b565-8b31e25e0c68"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "c8cbb536-9244-4c9f-87e2-caea979fa8c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "0fe99685-afaa-4d15-9a3d-63683e25c7be", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "c8cbb536-9244-4c9f-87e2-caea979fa8c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">Among the 87\u00a0</span><span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who were treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks, decreases in haemoglobin\nto less than 10\u00a0g/dL and 8.5\u00a0g/dL during treatment were experienced\nby 23% and 7%\u00a0</span>patients, respectively.<span style=\"layout-grid-mode:\nline\">\u00a0 Ribavirin was discontinued in 15% of </span>patients<span style=\"layout-grid-mode:line\"> treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks due to adverse events.</span></span></p>", "ID": "fc4acc7f-68c7-4cf4-b6d7-039c81a0dbb1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">Among the 87\u00a0</span>", "ID": "32b26e10-1b7a-4643-b2cf-f46ddc565a86", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "Among the 87\u00a0", "ParentId": "fc4acc7f-68c7-4cf4-b6d7-039c81a0dbb1"}, {"Element": "<span lang=\"EN-GB\">patients<span style=\"layout-grid-mode:line\"> who were treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks, decreases in haemoglobin\nto less than 10\u00a0g/dL and 8.5\u00a0g/dL during treatment were experienced\nby 23% and 7%\u00a0</span>patients, respectively.<span style=\"layout-grid-mode:\nline\">\u00a0 Ribavirin was discontinued in 15% of </span>patients<span style=\"layout-grid-mode:line\"> treated with </span>Epclusa <span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks due to adverse events.</span></span>", "ID": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab", "Styles": "None", "Classes": "None", "Text": "patientsEpclusa patients, respectively.patientsEpclusa ", "ParentId": "fc4acc7f-68c7-4cf4-b6d7-039c81a0dbb1"}, {"Element": "<span style=\"layout-grid-mode:line\"> who were treated with </span>", "ID": "f310291e-4bb8-4bc9-9f5a-c0fbe74ed90e", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " who were treated with ", "ParentId": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab"}, {"Element": "<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks, decreases in haemoglobin\nto less than 10\u00a0g/dL and 8.5\u00a0g/dL during treatment were experienced\nby 23% and 7%\u00a0</span>", "ID": "6e0c6fe4-14cc-4c24-9cae-2b527aa7f7c0", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "+ RBV for 12\u00a0weeks, decreases in haemoglobin to less than 10\u00a0g/dL and 8.5\u00a0g/dL during treatment were experienced by 23% and 7%\u00a0", "ParentId": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab"}, {"Element": "<span style=\"layout-grid-mode:\nline\">\u00a0 Ribavirin was discontinued in 15% of </span>", "ID": "55fb04e0-0384-4747-9507-2d8d7b4ae692", "Styles": "layout-grid-mode:\nline", "Classes": "None", "Text": "\u00a0 Ribavirin was discontinued in 15% of ", "ParentId": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab"}, {"Element": "<span style=\"layout-grid-mode:line\"> treated with </span>", "ID": "11a7d46d-296f-4d95-bee7-7c933076904b", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": " treated with ", "ParentId": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab"}, {"Element": "<span style=\"layout-grid-mode:line\">+ RBV for 12\u00a0weeks due to adverse events.</span>", "ID": "ee2237cb-4a1c-4f07-8904-09fe09fb9522", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "+ RBV for 12\u00a0weeks due to adverse events.", "ParentId": "92546a95-4fb2-4f1e-aedd-d4ca4bdcc3ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span></p>", "ID": "df5dd69a-54b9-4bf2-83fd-bb44b8a0ba21", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"layout-grid-mode:line\">\u00a0</span>", "ID": "7002888f-ae89-4514-83e1-2f2d76fe6c06", "Styles": "layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "df5dd69a-54b9-4bf2-83fd-bb44b8a0ba21"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>", "ID": "0b6fe9d1-2162-46a6-a4d6-450328e439be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u>", "ID": "05138922-cef9-4def-9a64-6ad96a6cb0ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b6fe9d1-2162-46a6-a4d6-450328e439be"}, {"Element": "<span lang=\"EN-GB\">Description of selected adverse reactions</span>", "ID": "11ac0e54-7b16-43de-abfd-b3db73ebeba6", "Styles": "None", "Classes": "None", "Text": "Description of selected adverse reactions", "ParentId": "05138922-cef9-4def-9a64-6ad96a6cb0ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Cardiac arrhythmias</span></i></p>", "ID": "1c6976db-f7cf-487f-b28a-82a33625ae29", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Cardiac arrhythmias</span></i>", "ID": "336ca5f1-d2f4-48b1-a294-534be1a47241", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c6976db-f7cf-487f-b28a-82a33625ae29"}, {"Element": "<span lang=\"EN-GB\">Cardiac arrhythmias</span>", "ID": "e9c53ce9-e0ea-44fe-9f8e-697ac80158ee", "Styles": "None", "Classes": "None", "Text": "Cardiac arrhythmias", "ParentId": "336ca5f1-d2f4-48b1-a294-534be1a47241"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone and/or other medicinal\nproducts that lower heart rate (see sections\u00a04.4 and\u00a04.5).</span></p>", "ID": "921de1df-937b-4073-a931-68052b2a60f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Cases of severe\nbradycardia and heart block have been observed when sofosbuvir-containing\nregimens are used in combination with amiodarone and/or other medicinal\nproducts that lower heart rate (see sections\u00a04.4 and\u00a04.5).</span>", "ID": "2517ce06-d7ab-4c87-b0b2-f696b3f08d37", "Styles": "None", "Classes": "None", "Text": "Cases of severe bradycardia and heart block have been observed when sofosbuvir-containing regimens are used in combination with amiodarone and/or other medicinal products that lower heart rate (see sections\u00a04.4 and\u00a04.5).", "ParentId": "921de1df-937b-4073-a931-68052b2a60f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5dfe43d6-3fe2-4eab-a95e-aae5c57fbf3e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1bf25476-6880-4ee3-bc9e-5f96c2e78969", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5dfe43d6-3fe2-4eab-a95e-aae5c57fbf3e"}, {"Element": "<p class=\"MsoNormal\"><i><span lang=\"EN-GB\">Skin disorders</span></i></p>", "ID": "337aca3e-bcd6-41e7-8786-c686d960d82b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Skin disorders</span></i>", "ID": "4c1866d0-aecb-4936-ba7b-7b28fb928459", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "337aca3e-bcd6-41e7-8786-c686d960d82b"}, {"Element": "<span lang=\"EN-GB\">Skin disorders</span>", "ID": "0beb16e1-b338-4eeb-9de0-060a4c9492bd", "Styles": "None", "Classes": "None", "Text": "Skin disorders", "ParentId": "4c1866d0-aecb-4936-ba7b-7b28fb928459"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">Frequency Not known: Stevens-Johnson\nsyndrome</span></p>", "ID": "03b73559-db00-4185-b467-104d653e4087", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Frequency Not known: Stevens-Johnson\nsyndrome</span>", "ID": "35dabf8d-4fd2-4dd4-9dba-a783ae4cfa11", "Styles": "None", "Classes": "None", "Text": "Frequency Not known: Stevens-Johnson syndrome", "ParentId": "03b73559-db00-4185-b467-104d653e4087"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9545605e-c394-4c84-ae32-762ebd68eb00", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb780337-c8b4-4041-bfd2-f6d3530a8e44", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9545605e-c394-4c84-ae32-762ebd68eb00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>", "ID": "865a061f-35c0-496a-b27c-a14da1e47ba6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u>", "ID": "e9ac595c-56b8-4950-9746-fe085fc7e9b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "865a061f-35c0-496a-b27c-a14da1e47ba6"}, {"Element": "<span lang=\"EN-GB\">Reporting of suspected adverse reactions</span>", "ID": "6ea0221f-06ad-4999-9f04-ae201dab7faa", "Styles": "None", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "e9ac595c-56b8-4950-9746-fe085fc7e9b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Reporting\nsuspected adverse reactions after authorisation of the medicinal product is\nimportant.\u00a0 It allows continued monitoring of the benefit/risk balance of\nthe medicinal product.\u00a0 Healthcare professionals are asked to report any\nsuspected adverse reactions via <span style=\"color:black;background:#BFBFBF\">the\nnational reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span><span lang=\"EN-GB\">.</span></p>", "ID": "56401c8a-f130-4896-b12e-a15604701534", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Reporting\nsuspected adverse reactions after authorisation of the medicinal product is\nimportant.\u00a0 It allows continued monitoring of the benefit/risk balance of\nthe medicinal product.\u00a0 Healthcare professionals are asked to report any\nsuspected adverse reactions via <span style=\"color:black;background:#BFBFBF\">the\nnational reporting system listed in </span></span>", "ID": "7a8c618c-79c8-49fc-9326-a948afba012c", "Styles": "None", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important.\u00a0 It allows continued monitoring of the benefit/risk balance of the medicinal product.\u00a0 Healthcare professionals are asked to report any suspected adverse reactions via ", "ParentId": "56401c8a-f130-4896-b12e-a15604701534"}, {"Element": "<span style=\"color:black;background:#BFBFBF\">the\nnational reporting system listed in </span>", "ID": "b195209f-c512-4800-abdb-6a81015c3d31", "Styles": "color:black;background:#BFBFBF", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "7a8c618c-79c8-49fc-9326-a948afba012c"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span>", "ID": "5a750b8d-35a9-4f68-b6b9-ee8725b8b870", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56401c8a-f130-4896-b12e-a15604701534"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a>", "ID": "54244435-5260-44df-8299-6bde42ae8fe0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5a750b8d-35a9-4f68-b6b9-ee8725b8b870"}, {"Element": "<span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span>", "ID": "a8cd2d1f-d6ae-4079-b3f0-385350608a40", "Styles": "color:black;background:#BFBFBF;text-decoration:none", "Classes": "None", "Text": "Appendix\u00a0V", "ParentId": "54244435-5260-44df-8299-6bde42ae8fe0"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "06b29635-ba56-4407-b0c8-59ba7a1c46d4", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "56401c8a-f130-4896-b12e-a15604701534"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8911fab5-d660-4289-a89c-b70014528ba8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e384203a-7cdf-4a51-961b-4be738302aac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8911fab5-d660-4289-a89c-b70014528ba8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>", "ID": "83323290-25be-446a-86ef-12cc9ae42da2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b>", "ID": "23d3a3f8-dfc2-4959-b5d2-b94158d420cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83323290-25be-446a-86ef-12cc9ae42da2"}, {"Element": "<span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "4ca25da3-57bb-4718-9865-f34a2df077d8", "Styles": "None", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "23d3a3f8-dfc2-4959-b5d2-b94158d420cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b634dbd3-47ab-4221-aed7-c956461cb52f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ee7b6f3-2248-403c-8fb9-6fb6ee365554", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b634dbd3-47ab-4221-aed7-c956461cb52f"}, {"Element": "<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The highest documented\ndoses of sofosbuvir and velpatasvir were a single dose of 1,200\u00a0mg and a\nsingle dose of 500\u00a0mg, respectively.\u00a0 In these healthy volunteer\nstudies, there were no untoward effects observed at these dose levels, and\nadverse events were similar in frequency and severity to those reported in the\nplacebo groups.\u00a0 The effects of higher doses/exposures are not known.</span></p>", "ID": "18eba2b9-887a-4153-ab71-552e7a1273ff", "Styles": "text-autospace:ideograph-numeric ideograph-other", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The highest documented\ndoses of sofosbuvir and velpatasvir were a single dose of 1,200\u00a0mg and a\nsingle dose of 500\u00a0mg, respectively.\u00a0 In these healthy volunteer\nstudies, there were no untoward effects observed at these dose levels, and\nadverse events were similar in frequency and severity to those reported in the\nplacebo groups.\u00a0 The effects of higher doses/exposures are not known.</span>", "ID": "e8b4a0a3-25a9-4637-ba82-0b05d6879be0", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "The highest documented doses of sofosbuvir and velpatasvir were a single dose of 1,200\u00a0mg and a single dose of 500\u00a0mg, respectively.\u00a0 In these healthy volunteer studies, there were no untoward effects observed at these dose levels, and adverse events were similar in frequency and severity to those reported in the placebo groups.\u00a0 The effects of higher doses/exposures are not known.", "ParentId": "18eba2b9-887a-4153-ab71-552e7a1273ff"}, {"Element": "<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "3bd805ea-f5e6-4b16-b6e6-b45adbea8de3", "Styles": "text-autospace:ideograph-numeric ideograph-other", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "c7ba30b5-9f6f-40ee-86d0-81e00efb4676", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "3bd805ea-f5e6-4b16-b6e6-b45adbea8de3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No specific\nantidote is available for overdose with Epclusa. \u00a0If overdose occurs the\npatient must be monitored for evidence of toxicity. \u00a0Treatment of overdose\nwith Epclusa consists of general supportive measures including monitoring of\nvital signs, as well as observation of the clinical status of the patient. \u00a0Haemodialysis\ncan efficiently remove the predominant circulating metabolite of sofosbuvir, GS\u2011331007,\nwith an extraction ratio of 53%.\u00a0 Haemodialysis is unlikely to result in\nsignificant removal of velpatasvir, since velpatasvir is highly bound to plasma\nprotein.</span></p>", "ID": "1b7198b7-4218-46dd-ad6e-4651a17207dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No specific\nantidote is available for overdose with Epclusa. \u00a0If overdose occurs the\npatient must be monitored for evidence of toxicity. \u00a0Treatment of overdose\nwith Epclusa consists of general supportive measures including monitoring of\nvital signs, as well as observation of the clinical status of the patient. \u00a0Haemodialysis\ncan efficiently remove the predominant circulating metabolite of sofosbuvir, GS\u2011331007,\nwith an extraction ratio of 53%.\u00a0 Haemodialysis is unlikely to result in\nsignificant removal of velpatasvir, since velpatasvir is highly bound to plasma\nprotein.</span>", "ID": "53f001b7-2e1a-45a2-a2e0-b0f567bc6dd7", "Styles": "None", "Classes": "None", "Text": "No specific antidote is available for overdose with Epclusa. \u00a0If overdose occurs the patient must be monitored for evidence of toxicity. \u00a0Treatment of overdose with Epclusa consists of general supportive measures including monitoring of vital signs, as well as observation of the clinical status of the patient. \u00a0Haemodialysis can efficiently remove the predominant circulating metabolite of sofosbuvir, GS\u2011331007, with an extraction ratio of 53%.\u00a0 Haemodialysis is unlikely to result in significant removal of velpatasvir, since velpatasvir is highly bound to plasma protein.", "ParentId": "1b7198b7-4218-46dd-ad6e-4651a17207dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df030415-6003-4983-a350-b437606b236f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "29bb82e1-c5a7-413f-b509-0b58ca0a270a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df030415-6003-4983-a350-b437606b236f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "527c7a02-d430-4193-b1a7-fc6d7f62294f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "36e1f4c9-4da8-47e7-9907-5a7d11573a4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "527c7a02-d430-4193-b1a7-fc6d7f62294f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>", "ID": "c1a4f518-e727-4b59-8b22-cc89d02f5bdc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b>", "ID": "249fe7a7-2f37-4cc2-902d-fa3ff064740c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c1a4f518-e727-4b59-8b22-cc89d02f5bdc"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span>", "ID": "659d8ec1-6549-44fa-a556-5c5d7bf09e0e", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "249fe7a7-2f37-4cc2-902d-fa3ff064740c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "55974cb1-5d54-4d7f-935a-1d7914cf0abc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d62de54-e13d-4f45-b86c-dc35e796eeaf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "55974cb1-5d54-4d7f-935a-1d7914cf0abc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b></p>", "ID": "c276609d-bb16-4bca-aaef-d66646d75a97", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b>", "ID": "478c1d6f-b0b3-423a-8aa8-6aba9dcca23f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c276609d-bb16-4bca-aaef-d66646d75a97"}, {"Element": "<span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span>", "ID": "0645208f-7810-427f-badc-bf9121e15df9", "Styles": "None", "Classes": "None", "Text": "5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "478c1d6f-b0b3-423a-8aa8-6aba9dcca23f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25dc7337-520f-452b-b92b-7c17df95817c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7fee8179-498d-4131-919a-06bd9b7f44a3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25dc7337-520f-452b-b92b-7c17df95817c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: </span><span lang=\"EN-GB\">Direct acting antiviral</span><span lang=\"EN-GB\">,\nATC code: </span><span lang=\"EN-GB\">J05AP55</span></p>", "ID": "b2e07758-255e-4bf4-aa08-cbafcf37f37a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: </span>", "ID": "bfff5f2c-7a0a-4723-9472-2499d1ee6cc9", "Styles": "None", "Classes": "None", "Text": "Pharmacotherapeutic group: ", "ParentId": "b2e07758-255e-4bf4-aa08-cbafcf37f37a"}, {"Element": "<span lang=\"EN-GB\">Direct acting antiviral</span>", "ID": "bbb88cca-98d0-43c6-b492-87dc2b4b8bdd", "Styles": "None", "Classes": "None", "Text": "Direct acting antiviral", "ParentId": "b2e07758-255e-4bf4-aa08-cbafcf37f37a"}, {"Element": "<span lang=\"EN-GB\">,\nATC code: </span>", "ID": "478d59f1-08ae-4e6d-8038-a7659a48bea5", "Styles": "None", "Classes": "None", "Text": ", ATC code: ", "ParentId": "b2e07758-255e-4bf4-aa08-cbafcf37f37a"}, {"Element": "<span lang=\"EN-GB\">J05AP55</span>", "ID": "c0b6f3e9-5fe8-41d8-8a49-b592b8289785", "Styles": "None", "Classes": "None", "Text": "J05AP55", "ParentId": "b2e07758-255e-4bf4-aa08-cbafcf37f37a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0307ff3-0fd5-4a56-8b0a-c90740def979", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "503ccc45-491a-492e-8cd2-fe8d947acd84", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0307ff3-0fd5-4a56-8b0a-c90740def979"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>", "ID": "7b489904-78e5-4168-b544-003416f8cd42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Mechanism of action</span></u>", "ID": "8a7034b1-9aea-4999-a9b6-386c5e81fe29", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b489904-78e5-4168-b544-003416f8cd42"}, {"Element": "<span lang=\"EN-GB\">Mechanism of action</span>", "ID": "e6382d53-c63b-44db-b37d-5b2455a6fcde", "Styles": "None", "Classes": "None", "Text": "Mechanism of action", "ParentId": "8a7034b1-9aea-4999-a9b6-386c5e81fe29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is a\npan\u2011genotypic inhibitor of the HCV NS5B RNA\u2011dependent\nRNA\u00a0polymerase, which is essential for viral replication.\u00a0 Sofosbuvir\nis a nucleotide prodrug that undergoes intracellular metabolism to form the\npharmacologically active uridine analogue triphosphate (GS\u2011461203), which\ncan be incorporated into HCV\u00a0RNA by the NS5B\u00a0polymerase and acts as a\nchain terminator.\u00a0 GS\u2011461203 (the active metabolite of sofosbuvir)\nis neither an inhibitor of human DNA and RNA\u00a0polymerases nor an inhibitor\nof mitochondrial RNA\u00a0polymerase.</span></p>", "ID": "fc31fb71-2988-4282-8947-c762e423f34b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir is a\npan\u2011genotypic inhibitor of the HCV NS5B RNA\u2011dependent\nRNA\u00a0polymerase, which is essential for viral replication.\u00a0 Sofosbuvir\nis a nucleotide prodrug that undergoes intracellular metabolism to form the\npharmacologically active uridine analogue triphosphate (GS\u2011461203), which\ncan be incorporated into HCV\u00a0RNA by the NS5B\u00a0polymerase and acts as a\nchain terminator.\u00a0 GS\u2011461203 (the active metabolite of sofosbuvir)\nis neither an inhibitor of human DNA and RNA\u00a0polymerases nor an inhibitor\nof mitochondrial RNA\u00a0polymerase.</span>", "ID": "fb107be5-134e-4a7e-bd99-d4794568d5ae", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir is a pan\u2011genotypic inhibitor of the HCV NS5B RNA\u2011dependent RNA\u00a0polymerase, which is essential for viral replication.\u00a0 Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analogue triphosphate (GS\u2011461203), which can be incorporated into HCV\u00a0RNA by the NS5B\u00a0polymerase and acts as a chain terminator.\u00a0 GS\u2011461203 (the active metabolite of sofosbuvir) is neither an inhibitor of human DNA and RNA\u00a0polymerases nor an inhibitor of mitochondrial RNA\u00a0polymerase.", "ParentId": "fc31fb71-2988-4282-8947-c762e423f34b"}, {"Element": "<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "5894fd6d-2d36-4596-a60a-c1409618f6dd", "Styles": "text-autospace:ideograph-numeric ideograph-other", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "79721210-f3b7-4947-97f5-1a287f3d259a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "5894fd6d-2d36-4596-a60a-c1409618f6dd"}, {"Element": "<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir is a HCV\ninhibitor targeting the HCV\u00a0NS5A protein, which is essential for both RNA\nreplication and the assembly of HCV virions. \u00a0<i>In\u00a0vitro</i>\nresistance selection and cross-resistance studies indicate velpatasvir targets\nNS5A as its mode of action.</span></p>", "ID": "395cdafd-2ece-4205-a618-8f5c59b86ddf", "Styles": "text-autospace:ideograph-numeric ideograph-other", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir is a HCV\ninhibitor targeting the HCV\u00a0NS5A protein, which is essential for both RNA\nreplication and the assembly of HCV virions. \u00a0<i>In\u00a0vitro</i>\nresistance selection and cross-resistance studies indicate velpatasvir targets\nNS5A as its mode of action.</span>", "ID": "84b8b7cd-b5a3-4122-8cdf-c20b3af2de2b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Velpatasvir is a HCV inhibitor targeting the HCV\u00a0NS5A protein, which is essential for both RNA replication and the assembly of HCV virions. \u00a0 resistance selection and cross-resistance studies indicate velpatasvir targets NS5A as its mode of action.", "ParentId": "395cdafd-2ece-4205-a618-8f5c59b86ddf"}, {"Element": "<i>In\u00a0vitro</i>", "ID": "2ebbab62-05ba-44b5-84eb-050817690245", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro", "ParentId": "84b8b7cd-b5a3-4122-8cdf-c20b3af2de2b"}, {"Element": "<p class=\"Default\" style=\"text-autospace:ideograph-numeric ideograph-other\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "0c90bdb9-0762-4079-8bfd-0144d19cc929", "Styles": "text-autospace:ideograph-numeric ideograph-other", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "a4933bc9-6bbc-43f2-acb0-da02259905b6", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "0c90bdb9-0762-4079-8bfd-0144d19cc929"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Antiviral activity</span></u></p>", "ID": "eeea347a-3e13-4e0d-9b0a-2be05ac077e9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Antiviral activity</span></u>", "ID": "ea79633c-66bd-4905-b07c-59840b345051", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eeea347a-3e13-4e0d-9b0a-2be05ac077e9"}, {"Element": "<span lang=\"EN-GB\">Antiviral activity</span>", "ID": "6171d95d-ee51-4fb8-8d96-0000038db4bf", "Styles": "None", "Classes": "None", "Text": "Antiviral activity", "ParentId": "ea79633c-66bd-4905-b07c-59840b345051"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The 50% effective concentration (EC<sub>50</sub>) values of sofosbuvir\nand velpatasvir against full\u2011length or chimeric replicons encoding NS5B\nand NS5A sequences from the laboratory strains are presented in Table\u00a04. \u00a0The\nEC<sub>50</sub> values of sofosbuvir and velpatasvir against clinical isolates\nare presented in Table\u00a05.</span></p>", "ID": "42ad58da-ab97-4ef3-93e1-d12b6f809084", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The 50% effective concentration (EC<sub>50</sub>) values of sofosbuvir\nand velpatasvir against full\u2011length or chimeric replicons encoding NS5B\nand NS5A sequences from the laboratory strains are presented in Table\u00a04. \u00a0The\nEC<sub>50</sub> values of sofosbuvir and velpatasvir against clinical isolates\nare presented in Table\u00a05.</span>", "ID": "fa38a69e-afee-43f1-aaf9-ee1ab804e89d", "Styles": "None", "Classes": "None", "Text": "The 50% effective concentration (EC) values of sofosbuvir and velpatasvir against full\u2011length or chimeric replicons encoding NS5B and NS5A sequences from the laboratory strains are presented in Table\u00a04. \u00a0The EC values of sofosbuvir and velpatasvir against clinical isolates are presented in Table\u00a05.", "ParentId": "42ad58da-ab97-4ef3-93e1-d12b6f809084"}, {"Element": "<sub>50</sub>", "ID": "081352df-bf11-4dfd-9cfb-0c120cad10af", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "fa38a69e-afee-43f1-aaf9-ee1ab804e89d"}, {"Element": "<sub>50</sub>", "ID": "c34378a8-1bc8-4fb3-9918-c92bc44db0cb", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "fa38a69e-afee-43f1-aaf9-ee1ab804e89d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1319ac6-b6bc-4254-91dd-8daa71e2f750", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6f8c222-a4c2-4ebe-aa87-e1ac79888bff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1319ac6-b6bc-4254-91dd-8daa71e2f750"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a04: Activity of sofosbuvir and velpatasvir\nagainst full\u2011length or chimeric laboratory replicons</span></b></p>", "ID": "acb46cc0-1afb-4520-b44a-0dde34a05b77", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a04: Activity of sofosbuvir and velpatasvir\nagainst full\u2011length or chimeric laboratory replicons</span></b>", "ID": "58146b3c-ba80-4704-b3e2-66a829f4db97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "acb46cc0-1afb-4520-b44a-0dde34a05b77"}, {"Element": "<span lang=\"EN-GB\">Table\u00a04: Activity of sofosbuvir and velpatasvir\nagainst full\u2011length or chimeric laboratory replicons</span>", "ID": "62815c56-973a-4fea-b378-236e0d0624ca", "Styles": "None", "Classes": "None", "Text": "Table\u00a04: Activity of sofosbuvir and velpatasvir against full\u2011length or chimeric laboratory replicons", "ParentId": "58146b3c-ba80-4704-b3e2-66a829f4db97"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:23.7pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td style=\"width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span></p>\n</td>\n</tr>\n</table>", "ID": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "            ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:23.7pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td style=\"width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>", "ID": "bf38e209-8b7d-4f8a-b8ff-4b7cb4704e7a", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<tr style=\"page-break-inside:avoid;height:23.7pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td style=\"width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>\n</tr>", "ID": "859b19c4-16ca-4ef2-a6f2-369b8173b8c4", "Styles": "page-break-inside:avoid;height:23.7pt", "Classes": "None", "Text": "    ", "ParentId": "bf38e209-8b7d-4f8a-b8ff-4b7cb4704e7a"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>", "ID": "31c1a139-2e22-4b2e-9cbb-710ca620a91b", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:23.7pt", "Classes": "None", "Text": "  ", "ParentId": "859b19c4-16ca-4ef2-a6f2-369b8173b8c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>", "ID": "250e3672-fbd9-4a63-8617-7a58b025a21e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31c1a139-2e22-4b2e-9cbb-710ca620a91b"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b>", "ID": "ef54c90c-d30a-44bc-bfa0-d78216a07efd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "250e3672-fbd9-4a63-8617-7a58b025a21e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span>", "ID": "dd6124c1-de5e-40e5-bbe4-a8451d5fcb7d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Replicon genotype", "ParentId": "ef54c90c-d30a-44bc-bfa0-d78216a07efd"}, {"Element": "<td style=\"width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>", "ID": "abfd1c1b-4dde-47b6-8e97-ed8ff24ad338", "Styles": "width:106.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt", "Classes": "None", "Text": "  ", "ParentId": "859b19c4-16ca-4ef2-a6f2-369b8173b8c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>", "ID": "0b42484e-0725-406b-b7d2-6b88f5f5eaea", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "abfd1c1b-4dde-47b6-8e97-ed8ff24ad338"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span></b>", "ID": "d89351b9-c6fb-4544-a0cb-6abb518678ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b42484e-0725-406b-b7d2-6b88f5f5eaea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Sofosbuvir EC<sub>50</sub>, nM<sup>a</sup></span>", "ID": "93ca8a16-a1ef-42c5-807f-7f14dd5ed90f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Sofosbuvir EC, nM", "ParentId": "d89351b9-c6fb-4544-a0cb-6abb518678ab"}, {"Element": "<sub>50</sub>", "ID": "a422d21a-ebfe-4e9d-9daa-68b9daadd052", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "93ca8a16-a1ef-42c5-807f-7f14dd5ed90f"}, {"Element": "<sup>a</sup>", "ID": "7f1b5608-b70c-4d4c-9914-9abd99aba532", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "93ca8a16-a1ef-42c5-807f-7f14dd5ed90f"}, {"Element": "<td style=\"width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>\n</td>", "ID": "452273ca-f377-4c42-bc76-9bc1e1d3642a", "Styles": "width:113.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:23.7pt", "Classes": "None", "Text": "  ", "ParentId": "859b19c4-16ca-4ef2-a6f2-369b8173b8c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b></p>", "ID": "a37ab075-55a2-48fe-a04b-a5e17a997100", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "452273ca-f377-4c42-bc76-9bc1e1d3642a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span></b>", "ID": "ee71c6b4-53ce-461a-bd09-3ff4563b4002", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a37ab075-55a2-48fe-a04b-a5e17a997100"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Velpatasvir EC<sub>50</sub>, nM<sup>a</sup></span>", "ID": "8d5c9de0-b898-44f2-87b3-ceae99814f8f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Velpatasvir EC, nM", "ParentId": "ee71c6b4-53ce-461a-bd09-3ff4563b4002"}, {"Element": "<sub>50</sub>", "ID": "66cb3d61-265e-49b3-83dd-708f0687fa1b", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "8d5c9de0-b898-44f2-87b3-ceae99814f8f"}, {"Element": "<sup>a</sup>", "ID": "25801454-add1-41a0-a870-68d21a2c783e", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "8d5c9de0-b898-44f2-87b3-ceae99814f8f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span></p>\n</td>\n</tr>", "ID": "a7a7ced2-7676-4061-b8f1-98adffb27919", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>", "ID": "6028920c-ba44-4600-b126-f8f4cab96293", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7a7ced2-7676-4061-b8f1-98adffb27919"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>", "ID": "702ca510-dd7e-46c0-b4c0-6a184dce28aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6028920c-ba44-4600-b126-f8f4cab96293"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span>", "ID": "f3a1abd1-aab6-4a3c-8035-4ca94e305026", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1a", "ParentId": "702ca510-dd7e-46c0-b4c0-6a184dce28aa"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>", "ID": "bb449722-869f-4d17-bf44-1bb4af758147", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7a7ced2-7676-4061-b8f1-98adffb27919"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>", "ID": "623e7ebc-ffa4-4754-83d0-377c5de6173a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb449722-869f-4d17-bf44-1bb4af758147"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span>", "ID": "3b309a21-330f-4c51-bd31-694ad6bde9d7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "40", "ParentId": "623e7ebc-ffa4-4754-83d0-377c5de6173a"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span></p>\n</td>", "ID": "7f8032b8-f5fe-4970-87a6-acaabf8b4c07", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7a7ced2-7676-4061-b8f1-98adffb27919"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span></p>", "ID": "3a776d6b-b26c-4ca7-b2ee-455e0b3eee33", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f8032b8-f5fe-4970-87a6-acaabf8b4c07"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.014</span>", "ID": "71e1ef0a-ec1d-4f41-9e07-ea031a186c3d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.014", "ParentId": "3a776d6b-b26c-4ca7-b2ee-455e0b3eee33"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span></p>\n</td>\n</tr>", "ID": "60f6263f-b7f3-4654-9416-4a233e777fdd", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>", "ID": "65e1f5e0-f60f-44a1-998d-37aeb3ae02a2", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "60f6263f-b7f3-4654-9416-4a233e777fdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>", "ID": "d51ef903-1105-419b-996b-e48400a6c097", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65e1f5e0-f60f-44a1-998d-37aeb3ae02a2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span>", "ID": "b586acdd-aefe-4ae4-aa7f-b20506617a66", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1b", "ParentId": "d51ef903-1105-419b-996b-e48400a6c097"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span></p>\n</td>", "ID": "4e3fd3f0-62cb-4f0b-b429-3c8fa25f4e72", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "60f6263f-b7f3-4654-9416-4a233e777fdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span></p>", "ID": "2ff226d4-040d-487a-855e-b424ff90a5d6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e3fd3f0-62cb-4f0b-b429-3c8fa25f4e72"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">110</span>", "ID": "dda6921a-4e5c-4946-ad2a-cb5c047a1d41", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "110", "ParentId": "2ff226d4-040d-487a-855e-b424ff90a5d6"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span></p>\n</td>", "ID": "267bac7b-1736-4ab8-99d3-54972f8cf397", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "60f6263f-b7f3-4654-9416-4a233e777fdd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span></p>", "ID": "3f27f0cb-a8c0-4da1-ac6b-67ae19e3d062", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "267bac7b-1736-4ab8-99d3-54972f8cf397"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.016</span>", "ID": "d5600338-2b74-4b2f-8321-f9a19c81fe37", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.016", "ParentId": "3f27f0cb-a8c0-4da1-ac6b-67ae19e3d062"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span></p>\n</td>\n</tr>", "ID": "c3c2e9c6-68c0-40cc-a8d3-b1d511198a1b", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>", "ID": "678da9fd-3be0-4b69-83bb-e27ed93a2e6a", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c3c2e9c6-68c0-40cc-a8d3-b1d511198a1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>", "ID": "22cff71f-34ba-49e6-b938-9752df80a85b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "678da9fd-3be0-4b69-83bb-e27ed93a2e6a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span>", "ID": "97331631-2860-40dd-a6cd-d9cff6f8de9b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2a", "ParentId": "22cff71f-34ba-49e6-b938-9752df80a85b"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>", "ID": "150baa4e-9eff-4ac8-aa3f-f8172c6682f4", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c3c2e9c6-68c0-40cc-a8d3-b1d511198a1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>", "ID": "772e0eb9-631d-4ef0-9f48-363caf71c2a2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "150baa4e-9eff-4ac8-aa3f-f8172c6682f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span>", "ID": "0fc3ea15-6fd5-4cd2-ad1b-0dbc55d68835", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "50", "ParentId": "772e0eb9-631d-4ef0-9f48-363caf71c2a2"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span></p>\n</td>", "ID": "c175d179-8c47-4d76-9f84-ed3633d101f6", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c3c2e9c6-68c0-40cc-a8d3-b1d511198a1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span></p>", "ID": "2231b27b-11d8-4c6e-a482-ef2ca02cc4dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c175d179-8c47-4d76-9f84-ed3633d101f6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005\u20110.016<sup>c</sup></span>", "ID": "9f718b53-8a09-4a58-ae0f-de1f874aa4a7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.005\u20110.016", "ParentId": "2231b27b-11d8-4c6e-a482-ef2ca02cc4dc"}, {"Element": "<sup>c</sup>", "ID": "7872146a-3445-4d24-b311-aadd1db49f3b", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "9f718b53-8a09-4a58-ae0f-de1f874aa4a7"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span></p>\n</td>\n</tr>", "ID": "58e5c1a7-91df-4f00-a882-b0e240e84399", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>", "ID": "9a729c88-519f-4428-89cc-28c7958c752e", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "58e5c1a7-91df-4f00-a882-b0e240e84399"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>", "ID": "c61ba3cc-86da-415c-b680-591ff2e296bf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9a729c88-519f-4428-89cc-28c7958c752e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span>", "ID": "adb85ca4-7445-4339-a9eb-1f1441938bd6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2b", "ParentId": "c61ba3cc-86da-415c-b680-591ff2e296bf"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>", "ID": "f8f4a023-4979-4ae3-b0e7-4b064bab3d1e", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "58e5c1a7-91df-4f00-a882-b0e240e84399"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>", "ID": "f68cd4d5-3bb3-4001-9d7f-65d47fede9ce", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8f4a023-4979-4ae3-b0e7-4b064bab3d1e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span>", "ID": "186388de-a8dd-4010-96d9-4213b416e253", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "15", "ParentId": "f68cd4d5-3bb3-4001-9d7f-65d47fede9ce"}, {"Element": "<sup>b</sup>", "ID": "6923f8f9-2e9f-47ad-8c98-97769ee017a1", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "186388de-a8dd-4010-96d9-4213b416e253"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span></p>\n</td>", "ID": "34ac2c8d-d3d5-4743-9bba-a7fd97216200", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "58e5c1a7-91df-4f00-a882-b0e240e84399"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span></p>", "ID": "90885f2a-bb56-4246-b31c-2bd415565efd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34ac2c8d-d3d5-4743-9bba-a7fd97216200"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002\u20110.006<sup>c</sup></span>", "ID": "70c01d54-66a7-4f24-b790-9b93c6b8305c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.002\u20110.006", "ParentId": "90885f2a-bb56-4246-b31c-2bd415565efd"}, {"Element": "<sup>c</sup>", "ID": "99c15ceb-cfb1-4f72-8ddc-8667499932ae", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "70c01d54-66a7-4f24-b790-9b93c6b8305c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>", "ID": "5ffb20ca-0b7c-46a5-97cf-6a0d9188a9fc", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>", "ID": "cbde6671-efe0-4eb3-8021-c528139ede30", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5ffb20ca-0b7c-46a5-97cf-6a0d9188a9fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>", "ID": "172e82f1-99dc-4b6a-81dd-5803809492c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cbde6671-efe0-4eb3-8021-c528139ede30"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span>", "ID": "9392c2a6-ca13-41f3-ab04-45c1e5862070", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3a", "ParentId": "172e82f1-99dc-4b6a-81dd-5803809492c0"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>\n</td>", "ID": "e0d7fafa-1108-4c26-9d72-1606a5e253ad", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5ffb20ca-0b7c-46a5-97cf-6a0d9188a9fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span></p>", "ID": "ca0f4782-655a-4b68-b696-f07e81dd0db8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0d7fafa-1108-4c26-9d72-1606a5e253ad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">50</span>", "ID": "516811a5-fcc3-495f-b4d4-2cb2c96dae62", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "50", "ParentId": "ca0f4782-655a-4b68-b696-f07e81dd0db8"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>", "ID": "a9a582fe-06cc-4a44-9581-ad2437d95fac", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5ffb20ca-0b7c-46a5-97cf-6a0d9188a9fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>", "ID": "8f60a0ec-a05b-42bd-a904-b93941689331", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9a582fe-06cc-4a44-9581-ad2437d95fac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span>", "ID": "b0787c94-818b-48c9-8cc0-b3755a45fa65", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.004", "ParentId": "8f60a0ec-a05b-42bd-a904-b93941689331"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span></p>\n</td>\n</tr>", "ID": "9aa9c184-b0cf-4d05-b463-f8f66216319f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>", "ID": "ce7c6577-3df9-4f82-9280-62d0d9ecb55f", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9aa9c184-b0cf-4d05-b463-f8f66216319f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>", "ID": "5fb554a5-e702-4048-b2ec-c8ca5d7b8334", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce7c6577-3df9-4f82-9280-62d0d9ecb55f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span>", "ID": "848d82bb-a941-4654-9082-a78c9b339e3d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4a", "ParentId": "5fb554a5-e702-4048-b2ec-c8ca5d7b8334"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>\n</td>", "ID": "d770270a-7501-4166-a49d-26cd73c9f68a", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9aa9c184-b0cf-4d05-b463-f8f66216319f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span></p>", "ID": "41145340-282b-4c86-ac54-23541a0681c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d770270a-7501-4166-a49d-26cd73c9f68a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">40</span>", "ID": "c95786cf-d6b2-47d4-b6f7-fad823f205d9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "40", "ParentId": "41145340-282b-4c86-ac54-23541a0681c5"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span></p>\n</td>", "ID": "f23de8df-106b-4cbb-a113-be2e3e7bfa70", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9aa9c184-b0cf-4d05-b463-f8f66216319f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span></p>", "ID": "1c6b0a00-75a3-4d3c-b91d-66b305dc8bbb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f23de8df-106b-4cbb-a113-be2e3e7bfa70"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.009</span>", "ID": "bcda55f1-506e-4fe8-a9d4-570b904b4fb9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.009", "ParentId": "1c6b0a00-75a3-4d3c-b91d-66b305dc8bbb"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>\n</tr>", "ID": "3162e565-5de5-42c1-a290-26beae20be28", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>", "ID": "060e6831-5ecf-4650-9f02-e590c1fef7d1", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3162e565-5de5-42c1-a290-26beae20be28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>", "ID": "5abd3c42-916b-4645-89f2-5b222a085ece", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "060e6831-5ecf-4650-9f02-e590c1fef7d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span>", "ID": "0e0198d0-7500-4090-82e7-d81f054aec74", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4d", "ParentId": "5abd3c42-916b-4645-89f2-5b222a085ece"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "2f8605a1-06b7-41b8-af43-bad5276f4929", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3162e565-5de5-42c1-a290-26beae20be28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "1f779341-29c2-4684-ba37-2e6583ec2af7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2f8605a1-06b7-41b8-af43-bad5276f4929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "cf6dde3e-7876-424a-8e17-14f295684195", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "1f779341-29c2-4684-ba37-2e6583ec2af7"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>\n</td>", "ID": "69a5e306-f86b-48c7-9661-4e00c6ecb629", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3162e565-5de5-42c1-a290-26beae20be28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span></p>", "ID": "84db3b14-64db-4d71-8af9-200cd7f810f9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69a5e306-f86b-48c7-9661-4e00c6ecb629"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.004</span>", "ID": "e1eedb2a-12c5-4f5e-8e0d-79a9de326acc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.004", "ParentId": "84db3b14-64db-4d71-8af9-200cd7f810f9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span></p>\n</td>\n</tr>", "ID": "8b8062df-dc95-4f0a-a2f7-1084203a425e", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>", "ID": "8b36cb44-7f4f-41bf-90a3-4b76595aa863", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8b8062df-dc95-4f0a-a2f7-1084203a425e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>", "ID": "2375a279-4ef5-400e-a894-a9f39c474134", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b36cb44-7f4f-41bf-90a3-4b76595aa863"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span>", "ID": "8424e8bb-1dce-4a04-aa77-b1c0a6318baa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "5a", "ParentId": "2375a279-4ef5-400e-a894-a9f39c474134"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>\n</td>", "ID": "c8991a42-49f2-4906-8206-ecf9f81a65b4", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8b8062df-dc95-4f0a-a2f7-1084203a425e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span></p>", "ID": "97ae47ed-d664-409b-b4c3-a7936953bb0f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c8991a42-49f2-4906-8206-ecf9f81a65b4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">15<sup>b</sup></span>", "ID": "ed782734-99f6-407d-b943-f4f74f9ee053", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "15", "ParentId": "97ae47ed-d664-409b-b4c3-a7936953bb0f"}, {"Element": "<sup>b</sup>", "ID": "46c1ebb2-dbfd-4cee-ae0d-ef154b64028a", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "ed782734-99f6-407d-b943-f4f74f9ee053"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span></p>\n</td>", "ID": "b221c510-e09b-4ecf-8eb2-6aaf8c6252cc", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8b8062df-dc95-4f0a-a2f7-1084203a425e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span></p>", "ID": "1ede7ec7-f9ae-410f-9fb1-9ec2841ae27a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b221c510-e09b-4ecf-8eb2-6aaf8c6252cc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.021\u20110.054<sup>d</sup></span>", "ID": "c3211601-1a47-4d48-8d06-fe891a675d3a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.021\u20110.054", "ParentId": "1ede7ec7-f9ae-410f-9fb1-9ec2841ae27a"}, {"Element": "<sup>d</sup>", "ID": "80d29a14-4517-4668-894e-b70020daea91", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "c3211601-1a47-4d48-8d06-fe891a675d3a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span></p>\n</td>\n</tr>", "ID": "261dc121-5eb2-4489-a1b1-62f2e9b1f0f4", "Styles": "page-break-inside:avoid;height:3.2pt", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>", "ID": "1dde2b56-9b2d-4521-8155-2dd3d00c0b48", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "261dc121-5eb2-4489-a1b1-62f2e9b1f0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>", "ID": "34e11873-05b4-4ee3-af45-d85d17e23746", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1dde2b56-9b2d-4521-8155-2dd3d00c0b48"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span>", "ID": "5d817530-8add-4888-ba33-6ab9f01bb707", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "6a", "ParentId": "34e11873-05b4-4ee3-af45-d85d17e23746"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span></p>\n</td>", "ID": "d02e84f0-cd09-43af-bc78-54784acfc5c2", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "261dc121-5eb2-4489-a1b1-62f2e9b1f0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span></p>", "ID": "2433a936-506b-42a7-9144-660224437114", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d02e84f0-cd09-43af-bc78-54784acfc5c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">14<sup>b</sup></span>", "ID": "9a74ff20-5917-40ee-b213-ca95da5c1bc3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "14", "ParentId": "2433a936-506b-42a7-9144-660224437114"}, {"Element": "<sup>b</sup>", "ID": "731105fc-717d-4803-a02e-19ead3ca8f84", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "9a74ff20-5917-40ee-b213-ca95da5c1bc3"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span></p>\n</td>", "ID": "e76882fe-f176-417d-ac3a-6bdd5174915b", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "261dc121-5eb2-4489-a1b1-62f2e9b1f0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span></p>", "ID": "8d44d89c-497a-43ab-81d0-ceafd7455605", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e76882fe-f176-417d-ac3a-6bdd5174915b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.006\u20110.009</span>", "ID": "a485f1a6-38ed-4ac1-aa42-064b2c18a7e1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.006\u20110.009", "ParentId": "8d44d89c-497a-43ab-81d0-ceafd7455605"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span></p>\n</td>\n</tr>", "ID": "2269ac21-a60c-4e05-8daf-4c6dd77ee6f5", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "a12c4177-e91c-4dfe-9c0f-47fe33d6b340"}, {"Element": "<td style=\"width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>", "ID": "9f36110b-71e5-4ca1-a996-e6c65c0d8b29", "Styles": "width:76.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2269ac21-a60c-4e05-8daf-4c6dd77ee6f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>", "ID": "799127ca-a57e-411e-84ee-f6fab4fd0b23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9f36110b-71e5-4ca1-a996-e6c65c0d8b29"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span>", "ID": "db94bfb1-1046-4d75-b1d9-db4e280285db", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "6e", "ParentId": "799127ca-a57e-411e-84ee-f6fab4fd0b23"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "0cfec5dd-508c-4fed-86cc-0d240cbd90d2", "Styles": "width:106.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2269ac21-a60c-4e05-8daf-4c6dd77ee6f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "061016a2-e791-48cf-87c6-19b34f8aaf41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0cfec5dd-508c-4fed-86cc-0d240cbd90d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "df11fb62-1354-4bf0-87f5-6f84096b72f9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "061016a2-e791-48cf-87c6-19b34f8aaf41"}, {"Element": "<td style=\"width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"151\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span></p>\n</td>", "ID": "563144b9-3d97-4ae0-ba5e-248f3994368a", "Styles": "width:113.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2269ac21-a60c-4e05-8daf-4c6dd77ee6f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span></p>", "ID": "5b722e92-f9ed-4566-b17a-fc16e73946b8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "563144b9-3d97-4ae0-ba5e-248f3994368a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.130<sup>d</sup></span>", "ID": "04b5ea02-4a15-4e58-94d2-f0500669260e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.130", "ParentId": "5b722e92-f9ed-4566-b17a-fc16e73946b8"}, {"Element": "<sup>d</sup>", "ID": "476fe09b-6abe-4600-8f68-bfc1f5fdf0d5", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "04b5ea02-4a15-4e58-94d2-f0500669260e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span></p>", "ID": "3c50af44-2b87-454f-9043-e52e8a2b0307", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span>", "ID": "38593356-0fd5-416e-9b3a-315790d7e84b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "NA\u00a0=\u00a0Not available", "ParentId": "3c50af44-2b87-454f-9043-e52e8a2b0307"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean value from multiple\nexperiments of same laboratory replicon.</span></p>", "ID": "8fd6f84c-920b-4737-b22c-7f4b2bdbb3a2", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 Mean value from multiple\nexperiments of same laboratory replicon.</span>", "ID": "2fd0a14f-32e4-4dff-95ab-0e3dad1d2f62", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 Mean value from multiple experiments of same laboratory replicon.", "ParentId": "8fd6f84c-920b-4737-b22c-7f4b2bdbb3a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 Stable chimeric 1b replicons\ncarrying NS5B genes from genotype\u00a02b, 5a or 6a were used for testing.</span></p>", "ID": "889856e2-d13d-4aaf-9d9d-14cbf5374972", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 Stable chimeric 1b replicons\ncarrying NS5B genes from genotype\u00a02b, 5a or 6a were used for testing.</span>", "ID": "2140f0ce-8ef7-4b1c-a062-b064f753b64f", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 Stable chimeric 1b replicons carrying NS5B genes from genotype\u00a02b, 5a or 6a were used for testing.", "ParentId": "889856e2-d13d-4aaf-9d9d-14cbf5374972"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Data from various strains of\nfull length NS5A replicons or chimeric NS5A replicons carrying full\u2011length\nNS5A genes that contain L31 or M31 polymorphisms.</span></p>", "ID": "0e0de464-8762-4cb6-b0ca-3eaa29921b03", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 Data from various strains of\nfull length NS5A replicons or chimeric NS5A replicons carrying full\u2011length\nNS5A genes that contain L31 or M31 polymorphisms.</span>", "ID": "8700bca5-8d14-4183-a2bd-50d0f5ab4eea", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "c\u00a0\u00a0\u00a0\u00a0 Data from various strains of full length NS5A replicons or chimeric NS5A replicons carrying full\u2011length NS5A genes that contain L31 or M31 polymorphisms.", "ParentId": "0e0de464-8762-4cb6-b0ca-3eaa29921b03"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Data\nfrom a chimeric NS5A replicon carrying NS5A amino acids 9\u2011184.</span></p>", "ID": "8044e19a-715b-44a9-a182-ac92422ce507", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">d\u00a0\u00a0\u00a0 Data\nfrom a chimeric NS5A replicon carrying NS5A amino acids 9\u2011184.</span>", "ID": "b70bb4d0-32aa-436c-a6c9-c1d7d6250d22", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "d\u00a0\u00a0\u00a0 Data from a chimeric NS5A replicon carrying NS5A amino acids 9\u2011184.", "ParentId": "8044e19a-715b-44a9-a182-ac92422ce507"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "73969650-122a-42b8-94d7-1f0f120c24fb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a967e7e1-89ad-4454-93dc-c2be0b60a9dc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "73969650-122a-42b8-94d7-1f0f120c24fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a05: Activity of sofosbuvir and velpatasvir against\ntransient replicons containing NS5A or NS5B from clinical isolates</span></b></p>", "ID": "194bed51-eaf2-4792-9655-1462f5bc3fd6", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a05: Activity of sofosbuvir and velpatasvir against\ntransient replicons containing NS5A or NS5B from clinical isolates</span></b>", "ID": "d168989f-dddb-47a0-b2c4-95a19c916347", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "194bed51-eaf2-4792-9655-1462f5bc3fd6"}, {"Element": "<span lang=\"EN-GB\">Table\u00a05: Activity of sofosbuvir and velpatasvir against\ntransient replicons containing NS5A or NS5B from clinical isolates</span>", "ID": "7c75a1b0-13b2-433e-924d-db254c362ea4", "Styles": "None", "Classes": "None", "Text": "Table\u00a05: Activity of sofosbuvir and velpatasvir against transient replicons containing NS5A or NS5B from clinical isolates", "ParentId": "d168989f-dddb-47a0-b2c4-95a19c916347"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span></p>\n</td>\n</tr>\n</table>", "ID": "159e7113-bd30-4fbf-98ce-f0599f7d4018", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "             ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "8cbb0dd7-be08-4e04-aaa9-3fd6a7545a12", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>\n</td>\n</tr>", "ID": "49c13f46-5cd4-478f-8d10-726de21985ca", "Styles": "page-break-inside:avoid;height:14.3pt", "Classes": "None", "Text": "    ", "ParentId": "8cbb0dd7-be08-4e04-aaa9-3fd6a7545a12"}, {"Element": "<td rowspan=\"2\" style=\"width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>\n</td>", "ID": "d7e61751-a7a1-4c0d-bd13-6cc48fe4d405", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "49c13f46-5cd4-478f-8d10-726de21985ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b></p>", "ID": "20bd4a18-94d6-4669-83a8-b1aca5e71f05", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7e61751-a7a1-4c0d-bd13-6cc48fe4d405"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span></b>", "ID": "2ae08865-122b-42f9-9c8b-003496bb28d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "20bd4a18-94d6-4669-83a8-b1aca5e71f05"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicon genotype</span>", "ID": "4a94389d-2160-4f35-a145-82d1b739c607", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Replicon genotype", "ParentId": "2ae08865-122b-42f9-9c8b-003496bb28d2"}, {"Element": "<td colspan=\"2\" style=\"width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>\n</td>", "ID": "2facd1c3-6c14-41ff-80fa-ebcd29e180a5", "Styles": "width:184.25pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "49c13f46-5cd4-478f-8d10-726de21985ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b></p>", "ID": "74cbc9a7-e606-4a0d-8d7a-c5fb8aa0b348", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2facd1c3-6c14-41ff-80fa-ebcd29e180a5"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span></b>", "ID": "bfbcddb5-6365-4816-bc5c-36ed470385d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74cbc9a7-e606-4a0d-8d7a-c5fb8aa0b348"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5B from clinical\n   isolates</span>", "ID": "940bdd2e-134a-41b2-99c0-8e1e0025187a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Replicons containing NS5B from clinical    isolates", "ParentId": "bfbcddb5-6365-4816-bc5c-36ed470385d4"}, {"Element": "<td colspan=\"2\" style=\"width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"246\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>\n</td>", "ID": "f89fb465-216a-4171-865c-41e0226a35c2", "Styles": "width:184.3pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "49c13f46-5cd4-478f-8d10-726de21985ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b></p>", "ID": "259f71c0-b7be-4497-9c11-8b20cf1ff587", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f89fb465-216a-4171-865c-41e0226a35c2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span></b>", "ID": "42a577f3-5f6a-4b1d-99c3-d12d47bf7244", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "259f71c0-b7be-4497-9c11-8b20cf1ff587"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Replicons containing NS5A from clinical\n   isolates</span>", "ID": "85424682-b641-47dc-b980-591804f08619", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Replicons containing NS5A from clinical    isolates", "ParentId": "42a577f3-5f6a-4b1d-99c3-d12d47bf7244"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>\n</tr>", "ID": "9ddf7212-06b6-4f4f-ac3e-7fc3835275fb", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "8cbb0dd7-be08-4e04-aaa9-3fd6a7545a12"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>", "ID": "d2895aee-d990-4242-8207-1ab49df144d6", "Styles": "width:92.1pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9ddf7212-06b6-4f4f-ac3e-7fc3835275fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>", "ID": "625216e2-11c5-475a-9ef8-85375cacf65b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2895aee-d990-4242-8207-1ab49df144d6"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b>", "ID": "a3b835fa-144c-4e25-a52e-43ad1c7606da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "625216e2-11c5-475a-9ef8-85375cacf65b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span>", "ID": "d0152535-90b8-446e-b6c4-a706e38af1b2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Number of clinical isolates", "ParentId": "a3b835fa-144c-4e25-a52e-43ad1c7606da"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>", "ID": "3fee8cda-e960-47f9-b566-f3169d92773f", "Styles": "width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9ddf7212-06b6-4f4f-ac3e-7fc3835275fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b></p>", "ID": "765f50e0-f3dc-4e6d-9266-1f920503c195", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee8cda-e960-47f9-b566-f3169d92773f"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span></b>", "ID": "b1a972d5-30f7-4022-8e28-f9023e307166", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "765f50e0-f3dc-4e6d-9266-1f920503c195"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median sofosbuvir EC<sub>50</sub>, nM\n   (range)</span>", "ID": "3cdc0fc1-18e7-4fbf-9626-1f571216c008", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Median sofosbuvir EC, nM    (range)", "ParentId": "b1a972d5-30f7-4022-8e28-f9023e307166"}, {"Element": "<sub>50</sub>", "ID": "76fee1c7-7ccc-4677-9b94-480eaa446ef2", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "3cdc0fc1-18e7-4fbf-9626-1f571216c008"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>\n</td>", "ID": "d1ea6a4f-7933-4c89-bfc5-8c9ce5ccf461", "Styles": "width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9ddf7212-06b6-4f4f-ac3e-7fc3835275fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b></p>", "ID": "a84ef10d-94e8-45c2-bbf5-d3d8affac450", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1ea6a4f-7933-4c89-bfc5-8c9ce5ccf461"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span></b>", "ID": "455c5c34-841c-4aaf-8ac8-a74f4771c5d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a84ef10d-94e8-45c2-bbf5-d3d8affac450"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Number of clinical isolates</span>", "ID": "b6afb7d5-3273-4528-ad2b-827837145288", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Number of clinical isolates", "ParentId": "455c5c34-841c-4aaf-8ac8-a74f4771c5d2"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>\n</td>", "ID": "8d6e694a-4a50-4ebc-8092-d84506c82e76", "Styles": "width:99.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9ddf7212-06b6-4f4f-ac3e-7fc3835275fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b></p>", "ID": "7249ef02-15fe-4caa-8acb-1d07bbf071eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d6e694a-4a50-4ebc-8092-d84506c82e76"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span></b>", "ID": "71d74f2c-f106-49cc-9171-64f9fde19c8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7249ef02-15fe-4caa-8acb-1d07bbf071eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Median velpatasvir EC<sub>50</sub>, nM\n   (range)</span>", "ID": "43fa459a-1434-48c2-b8b7-8615ae25b924", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Median velpatasvir EC, nM    (range)", "ParentId": "71d74f2c-f106-49cc-9171-64f9fde19c8a"}, {"Element": "<sub>50</sub>", "ID": "bd522bec-8024-4dd5-aed0-f81f95726e97", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "43fa459a-1434-48c2-b8b7-8615ae25b924"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span></p>\n</td>\n</tr>", "ID": "20538793-e331-4db3-9a53-cd09d5ef7e83", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>\n</td>", "ID": "04b4c515-becb-46f8-9196-a94bedffc5f7", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20538793-e331-4db3-9a53-cd09d5ef7e83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span></p>", "ID": "1c77689f-309c-44ec-b4e0-3d76ec3c1836", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "04b4c515-becb-46f8-9196-a94bedffc5f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1a</span>", "ID": "0814ba7d-d05e-4bf7-a50b-a4a201e915c2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1a", "ParentId": "1c77689f-309c-44ec-b4e0-3d76ec3c1836"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span></p>\n</td>", "ID": "3a1868f0-4c90-48a9-a93e-bd789d972b39", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20538793-e331-4db3-9a53-cd09d5ef7e83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span></p>", "ID": "b1a8a1d5-6c4c-4721-b392-c167f530561a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a1868f0-4c90-48a9-a93e-bd789d972b39"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">67</span>", "ID": "78e559e7-6ca0-4107-ac11-89f810c0852b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "67", "ParentId": "b1a8a1d5-6c4c-4721-b392-c167f530561a"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span></p>\n</td>", "ID": "d196a7ed-1a80-47be-88aa-3beac6f0dccd", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20538793-e331-4db3-9a53-cd09d5ef7e83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span></p>", "ID": "61bf42f2-de70-4ec0-bb69-8306fc31ad8d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d196a7ed-1a80-47be-88aa-3beac6f0dccd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">62 (29\u2011128)</span>", "ID": "000a5b89-c834-472b-8c77-c8507db357f3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "62 (29\u2011128)", "ParentId": "61bf42f2-de70-4ec0-bb69-8306fc31ad8d"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span></p>\n</td>", "ID": "304a7c8f-3ccf-4a0a-8726-fc82d1e9364e", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20538793-e331-4db3-9a53-cd09d5ef7e83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span></p>", "ID": "cb8da20e-2928-4dd0-88e2-71a796b2a77d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "304a7c8f-3ccf-4a0a-8726-fc82d1e9364e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">23</span>", "ID": "871c6061-c673-4e8a-a400-374886bc0bb8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "23", "ParentId": "cb8da20e-2928-4dd0-88e2-71a796b2a77d"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span></p>\n</td>", "ID": "5ee2779c-41b0-40a9-bdf0-e1541bee9ef5", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20538793-e331-4db3-9a53-cd09d5ef7e83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span></p>", "ID": "3f62121f-4986-47fe-a494-3f2b4faa4744", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ee2779c-41b0-40a9-bdf0-e1541bee9ef5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.019 (0.011\u20110.078)</span>", "ID": "0624607b-9592-47b1-b13c-2d2afd3b86d9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.019 (0.011\u20110.078)", "ParentId": "3f62121f-4986-47fe-a494-3f2b4faa4744"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span></p>\n</td>\n</tr>", "ID": "e6395930-2bbd-4410-b4c7-876bd5571f56", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>\n</td>", "ID": "94cf830b-2018-4eef-a2fe-afe609bcf61d", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e6395930-2bbd-4410-b4c7-876bd5571f56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span></p>", "ID": "78fc24d2-b969-4eaf-8e43-acc78afa88e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94cf830b-2018-4eef-a2fe-afe609bcf61d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1b</span>", "ID": "edaeb8a6-bf42-4529-a70a-fe55d85acdee", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1b", "ParentId": "78fc24d2-b969-4eaf-8e43-acc78afa88e3"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span></p>\n</td>", "ID": "3775a97b-33bc-457a-bc38-80ba3032c0ab", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e6395930-2bbd-4410-b4c7-876bd5571f56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span></p>", "ID": "c977f61b-d7b1-49e9-b7f0-7cc055912115", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3775a97b-33bc-457a-bc38-80ba3032c0ab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">29</span>", "ID": "fb3de330-c964-4a38-9e5b-bc89bf207549", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "29", "ParentId": "c977f61b-d7b1-49e9-b7f0-7cc055912115"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span></p>\n</td>", "ID": "90385e4c-6988-4631-8e1c-16864c158c5b", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e6395930-2bbd-4410-b4c7-876bd5571f56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span></p>", "ID": "356b53c7-a698-44d1-ab8f-cf8b1c7de595", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "90385e4c-6988-4631-8e1c-16864c158c5b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">102 (45\u2011170)</span>", "ID": "930fdec7-195a-449e-a55b-bbf493f8de8f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "102 (45\u2011170)", "ParentId": "356b53c7-a698-44d1-ab8f-cf8b1c7de595"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span></p>\n</td>", "ID": "bb61ccdf-b47e-49ae-972d-181abab2fda6", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e6395930-2bbd-4410-b4c7-876bd5571f56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span></p>", "ID": "ca54570f-88bb-4ecb-b08a-d21facf340e4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb61ccdf-b47e-49ae-972d-181abab2fda6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">34</span>", "ID": "19bc8b7b-39dd-4fab-b3ed-f35ac4829460", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "34", "ParentId": "ca54570f-88bb-4ecb-b08a-d21facf340e4"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span></p>\n</td>", "ID": "e9edc63c-d0da-443a-91d5-a6ce89cb7577", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e6395930-2bbd-4410-b4c7-876bd5571f56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span></p>", "ID": "7f94c476-b998-44ba-ab43-1266cb05306f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9edc63c-d0da-443a-91d5-a6ce89cb7577"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.012 (0.005\u20110.500)</span>", "ID": "0ac379d6-a326-4671-bda5-3762b00e8ba9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.012 (0.005\u20110.500)", "ParentId": "7f94c476-b998-44ba-ab43-1266cb05306f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span></p>\n</td>\n</tr>", "ID": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>\n</td>", "ID": "6f62960f-06e0-48f9-a66a-60dccdc81f11", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span></p>", "ID": "4e548de1-9edd-4c37-9473-fce36bc8062e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6f62960f-06e0-48f9-a66a-60dccdc81f11"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2a</span>", "ID": "e76729bb-464c-433d-955b-45fdfd80bd77", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2a", "ParentId": "4e548de1-9edd-4c37-9473-fce36bc8062e"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>", "ID": "fa067219-e832-4aba-a536-d11ec87952f9", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>", "ID": "5ea07da0-cd29-4e9d-bfea-e52c7d39e9ab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa067219-e832-4aba-a536-d11ec87952f9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span>", "ID": "fc048b44-92d9-4bdc-bff6-867681c09e9a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "15", "ParentId": "5ea07da0-cd29-4e9d-bfea-e52c7d39e9ab"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span></p>\n</td>", "ID": "19b968d2-e814-4948-8fa3-05179a850393", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span></p>", "ID": "8fd8674e-8af2-41b8-8783-93e4fce01945", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19b968d2-e814-4948-8fa3-05179a850393"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">29 (14\u201181)</span>", "ID": "eea9c61f-68c5-43b9-8553-812e69f263ab", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "29 (14\u201181)", "ParentId": "8fd8674e-8af2-41b8-8783-93e4fce01945"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span></p>\n</td>", "ID": "96b89ba8-8bfa-4ade-af2b-454221f380b7", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span></p>", "ID": "48768634-9ec9-4512-9b01-a15b13833493", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96b89ba8-8bfa-4ade-af2b-454221f380b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">8</span>", "ID": "1d976383-19ba-42f1-a8b8-b8b2cf071991", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "8", "ParentId": "48768634-9ec9-4512-9b01-a15b13833493"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span></p>\n</td>", "ID": "411f49b1-092a-443c-aa40-f043e3f909d5", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1a8e6e71-ae99-4a22-90eb-1783b2c0d63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span></p>", "ID": "23a95c80-90eb-4a79-bbc6-169f5227d3d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "411f49b1-092a-443c-aa40-f043e3f909d5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.011 (0.006\u20110.364)</span>", "ID": "ed26658d-4755-4fd0-8ca1-128b8a8a40bd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.011 (0.006\u20110.364)", "ParentId": "23a95c80-90eb-4a79-bbc6-169f5227d3d2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span></p>\n</td>\n</tr>", "ID": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>\n</td>", "ID": "a3cc7b60-ff29-402e-a9e5-26ebc740a9db", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span></p>", "ID": "23b5874a-585a-4751-950d-d93f56b8ed3c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a3cc7b60-ff29-402e-a9e5-26ebc740a9db"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2b</span>", "ID": "97d9f484-d406-4cfe-9bcb-43cb6b864d7b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2b", "ParentId": "23b5874a-585a-4751-950d-d93f56b8ed3c"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "1dadddbd-706f-4406-b81c-b6357e196425", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "f523ef90-f613-4a66-bdc0-be223b25dec8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1dadddbd-706f-4406-b81c-b6357e196425"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "047af321-8971-47a7-ac39-3d3dae8475dd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "f523ef90-f613-4a66-bdc0-be223b25dec8"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "eeaf09ba-c7d5-40ba-9e37-718be6d75ae9", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "2cb29ae6-56e4-474d-9d4b-b39130900bbc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eeaf09ba-c7d5-40ba-9e37-718be6d75ae9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "5789a20b-9f74-4be4-b18b-e9a48f4b72f2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "2cb29ae6-56e4-474d-9d4b-b39130900bbc"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span></p>\n</td>", "ID": "dafe62d2-5108-4a20-a539-dcea923b0b09", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span></p>", "ID": "9dff1761-3504-4482-8643-fdeeb9f881c2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dafe62d2-5108-4a20-a539-dcea923b0b09"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">16</span>", "ID": "bc834bd1-44b9-438c-827d-6aa77ac917c2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "16", "ParentId": "9dff1761-3504-4482-8643-fdeeb9f881c2"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span></p>\n</td>", "ID": "b49b655c-8f05-4647-ba4b-2cc5e622d56e", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8b03885-2742-4cd2-ad04-a4367dd3c2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span></p>", "ID": "e980b388-1eee-4f1a-9086-c6e290a0b4bc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b49b655c-8f05-4647-ba4b-2cc5e622d56e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.0003\u20110.007)</span>", "ID": "cb32f848-53d9-49f5-9fa5-748fec0e2f0f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.002 (0.0003\u20110.007)", "ParentId": "e980b388-1eee-4f1a-9086-c6e290a0b4bc"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span></p>\n</td>\n</tr>", "ID": "f399c452-d486-4eae-b5ed-1fd5a57c0074", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>\n</td>", "ID": "bf51513f-36e9-464d-a217-53d10b503dd8", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f399c452-d486-4eae-b5ed-1fd5a57c0074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span></p>", "ID": "ae8c0af2-b940-46c3-8863-5319272b3d42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf51513f-36e9-464d-a217-53d10b503dd8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3a</span>", "ID": "111bca91-9316-4fd9-95e2-133160ed60d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3a", "ParentId": "ae8c0af2-b940-46c3-8863-5319272b3d42"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span></p>\n</td>", "ID": "338f118a-52d5-4bc2-9195-0fd9cd3a36f4", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f399c452-d486-4eae-b5ed-1fd5a57c0074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span></p>", "ID": "ad59a54d-d82e-4fd2-a7a7-b84e17e7bb04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "338f118a-52d5-4bc2-9195-0fd9cd3a36f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">106</span>", "ID": "5eacb5ab-c6b8-46be-9bb0-d2edcb930f39", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "106", "ParentId": "ad59a54d-d82e-4fd2-a7a7-b84e17e7bb04"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span></p>\n</td>", "ID": "05371506-9fe7-49d9-b1b8-f81b7d3aa932", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f399c452-d486-4eae-b5ed-1fd5a57c0074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span></p>", "ID": "fe4c6696-8ae3-4dea-8bb5-a0226c59ebbb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "05371506-9fe7-49d9-b1b8-f81b7d3aa932"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">81 (24\u2011181)</span>", "ID": "2901e947-1aa9-4c9f-bb32-760a517b2e26", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "81 (24\u2011181)", "ParentId": "fe4c6696-8ae3-4dea-8bb5-a0226c59ebbb"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span></p>\n</td>", "ID": "14af301c-3d44-4118-a2d8-aa885a70baa8", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f399c452-d486-4eae-b5ed-1fd5a57c0074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span></p>", "ID": "b7d9a26f-e8f9-4e13-9bf4-41be69d4d9f2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "14af301c-3d44-4118-a2d8-aa885a70baa8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">38</span>", "ID": "dac08417-5450-42c7-b927-faebdc0530de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "38", "ParentId": "b7d9a26f-e8f9-4e13-9bf4-41be69d4d9f2"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span></p>\n</td>", "ID": "743e51d1-e703-4adb-80f8-df57d913d46d", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f399c452-d486-4eae-b5ed-1fd5a57c0074"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span></p>", "ID": "9f84dcd1-49fe-41ca-94e6-6049ee912784", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "743e51d1-e703-4adb-80f8-df57d913d46d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.002\u20111.871)</span>", "ID": "95dddba7-5ee6-484c-8728-60786193f001", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.005 (0.002\u20111.871)", "ParentId": "9f84dcd1-49fe-41ca-94e6-6049ee912784"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span></p>\n</td>\n</tr>", "ID": "39464a0a-489d-4ce7-99e5-0260cce54370", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>\n</td>", "ID": "73b78d23-c328-4282-907e-ccb57fd189ea", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39464a0a-489d-4ce7-99e5-0260cce54370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span></p>", "ID": "d8c094d0-ad42-486e-94ff-de523a5ed3cf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73b78d23-c328-4282-907e-ccb57fd189ea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4a</span>", "ID": "c6103120-27aa-4607-92c2-d5d7852b1b30", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4a", "ParentId": "d8c094d0-ad42-486e-94ff-de523a5ed3cf"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "31bb64b0-8a01-419b-accb-6c6c593eea0e", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39464a0a-489d-4ce7-99e5-0260cce54370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "9147f202-c0df-4f7f-9a50-cb947aa7c1a7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31bb64b0-8a01-419b-accb-6c6c593eea0e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "e0447ec8-f8fe-4285-8f9e-94b60902327d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "9147f202-c0df-4f7f-9a50-cb947aa7c1a7"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "44452fff-1799-4547-b1dc-3ed96f62b11b", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39464a0a-489d-4ce7-99e5-0260cce54370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "b5d44d81-19ad-46dd-bb12-506123ebf873", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44452fff-1799-4547-b1dc-3ed96f62b11b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "bc326580-2de5-4bcb-9765-3f47ad71a707", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "b5d44d81-19ad-46dd-bb12-506123ebf873"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span></p>\n</td>", "ID": "3ff5cd21-46ad-4bf9-8166-1e8db1dad97c", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39464a0a-489d-4ce7-99e5-0260cce54370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span></p>", "ID": "cc32ccb2-b9c3-4b7c-927c-e897fcb7d9c2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ff5cd21-46ad-4bf9-8166-1e8db1dad97c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">5</span>", "ID": "c3f6a986-c54d-4128-b038-e0ffb5c72b28", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "5", "ParentId": "cc32ccb2-b9c3-4b7c-927c-e897fcb7d9c2"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span></p>\n</td>", "ID": "a190ecfa-8ca6-4219-ae82-21af0157b45e", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39464a0a-489d-4ce7-99e5-0260cce54370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span></p>", "ID": "9d4f2521-9779-4f17-b640-e0135feb073a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a190ecfa-8ca6-4219-ae82-21af0157b45e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.002 (0.001\u20110.004)</span>", "ID": "65a07c27-3a54-49f5-b4c2-2d3660a1ae03", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.002 (0.001\u20110.004)", "ParentId": "9d4f2521-9779-4f17-b640-e0135feb073a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span></p>\n</td>\n</tr>", "ID": "e597a332-537b-4a0a-a7f2-e9419d617ba3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>\n</td>", "ID": "e2a112ef-533e-4949-aa7e-3581f0a1d9e9", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e597a332-537b-4a0a-a7f2-e9419d617ba3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span></p>", "ID": "f1dab033-ab7a-40bc-99a6-a6b7ec4b0b1a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e2a112ef-533e-4949-aa7e-3581f0a1d9e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4d</span>", "ID": "561ef02c-a27c-44e5-82fd-15ebb6fcb669", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4d", "ParentId": "f1dab033-ab7a-40bc-99a6-a6b7ec4b0b1a"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "393eec87-2852-4c05-a999-c77243d1d593", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e597a332-537b-4a0a-a7f2-e9419d617ba3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "4f8677e6-1199-4acb-a235-1a63edc7d21f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "393eec87-2852-4c05-a999-c77243d1d593"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "d89b889b-60fe-4b46-b0fd-535de0e1817b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "4f8677e6-1199-4acb-a235-1a63edc7d21f"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "53a75581-2ba7-40a6-baf6-f9ed83c70875", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e597a332-537b-4a0a-a7f2-e9419d617ba3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "27f3b8d6-6f33-480f-9846-cbb0974f9489", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "53a75581-2ba7-40a6-baf6-f9ed83c70875"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "a4946251-35b1-44c5-8f2f-9ae5ff51ad15", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "27f3b8d6-6f33-480f-9846-cbb0974f9489"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span></p>\n</td>", "ID": "bfa74c66-a5d6-453d-aa6f-8f86d7a0b774", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e597a332-537b-4a0a-a7f2-e9419d617ba3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span></p>", "ID": "530771bc-fef7-4503-b3c9-4e824e4d405f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bfa74c66-a5d6-453d-aa6f-8f86d7a0b774"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">10</span>", "ID": "847f9d58-5580-4226-ae66-642c052c7917", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "10", "ParentId": "530771bc-fef7-4503-b3c9-4e824e4d405f"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span></p>\n</td>", "ID": "8c535b59-4958-4c08-817b-57eac2f731b8", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e597a332-537b-4a0a-a7f2-e9419d617ba3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span></p>", "ID": "41bc442b-6cc3-4d30-bfcb-b398d74dcdba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8c535b59-4958-4c08-817b-57eac2f731b8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.004\u20110.011)</span>", "ID": "f8031f4c-d60f-497e-9647-16ddc9852621", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.007 (0.004\u20110.011)", "ParentId": "41bc442b-6cc3-4d30-bfcb-b398d74dcdba"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span></p>\n</td>\n</tr>", "ID": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span></p>\n</td>", "ID": "1cb401b4-6480-4097-a64c-3006bf91b880", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span></p>", "ID": "1dd521e6-8374-4ef6-bed2-281d7ec94789", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1cb401b4-6480-4097-a64c-3006bf91b880"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4r</span>", "ID": "a81762f3-3d35-4158-afde-959737bfb712", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4r", "ParentId": "1dd521e6-8374-4ef6-bed2-281d7ec94789"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "678ae18f-200a-4533-9a11-562d3865f492", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "8cba13ae-339c-4c20-8dd8-cb7cac32613e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "678ae18f-200a-4533-9a11-562d3865f492"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "24a2cc40-a35a-43a6-9cbe-3c5ad921a6de", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "8cba13ae-339c-4c20-8dd8-cb7cac32613e"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "18aecf34-c134-4015-8088-c760b1a15454", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "96e60fcf-4310-44af-a44d-4ac3c3717ce4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18aecf34-c134-4015-8088-c760b1a15454"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "755d884a-c65d-4e99-a4d1-6bdcfe0de41f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "96e60fcf-4310-44af-a44d-4ac3c3717ce4"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span></p>\n</td>", "ID": "69a84edc-2114-4987-a4a0-fb3aa915c4a3", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span></p>", "ID": "4faf15ff-ed81-460a-92df-a926791ab0cf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69a84edc-2114-4987-a4a0-fb3aa915c4a3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">7</span>", "ID": "0234b20a-0c9f-40be-bf8a-ca398d530701", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "7", "ParentId": "4faf15ff-ed81-460a-92df-a926791ab0cf"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span></p>\n</td>", "ID": "70337eba-9e23-4ced-976d-c5a3819a723f", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "764a47ce-17bc-4f3d-a50f-c2eb6cb53e51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span></p>", "ID": "4d04fabb-8cda-449f-b0aa-763b2920a7a2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "70337eba-9e23-4ced-976d-c5a3819a723f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.003 (0.002\u20110.006)</span>", "ID": "83195dda-02f6-48ed-8f91-e49709bfa4d2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.003 (0.002\u20110.006)", "ParentId": "4d04fabb-8cda-449f-b0aa-763b2920a7a2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span></p>\n</td>\n</tr>", "ID": "194f1a7d-ac33-4815-a68f-85500b0e3a0a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>\n</td>", "ID": "7d3f5d31-26a2-47a3-a5bf-b24f98aa9cf8", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "194f1a7d-ac33-4815-a68f-85500b0e3a0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span></p>", "ID": "45bb9638-2e7b-45f2-970a-d8a14386f964", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d3f5d31-26a2-47a3-a5bf-b24f98aa9cf8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">5a</span>", "ID": "ec62f7ef-189f-46da-a9b7-6b3cb73faabb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "5a", "ParentId": "45bb9638-2e7b-45f2-970a-d8a14386f964"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "e43b44ea-44b0-421a-81d7-2cdbd62f82c7", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "194f1a7d-ac33-4815-a68f-85500b0e3a0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "8be8c0ca-ebb2-482a-8817-904c0784f3b6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e43b44ea-44b0-421a-81d7-2cdbd62f82c7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "2e6796d5-98ae-41c3-bd52-551e2b8319ee", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "8be8c0ca-ebb2-482a-8817-904c0784f3b6"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "2914ac48-00b6-47c0-b5f5-89643576fc57", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "194f1a7d-ac33-4815-a68f-85500b0e3a0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "70c30d2c-755e-4492-970c-151c5e33715f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2914ac48-00b6-47c0-b5f5-89643576fc57"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "78d2afed-ecb7-4ad4-9e3d-ad7a3acede2d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "70c30d2c-755e-4492-970c-151c5e33715f"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span></p>\n</td>", "ID": "5a68216f-8318-4eb9-a912-e3aba77516f4", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "194f1a7d-ac33-4815-a68f-85500b0e3a0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span></p>", "ID": "5fdb60b6-e388-44e3-8ad6-cc807a9cff33", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a68216f-8318-4eb9-a912-e3aba77516f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">42</span>", "ID": "71c19872-97d4-4a65-a60e-88055415a57a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "42", "ParentId": "5fdb60b6-e388-44e3-8ad6-cc807a9cff33"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span></p>\n</td>", "ID": "fea8d07f-644b-47b1-a2d3-3ea01059281b", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "194f1a7d-ac33-4815-a68f-85500b0e3a0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span></p>", "ID": "ba9b5451-82cd-4d2f-b289-937f3665283e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fea8d07f-644b-47b1-a2d3-3ea01059281b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.005 (0.001\u20110.019)</span>", "ID": "c60328d5-47a1-4938-8cd6-6701b8f5b95c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.005 (0.001\u20110.019)", "ParentId": "ba9b5451-82cd-4d2f-b289-937f3665283e"}, {"Element": "<tr style=\"page-break-inside:avoid;height:3.2pt\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span></p>\n</td>\n</tr>", "ID": "973dcf3a-2460-4f68-8622-addd69633091", "Styles": "page-break-inside:avoid;height:3.2pt", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>\n</td>", "ID": "d5e46c42-15a6-488f-8087-a9f34e83c914", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "973dcf3a-2460-4f68-8622-addd69633091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span></p>", "ID": "d52c6a03-5f5e-419d-9a12-e70096b549d7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5e46c42-15a6-488f-8087-a9f34e83c914"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">6a</span>", "ID": "959c75e5-8d3c-4c6a-8fef-c1bf180abb73", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "6a", "ParentId": "d52c6a03-5f5e-419d-9a12-e70096b549d7"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "c4576222-9a0d-4da2-b910-4099d783efcb", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "973dcf3a-2460-4f68-8622-addd69633091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "eb9f779e-f93f-4a8c-8cda-e78351c7457f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c4576222-9a0d-4da2-b910-4099d783efcb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "29266b36-39e4-4ec4-8068-9f1f7087d0d7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "eb9f779e-f93f-4a8c-8cda-e78351c7457f"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "1147ce70-1404-48f4-9f56-b39e2ea9801e", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "973dcf3a-2460-4f68-8622-addd69633091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "245fe256-112f-42e0-815d-2d45a2f62c6f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1147ce70-1404-48f4-9f56-b39e2ea9801e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "988c3b08-5ce9-45b8-9255-8ac27de3dac9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "245fe256-112f-42e0-815d-2d45a2f62c6f"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span></p>\n</td>", "ID": "f94a6a90-9810-40f4-b73b-3aec5cb6db66", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "973dcf3a-2460-4f68-8622-addd69633091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span></p>", "ID": "dc4bf713-89e5-4367-be1e-2686d5115453", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f94a6a90-9810-40f4-b73b-3aec5cb6db66"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">26</span>", "ID": "57c1359f-0e88-4447-9cde-37a09b34a8ee", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "26", "ParentId": "dc4bf713-89e5-4367-be1e-2686d5115453"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span></p>\n</td>", "ID": "014c4114-7310-4b66-a184-ef618ddee379", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:3.2pt", "Classes": "None", "Text": "  ", "ParentId": "973dcf3a-2460-4f68-8622-addd69633091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span></p>", "ID": "2143d9fd-2ec4-4b19-ae2c-c59464a1afb2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "014c4114-7310-4b66-a184-ef618ddee379"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.007 (0.0005\u20110.113)</span>", "ID": "4e72b15e-f856-4ece-bdd2-c7112a10f071", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.007 (0.0005\u20110.113)", "ParentId": "2143d9fd-2ec4-4b19-ae2c-c59464a1afb2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>\n<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>\n<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span></p>\n</td>\n</tr>", "ID": "5b039275-203f-41e5-8508-639c38196aa2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "159e7113-bd30-4fbf-98ce-f0599f7d4018"}, {"Element": "<td style=\"width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>\n</td>", "ID": "b298f36b-73a6-4b46-aaf7-c9375c8404c4", "Styles": "width:55.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5b039275-203f-41e5-8508-639c38196aa2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span></p>", "ID": "73373756-3908-4367-b153-f6dc33e46f6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b298f36b-73a6-4b46-aaf7-c9375c8404c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">6e</span>", "ID": "d8959e25-4b53-455e-95a4-0a98df401735", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "6e", "ParentId": "73373756-3908-4367-b153-f6dc33e46f6d"}, {"Element": "<td style=\"width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "8fe32622-5b66-41ef-8f0c-eaefb80d8d06", "Styles": "width:92.1pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5b039275-203f-41e5-8508-639c38196aa2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "b03f0994-809e-4b64-a475-3f0ad418bc40", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fe32622-5b66-41ef-8f0c-eaefb80d8d06"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "4c8139d3-cb09-4263-be8b-be38acdc959e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "b03f0994-809e-4b64-a475-3f0ad418bc40"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>\n</td>", "ID": "b9fe23eb-3de1-48ac-a622-8361b1af2d82", "Styles": "width:92.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5b039275-203f-41e5-8508-639c38196aa2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span></p>", "ID": "c759fbd9-8394-4f16-87b8-5af94ebb95d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b9fe23eb-3de1-48ac-a622-8361b1af2d82"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NA</span>", "ID": "68271814-6982-4b4e-ae19-dea2de27f950", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NA", "ParentId": "c759fbd9-8394-4f16-87b8-5af94ebb95d8"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>\n</td>", "ID": "66c3f168-fc8a-40d5-819a-dd3a469ebdce", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5b039275-203f-41e5-8508-639c38196aa2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span></p>", "ID": "fdbf63dc-3b1a-46cd-9071-74adafa06a91", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "66c3f168-fc8a-40d5-819a-dd3a469ebdce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">15</span>", "ID": "a643db14-601d-4487-834b-e9c966947f7b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "15", "ParentId": "fdbf63dc-3b1a-46cd-9071-74adafa06a91"}, {"Element": "<td style=\"width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"132\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span></p>\n</td>", "ID": "175bfda6-0a8f-455a-840d-d9abd68eb63f", "Styles": "width:99.25pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5b039275-203f-41e5-8508-639c38196aa2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span></p>", "ID": "49db063e-4415-4515-a6ba-594be24b1063", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "175bfda6-0a8f-455a-840d-d9abd68eb63f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0.024 (0.005\u20110.433))</span>", "ID": "1d20746b-274a-409a-96ad-d7cd24468929", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0.024 (0.005\u20110.433))", "ParentId": "49db063e-4415-4515-a6ba-594be24b1063"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span></p>", "ID": "0b597d13-8baf-44df-a383-1ef3f70d3c4d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">NA\u00a0=\u00a0Not available</span>", "ID": "3769f79d-1c40-49c2-af08-ce9725ae15b5", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "NA\u00a0=\u00a0Not available", "ParentId": "0b597d13-8baf-44df-a383-1ef3f70d3c4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "92e8cbbe-0d19-4661-9fd5-6e03797c1fb5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e04cca5-81f9-4c1b-afa0-7c36e8e2faf7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "92e8cbbe-0d19-4661-9fd5-6e03797c1fb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The presence of\n40% human serum had no effect on the anti\u2011HCV activity of sofosbuvir but\nreduced the anti\u2011HCV activity of velpatasvir by 13\u2011fold against\ngenotype\u00a01a HCV replicons.</span></p>", "ID": "fbf5c961-db71-4f3c-bd2a-dca377f9baa9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The presence of\n40% human serum had no effect on the anti\u2011HCV activity of sofosbuvir but\nreduced the anti\u2011HCV activity of velpatasvir by 13\u2011fold against\ngenotype\u00a01a HCV replicons.</span>", "ID": "a00a5a5b-fa74-491c-9b38-38e8c093aeb5", "Styles": "None", "Classes": "None", "Text": "The presence of 40% human serum had no effect on the anti\u2011HCV activity of sofosbuvir but reduced the anti\u2011HCV activity of velpatasvir by 13\u2011fold against genotype\u00a01a HCV replicons.", "ParentId": "fbf5c961-db71-4f3c-bd2a-dca377f9baa9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8cd02578-7b66-492e-9eb9-d369cb15be82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "093a0164-c041-4c71-8f78-c300bdef8abd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8cd02578-7b66-492e-9eb9-d369cb15be82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Evaluation of\nsofosbuvir in combination with velpatasvir showed no antagonistic effect in\nreducing HCV\u00a0RNA levels in replicon cells.</span></p>", "ID": "f5bbf7fa-fcab-4c91-b404-c0649f05d6e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Evaluation of\nsofosbuvir in combination with velpatasvir showed no antagonistic effect in\nreducing HCV\u00a0RNA levels in replicon cells.</span>", "ID": "634623d1-369b-4dc2-83b4-963935b50e16", "Styles": "None", "Classes": "None", "Text": "Evaluation of sofosbuvir in combination with velpatasvir showed no antagonistic effect in reducing HCV\u00a0RNA levels in replicon cells.", "ParentId": "f5bbf7fa-fcab-4c91-b404-c0649f05d6e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa8693ef-db37-43af-a350-41a7dfff7c8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b42d02cb-ea27-42fa-bb26-248a046a3221", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa8693ef-db37-43af-a350-41a7dfff7c8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Resistance</span></u></p>", "ID": "db9186b8-3daf-4448-92d3-a14d93392642", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Resistance</span></u>", "ID": "819a30f7-c57c-43d8-8fbb-48f4270ec8b2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "db9186b8-3daf-4448-92d3-a14d93392642"}, {"Element": "<span lang=\"EN-GB\">Resistance</span>", "ID": "4ee89bf1-9c97-4b70-b3ab-6ff5c4a05c90", "Styles": "None", "Classes": "None", "Text": "Resistance", "ParentId": "819a30f7-c57c-43d8-8fbb-48f4270ec8b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">In cell culture</span></i></p>", "ID": "860960ff-4530-4ca4-a38e-17f663dbacab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">In cell culture</span></i>", "ID": "16ce5298-f327-401e-b6d2-a37601d68132", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "860960ff-4530-4ca4-a38e-17f663dbacab"}, {"Element": "<span lang=\"EN-GB\">In cell culture</span>", "ID": "2b2c59eb-d5b3-425e-bacd-fe368eb821a7", "Styles": "None", "Classes": "None", "Text": "In cell culture", "ParentId": "16ce5298-f327-401e-b6d2-a37601d68132"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">HCV replicons\nwith reduced susceptibility to sofosbuvir have been selected in cell culture\nfor multiple genotypes including 1b, 2a, 2b, 3a, 4a, 5a and 6a.\u00a0 Reduced\nsusceptibility to sofosbuvir was associated with the primary NS5B substitution\nS282T in all replicon genotypes examined.\u00a0 Site-directed mutagenesis of\nthe S282T substitution in replicons of genotype\u00a01 to 6 conferred 2\u2011\nto 18\u2011fold reduced susceptibility to sofosbuvir and reduced the\nreplication viral capacity by 89% to 99% compared to the corresponding\nwild-type.\u00a0 In biochemical assays, the ability of the active triphosphate\nof sofosbuvir (GS\u2011461203) to inhibit recombinant NS5B polymerase from\ngenotypes\u00a01b, 2a, 3a and 4a expressing the S282T substitution was reduced\ncompared to its ability to inhibit wild-type recombinant NS5B polymerase, as\nindicated by a 8.5\u2011 to 24\u2011fold increase in the 50% inhibitory\nconcentration (IC<sub>50</sub>).</span></p>", "ID": "08cbbd85-f7c4-4c1c-a112-609ee65467bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">HCV replicons\nwith reduced susceptibility to sofosbuvir have been selected in cell culture\nfor multiple genotypes including 1b, 2a, 2b, 3a, 4a, 5a and 6a.\u00a0 Reduced\nsusceptibility to sofosbuvir was associated with the primary NS5B substitution\nS282T in all replicon genotypes examined.\u00a0 Site-directed mutagenesis of\nthe S282T substitution in replicons of genotype\u00a01 to 6 conferred 2\u2011\nto 18\u2011fold reduced susceptibility to sofosbuvir and reduced the\nreplication viral capacity by 89% to 99% compared to the corresponding\nwild-type.\u00a0 In biochemical assays, the ability of the active triphosphate\nof sofosbuvir (GS\u2011461203) to inhibit recombinant NS5B polymerase from\ngenotypes\u00a01b, 2a, 3a and 4a expressing the S282T substitution was reduced\ncompared to its ability to inhibit wild-type recombinant NS5B polymerase, as\nindicated by a 8.5\u2011 to 24\u2011fold increase in the 50% inhibitory\nconcentration (IC<sub>50</sub>).</span>", "ID": "642697fe-c5b5-418d-81fa-ce0d9943c25d", "Styles": "None", "Classes": "None", "Text": "HCV replicons with reduced susceptibility to sofosbuvir have been selected in cell culture for multiple genotypes including 1b, 2a, 2b, 3a, 4a, 5a and 6a.\u00a0 Reduced susceptibility to sofosbuvir was associated with the primary NS5B substitution S282T in all replicon genotypes examined.\u00a0 Site-directed mutagenesis of the S282T substitution in replicons of genotype\u00a01 to 6 conferred 2\u2011 to 18\u2011fold reduced susceptibility to sofosbuvir and reduced the replication viral capacity by 89% to 99% compared to the corresponding wild-type.\u00a0 In biochemical assays, the ability of the active triphosphate of sofosbuvir (GS\u2011461203) to inhibit recombinant NS5B polymerase from genotypes\u00a01b, 2a, 3a and 4a expressing the S282T substitution was reduced compared to its ability to inhibit wild-type recombinant NS5B polymerase, as indicated by a 8.5\u2011 to 24\u2011fold increase in the 50% inhibitory concentration (IC).", "ParentId": "08cbbd85-f7c4-4c1c-a112-609ee65467bc"}, {"Element": "<sub>50</sub>", "ID": "d790ca35-19bb-42db-8c0d-a45106b5e389", "Styles": "None", "Classes": "None", "Text": "50", "ParentId": "642697fe-c5b5-418d-81fa-ce0d9943c25d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e0d2e04-9bef-4e8c-a0d9-62ea80f2cd8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4b671e6b-6ee1-466c-a58e-3bd9ba3833cc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e0d2e04-9bef-4e8c-a0d9-62ea80f2cd8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In\u00a0vitro</span></i><span lang=\"EN-GB\"> selection of HCV replicons with reduced susceptibility to\nvelpatasvir was performed in cell culture for multiple genotypes including 1a,\n1b, 2a, 3a, 4a, 5a and 6a.\u00a0 Variants were selected at NS5A resistance\nassociated positions 24, 28, 30, 31, 32, 58, 92 and 93. \u00a0The resistance\nassociated variants (RAVs) selected in 2 or more genotypes were F28S, L31I/V\nand Y93H.\u00a0 Site-directed mutagenesis of known NS5A\u00a0RAVs showed that\nsubstitutions conferring a &gt;\u00a0100\u2011fold reduction in velpatasvir\nsusceptibility are M28G, A92K and Y93H/N/R/W in genotype\u00a01a, A92K in\ngenotype\u00a01b, C92T and Y93H/N in genotype\u00a02b, Y93H in genotype\u00a03,\nand L31V and P32A/L/Q/R in genotype\u00a06.\u00a0 No individual substitutions\ntested in genotypes\u00a02a, 4a, or 5a conferred a &gt;\u00a0100\u2011fold\nreduction in velpatasvir susceptibility. \u00a0Combinations of these variants\noften showed greater reductions in susceptibility to velpatasvir than single\nRAVs alone.</span></p>", "ID": "165b7f95-4ba2-4db7-a16e-5d6efaaa068a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">In\u00a0vitro</span></i>", "ID": "96ab76c8-cb3f-4d60-aaa0-997ea30b71e7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "165b7f95-4ba2-4db7-a16e-5d6efaaa068a"}, {"Element": "<span lang=\"EN-GB\">In\u00a0vitro</span>", "ID": "58dfe106-0216-4248-b4e0-1e4070813574", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro", "ParentId": "96ab76c8-cb3f-4d60-aaa0-997ea30b71e7"}, {"Element": "<span lang=\"EN-GB\"> selection of HCV replicons with reduced susceptibility to\nvelpatasvir was performed in cell culture for multiple genotypes including 1a,\n1b, 2a, 3a, 4a, 5a and 6a.\u00a0 Variants were selected at NS5A resistance\nassociated positions 24, 28, 30, 31, 32, 58, 92 and 93. \u00a0The resistance\nassociated variants (RAVs) selected in 2 or more genotypes were F28S, L31I/V\nand Y93H.\u00a0 Site-directed mutagenesis of known NS5A\u00a0RAVs showed that\nsubstitutions conferring a &gt;\u00a0100\u2011fold reduction in velpatasvir\nsusceptibility are M28G, A92K and Y93H/N/R/W in genotype\u00a01a, A92K in\ngenotype\u00a01b, C92T and Y93H/N in genotype\u00a02b, Y93H in genotype\u00a03,\nand L31V and P32A/L/Q/R in genotype\u00a06.\u00a0 No individual substitutions\ntested in genotypes\u00a02a, 4a, or 5a conferred a &gt;\u00a0100\u2011fold\nreduction in velpatasvir susceptibility. \u00a0Combinations of these variants\noften showed greater reductions in susceptibility to velpatasvir than single\nRAVs alone.</span>", "ID": "0b5053e8-ea7e-4689-897a-c072b1e9b65c", "Styles": "None", "Classes": "None", "Text": " selection of HCV replicons with reduced susceptibility to velpatasvir was performed in cell culture for multiple genotypes including 1a, 1b, 2a, 3a, 4a, 5a and 6a.\u00a0 Variants were selected at NS5A resistance associated positions 24, 28, 30, 31, 32, 58, 92 and 93. \u00a0The resistance associated variants (RAVs) selected in 2 or more genotypes were F28S, L31I/V and Y93H.\u00a0 Site-directed mutagenesis of known NS5A\u00a0RAVs showed that substitutions conferring a >\u00a0100\u2011fold reduction in velpatasvir susceptibility are M28G, A92K and Y93H/N/R/W in genotype\u00a01a, A92K in genotype\u00a01b, C92T and Y93H/N in genotype\u00a02b, Y93H in genotype\u00a03, and L31V and P32A/L/Q/R in genotype\u00a06.\u00a0 No individual substitutions tested in genotypes\u00a02a, 4a, or 5a conferred a >\u00a0100\u2011fold reduction in velpatasvir susceptibility. \u00a0Combinations of these variants often showed greater reductions in susceptibility to velpatasvir than single RAVs alone.", "ParentId": "165b7f95-4ba2-4db7-a16e-5d6efaaa068a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "601c3d44-b10c-41f7-be40-e98c3b820f2f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "816bc807-50ba-4567-aa69-ff0f71f14ba2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "601c3d44-b10c-41f7-be40-e98c3b820f2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">In clinical studies</span></i></p>", "ID": "1e1bf17d-3c69-41db-bb9e-f94643d9a561", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">In clinical studies</span></i>", "ID": "a68ccec9-dd82-4c9d-a822-48baf3742cef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1e1bf17d-3c69-41db-bb9e-f94643d9a561"}, {"Element": "<span lang=\"EN-GB\">In clinical studies</span>", "ID": "db7681cb-0972-4192-83f9-d6f3c49d17ca", "Styles": "None", "Classes": "None", "Text": "In clinical studies", "ParentId": "a68ccec9-dd82-4c9d-a822-48baf3742cef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>", "ID": "cb2622c3-0fd4-4366-a98b-31de74805d1b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i>", "ID": "baa9f11e-ff43-4db8-905a-95e31308ae95", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb2622c3-0fd4-4366-a98b-31de74805d1b"}, {"Element": "<span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span>", "ID": "48e7d461-db82-4a4f-b56b-312fcd819743", "Styles": "None", "Classes": "None", "Text": "Studies in patients without cirrhosis and patients with compensated cirrhosis", "ParentId": "baa9f11e-ff43-4db8-905a-95e31308ae95"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a pooled\nanalysis of patients without cirrhosis or with compensated cirrhosis who\nreceived Epclusa for 12\u00a0weeks in three Phase\u00a03 studies, 12\u00a0patients\n(2 with genotype\u00a01 and 10 with genotype\u00a03) qualified for resistance\nanalysis due to virologic failure.\u00a0 One additional patient with genotype\u00a03\nHCV infection at baseline was reinfected with genotype\u00a01a HCV at virologic\nfailure and was excluded from the virological analysis.\u00a0 No patients with\ngenotype\u00a02, 4, 5, or 6 HCV infection experienced virologic failure.</span></p>", "ID": "41143235-7e02-41ed-931e-cd018df153ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">In a pooled\nanalysis of patients without cirrhosis or with compensated cirrhosis who\nreceived Epclusa for 12\u00a0weeks in three Phase\u00a03 studies, 12\u00a0patients\n(2 with genotype\u00a01 and 10 with genotype\u00a03) qualified for resistance\nanalysis due to virologic failure.\u00a0 One additional patient with genotype\u00a03\nHCV infection at baseline was reinfected with genotype\u00a01a HCV at virologic\nfailure and was excluded from the virological analysis.\u00a0 No patients with\ngenotype\u00a02, 4, 5, or 6 HCV infection experienced virologic failure.</span>", "ID": "0d211d3f-1a26-4edd-9502-5034f5d1f964", "Styles": "None", "Classes": "None", "Text": "In a pooled analysis of patients without cirrhosis or with compensated cirrhosis who received Epclusa for 12\u00a0weeks in three Phase\u00a03 studies, 12\u00a0patients (2 with genotype\u00a01 and 10 with genotype\u00a03) qualified for resistance analysis due to virologic failure.\u00a0 One additional patient with genotype\u00a03 HCV infection at baseline was reinfected with genotype\u00a01a HCV at virologic failure and was excluded from the virological analysis.\u00a0 No patients with genotype\u00a02, 4, 5, or 6 HCV infection experienced virologic failure.", "ParentId": "41143235-7e02-41ed-931e-cd018df153ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc225a36-fca2-440c-9963-2139e97a328e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "145490f8-3b41-48df-83a7-3154fe11f169", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc225a36-fca2-440c-9963-2139e97a328e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 2\ngenotype\u00a01 virologic failure patients, one patient had virus with emergent\nNS5A\u00a0RAV Y93N and the other patient had virus with emergent NS5A\u00a0RAVs\nL31I/V and Y93H at virologic failure. \u00a0Both patients had virus at baseline\nharboring NS5A\u00a0RAVs.\u00a0 No NS5B nucleoside inhibitor (NI) RAVs were\nobserved at failure in the 2\u00a0patients.</span></p>", "ID": "2dbdc86e-1ea9-4404-83bf-6904e29a04c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Of the 2\ngenotype\u00a01 virologic failure patients, one patient had virus with emergent\nNS5A\u00a0RAV Y93N and the other patient had virus with emergent NS5A\u00a0RAVs\nL31I/V and Y93H at virologic failure. \u00a0Both patients had virus at baseline\nharboring NS5A\u00a0RAVs.\u00a0 No NS5B nucleoside inhibitor (NI) RAVs were\nobserved at failure in the 2\u00a0patients.</span>", "ID": "85a99fb8-32aa-400b-9ad1-be5e08543262", "Styles": "None", "Classes": "None", "Text": "Of the 2 genotype\u00a01 virologic failure patients, one patient had virus with emergent NS5A\u00a0RAV Y93N and the other patient had virus with emergent NS5A\u00a0RAVs L31I/V and Y93H at virologic failure. \u00a0Both patients had virus at baseline harboring NS5A\u00a0RAVs.\u00a0 No NS5B nucleoside inhibitor (NI) RAVs were observed at failure in the 2\u00a0patients.", "ParentId": "2dbdc86e-1ea9-4404-83bf-6904e29a04c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "93059b68-1d49-49c9-9718-4ca55c86982f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b89814e2-32d5-49b8-a160-8d04571feadd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "93059b68-1d49-49c9-9718-4ca55c86982f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 10\ngenotype\u00a03 virologic failure patients, Y93H was observed in all 10\u00a0patients\nat failure (6 had Y93H emerge post-treatment and 4\u00a0patients had Y93H at\nbaseline and post-treatment).\u00a0 No NS5B\u00a0NI\u00a0RAVs were observed at\nfailure in the 10\u00a0patients.</span></p>", "ID": "31687b52-83cd-4496-938f-3c14abac63c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Of the 10\ngenotype\u00a03 virologic failure patients, Y93H was observed in all 10\u00a0patients\nat failure (6 had Y93H emerge post-treatment and 4\u00a0patients had Y93H at\nbaseline and post-treatment).\u00a0 No NS5B\u00a0NI\u00a0RAVs were observed at\nfailure in the 10\u00a0patients.</span>", "ID": "e61c363b-297a-459f-8233-3c3230e7aa20", "Styles": "None", "Classes": "None", "Text": "Of the 10 genotype\u00a03 virologic failure patients, Y93H was observed in all 10\u00a0patients at failure (6 had Y93H emerge post-treatment and 4\u00a0patients had Y93H at baseline and post-treatment).\u00a0 No NS5B\u00a0NI\u00a0RAVs were observed at failure in the 10\u00a0patients.", "ParentId": "31687b52-83cd-4496-938f-3c14abac63c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83cda4fc-0d78-4b1c-a3e9-0ca15d50dafc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a45fb86f-b62e-47c3-9c86-91da3e4c4e9e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83cda4fc-0d78-4b1c-a3e9-0ca15d50dafc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis</span></i></p>", "ID": "7cf6e573-e218-4a60-b354-623d661f1559", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis</span></i>", "ID": "3e8f2f75-badc-4526-9c4a-e1ab1c014223", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7cf6e573-e218-4a60-b354-623d661f1559"}, {"Element": "<span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis</span>", "ID": "cfd09d71-a373-4bf1-b674-cfafa04a6944", "Styles": "None", "Classes": "None", "Text": "Studies in patients with decompensated cirrhosis", "ParentId": "3e8f2f75-badc-4526-9c4a-e1ab1c014223"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In one Phase\u00a03\nstudy in patients with decompensated cirrhosis who received Epclusa + RBV for\n12\u00a0weeks, 3\u00a0patients (1 with genotype\u00a01 and 2 with\ngenotype\u00a03) qualified for resistance analysis due to virologic\nfailure.\u00a0 No patients with genotype\u00a02 or 4 HCV infection in the Epclusa\n+ RBV 12\u00a0weeks group experienced virologic failure.</span></p>", "ID": "580c8c66-6002-485d-8464-96d37cd8d096", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">In one Phase\u00a03\nstudy in patients with decompensated cirrhosis who received Epclusa + RBV for\n12\u00a0weeks, 3\u00a0patients (1 with genotype\u00a01 and 2 with\ngenotype\u00a03) qualified for resistance analysis due to virologic\nfailure.\u00a0 No patients with genotype\u00a02 or 4 HCV infection in the Epclusa\n+ RBV 12\u00a0weeks group experienced virologic failure.</span>", "ID": "1d2a2331-d694-4f01-aaa8-2c67ae7f3678", "Styles": "None", "Classes": "None", "Text": "In one Phase\u00a03 study in patients with decompensated cirrhosis who received Epclusa + RBV for 12\u00a0weeks, 3\u00a0patients (1 with genotype\u00a01 and 2 with genotype\u00a03) qualified for resistance analysis due to virologic failure.\u00a0 No patients with genotype\u00a02 or 4 HCV infection in the Epclusa + RBV 12\u00a0weeks group experienced virologic failure.", "ParentId": "580c8c66-6002-485d-8464-96d37cd8d096"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b02a98dc-3b5d-4874-9be3-910605605b28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "50335309-2d40-46c1-9949-22d7f5bf7f87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b02a98dc-3b5d-4874-9be3-910605605b28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The 1 virologic\nfailure patient with genotype\u00a01 HCV had no NS5A or NS5B\u00a0RAVs at\nfailure.</span></p>", "ID": "c3e440f2-fa71-4680-961d-ad806800a1db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The 1 virologic\nfailure patient with genotype\u00a01 HCV had no NS5A or NS5B\u00a0RAVs at\nfailure.</span>", "ID": "044facd2-a9a6-4b44-830c-dcdaa8e36fc9", "Styles": "None", "Classes": "None", "Text": "The 1 virologic failure patient with genotype\u00a01 HCV had no NS5A or NS5B\u00a0RAVs at failure.", "ParentId": "c3e440f2-fa71-4680-961d-ad806800a1db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "79aed85a-fc11-4459-8b72-5f1470a13f8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4eaa3a1f-d8d1-4adb-83ce-e974f5a58f0a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "79aed85a-fc11-4459-8b72-5f1470a13f8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 2 genotype\u00a03\nvirologic failure patients, one had NS5A\u00a0RAV Y93H emerge at failure.\u00a0\nAnother patient had virus with Y93H at baseline and virologic failure and also\ndeveloped low levels (&lt;\u00a05%) of NS5B\u00a0NI\u00a0RAVs N142T and E237G\nat failure.\u00a0 Pharmacokinetic data from this patient was consistent with\nnon-adherence to treatment.</span></p>", "ID": "c38cd7fb-7e46-4a77-a6dc-6a93db8845a5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Of the 2 genotype\u00a03\nvirologic failure patients, one had NS5A\u00a0RAV Y93H emerge at failure.\u00a0\nAnother patient had virus with Y93H at baseline and virologic failure and also\ndeveloped low levels (&lt;\u00a05%) of NS5B\u00a0NI\u00a0RAVs N142T and E237G\nat failure.\u00a0 Pharmacokinetic data from this patient was consistent with\nnon-adherence to treatment.</span>", "ID": "fdfb16ac-d56b-4daf-b5ec-72b65143b1a1", "Styles": "None", "Classes": "None", "Text": "Of the 2 genotype\u00a03 virologic failure patients, one had NS5A\u00a0RAV Y93H emerge at failure.\u00a0 Another patient had virus with Y93H at baseline and virologic failure and also developed low levels (<\u00a05%) of NS5B\u00a0NI\u00a0RAVs N142T and E237G at failure.\u00a0 Pharmacokinetic data from this patient was consistent with non-adherence to treatment.", "ParentId": "c38cd7fb-7e46-4a77-a6dc-6a93db8845a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d1f65b9-c755-4c05-bf46-c341529e95aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "07fde398-e761-4f9e-ab51-a39f2cc6afd8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d1f65b9-c755-4c05-bf46-c341529e95aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In this study,\n2\u00a0patients treated with Epclusa for 12 or 24\u00a0weeks without ribavirin\nhad emergent NS5B S282T at low levels (&lt;\u00a05%) along with L159F.</span></p>", "ID": "4fd22e40-5c31-4f63-8562-e86fd4639299", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">In this study,\n2\u00a0patients treated with Epclusa for 12 or 24\u00a0weeks without ribavirin\nhad emergent NS5B S282T at low levels (&lt;\u00a05%) along with L159F.</span>", "ID": "67ae9232-e086-4555-a9cc-e93ebf16e591", "Styles": "None", "Classes": "None", "Text": "In this study, 2\u00a0patients treated with Epclusa for 12 or 24\u00a0weeks without ribavirin had emergent NS5B S282T at low levels (<\u00a05%) along with L159F.", "ParentId": "4fd22e40-5c31-4f63-8562-e86fd4639299"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2ecadda5-5a5c-4528-b10a-b7b2e040fce2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d5f12c9-f9bf-4f1d-8743-432fb8bf54eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2ecadda5-5a5c-4528-b10a-b7b2e040fce2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Effect of baseline HCV resistance-associated variants on treatment outcome</span></u></p>", "ID": "f3637616-d967-4795-9dde-51d92d3c621b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Effect of baseline HCV resistance-associated variants on treatment outcome</span></u>", "ID": "cc54d376-e76d-4707-9441-bb7ac3d8d8bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f3637616-d967-4795-9dde-51d92d3c621b"}, {"Element": "<span lang=\"EN-GB\">Effect of baseline HCV resistance-associated variants on treatment outcome</span>", "ID": "f95e84c4-8922-495c-8f1d-9b4e24cdf7e9", "Styles": "None", "Classes": "None", "Text": "Effect of baseline HCV resistance-associated variants on treatment outcome", "ParentId": "cc54d376-e76d-4707-9441-bb7ac3d8d8bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>", "ID": "1ae931f4-f2a6-4ef2-b76b-967bb6a640d3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i>", "ID": "967ad513-b2de-4c77-ad63-3965bd81f0d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ae931f4-f2a6-4ef2-b76b-967bb6a640d3"}, {"Element": "<span lang=\"EN-GB\">Studies in patients without cirrhosis and patients with compensated\ncirrhosis</span>", "ID": "2771b772-a944-499d-8e12-2213e4fc8a0b", "Styles": "None", "Classes": "None", "Text": "Studies in patients without cirrhosis and patients with compensated cirrhosis", "ParentId": "967ad513-b2de-4c77-ad63-3965bd81f0d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients without cirrhosis or with compensated\ncirrhosis in three Phase\u00a03 clinical studies (ASTRAL\u20111, ASTRAL\u20112\nand ASTRAL\u20113).\u00a0 Of the 1,035\u00a0patients treated with\nsofosbuvir/velpatasvir in the three Phase\u00a03 clinical studies, 1,023\u00a0patients\nwere included in the analysis of NS5A\u00a0RAVs; 7\u00a0patients were excluded\nas they neither achieved sustained virologic response (SVR12) nor had virologic\nfailure and 5\u00a0additional patients were excluded as NS5A gene sequencing\nfailed.\u00a0 In the pooled analysis of the Phase\u00a03 studies, 380/1,023\n(37%) patients\u2019 virus had baseline NS5A\u00a0RAVs.\u00a0 Genotype\u00a02,\n4, and 6 HCV\u2011infected patients had a higher prevalence of NS5A\u00a0RAVs\n(70%, 63% and 52%, respectively) compared to genotype\u00a01 (23%), genotype\u00a03\n(16%), and genotype\u00a05 (18%) HCV\u2011infected patients.</span></p>", "ID": "7a436a1b-f640-4463-a12d-c46dfd6ad363", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients without cirrhosis or with compensated\ncirrhosis in three Phase\u00a03 clinical studies (ASTRAL\u20111, ASTRAL\u20112\nand ASTRAL\u20113).\u00a0 Of the 1,035\u00a0patients treated with\nsofosbuvir/velpatasvir in the three Phase\u00a03 clinical studies, 1,023\u00a0patients\nwere included in the analysis of NS5A\u00a0RAVs; 7\u00a0patients were excluded\nas they neither achieved sustained virologic response (SVR12) nor had virologic\nfailure and 5\u00a0additional patients were excluded as NS5A gene sequencing\nfailed.\u00a0 In the pooled analysis of the Phase\u00a03 studies, 380/1,023\n(37%) patients\u2019 virus had baseline NS5A\u00a0RAVs.\u00a0 Genotype\u00a02,\n4, and 6 HCV\u2011infected patients had a higher prevalence of NS5A\u00a0RAVs\n(70%, 63% and 52%, respectively) compared to genotype\u00a01 (23%), genotype\u00a03\n(16%), and genotype\u00a05 (18%) HCV\u2011infected patients.</span>", "ID": "1e01dc9c-2472-44e0-9480-acfde3ed58d5", "Styles": "None", "Classes": "None", "Text": "Analyses were conducted to explore the association between pre-existing baseline NS5A\u00a0RAVs and treatment outcome for patients without cirrhosis or with compensated cirrhosis in three Phase\u00a03 clinical studies (ASTRAL\u20111, ASTRAL\u20112 and ASTRAL\u20113).\u00a0 Of the 1,035\u00a0patients treated with sofosbuvir/velpatasvir in the three Phase\u00a03 clinical studies, 1,023\u00a0patients were included in the analysis of NS5A\u00a0RAVs; 7\u00a0patients were excluded as they neither achieved sustained virologic response (SVR12) nor had virologic failure and 5\u00a0additional patients were excluded as NS5A gene sequencing failed.\u00a0 In the pooled analysis of the Phase\u00a03 studies, 380/1,023 (37%) patients\u2019 virus had baseline NS5A\u00a0RAVs.\u00a0 Genotype\u00a02, 4, and 6 HCV\u2011infected patients had a higher prevalence of NS5A\u00a0RAVs (70%, 63% and 52%, respectively) compared to genotype\u00a01 (23%), genotype\u00a03 (16%), and genotype\u00a05 (18%) HCV\u2011infected patients.", "ParentId": "7a436a1b-f640-4463-a12d-c46dfd6ad363"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0cf1fba-b41f-4bac-b11a-4d27fabe4777", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "44992c28-9c3a-4710-8c47-28f04323ce2b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0cf1fba-b41f-4bac-b11a-4d27fabe4777"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Baseline RAVs\nhad no relevant impact on SVR12 rates in patients infected with genotype\u00a01,\n2, 4, 5 and 6 HCV, as summarised in Table\u00a06. \u00a0Genotype\u00a03\ninfected patients with the NS5A RAV Y93H at baseline had a lower SVR12 rate\nthan patients without Y93H after treatment with Epclusa for </span><span lang=\"EN-GB\">12\u00a0weeks</span><span lang=\"EN-GB\">, as summarised in Table\u00a07.\n\u00a0In the ASTRAL\u20113 study, the Y93H RAV was detected at baseline in 9%\nof patients treated with Epclusa.</span></p>", "ID": "d2dbeee9-76d4-45f1-9c57-873b93a79bf9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Baseline RAVs\nhad no relevant impact on SVR12 rates in patients infected with genotype\u00a01,\n2, 4, 5 and 6 HCV, as summarised in Table\u00a06. \u00a0Genotype\u00a03\ninfected patients with the NS5A RAV Y93H at baseline had a lower SVR12 rate\nthan patients without Y93H after treatment with Epclusa for </span>", "ID": "5c515ccd-8fb8-479d-94c8-c49081f869e0", "Styles": "None", "Classes": "None", "Text": "Baseline RAVs had no relevant impact on SVR12 rates in patients infected with genotype\u00a01, 2, 4, 5 and 6 HCV, as summarised in Table\u00a06. \u00a0Genotype\u00a03 infected patients with the NS5A RAV Y93H at baseline had a lower SVR12 rate than patients without Y93H after treatment with Epclusa for ", "ParentId": "d2dbeee9-76d4-45f1-9c57-873b93a79bf9"}, {"Element": "<span lang=\"EN-GB\">12\u00a0weeks</span>", "ID": "a7d9baf5-b71c-485b-bd52-8fad70ab923e", "Styles": "None", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "d2dbeee9-76d4-45f1-9c57-873b93a79bf9"}, {"Element": "<span lang=\"EN-GB\">, as summarised in Table\u00a07.\n\u00a0In the ASTRAL\u20113 study, the Y93H RAV was detected at baseline in 9%\nof patients treated with Epclusa.</span>", "ID": "3d7732d7-96a5-4310-8c55-54f326bcad53", "Styles": "None", "Classes": "None", "Text": ", as summarised in Table\u00a07. \u00a0In the ASTRAL\u20113 study, the Y93H RAV was detected at baseline in 9% of patients treated with Epclusa.", "ParentId": "d2dbeee9-76d4-45f1-9c57-873b93a79bf9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dec9db2c-fc9a-46e8-ad8f-e9001522a302", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8b51979e-be5e-4984-bd68-630bba6b6944", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dec9db2c-fc9a-46e8-ad8f-e9001522a302"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a06: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (studies ASTRAL\u20111, ASTRAL\u20112 and\nASTRAL\u20113)</span></b></p>", "ID": "4299d98a-5cd7-44d8-9d23-d0a55673cc11", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a06: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (studies ASTRAL\u20111, ASTRAL\u20112 and\nASTRAL\u20113)</span></b>", "ID": "3aeb78bf-518f-4e8d-9975-72c3811eb969", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4299d98a-5cd7-44d8-9d23-d0a55673cc11"}, {"Element": "<span lang=\"EN-GB\">Table\u00a06: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (studies ASTRAL\u20111, ASTRAL\u20112 and\nASTRAL\u20113)</span>", "ID": "cc81773c-1f50-471a-97fe-7a56e9b13315", "Styles": "None", "Classes": "None", "Text": "Table\u00a06: SVR12 in patients with or without baseline NS5A\u00a0RAVs by HCV genotype (studies ASTRAL\u20111, ASTRAL\u20112 and ASTRAL\u20113)", "ParentId": "3aeb78bf-518f-4e8d-9975-72c3811eb969"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span></p>\n</td>\n</tr>\n</table>", "ID": "fa6e828b-9e00-43ae-99d1-520d7e4463ee", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "    ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "8de996bb-58c0-4610-9392-8372754f5a79", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "fa6e828b-9e00-43ae-99d1-520d7e4463ee"}, {"Element": "<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n</td>\n</tr>", "ID": "7697404c-150d-43ce-9f0d-5fe65a933973", "Styles": "page-break-inside:avoid;height:14.3pt", "Classes": "None", "Text": "   ", "ParentId": "8de996bb-58c0-4610-9392-8372754f5a79"}, {"Element": "<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "e2b746cc-00f6-4a6f-93b7-70226f6b1a8c", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "7697404c-150d-43ce-9f0d-5fe65a933973"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "763d2f6a-7c16-409b-b107-1b79636b664b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e2b746cc-00f6-4a6f-93b7-70226f6b1a8c"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "3c9ffab8-bd1f-48f6-bd15-192a666becc1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "763d2f6a-7c16-409b-b107-1b79636b664b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b4bb83c3-e871-4f45-88aa-f5e75134ae1a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "3c9ffab8-bd1f-48f6-bd15-192a666becc1"}, {"Element": "<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n</td>", "ID": "4e8ef76c-1988-457e-b2f8-1f703d40e20a", "Styles": "width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "7697404c-150d-43ce-9f0d-5fe65a933973"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>", "ID": "c4a87efe-0299-425b-a63a-56f802916aba", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e8ef76c-1988-457e-b2f8-1f703d40e20a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b>", "ID": "743a6e3d-91ae-4f90-b725-642fabacaaa3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c4a87efe-0299-425b-a63a-56f802916aba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span>", "ID": "0227c9c3-8637-429f-ae6b-2466de8c9f44", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa    12\u00a0weeks", "ParentId": "743a6e3d-91ae-4f90-b725-642fabacaaa3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>", "ID": "b6c86796-3dc1-4730-b5a0-eb5b45738a7a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "8de996bb-58c0-4610-9392-8372754f5a79"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>", "ID": "82906ab7-dbb7-40dc-b08f-58ab2fcb22ae", "Styles": "width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b6c86796-3dc1-4730-b5a0-eb5b45738a7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>", "ID": "4a47e53b-5232-49b5-b94c-98f857d7a795", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82906ab7-dbb7-40dc-b08f-58ab2fcb22ae"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b>", "ID": "69f61bed-5983-430e-98fd-378271158db5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4a47e53b-5232-49b5-b94c-98f857d7a795"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span>", "ID": "81a93876-f3ea-49c0-a22e-28d17b4b9e48", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01", "ParentId": "69f61bed-5983-430e-98fd-378271158db5"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>", "ID": "bd4a5021-9667-4978-97af-24f489cc3322", "Styles": "width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b6c86796-3dc1-4730-b5a0-eb5b45738a7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>", "ID": "92c545f4-53e4-4727-a921-ce6880d113eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bd4a5021-9667-4978-97af-24f489cc3322"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b>", "ID": "5f3dce1d-f87d-43e2-af8f-a72960c55d74", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92c545f4-53e4-4727-a921-ce6880d113eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span>", "ID": "08d22569-c029-4871-9be0-75776d26b3ef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a03", "ParentId": "5f3dce1d-f87d-43e2-af8f-a72960c55d74"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>\n</td>", "ID": "1f995448-2373-4a16-ad37-85c820478677", "Styles": "width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b6c86796-3dc1-4730-b5a0-eb5b45738a7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b></p>", "ID": "caa3c341-198f-4c59-8110-d933469e0f2d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f995448-2373-4a16-ad37-85c820478677"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span></b>", "ID": "3bc506b2-2b19-4945-9a24-ecc85148e3b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "caa3c341-198f-4c59-8110-d933469e0f2d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02, 4, 5 or 6</span>", "ID": "5d91f98e-5685-4e73-ba85-c3b954e3bc2a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotypes\u00a02, 4, 5 or 6", "ParentId": "3bc506b2-2b19-4945-9a24-ecc85148e3b5"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>", "ID": "112f875b-4295-4183-81a2-17749857ba43", "Styles": "width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b6c86796-3dc1-4730-b5a0-eb5b45738a7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "e3168a62-8b35-4321-84b0-19f443239280", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "112f875b-4295-4183-81a2-17749857ba43"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "5a150860-025c-44ec-ba31-cb2b07e837a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e3168a62-8b35-4321-84b0-19f443239280"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "a199e58b-a70b-4d43-897f-055d1ba9eff4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "5a150860-025c-44ec-ba31-cb2b07e837a1"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span></p>\n</td>\n</tr>", "ID": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "fa6e828b-9e00-43ae-99d1-520d7e4463ee"}, {"Element": "<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>", "ID": "d8a50dd9-7b4c-4158-8877-4667ccd28266", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>", "ID": "789879fc-f363-435a-a19d-3a3da4e7c2e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8a50dd9-7b4c-4158-8877-4667ccd28266"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span>", "ID": "cc96e1a9-67b8-4d95-b34c-c501f8a58ae3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "With any baseline NS5A\u00a0RAVs", "ParentId": "789879fc-f363-435a-a19d-3a3da4e7c2e0"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span></p>\n</td>", "ID": "9668f4c1-e78d-4467-88d7-43e3b1daa763", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span></p>", "ID": "ed42f5a7-2d38-44bf-b5dc-2ff71f960ab9", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "9668f4c1-e78d-4467-88d7-43e3b1daa763"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (73/75)</span>", "ID": "4617f78d-9cc4-4fe0-ac72-ff4e3756c4c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "97% (73/75)", "ParentId": "ed42f5a7-2d38-44bf-b5dc-2ff71f960ab9"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span></p>\n</td>", "ID": "6c7552fa-a4ca-4559-b283-06968f350254", "Styles": "width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span></p>", "ID": "dc52b944-5e88-40a9-8857-915cbdaa54d1", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "6c7552fa-a4ca-4559-b283-06968f350254"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">88% (38/43)</span>", "ID": "28c54798-6df8-40ab-9dc9-913275e76c7f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "88% (38/43)", "ParentId": "dc52b944-5e88-40a9-8857-915cbdaa54d1"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span></p>\n</td>", "ID": "e4b65a97-3243-45d1-a25c-e3ff55c40ffa", "Styles": "width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span></p>", "ID": "cf87db7f-80ec-4a77-abb7-530c3587893c", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "e4b65a97-3243-45d1-a25c-e3ff55c40ffa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (262/262)</span>", "ID": "239ffd0e-1ec2-48e4-b730-043ccb8eebcf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%   (262/262)", "ParentId": "cf87db7f-80ec-4a77-abb7-530c3587893c"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span></p>\n</td>", "ID": "03d95fc9-dd92-4fcc-9eb7-649c3cdae17b", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e95c5ff5-7f39-49a2-a63a-68e1dc6e5df2"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span></p>", "ID": "93de0877-3483-4f9b-b6af-b126b4f89b83", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "03d95fc9-dd92-4fcc-9eb7-649c3cdae17b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%\n  (373/380)</span>", "ID": "18102122-b76e-440b-bd4a-e7da92c201ec", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98%   (373/380)", "ParentId": "93de0877-3483-4f9b-b6af-b126b4f89b83"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span></p>\n</td>\n</tr>", "ID": "8f95d382-33e7-4332-89f2-b8a600ed8017", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "fa6e828b-9e00-43ae-99d1-520d7e4463ee"}, {"Element": "<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>", "ID": "9001be6e-895e-4a4c-9baf-e85238767d46", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f95d382-33e7-4332-89f2-b8a600ed8017"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>", "ID": "a4852258-2d97-43e3-9ca3-54ec03bd08ff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9001be6e-895e-4a4c-9baf-e85238767d46"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span>", "ID": "02b16b7d-f30d-4746-a599-ab7e7f0c2865", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Without baseline NS5A\u00a0RAVs", "ParentId": "a4852258-2d97-43e3-9ca3-54ec03bd08ff"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span></p>\n</td>", "ID": "2d876446-84f4-428b-b12b-1f1a4c7df0c7", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f95d382-33e7-4332-89f2-b8a600ed8017"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span></p>", "ID": "25bb4a83-3674-4aa2-afd3-021575f01ec7", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "2d876446-84f4-428b-b12b-1f1a4c7df0c7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (251/251)</span>", "ID": "50f5b9fc-ca00-49a8-a4fa-35f3e3e8c9ab", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100% (251/251)", "ParentId": "25bb4a83-3674-4aa2-afd3-021575f01ec7"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span></p>\n</td>", "ID": "1f805008-bd1d-476b-9e93-43362d500d5e", "Styles": "width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f95d382-33e7-4332-89f2-b8a600ed8017"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span></p>", "ID": "cb401062-558c-42da-9422-6e68941b968f", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "1f805008-bd1d-476b-9e93-43362d500d5e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">97% (225/231)</span>", "ID": "a57302cf-1b35-4751-8fb0-10db02bde4ed", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "97% (225/231)", "ParentId": "cb401062-558c-42da-9422-6e68941b968f"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span></p>\n</td>", "ID": "31052590-140b-4890-b4ea-f0040dc3c8a9", "Styles": "width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f95d382-33e7-4332-89f2-b8a600ed8017"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span></p>", "ID": "0088326c-e8dd-4c31-81a3-d6c4578bb596", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "31052590-140b-4890-b4ea-f0040dc3c8a9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (161/161)</span>", "ID": "0dbad9d9-1678-4db3-8a65-f35e2d25873c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100% (161/161)", "ParentId": "0088326c-e8dd-4c31-81a3-d6c4578bb596"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span></p>\n</td>", "ID": "dc16b36d-5b60-4f89-aa48-4271fd41f227", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f95d382-33e7-4332-89f2-b8a600ed8017"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span></p>", "ID": "865679cf-5f99-46bc-9f16-ec4f09877cac", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "dc16b36d-5b60-4f89-aa48-4271fd41f227"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (637/643)</span>", "ID": "345b56aa-ddb1-40e0-9c3f-a0a2ba115a26", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "99% (637/643)", "ParentId": "865679cf-5f99-46bc-9f16-ec4f09877cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a7d21a0c-87b8-4a3d-ae6f-bbb470b96375", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "13c8c66e-bf2e-4884-875a-569bb8604b43", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a7d21a0c-87b8-4a3d-ae6f-bbb470b96375"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a07: SVR12 in patients with and without baseline Y93H, 1%\nCut-off (Resistance Analysis Population Set) ASTRAL 3</span></b></p>", "ID": "d7e379f2-75af-407e-bbf8-f33650a77d94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a07: SVR12 in patients with and without baseline Y93H, 1%\nCut-off (Resistance Analysis Population Set) ASTRAL 3</span></b>", "ID": "0389e190-aace-4e8d-8c75-ab3c4dff0526", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7e379f2-75af-407e-bbf8-f33650a77d94"}, {"Element": "<span lang=\"EN-GB\">Table\u00a07: SVR12 in patients with and without baseline Y93H, 1%\nCut-off (Resistance Analysis Population Set) ASTRAL 3</span>", "ID": "ee59650b-7cbb-4bfd-bece-5175d199b7b5", "Styles": "None", "Classes": "None", "Text": "Table\u00a07: SVR12 in patients with and without baseline Y93H, 1% Cut-off (Resistance Analysis Population Set) ASTRAL 3", "ParentId": "0389e190-aace-4e8d-8c75-ab3c4dff0526"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:455.7pt;border-collapse:collapse;border:none\" width=\"608\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" rowspan=\"2\" style=\"width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" valign=\"bottom\" width=\"192\"></td>\n<td colspan=\"3\" nowrap=\"\" style=\"width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"415\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:30.65pt\">\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span></p>\n</td>\n</tr>\n</table>", "ID": "f692519d-5fda-46ee-a048-e645c25fc941", "Styles": "width:455.7pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "        ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" rowspan=\"2\" style=\"width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" valign=\"bottom\" width=\"192\"></td>\n<td colspan=\"3\" nowrap=\"\" style=\"width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"415\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:30.65pt\">\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "93b8c6d3-ef95-4b7c-b2cd-190b2f40963d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" rowspan=\"2\" style=\"width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" valign=\"bottom\" width=\"192\"></td>\n<td colspan=\"3\" nowrap=\"\" style=\"width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"415\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>\n</td>\n</tr>", "ID": "dd4333c7-62cd-494e-b8e2-b3dda0c03fd2", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "   ", "ParentId": "93b8c6d3-ef95-4b7c-b2cd-190b2f40963d"}, {"Element": "<td nowrap=\"\" rowspan=\"2\" style=\"width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" valign=\"bottom\" width=\"192\"></td>", "ID": "8c6db207-fad7-4526-a49c-32c534fd90bd", "Styles": "width:144.25pt;\n   border:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "", "ParentId": "dd4333c7-62cd-494e-b8e2-b3dda0c03fd2"}, {"Element": "<td colspan=\"3\" nowrap=\"\" style=\"width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"415\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>\n</td>", "ID": "37335c5c-9254-4fa0-b140-497ff644c0cc", "Styles": "width:311.45pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "dd4333c7-62cd-494e-b8e2-b3dda0c03fd2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b></p>", "ID": "f6fdf492-f15b-4ce1-b695-bd50651a7d83", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37335c5c-9254-4fa0-b140-497ff644c0cc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span></b>", "ID": "2b5d9f74-45c0-4a19-89b1-47ab8163ac1c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f6fdf492-f15b-4ce1-b695-bd50651a7d83"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0Weeks</span>", "ID": "6ca75f58-cc14-46ea-8e23-58b533ca24ef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa    12\u00a0Weeks", "ParentId": "2b5d9f74-45c0-4a19-89b1-47ab8163ac1c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:30.65pt\">\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>\n</td>\n</tr>", "ID": "46019dfd-f039-474d-ad62-895177745c29", "Styles": "page-break-inside:avoid;height:30.65pt", "Classes": "None", "Text": "    ", "ParentId": "93b8c6d3-ef95-4b7c-b2cd-190b2f40963d"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>\n</td>", "ID": "fc0d0474-7a3a-493b-862a-3b2d5c07cdcd", "Styles": "width:95.15pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt", "Classes": "None", "Text": "   ", "ParentId": "46019dfd-f039-474d-ad62-895177745c29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b></p>", "ID": "15fce251-bb4e-4ac8-9b35-d92d95e72499", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc0d0474-7a3a-493b-862a-3b2d5c07cdcd"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span></b>", "ID": "5f5f5788-6970-453d-988b-1b59a68d099a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15fce251-bb4e-4ac8-9b35-d92d95e72499"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">All Subjects</span>", "ID": "d7cd7524-2f9a-4abe-ada0-265460e54a4a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "All Subjects", "ParentId": "5f5f5788-6970-453d-988b-1b59a68d099a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b></p>", "ID": "61403f8d-c310-4efe-9cef-d24615839182", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc0d0474-7a3a-493b-862a-3b2d5c07cdcd"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span></b>", "ID": "90200b0e-8c75-41af-9860-5da6a1d85f21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "61403f8d-c310-4efe-9cef-d24615839182"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0274)</span>", "ID": "6ff576f5-3722-4c9c-a6f7-aa87767baf8b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0274)", "ParentId": "90200b0e-8c75-41af-9860-5da6a1d85f21"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>\n</td>", "ID": "0b3f265d-b4d9-41c7-a8b1-29593dac3f0a", "Styles": "width:106.35pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt", "Classes": "None", "Text": "   ", "ParentId": "46019dfd-f039-474d-ad62-895177745c29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b></p>", "ID": "580562a7-7137-4e85-ad42-fe931d333005", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b3f265d-b4d9-41c7-a8b1-29593dac3f0a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span></b>", "ID": "d3cbb1b6-d4de-4175-b141-095b83edfb63", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "580562a7-7137-4e85-ad42-fe931d333005"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Cirrhotic</span>", "ID": "fff5f79c-fc52-4ad9-a398-ced47542875c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Cirrhotic", "ParentId": "d3cbb1b6-d4de-4175-b141-095b83edfb63"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b></p>", "ID": "e224060e-f2bf-49cb-9011-8de68d2dcfc4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b3f265d-b4d9-41c7-a8b1-29593dac3f0a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span></b>", "ID": "071e2ad7-1d54-4371-a35e-b108a14b2992", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e224060e-f2bf-49cb-9011-8de68d2dcfc4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a080)</span>", "ID": "0a2a4a0e-2897-4298-a6e6-1054c611ec8c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a080)", "ParentId": "071e2ad7-1d54-4371-a35e-b108a14b2992"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>\n</td>", "ID": "df150a3e-92a9-4602-9111-cae1e125fd5f", "Styles": "width:109.95pt;border-top:none;border-left:none;\n   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 3.5pt 0in 3.5pt;height:30.65pt", "Classes": "None", "Text": "   ", "ParentId": "46019dfd-f039-474d-ad62-895177745c29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b></p>", "ID": "60cf9304-0884-4f5e-bf00-076d2fb642c1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df150a3e-92a9-4602-9111-cae1e125fd5f"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span></b>", "ID": "5dbc9f9d-99c3-4c24-974e-9c0335e3bbe6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "60cf9304-0884-4f5e-bf00-076d2fb642c1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Non-Cirrhotic</span>", "ID": "b522d9d3-caf0-47dc-bb2b-6cd470253b1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Non-Cirrhotic", "ParentId": "5dbc9f9d-99c3-4c24-974e-9c0335e3bbe6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b></p>", "ID": "d355f775-687e-4ccb-ba53-bb10d366fc13", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df150a3e-92a9-4602-9111-cae1e125fd5f"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span></b>", "ID": "ac90cd7c-0569-4567-8b24-ff3c035aa021", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d355f775-687e-4ccb-ba53-bb10d366fc13"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0197)</span>", "ID": "8a3812ab-3a43-416b-91a6-1dfdc99f20a6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0197)", "ParentId": "ac90cd7c-0569-4567-8b24-ff3c035aa021"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span></p>\n</td>\n</tr>", "ID": "7fada83b-fe7d-441e-862b-a9f581eef09b", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span></p>\n</td>", "ID": "e39aede4-4ee3-49e8-9e10-b13ed4f3968e", "Styles": "width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "7fada83b-fe7d-441e-862b-a9f581eef09b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span></p>", "ID": "52aaf950-3bd4-408f-a707-60be1e9fac4c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e39aede4-4ee3-49e8-9e10-b13ed4f3968e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall</span>", "ID": "e3ed16b3-b577-4ddd-976d-5b1959d7f284", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Overall", "ParentId": "52aaf950-3bd4-408f-a707-60be1e9fac4c"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span></p>\n</td>", "ID": "5307f51f-23fb-4d04-8d2a-da2db778d96c", "Styles": "width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "7fada83b-fe7d-441e-862b-a9f581eef09b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span></p>", "ID": "3fd22660-0052-498c-8472-97e7b6a1c4f1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5307f51f-23fb-4d04-8d2a-da2db778d96c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.3% (263/274) </span>", "ID": "2eb898e5-e949-40cd-8c94-3b5edf5cad1a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95.3% (263/274) ", "ParentId": "3fd22660-0052-498c-8472-97e7b6a1c4f1"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span></p>\n</td>", "ID": "a2d42b0c-6e71-49e2-980f-a4dd50f3ee7b", "Styles": "width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "7fada83b-fe7d-441e-862b-a9f581eef09b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span></p>", "ID": "a3585d92-b803-49f6-8ac0-053dd65b2232", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2d42b0c-6e71-49e2-980f-a4dd50f3ee7b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">91.3% (73/80) </span>", "ID": "e3eed046-e34a-4568-b711-fc0fa59d4efd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "91.3% (73/80) ", "ParentId": "a3585d92-b803-49f6-8ac0-053dd65b2232"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span></p>\n</td>", "ID": "97085d83-cf55-4fce-b1cd-7887389c094a", "Styles": "width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "7fada83b-fe7d-441e-862b-a9f581eef09b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span></p>", "ID": "f4894030-76a4-4a29-be30-7f1f17bce62a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97085d83-cf55-4fce-b1cd-7887389c094a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">97.9% (190/194) </span>", "ID": "55bcc240-3391-4fb2-8f5c-b26a31c09739", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "97.9% (190/194) ", "ParentId": "f4894030-76a4-4a29-be30-7f1f17bce62a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span></p>\n</td>\n</tr>", "ID": "077a7f8a-ce82-4d28-97b1-8be71bb0a96e", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>", "ID": "3383cdc4-fd50-418f-9dfd-f604be744b23", "Styles": "width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "077a7f8a-ce82-4d28-97b1-8be71bb0a96e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>", "ID": "445079f2-7fb0-4c2e-ab41-24b2ecb62c63", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3383cdc4-fd50-418f-9dfd-f604be744b23"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span>", "ID": "65691bbf-86d3-45c4-9b53-7ad14144ba8e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%\u00a0CI", "ParentId": "445079f2-7fb0-4c2e-ab41-24b2ecb62c63"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span></p>\n</td>", "ID": "f8eca021-9db4-422f-844c-6883152b341b", "Styles": "width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "077a7f8a-ce82-4d28-97b1-8be71bb0a96e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span></p>", "ID": "6c2f3cc5-247c-47d8-8daa-6dd2eb2759d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8eca021-9db4-422f-844c-6883152b341b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.9% to 98.0%</span>", "ID": "8fa50716-2ba5-4cd0-9693-821fc0532100", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "92.9% to 98.0%", "ParentId": "6c2f3cc5-247c-47d8-8daa-6dd2eb2759d0"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span></p>\n</td>", "ID": "042d703a-18ea-4948-bbe8-3d9afa54901e", "Styles": "width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "077a7f8a-ce82-4d28-97b1-8be71bb0a96e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span></p>", "ID": "8a1534b2-76e1-4dfc-9038-a0f4ec695d49", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "042d703a-18ea-4948-bbe8-3d9afa54901e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">82.8% to 96.4%</span>", "ID": "05c10ae6-b0e7-4b17-a56b-75b2ee099c5d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "82.8% to 96.4%", "ParentId": "8a1534b2-76e1-4dfc-9038-a0f4ec695d49"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span></p>\n</td>", "ID": "c2dca6ca-68c6-4c32-b917-b78362dae761", "Styles": "width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "077a7f8a-ce82-4d28-97b1-8be71bb0a96e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span></p>", "ID": "3b9e92bb-cf4d-4284-932f-612ced744b8a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c2dca6ca-68c6-4c32-b917-b78362dae761"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">92.8% to 98.6%</span>", "ID": "bbe7447b-94c1-4398-8448-ded8fc0db284", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "92.8% to 98.6%", "ParentId": "3b9e92bb-cf4d-4284-932f-612ced744b8a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span></p>\n</td>\n</tr>", "ID": "2c0cb435-87c7-4142-a0cd-8614742afa30", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span></p>\n</td>", "ID": "7768f4f1-a2a2-439e-bf1c-5a90f12fb45d", "Styles": "width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "2c0cb435-87c7-4142-a0cd-8614742afa30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span></p>", "ID": "a0bf5409-51e4-4eb6-8bf4-b4f15f697eea", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7768f4f1-a2a2-439e-bf1c-5a90f12fb45d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR with Y93H</span>", "ID": "a8839c05-afff-47cd-b3b4-1644f3f4b60f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR with Y93H", "ParentId": "a0bf5409-51e4-4eb6-8bf4-b4f15f697eea"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span></p>\n</td>", "ID": "00f6804e-8f10-4179-a886-403b489326ac", "Styles": "width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "2c0cb435-87c7-4142-a0cd-8614742afa30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span></p>", "ID": "d1955340-1327-4201-9fa4-dce8e84823b0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "00f6804e-8f10-4179-a886-403b489326ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">84.0% (21/25) </span>", "ID": "bb50e03a-e7a3-4a7d-a731-4d658ba33798", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "84.0% (21/25) ", "ParentId": "d1955340-1327-4201-9fa4-dce8e84823b0"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span></p>\n</td>", "ID": "1506ec24-15ba-418f-9a55-b10298566e46", "Styles": "width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "2c0cb435-87c7-4142-a0cd-8614742afa30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span></p>", "ID": "64a79777-0b9f-4835-93b8-90454c257cae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1506ec24-15ba-418f-9a55-b10298566e46"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">50.0% (2/4) </span>", "ID": "c09ac4f4-2a26-4f5e-be8f-9337cd45d54b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "50.0% (2/4) ", "ParentId": "64a79777-0b9f-4835-93b8-90454c257cae"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span></p>\n</td>", "ID": "c1f8320b-5ef3-4372-bc8d-a595992fa587", "Styles": "width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "2c0cb435-87c7-4142-a0cd-8614742afa30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span></p>", "ID": "5b698871-045c-438d-a176-6d3626fc3ae4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1f8320b-5ef3-4372-bc8d-a595992fa587"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">90.5% (19/21) </span>", "ID": "18985f1f-bce2-4ce2-96a8-20470a0fb918", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "90.5% (19/21) ", "ParentId": "5b698871-045c-438d-a176-6d3626fc3ae4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span></p>\n</td>\n</tr>", "ID": "49972acf-83d3-433d-be2b-2dced08d69c3", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>", "ID": "6c5f611d-6e18-4d50-94ba-cf3f2bb81ebd", "Styles": "width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "49972acf-83d3-433d-be2b-2dced08d69c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>", "ID": "63ba0e4b-a9fe-4166-98b4-c8208f8593a8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c5f611d-6e18-4d50-94ba-cf3f2bb81ebd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span>", "ID": "b9a7ebc6-5432-4413-bb05-a1a243d57a5a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%\u00a0CI", "ParentId": "63ba0e4b-a9fe-4166-98b4-c8208f8593a8"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span></p>\n</td>", "ID": "aaa4945e-3065-453f-865e-bd09c62cc93c", "Styles": "width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "49972acf-83d3-433d-be2b-2dced08d69c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span></p>", "ID": "7f2ff294-14be-499f-a7f8-cd93a742ce27", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaa4945e-3065-453f-865e-bd09c62cc93c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">63.9% to 95.5%</span>", "ID": "c4a31953-7d02-418c-892c-ca8b447202d8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "63.9% to 95.5%", "ParentId": "7f2ff294-14be-499f-a7f8-cd93a742ce27"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span></p>\n</td>", "ID": "aa62d6e3-daeb-4fe9-a1ba-709a34ef4af8", "Styles": "width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "49972acf-83d3-433d-be2b-2dced08d69c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span></p>", "ID": "9de7a8bc-1874-4fe6-9b69-bb7cd169366b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aa62d6e3-daeb-4fe9-a1ba-709a34ef4af8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">6.8% to 93.2%</span>", "ID": "62dd03a0-b4f2-4e0b-9ca6-d36e2cb2c4df", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "6.8% to 93.2%", "ParentId": "9de7a8bc-1874-4fe6-9b69-bb7cd169366b"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span></p>\n</td>", "ID": "7ab30151-98f9-4be3-9c0c-2460b9d39889", "Styles": "width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "49972acf-83d3-433d-be2b-2dced08d69c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span></p>", "ID": "7f2721b3-3516-41fe-8847-bdd831494770", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7ab30151-98f9-4be3-9c0c-2460b9d39889"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">69.6% to 98.8%</span>", "ID": "e1573d46-d7a3-46f2-9c53-224eff85357e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "69.6% to 98.8%", "ParentId": "7f2721b3-3516-41fe-8847-bdd831494770"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span></p>\n</td>\n</tr>", "ID": "9dbc8988-99d9-497d-ae95-0539e7cd598d", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span></p>\n</td>", "ID": "8b18cf88-3f1c-4fd9-b616-678bad596e64", "Styles": "width:144.25pt;border-top:none;border-left:solid windowtext 1.0pt;\n  border-bottom:none;border-right:solid windowtext 1.0pt;padding:0in 3.5pt 0in 3.5pt;\n  height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "9dbc8988-99d9-497d-ae95-0539e7cd598d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span></p>", "ID": "7f48ef14-d09a-4aab-be50-2368eb0842a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b18cf88-3f1c-4fd9-b616-678bad596e64"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR without Y93H</span>", "ID": "f7ecfcf2-6eed-4685-8e4e-7316a99b4d38", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR without Y93H", "ParentId": "7f48ef14-d09a-4aab-be50-2368eb0842a5"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span></p>\n</td>", "ID": "60eb0e25-a1f6-4eb8-b152-38fd7ab1b442", "Styles": "width:95.15pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "9dbc8988-99d9-497d-ae95-0539e7cd598d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span></p>", "ID": "5414a92e-270e-49f7-95e2-ff37f6f1ea41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60eb0e25-a1f6-4eb8-b152-38fd7ab1b442"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">96.4% (242/249)</span>", "ID": "229d04e2-1335-481a-9c11-cffc14401530", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "96.4% (242/249)", "ParentId": "5414a92e-270e-49f7-95e2-ff37f6f1ea41"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span></p>\n</td>", "ID": "8c4d982c-c6d1-42f4-8bc3-bdb4d7d2a13b", "Styles": "width:106.35pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "9dbc8988-99d9-497d-ae95-0539e7cd598d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span></p>", "ID": "b7e3a7d7-87eb-4500-96c3-594cec595c1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8c4d982c-c6d1-42f4-8bc3-bdb4d7d2a13b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">93.4% (71/76) </span>", "ID": "35ef297b-1e7f-4620-9ae0-6e118e0245d9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "93.4% (71/76) ", "ParentId": "b7e3a7d7-87eb-4500-96c3-594cec595c1c"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span></p>\n</td>", "ID": "c0539425-c383-4255-b5bf-c1464d13efc7", "Styles": "width:109.95pt;border:none;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "9dbc8988-99d9-497d-ae95-0539e7cd598d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span></p>", "ID": "984794be-4586-4934-a06a-82bca056c0e4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c0539425-c383-4255-b5bf-c1464d13efc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98.8% (171/173) </span>", "ID": "ab5bf584-af0f-457b-8fc7-3ac30ae66eae", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98.8% (171/173) ", "ParentId": "984794be-4586-4934-a06a-82bca056c0e4"}, {"Element": "<tr style=\"page-break-inside:avoid;height:15.1pt\">\n<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>\n<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span></p>\n</td>\n<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span></p>\n</td>\n</tr>", "ID": "23feaffb-e318-4697-b4f7-3abfd7a1a743", "Styles": "page-break-inside:avoid;height:15.1pt", "Classes": "None", "Text": "     ", "ParentId": "f692519d-5fda-46ee-a048-e645c25fc941"}, {"Element": "<td nowrap=\"\" style=\"width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"192\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>\n</td>", "ID": "1b97a0d3-5ee2-4c3b-838b-b7408e97653c", "Styles": "width:144.25pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "23feaffb-e318-4697-b4f7-3abfd7a1a743"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span></p>", "ID": "07127bb0-aa3c-4e83-b1ad-802a648bf6c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b97a0d3-5ee2-4c3b-838b-b7408e97653c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%\u00a0CI</span>", "ID": "5fb21b7c-a84d-4672-97dc-04595a3b9b4c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%\u00a0CI", "ParentId": "07127bb0-aa3c-4e83-b1ad-802a648bf6c6"}, {"Element": "<td nowrap=\"\" style=\"width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"127\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span></p>\n</td>", "ID": "396bf9e4-96f8-4415-8122-8ca0df659307", "Styles": "width:95.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "23feaffb-e318-4697-b4f7-3abfd7a1a743"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span></p>", "ID": "9aaa5a98-9098-4fe7-acab-c2f07277a2f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "396bf9e4-96f8-4415-8122-8ca0df659307"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">94.3% to 98.9%</span>", "ID": "8aa9ed69-aeb5-4c3d-b079-f2b664508d0a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "94.3% to 98.9%", "ParentId": "9aaa5a98-9098-4fe7-acab-c2f07277a2f8"}, {"Element": "<td nowrap=\"\" style=\"width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span></p>\n</td>", "ID": "82dc7dbd-fc3d-4f9a-848d-8eef9b736f12", "Styles": "width:106.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "23feaffb-e318-4697-b4f7-3abfd7a1a743"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span></p>", "ID": "76a00664-deba-4cdc-a509-3cba99c581f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82dc7dbd-fc3d-4f9a-848d-8eef9b736f12"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">85.3% to 97.8%</span>", "ID": "99482cc6-2508-4a70-9167-cced7e550635", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "85.3% to 97.8%", "ParentId": "76a00664-deba-4cdc-a509-3cba99c581f8"}, {"Element": "<td nowrap=\"\" style=\"width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt\" width=\"147\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span></p>\n</td>", "ID": "d1de27f6-6fa1-4595-b238-82dda6fa9617", "Styles": "width:109.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 3.5pt 0in 3.5pt;height:15.1pt", "Classes": "None", "Text": "  ", "ParentId": "23feaffb-e318-4697-b4f7-3abfd7a1a743"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span></p>", "ID": "bdc11387-4ca1-4c3b-835b-f271821935e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1de27f6-6fa1-4595-b238-82dda6fa9617"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95.9% to 99.9%</span>", "ID": "c7e78a6c-ad5c-49ba-8d3b-a56dda879398", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95.9% to 99.9%", "ParentId": "bdc11387-4ca1-4c3b-835b-f271821935e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0854c61c-b5a2-47ba-a79e-453c87a18e14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "756ef79e-0ed8-405c-8af9-4bda4cada8ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0854c61c-b5a2-47ba-a79e-453c87a18e14"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The NS5B NI RAV\nS282T was not detected in the baseline NS5B sequence of any patient in Phase\u00a03\nstudies.\u00a0 SVR12 was achieved in all 77\u00a0patients who had baseline NS5B\u00a0NI\u00a0RAVs\nincluding N142T, L159F, E/N237G, C/M289L/I, L320F/I/V, V321A/I, and\nS282G+V321I.</span></p>", "ID": "d27fe66f-3c76-4c0a-92e0-22849146b205", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The NS5B NI RAV\nS282T was not detected in the baseline NS5B sequence of any patient in Phase\u00a03\nstudies.\u00a0 SVR12 was achieved in all 77\u00a0patients who had baseline NS5B\u00a0NI\u00a0RAVs\nincluding N142T, L159F, E/N237G, C/M289L/I, L320F/I/V, V321A/I, and\nS282G+V321I.</span>", "ID": "88c756b3-2909-4be5-869d-66d2826d2898", "Styles": "None", "Classes": "None", "Text": "The NS5B NI RAV S282T was not detected in the baseline NS5B sequence of any patient in Phase\u00a03 studies.\u00a0 SVR12 was achieved in all 77\u00a0patients who had baseline NS5B\u00a0NI\u00a0RAVs including N142T, L159F, E/N237G, C/M289L/I, L320F/I/V, V321A/I, and S282G+V321I.", "ParentId": "d27fe66f-3c76-4c0a-92e0-22849146b205"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "490881a9-c3fd-4801-a7d8-994f2fa6447d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b4cc3a9-54e5-4387-b497-1410fc417525", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "490881a9-c3fd-4801-a7d8-994f2fa6447d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis (CPT Class\u00a0B)</span></i></p>", "ID": "aa4a31df-6f05-4a05-af58-111e95f8c3b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis (CPT Class\u00a0B)</span></i>", "ID": "1f4b1078-48b9-4752-a269-2fe3db1b7f6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa4a31df-6f05-4a05-af58-111e95f8c3b1"}, {"Element": "<span lang=\"EN-GB\">Studies in patients with decompensated cirrhosis (CPT Class\u00a0B)</span>", "ID": "b6b9dabb-44ac-4b8e-a258-b50f9ebc800b", "Styles": "None", "Classes": "None", "Text": "Studies in patients with decompensated cirrhosis (CPT Class\u00a0B)", "ParentId": "1f4b1078-48b9-4752-a269-2fe3db1b7f6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients with decompensated cirrhosis in one Phase\u00a03\nstudy (ASTRAL\u20114).\u00a0 Of the 87\u00a0patients treated with Epclusa + RBV,\n85\u00a0patients were included in the analysis of NS5A\u00a0RAVs; 2\u00a0patients\nwere excluded as they neither achieved SVR12 nor had virologic failure.\u00a0\nAmong the patients who received treatment with Epclusa + RBV for 12\u00a0weeks,\n29% (25/85) of patients had baseline virus with NS5A\u00a0RAVs: 29% (19/66),\n75% (3/4), 15% (2/13), and 50% (1/2) for patients with genotype\u00a01, 2, 3\nand 4 HCV, respectively.</span></p>", "ID": "b85e69a2-fae0-4f8c-8438-91b942e288fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Analyses were\nconducted to explore the association between pre-existing baseline NS5A\u00a0RAVs\nand treatment outcome for patients with decompensated cirrhosis in one Phase\u00a03\nstudy (ASTRAL\u20114).\u00a0 Of the 87\u00a0patients treated with Epclusa + RBV,\n85\u00a0patients were included in the analysis of NS5A\u00a0RAVs; 2\u00a0patients\nwere excluded as they neither achieved SVR12 nor had virologic failure.\u00a0\nAmong the patients who received treatment with Epclusa + RBV for 12\u00a0weeks,\n29% (25/85) of patients had baseline virus with NS5A\u00a0RAVs: 29% (19/66),\n75% (3/4), 15% (2/13), and 50% (1/2) for patients with genotype\u00a01, 2, 3\nand 4 HCV, respectively.</span>", "ID": "a24cab39-6729-4e60-bde2-22c5b3f1267d", "Styles": "None", "Classes": "None", "Text": "Analyses were conducted to explore the association between pre-existing baseline NS5A\u00a0RAVs and treatment outcome for patients with decompensated cirrhosis in one Phase\u00a03 study (ASTRAL\u20114).\u00a0 Of the 87\u00a0patients treated with Epclusa + RBV, 85\u00a0patients were included in the analysis of NS5A\u00a0RAVs; 2\u00a0patients were excluded as they neither achieved SVR12 nor had virologic failure.\u00a0 Among the patients who received treatment with Epclusa + RBV for 12\u00a0weeks, 29% (25/85) of patients had baseline virus with NS5A\u00a0RAVs: 29% (19/66), 75% (3/4), 15% (2/13), and 50% (1/2) for patients with genotype\u00a01, 2, 3 and 4 HCV, respectively.", "ParentId": "b85e69a2-fae0-4f8c-8438-91b942e288fc"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7402ffa8-b59a-4076-b6fe-3d56d9c54bcf", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d3c7502-ffd5-43f0-8a85-3daf17076212", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7402ffa8-b59a-4076-b6fe-3d56d9c54bcf"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\">SVR12 in patients with or without baseline NS5A\u00a0RAVs in the Epclusa\n+ RBV 12\u00a0week group for this study is shown in Table\u00a08.</span></p>", "ID": "97183230-a1f3-4d94-90c9-eb4c3385be94", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">SVR12 in patients with or without baseline NS5A\u00a0RAVs in the Epclusa\n+ RBV 12\u00a0week group for this study is shown in Table\u00a08.</span>", "ID": "d297d315-0b0b-45e4-950d-1654c2c5ebee", "Styles": "None", "Classes": "None", "Text": "SVR12 in patients with or without baseline NS5A\u00a0RAVs in the Epclusa + RBV 12\u00a0week group for this study is shown in Table\u00a08.", "ParentId": "97183230-a1f3-4d94-90c9-eb4c3385be94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "66e56310-7027-4364-8a12-39d32e742da0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f865f825-1d63-41e0-86b7-0a5dd9e1fce3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "66e56310-7027-4364-8a12-39d32e742da0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Table\u00a08: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (study ASTRAL\u20114)</span></b></p>", "ID": "6dd97017-a156-441c-bf4c-d128485a28ce", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a08: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (study ASTRAL\u20114)</span></b>", "ID": "4296213e-e81e-421f-8912-46f861b32e3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6dd97017-a156-441c-bf4c-d128485a28ce"}, {"Element": "<span lang=\"EN-GB\">Table\u00a08: SVR12 in patients with or without baseline\nNS5A\u00a0RAVs by HCV genotype (study ASTRAL\u20114)</span>", "ID": "4b7770de-68ef-4db9-bf3d-f39ff9c9f6a5", "Styles": "None", "Classes": "None", "Text": "Table\u00a08: SVR12 in patients with or without baseline NS5A\u00a0RAVs by HCV genotype (study ASTRAL\u20114)", "ParentId": "4296213e-e81e-421f-8912-46f861b32e3b"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span></p>\n</td>\n</tr>\n</table>", "ID": "1a5636a0-9454-4381-9fdb-35cf73e2d17a", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "    ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "d463e04e-ab9f-4ee8-a1a3-b72fa9ce6622", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "1a5636a0-9454-4381-9fdb-35cf73e2d17a"}, {"Element": "<tr style=\"page-break-inside:avoid;height:14.3pt\">\n<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>\n</td>\n</tr>", "ID": "6afbadd8-5fd5-4d28-946f-26e732688fe4", "Styles": "page-break-inside:avoid;height:14.3pt", "Classes": "None", "Text": "   ", "ParentId": "d463e04e-ab9f-4ee8-a1a3-b72fa9ce6622"}, {"Element": "<td rowspan=\"2\" style=\"width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "440d4fe6-9e14-46ef-81d5-3d3b3cc62219", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "6afbadd8-5fd5-4d28-946f-26e732688fe4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "08cbcb58-1a27-4665-8bc8-fb8565fb1c49", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "440d4fe6-9e14-46ef-81d5-3d3b3cc62219"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "9b38c8ac-9bdc-4c3b-b47f-dcc7701cd5ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08cbcb58-1a27-4665-8bc8-fb8565fb1c49"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "3c47ccd4-ddee-4692-9ac1-911964db0c03", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "9b38c8ac-9bdc-4c3b-b47f-dcc7701cd5ee"}, {"Element": "<td colspan=\"4\" style=\"width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt\" valign=\"top\" width=\"491\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>\n</td>", "ID": "cf1fe4fb-ca3c-4e1b-b571-18474aebd075", "Styles": "width:368.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:14.3pt", "Classes": "None", "Text": "  ", "ParentId": "6afbadd8-5fd5-4d28-946f-26e732688fe4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b></p>", "ID": "a174b680-f3a5-421e-866d-b04d5aff9a1c", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf1fe4fb-ca3c-4e1b-b571-18474aebd075"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span></b>", "ID": "14f06f49-6942-4950-bdbf-b869047bbe65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a174b680-f3a5-421e-866d-b04d5aff9a1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   + RBV 12\u00a0weeks</span>", "ID": "669cc3cf-d759-4466-8cd4-167f8e6ea497", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa    + RBV 12\u00a0weeks", "ParentId": "14f06f49-6942-4950-bdbf-b869047bbe65"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>\n</tr>", "ID": "49dafef7-4cce-4637-ac6a-06b3092c4742", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "d463e04e-ab9f-4ee8-a1a3-b72fa9ce6622"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>", "ID": "ad414013-6e40-4b11-81bc-611f94cb58e2", "Styles": "width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "49dafef7-4cce-4637-ac6a-06b3092c4742"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>", "ID": "ae95838f-abd7-426e-a543-407b1956e600", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad414013-6e40-4b11-81bc-611f94cb58e2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b>", "ID": "c861a661-6fb6-46ea-9ea2-042e226df2af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ae95838f-abd7-426e-a543-407b1956e600"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span>", "ID": "96d3348b-e770-465b-9a26-b11dcc5ba599", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01", "ParentId": "c861a661-6fb6-46ea-9ea2-042e226df2af"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>", "ID": "d99876ed-0121-48ee-b705-f7c07f31d0d5", "Styles": "width:92.15pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "49dafef7-4cce-4637-ac6a-06b3092c4742"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>", "ID": "ea4b8283-174f-4aae-99cb-9410c7648bb4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d99876ed-0121-48ee-b705-f7c07f31d0d5"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b>", "ID": "f8daa8cb-bcdf-4ddb-a0d9-62bf66e3ea87", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea4b8283-174f-4aae-99cb-9410c7648bb4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span>", "ID": "43a9c45a-35c7-4d7c-9788-aa30709a65b4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a03", "ParentId": "f8daa8cb-bcdf-4ddb-a0d9-62bf66e3ea87"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>\n</td>", "ID": "047cffe9-7840-4320-8bce-191355d07bbf", "Styles": "width:106.3pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "49dafef7-4cce-4637-ac6a-06b3092c4742"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b></p>", "ID": "f2c9cc6e-d9a8-4eac-8c37-d549eb2194c8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "047cffe9-7840-4320-8bce-191355d07bbf"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span></b>", "ID": "517671d3-ce4b-4d5c-ae46-b234c52da357", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2c9cc6e-d9a8-4eac-8c37-d549eb2194c8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotypes\u00a02 or 4</span>", "ID": "3ab1fc48-11cd-4d57-a8c2-cd9c37e10281", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotypes\u00a02 or 4", "ParentId": "517671d3-ce4b-4d5c-ae46-b234c52da357"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n</td>", "ID": "0e3ea9ba-cbe5-4d27-abe9-847ac588aa0c", "Styles": "width:85.05pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "49dafef7-4cce-4637-ac6a-06b3092c4742"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "0c150a61-55d4-4c37-9483-93974571a351", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e3ea9ba-cbe5-4d27-abe9-847ac588aa0c"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "40af8d5c-3261-4fe0-9dca-ede567b9ae2e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c150a61-55d4-4c37-9483-93974571a351"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "708a881c-406a-4072-ab49-db1f3dd73b91", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "40af8d5c-3261-4fe0-9dca-ede567b9ae2e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span></p>\n</td>\n</tr>", "ID": "64d70a63-3de5-4faa-9841-6c4b66e41b67", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "1a5636a0-9454-4381-9fdb-35cf73e2d17a"}, {"Element": "<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>\n</td>", "ID": "da6a857d-8f2a-458d-89f0-bd546232516f", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "64d70a63-3de5-4faa-9841-6c4b66e41b67"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span></p>", "ID": "63209740-e906-40f9-98de-72f679915697", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da6a857d-8f2a-458d-89f0-bd546232516f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">With any baseline NS5A\u00a0RAVs</span>", "ID": "4a3df09d-9fe7-4c76-891e-d009b89a5317", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "With any baseline NS5A\u00a0RAVs", "ParentId": "63209740-e906-40f9-98de-72f679915697"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span></p>\n</td>", "ID": "59f9e2bd-c2c2-4180-8057-4267af9ccd85", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "64d70a63-3de5-4faa-9841-6c4b66e41b67"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span></p>", "ID": "6bceaa25-410d-4c37-92c9-07046f9a07e5", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "59f9e2bd-c2c2-4180-8057-4267af9ccd85"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%\n  (19/19)</span>", "ID": "b1157429-8bdb-4a54-b8cb-f38bede89948", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%   (19/19)", "ParentId": "6bceaa25-410d-4c37-92c9-07046f9a07e5"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span></p>\n</td>", "ID": "2e277254-1e64-4072-973a-a57cc5431455", "Styles": "width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "64d70a63-3de5-4faa-9841-6c4b66e41b67"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span></p>", "ID": "6370e236-9c40-422f-9ea4-530198049ede", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "2e277254-1e64-4072-973a-a57cc5431455"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">50% (1/2)</span>", "ID": "abef4714-0c68-44fc-ad2b-4044c710d499", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "50% (1/2)", "ParentId": "6370e236-9c40-422f-9ea4-530198049ede"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span></p>\n</td>", "ID": "a59f1b9b-b31a-4b2e-b099-b1953362075b", "Styles": "width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "64d70a63-3de5-4faa-9841-6c4b66e41b67"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span></p>", "ID": "5a394603-15e1-41cb-8eaa-86d76707e1cd", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "a59f1b9b-b31a-4b2e-b099-b1953362075b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (4/4)</span>", "ID": "ea3092ec-e7e8-4443-bbe6-7b904c52af0f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100% (4/4)", "ParentId": "5a394603-15e1-41cb-8eaa-86d76707e1cd"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span></p>\n</td>", "ID": "4386fc30-da85-4308-bc5e-17878c1853ce", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "64d70a63-3de5-4faa-9841-6c4b66e41b67"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\n  page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span></p>", "ID": "4c49dde9-65b1-436e-b007-f50ca8176122", "Styles": "margin:0in;text-align:left;\n  page-break-after:avoid", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "4386fc30-da85-4308-bc5e-17878c1853ce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">96% (24/25)</span>", "ID": "512bc506-7f34-4fdb-97c0-bf3c18f04ab6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "96% (24/25)", "ParentId": "4c49dde9-65b1-436e-b007-f50ca8176122"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span></p>\n</td>\n<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span></p>\n</td>\n<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span></p>\n</td>\n</tr>", "ID": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "1a5636a0-9454-4381-9fdb-35cf73e2d17a"}, {"Element": "<td style=\"width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"121\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>\n</td>", "ID": "e071d0bb-3901-49b7-b6d7-ed96fe084e9c", "Styles": "width:90.45pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span></p>", "ID": "c9361602-2391-4f65-b436-6d2a8a5d847a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e071d0bb-3901-49b7-b6d7-ed96fe084e9c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without baseline NS5A\u00a0RAVs</span>", "ID": "3f4a528b-cfb4-45f8-bcbf-56d645f29bfa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Without baseline NS5A\u00a0RAVs", "ParentId": "c9361602-2391-4f65-b436-6d2a8a5d847a"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span></p>\n</td>", "ID": "fb9ea626-6d07-4940-b829-6cb6704843db", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span></p>", "ID": "f2bfc32c-f7d2-4774-a940-9670fed0cb68", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "fb9ea626-6d07-4940-b829-6cb6704843db"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (46/47)</span>", "ID": "16d69176-f654-4306-b706-afa07a5d4d91", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98% (46/47)", "ParentId": "f2bfc32c-f7d2-4774-a940-9670fed0cb68"}, {"Element": "<td style=\"width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"123\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span></p>\n</td>", "ID": "8409109e-a0f0-40e6-97a3-3557ea202753", "Styles": "width:92.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span></p>", "ID": "a9681d7d-de95-41a1-8c7b-cc4d0d39a074", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "8409109e-a0f0-40e6-97a3-3557ea202753"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (10/11)</span>", "ID": "ecd8417a-1d3f-42a9-bbaf-12a4f26b1290", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "91% (10/11)", "ParentId": "a9681d7d-de95-41a1-8c7b-cc4d0d39a074"}, {"Element": "<td style=\"width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"142\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span></p>\n</td>", "ID": "1baac933-eeae-488d-a906-0789ed98d1d1", "Styles": "width:106.3pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span></p>", "ID": "9b5f1477-abb4-4b2c-b8a0-6c29b38b6ef5", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "1baac933-eeae-488d-a906-0789ed98d1d1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100% (2/2)</span>", "ID": "da2ae849-a033-4aeb-b564-14eaec08c842", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100% (2/2)", "ParentId": "9b5f1477-abb4-4b2c-b8a0-6c29b38b6ef5"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span></p>\n</td>", "ID": "661d1779-edee-4641-a626-76987626dc0a", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7fd214e-acc6-4b0a-8b6b-3a2f1b15aeb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span></p>", "ID": "aa1ba35b-b7b5-4d82-a6af-59d898a88c2e", "Styles": "margin:0in;text-align:left", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "661d1779-edee-4641-a626-76987626dc0a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (58/60)</span>", "ID": "67919bda-f29f-4e43-9f6f-204226f37085", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98% (58/60)", "ParentId": "aa1ba35b-b7b5-4d82-a6af-59d898a88c2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5aa6c040-471d-45b1-9a7d-99b86c411988", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d3f0a07a-f928-473b-8521-d02b9e84fa09", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5aa6c040-471d-45b1-9a7d-99b86c411988"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The single\ngenotype\u00a03 patient who had baseline NS5A\u00a0RAVs and failed to achieve\nSVR12 had NS5A substitution Y93H at baseline; pharmacokinetic data from this\npatient was consistent with non\u2011adherence to treatment.</span></p>", "ID": "49915092-9590-4745-94d8-d41b661cd9bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The single\ngenotype\u00a03 patient who had baseline NS5A\u00a0RAVs and failed to achieve\nSVR12 had NS5A substitution Y93H at baseline; pharmacokinetic data from this\npatient was consistent with non\u2011adherence to treatment.</span>", "ID": "f97ce835-177d-439b-9001-f5aa0273093d", "Styles": "None", "Classes": "None", "Text": "The single genotype\u00a03 patient who had baseline NS5A\u00a0RAVs and failed to achieve SVR12 had NS5A substitution Y93H at baseline; pharmacokinetic data from this patient was consistent with non\u2011adherence to treatment.", "ParentId": "49915092-9590-4745-94d8-d41b661cd9bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8a7989c3-ab26-47a3-ab4e-8c298c4c0306", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2d3149f-5db3-4adb-a4bc-75cced60e344", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a7989c3-ab26-47a3-ab4e-8c298c4c0306"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Three patients\nin the Epclusa + RBV 12\u00a0week group had baseline NS5B\u00a0NI\u00a0RAVs\n(N142T and L159F) and all three patients achieved SVR12.</span></p>", "ID": "4b98df9a-8a14-4773-98b8-d283c732bd1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Three patients\nin the Epclusa + RBV 12\u00a0week group had baseline NS5B\u00a0NI\u00a0RAVs\n(N142T and L159F) and all three patients achieved SVR12.</span>", "ID": "45db226d-83e6-4aa5-88c2-b6568eec8512", "Styles": "None", "Classes": "None", "Text": "Three patients in the Epclusa + RBV 12\u00a0week group had baseline NS5B\u00a0NI\u00a0RAVs (N142T and L159F) and all three patients achieved SVR12.", "ParentId": "4b98df9a-8a14-4773-98b8-d283c732bd1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f3a2c574-38a3-46bd-8e9e-123c58090fa0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68e48a2e-a301-4382-8842-89779e6f2eda", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f3a2c574-38a3-46bd-8e9e-123c58090fa0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cross\u2011resistance</span></u></p>", "ID": "72052357-34c9-4cad-ad97-5b056bdbc759", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Cross\u2011resistance</span></u>", "ID": "f99a654a-22c6-4f79-acbc-39ce0b749c2f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "72052357-34c9-4cad-ad97-5b056bdbc759"}, {"Element": "<span lang=\"EN-GB\">Cross\u2011resistance</span>", "ID": "d816e616-3279-46e5-92ce-c41b206c213d", "Styles": "None", "Classes": "None", "Text": "Cross\u2011resistance", "ParentId": "f99a654a-22c6-4f79-acbc-39ce0b749c2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In\u00a0vitro</span></i><span lang=\"EN-GB\"> data suggests that the majority of NS5A\u00a0RAVs that confer\nresistance to ledipasvir and daclatasvir remained susceptible to\nvelpatasvir.\u00a0 Velpatasvir was fully active against the sofosbuvir\nresistance-associated substitution S282T in NS5B while all velpatasvir resistance-associated\nsubstitutions in NS5A were fully susceptible to sofosbuvir.\u00a0 Both\nsofosbuvir and velpatasvir were fully active against substitutions associated\nwith resistance to other classes of direct-acting antivirals with different\nmechanisms of actions, such as NS5B non\u2011nucleoside inhibitors and NS3\nprotease inhibitors.\u00a0 The efficacy of Epclusa has not been assessed in\npatients who have previously failed treatment with other regimens that include\nan NS5A inhibitor.</span></p>", "ID": "2dd10fb1-922f-48b5-847b-4877a336b2a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">In\u00a0vitro</span></i>", "ID": "8316d43b-d7cf-4ca8-abd7-c4d0b597f5cd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2dd10fb1-922f-48b5-847b-4877a336b2a9"}, {"Element": "<span lang=\"EN-GB\">In\u00a0vitro</span>", "ID": "2e804ff7-7020-4979-97b9-e1bc92ad7483", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro", "ParentId": "8316d43b-d7cf-4ca8-abd7-c4d0b597f5cd"}, {"Element": "<span lang=\"EN-GB\"> data suggests that the majority of NS5A\u00a0RAVs that confer\nresistance to ledipasvir and daclatasvir remained susceptible to\nvelpatasvir.\u00a0 Velpatasvir was fully active against the sofosbuvir\nresistance-associated substitution S282T in NS5B while all velpatasvir resistance-associated\nsubstitutions in NS5A were fully susceptible to sofosbuvir.\u00a0 Both\nsofosbuvir and velpatasvir were fully active against substitutions associated\nwith resistance to other classes of direct-acting antivirals with different\nmechanisms of actions, such as NS5B non\u2011nucleoside inhibitors and NS3\nprotease inhibitors.\u00a0 The efficacy of Epclusa has not been assessed in\npatients who have previously failed treatment with other regimens that include\nan NS5A inhibitor.</span>", "ID": "0300f734-354e-4fa4-a3e1-ce617309df85", "Styles": "None", "Classes": "None", "Text": " data suggests that the majority of NS5A\u00a0RAVs that confer resistance to ledipasvir and daclatasvir remained susceptible to velpatasvir.\u00a0 Velpatasvir was fully active against the sofosbuvir resistance-associated substitution S282T in NS5B while all velpatasvir resistance-associated substitutions in NS5A were fully susceptible to sofosbuvir.\u00a0 Both sofosbuvir and velpatasvir were fully active against substitutions associated with resistance to other classes of direct-acting antivirals with different mechanisms of actions, such as NS5B non\u2011nucleoside inhibitors and NS3 protease inhibitors.\u00a0 The efficacy of Epclusa has not been assessed in patients who have previously failed treatment with other regimens that include an NS5A inhibitor.", "ParentId": "2dd10fb1-922f-48b5-847b-4877a336b2a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d09e8827-24b1-4b57-84c4-cb48de5fe224", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fdbb4f4d-194a-41da-a0f4-47ba804d11c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d09e8827-24b1-4b57-84c4-cb48de5fe224"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>", "ID": "c8fae203-bfc1-42b1-b097-2664a6864240", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u>", "ID": "333d0391-5a2d-40b6-9758-fa4e43fccacb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c8fae203-bfc1-42b1-b097-2664a6864240"}, {"Element": "<span lang=\"EN-GB\">Clinical efficacy and safety</span>", "ID": "01757dc8-3028-4458-b42c-30b016bce371", "Styles": "None", "Classes": "None", "Text": "Clinical efficacy and safety", "ParentId": "333d0391-5a2d-40b6-9758-fa4e43fccacb"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nefficacy of </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> was evaluated in three\nPhase\u00a03 studies in patients with genotype\u00a01 to 6 HCV infection with\nor without compensated cirrhosis, one Phase\u00a03 study in patients with\ngenotype\u00a01 to 6 HCV infection with decompensated cirrhosis, and one\nPhase\u00a03 study in HCV/HIV\u20111 co-infected patients with genotype\u00a01\nto 6 HCV infection, as summarised in Table\u00a09.</span></p>", "ID": "18ad27d9-b263-49f6-84aa-3e213578b003", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The\nefficacy of </span>", "ID": "888ed533-3c52-4199-b5b1-e05a590d9991", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "The efficacy of ", "ParentId": "18ad27d9-b263-49f6-84aa-3e213578b003"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span>", "ID": "e91fbb3e-5077-4a42-8001-ebdd1565388a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Epclusa", "ParentId": "18ad27d9-b263-49f6-84aa-3e213578b003"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> was evaluated in three\nPhase\u00a03 studies in patients with genotype\u00a01 to 6 HCV infection with\nor without compensated cirrhosis, one Phase\u00a03 study in patients with\ngenotype\u00a01 to 6 HCV infection with decompensated cirrhosis, and one\nPhase\u00a03 study in HCV/HIV\u20111 co-infected patients with genotype\u00a01\nto 6 HCV infection, as summarised in Table\u00a09.</span>", "ID": "7d89ea66-ae25-4b52-8e68-766a5b0a3e74", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " was evaluated in three Phase\u00a03 studies in patients with genotype\u00a01 to 6 HCV infection with or without compensated cirrhosis, one Phase\u00a03 study in patients with genotype\u00a01 to 6 HCV infection with decompensated cirrhosis, and one Phase\u00a03 study in HCV/HIV\u20111 co-infected patients with genotype\u00a01 to 6 HCV infection, as summarised in Table\u00a09.", "ParentId": "18ad27d9-b263-49f6-84aa-3e213578b003"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f3fc19a-0a5b-4e68-8a0f-ca532322e402", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae07992d-3490-45df-9bbd-afc2e4aa096f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f3fc19a-0a5b-4e68-8a0f-ca532322e402"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a09: Studies conducted with Epclusa in patients with genotype\u00a01,\n2, 3, 4, 5 or 6 HCV infection</span></b></p>", "ID": "59850075-7a2c-457c-a5ef-2ef421c65773", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a09: Studies conducted with Epclusa in patients with genotype\u00a01,\n2, 3, 4, 5 or 6 HCV infection</span></b>", "ID": "2514f81e-c950-4c09-ae88-6cd80d9e3667", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "59850075-7a2c-457c-a5ef-2ef421c65773"}, {"Element": "<span lang=\"EN-GB\">Table\u00a09: Studies conducted with Epclusa in patients with genotype\u00a01,\n2, 3, 4, 5 or 6 HCV infection</span>", "ID": "b815c101-2931-4d24-a17f-f09e0625a9ad", "Styles": "None", "Classes": "None", "Text": "Table\u00a09: Studies conducted with Epclusa in patients with genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection", "ParentId": "2514f81e-c950-4c09-ae88-6cd80d9e3667"}, {"Element": "<div align=\"center\">\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:25.45pt\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>\n<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>\n<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>\n</td>\n</tr>\n</table>\n</div>", "ID": "5273e3ba-cd6a-459f-a965-51e6113bf75f", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:25.45pt\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>\n<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>\n<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>\n</td>\n</tr>\n</table>", "ID": "745005d7-a754-4210-8a6f-fa6017bfdfbb", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "5273e3ba-cd6a-459f-a965-51e6113bf75f"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:25.45pt\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>\n<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>\n<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "4a240ca6-7647-401c-97e5-e0e7e00d5262", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<tr style=\"page-break-inside:avoid;height:25.45pt\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>\n<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>\n<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>\n</tr>", "ID": "388a48ca-b9f3-4c11-99b7-443426419a00", "Styles": "page-break-inside:avoid;height:25.45pt", "Classes": "None", "Text": "    ", "ParentId": "4a240ca6-7647-401c-97e5-e0e7e00d5262"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>\n</td>", "ID": "36150668-666c-41a2-8872-5f11018ee6c0", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:25.45pt", "Classes": "None", "Text": "  ", "ParentId": "388a48ca-b9f3-4c11-99b7-443426419a00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b></p>", "ID": "fefe4c82-4698-4194-b34c-cb201fc09e8c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "36150668-666c-41a2-8872-5f11018ee6c0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span></b>", "ID": "23e47ad4-6c1e-449d-9f11-cb87384ec6c4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fefe4c82-4698-4194-b34c-cb201fc09e8c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study</span>", "ID": "66748968-2fdb-4339-a9e2-82a35004dc1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Study", "ParentId": "23e47ad4-6c1e-449d-9f11-cb87384ec6c4"}, {"Element": "<td style=\"width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>\n</td>", "ID": "aa2842d7-b4c8-4104-96a7-06983705e1b1", "Styles": "width:163.0pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt", "Classes": "None", "Text": "  ", "ParentId": "388a48ca-b9f3-4c11-99b7-443426419a00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b></p>", "ID": "fe0c4928-71c0-4a66-94b5-fda863af987e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aa2842d7-b4c8-4104-96a7-06983705e1b1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span></b>", "ID": "9350d119-fa3f-46bb-b815-f4a7a940fbac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe0c4928-71c0-4a66-94b5-fda863af987e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Population</span>", "ID": "361bd08e-2277-4d8c-b508-8fb3595750ed", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Population", "ParentId": "9350d119-fa3f-46bb-b815-f4a7a940fbac"}, {"Element": "<td style=\"width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt\" valign=\"top\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>\n</td>", "ID": "d947798e-7789-4c81-bf96-290e639b2bc1", "Styles": "width:230.15pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:25.45pt", "Classes": "None", "Text": "   ", "ParentId": "388a48ca-b9f3-4c11-99b7-443426419a00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b></p>", "ID": "5d77c9d3-41c5-4b1d-bfc8-c7538a8c403e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d947798e-7789-4c81-bf96-290e639b2bc1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span></b>", "ID": "f6aa9da1-98c1-428e-b588-06ce66e4570a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d77c9d3-41c5-4b1d-bfc8-c7538a8c403e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Study arms</span>", "ID": "3f8b4c5c-abc2-487a-88b5-b3bbd2eaa089", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Study arms", "ParentId": "f6aa9da1-98c1-428e-b588-06ce66e4570a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b></p>", "ID": "ab5ef1c1-678a-4f18-aa82-2d4e82481e66", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d947798e-7789-4c81-bf96-290e639b2bc1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span></b>", "ID": "c21a36ab-3202-466d-9a2a-b9c465c2319f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab5ef1c1-678a-4f18-aa82-2d4e82481e66"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(Number of patients treated)</span>", "ID": "3bb8569f-915f-4627-8906-f358224631bd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(Number of patients treated)", "ParentId": "c21a36ab-3202-466d-9a2a-b9c465c2319f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>\n</td>\n</tr>", "ID": "55e7d110-832b-4289-ae7b-70d9d2f62980", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>\n</td>", "ID": "859da308-60c7-4fb1-a2bf-54b181d6ef7b", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "55e7d110-832b-4289-ae7b-70d9d2f62980"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span></p>", "ID": "1ec7098f-803b-4790-81aa-95d4221e0688", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "859da308-60c7-4fb1-a2bf-54b181d6ef7b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20111</span>", "ID": "ade96816-0cf6-407e-9728-babc7eed8518", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ASTRAL\u20111", "ParentId": "1ec7098f-803b-4790-81aa-95d4221e0688"}, {"Element": "<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>\n</td>", "ID": "958a28f3-6832-4059-a3de-431b0d5c8948", "Styles": "width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "55e7d110-832b-4289-ae7b-70d9d2f62980"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span></p>", "ID": "f8740473-5995-479c-870a-5c9fded1aab2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "958a28f3-6832-4059-a3de-431b0d5c8948"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 4, 5 and 6</span>", "ID": "369b11e6-942b-4caf-9c6c-6fa170ae934b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01, 2, 4, 5 and 6", "ParentId": "f8740473-5995-479c-870a-5c9fded1aab2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span></p>", "ID": "c4153565-aae9-418c-9800-6e3d0a97dc14", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "958a28f3-6832-4059-a3de-431b0d5c8948"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis</span>", "ID": "6fd1278e-7b40-46c4-ae92-1971e83f41b3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "TN and TE, without cirrhosis or with   compensated cirrhosis", "ParentId": "c4153565-aae9-418c-9800-6e3d0a97dc14"}, {"Element": "<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>\n</td>", "ID": "0c5f61f3-23ef-4e71-94c2-7312bf7babd2", "Styles": "width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "55e7d110-832b-4289-ae7b-70d9d2f62980"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span></p>", "ID": "cd266927-d0ef-4748-912b-00ab568b2f95", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c5f61f3-23ef-4e71-94c2-7312bf7babd2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (624)</span>", "ID": "68947ab6-95b4-4efe-9fe8-fd76886d95b8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks (624)", "ParentId": "cd266927-d0ef-4748-912b-00ab568b2f95"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span></p>", "ID": "1b55e2b3-75d2-4dc2-800c-3b06bb51d1ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c5f61f3-23ef-4e71-94c2-7312bf7babd2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Placebo 12\u00a0weeks (116)</span>", "ID": "9b317e15-a154-483a-9b0d-44ff8c4548a2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Placebo 12\u00a0weeks (116)", "ParentId": "1b55e2b3-75d2-4dc2-800c-3b06bb51d1ef"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>\n</td>\n</tr>", "ID": "0767fecb-51dd-4dd6-abe4-e6550693b9eb", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>\n</td>", "ID": "95792a68-9eb8-4d49-a22b-2f484cfca200", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0767fecb-51dd-4dd6-abe4-e6550693b9eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span></p>", "ID": "feb76a3e-fe1e-47bc-8e9d-534c22a7bdb4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "95792a68-9eb8-4d49-a22b-2f484cfca200"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20112</span>", "ID": "fa249a11-e4dc-4d59-a73d-d86f47d29574", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ASTRAL\u20112", "ParentId": "feb76a3e-fe1e-47bc-8e9d-534c22a7bdb4"}, {"Element": "<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>", "ID": "86cc90fe-3105-4904-8e62-bfb95b81f136", "Styles": "width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0767fecb-51dd-4dd6-abe4-e6550693b9eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span></p>", "ID": "7a7a5f0a-448d-4e44-8422-b55bf28c86c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86cc90fe-3105-4904-8e62-bfb95b81f136"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02</span>", "ID": "ada3cd7d-2d5c-47f1-9846-dee6551959b6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a02", "ParentId": "7a7a5f0a-448d-4e44-8422-b55bf28c86c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>", "ID": "d57aa6a9-3d7c-439d-b9c9-29fb4aac8d2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86cc90fe-3105-4904-8e62-bfb95b81f136"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span>", "ID": "40e43c12-750c-44e6-af63-a2cab5fce26a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "TN and TE, without cirrhosis or with compensated   cirrhosis", "ParentId": "d57aa6a9-3d7c-439d-b9c9-29fb4aac8d2d"}, {"Element": "<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>\n</td>", "ID": "7f179dcb-834d-4eb1-a976-c8a3857488a0", "Styles": "width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0767fecb-51dd-4dd6-abe4-e6550693b9eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span></p>", "ID": "8adc1686-ee1d-4fd8-855d-5548d9ffaaa1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f179dcb-834d-4eb1-a976-c8a3857488a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (134)</span>", "ID": "c2e095a4-31e7-4016-8765-1a832925f77a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks (134)", "ParentId": "8adc1686-ee1d-4fd8-855d-5548d9ffaaa1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span></p>", "ID": "bf70f6c2-409a-44bb-a9fc-a4f8159b9302", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f179dcb-834d-4eb1-a976-c8a3857488a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 12\u00a0weeks (132)</span>", "ID": "da679107-9b49-47d8-b44f-c0305a34ef19", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SOF+RBV 12\u00a0weeks (132)", "ParentId": "bf70f6c2-409a-44bb-a9fc-a4f8159b9302"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>\n</td>\n</tr>", "ID": "76d0391c-2d5f-41be-9271-2dbefa734309", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>\n</td>", "ID": "bab6551b-93f5-47ad-a0a4-441d100799d8", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "76d0391c-2d5f-41be-9271-2dbefa734309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span></p>", "ID": "d07ba998-9e69-48fc-a5cc-42e3b8c29ee3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bab6551b-93f5-47ad-a0a4-441d100799d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20113</span>", "ID": "b92d3074-5067-4e2b-8d9e-245ec82a326c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ASTRAL\u20113", "ParentId": "d07ba998-9e69-48fc-a5cc-42e3b8c29ee3"}, {"Element": "<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>\n</td>", "ID": "48f5fd6c-d44b-48e4-b2be-f54bf307a682", "Styles": "width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "76d0391c-2d5f-41be-9271-2dbefa734309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></p>", "ID": "1a8d04a2-ec8f-47f3-b714-e4c56f1c8877", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48f5fd6c-d44b-48e4-b2be-f54bf307a682"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span>", "ID": "b6bbafb6-4a95-46dc-a4b9-6f360e5763df", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a03", "ParentId": "1a8d04a2-ec8f-47f3-b714-e4c56f1c8877"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span></p>", "ID": "bb5d6591-95e8-4cd0-b36e-7d8664f15ab0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48f5fd6c-d44b-48e4-b2be-f54bf307a682"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with compensated\n  cirrhosis</span>", "ID": "aaf7a11a-f3bf-49d6-8caf-fd1c49ce0351", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "TN and TE, without cirrhosis or with compensated   cirrhosis", "ParentId": "bb5d6591-95e8-4cd0-b36e-7d8664f15ab0"}, {"Element": "<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>\n</td>", "ID": "575e36c7-673f-4072-874d-72d457920727", "Styles": "width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "76d0391c-2d5f-41be-9271-2dbefa734309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span></p>", "ID": "9f55a2e5-66e5-4d88-867e-8bfc6a85066e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "575e36c7-673f-4072-874d-72d457920727"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (277)</span>", "ID": "3e4396cb-6df0-4488-b943-74ce1d8a3a38", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks (277)", "ParentId": "9f55a2e5-66e5-4d88-867e-8bfc6a85066e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span></p>", "ID": "afd3b949-a80d-488c-b109-18b2ee9ef55f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "575e36c7-673f-4072-874d-72d457920727"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV 24\u00a0weeks (275)</span>", "ID": "71bf9872-2b6e-4458-ae45-1b30c59fa78e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SOF+RBV 24\u00a0weeks (275)", "ParentId": "afd3b949-a80d-488c-b109-18b2ee9ef55f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>\n</td>\n</tr>", "ID": "30b7f8c7-088f-46e9-9dd7-6fa04ec9db29", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>\n</td>", "ID": "4ef0585a-16a8-447f-af01-da893382004a", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "30b7f8c7-088f-46e9-9dd7-6fa04ec9db29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span></p>", "ID": "2f523a92-65b7-463a-ba34-53ab134a20c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ef0585a-16a8-447f-af01-da893382004a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20114</span>", "ID": "8d494fd4-aea5-4578-8594-c7db8d316642", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ASTRAL\u20114", "ParentId": "2f523a92-65b7-463a-ba34-53ab134a20c5"}, {"Element": "<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>\n</td>", "ID": "4d1367e6-7462-45a9-afcb-c8613d8f77ee", "Styles": "width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "30b7f8c7-088f-46e9-9dd7-6fa04ec9db29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>", "ID": "85349560-7e6d-47f7-ad74-c78e553512dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d1367e6-7462-45a9-afcb-c8613d8f77ee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span>", "ID": "9a6fd6c1-8da5-4b19-b69c-2b41dbfe8460", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01, 2, 3, 4, 5 and 6", "ParentId": "85349560-7e6d-47f7-ad74-c78e553512dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span></p>", "ID": "e28260de-40af-4b77-8b2a-00c12266f249", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d1367e6-7462-45a9-afcb-c8613d8f77ee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, with CPT Class\u00a0B decompensated\n  cirrhosis </span>", "ID": "090ad9b1-d0ce-4f73-9275-0dfd7737118f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "TN and TE, with CPT Class\u00a0B decompensated   cirrhosis ", "ParentId": "e28260de-40af-4b77-8b2a-00c12266f249"}, {"Element": "<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>\n</td>", "ID": "dda3113a-8b5b-4a41-87cb-f4cc633dbc87", "Styles": "width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "30b7f8c7-088f-46e9-9dd7-6fa04ec9db29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span></p>", "ID": "3a48f595-2245-418a-8365-c509748af66d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dda3113a-8b5b-4a41-87cb-f4cc633dbc87"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (90)</span>", "ID": "98d0d0fc-6144-4606-917f-f27b22ae5e3b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks (90)", "ParentId": "3a48f595-2245-418a-8365-c509748af66d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span></p>", "ID": "1c76d8b0-e6ef-4454-9592-589a979bddf6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dda3113a-8b5b-4a41-87cb-f4cc633dbc87"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks (87)</span>", "ID": "e2864658-0c4a-4ae7-b4bd-5f3111087df7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa + RBV 12\u00a0weeks (87)", "ParentId": "1c76d8b0-e6ef-4454-9592-589a979bddf6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span></p>", "ID": "58fad343-947b-47f3-a106-d199420e988c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dda3113a-8b5b-4a41-87cb-f4cc633dbc87"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks (90)</span>", "ID": "24af0801-8880-4fbf-8f8e-fb7adbc50a3b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 24\u00a0weeks (90)", "ParentId": "58fad343-947b-47f3-a106-d199420e988c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>\n</td>\n<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>\n</td>\n<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>\n</td>\n</tr>", "ID": "027d741c-3978-4a86-a832-07f34605e86f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "745005d7-a754-4210-8a6f-fa6017bfdfbb"}, {"Element": "<td style=\"width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"90\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>\n</td>", "ID": "74ff5554-4cd5-44ce-8372-ad71a1ddde14", "Styles": "width:67.25pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "027d741c-3978-4a86-a832-07f34605e86f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span></p>", "ID": "cc388365-7276-4b22-bc24-6fcc43e3fbb8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "74ff5554-4cd5-44ce-8372-ad71a1ddde14"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ASTRAL\u20115</span>", "ID": "f2042e7b-15d4-4ec8-a120-5fd330addcf7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ASTRAL\u20115", "ParentId": "cc388365-7276-4b22-bc24-6fcc43e3fbb8"}, {"Element": "<td style=\"width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"217\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>\n</td>", "ID": "2b8dd9b7-221c-478f-8a53-fd1d2629684c", "Styles": "width:163.0pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "027d741c-3978-4a86-a832-07f34605e86f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span></p>", "ID": "72d6d8bd-8c8d-42fc-97e9-4e70343def51", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b8dd9b7-221c-478f-8a53-fd1d2629684c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01, 2, 3, 4, 5 and 6</span>", "ID": "bfb4e8a2-8820-4eea-91a9-6b46d645099d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01, 2, 3, 4, 5 and 6", "ParentId": "72d6d8bd-8c8d-42fc-97e9-4e70343def51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span></p>", "ID": "aef2b256-e5f4-4192-a9fb-93ca04198393", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b8dd9b7-221c-478f-8a53-fd1d2629684c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">TN and TE, without cirrhosis or with\n  compensated cirrhosis, with HCV/HIV\u20111 co-infection</span>", "ID": "9f3c8175-8ed8-4c82-9a68-31df9031c0e6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "TN and TE, without cirrhosis or with   compensated cirrhosis, with HCV/HIV\u20111 co-infection", "ParentId": "aef2b256-e5f4-4192-a9fb-93ca04198393"}, {"Element": "<td style=\"width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"307\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>\n</td>", "ID": "8444a6a1-d5df-45b7-a080-0d179c40e4fd", "Styles": "width:230.15pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "027d741c-3978-4a86-a832-07f34605e86f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span></p>", "ID": "0a080b8a-bb5e-499d-af58-1801d89b3c16", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8444a6a1-d5df-45b7-a080-0d179c40e4fd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks (106)</span>", "ID": "ba8b0d73-f418-468e-aff7-c85261502857", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks (106)", "ParentId": "0a080b8a-bb5e-499d-af58-1801d89b3c16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">TN\u00a0=\u00a0treatment-na\u00efve patients; TE\u00a0=\u00a0treatment-experienced\npatients (including those who have failed a peginterferon alfa + ribavirin\nbased regimen with or without an HCV protease inhibitor)</span></p>", "ID": "8556deb3-e0bc-4d02-a2cb-483ab224cc44", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">TN\u00a0=\u00a0treatment-na\u00efve patients; TE\u00a0=\u00a0treatment-experienced\npatients (including those who have failed a peginterferon alfa + ribavirin\nbased regimen with or without an HCV protease inhibitor)</span>", "ID": "5fe083d5-96eb-4018-892d-9e61b7349f7a", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "TN\u00a0=\u00a0treatment-na\u00efve patients; TE\u00a0=\u00a0treatment-experienced patients (including those who have failed a peginterferon alfa + ribavirin based regimen with or without an HCV protease inhibitor)", "ParentId": "8556deb3-e0bc-4d02-a2cb-483ab224cc44"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b9e57171-9bd4-41a8-9c79-066f0a79ce16", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cec195cd-92fd-4963-b5f6-4b2c76b5bd57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9e57171-9bd4-41a8-9c79-066f0a79ce16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The ribavirin dose\nwas weight-based (1,000\u00a0mg daily administered in two divided doses for\npatients &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those \u2265\u00a075\u00a0kg)\nand administered in two divided doses when used in combination with sofosbuvir\nin the ASTRAL\u20112 and ASTRAL\u20113 studies or in combination with Epclusa\nin the ASTRAL\u20114 study. \u00a0Ribavirin dose adjustments were performed\naccording to the ribavirin prescribing information.\u00a0 Serum HCV\u00a0RNA\nvalues were measured during the clinical studies using the COBAS\nAmpliPrep/COBAS Taqman HCV test (version\u00a02.0) with a lower limit of\nquantification (LLOQ) of 15\u00a0IU/mL. \u00a0Sustained virologic response\n(SVR12), defined as HCV\u00a0RNA less than LLOQ at 12\u00a0weeks after the\ncessation of treatment, was the primary endpoint to determine the HCV cure\nrate.</span></p>", "ID": "cfe438f2-5b15-466e-b14e-bd35b1a68311", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The ribavirin dose\nwas weight-based (1,000\u00a0mg daily administered in two divided doses for\npatients &lt;\u00a075\u00a0kg and 1,200\u00a0mg for those \u2265\u00a075\u00a0kg)\nand administered in two divided doses when used in combination with sofosbuvir\nin the ASTRAL\u20112 and ASTRAL\u20113 studies or in combination with Epclusa\nin the ASTRAL\u20114 study. \u00a0Ribavirin dose adjustments were performed\naccording to the ribavirin prescribing information.\u00a0 Serum HCV\u00a0RNA\nvalues were measured during the clinical studies using the COBAS\nAmpliPrep/COBAS Taqman HCV test (version\u00a02.0) with a lower limit of\nquantification (LLOQ) of 15\u00a0IU/mL. \u00a0Sustained virologic response\n(SVR12), defined as HCV\u00a0RNA less than LLOQ at 12\u00a0weeks after the\ncessation of treatment, was the primary endpoint to determine the HCV cure\nrate.</span>", "ID": "ed8e3b10-173b-47c2-85f5-9cb2e404e3a4", "Styles": "None", "Classes": "None", "Text": "The ribavirin dose was weight-based (1,000\u00a0mg daily administered in two divided doses for patients <\u00a075\u00a0kg and 1,200\u00a0mg for those \u2265\u00a075\u00a0kg) and administered in two divided doses when used in combination with sofosbuvir in the ASTRAL\u20112 and ASTRAL\u20113 studies or in combination with Epclusa in the ASTRAL\u20114 study. \u00a0Ribavirin dose adjustments were performed according to the ribavirin prescribing information.\u00a0 Serum HCV\u00a0RNA values were measured during the clinical studies using the COBAS AmpliPrep/COBAS Taqman HCV test (version\u00a02.0) with a lower limit of quantification (LLOQ) of 15\u00a0IU/mL. \u00a0Sustained virologic response (SVR12), defined as HCV\u00a0RNA less than LLOQ at 12\u00a0weeks after the cessation of treatment, was the primary endpoint to determine the HCV cure rate.", "ParentId": "cfe438f2-5b15-466e-b14e-bd35b1a68311"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "efb089df-ec6e-4648-a94a-2f2b22598c86", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "febc6187-cffd-4f44-a233-ac389296e1f0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "efb089df-ec6e-4648-a94a-2f2b22598c86"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i></p>", "ID": "60129cea-08c3-407e-93a5-efaa44289f4d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Clinical studies in patients without cirrhosis and patients with compensated\ncirrhosis</span></i>", "ID": "46da684a-0323-441e-a8df-4dc59c284da4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "60129cea-08c3-407e-93a5-efaa44289f4d"}, {"Element": "<span lang=\"EN-GB\">Clinical studies in patients without cirrhosis and patients with compensated\ncirrhosis</span>", "ID": "41ff654c-e7cf-4893-ba55-bf23cca75dcb", "Styles": "None", "Classes": "None", "Text": "Clinical studies in patients without cirrhosis and patients with compensated cirrhosis", "ParentId": "46da684a-0323-441e-a8df-4dc59c284da4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a01, 2, 4, 5 and 6 HCV\u2011infected adults <b>\u2013</b>\nASTRAL\u20111 (study\u00a01138)</span></i></p>", "ID": "0cc76775-3b6a-44df-8af8-f8a63e3cf89e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Genotype\u00a01, 2, 4, 5 and 6 HCV\u2011infected adults <b>\u2013</b>\nASTRAL\u20111 (study\u00a01138)</span></i>", "ID": "0c92b605-90a5-48e7-90ed-61f5b9e89788", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0cc76775-3b6a-44df-8af8-f8a63e3cf89e"}, {"Element": "<span lang=\"EN-GB\">Genotype\u00a01, 2, 4, 5 and 6 HCV\u2011infected adults <b>\u2013</b>\nASTRAL\u20111 (study\u00a01138)</span>", "ID": "35e89835-7f27-4cdd-ad18-3de6f126cd7a", "Styles": "None", "Classes": "None", "Text": "Genotype\u00a01, 2, 4, 5 and 6 HCV\u2011infected adults  ASTRAL\u20111 (study\u00a01138)", "ParentId": "0c92b605-90a5-48e7-90ed-61f5b9e89788"}, {"Element": "<b>\u2013</b>", "ID": "969331e0-fa30-4446-9d17-d70bc46bd695", "Styles": "None", "Classes": "None", "Text": "\u2013", "ParentId": "35e89835-7f27-4cdd-ad18-3de6f126cd7a"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20111\nwas a randomised, double-blind, placebo-controlled study that evaluated\n12\u00a0weeks of treatment with </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">compared with 12\u00a0weeks of placebo in patients with\ngenotype\u00a01, 2, 4, 5, or 6 HCV infection.\u00a0 Patients with genotype\u00a01,\n2, 4 or 6 HCV infection were randomised in a 5:1 ratio to treatment with </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks or\nplacebo for 12\u00a0weeks. \u00a0Patients with genotype\u00a05 HCV infection\nwere enrolled to the </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">group.\u00a0 Randomisation was stratified by HCV genotype (1,\n2, 4, 6, and indeterminate) and the presence or absence of cirrhosis.</span></p>", "ID": "c9fc494f-5184-402a-b029-b24f3a7533df", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20111\nwas a randomised, double-blind, placebo-controlled study that evaluated\n12\u00a0weeks of treatment with </span>", "ID": "adb7b42d-7d17-4fc8-9be7-da45b116e19c", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "ASTRAL\u20111 was a randomised, double-blind, placebo-controlled study that evaluated 12\u00a0weeks of treatment with ", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span>", "ID": "23c0a9b2-9ed5-473f-bad1-2aa8bec5e249", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": "Epclusa ", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">compared with 12\u00a0weeks of placebo in patients with\ngenotype\u00a01, 2, 4, 5, or 6 HCV infection.\u00a0 Patients with genotype\u00a01,\n2, 4 or 6 HCV infection were randomised in a 5:1 ratio to treatment with </span>", "ID": "a0d1da0b-c311-4139-b093-9b7d9949bd01", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": "compared with 12\u00a0weeks of placebo in patients with genotype\u00a01, 2, 4, 5, or 6 HCV infection.\u00a0 Patients with genotype\u00a01, 2, 4 or 6 HCV infection were randomised in a 5:1 ratio to treatment with ", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span>", "ID": "0ebaa96e-af71-4739-bf4f-06d6c026bcd1", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Epclusa", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks or\nplacebo for 12\u00a0weeks. \u00a0Patients with genotype\u00a05 HCV infection\nwere enrolled to the </span>", "ID": "836eec56-915b-416f-8f83-31935400a221", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " for 12\u00a0weeks or placebo for 12\u00a0weeks. \u00a0Patients with genotype\u00a05 HCV infection were enrolled to the ", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">Epclusa </span>", "ID": "5ac3b8c8-3298-4927-9c95-4dadbce7c6df", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": "Epclusa ", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\">group.\u00a0 Randomisation was stratified by HCV genotype (1,\n2, 4, 6, and indeterminate) and the presence or absence of cirrhosis.</span>", "ID": "03550c8e-2a95-415c-b6e1-3dd3cf47f605", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": "group.\u00a0 Randomisation was stratified by HCV genotype (1, 2, 4, 6, and indeterminate) and the presence or absence of cirrhosis.", "ParentId": "c9fc494f-5184-402a-b029-b24f3a7533df"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "3bce0ccc-f021-4e27-9cd2-d26af64ddf76", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "d7f9fa80-f7ea-4884-a6d1-14289947696d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "3bce0ccc-f021-4e27-9cd2-d26af64ddf76"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced between the Epclusa and placebo\ngroup. \u00a0Of the 740\u00a0treated patients, the median age was 56\u00a0years\n(range: 18 to 82); 60% of the patients were male; 79% were White, 9% were\nBlack; 21% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\nthe proportions of patients with genotype\u00a01, 2, 4, 5, or 6 HCV infection\nwere 53%, 17%, 19%, 5% and 7%, respectively; 69% had non\u2011CC IL28B alleles\n(CT or TT); 74% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL;\n19% had compensated cirrhosis; and 32% were treatment-experienced.</span></p>", "ID": "e4c8059d-ff12-457b-a7df-cc557e09699d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced between the Epclusa and placebo\ngroup. \u00a0Of the 740\u00a0treated patients, the median age was 56\u00a0years\n(range: 18 to 82); 60% of the patients were male; 79% were White, 9% were\nBlack; 21% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\nthe proportions of patients with genotype\u00a01, 2, 4, 5, or 6 HCV infection\nwere 53%, 17%, 19%, 5% and 7%, respectively; 69% had non\u2011CC IL28B alleles\n(CT or TT); 74% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL;\n19% had compensated cirrhosis; and 32% were treatment-experienced.</span>", "ID": "6907135b-643e-436c-b73e-cf2fc2d08c31", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Demographics and baseline characteristics were balanced between the Epclusa and placebo group. \u00a0Of the 740\u00a0treated patients, the median age was 56\u00a0years (range: 18 to 82); 60% of the patients were male; 79% were White, 9% were Black; 21% had a baseline body mass index of at least 30\u00a0kg/m; the proportions of patients with genotype\u00a01, 2, 4, 5, or 6 HCV infection were 53%, 17%, 19%, 5% and 7%, respectively; 69% had non\u2011CC IL28B alleles (CT or TT); 74% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL; 19% had compensated cirrhosis; and 32% were treatment-experienced.", "ParentId": "e4c8059d-ff12-457b-a7df-cc557e09699d"}, {"Element": "<sup>2</sup>", "ID": "91158ca3-96d3-4ed9-848c-613ca7c07d45", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "6907135b-643e-436c-b73e-cf2fc2d08c31"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "f777dea8-e5e4-4a2a-9671-cfc4082eb318", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "36253377-36a4-4f72-a96e-bfa9574f2b35", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f777dea8-e5e4-4a2a-9671-cfc4082eb318"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Table\u00a010\npresents the SVR12 for the ASTRAL\u20111 study by HCV genotypes. \u00a0No\npatients in the placebo group achieved SVR12.</span></p>", "ID": "a876b768-a58b-4941-a315-04afbe2fb14d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Table\u00a010\npresents the SVR12 for the ASTRAL\u20111 study by HCV genotypes. \u00a0No\npatients in the placebo group achieved SVR12.</span>", "ID": "f7e20988-5e06-45e9-a16d-ae3803109e2c", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Table\u00a010 presents the SVR12 for the ASTRAL\u20111 study by HCV genotypes. \u00a0No patients in the placebo group achieved SVR12.", "ParentId": "a876b768-a58b-4941-a315-04afbe2fb14d"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "e97ce43b-8001-4807-a505-803db680b96a", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "deb1a2e3-1f32-4173-95e6-b38b4899450f", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "e97ce43b-8001-4807-a505-803db680b96a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a010: SVR12 in study ASTRAL\u20111 by HCV genotype</span></b></p>", "ID": "880f4cfc-6146-447b-b55d-862ae4412dfd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a010: SVR12 in study ASTRAL\u20111 by HCV genotype</span></b>", "ID": "9ceeea74-74f5-4356-8c94-91fdb6ac69b3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "880f4cfc-6146-447b-b55d-862ae4412dfd"}, {"Element": "<span lang=\"EN-GB\">Table\u00a010: SVR12 in study ASTRAL\u20111 by HCV genotype</span>", "ID": "52bd6474-5bda-4b1d-9fc5-f3a96241a7bc", "Styles": "None", "Classes": "None", "Text": "Table\u00a010: SVR12 in study ASTRAL\u20111 by HCV genotype", "ParentId": "9ceeea74-74f5-4356-8c94-91fdb6ac69b3"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"631\">\n<thead>\n<tr style=\"page-break-inside:avoid;height:27.0pt\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"8\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td rowspan=\"2\" style=\"width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"211\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td style=\"width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td colspan=\"9\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:50.25pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:25.5pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>\n</table>", "ID": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid;height:27.0pt\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"8\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td rowspan=\"2\" style=\"width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"211\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td style=\"width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "0fd38137-3d76-41c0-bf47-23839b92cfa6", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<tr style=\"page-break-inside:avoid;height:27.0pt\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"8\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n</tr>", "ID": "03753c8d-f8bd-4e03-8e52-a0b9f8eb8964", "Styles": "page-break-inside:avoid;height:27.0pt", "Classes": "None", "Text": "   ", "ParentId": "0fd38137-3d76-41c0-bf47-23839b92cfa6"}, {"Element": "<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "494ff2f3-f1a6-4395-bccd-10589dbd1c89", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:27.0pt", "Classes": "None", "Text": "  ", "ParentId": "03753c8d-f8bd-4e03-8e52-a0b9f8eb8964"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "d7156fdb-e058-46f8-a484-25ca3f8f513f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "494ff2f3-f1a6-4395-bccd-10589dbd1c89"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "eb1e968e-41a6-43fa-8bb9-5910fdebb4da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7156fdb-e058-46f8-a484-25ca3f8f513f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "34c30ec1-a34c-4ed6-a330-7b1a305a9a17", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "eb1e968e-41a6-43fa-8bb9-5910fdebb4da"}, {"Element": "<td colspan=\"8\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>", "ID": "c08e422d-b923-482b-b336-6d62fa4a5ea6", "Styles": "width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt;height:27.0pt", "Classes": "None", "Text": "   ", "ParentId": "03753c8d-f8bd-4e03-8e52-a0b9f8eb8964"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>", "ID": "db17e964-418c-4f73-9513-8f81259ad7ee", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c08e422d-b923-482b-b336-6d62fa4a5ea6"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b>", "ID": "de632e96-0be1-4dca-956d-311ea2c5edc3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "db17e964-418c-4f73-9513-8f81259ad7ee"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span>", "ID": "1713175a-6822-4b25-8955-209bfbbb989e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa    12\u00a0weeks", "ParentId": "de632e96-0be1-4dca-956d-311ea2c5edc3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>", "ID": "e2a596d4-65a1-4383-8b23-5b137a6f425d", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c08e422d-b923-482b-b336-6d62fa4a5ea6"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b>", "ID": "5b7f0e33-b7b8-494b-9328-1a16d99321d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2a596d4-65a1-4383-8b23-5b137a6f425d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span>", "ID": "40d63353-c8b0-453d-bcfe-b25e8becbfd2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0624)", "ParentId": "5b7f0e33-b7b8-494b-9328-1a16d99321d8"}, {"Element": "<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td rowspan=\"2\" style=\"width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"211\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>\n</td>\n</tr>", "ID": "04494da0-15e5-4b37-ab69-0f57cf791a4f", "Styles": "page-break-inside:avoid;height:12.75pt", "Classes": "None", "Text": "       ", "ParentId": "0fd38137-3d76-41c0-bf47-23839b92cfa6"}, {"Element": "<td rowspan=\"2\" style=\"width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>\n</td>", "ID": "2ad5fb8c-0365-40c8-8aa2-0b864a8495d8", "Styles": "width:51.5pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "    ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "c0c33c27-ba8c-495e-8968-93d19c47b557", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ad5fb8c-0365-40c8-8aa2-0b864a8495d8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "3bdb1781-01ab-4184-9c0f-ddd826da97e5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0c33c27-ba8c-495e-8968-93d19c47b557"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "0d718d08-40ae-4f26-bf2b-5831b3c0637d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "3bdb1781-01ab-4184-9c0f-ddd826da97e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>", "ID": "3d6d5c4e-3edc-4244-8a14-54a4618bd684", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ad5fb8c-0365-40c8-8aa2-0b864a8495d8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b>", "ID": "5f4a5bf4-86aa-4ae5-8347-7228747694f1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d6d5c4e-3edc-4244-8a14-54a4618bd684"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span>", "ID": "23bbb62e-e3b8-44cf-af5c-bcae326f2441", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(all GTs)", "ParentId": "5f4a5bf4-86aa-4ae5-8347-7228747694f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b></p>", "ID": "2a16ab35-d26f-4e22-9db2-d84a72c57621", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ad5fb8c-0365-40c8-8aa2-0b864a8495d8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span></b>", "ID": "726197c1-c5fc-40c0-b847-03db09a8a102", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2a16ab35-d26f-4e22-9db2-d84a72c57621"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0624)</span>", "ID": "f911e46d-6d61-4598-ada9-f3b35b9ab2c3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0624)", "ParentId": "726197c1-c5fc-40c0-b847-03db09a8a102"}, {"Element": "<td colspan=\"3\" style=\"width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"211\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>", "ID": "fa6be862-9eee-4ea0-9f1e-10d9c9cdc051", "Styles": "width:158.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "  ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>", "ID": "d66b148f-d2ab-411e-a294-ae2456ad76f7", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa6be862-9eee-4ea0-9f1e-10d9c9cdc051"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b>", "ID": "923229bb-a1f8-4509-b225-50582ad3e97c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d66b148f-d2ab-411e-a294-ae2456ad76f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span>", "ID": "5e1f1d3a-e483-47a5-bb9a-04b99348b8e0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111", "ParentId": "923229bb-a1f8-4509-b225-50582ad3e97c"}, {"Element": "<td rowspan=\"2\" style=\"width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>\n</td>", "ID": "7527668e-9a99-4de5-8529-bab7da98222d", "Styles": "width:52.85pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>", "ID": "477e21dd-9bf4-4db9-8a9b-cda09db9c6df", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7527668e-9a99-4de5-8529-bab7da98222d"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b>", "ID": "88a31f43-24b1-481f-a788-56daa657bbc0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "477e21dd-9bf4-4db9-8a9b-cda09db9c6df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span>", "ID": "48aba09d-c1dd-46be-817f-d88bdb640332", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20112", "ParentId": "88a31f43-24b1-481f-a788-56daa657bbc0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b></p>", "ID": "1db783bc-f80e-456d-a5bd-99ba45a710e2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7527668e-9a99-4de5-8529-bab7da98222d"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span></b>", "ID": "2898308d-734b-4356-a417-1747a462ab01", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1db783bc-f80e-456d-a5bd-99ba45a710e2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0104)</span>", "ID": "6e6ca2bc-b310-400c-816a-aba375d4aabf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0104)", "ParentId": "2898308d-734b-4356-a417-1747a462ab01"}, {"Element": "<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>\n</td>", "ID": "37a84d65-c3e6-4270-b73b-f3fae2a4a148", "Styles": "width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>", "ID": "7de92650-9601-4762-80eb-0d446fdd13f8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37a84d65-c3e6-4270-b73b-f3fae2a4a148"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b>", "ID": "3c0f7b24-0bb3-481f-b1cc-c7eb7e87c474", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7de92650-9601-4762-80eb-0d446fdd13f8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span>", "ID": "71870a72-731f-401d-9eb8-f3ed78ea97eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20114", "ParentId": "3c0f7b24-0bb3-481f-b1cc-c7eb7e87c474"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b></p>", "ID": "8f1147b4-ceae-48d2-9b7a-6b614ed0e0d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37a84d65-c3e6-4270-b73b-f3fae2a4a148"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span></b>", "ID": "9bc254c2-72ae-47f2-8315-a7eb4cb97ba9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f1147b4-ceae-48d2-9b7a-6b614ed0e0d0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0116)</span>", "ID": "e081c2d4-7c82-4890-b6a8-669fbf8198aa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0116)", "ParentId": "9bc254c2-72ae-47f2-8315-a7eb4cb97ba9"}, {"Element": "<td rowspan=\"2\" style=\"width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>\n</td>", "ID": "ec61103c-be32-4910-9232-ff4e6561a85a", "Styles": "width:49.65pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b></p>", "ID": "0a38bd55-400a-4454-88f1-b435bee892bc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec61103c-be32-4910-9232-ff4e6561a85a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span></b>", "ID": "55143664-3c97-4dac-aaac-73f1ef3db086", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a38bd55-400a-4454-88f1-b435bee892bc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20115</span>", "ID": "b72c3c5b-0be7-4c86-88b0-e97e7f707675", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20115", "ParentId": "55143664-3c97-4dac-aaac-73f1ef3db086"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b></p>", "ID": "22b5d85a-a920-4163-a276-066b3c0ea0ae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec61103c-be32-4910-9232-ff4e6561a85a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span></b>", "ID": "7f0eea11-3578-44c9-b75e-7a926e88f048", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "22b5d85a-a920-4163-a276-066b3c0ea0ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a035)</span>", "ID": "605fcf83-a239-4edb-8cf4-2f2a7c9b8798", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a035)", "ParentId": "7f0eea11-3578-44c9-b75e-7a926e88f048"}, {"Element": "<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>\n</td>", "ID": "7a55168c-b112-43a6-9f5f-8cf3c2f43acc", "Styles": "width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "04494da0-15e5-4b37-ab69-0f57cf791a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b></p>", "ID": "6eb9045d-4d9b-4b75-97cf-ec1132a411e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7a55168c-b112-43a6-9f5f-8cf3c2f43acc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span></b>", "ID": "2fc19583-a63e-46c9-b76e-06593999c614", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6eb9045d-4d9b-4b75-97cf-ec1132a411e3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20116</span>", "ID": "ba405d5e-532b-499a-a182-ce81fcd1001b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20116", "ParentId": "2fc19583-a63e-46c9-b76e-06593999c614"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b></p>", "ID": "cd3ce7d0-07bb-48e6-b058-5e6942ce18ad", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7a55168c-b112-43a6-9f5f-8cf3c2f43acc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span></b>", "ID": "60707a8c-3280-4949-91c3-b18910a8639c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd3ce7d0-07bb-48e6-b058-5e6942ce18ad"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a041)</span>", "ID": "3d94c140-f41a-4071-9abd-be49c931e876", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a041)", "ParentId": "60707a8c-3280-4949-91c3-b18910a8639c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td style=\"width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>\n</td>\n</tr>", "ID": "455f5c58-5b0f-4f3e-88df-6c701563e422", "Styles": "page-break-inside:avoid;height:12.75pt", "Classes": "None", "Text": "    ", "ParentId": "0fd38137-3d76-41c0-bf47-23839b92cfa6"}, {"Element": "<td style=\"width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>\n</td>", "ID": "f5e2fe42-2726-4b3b-b03a-b57f3f6c1a15", "Styles": "width:52.5pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "455f5c58-5b0f-4f3e-88df-6c701563e422"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>", "ID": "16d6813f-06d4-4aef-8e73-b0ee979193da", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5e2fe42-2726-4b3b-b03a-b57f3f6c1a15"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b>", "ID": "cdce0722-4eb7-460d-855d-471c43a86e45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d6813f-06d4-4aef-8e73-b0ee979193da"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span>", "ID": "0c4de585-8ea8-416b-9244-1c0833709d8b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111a", "ParentId": "cdce0722-4eb7-460d-855d-471c43a86e45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b></p>", "ID": "d643949e-866f-429e-8b06-2d1e59723bdd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5e2fe42-2726-4b3b-b03a-b57f3f6c1a15"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span></b>", "ID": "dc71b787-274d-4d34-b806-7320491632e0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d643949e-866f-429e-8b06-2d1e59723bdd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0210)</span>", "ID": "4f4caf11-52da-4f16-85ac-8ab24ea9f0a3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0210)", "ParentId": "dc71b787-274d-4d34-b806-7320491632e0"}, {"Element": "<td style=\"width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>\n</td>", "ID": "a8d12652-9f34-45ed-90a4-e9da4fe2bff7", "Styles": "width:52.25pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "455f5c58-5b0f-4f3e-88df-6c701563e422"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>", "ID": "71a6159b-86d8-4ced-a270-c86f195ed596", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8d12652-9f34-45ed-90a4-e9da4fe2bff7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b>", "ID": "d9344fbb-1ad1-487c-8d5d-156b7f440f2d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71a6159b-86d8-4ced-a270-c86f195ed596"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span>", "ID": "db632c29-f68e-4626-a588-a7d0e352dd83", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111b", "ParentId": "d9344fbb-1ad1-487c-8d5d-156b7f440f2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b></p>", "ID": "86847bf6-9179-4945-bec6-dc4cb91d44cd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8d12652-9f34-45ed-90a4-e9da4fe2bff7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span></b>", "ID": "20a24a8d-ccf1-4f22-a6ec-c2c4f784f13e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "86847bf6-9179-4945-bec6-dc4cb91d44cd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0118)</span>", "ID": "e2c96fc0-5079-4a45-aec5-086a5e0909b7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0118)", "ParentId": "20a24a8d-ccf1-4f22-a6ec-c2c4f784f13e"}, {"Element": "<td style=\"width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" valign=\"top\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>\n</td>", "ID": "72bae11c-d5fe-4bee-a341-6ef6f5de9fdb", "Styles": "width:53.45pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "   ", "ParentId": "455f5c58-5b0f-4f3e-88df-6c701563e422"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "fdc88ab2-2300-45d0-bf34-6e9443f2af71", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "72bae11c-d5fe-4bee-a341-6ef6f5de9fdb"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "8c89e405-84d2-475a-8c2b-ab6537120d8e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fdc88ab2-2300-45d0-bf34-6e9443f2af71"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "9c250529-0b79-4a13-9510-510504101f9c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "8c89e405-84d2-475a-8c2b-ab6537120d8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b></p>", "ID": "7cd8c27d-8893-4e8e-be95-73a04e81cfc6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "72bae11c-d5fe-4bee-a341-6ef6f5de9fdb"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span></b>", "ID": "bd6c3317-f509-453c-b1d2-e56c12e2a5d7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7cd8c27d-8893-4e8e-be95-73a04e81cfc6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0328)</span>", "ID": "5e577721-2b1a-49d3-86e9-4479b3f5fa8f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0328)", "ParentId": "bd6c3317-f509-453c-b1d2-e56c12e2a5d7"}, {"Element": "<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span></p>\n</td>\n</tr>", "ID": "72f27811-dac1-4ca0-ba9c-cd142d10b145", "Styles": "page-break-inside:avoid;height:24.75pt", "Classes": "None", "Text": "          ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>", "ID": "1c4b2db8-155f-471f-bc71-c4df77cd9a33", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>", "ID": "76006f17-c255-416d-ae06-d02eba4c237a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1c4b2db8-155f-471f-bc71-c4df77cd9a33"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span>", "ID": "50ad272b-806c-4bbc-a494-3191716b78ac", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR12", "ParentId": "76006f17-c255-416d-ae06-d02eba4c237a"}, {"Element": "<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span></p>\n</td>", "ID": "5722ba0b-5103-447a-9a4d-0f9dfe29f566", "Styles": "width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>", "ID": "28fbd26d-983c-449f-9263-e3aba3c255d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5722ba0b-5103-447a-9a4d-0f9dfe29f566"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span>", "ID": "11474caf-0b6c-471d-b03f-7cd412719666", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "99%", "ParentId": "28fbd26d-983c-449f-9263-e3aba3c255d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span></p>", "ID": "ed81af72-5868-4aed-9033-99d2622ed6af", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5722ba0b-5103-447a-9a4d-0f9dfe29f566"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(618/624)</span>", "ID": "fa488043-b3a5-443d-bc19-41a732c16ce5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(618/624)", "ParentId": "ed81af72-5868-4aed-9033-99d2622ed6af"}, {"Element": "<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span></p>\n</td>", "ID": "3c1ee80f-cf5b-458c-b6e3-2af8f8c074c9", "Styles": "width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>", "ID": "b1ea0d69-bd43-47c4-bf43-e778a7883870", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c1ee80f-cf5b-458c-b6e3-2af8f8c074c9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span>", "ID": "11f84301-0c39-43cc-982d-2d946652d8fb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98%", "ParentId": "b1ea0d69-bd43-47c4-bf43-e778a7883870"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span></p>", "ID": "963a0295-1b33-464a-9b5f-cb1458b5cd9d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c1ee80f-cf5b-458c-b6e3-2af8f8c074c9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(206/210)</span>", "ID": "cd5fc0fd-463c-4c37-8a2f-50f119e019ca", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(206/210)", "ParentId": "963a0295-1b33-464a-9b5f-cb1458b5cd9d"}, {"Element": "<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span></p>\n</td>", "ID": "a5445748-2b6f-44f2-9cbd-ae5b279b8058", "Styles": "width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span></p>", "ID": "655395a6-024e-4697-ab8d-369f3cb1a1c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5445748-2b6f-44f2-9cbd-ae5b279b8058"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">99%</span>", "ID": "d246f306-a372-41c6-b2b9-b9f3db3f65d6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "99%", "ParentId": "655395a6-024e-4697-ab8d-369f3cb1a1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span></p>", "ID": "89afe9f9-19c2-4f9b-9d14-82e2f343909d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5445748-2b6f-44f2-9cbd-ae5b279b8058"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(117/118)</span>", "ID": "6e40c524-d850-4dcd-b345-b4a83d2c8fae", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(117/118)", "ParentId": "89afe9f9-19c2-4f9b-9d14-82e2f343909d"}, {"Element": "<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span></p>\n</td>", "ID": "4ef9b19a-0750-40d4-8c0c-1047cbaa7d7f", "Styles": "width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span></p>", "ID": "593f543b-329d-4b72-b17a-9368b6460dc1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ef9b19a-0750-40d4-8c0c-1047cbaa7d7f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98%</span>", "ID": "08fbeaa9-88b9-4f54-a898-63d46dcdcbb3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98%", "ParentId": "593f543b-329d-4b72-b17a-9368b6460dc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span></p>", "ID": "7447a3fc-9058-4974-9dc5-1c8c907a1366", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ef9b19a-0750-40d4-8c0c-1047cbaa7d7f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(323/328)</span>", "ID": "7de85a86-5f4d-4e70-b406-b9a202208a6f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(323/328)", "ParentId": "7447a3fc-9058-4974-9dc5-1c8c907a1366"}, {"Element": "<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span></p>\n</td>", "ID": "94a778e8-eab6-49a6-8f08-dacdfa7f7283", "Styles": "width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>", "ID": "ce715508-8fa7-4f56-a7c5-cb0d907e7717", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94a778e8-eab6-49a6-8f08-dacdfa7f7283"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span>", "ID": "b47d4608-4c54-497a-a328-c2850667c580", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%", "ParentId": "ce715508-8fa7-4f56-a7c5-cb0d907e7717"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span></p>", "ID": "a336b610-1822-494a-9fe5-ead5221ee534", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94a778e8-eab6-49a6-8f08-dacdfa7f7283"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(104/104)</span>", "ID": "7b7b6fd5-427e-4ed7-b061-c98dba0c309a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(104/104)", "ParentId": "a336b610-1822-494a-9fe5-ead5221ee534"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span></p>\n</td>", "ID": "a10f0df8-1f5a-4add-b333-233b5942b208", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>", "ID": "edad8bea-d5c5-4414-8780-40f081701651", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a10f0df8-1f5a-4add-b333-233b5942b208"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span>", "ID": "b5882f3a-2fad-47ff-9c00-c2fe810ca714", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%", "ParentId": "edad8bea-d5c5-4414-8780-40f081701651"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span></p>", "ID": "911064eb-2570-4fe5-ace4-6bcb0b8c8c6e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a10f0df8-1f5a-4add-b333-233b5942b208"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(116/116)</span>", "ID": "173f9ecb-e782-4bca-aaa6-04cd5ce9f914", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(116/116)", "ParentId": "911064eb-2570-4fe5-ace4-6bcb0b8c8c6e"}, {"Element": "<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span></p>\n</td>", "ID": "e95aa12a-dc3e-42d4-87ef-63d820520f2f", "Styles": "width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span></p>", "ID": "9152a0aa-fae6-451e-927d-be1512da923c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e95aa12a-dc3e-42d4-87ef-63d820520f2f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">97%</span>", "ID": "b314b58f-c46e-4017-b7a8-5f95862e6057", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "97%", "ParentId": "9152a0aa-fae6-451e-927d-be1512da923c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span></p>", "ID": "cc0d9a85-feec-4a41-80d1-52f1247b0c04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e95aa12a-dc3e-42d4-87ef-63d820520f2f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(34/35)</span>", "ID": "fb415cce-f44b-44e6-ae3d-0f310a9c4b07", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(34/35)", "ParentId": "cc0d9a85-feec-4a41-80d1-52f1247b0c04"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span></p>\n</td>", "ID": "d134f233-b981-40a2-905a-beabe442c9dd", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "72f27811-dac1-4ca0-ba9c-cd142d10b145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>", "ID": "8d1c2645-6883-43a4-9c67-1660faef2d9c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d134f233-b981-40a2-905a-beabe442c9dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span>", "ID": "8168f3a4-52aa-4f0d-b974-a2dc13c15e32", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%", "ParentId": "8d1c2645-6883-43a4-9c67-1660faef2d9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span></p>", "ID": "4d400de6-b3b6-4bd6-82d0-0cb11a37767d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d134f233-b981-40a2-905a-beabe442c9dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(41/41)</span>", "ID": "3a3909dd-f107-4c27-b1a7-64254c62d85b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(41/41)", "ParentId": "4d400de6-b3b6-4bd6-82d0-0cb11a37767d"}, {"Element": "<tr style=\"page-break-inside:avoid;height:12.75pt\">\n<td colspan=\"9\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>", "ID": "9595e88b-39e2-4042-9eca-82b084507684", "Styles": "page-break-inside:avoid;height:12.75pt", "Classes": "None", "Text": "  ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<td colspan=\"9\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>", "ID": "f8871f25-8c51-47ae-895a-1a95747339a7", "Styles": "width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:12.75pt", "Classes": "None", "Text": "  ", "ParentId": "9595e88b-39e2-4042-9eca-82b084507684"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>", "ID": "99527609-342e-4961-8b51-50ebb177d318", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8871f25-8c51-47ae-895a-1a95747339a7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span>", "ID": "dede94c4-00a3-4805-8bbd-b4a0fa59fc4f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Outcome for patients without SVR12", "ParentId": "99527609-342e-4961-8b51-50ebb177d318"}, {"Element": "<tr style=\"page-break-inside:avoid;height:50.25pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>", "ID": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0", "Styles": "page-break-inside:avoid;height:50.25pt", "Classes": "None", "Text": "          ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>", "ID": "bf7bde12-fa0a-4cb9-af04-74b68b7c8ef5", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>", "ID": "888826d3-10d2-476d-9809-385b8c5afa25", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf7bde12-fa0a-4cb9-af04-74b68b7c8ef5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span>", "ID": "c39b21a4-5939-4182-a82c-1ebcdd7a97e4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "On-treatment virologic failure", "ParentId": "888826d3-10d2-476d-9809-385b8c5afa25"}, {"Element": "<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span></p>\n</td>", "ID": "02c2379e-a8e5-4eaf-93a6-8f9fea82d6a0", "Styles": "width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span></p>", "ID": "094bc845-d767-45d6-9d8b-0d02c69350da", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "02c2379e-a8e5-4eaf-93a6-8f9fea82d6a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/624</span>", "ID": "a7bdf7c0-b675-4ecd-ba0a-80ffd7c99edc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/624", "ParentId": "094bc845-d767-45d6-9d8b-0d02c69350da"}, {"Element": "<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span></p>\n</td>", "ID": "746de9a9-42d5-45bc-bfc3-c367ca948f81", "Styles": "width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span></p>", "ID": "ef2dd66f-f6a2-468d-8601-4b0bb7c0e66d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "746de9a9-42d5-45bc-bfc3-c367ca948f81"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/210</span>", "ID": "85fc5553-31fc-4689-bd7f-6df7f0d09c10", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/210", "ParentId": "ef2dd66f-f6a2-468d-8601-4b0bb7c0e66d"}, {"Element": "<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>", "ID": "4513d7fb-c3ce-4fd1-8c53-7e32e6b4c3c3", "Styles": "width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>", "ID": "e3bbab8f-0308-483b-af34-09bf1ba62a64", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4513d7fb-c3ce-4fd1-8c53-7e32e6b4c3c3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span>", "ID": "14a84685-e903-48ac-aaec-f7afc1c2ee0a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/118", "ParentId": "e3bbab8f-0308-483b-af34-09bf1ba62a64"}, {"Element": "<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span></p>\n</td>", "ID": "381bd337-3910-4d23-8550-cfbac71ba444", "Styles": "width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span></p>", "ID": "fb3aacff-22b5-4d90-b056-0d600fa25cf0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "381bd337-3910-4d23-8550-cfbac71ba444"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/328</span>", "ID": "f42e9a2d-cec9-4b67-bf4f-2e1696f8570c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/328", "ParentId": "fb3aacff-22b5-4d90-b056-0d600fa25cf0"}, {"Element": "<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>", "ID": "34f46072-16ea-497c-82ad-8f49983e91fa", "Styles": "width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>", "ID": "650fbc6c-a2f1-42eb-8115-252776424cbf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34f46072-16ea-497c-82ad-8f49983e91fa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span>", "ID": "d28ff942-ed88-4746-b2ca-80f8f6306dbb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/104", "ParentId": "650fbc6c-a2f1-42eb-8115-252776424cbf"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>", "ID": "244cc4be-0ca4-4a8d-829f-21e4878fbdc1", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>", "ID": "90cd04af-f808-4db1-b49d-0771749742eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "244cc4be-0ca4-4a8d-829f-21e4878fbdc1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span>", "ID": "3580403a-7c61-46f5-bb0b-0431a2f38335", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/116", "ParentId": "90cd04af-f808-4db1-b49d-0771749742eb"}, {"Element": "<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>", "ID": "4e86051a-c2bc-47d4-bf4c-67a4044b6450", "Styles": "width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>", "ID": "718756ca-9307-43e1-89bb-b848197c17c1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e86051a-c2bc-47d4-bf4c-67a4044b6450"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span>", "ID": "8dbbcd37-ec05-43b1-ae90-9518ce3474bb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/35", "ParentId": "718756ca-9307-43e1-89bb-b848197c17c1"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>", "ID": "a2c4f641-b0cd-4032-a66f-417224550747", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:50.25pt", "Classes": "None", "Text": "  ", "ParentId": "a28c4c87-9ccd-42a3-81f8-b6f00a3770e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>", "ID": "ecd6002e-d1cd-46bc-ae40-16e823f9155c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2c4f641-b0cd-4032-a66f-417224550747"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span>", "ID": "73f17f32-18bc-4759-9860-2283da68533b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/41", "ParentId": "ecd6002e-d1cd-46bc-ae40-16e823f9155c"}, {"Element": "<tr style=\"page-break-inside:avoid;height:24.75pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>", "ID": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763", "Styles": "page-break-inside:avoid;height:24.75pt", "Classes": "None", "Text": "          ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>", "ID": "c8842e5a-5b03-4bc4-ad61-9d6ca7293071", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>", "ID": "e6c17d1f-bab2-479c-beee-6170ceefd4ab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c8842e5a-5b03-4bc4-ad61-9d6ca7293071"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span>", "ID": "b9f45cdf-9622-473b-ad16-9b7b9b236580", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Relapse", "ParentId": "e6c17d1f-bab2-479c-beee-6170ceefd4ab"}, {"Element": "<sup>a</sup>", "ID": "cb7c2500-1719-40a8-97fb-ca87992cb8a0", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "b9f45cdf-9622-473b-ad16-9b7b9b236580"}, {"Element": "<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span></p>\n</td>", "ID": "4fe567d2-bf83-4940-a890-bff544b58c49", "Styles": "width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>", "ID": "749f1d26-b73c-47dc-9153-b8b3c32f8c54", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe567d2-bf83-4940-a890-bff544b58c49"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span>", "ID": "8b190f3c-0e97-413c-9903-86a5a1c025db", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "<\u00a01%", "ParentId": "749f1d26-b73c-47dc-9153-b8b3c32f8c54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span></p>", "ID": "90c845ff-b7d7-43b6-bfc1-1b8b328c1776", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fe567d2-bf83-4940-a890-bff544b58c49"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/623)</span>", "ID": "757f19f9-9f14-41e4-b524-4d15578a9565", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/623)", "ParentId": "90c845ff-b7d7-43b6-bfc1-1b8b328c1776"}, {"Element": "<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span></p>\n</td>", "ID": "d5f33157-d103-4bc8-9dd8-7ef7b372c9ab", "Styles": "width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span></p>", "ID": "635091f2-70d1-46d6-a27e-39e6d73187ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5f33157-d103-4bc8-9dd8-7ef7b372c9ab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01%</span>", "ID": "9243191f-6f5c-48db-8166-68447a710932", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "<\u00a01%", "ParentId": "635091f2-70d1-46d6-a27e-39e6d73187ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span></p>", "ID": "6795ea8e-b672-4729-a06b-1f977ec2f4c3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5f33157-d103-4bc8-9dd8-7ef7b372c9ab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/209)</span>", "ID": "6167d131-1b09-482e-a81c-abd30387d507", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/209)", "ParentId": "6795ea8e-b672-4729-a06b-1f977ec2f4c3"}, {"Element": "<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span></p>\n</td>", "ID": "2205796a-96f6-466f-ad53-d7735273e28c", "Styles": "width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>", "ID": "50cbe03d-3c31-4748-8103-247c5467981c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2205796a-96f6-466f-ad53-d7735273e28c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span>", "ID": "b2e1b36b-45ed-4dd4-aa85-2d52d5a6d2a9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1%", "ParentId": "50cbe03d-3c31-4748-8103-247c5467981c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span></p>", "ID": "69813967-7ae8-4745-a9db-1db92d32825b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2205796a-96f6-466f-ad53-d7735273e28c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/118)</span>", "ID": "435ea455-8d7e-4186-af3a-e0c7359ac759", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/118)", "ParentId": "69813967-7ae8-4745-a9db-1db92d32825b"}, {"Element": "<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span></p>\n</td>", "ID": "e47620bd-b717-41d3-a955-b60683531cb9", "Styles": "width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "   ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>", "ID": "726e1aa1-a4f1-4fd6-87e7-b8f5fda08331", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e47620bd-b717-41d3-a955-b60683531cb9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span>", "ID": "5eab875d-e3ab-49ff-96f5-eb58677bd5eb", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1%", "ParentId": "726e1aa1-a4f1-4fd6-87e7-b8f5fda08331"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span></p>", "ID": "c8944cb2-31ef-4a64-96c8-8252f91e5863", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e47620bd-b717-41d3-a955-b60683531cb9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/327)</span>", "ID": "17d9238a-7ca9-49b9-a6ff-87ed76ef0fef", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/327)", "ParentId": "c8944cb2-31ef-4a64-96c8-8252f91e5863"}, {"Element": "<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>", "ID": "276a4261-c5ec-4b4d-a256-2715e7a330b9", "Styles": "width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>", "ID": "ee038896-827b-4f56-8336-bc0eaf90c8ca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "276a4261-c5ec-4b4d-a256-2715e7a330b9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span>", "ID": "924eeb18-2087-430b-8f92-62bce15b2585", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/104", "ParentId": "ee038896-827b-4f56-8336-bc0eaf90c8ca"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>", "ID": "79182bca-a206-42e4-a150-275caf8ea938", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>", "ID": "c9d1d5e4-0a42-4d97-af6c-94c66634f6d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "79182bca-a206-42e4-a150-275caf8ea938"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span>", "ID": "845c3292-e2fd-43d0-b6e2-53d32776be10", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/116", "ParentId": "c9d1d5e4-0a42-4d97-af6c-94c66634f6d0"}, {"Element": "<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>\n</td>", "ID": "f70db7ef-bb80-4b44-ac0f-9c374b059416", "Styles": "width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span></p>", "ID": "1de873e8-129d-4a12-9048-93776d10f9e1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f70db7ef-bb80-4b44-ac0f-9c374b059416"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/35</span>", "ID": "1f43c6fe-a4b3-4050-89ab-769ada43e58a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/35", "ParentId": "1de873e8-129d-4a12-9048-93776d10f9e1"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>", "ID": "be61444d-79e8-4a11-bf2c-e8c617da5134", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:24.75pt", "Classes": "None", "Text": "  ", "ParentId": "e7ff7c8d-edf3-4e33-bcae-aaf23ebbd763"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>", "ID": "da9636f0-e640-485b-b4ae-e5f6ef992ebf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be61444d-79e8-4a11-bf2c-e8c617da5134"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span>", "ID": "da13595d-0407-4305-b308-edf33558e5cc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/41", "ParentId": "da9636f0-e640-485b-b4ae-e5f6ef992ebf"}, {"Element": "<tr style=\"page-break-inside:avoid;height:25.5pt\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span></p>\n</td>\n<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span></p>\n</td>\n<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>\n<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span></p>\n</td>\n<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>\n<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>\n</tr>", "ID": "972ea52d-7878-4d66-b40d-c2a578b2ff09", "Styles": "page-break-inside:avoid;height:25.5pt", "Classes": "None", "Text": "          ", "ParentId": "3f4c94a8-9f96-457f-a8d0-a90c3c98d79b"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>", "ID": "f3b38aeb-5f66-4780-acde-d13dab19cb16", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt;height:25.5pt", "Classes": "None", "Text": "  ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>", "ID": "ff9924ef-7cf6-47c0-8b1d-1b17b04ed657", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3b38aeb-5f66-4780-acde-d13dab19cb16"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span>", "ID": "1b536607-1e83-44cb-9bf2-424f4dceddf1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other", "ParentId": "ff9924ef-7cf6-47c0-8b1d-1b17b04ed657"}, {"Element": "<sup>b</sup>", "ID": "7703e6c4-dfe8-428d-814c-42220059b49c", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "1b536607-1e83-44cb-9bf2-424f4dceddf1"}, {"Element": "<td style=\"width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span></p>\n</td>", "ID": "573456e7-0699-4c28-8f1e-b0ab6c4b556f", "Styles": "width:51.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt", "Classes": "None", "Text": "   ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>", "ID": "1ef7239a-6785-491d-945b-f227fa64a1ac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "573456e7-0699-4c28-8f1e-b0ab6c4b556f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span>", "ID": "2c1da11e-08cf-4de7-9c8e-99e9af92b060", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1%", "ParentId": "1ef7239a-6785-491d-945b-f227fa64a1ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span></p>", "ID": "e136c08c-ab98-4dac-ae45-d4ea1395b140", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "573456e7-0699-4c28-8f1e-b0ab6c4b556f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(4/624)</span>", "ID": "924cfb52-d7bd-4311-b3b8-6f26f83929d8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(4/624)", "ParentId": "e136c08c-ab98-4dac-ae45-d4ea1395b140"}, {"Element": "<td style=\"width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span></p>\n</td>", "ID": "78e873fe-5064-48f2-9552-1feda7d778df", "Styles": "width:52.5pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt", "Classes": "None", "Text": "   ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>", "ID": "d9badb2e-04e0-481a-be38-9b89ad8a0fc6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78e873fe-5064-48f2-9552-1feda7d778df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span>", "ID": "af6c4a43-8792-4cd0-a36b-b6bdea5c1d13", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1%", "ParentId": "d9badb2e-04e0-481a-be38-9b89ad8a0fc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span></p>", "ID": "e2db71c7-1b9c-488d-94a1-95f4d08f039d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78e873fe-5064-48f2-9552-1feda7d778df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/210)</span>", "ID": "95c14c9f-9c95-42ed-9c56-abd1a5e9936e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(3/210)", "ParentId": "e2db71c7-1b9c-488d-94a1-95f4d08f039d"}, {"Element": "<td style=\"width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>\n</td>", "ID": "93e4d237-a921-4eb0-b1c2-2b2e304388d8", "Styles": "width:52.25pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt", "Classes": "None", "Text": "  ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span></p>", "ID": "93840049-25f0-4701-ba80-ace6f5e685d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93e4d237-a921-4eb0-b1c2-2b2e304388d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/118</span>", "ID": "3474a229-cc1a-4fb9-b446-e2a3e6aadffc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/118", "ParentId": "93840049-25f0-4701-ba80-ace6f5e685d2"}, {"Element": "<td style=\"width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"71\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span></p>\n</td>", "ID": "3b0926ca-b52d-4faf-b9d5-18e2d5202df5", "Styles": "width:53.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt", "Classes": "None", "Text": "   ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span></p>", "ID": "fbd139bc-a9dd-49cb-8a22-408d14cb012a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b0926ca-b52d-4faf-b9d5-18e2d5202df5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1%</span>", "ID": "60097e94-b403-4307-a938-ae2d32ab4ba8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1%", "ParentId": "fbd139bc-a9dd-49cb-8a22-408d14cb012a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span></p>", "ID": "8869108b-ec2f-4f2e-affa-d0c00d8f240a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b0926ca-b52d-4faf-b9d5-18e2d5202df5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/328)</span>", "ID": "fd4d171b-d1b1-4529-b7f1-12352c906a55", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(3/328)", "ParentId": "8869108b-ec2f-4f2e-affa-d0c00d8f240a"}, {"Element": "<td style=\"width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"70\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>\n</td>", "ID": "a07d40c8-25dd-47b7-9552-165df544885c", "Styles": "width:52.85pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt", "Classes": "None", "Text": "  ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span></p>", "ID": "c0736e43-436e-4c9f-87a2-8987b2a9bfff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a07d40c8-25dd-47b7-9552-165df544885c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/104</span>", "ID": "29b21a74-0e38-4ce4-90f9-f7ea98946b3b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/104", "ParentId": "c0736e43-436e-4c9f-87a2-8987b2a9bfff"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>\n</td>", "ID": "4998ee64-5989-4440-8375-9cec33413173", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt", "Classes": "None", "Text": "  ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span></p>", "ID": "32c217cd-677a-476f-8ca9-5cf1c5d78d9b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4998ee64-5989-4440-8375-9cec33413173"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/116</span>", "ID": "8798dcbf-4d19-499b-9086-fc4d5b64bd7f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/116", "ParentId": "32c217cd-677a-476f-8ca9-5cf1c5d78d9b"}, {"Element": "<td style=\"width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span></p>\n</td>", "ID": "d468fa08-63c9-4212-9ee6-28421381eace", "Styles": "width:49.65pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:25.5pt", "Classes": "None", "Text": "   ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>", "ID": "66aa781e-7bda-4e66-8c13-b016ee5856e2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d468fa08-63c9-4212-9ee6-28421381eace"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span>", "ID": "3597a975-6b5c-4df3-97f5-ed5ecb0a9192", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3%", "ParentId": "66aa781e-7bda-4e66-8c13-b016ee5856e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span></p>", "ID": "8f7c30fb-62cc-42c4-8f72-347c3eed0662", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d468fa08-63c9-4212-9ee6-28421381eace"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/35)</span>", "ID": "8e2c054a-78f3-4a1d-88d4-740057d45f7d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/35)", "ParentId": "8f7c30fb-62cc-42c4-8f72-347c3eed0662"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>\n</td>", "ID": "21ba36e9-5bfb-4a01-86d0-715876787fa2", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\n  height:25.5pt", "Classes": "None", "Text": "  ", "ParentId": "972ea52d-7878-4d66-b40d-c2a578b2ff09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span></p>", "ID": "645334db-f595-4b3f-969a-ff76cd46ea92", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21ba36e9-5bfb-4a01-86d0-715876787fa2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/41</span>", "ID": "95a9b53b-77c4-45bb-bac4-cc3636d1872c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/41", "ParentId": "645334db-f595-4b3f-969a-ff76cd46ea92"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:white\">GT\u00a0=\u00a0genotype</span></p>", "ID": "1006d808-36dd-45cd-889f-2b2294e5400f", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:white\">GT\u00a0=\u00a0genotype</span>", "ID": "5206d079-9f61-4fc2-9a6b-1e66bd6312c1", "Styles": "font-size:9.0pt;color:white", "Classes": "None", "Text": "GT\u00a0=\u00a0genotype", "ParentId": "1006d808-36dd-45cd-889f-2b2294e5400f"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>", "ID": "fa2f1c2f-2ef2-44b6-a658-6a73b2341df8", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span>", "ID": "620e2408-ff71-4416-bba1-b0d22e152724", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 The denominator for relapse is the number of patients with HCV\u00a0RNA <\u00a0LLOQ at their last on-treatment assessment.", "ParentId": "fa2f1c2f-2ef2-44b6-a658-6a73b2341df8"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>", "ID": "151e6fa1-87c6-4f1b-83ac-ec6c62b08c05", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span>", "ID": "2afd34b4-1c98-401f-85f6-02df34ff5006", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.", "ParentId": "151e6fa1-87c6-4f1b-83ac-ec6c62b08c05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "78b0d2b9-86a0-46a7-b0c1-75b1d615c723", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a5c903ba-1e05-416d-828d-f388549ece13", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "78b0d2b9-86a0-46a7-b0c1-75b1d615c723"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a02 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20112\n(study\u00a01139)</span></i></p>", "ID": "8cd05e92-a8d6-4319-b206-b308239322da", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Genotype\u00a02 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20112\n(study\u00a01139)</span></i>", "ID": "32c5aa92-f14b-42c6-a79a-460602ae94a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8cd05e92-a8d6-4319-b206-b308239322da"}, {"Element": "<span lang=\"EN-GB\">Genotype\u00a02 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20112\n(study\u00a01139)</span>", "ID": "29842476-0600-44fd-aab1-41f27705d76e", "Styles": "None", "Classes": "None", "Text": "Genotype\u00a02 HCV\u2011infected adults  ASTRAL\u20112 (study\u00a01139)", "ParentId": "32c5aa92-f14b-42c6-a79a-460602ae94a0"}, {"Element": "<b>\u2013</b>", "ID": "3fdb2352-a1b9-4fe2-b552-7a1055fa0686", "Styles": "None", "Classes": "None", "Text": "\u2013", "ParentId": "29842476-0600-44fd-aab1-41f27705d76e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20112\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 12\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a02 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n12\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00ef</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ve <i>versus</i> treatment\u2011experienced).</span></p>", "ID": "8f98c6dd-06ee-440d-a027-8ac0fe1261c7", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ASTRAL\u20112\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 12\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a02 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n12\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na</span>", "ID": "0bc6b2cc-a057-4f8e-b02d-4cdba1881c81", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "ASTRAL\u20112 was a randomised, open-label study that evaluated 12\u00a0weeks of treatment with Epclusa compared with 12\u00a0weeks of treatment with SOF+RBV in patients with genotype\u00a02 HCV infection.\u00a0 Patients were randomised in a 1:1 ratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for 12\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of cirrhosis and prior treatment experience (treatment\u2011na", "ParentId": "8f98c6dd-06ee-440d-a027-8ac0fe1261c7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00ef</span>", "ID": "cf221f16-4338-4541-8505-686945cc8d5b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00ef", "ParentId": "8f98c6dd-06ee-440d-a027-8ac0fe1261c7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">ve <i>versus</i> treatment\u2011experienced).</span>", "ID": "df6addba-c6bf-4176-9684-c31c5722aa96", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "ve  treatment\u2011experienced).", "ParentId": "8f98c6dd-06ee-440d-a027-8ac0fe1261c7"}, {"Element": "<i>versus</i>", "ID": "a0954815-0dd2-4226-b012-d8195af047c9", "Styles": "None", "Classes": "None", "Text": "versus", "ParentId": "df6addba-c6bf-4176-9684-c31c5722aa96"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "41f651a3-a0e9-4586-aa5c-5764ebfe3905", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "e76149a1-421a-4f83-83f0-ab6a5603f71a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "41f651a3-a0e9-4586-aa5c-5764ebfe3905"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced across the two treatment\ngroups.\u00a0 Of the 266 treated patients, the median age was 58\u00a0years\n(range: 23 to 81); 59% of the patients were male; 88% were White, 7% were\nBlack; 33% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n62% had non\u2011CC IL28B alleles (CT or TT); 80% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL; 14% had compensated cirrhosis and 15%\nwere treatment-experienced.</span></p>", "ID": "bf0173d4-cd93-454b-86bf-7624c9fb1a11", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Demographics\nand baseline characteristics were balanced across the two treatment\ngroups.\u00a0 Of the 266 treated patients, the median age was 58\u00a0years\n(range: 23 to 81); 59% of the patients were male; 88% were White, 7% were\nBlack; 33% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n62% had non\u2011CC IL28B alleles (CT or TT); 80% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL; 14% had compensated cirrhosis and 15%\nwere treatment-experienced.</span>", "ID": "9d5e587b-e10a-411d-acd1-ef70f88f0371", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Demographics and baseline characteristics were balanced across the two treatment groups.\u00a0 Of the 266 treated patients, the median age was 58\u00a0years (range: 23 to 81); 59% of the patients were male; 88% were White, 7% were Black; 33% had a baseline body mass index of at least 30\u00a0kg/m; 62% had non\u2011CC IL28B alleles (CT or TT); 80% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL; 14% had compensated cirrhosis and 15% were treatment-experienced.", "ParentId": "bf0173d4-cd93-454b-86bf-7624c9fb1a11"}, {"Element": "<sup>2</sup>", "ID": "2af9f6b3-6705-4f18-9d2a-41edc37a312d", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "9d5e587b-e10a-411d-acd1-ef70f88f0371"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "845eeb20-0697-4c39-b07b-6e7236578fb7", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "5c9e62ec-af4f-47d8-a7e3-f1e5e5bb4b65", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "845eeb20-0697-4c39-b07b-6e7236578fb7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a011 presents\nthe SVR12 for the ASTRAL\u20112 study.</span></p>", "ID": "b11046e6-560c-482e-ad6a-eac2bee00789", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table\u00a011 presents\nthe SVR12 for the ASTRAL\u20112 study.</span>", "ID": "98ff534b-9dab-4f55-87c1-dfede8ce5a7f", "Styles": "None", "Classes": "None", "Text": "Table\u00a011 presents the SVR12 for the ASTRAL\u20112 study.", "ParentId": "b11046e6-560c-482e-ad6a-eac2bee00789"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "080464d6-5fdf-42c9-b045-22c8bc67ecc0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dab79282-d440-4e92-a583-c2cc97705ed9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "080464d6-5fdf-42c9-b045-22c8bc67ecc0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a011: SVR12 in study ASTRAL\u20112 (HCV genotype\u00a02)</span></b></p>", "ID": "62570e19-730b-4481-a87d-e603920a0e61", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a011: SVR12 in study ASTRAL\u20112 (HCV genotype\u00a02)</span></b>", "ID": "1efa4002-9990-499e-b11b-84c77dde5669", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62570e19-730b-4481-a87d-e603920a0e61"}, {"Element": "<span lang=\"EN-GB\">Table\u00a011: SVR12 in study ASTRAL\u20112 (HCV genotype\u00a02)</span>", "ID": "b95a8eb5-2d10-4342-9a1a-858af09f582b", "Styles": "None", "Classes": "None", "Text": "Table\u00a011: SVR12 in study ASTRAL\u20112 (HCV genotype\u00a02)", "ParentId": "1efa4002-9990-499e-b11b-84c77dde5669"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span></p>\n</td>\n</tr>\n</table>", "ID": "b58417cc-d35f-4a9f-8024-7bd9905e057b", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "07452710-6493-4667-80ef-51063b01c6fd", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>\n</td>\n</tr>", "ID": "3625d2a5-a72c-4934-9053-602d45d11b9d", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "07452710-6493-4667-80ef-51063b01c6fd"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "3943178a-f832-4086-9bab-ff4cc77ce9f9", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3625d2a5-a72c-4934-9053-602d45d11b9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "d4edc4ab-b584-45e8-bab3-500a167142be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3943178a-f832-4086-9bab-ff4cc77ce9f9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "812ac64e-cceb-487d-8264-879f40680572", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d4edc4ab-b584-45e8-bab3-500a167142be"}, {"Element": "<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>\n</td>", "ID": "f79b37f2-8b16-4dfb-a334-0a6551608e8e", "Styles": "width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "3625d2a5-a72c-4934-9053-602d45d11b9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>", "ID": "c68d8007-54c8-436b-bc5a-c6cd1951e93d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f79b37f2-8b16-4dfb-a334-0a6551608e8e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b>", "ID": "89dd6bc1-8459-403b-8b0c-3fcbbd3993b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c68d8007-54c8-436b-bc5a-c6cd1951e93d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "18aab2c7-5880-4dc9-89ef-a71b82d263dc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "89dd6bc1-8459-403b-8b0c-3fcbbd3993b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "1060918c-6a42-4542-8deb-0d04b0fb0c9c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f79b37f2-8b16-4dfb-a334-0a6551608e8e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "81c1f900-0d5a-490a-aeac-22e54fdffad2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1060918c-6a42-4542-8deb-0d04b0fb0c9c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "4f62ecf5-f146-4ad1-a4b8-dbc21929880d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "81c1f900-0d5a-490a-aeac-22e54fdffad2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b></p>", "ID": "d36e81c8-ee01-493c-b51c-ef9883a707dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f79b37f2-8b16-4dfb-a334-0a6551608e8e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span></b>", "ID": "6ec0fb98-c17e-4a5c-bd37-46f5862a4d4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d36e81c8-ee01-493c-b51c-ef9883a707dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0134)</span>", "ID": "36ee3d4b-1f90-4562-aaae-6f0c93b0398c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0134)", "ParentId": "6ec0fb98-c17e-4a5c-bd37-46f5862a4d4c"}, {"Element": "<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>\n</td>", "ID": "bc68b3c4-bbbf-4431-96b9-5ecd97fdddfa", "Styles": "width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "3625d2a5-a72c-4934-9053-602d45d11b9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>", "ID": "c48283cd-587d-4118-af19-eb12b3357611", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc68b3c4-bbbf-4431-96b9-5ecd97fdddfa"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b>", "ID": "26425830-d6ac-427f-93ad-1bfd918d669a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c48283cd-587d-4118-af19-eb12b3357611"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span>", "ID": "b84e74fd-d2f2-4721-9e5e-ab73a3737dd9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SOF+RBV", "ParentId": "26425830-d6ac-427f-93ad-1bfd918d669a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "e8de19f6-9efe-4430-b2aa-d1db4d183d80", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc68b3c4-bbbf-4431-96b9-5ecd97fdddfa"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "b0df4db5-4f62-47e9-85b2-df95a253cbc3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8de19f6-9efe-4430-b2aa-d1db4d183d80"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "663d75fc-5d29-4cd4-8d44-53040f97e295", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "b0df4db5-4f62-47e9-85b2-df95a253cbc3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b></p>", "ID": "b9d64eeb-842c-4bd7-8ecc-23cf850e8855", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc68b3c4-bbbf-4431-96b9-5ecd97fdddfa"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span></b>", "ID": "ea9c5dfc-3048-40ad-8368-cd38da41e95b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9d64eeb-842c-4bd7-8ecc-23cf850e8855"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0132)</span>", "ID": "7f57a2e6-b4da-4d98-a91c-0068079e4efa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0132)", "ParentId": "ea9c5dfc-3048-40ad-8368-cd38da41e95b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span></p>\n</td>\n</tr>", "ID": "fcd360dc-4eda-4b11-aaac-e3a01d8210fa", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>", "ID": "8c9b5571-9459-4dc4-ae4f-7406555af4c2", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fcd360dc-4eda-4b11-aaac-e3a01d8210fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>", "ID": "e7e8b08a-6007-4858-b0a3-0b1ec9b6cb7c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8c9b5571-9459-4dc4-ae4f-7406555af4c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span>", "ID": "8a219ac9-3be5-4e37-a61d-b2cfc53633bf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR12", "ParentId": "e7e8b08a-6007-4858-b0a3-0b1ec9b6cb7c"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span></p>\n</td>", "ID": "6cb9b6cc-92d7-4caf-bec0-f533e879887e", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fcd360dc-4eda-4b11-aaac-e3a01d8210fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span></p>", "ID": "c80e813d-0fe4-4940-b005-c84b3df457be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6cb9b6cc-92d7-4caf-bec0-f533e879887e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">99% (133/134)</span>", "ID": "fe3520d3-092b-45f8-a08b-a660e3347333", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "99% (133/134)", "ParentId": "c80e813d-0fe4-4940-b005-c84b3df457be"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span></p>\n</td>", "ID": "5db766c7-eeab-4538-845f-ba82f871c762", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fcd360dc-4eda-4b11-aaac-e3a01d8210fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span></p>", "ID": "93618c9c-bf96-4f72-a6b0-9610751b270a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5db766c7-eeab-4538-845f-ba82f871c762"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">94% (124/132)</span>", "ID": "37aead6f-3c2c-4ddb-be03-253915482e49", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "94% (124/132)", "ParentId": "93618c9c-bf96-4f72-a6b0-9610751b270a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>", "ID": "fd756167-3e67-41ee-876d-5660518779ff", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>", "ID": "34c2c5a8-02bf-4eb4-bac0-7ee50bf9e038", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd756167-3e67-41ee-876d-5660518779ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>", "ID": "d97ca493-b2b0-4938-821c-81821eb5e4e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34c2c5a8-02bf-4eb4-bac0-7ee50bf9e038"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span>", "ID": "624fbe70-830e-4122-af12-1265d1317552", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Outcome for patients without SVR12", "ParentId": "d97ca493-b2b0-4938-821c-81821eb5e4e0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span></p>\n</td>\n</tr>", "ID": "8397f6d4-8e0a-4db0-a408-a6d71a2ff1a0", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>", "ID": "7e4ad599-d905-4dce-8aa8-1addf3fbe1c2", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8397f6d4-8e0a-4db0-a408-a6d71a2ff1a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>", "ID": "df26649a-afde-45a3-ac14-4198d1b66e48", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e4ad599-d905-4dce-8aa8-1addf3fbe1c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span>", "ID": "75ebc5d2-19f0-493e-aa6e-e68264e016b5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "On-treatment virologic failure", "ParentId": "df26649a-afde-45a3-ac14-4198d1b66e48"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span></p>\n</td>", "ID": "c763ca43-c688-41b7-91a3-300c3a769b8a", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8397f6d4-8e0a-4db0-a408-a6d71a2ff1a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span></p>", "ID": "b2b67e7a-5573-4bb0-b09a-c37b15c7261e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c763ca43-c688-41b7-91a3-300c3a769b8a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/134</span>", "ID": "e891a821-6ce5-4e32-9ea8-eda727bc2ffa", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/134", "ParentId": "b2b67e7a-5573-4bb0-b09a-c37b15c7261e"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span></p>\n</td>", "ID": "b67b8f11-ae4d-4562-8752-35e6ce759cb3", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8397f6d4-8e0a-4db0-a408-a6d71a2ff1a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span></p>", "ID": "244d4722-1a12-4c46-b225-3cd81b11812e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b67b8f11-ae4d-4562-8752-35e6ce759cb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/132</span>", "ID": "b5f743de-cadd-45c9-bbf7-755f402c3830", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/132", "ParentId": "244d4722-1a12-4c46-b225-3cd81b11812e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span></p>\n</td>\n</tr>", "ID": "898ed9f2-c00b-4df3-b547-3d400801818f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>", "ID": "67f7418f-07f6-49b2-8f14-b35ab733e6b4", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "898ed9f2-c00b-4df3-b547-3d400801818f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>", "ID": "d0eb9589-df2f-449d-be77-dc06024b058f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "67f7418f-07f6-49b2-8f14-b35ab733e6b4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span>", "ID": "98bb7f55-bde7-4bf6-aa5b-9881dd6d8f32", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Relapse", "ParentId": "d0eb9589-df2f-449d-be77-dc06024b058f"}, {"Element": "<sup>a</sup>", "ID": "4a232c30-b68f-4f62-ae26-e246e05c6dbe", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "98bb7f55-bde7-4bf6-aa5b-9881dd6d8f32"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span></p>\n</td>", "ID": "8341dfd6-178c-4021-bf1c-334f11962638", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "898ed9f2-c00b-4df3-b547-3d400801818f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span></p>", "ID": "fa336577-4fb6-4e86-bf93-2e238b574ee5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8341dfd6-178c-4021-bf1c-334f11962638"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/133</span>", "ID": "bb3ebd72-08fa-4b93-96e3-3cd259280fd3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/133", "ParentId": "fa336577-4fb6-4e86-bf93-2e238b574ee5"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span></p>\n</td>", "ID": "9dbc66e0-3142-48ef-a51b-43db9442c929", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "898ed9f2-c00b-4df3-b547-3d400801818f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span></p>", "ID": "fe088373-906a-400f-9703-780a9d6958d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9dbc66e0-3142-48ef-a51b-43db9442c929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (6/132)</span>", "ID": "13de71eb-29e6-4950-9a15-de486f62441b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "5% (6/132)", "ParentId": "fe088373-906a-400f-9703-780a9d6958d0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span></p>\n</td>\n</tr>", "ID": "c9a6f0cd-e8c9-41bf-95c2-af9fda3c25c3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "b58417cc-d35f-4a9f-8024-7bd9905e057b"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>", "ID": "edb8ffc0-bee7-41ae-9074-4b85e466ba1d", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c9a6f0cd-e8c9-41bf-95c2-af9fda3c25c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>", "ID": "13faf081-4f45-4d0e-8086-4087d43c9046", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "edb8ffc0-bee7-41ae-9074-4b85e466ba1d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span>", "ID": "28b5e4bb-fcc2-48d2-954c-70f51e9682d1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other", "ParentId": "13faf081-4f45-4d0e-8086-4087d43c9046"}, {"Element": "<sup>b</sup>", "ID": "847a7063-0ef4-4897-a0e7-84a64bb83435", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "28b5e4bb-fcc2-48d2-954c-70f51e9682d1"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span></p>\n</td>", "ID": "7d25d818-7536-4892-ae8c-e3fddf9c9706", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c9a6f0cd-e8c9-41bf-95c2-af9fda3c25c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span></p>", "ID": "715749c8-9afc-4cce-b6b5-b203695f8da2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d25d818-7536-4892-ae8c-e3fddf9c9706"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (1/134)</span>", "ID": "d96e83a5-9025-4be5-8690-928c5e5f8c5d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1% (1/134)", "ParentId": "715749c8-9afc-4cce-b6b5-b203695f8da2"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span></p>\n</td>", "ID": "ffba6e79-a5c7-4aad-b1e9-79f3838dc3dc", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c9a6f0cd-e8c9-41bf-95c2-af9fda3c25c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span></p>", "ID": "8862df39-1a67-4bbc-baca-40171218dd18", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ffba6e79-a5c7-4aad-b1e9-79f3838dc3dc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2% (2/132)</span>", "ID": "21dc3599-3f6c-4d99-bc34-0b9dccb1ed76", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2% (2/132)", "ParentId": "8862df39-1a67-4bbc-baca-40171218dd18"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>", "ID": "84e65472-5505-443b-9292-000a8b0b0b4d", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span>", "ID": "f5d9f695-c87e-4d4b-8378-6737c8e770a2", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 The denominator for relapse is the number of patients with HCV\u00a0RNA <\u00a0LLOQ at their last on-treatment assessment.", "ParentId": "84e65472-5505-443b-9292-000a8b0b0b4d"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>", "ID": "8cf8c1d3-55f7-4776-b6f9-5682931f97df", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span>", "ID": "c8c6a1da-68ff-4888-9f00-6a17d3040bff", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.", "ParentId": "8cf8c1d3-55f7-4776-b6f9-5682931f97df"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "e9dcf7c8-86a2-4765-8a04-a1b8d2406771", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "ebf8a6ad-09eb-4fee-8532-b90db9737ac4", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "e9dcf7c8-86a2-4765-8a04-a1b8d2406771"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment\nwith </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks\ndemonstrated the statistical superiority (p\u00a0=\u00a00.018) over treatment\nwith SOF+RBV for 12\u00a0weeks (treatment difference +5.2%; 95% confidence\ninterval: +0.2% to +10.3%).</span></p>", "ID": "a2e1f4af-c80c-4e43-bc14-6ed011599455", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment\nwith </span>", "ID": "542375a4-ca66-4650-813e-2562ece3e70b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Treatment with ", "ParentId": "a2e1f4af-c80c-4e43-bc14-6ed011599455"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Epclusa</span>", "ID": "9ef9603e-e116-4783-8cc4-917893f8fb9a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Epclusa", "ParentId": "a2e1f4af-c80c-4e43-bc14-6ed011599455"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> for 12\u00a0weeks\ndemonstrated the statistical superiority (p\u00a0=\u00a00.018) over treatment\nwith SOF+RBV for 12\u00a0weeks (treatment difference +5.2%; 95% confidence\ninterval: +0.2% to +10.3%).</span>", "ID": "4ecadcc7-61bd-4ae0-b432-6b7ad150cd40", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " for 12\u00a0weeks demonstrated the statistical superiority (p\u00a0=\u00a00.018) over treatment with SOF+RBV for 12\u00a0weeks (treatment difference +5.2%; 95% confidence interval: +0.2% to +10.3%).", "ParentId": "a2e1f4af-c80c-4e43-bc14-6ed011599455"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "f2d18cb0-1c52-434a-bccd-f8cf911d52d5", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "291b3df6-6a39-43ee-a059-2188f2e9818d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f2d18cb0-1c52-434a-bccd-f8cf911d52d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Genotype\u00a03 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20113\n(study\u00a01140)</span></i></p>", "ID": "46262220-76ae-4bc9-b7f3-fb453b003203", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Genotype\u00a03 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20113\n(study\u00a01140)</span></i>", "ID": "dbd89722-52ff-40c1-aff4-a787fc6f2e45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46262220-76ae-4bc9-b7f3-fb453b003203"}, {"Element": "<span lang=\"EN-GB\">Genotype\u00a03 HCV\u2011infected adults <b>\u2013</b> ASTRAL\u20113\n(study\u00a01140)</span>", "ID": "37aac8ea-fbd6-4e60-bba2-d53b3b6e238e", "Styles": "None", "Classes": "None", "Text": "Genotype\u00a03 HCV\u2011infected adults  ASTRAL\u20113 (study\u00a01140)", "ParentId": "dbd89722-52ff-40c1-aff4-a787fc6f2e45"}, {"Element": "<b>\u2013</b>", "ID": "b124084c-1bc7-4100-bd0e-71aad59d4661", "Styles": "None", "Classes": "None", "Text": "\u2013", "ParentId": "37aac8ea-fbd6-4e60-bba2-d53b3b6e238e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20113\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 24\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a03 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n24\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na\u00efve <i>versus</i>\ntreatment\u2011experienced).</span></p>", "ID": "69b9a201-e684-4cf5-b20f-938e3d9d47e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">ASTRAL\u20113\nwas a randomised, open-label study that evaluated 12\u00a0weeks of treatment\nwith Epclusa compared with 24\u00a0weeks of treatment with SOF+RBV in patients\nwith genotype\u00a03 HCV infection.\u00a0 Patients were randomised in a 1:1\nratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for\n24\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of\ncirrhosis and prior treatment experience (treatment\u2011na\u00efve <i>versus</i>\ntreatment\u2011experienced).</span>", "ID": "74e44e73-a5f4-4ab8-a220-5075b6932d99", "Styles": "None", "Classes": "None", "Text": "ASTRAL\u20113 was a randomised, open-label study that evaluated 12\u00a0weeks of treatment with Epclusa compared with 24\u00a0weeks of treatment with SOF+RBV in patients with genotype\u00a03 HCV infection.\u00a0 Patients were randomised in a 1:1 ratio to treatment with Epclusa for 12\u00a0weeks or SOF+RBV for 24\u00a0weeks.\u00a0 Randomisation was stratified by the presence or absence of cirrhosis and prior treatment experience (treatment\u2011na\u00efve  treatment\u2011experienced).", "ParentId": "69b9a201-e684-4cf5-b20f-938e3d9d47e2"}, {"Element": "<i>versus</i>", "ID": "d200da68-e465-48fe-85a9-4674a2b2e1e1", "Styles": "None", "Classes": "None", "Text": "versus", "ParentId": "74e44e73-a5f4-4ab8-a220-5075b6932d99"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f8a3ddb-7419-4be2-bebf-2c6bbb48d7a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "506633aa-8449-46dd-9454-c278f9382dc9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f8a3ddb-7419-4be2-bebf-2c6bbb48d7a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the two treatment groups.\u00a0\nOf the 552 treated patients, the median age was 52\u00a0years (range: 19 to\n76); 62% of the patients were male; 89% were White, 9% were Asian; 1% were\nBlack; 20% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n61% had non\u2011CC IL28B alleles (CT or TT); 70% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL, 30% had compensated cirrhosis and 26%\nwere treatment-experienced.</span></p>", "ID": "75450c17-979c-48cc-81a5-8763545287d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the two treatment groups.\u00a0\nOf the 552 treated patients, the median age was 52\u00a0years (range: 19 to\n76); 62% of the patients were male; 89% were White, 9% were Asian; 1% were\nBlack; 20% had a baseline body mass index of at least 30\u00a0kg/m<sup>2</sup>;\n61% had non\u2011CC IL28B alleles (CT or TT); 70% had baseline HCV\u00a0RNA\nlevels of at least 800,000\u00a0IU/mL, 30% had compensated cirrhosis and 26%\nwere treatment-experienced.</span>", "ID": "339d3885-2e41-475a-b9f0-da465dd043bd", "Styles": "None", "Classes": "None", "Text": "Demographics and baseline characteristics were balanced across the two treatment groups.\u00a0 Of the 552 treated patients, the median age was 52\u00a0years (range: 19 to 76); 62% of the patients were male; 89% were White, 9% were Asian; 1% were Black; 20% had a baseline body mass index of at least 30\u00a0kg/m; 61% had non\u2011CC IL28B alleles (CT or TT); 70% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL, 30% had compensated cirrhosis and 26% were treatment-experienced.", "ParentId": "75450c17-979c-48cc-81a5-8763545287d9"}, {"Element": "<sup>2</sup>", "ID": "25361274-42eb-4708-9ad0-5af697f6c637", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "339d3885-2e41-475a-b9f0-da465dd043bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "88c998aa-5b86-45bb-982f-af5eeab50f07", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9137850-b124-4dc0-9db3-f2770776a4c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "88c998aa-5b86-45bb-982f-af5eeab50f07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a012\npresents the SVR12 for the ASTRAL\u20113 study.</span></p>", "ID": "f6cad4aa-6740-42c2-9a79-091fb0e4c59b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table\u00a012\npresents the SVR12 for the ASTRAL\u20113 study.</span>", "ID": "a360b784-83df-40e4-a8e0-3aef67f99c29", "Styles": "None", "Classes": "None", "Text": "Table\u00a012 presents the SVR12 for the ASTRAL\u20113 study.", "ParentId": "f6cad4aa-6740-42c2-9a79-091fb0e4c59b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4cc8a08e-a4be-413d-b32a-0e3c136994d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "99f7c6fa-59f6-4157-8756-42c43ac4a23e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4cc8a08e-a4be-413d-b32a-0e3c136994d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a012: SVR12 in study ASTRAL\u20113 (HCV genotype\u00a03)</span></b></p>", "ID": "eebc5998-714e-4620-abb6-ae538ee21734", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a012: SVR12 in study ASTRAL\u20113 (HCV genotype\u00a03)</span></b>", "ID": "69dda3f4-1666-4573-9dce-4cb63d98bc4d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eebc5998-714e-4620-abb6-ae538ee21734"}, {"Element": "<span lang=\"EN-GB\">Table\u00a012: SVR12 in study ASTRAL\u20113 (HCV genotype\u00a03)</span>", "ID": "c9c12f13-b98b-499d-bf52-92cac86f720d", "Styles": "None", "Classes": "None", "Text": "Table\u00a012: SVR12 in study ASTRAL\u20113 (HCV genotype\u00a03)", "ParentId": "69dda3f4-1666-4573-9dce-4cb63d98bc4d"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span></p>\n</td>\n</tr>\n</table>", "ID": "f1f683bc-4e38-46ca-92b8-77bd98fd2246", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "0d0be725-a21b-4a8d-8eb9-9ae6f0b46bf8", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>\n</td>\n<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>\n</td>\n</tr>", "ID": "80f76582-4f55-47e7-b4d4-14d98aecf0f4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "0d0be725-a21b-4a8d-8eb9-9ae6f0b46bf8"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "69cbfa6d-a802-4c0f-a1d2-a9af037f3cfe", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "80f76582-4f55-47e7-b4d4-14d98aecf0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d71344d-2c2d-494e-87aa-eafc4db21e69", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69cbfa6d-a802-4c0f-a1d2-a9af037f3cfe"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4da27781-ca83-4bc5-ae9d-503244e3de51", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d71344d-2c2d-494e-87aa-eafc4db21e69"}, {"Element": "<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>\n</td>", "ID": "1e6df293-2acd-4803-bc46-b55a6687fdc1", "Styles": "width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "80f76582-4f55-47e7-b4d4-14d98aecf0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>", "ID": "b261bb27-6581-44c5-9428-8ec4e7f771e1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e6df293-2acd-4803-bc46-b55a6687fdc1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b>", "ID": "e8983823-d025-4e32-996a-3a457d3909d3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b261bb27-6581-44c5-9428-8ec4e7f771e1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "910905b1-675f-45c9-b243-215a8f6df767", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "e8983823-d025-4e32-996a-3a457d3909d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "b46f3bf3-1134-4b05-97a8-8e2cd9cfaaaa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e6df293-2acd-4803-bc46-b55a6687fdc1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "dcdd4b25-7599-47b1-90e9-211cbfcb092e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b46f3bf3-1134-4b05-97a8-8e2cd9cfaaaa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "488b0baf-3a2c-4017-9d35-cd3353afdb74", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "dcdd4b25-7599-47b1-90e9-211cbfcb092e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b></p>", "ID": "16460ef0-c35f-4341-9680-fd8469be202f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e6df293-2acd-4803-bc46-b55a6687fdc1"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span></b>", "ID": "7b58b8e2-19e5-4c5f-ba4f-fa160072e44f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16460ef0-c35f-4341-9680-fd8469be202f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0277)</span>", "ID": "6181bd1e-7696-4253-9ad2-0648dde437f2", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0277)", "ParentId": "7b58b8e2-19e5-4c5f-ba4f-fa160072e44f"}, {"Element": "<td style=\"width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>\n</td>", "ID": "124babda-6344-4c67-8ec1-3dc869a7965a", "Styles": "width:2.15in;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "80f76582-4f55-47e7-b4d4-14d98aecf0f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>", "ID": "df269f70-0f47-425c-a1f8-779218bd6df2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "124babda-6344-4c67-8ec1-3dc869a7965a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b>", "ID": "db9121e5-e8aa-497b-9fa6-abeceebdee8c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "df269f70-0f47-425c-a1f8-779218bd6df2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span>", "ID": "99326b97-75a7-459c-8bfb-404d8dccf9d7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SOF+RBV", "ParentId": "db9121e5-e8aa-497b-9fa6-abeceebdee8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>", "ID": "2440dfda-268f-425c-9e98-8e201a2842c9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "124babda-6344-4c67-8ec1-3dc869a7965a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b>", "ID": "76234231-f162-4604-b782-cffc2f19adaa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2440dfda-268f-425c-9e98-8e201a2842c9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span>", "ID": "92b9ccac-c5e6-4a1d-b1b7-fa7145b8af2f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "24\u00a0weeks", "ParentId": "76234231-f162-4604-b782-cffc2f19adaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b></p>", "ID": "12b6b001-588d-483d-9377-a76373471124", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "124babda-6344-4c67-8ec1-3dc869a7965a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span></b>", "ID": "1378f47a-32fb-481a-80c6-88740a434393", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "12b6b001-588d-483d-9377-a76373471124"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0275)</span>", "ID": "b7da4a78-eaea-4bec-964f-df51987d04fd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0275)", "ParentId": "1378f47a-32fb-481a-80c6-88740a434393"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span></p>\n</td>\n</tr>", "ID": "281d4f31-a168-499a-afd6-6644340f8c11", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>", "ID": "21a19ca8-80c5-439b-9175-d66a2c7eaab0", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "281d4f31-a168-499a-afd6-6644340f8c11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>", "ID": "778e811e-cc65-4c55-870b-1c07b3dedee7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21a19ca8-80c5-439b-9175-d66a2c7eaab0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span>", "ID": "c20a77a5-0ff5-4812-8c57-2b41bbeb4383", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR12", "ParentId": "778e811e-cc65-4c55-870b-1c07b3dedee7"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span></p>\n</td>", "ID": "e9794e41-8080-48e4-bec8-9b16a5ef4b1c", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "281d4f31-a168-499a-afd6-6644340f8c11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span></p>", "ID": "796cda1e-82cd-4d67-902d-8a6b4bb75d49", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9794e41-8080-48e4-bec8-9b16a5ef4b1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95% (264/277)</span>", "ID": "ed45f011-ccad-4c31-ad04-fe762088b5bf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95% (264/277)", "ParentId": "796cda1e-82cd-4d67-902d-8a6b4bb75d49"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span></p>\n</td>", "ID": "e51086d0-fd20-480b-b87f-acb16de3c63a", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "281d4f31-a168-499a-afd6-6644340f8c11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span></p>", "ID": "b9ac921b-7893-44b1-84f2-c058054e353d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e51086d0-fd20-480b-b87f-acb16de3c63a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">80% (221/275)</span>", "ID": "ebec46cb-43ca-4bcc-8e7e-cf2ddd8521e0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "80% (221/275)", "ParentId": "b9ac921b-7893-44b1-84f2-c058054e353d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>\n</tr>", "ID": "bff08ef5-bd5b-4e9d-9f7a-261d0a3ff490", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>\n</td>", "ID": "02931b77-18af-4e3e-90b2-5b482504dd9f", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bff08ef5-bd5b-4e9d-9f7a-261d0a3ff490"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span></p>", "ID": "109daabe-386e-4c00-8c6b-06f753600b02", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "02931b77-18af-4e3e-90b2-5b482504dd9f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR12</span>", "ID": "64739abc-6b6b-407c-b6f0-a44ae5a7f993", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Outcome for patients without SVR12", "ParentId": "109daabe-386e-4c00-8c6b-06f753600b02"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span></p>\n</td>\n</tr>", "ID": "d5a588b1-248b-4d52-99e6-7b95e61eb0fd", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>", "ID": "8e11b4f0-56bf-4a5c-afc3-905f253f9718", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5a588b1-248b-4d52-99e6-7b95e61eb0fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>", "ID": "c565122d-6f8f-4981-bd61-8688cd1b0df6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8e11b4f0-56bf-4a5c-afc3-905f253f9718"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span>", "ID": "1f12eed4-a574-462c-a83b-b2f0e738f36d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "On-treatment virologic failure", "ParentId": "c565122d-6f8f-4981-bd61-8688cd1b0df6"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span></p>\n</td>", "ID": "c745e7d8-16bd-4ff3-8942-5442078a780d", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5a588b1-248b-4d52-99e6-7b95e61eb0fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span></p>", "ID": "a62b787d-6063-4d3d-a318-aa57f6511bb1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c745e7d8-16bd-4ff3-8942-5442078a780d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/277</span>", "ID": "18f927d8-9be7-4bc9-bfa4-8b3d0608be9e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/277", "ParentId": "a62b787d-6063-4d3d-a318-aa57f6511bb1"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span></p>\n</td>", "ID": "78028947-b14c-4035-b8ed-b4d4a1f7eb43", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5a588b1-248b-4d52-99e6-7b95e61eb0fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span></p>", "ID": "3e47e982-bfaa-485e-963e-ed9c68ee1eb4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78028947-b14c-4035-b8ed-b4d4a1f7eb43"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">&lt;\u00a01% (1/275)</span>", "ID": "a66ecaae-4173-45d2-b9c4-66893e3de133", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "<\u00a01% (1/275)", "ParentId": "3e47e982-bfaa-485e-963e-ed9c68ee1eb4"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span></p>\n</td>\n</tr>", "ID": "532e3bd6-9e42-4047-a203-690b86b6a2e2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>", "ID": "21d5b0ae-e6eb-49f6-9c70-694baea779aa", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "532e3bd6-9e42-4047-a203-690b86b6a2e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>", "ID": "ae2453e6-640a-42ca-9136-d2fa402665c2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21d5b0ae-e6eb-49f6-9c70-694baea779aa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span>", "ID": "9e11629f-9d8b-4fca-9a66-f046bbb62246", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Relapse", "ParentId": "ae2453e6-640a-42ca-9136-d2fa402665c2"}, {"Element": "<sup>a</sup>", "ID": "72910bb5-15b1-4c28-8018-2bffcfb57080", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "9e11629f-9d8b-4fca-9a66-f046bbb62246"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span></p>\n</td>", "ID": "2e244963-24c6-483c-9c8a-e10762c5d774", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "532e3bd6-9e42-4047-a203-690b86b6a2e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span></p>", "ID": "57d68ed7-67e6-49a1-abeb-16c432797922", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e244963-24c6-483c-9c8a-e10762c5d774"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">4% (11/276)</span>", "ID": "c19117e9-2d0f-415d-8b70-b8f7bef7f3e9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "4% (11/276)", "ParentId": "57d68ed7-67e6-49a1-abeb-16c432797922"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span></p>\n</td>", "ID": "ce2b44b3-53d5-4b06-8aa0-f7f31e511397", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "532e3bd6-9e42-4047-a203-690b86b6a2e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span></p>", "ID": "558bd53f-ff18-4807-bfdf-d5a0ec098285", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce2b44b3-53d5-4b06-8aa0-f7f31e511397"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">14% (38/272)</span>", "ID": "4c38c7ac-e593-4242-b7cd-ea6593ddfc17", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "14% (38/272)", "ParentId": "558bd53f-ff18-4807-bfdf-d5a0ec098285"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span></p>\n</td>\n<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span></p>\n</td>\n</tr>", "ID": "ca8207a2-e5f2-4eba-8f3e-6ddd8169e5d0", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f1f683bc-4e38-46ca-92b8-77bd98fd2246"}, {"Element": "<td style=\"width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>", "ID": "c7056ee2-6da3-44b0-afca-2a709fb2787f", "Styles": "width:154.75pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca8207a2-e5f2-4eba-8f3e-6ddd8169e5d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>", "ID": "99215dcf-a3bc-4cec-8c6a-4c4d35e097b0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c7056ee2-6da3-44b0-afca-2a709fb2787f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span>", "ID": "4af08a39-1d37-4ab0-8565-466cfcdf300f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other", "ParentId": "99215dcf-a3bc-4cec-8c6a-4c4d35e097b0"}, {"Element": "<sup>b</sup>", "ID": "45d03191-9291-4b10-acbc-0ef94b6ef8f0", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "4af08a39-1d37-4ab0-8565-466cfcdf300f"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span></p>\n</td>", "ID": "df1b74e3-ae12-4f58-b927-1c3833859693", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca8207a2-e5f2-4eba-8f3e-6ddd8169e5d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span></p>", "ID": "e8ae9700-131e-4288-8635-52dd338a32db", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df1b74e3-ae12-4f58-b927-1c3833859693"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">1% (2/277)</span>", "ID": "8efc725b-64f2-42f1-9a0c-0dda165b51e9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "1% (2/277)", "ParentId": "e8ae9700-131e-4288-8635-52dd338a32db"}, {"Element": "<td style=\"width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span></p>\n</td>", "ID": "427b4a2e-03f9-4098-b030-6c2a737b76e9", "Styles": "width:2.15in;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca8207a2-e5f2-4eba-8f3e-6ddd8169e5d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span></p>", "ID": "3c09a00d-8265-42cf-91aa-cbda82cacf43", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "427b4a2e-03f9-4098-b030-6c2a737b76e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">5% (15/275)</span>", "ID": "6998713e-c23c-4c21-8e50-b92b22e87ab1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "5% (15/275)", "ParentId": "3c09a00d-8265-42cf-91aa-cbda82cacf43"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span></p>", "ID": "b41e288b-601c-4d95-b744-7ed10ac357d3", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA &lt;\u00a0LLOQ\nat their last on-treatment assessment.</span>", "ID": "5fd7625c-f5ec-41b0-bd32-315f055f0cff", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 The denominator for relapse is the number of patients with HCV\u00a0RNA <\u00a0LLOQ at their last on-treatment assessment.", "ParentId": "b41e288b-601c-4d95-b744-7ed10ac357d3"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>", "ID": "042abd59-cfe5-4639-ba79-fad21beb4e9c", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span>", "ID": "cd288b3e-5a6e-4c4b-b1db-1b8c34f7adf8", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.", "ParentId": "042abd59-cfe5-4639-ba79-fad21beb4e9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a71dd55c-98ef-4ca5-8158-781ed73f9ba1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ef0ff776-ac2b-4d86-97ad-a957c0d842ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a71dd55c-98ef-4ca5-8158-781ed73f9ba1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment with Epclusa\nfor 12\u00a0weeks demonstrated the statistical superiority (p\u00a0&lt;\u00a00.001)\ncompared to treatment with SOF+RBV for 24\u00a0weeks (treatment difference +14.8%;\n95% confidence interval: +9.6% to +20.0%).</span></p>", "ID": "81e4a5d7-cc2b-4078-a398-b891e9e51d5c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Treatment with Epclusa\nfor 12\u00a0weeks demonstrated the statistical superiority (p\u00a0&lt;\u00a00.001)\ncompared to treatment with SOF+RBV for 24\u00a0weeks (treatment difference +14.8%;\n95% confidence interval: +9.6% to +20.0%).</span>", "ID": "4e166059-2719-418a-abbf-47181dcc9b38", "Styles": "None", "Classes": "None", "Text": "Treatment with Epclusa for 12\u00a0weeks demonstrated the statistical superiority (p\u00a0<\u00a00.001) compared to treatment with SOF+RBV for 24\u00a0weeks (treatment difference +14.8%; 95% confidence interval: +9.6% to +20.0%).", "ParentId": "81e4a5d7-cc2b-4078-a398-b891e9e51d5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f88757aa-2531-42f9-ba24-bc32731291e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3ad7e1a6-a4b3-4ff1-a813-0ab31116e952", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f88757aa-2531-42f9-ba24-bc32731291e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SVR12 for\nselected subgroups are presented in Table\u00a013.</span></p>", "ID": "2057364e-5268-4751-ad9b-7c857eafec0b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">SVR12 for\nselected subgroups are presented in Table\u00a013.</span>", "ID": "a6027e0c-c30c-4fac-8467-4ea0fe3505e2", "Styles": "None", "Classes": "None", "Text": "SVR12 for selected subgroups are presented in Table\u00a013.", "ParentId": "2057364e-5268-4751-ad9b-7c857eafec0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f23ebdf-9f0c-4d79-87e9-cdebd46f51fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d991a43-6830-4c59-a873-a185c473445a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f23ebdf-9f0c-4d79-87e9-cdebd46f51fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a013: SVR12 for selected subgroups in study ASTRAL\u20113\n(HCV genotype\u00a03)</span></b></p>", "ID": "f6e60fd3-f6ad-44be-8a21-b2941cc29653", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a013: SVR12 for selected subgroups in study ASTRAL\u20113\n(HCV genotype\u00a03)</span></b>", "ID": "97135608-6e14-4dd5-96ef-38352bc0ddf1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f6e60fd3-f6ad-44be-8a21-b2941cc29653"}, {"Element": "<span lang=\"EN-GB\">Table\u00a013: SVR12 for selected subgroups in study ASTRAL\u20113\n(HCV genotype\u00a03)</span>", "ID": "c82bf735-407e-402c-91d6-692fd1719e2f", "Styles": "None", "Classes": "None", "Text": "Table\u00a013: SVR12 for selected subgroups in study ASTRAL\u20113 (HCV genotype\u00a03)", "ParentId": "97135608-6e14-4dd5-96ef-38352bc0ddf1"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span></p>\n</td>\n</tr>\n</table>", "ID": "35569544-8620-4074-8d86-2d600ec5f7b8", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "     ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>\n</td>\n</tr>\n</thead>", "ID": "9eec3db3-0d16-4733-9967-d9fd8559c8d4", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "35569544-8620-4074-8d86-2d600ec5f7b8"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>\n</td>\n</tr>", "ID": "f610b247-e156-4ff0-ab11-6498a5fcd7be", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "9eec3db3-0d16-4733-9967-d9fd8559c8d4"}, {"Element": "<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "c181e83a-fcf1-4e14-a42e-ede9de65d56f", "Styles": "width:92.85pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f610b247-e156-4ff0-ab11-6498a5fcd7be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "f29177ae-cc62-412e-aeae-c5764071a007", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c181e83a-fcf1-4e14-a42e-ede9de65d56f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "21a928eb-4486-40e5-b1bb-1b897bc91e4d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f29177ae-cc62-412e-aeae-c5764071a007"}, {"Element": "<td colspan=\"2\" style=\"width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n</td>", "ID": "2dc6699c-6296-4084-a7c7-ea28aed18115", "Styles": "width:185.7pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f610b247-e156-4ff0-ab11-6498a5fcd7be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>", "ID": "c2c226be-47ac-42f8-9b03-183ef5fdbfe0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2dc6699c-6296-4084-a7c7-ea28aed18115"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b>", "ID": "4b2d3597-9ce3-4b71-9e47-80a1f12be495", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c2c226be-47ac-42f8-9b03-183ef5fdbfe0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "8a5dcf75-a944-4d95-8c72-79a3bbc80db4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "4b2d3597-9ce3-4b71-9e47-80a1f12be495"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "b64aa527-55ad-4b5f-9b90-078c02fd3cc9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2dc6699c-6296-4084-a7c7-ea28aed18115"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "4ef1a82e-c61a-4174-8d0d-be203eb6e00c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b64aa527-55ad-4b5f-9b90-078c02fd3cc9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "20f6c970-1577-4b34-affa-b1d1ea88f7f0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "4ef1a82e-c61a-4174-8d0d-be203eb6e00c"}, {"Element": "<td colspan=\"2\" style=\"width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"248\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>\n</td>", "ID": "b601da5b-f5b9-4edd-ba7a-8d779943ddf3", "Styles": "width:185.8pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f610b247-e156-4ff0-ab11-6498a5fcd7be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b></p>", "ID": "7aab2997-e6a5-4455-966f-f3e80c8d0c9a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b601da5b-f5b9-4edd-ba7a-8d779943ddf3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span></b>", "ID": "b2722d24-00ab-49ec-b8a9-c5a7fcb6901c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7aab2997-e6a5-4455-966f-f3e80c8d0c9a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SOF+RBV</span>", "ID": "6ed35899-45f4-4a57-b096-561e76ce0586", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SOF+RBV", "ParentId": "b2722d24-00ab-49ec-b8a9-c5a7fcb6901c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b></p>", "ID": "c903ca06-ceb2-4f72-b099-ebc6afe1211c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b601da5b-f5b9-4edd-ba7a-8d779943ddf3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span></b>", "ID": "2ddaf573-e41f-43cb-8a71-58359878e542", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c903ca06-ceb2-4f72-b099-ebc6afe1211c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks<sup>a</sup></span>", "ID": "dabf7a89-663d-4e1c-9dd7-e3a9423d1ac5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "24\u00a0weeks", "ParentId": "2ddaf573-e41f-43cb-8a71-58359878e542"}, {"Element": "<sup>a</sup>", "ID": "c298dcb0-b3f1-40dc-97d4-891734ad8898", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "dabf7a89-663d-4e1c-9dd7-e3a9423d1ac5"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span></p>\n</td>\n</tr>", "ID": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "35569544-8620-4074-8d86-2d600ec5f7b8"}, {"Element": "<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>", "ID": "41079dc3-1648-482f-8797-0ef43889dd2a", "Styles": "width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>", "ID": "fd078063-a58f-4396-a17a-2e67fba9d95c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41079dc3-1648-482f-8797-0ef43889dd2a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span>", "ID": "e64b6632-e5c6-49de-bc7f-84f5d243df82", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR12", "ParentId": "fd078063-a58f-4396-a17a-2e67fba9d95c"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span></p>\n</td>", "ID": "96cb6d9d-652b-4889-8c1a-f4a567f802c3", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>", "ID": "533486b6-c8a0-42d6-9028-d0039d97788f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96cb6d9d-652b-4889-8c1a-f4a567f802c3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span>", "ID": "91237967-f5b2-47db-859f-4dd2ed64303b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Treatment-na\u00efve", "ParentId": "533486b6-c8a0-42d6-9028-d0039d97788f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span></p>", "ID": "34216ee8-94f2-4b9d-bd52-3682e045ee45", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96cb6d9d-652b-4889-8c1a-f4a567f802c3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0206)</span>", "ID": "ce801445-0f92-48c8-af90-3a05237cd2e9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0206)", "ParentId": "34216ee8-94f2-4b9d-bd52-3682e045ee45"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span></p>\n</td>", "ID": "c3651bb4-b946-4776-b886-f7480d19e512", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>", "ID": "822a58ee-439e-4f45-8c52-9f32a09bf5c8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3651bb4-b946-4776-b886-f7480d19e512"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span>", "ID": "e46951d9-2599-44a7-94a4-be6ae16fc74a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Treatment-experienced", "ParentId": "822a58ee-439e-4f45-8c52-9f32a09bf5c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span></p>", "ID": "c59e8354-22fe-42ac-807b-1a738846abb5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3651bb4-b946-4776-b886-f7480d19e512"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a071)</span>", "ID": "6799943e-b374-417e-8958-c9ac63ffd416", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a071)", "ParentId": "c59e8354-22fe-42ac-807b-1a738846abb5"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span></p>\n</td>", "ID": "4fb1d188-ed15-4c03-8d33-d02d39bbacec", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span></p>", "ID": "dea56825-b4f0-4425-931a-4739e287f4e4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fb1d188-ed15-4c03-8d33-d02d39bbacec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-na\u00efve</span>", "ID": "c31c21a5-7cc3-4a7f-86f8-0aaff69d222a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Treatment-na\u00efve", "ParentId": "dea56825-b4f0-4425-931a-4739e287f4e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span></p>", "ID": "657bc8ef-b301-4189-8d45-377cd5fd5be0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4fb1d188-ed15-4c03-8d33-d02d39bbacec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0201)</span>", "ID": "ac03b980-7c9a-4452-bd11-20291b2ec903", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0201)", "ParentId": "657bc8ef-b301-4189-8d45-377cd5fd5be0"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span></p>\n</td>", "ID": "2a2e6744-6215-404f-a274-d0c104e2bd9f", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "e8262f50-4c54-4f6c-911f-c2f32b8b0c45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span></p>", "ID": "7c1530e6-739e-460d-87f4-4b1a83d7bcef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a2e6744-6215-404f-a274-d0c104e2bd9f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Treatment-experienced</span>", "ID": "d7c59a81-090b-4d78-8f48-0947a534d804", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Treatment-experienced", "ParentId": "7c1530e6-739e-460d-87f4-4b1a83d7bcef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span></p>", "ID": "4734c152-ffa6-4876-ac1b-be585b604137", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a2e6744-6215-404f-a274-d0c104e2bd9f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a069)</span>", "ID": "a64a0c02-7e3a-43f9-8e6d-16671c1c0bb7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a069)", "ParentId": "4734c152-ffa6-4876-ac1b-be585b604137"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span></p>\n</td>\n</tr>", "ID": "921be415-8fa5-43a6-9ab4-d8c932cddd78", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "35569544-8620-4074-8d86-2d600ec5f7b8"}, {"Element": "<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span></p>\n</td>", "ID": "40358f63-46b0-4101-992c-da625d087749", "Styles": "width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "921be415-8fa5-43a6-9ab4-d8c932cddd78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span></p>", "ID": "9d616727-000a-48d4-94a1-ca7758942c5e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "40358f63-46b0-4101-992c-da625d087749"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Without cirrhosis</span>", "ID": "9f9cacac-5628-45b7-b8af-a35c897ce64c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Without cirrhosis", "ParentId": "9d616727-000a-48d4-94a1-ca7758942c5e"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span></p>\n</td>", "ID": "65c63a28-aa87-498d-8888-309d45eb9b13", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "921be415-8fa5-43a6-9ab4-d8c932cddd78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span></p>", "ID": "5b688c40-d3fc-472e-a2a7-f0416045acb2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65c63a28-aa87-498d-8888-309d45eb9b13"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">98% (160/163)</span>", "ID": "eb40c44e-3099-4eae-beb1-26d08acbfdee", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "98% (160/163)", "ParentId": "5b688c40-d3fc-472e-a2a7-f0416045acb2"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span></p>\n</td>", "ID": "13943ce7-9c76-4a71-8d8f-d3e05a4d3b73", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "921be415-8fa5-43a6-9ab4-d8c932cddd78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span></p>", "ID": "4531731b-3f76-4ce2-b163-938b5f56fd35", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "13943ce7-9c76-4a71-8d8f-d3e05a4d3b73"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">91% (31/34)</span>", "ID": "c61820e7-dbf5-4fc4-9f54-d06236695483", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "91% (31/34)", "ParentId": "4531731b-3f76-4ce2-b163-938b5f56fd35"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span></p>\n</td>", "ID": "7c5fd2f0-355f-483f-a2a2-8c8343088bf2", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "921be415-8fa5-43a6-9ab4-d8c932cddd78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span></p>", "ID": "e17e2d88-2183-4d96-ab76-f81e07406e2c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7c5fd2f0-355f-483f-a2a2-8c8343088bf2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">90% (141/156)</span>", "ID": "96710fe6-7a0a-4874-9e5d-07bb7563e163", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "90% (141/156)", "ParentId": "e17e2d88-2183-4d96-ab76-f81e07406e2c"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span></p>\n</td>", "ID": "2849fd65-c51b-4904-ba76-803592a8dcdc", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "921be415-8fa5-43a6-9ab4-d8c932cddd78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span></p>", "ID": "452bd7cb-cfff-4333-9b10-e057f7c00538", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2849fd65-c51b-4904-ba76-803592a8dcdc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">71% (22/31)</span>", "ID": "a8a120dc-fa2b-4822-8610-87fbea4c7bb3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "71% (22/31)", "ParentId": "452bd7cb-cfff-4333-9b10-e057f7c00538"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span></p>\n</td>\n<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span></p>\n</td>\n<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span></p>\n</td>\n</tr>", "ID": "345d69ab-ae0d-49e6-b825-427bfa726e41", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "35569544-8620-4074-8d86-2d600ec5f7b8"}, {"Element": "<td style=\"width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span></p>\n</td>", "ID": "3fa29b0c-e511-4603-be64-fcb921f4b3c2", "Styles": "width:92.85pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "345d69ab-ae0d-49e6-b825-427bfa726e41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span></p>", "ID": "9318e445-5b16-44df-b2c3-76062dc10e3a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fa29b0c-e511-4603-be64-fcb921f4b3c2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">With cirrhosis</span>", "ID": "ecb56e1a-d23b-45d1-a6f8-f6734d87cce3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "With cirrhosis", "ParentId": "9318e445-5b16-44df-b2c3-76062dc10e3a"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span></p>\n</td>", "ID": "4488abc8-3afa-47a9-9af6-d2e5b3f687ab", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "345d69ab-ae0d-49e6-b825-427bfa726e41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span></p>", "ID": "2de6fbee-2cb9-43f6-b5fa-cb67f34c56e5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4488abc8-3afa-47a9-9af6-d2e5b3f687ab"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">93% (40/43)</span>", "ID": "3836d88d-433d-465c-ba53-ccb475bb29a6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "93% (40/43)", "ParentId": "2de6fbee-2cb9-43f6-b5fa-cb67f34c56e5"}, {"Element": "<td style=\"width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span></p>\n</td>", "ID": "335a181a-f20c-4bae-b3bc-ba6ca8e2a0da", "Styles": "width:92.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "345d69ab-ae0d-49e6-b825-427bfa726e41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span></p>", "ID": "0bc11e86-1417-4490-82e4-88221b9341e7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "335a181a-f20c-4bae-b3bc-ba6ca8e2a0da"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">89% (33/37)</span>", "ID": "8ab3e8fd-8a70-40f7-935e-2d389601282e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "89% (33/37)", "ParentId": "0bc11e86-1417-4490-82e4-88221b9341e7"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span></p>\n</td>", "ID": "e187712a-eff5-441b-bb3e-ef577e80f1e2", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "345d69ab-ae0d-49e6-b825-427bfa726e41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span></p>", "ID": "d9a2f2ef-f084-4e52-b46b-4264e874bdaf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e187712a-eff5-441b-bb3e-ef577e80f1e2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">73% (33/45)</span>", "ID": "bbc9ffa1-54aa-41a8-91cb-a7e1bfcbaaa0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "73% (33/45)", "ParentId": "d9a2f2ef-f084-4e52-b46b-4264e874bdaf"}, {"Element": "<td style=\"width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"124\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span></p>\n</td>", "ID": "173c9814-681b-47be-99dd-a452cd7980b1", "Styles": "width:92.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "345d69ab-ae0d-49e6-b825-427bfa726e41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span></p>", "ID": "38f51fb6-deb4-4b7b-b420-52b43e3c8a20", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "173c9814-681b-47be-99dd-a452cd7980b1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">58% (22/38)</span>", "ID": "a9d01179-14a4-4227-b8fe-3d13d6d4f967", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "58% (22/38)", "ParentId": "38f51fb6-deb4-4b7b-b420-52b43e3c8a20"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 Five\npatients with missing cirrhosis status in the SOF+RBV 24\u00a0week group were\nexcluded from this subgroup analysis.</span></p>", "ID": "1452e09a-c5eb-4948-9347-95f4833ea673", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 Five\npatients with missing cirrhosis status in the SOF+RBV 24\u00a0week group were\nexcluded from this subgroup analysis.</span>", "ID": "820fa97a-5592-428d-8ca3-765a0d1f594a", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 Five patients with missing cirrhosis status in the SOF+RBV 24\u00a0week group were excluded from this subgroup analysis.", "ParentId": "1452e09a-c5eb-4948-9347-95f4833ea673"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "07e07e47-ab66-46ec-bf62-4c4cd3399fcc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e9b1ab1-eb6a-47be-ae87-f10231d2ef1c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "07e07e47-ab66-46ec-bf62-4c4cd3399fcc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients with decompensated cirrhosis <b>\u2013</b>\nASTRAL\u20114 (study\u00a01137)</span></i></p>", "ID": "8ea251f5-44a9-4206-ad3c-b249edbb6145", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Clinical studies in patients with decompensated cirrhosis <b>\u2013</b>\nASTRAL\u20114 (study\u00a01137)</span></i>", "ID": "faaca0f6-616a-47ce-9f78-b68d592d694b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ea251f5-44a9-4206-ad3c-b249edbb6145"}, {"Element": "<span lang=\"EN-GB\">Clinical studies in patients with decompensated cirrhosis <b>\u2013</b>\nASTRAL\u20114 (study\u00a01137)</span>", "ID": "f7dfc4b6-109f-4f00-87af-3879fbae35a6", "Styles": "None", "Classes": "None", "Text": "Clinical studies in patients with decompensated cirrhosis  ASTRAL\u20114 (study\u00a01137)", "ParentId": "faaca0f6-616a-47ce-9f78-b68d592d694b"}, {"Element": "<b>\u2013</b>", "ID": "40f6807b-063d-43c0-a6c3-12ea6ca7146b", "Styles": "None", "Classes": "None", "Text": "\u2013", "ParentId": "f7dfc4b6-109f-4f00-87af-3879fbae35a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20114\nwas a randomised, open-label study in patients with genotype\u00a01, 2, 3, 4, 5\nor 6 HCV infection and CPT Class\u00a0B cirrhosis.\u00a0 Patients were randomised\nin a 1:1:1 ratio to treatment with Epclusa for 12\u00a0weeks, Epclusa + RBV for\n12\u00a0weeks or Epclusa for 24\u00a0weeks.\u00a0 Randomisation was stratified\nby HCV genotype (1, 2, 3, 4, 5, 6 and indeterminate).</span></p>", "ID": "474c88b1-10e7-43ab-b8c6-ba50321ed49e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">ASTRAL\u20114\nwas a randomised, open-label study in patients with genotype\u00a01, 2, 3, 4, 5\nor 6 HCV infection and CPT Class\u00a0B cirrhosis.\u00a0 Patients were randomised\nin a 1:1:1 ratio to treatment with Epclusa for 12\u00a0weeks, Epclusa + RBV for\n12\u00a0weeks or Epclusa for 24\u00a0weeks.\u00a0 Randomisation was stratified\nby HCV genotype (1, 2, 3, 4, 5, 6 and indeterminate).</span>", "ID": "98907d4c-6626-4117-9b2b-555a558af565", "Styles": "None", "Classes": "None", "Text": "ASTRAL\u20114 was a randomised, open-label study in patients with genotype\u00a01, 2, 3, 4, 5 or 6 HCV infection and CPT Class\u00a0B cirrhosis.\u00a0 Patients were randomised in a 1:1:1 ratio to treatment with Epclusa for 12\u00a0weeks, Epclusa + RBV for 12\u00a0weeks or Epclusa for 24\u00a0weeks.\u00a0 Randomisation was stratified by HCV genotype (1, 2, 3, 4, 5, 6 and indeterminate).", "ParentId": "474c88b1-10e7-43ab-b8c6-ba50321ed49e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "101c28f0-a916-4709-880e-54166da21292", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "344ec3a4-9c4c-40a4-8466-51240f956905", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "101c28f0-a916-4709-880e-54166da21292"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the treatment groups.\u00a0 Of\nthe 267 treated patients, the median age was 59\u00a0years (range: 40 to 73);\n70% of the patients were male; 90% were White, 6% were Black; 42% had a\nbaseline body mass index of at least 30\u00a0kg/m<sup>2</sup>.\u00a0 The\nproportions of patients with genotype\u00a01, 2, 3, 4 or 6 HCV were 78%, 4%,\n15%, 3%, and &lt;\u00a01% (1\u00a0patient), respectively.\u00a0 No patients\nwith genotype\u00a05 HCV infection were enrolled.\u00a0 76% of the patients had\nnon\u2011CC IL28B alleles (CT or TT); 56% had baseline HCV\u00a0RNA levels of at\nleast 800,000\u00a0IU/mL, 55% were treatment-experienced; 90% and 95% of\npatients had CPT Class\u00a0B cirrhosis and Model for End Stage Liver Disease\n(MELD) score \u2264\u00a015 at baseline, respectively.</span></p>", "ID": "d58f544c-585c-4789-9296-6b84b49b42a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Demographics and\nbaseline characteristics were balanced across the treatment groups.\u00a0 Of\nthe 267 treated patients, the median age was 59\u00a0years (range: 40 to 73);\n70% of the patients were male; 90% were White, 6% were Black; 42% had a\nbaseline body mass index of at least 30\u00a0kg/m<sup>2</sup>.\u00a0 The\nproportions of patients with genotype\u00a01, 2, 3, 4 or 6 HCV were 78%, 4%,\n15%, 3%, and &lt;\u00a01% (1\u00a0patient), respectively.\u00a0 No patients\nwith genotype\u00a05 HCV infection were enrolled.\u00a0 76% of the patients had\nnon\u2011CC IL28B alleles (CT or TT); 56% had baseline HCV\u00a0RNA levels of at\nleast 800,000\u00a0IU/mL, 55% were treatment-experienced; 90% and 95% of\npatients had CPT Class\u00a0B cirrhosis and Model for End Stage Liver Disease\n(MELD) score \u2264\u00a015 at baseline, respectively.</span>", "ID": "723fd4c3-1dfa-4ff1-959c-525a69ae94f5", "Styles": "None", "Classes": "None", "Text": "Demographics and baseline characteristics were balanced across the treatment groups.\u00a0 Of the 267 treated patients, the median age was 59\u00a0years (range: 40 to 73); 70% of the patients were male; 90% were White, 6% were Black; 42% had a baseline body mass index of at least 30\u00a0kg/m.\u00a0 The proportions of patients with genotype\u00a01, 2, 3, 4 or 6 HCV were 78%, 4%, 15%, 3%, and <\u00a01% (1\u00a0patient), respectively.\u00a0 No patients with genotype\u00a05 HCV infection were enrolled.\u00a0 76% of the patients had non\u2011CC IL28B alleles (CT or TT); 56% had baseline HCV\u00a0RNA levels of at least 800,000\u00a0IU/mL, 55% were treatment-experienced; 90% and 95% of patients had CPT Class\u00a0B cirrhosis and Model for End Stage Liver Disease (MELD) score \u2264\u00a015 at baseline, respectively.", "ParentId": "d58f544c-585c-4789-9296-6b84b49b42a8"}, {"Element": "<sup>2</sup>", "ID": "c9214bf1-2d4e-4ba7-a186-02a1b9b42266", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "723fd4c3-1dfa-4ff1-959c-525a69ae94f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4b8b824-da1f-4640-bfa4-9a6f0048f67e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7478805e-7d8a-48e4-861e-069b7561bb5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4b8b824-da1f-4640-bfa4-9a6f0048f67e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a014 presents\nthe SVR12 for the ASTRAL\u20114 study by HCV genotype.</span></p>", "ID": "1866acc2-39d2-4c8d-adce-7e016836f3fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table\u00a014 presents\nthe SVR12 for the ASTRAL\u20114 study by HCV genotype.</span>", "ID": "54ab5e6d-3067-4e82-8a1d-60c44833b226", "Styles": "None", "Classes": "None", "Text": "Table\u00a014 presents the SVR12 for the ASTRAL\u20114 study by HCV genotype.", "ParentId": "1866acc2-39d2-4c8d-adce-7e016836f3fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b44410ec-3dc4-43f5-a7e0-61788dc251eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "16783697-1f09-4e1c-8bec-b140c10eda67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b44410ec-3dc4-43f5-a7e0-61788dc251eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a014: SVR12 in study ASTRAL\u20114 by HCV genotype</span></b></p>", "ID": "f7ccbbd9-1a07-44a8-b7cb-eb846471f038", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a014: SVR12 in study ASTRAL\u20114 by HCV genotype</span></b>", "ID": "24903f31-9017-4a1a-9006-9fa5d72373eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7ccbbd9-1a07-44a8-b7cb-eb846471f038"}, {"Element": "<span lang=\"EN-GB\">Table\u00a014: SVR12 in study ASTRAL\u20114 by HCV genotype</span>", "ID": "7865e6ea-9abc-493d-aca3-9d873c428b11", "Styles": "None", "Classes": "None", "Text": "Table\u00a014: SVR12 in study ASTRAL\u20114 by HCV genotype", "ParentId": "24903f31-9017-4a1a-9006-9fa5d72373eb"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"621\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span></p>\n</td>\n</tr>\n</table>", "ID": "ca799ae3-4006-45b1-98ab-7a08328815a0", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "        ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "03fc65c5-332a-4567-8256-bf605b5e271f", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>\n</td>\n<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>\n</tr>", "ID": "279313b4-2dad-484a-aa42-deba8144905c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "03fc65c5-332a-4567-8256-bf605b5e271f"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "fe1fd5a2-d4f7-4913-a5cc-e5f72938c6f3", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "279313b4-2dad-484a-aa42-deba8144905c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "17042ad2-a8b4-4abd-9609-81470af60fa5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe1fd5a2-d4f7-4913-a5cc-e5f72938c6f3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "6dced9e3-986e-4c4c-aebf-ed49468aab95", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17042ad2-a8b4-4abd-9609-81470af60fa5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "c78e8ca1-ad84-49bd-8f6b-72807c4e3766", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6dced9e3-986e-4c4c-aebf-ed49468aab95"}, {"Element": "<td style=\"width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>", "ID": "56d4f57b-1d27-4784-a761-50eef50fe7ab", "Styles": "width:117.6pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "279313b4-2dad-484a-aa42-deba8144905c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>", "ID": "b3775f26-d2d1-47ea-b05c-904e50ecfa53", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "56d4f57b-1d27-4784-a761-50eef50fe7ab"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b>", "ID": "e4cd710d-de8d-498b-8c53-8bb1de5f108b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3775f26-d2d1-47ea-b05c-904e50ecfa53"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "b0355233-75f1-402b-b4d8-eb7f4c06880e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "e4cd710d-de8d-498b-8c53-8bb1de5f108b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "a352b9f4-747b-4021-8d5a-203121a10f2b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "56d4f57b-1d27-4784-a761-50eef50fe7ab"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "9b7eadb2-7e15-4889-9339-231d33cfa44e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a352b9f4-747b-4021-8d5a-203121a10f2b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "f904d8b3-544c-4cb6-88bd-cee1d4b043c8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "9b7eadb2-7e15-4889-9339-231d33cfa44e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>", "ID": "06d4058b-0c3c-4457-b7f3-1d6ea8acb09c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "56d4f57b-1d27-4784-a761-50eef50fe7ab"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b>", "ID": "1bd8df51-4da4-496d-b02a-f427d7bf9c1b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06d4058b-0c3c-4457-b7f3-1d6ea8acb09c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span>", "ID": "51eb5630-3a6b-4a22-ae7c-3a9ee3576d1f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a090)", "ParentId": "1bd8df51-4da4-496d-b02a-f427d7bf9c1b"}, {"Element": "<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>\n</td>", "ID": "9dfdd5c2-600f-4403-9b2e-b1e093cd89ed", "Styles": "width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "279313b4-2dad-484a-aa42-deba8144905c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b></p>", "ID": "5867e951-127e-4515-91f9-be7ce0bc7931", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9dfdd5c2-600f-4403-9b2e-b1e093cd89ed"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span></b>", "ID": "5993c0aa-cbc3-4394-a03e-6dda56e11c12", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5867e951-127e-4515-91f9-be7ce0bc7931"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV</span>", "ID": "58af7602-19a8-40c1-9751-c1787452f7e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa + RBV", "ParentId": "5993c0aa-cbc3-4394-a03e-6dda56e11c12"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b></p>", "ID": "8489f8f4-d3c2-4935-85c5-60a3284989c1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9dfdd5c2-600f-4403-9b2e-b1e093cd89ed"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span></b>", "ID": "50fe5ab9-2d01-45b4-9740-b7f9fce93ad8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8489f8f4-d3c2-4935-85c5-60a3284989c1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">12\u00a0weeks</span>", "ID": "d396838c-b06e-4ca0-935b-737ff7974014", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "12\u00a0weeks", "ParentId": "50fe5ab9-2d01-45b4-9740-b7f9fce93ad8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b></p>", "ID": "ac5238e2-7036-4c6d-a7d8-cd8d03cc65a0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9dfdd5c2-600f-4403-9b2e-b1e093cd89ed"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span></b>", "ID": "0546c53e-8656-4c3f-ba7a-253c04edf942", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac5238e2-7036-4c6d-a7d8-cd8d03cc65a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a087)</span>", "ID": "2596e99e-c1f2-4b50-a022-5d1429e518a0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a087)", "ParentId": "0546c53e-8656-4c3f-ba7a-253c04edf942"}, {"Element": "<td style=\"width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>\n</td>", "ID": "764bab87-12f3-4506-a17f-6d99e39670e4", "Styles": "width:134.65pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "279313b4-2dad-484a-aa42-deba8144905c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b></p>", "ID": "f1a248d5-0125-46d0-8ecc-8a489864b45a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "764bab87-12f3-4506-a17f-6d99e39670e4"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span></b>", "ID": "9f8f8415-2451-4ade-b40f-842752952a34", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1a248d5-0125-46d0-8ecc-8a489864b45a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa</span>", "ID": "afec76cd-54b3-4577-8cf6-ab63bbe5461a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa", "ParentId": "9f8f8415-2451-4ade-b40f-842752952a34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b></p>", "ID": "fd00a3be-ed59-492f-8ddc-36344e6d39ca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "764bab87-12f3-4506-a17f-6d99e39670e4"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span></b>", "ID": "b93f5118-fad6-48f4-a7b1-747d003c1d51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fd00a3be-ed59-492f-8ddc-36344e6d39ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">24\u00a0weeks</span>", "ID": "bb7998ac-2066-4aca-820c-d9626e7e37cf", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "24\u00a0weeks", "ParentId": "b93f5118-fad6-48f4-a7b1-747d003c1d51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b></p>", "ID": "dc503aa0-9eb7-4e12-9be9-0cb8a6a14fb9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "764bab87-12f3-4506-a17f-6d99e39670e4"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span></b>", "ID": "c0204f33-92de-4743-8ec8-6f673854648e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc503aa0-9eb7-4e12-9be9-0cb8a6a14fb9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a090)</span>", "ID": "d60337a7-f03f-491c-b8df-d4a677103b82", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a090)", "ParentId": "c0204f33-92de-4743-8ec8-6f673854648e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span></p>\n</td>\n</tr>", "ID": "bad298e1-1d1a-4a31-afa8-9e0b7dedc990", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b></p>\n</td>", "ID": "3fd7b944-b5f8-4f0e-b710-487d1ff2528f", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bad298e1-1d1a-4a31-afa8-9e0b7dedc990"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b></p>", "ID": "0faa6fd9-594a-45b9-8cbb-8bbfd0f25b3f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fd7b944-b5f8-4f0e-b710-487d1ff2528f"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span></b>", "ID": "a8a72a12-ee73-4354-bbe6-a188409a4af8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0faa6fd9-594a-45b9-8cbb-8bbfd0f25b3f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Overall SVR12</span>", "ID": "75c7ec85-cc99-4b0e-945a-24f21740c90e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Overall SVR12", "ParentId": "a8a72a12-ee73-4354-bbe6-a188409a4af8"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span></p>\n</td>", "ID": "b5125ba1-a2d7-46fd-a1f9-4622ec718728", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bad298e1-1d1a-4a31-afa8-9e0b7dedc990"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span></p>", "ID": "4ea5578e-53c6-42c2-abe2-45a7bf335624", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "b5125ba1-a2d7-46fd-a1f9-4622ec718728"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>83% (75/90)</span>", "ID": "ee13a380-cbab-4144-96ea-389640950261", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "83% (75/90)", "ParentId": "4ea5578e-53c6-42c2-abe2-45a7bf335624"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span></p>\n</td>", "ID": "89d5a6d3-d81b-432a-8584-5cfab8a68e9f", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bad298e1-1d1a-4a31-afa8-9e0b7dedc990"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span></p>", "ID": "ad5432c3-2222-4679-aac6-ac5b1a1e89f6", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "89d5a6d3-d81b-432a-8584-5cfab8a68e9f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (82/87)</span>", "ID": "52c26b2a-c54e-4d40-8e7c-368c65017566", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "94% (82/87)", "ParentId": "ad5432c3-2222-4679-aac6-ac5b1a1e89f6"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span></p>\n</td>", "ID": "0cf93ef9-0fa5-474b-8cce-8fb2a1894b56", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bad298e1-1d1a-4a31-afa8-9e0b7dedc990"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span></p>", "ID": "296c81cf-93e6-4368-abc4-27a6f50902e9", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "0cf93ef9-0fa5-474b-8cce-8fb2a1894b56"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (77/90)</span>", "ID": "07176d33-d543-4751-87f4-b9a25591172a", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "86% (77/90)", "ParentId": "296c81cf-93e6-4368-abc4-27a6f50902e9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span></p>\n</td>\n</tr>", "ID": "1adcdeb0-f6ba-4952-b029-3401a61a0bf3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>\n</td>", "ID": "813c6634-b6fd-4c38-ba95-73e3c6da7206", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1adcdeb0-f6ba-4952-b029-3401a61a0bf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b></p>", "ID": "c348621f-65ea-40fe-b0a5-16072fd6e901", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "813c6634-b6fd-4c38-ba95-73e3c6da7206"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span></b>", "ID": "b0b17e90-038a-483e-910e-eb29bd9a56e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c348621f-65ea-40fe-b0a5-16072fd6e901"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01</span>", "ID": "56eafe53-0393-4a1a-8b2e-b5a0f9a53295", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01", "ParentId": "b0b17e90-038a-483e-910e-eb29bd9a56e8"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span></p>\n</td>", "ID": "7b3ca6f5-907b-47f8-8464-0cb8a4c2d9e1", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1adcdeb0-f6ba-4952-b029-3401a61a0bf3"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span></p>", "ID": "32148402-d80a-4961-b9a6-fb4f6e560c99", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "7b3ca6f5-907b-47f8-8464-0cb8a4c2d9e1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (60/68)</span>", "ID": "d2d45dee-5726-45d2-a5cb-dc49b0a9c54c", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "88% (60/68)", "ParentId": "32148402-d80a-4961-b9a6-fb4f6e560c99"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span></p>\n</td>", "ID": "6a36b949-5e63-410b-bf78-e9f7ba672c95", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1adcdeb0-f6ba-4952-b029-3401a61a0bf3"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span></p>", "ID": "6a381572-6cc8-48f0-899e-d40aff3ad773", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "6a36b949-5e63-410b-bf78-e9f7ba672c95"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>96% (65/68)</span>", "ID": "1b5b53b7-c0a6-4a08-8406-f7c1674b1a14", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "96% (65/68)", "ParentId": "6a381572-6cc8-48f0-899e-d40aff3ad773"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span></p>\n</td>", "ID": "7bbcb3d2-c596-4f17-bc6b-c5a2eb24c328", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1adcdeb0-f6ba-4952-b029-3401a61a0bf3"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span></p>", "ID": "30ae2c3d-f027-4477-9da7-62e6d20230d2", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "7bbcb3d2-c596-4f17-bc6b-c5a2eb24c328"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>92% (65/71)</span>", "ID": "e5e44406-97ed-47c8-a374-3a714cb59284", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "92% (65/71)", "ParentId": "30ae2c3d-f027-4477-9da7-62e6d20230d2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span></p>\n</td>\n</tr>", "ID": "054c348c-7214-4a1b-876e-e300b18bfc13", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>", "ID": "01b4c90a-c058-4830-b6a7-576acc7dd608", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "054c348c-7214-4a1b-876e-e300b18bfc13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>", "ID": "bfb447d3-993e-4388-b660-95141b6eb0bf", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "01b4c90a-c058-4830-b6a7-576acc7dd608"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b>", "ID": "22f794e4-f077-40fa-a80f-ee95f381a8ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfb447d3-993e-4388-b660-95141b6eb0bf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span>", "ID": "2f359ca9-0ea4-490a-b2ba-244cc4054016", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a", "ParentId": "22f794e4-f077-40fa-a80f-ee95f381a8ed"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span></p>\n</td>", "ID": "f7d297e7-ae84-4ce9-821d-16e0c2def5a8", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "054c348c-7214-4a1b-876e-e300b18bfc13"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span></p>", "ID": "755ed100-0353-413b-a93e-b9bc782e1042", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "f7d297e7-ae84-4ce9-821d-16e0c2def5a8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (44/50)</span>", "ID": "78f50c25-2070-44df-9850-c790da948cda", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "88% (44/50)", "ParentId": "755ed100-0353-413b-a93e-b9bc782e1042"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span></p>\n</td>", "ID": "5a6972a4-332b-435d-a00c-3a15fd7f8ce2", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "054c348c-7214-4a1b-876e-e300b18bfc13"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span></p>", "ID": "92abe08d-7b8a-455a-a66b-67e766987b3f", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "5a6972a4-332b-435d-a00c-3a15fd7f8ce2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>94% (51/54)</span>", "ID": "53969af9-36e2-46bb-9ff2-79d96c15d424", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "94% (51/54)", "ParentId": "92abe08d-7b8a-455a-a66b-67e766987b3f"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span></p>\n</td>", "ID": "4ce3ce88-28eb-4c25-a89a-63923a0b87e3", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "054c348c-7214-4a1b-876e-e300b18bfc13"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span></p>", "ID": "b75068c8-6bed-45a6-9df0-ae39a0036b93", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "4ce3ce88-28eb-4c25-a89a-63923a0b87e3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>93% (51/55)</span>", "ID": "95f13187-d650-4446-a61f-25b3492a73ed", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "93% (51/55)", "ParentId": "b75068c8-6bed-45a6-9df0-ae39a0036b93"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span></p>\n</td>\n</tr>", "ID": "d4001594-9fe3-48f6-8adb-684a76cc6efa", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>", "ID": "0fcdec45-eb96-45cb-a6e7-ce023d2e2113", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d4001594-9fe3-48f6-8adb-684a76cc6efa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>", "ID": "ea53e7fb-5cc1-4047-800b-04b3ba8ce060", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0fcdec45-eb96-45cb-a6e7-ce023d2e2113"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b>", "ID": "8cb5cdd8-094b-4732-bcae-94a6766395da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea53e7fb-5cc1-4047-800b-04b3ba8ce060"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span>", "ID": "b23ff553-7234-4634-9925-19bf9d7b882b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b", "ParentId": "8cb5cdd8-094b-4732-bcae-94a6766395da"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span></p>\n</td>", "ID": "299f80bf-d982-426e-94e5-2f9457b3d3b7", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d4001594-9fe3-48f6-8adb-684a76cc6efa"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span></p>", "ID": "61bda4b7-f78a-4e7e-b782-fe459d92ecb4", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "299f80bf-d982-426e-94e5-2f9457b3d3b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>89% (16/18)</span>", "ID": "b731a878-4e3a-43e6-a16a-51626332ff31", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "89% (16/18)", "ParentId": "61bda4b7-f78a-4e7e-b782-fe459d92ecb4"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span></p>\n</td>", "ID": "66ddde14-abd1-4ab4-b014-cee02fce751a", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d4001594-9fe3-48f6-8adb-684a76cc6efa"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span></p>", "ID": "6a38dc94-dde0-4026-b250-65f290f52f77", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "66ddde14-abd1-4ab4-b014-cee02fce751a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (14/14)</span>", "ID": "b627ba47-be6c-4505-9941-2d197bb12837", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "100% (14/14)", "ParentId": "6a38dc94-dde0-4026-b250-65f290f52f77"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span></p>\n</td>", "ID": "3ab57ea7-e269-4246-aa66-9249d6b0e1a6", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d4001594-9fe3-48f6-8adb-684a76cc6efa"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span></p>", "ID": "f86882be-7efb-4b16-809a-5f3f957780a8", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "3ab57ea7-e269-4246-aa66-9249d6b0e1a6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>88% (14/16)</span>", "ID": "f7a1f06c-7066-467f-812f-11a728804f8b", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "88% (14/16)", "ParentId": "f86882be-7efb-4b16-809a-5f3f957780a8"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span></p>\n</td>\n</tr>", "ID": "66ad4d04-02c1-4ddc-943c-f8eaa8a0539e", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>", "ID": "8560868d-15af-43fc-8d85-b50da929bd1a", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "66ad4d04-02c1-4ddc-943c-f8eaa8a0539e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>", "ID": "5ab38378-e767-4920-ab6d-42c164063d90", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8560868d-15af-43fc-8d85-b50da929bd1a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b>", "ID": "f85e0153-6a70-482d-a8d0-c4e4c56cd048", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ab38378-e767-4920-ab6d-42c164063d90"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span>", "ID": "1d2c471f-960d-4033-a188-864fceea86a1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a03", "ParentId": "f85e0153-6a70-482d-a8d0-c4e4c56cd048"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span></p>\n</td>", "ID": "1ed7a1b5-41bb-4035-a42c-b194974819fe", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "66ad4d04-02c1-4ddc-943c-f8eaa8a0539e"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span></p>", "ID": "56826531-be8a-4b9b-8af5-1ef1014dd674", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "1ed7a1b5-41bb-4035-a42c-b194974819fe"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (7/14)</span>", "ID": "67bc3e96-d237-41c8-8319-5edbda811a6d", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "50% (7/14)", "ParentId": "56826531-be8a-4b9b-8af5-1ef1014dd674"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span></p>\n</td>", "ID": "0437a4d6-74f9-4486-b7a8-5f2e55a2e34b", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "66ad4d04-02c1-4ddc-943c-f8eaa8a0539e"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span></p>", "ID": "39dcff3b-71e8-48c6-99b3-703bad083938", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "0437a4d6-74f9-4486-b7a8-5f2e55a2e34b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>85% (11/13)</span>", "ID": "cf960ea0-7a97-4848-8b4a-a044f4c11085", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "85% (11/13)", "ParentId": "39dcff3b-71e8-48c6-99b3-703bad083938"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span></p>\n</td>", "ID": "9ff4d66b-86ce-4cb7-9fe2-e1ed3548aab0", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "66ad4d04-02c1-4ddc-943c-f8eaa8a0539e"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span></p>", "ID": "7ec67654-6874-4f93-9574-a1a143509cbb", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "9ff4d66b-86ce-4cb7-9fe2-e1ed3548aab0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>50% (6/12)</span>", "ID": "c818b3be-8e52-4a0b-a924-6dc19d6c6fd6", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "50% (6/12)", "ParentId": "7ec67654-6874-4f93-9574-a1a143509cbb"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b></p>\n</td>\n<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span></p>\n</td>\n<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span></p>\n</td>\n</tr>", "ID": "172ba711-ded2-44cd-be9b-38d7a95eeec7", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "ca799ae3-4006-45b1-98ab-7a08328815a0"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b></p>\n</td>", "ID": "7093f1bc-9081-404c-831e-b204adaca393", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "172ba711-ded2-44cd-be9b-38d7a95eeec7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b></p>", "ID": "1b7be92e-4ab9-4b34-8523-941f7fe5abf8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7093f1bc-9081-404c-831e-b204adaca393"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span></b>", "ID": "cf78b461-be2a-4dd9-bbbb-4d1470772bf3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b7be92e-4ab9-4b34-8523-941f7fe5abf8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a02, 4 and 6</span>", "ID": "ae2ffd16-b835-41e8-a5ba-40a359651883", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a02, 4 and 6", "ParentId": "cf78b461-be2a-4dd9-bbbb-4d1470772bf3"}, {"Element": "<td style=\"width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span></p>\n</td>", "ID": "023d4cc6-fe01-429f-94d5-8144070f977a", "Styles": "width:117.6pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "172ba711-ded2-44cd-be9b-38d7a95eeec7"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span></p>", "ID": "c70d13dd-c411-49df-a275-7f4023b56b51", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "023d4cc6-fe01-429f-94d5-8144070f977a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (8/8)<sup>a</sup></span>", "ID": "172db7d0-af64-4bfc-a8b0-a60b46c3e509", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "100% (8/8)", "ParentId": "c70d13dd-c411-49df-a275-7f4023b56b51"}, {"Element": "<sup>a</sup>", "ID": "34eb8668-a137-4cdf-9e36-885a53a1878f", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "172db7d0-af64-4bfc-a8b0-a60b46c3e509"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span></p>\n</td>", "ID": "82f5a972-72e9-4e2e-8ac1-0cc044f3d697", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "172ba711-ded2-44cd-be9b-38d7a95eeec7"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span></p>", "ID": "1d8d60d0-c3c5-4780-bbb3-8ec3f0654be9", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "82f5a972-72e9-4e2e-8ac1-0cc044f3d697"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>100% (6/6)<sup>b</sup></span>", "ID": "d6e45513-69be-48f6-bdea-9a5eb180e0d1", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "100% (6/6)", "ParentId": "1d8d60d0-c3c5-4780-bbb3-8ec3f0654be9"}, {"Element": "<sup>b</sup>", "ID": "4aa27d6f-cebb-4ed1-a641-1035d724850a", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "d6e45513-69be-48f6-bdea-9a5eb180e0d1"}, {"Element": "<td style=\"width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"180\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span></p>\n</td>", "ID": "8aedf555-320b-45cb-b098-045e6bdf6e1c", "Styles": "width:134.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "172ba711-ded2-44cd-be9b-38d7a95eeec7"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span></p>", "ID": "203fa2ee-f7ac-46bb-b998-ba40aeb59469", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "8aedf555-320b-45cb-b098-045e6bdf6e1c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>86% (6/7)<sup>c</sup></span>", "ID": "49cad98f-791e-4300-ae44-b03ad2de64a2", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "86% (6/7)", "ParentId": "203fa2ee-f7ac-46bb-b998-ba40aeb59469"}, {"Element": "<sup>c</sup>", "ID": "d20bbe7f-2edd-4f55-85c5-98f7cdfb455c", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "49cad98f-791e-4300-ae44-b03ad2de64a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a04 for genotype\u00a04.</span></p>", "ID": "d658b494-4381-47ef-96ba-5d3193c38014", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">a\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a04 for genotype\u00a04.</span>", "ID": "eeaf900c-9a74-499d-a115-334c96f180fe", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04 for genotype\u00a02 and n\u00a0=\u00a04 for genotype\u00a04.", "ParentId": "d658b494-4381-47ef-96ba-5d3193c38014"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a02 for genotype\u00a04.</span></p>", "ID": "01c39391-2627-4e00-8af7-94741b048fb6", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">b\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02 and n\u00a0=\u00a02 for genotype\u00a04.</span>", "ID": "78643fad-53e1-46a4-89a8-f2100791373c", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 n\u00a0=\u00a04 for genotype\u00a02 and n\u00a0=\u00a02 for genotype\u00a04.", "ParentId": "01c39391-2627-4e00-8af7-94741b048fb6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02, n\u00a0=\u00a02 for genotype\u00a04 and n\u00a0=\u00a01\nfor genotype\u00a06.</span></p>", "ID": "e25c88fa-7e1b-4fe7-8c20-7749eb3da935", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">c\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04\nfor genotype\u00a02, n\u00a0=\u00a02 for genotype\u00a04 and n\u00a0=\u00a01\nfor genotype\u00a06.</span>", "ID": "670a379d-c94b-4524-a5a8-2efd81776780", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "c\u00a0\u00a0\u00a0\u00a0 n\u00a0=\u00a04 for genotype\u00a02, n\u00a0=\u00a02 for genotype\u00a04 and n\u00a0=\u00a01 for genotype\u00a06.", "ParentId": "e25c88fa-7e1b-4fe7-8c20-7749eb3da935"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d73ce73f-d640-48a8-af66-b5670e9735bd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b1739db-442a-4cca-8048-6f304ca22356", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d73ce73f-d640-48a8-af66-b5670e9735bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a015\npresents the virologic outcome for patients with genotype\u00a01 or 3 HCV\ninfection in the ASTRAL\u20114 study.</span></p>", "ID": "c6e860c7-0dc5-4bb9-aa2f-49f0078bd9d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table\u00a015\npresents the virologic outcome for patients with genotype\u00a01 or 3 HCV\ninfection in the ASTRAL\u20114 study.</span>", "ID": "ba4d426d-dce7-40d3-a0eb-ae039c1bac85", "Styles": "None", "Classes": "None", "Text": "Table\u00a015 presents the virologic outcome for patients with genotype\u00a01 or 3 HCV infection in the ASTRAL\u20114 study.", "ParentId": "c6e860c7-0dc5-4bb9-aa2f-49f0078bd9d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d5df7565-5276-435b-830f-f3b76029a6ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b1b665c-8611-4a78-ab40-3eee858c8ec3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d5df7565-5276-435b-830f-f3b76029a6ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No patients with\ngenotype\u00a02, 4 or 6 HCV infection experienced virologic failure.</span></p>", "ID": "91e634e4-a7c1-4e08-a7f7-ef65ac0e1f7c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No patients with\ngenotype\u00a02, 4 or 6 HCV infection experienced virologic failure.</span>", "ID": "03d8fd64-4a6c-4c7b-a3a4-8bf5aa84e24c", "Styles": "None", "Classes": "None", "Text": "No patients with genotype\u00a02, 4 or 6 HCV infection experienced virologic failure.", "ParentId": "91e634e4-a7c1-4e08-a7f7-ef65ac0e1f7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d1a20ff4-617b-4d09-aaa1-1b38acff5913", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67a3c85f-d280-4808-8742-1f3ef0d15ef6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d1a20ff4-617b-4d09-aaa1-1b38acff5913"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a015: Virologic outcome for patients with genotype\u00a01 and\n3 HCV infection in study ASTRAL\u20114</span></b></p>", "ID": "87f25c3a-d755-4750-b870-bfcf1b4874ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a015: Virologic outcome for patients with genotype\u00a01 and\n3 HCV infection in study ASTRAL\u20114</span></b>", "ID": "406f4d94-08ed-480c-8b4d-466d73e85408", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87f25c3a-d755-4750-b870-bfcf1b4874ef"}, {"Element": "<span lang=\"EN-GB\">Table\u00a015: Virologic outcome for patients with genotype\u00a01 and\n3 HCV infection in study ASTRAL\u20114</span>", "ID": "c5cd081a-6823-4a3a-a583-0674d1f572ee", "Styles": "None", "Classes": "None", "Text": "Table\u00a015: Virologic outcome for patients with genotype\u00a01 and 3 HCV infection in study ASTRAL\u20114", "ParentId": "406f4d94-08ed-480c-8b4d-466d73e85408"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:466.1pt;border-collapse:collapse;border:none\" width=\"621\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"4\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span></p>\n</td>\n</tr>\n</table>", "ID": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a", "Styles": "width:466.1pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "        ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "e52ce104-e98d-4405-bfb2-138c523fa0be", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td style=\"width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>\n</td>\n<td style=\"width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>\n</td>\n</tr>", "ID": "1c354e14-0555-4e25-b253-557e8e6d6d6a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "e52ce104-e98d-4405-bfb2-138c523fa0be"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "49583007-a00f-4501-8337-9f7622efd81b", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c354e14-0555-4e25-b253-557e8e6d6d6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "33b014a4-107a-4dfa-9ff6-e6dc72f7d1f4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "49583007-a00f-4501-8337-9f7622efd81b"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "895df8d8-5d16-4dc6-aa22-c789ba96dbe6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33b014a4-107a-4dfa-9ff6-e6dc72f7d1f4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "d22c2358-5110-48f3-b74c-cca03b026790", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "895df8d8-5d16-4dc6-aa22-c789ba96dbe6"}, {"Element": "<td style=\"width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>\n</td>", "ID": "ea2bb285-41d1-4dfc-b7ea-93b632ec7d64", "Styles": "width:103.4pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c354e14-0555-4e25-b253-557e8e6d6d6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b></p>", "ID": "a6a02e7e-d5ea-43c8-a23e-3a85bc364836", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ea2bb285-41d1-4dfc-b7ea-93b632ec7d64"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span></b>", "ID": "9e0d9e00-aef9-45ba-97cf-fa5bb5a34917", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a6a02e7e-d5ea-43c8-a23e-3a85bc364836"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 12\u00a0weeks</span>", "ID": "f7ec7370-d7d3-415e-b82f-98e618d01662", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 12\u00a0weeks", "ParentId": "9e0d9e00-aef9-45ba-97cf-fa5bb5a34917"}, {"Element": "<td style=\"width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>\n</td>", "ID": "e6a4344b-e74f-4921-b4ce-8402df4083d0", "Styles": "width:155.95pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c354e14-0555-4e25-b253-557e8e6d6d6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b></p>", "ID": "c5391d19-2d4f-4477-9cfb-50af965e90c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e6a4344b-e74f-4921-b4ce-8402df4083d0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span></b>", "ID": "0679f2df-a765-4bed-a94e-80b4801a473a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c5391d19-2d4f-4477-9cfb-50af965e90c5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa + RBV 12\u00a0weeks</span>", "ID": "ffbe507b-ba4b-4114-ad47-4f089fdf55bc", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa + RBV 12\u00a0weeks", "ParentId": "0679f2df-a765-4bed-a94e-80b4801a473a"}, {"Element": "<td style=\"width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>\n</td>", "ID": "84196269-ddd9-450d-a1f3-bb0aab79b8d2", "Styles": "width:127.55pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c354e14-0555-4e25-b253-557e8e6d6d6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b></p>", "ID": "511f74b0-ffcb-4281-aee9-d99f57c4e624", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84196269-ddd9-450d-a1f3-bb0aab79b8d2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span></b>", "ID": "97f321c0-103b-4953-bab2-f857b84f7370", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "511f74b0-ffcb-4281-aee9-d99f57c4e624"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa 24\u00a0weeks</span>", "ID": "7efa531d-38cc-4401-af6f-32a561bd48f8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa 24\u00a0weeks", "ParentId": "97f321c0-103b-4953-bab2-f857b84f7370"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"4\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span></p>\n</td>\n</tr>", "ID": "7e1e5630-47b2-41eb-adba-e53b89b13f6f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td colspan=\"4\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span></p>\n</td>", "ID": "36701fa2-da3b-419e-982c-f8aeaa08f7cc", "Styles": "width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7e1e5630-47b2-41eb-adba-e53b89b13f6f"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span></p>", "ID": "f448933c-1cde-4029-8d11-1b7d57dc9b06", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "36701fa2-da3b-419e-982c-f8aeaa08f7cc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Virologic failure (relapse and on-treatment failure)</span>", "ID": "615f65e3-7d35-445c-8985-e760df2ab264", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "Virologic failure (relapse and on-treatment failure)", "ParentId": "f448933c-1cde-4029-8d11-1b7d57dc9b06"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span></p>\n</td>\n</tr>", "ID": "d79874c1-e50d-4776-81a5-a2f8c8bdb3f2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b></p>\n</td>", "ID": "bc544266-2e37-4ecd-8ff1-0291110b6cc9", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d79874c1-e50d-4776-81a5-a2f8c8bdb3f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b></p>", "ID": "04d2e386-1358-4979-b09f-c029dad3375a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc544266-2e37-4ecd-8ff1-0291110b6cc9"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span></b>", "ID": "f9b23c28-bc8c-4a2c-befd-2e4b14a903f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04d2e386-1358-4979-b09f-c029dad3375a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a01<sup>a</sup></span>", "ID": "349296cd-8c67-4ac9-a3f5-682880b2f46d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a01", "ParentId": "f9b23c28-bc8c-4a2c-befd-2e4b14a903f2"}, {"Element": "<sup>a</sup>", "ID": "5e82340e-fde7-488d-9d42-f7a4a23c8252", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "349296cd-8c67-4ac9-a3f5-682880b2f46d"}, {"Element": "<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span></p>\n</td>", "ID": "71b90db4-caa1-49a3-b42e-a42ebc073dad", "Styles": "width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d79874c1-e50d-4776-81a5-a2f8c8bdb3f2"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span></p>", "ID": "a7d7a50f-fa7c-48b7-9941-b6290ce7da5b", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "71b90db4-caa1-49a3-b42e-a42ebc073dad"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>7% (5/68)</span>", "ID": "bf7e74c0-7d75-4476-b3a5-64c8f93253f6", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "7% (5/68)", "ParentId": "a7d7a50f-fa7c-48b7-9941-b6290ce7da5b"}, {"Element": "<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span></p>\n</td>", "ID": "6b3b0b77-f668-49f6-b71b-dcced125baef", "Styles": "width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d79874c1-e50d-4776-81a5-a2f8c8bdb3f2"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span></p>", "ID": "4037032e-3975-40da-853d-864b92c7ccad", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "6b3b0b77-f668-49f6-b71b-dcced125baef"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>1% (1/68)</span>", "ID": "bdb31212-1734-4e4f-bda8-012c96bf4a07", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "1% (1/68)", "ParentId": "4037032e-3975-40da-853d-864b92c7ccad"}, {"Element": "<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span></p>\n</td>", "ID": "d2697eba-83c5-4fe2-b55d-68581977afd7", "Styles": "width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d79874c1-e50d-4776-81a5-a2f8c8bdb3f2"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span></p>", "ID": "b4e1ea00-dfb3-4de8-a0e2-a9ee630b3a6d", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "d2697eba-83c5-4fe2-b55d-68581977afd7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (3/71)</span>", "ID": "22e6fec2-08b6-48e2-af12-1b7fe0b5057e", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "4% (3/71)", "ParentId": "b4e1ea00-dfb3-4de8-a0e2-a9ee630b3a6d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span></p>\n</td>\n</tr>", "ID": "11f37165-64eb-4e17-9b03-6ff8cda942ec", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>\n</td>", "ID": "95dbbfa5-8d3b-4c7e-ba85-d8c2f82b579c", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "11f37165-64eb-4e17-9b03-6ff8cda942ec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b></p>", "ID": "68e46d44-ee24-401d-a026-09113f7551a3", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "95dbbfa5-8d3b-4c7e-ba85-d8c2f82b579c"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span></b>", "ID": "32dfed9f-cf62-4d72-afbc-f051cea101bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68e46d44-ee24-401d-a026-09113f7551a3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a</span>", "ID": "00968993-c83d-40b3-9708-88b4edd01662", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01a", "ParentId": "32dfed9f-cf62-4d72-afbc-f051cea101bd"}, {"Element": "<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span></p>\n</td>", "ID": "aac2e3da-42c3-4379-a453-250bb4952f50", "Styles": "width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "11f37165-64eb-4e17-9b03-6ff8cda942ec"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span></p>", "ID": "84566d35-b14c-4225-a0e9-87491dccd17c", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "aac2e3da-42c3-4379-a453-250bb4952f50"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (3/50) </span>", "ID": "3871bec5-9a5d-4c08-9dab-d49f57c6e149", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "6% (3/50) ", "ParentId": "84566d35-b14c-4225-a0e9-87491dccd17c"}, {"Element": "<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span></p>\n</td>", "ID": "4b22a19b-be2a-477e-a7bc-755f659b6261", "Styles": "width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "11f37165-64eb-4e17-9b03-6ff8cda942ec"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span></p>", "ID": "28e5b84d-e6b2-4243-bf0a-dbfb6725671c", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "4b22a19b-be2a-477e-a7bc-755f659b6261"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (1/54)</span>", "ID": "bd8f84c4-5aa5-439b-9830-049f18f236b5", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "2% (1/54)", "ParentId": "28e5b84d-e6b2-4243-bf0a-dbfb6725671c"}, {"Element": "<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span></p>\n</td>", "ID": "b2a5714d-2e69-4f5f-a65c-ed52ea6a78d3", "Styles": "width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "11f37165-64eb-4e17-9b03-6ff8cda942ec"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span></p>", "ID": "cb5a4c37-a2f3-4cd9-b6d1-7a5e830604d0", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "b2a5714d-2e69-4f5f-a65c-ed52ea6a78d3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>4% (2/55)</span>", "ID": "3b6a4efa-e5ed-4495-9145-807f486c4b34", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "4% (2/55)", "ParentId": "cb5a4c37-a2f3-4cd9-b6d1-7a5e830604d0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span></p>\n</td>\n</tr>", "ID": "45cdff95-4426-4bc0-be29-b3a5f1089613", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>\n</td>", "ID": "41ebe6c9-f3c1-4244-b49e-7a19bb89ebeb", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "45cdff95-4426-4bc0-be29-b3a5f1089613"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b></p>", "ID": "65f55873-5b0b-46c9-bce9-18b11f2278b2", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41ebe6c9-f3c1-4244-b49e-7a19bb89ebeb"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span></b>", "ID": "4f167101-4a92-4600-a238-0e8243921568", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65f55873-5b0b-46c9-bce9-18b11f2278b2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b</span>", "ID": "30617f9a-7420-4303-8182-8e675f9bf983", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 Genotype\u00a01b", "ParentId": "4f167101-4a92-4600-a238-0e8243921568"}, {"Element": "<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span></p>\n</td>", "ID": "1915fa0e-7dfa-4eea-8452-9b5fc72b3e8f", "Styles": "width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "45cdff95-4426-4bc0-be29-b3a5f1089613"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span></p>", "ID": "1f9040ad-8005-4a76-b0f8-eb31725ba206", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "1915fa0e-7dfa-4eea-8452-9b5fc72b3e8f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>11% (2/18)</span>", "ID": "6e7afcd4-1170-4eb6-800f-938ebe5efa84", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "11% (2/18)", "ParentId": "1f9040ad-8005-4a76-b0f8-eb31725ba206"}, {"Element": "<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span></p>\n</td>", "ID": "cbb678e8-d465-4f20-a35a-92daf8fb3120", "Styles": "width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "45cdff95-4426-4bc0-be29-b3a5f1089613"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span></p>", "ID": "35cb88db-f59a-4d35-9b2e-1651441c5ec9", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "cbb678e8-d465-4f20-a35a-92daf8fb3120"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>0% (0/14)</span>", "ID": "468fc99c-4f28-43d5-891d-bc64acad56ac", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "0% (0/14)", "ParentId": "35cb88db-f59a-4d35-9b2e-1651441c5ec9"}, {"Element": "<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span></p>\n</td>", "ID": "f42f897f-ddea-467f-a652-8708883ff57c", "Styles": "width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "45cdff95-4426-4bc0-be29-b3a5f1089613"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span></p>", "ID": "cfc6cae9-dafc-4cf0-8d59-db9a1780e768", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "f42f897f-ddea-467f-a652-8708883ff57c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>6% (1/16)</span>", "ID": "bcfed4db-d169-46dd-bf55-43a903767bee", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "6% (1/16)", "ParentId": "cfc6cae9-dafc-4cf0-8d59-db9a1780e768"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span></p>\n</td>\n</tr>", "ID": "d270d4a4-9cf0-4d8f-a3dd-486a8f35829f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>\n</td>", "ID": "837522ba-1652-4fa8-b991-e6b2e71cc9fc", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d270d4a4-9cf0-4d8f-a3dd-486a8f35829f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b></p>", "ID": "af47497a-af9b-4a45-be12-ada50c5e2716", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "837522ba-1652-4fa8-b991-e6b2e71cc9fc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span></b>", "ID": "58892e36-275e-4bbb-aa58-4165cbfb943d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af47497a-af9b-4a45-be12-ada50c5e2716"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Genotype\u00a03</span>", "ID": "a2a8c16f-9092-48f1-86d5-dcbee8750209", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Genotype\u00a03", "ParentId": "58892e36-275e-4bbb-aa58-4165cbfb943d"}, {"Element": "<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span></p>\n</td>", "ID": "77648e93-0fce-429b-928d-b4929a4eb384", "Styles": "width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d270d4a4-9cf0-4d8f-a3dd-486a8f35829f"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span></p>", "ID": "15cde2c2-cc23-4aef-9175-6474477d2067", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "77648e93-0fce-429b-928d-b4929a4eb384"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>43% (6/14)</span>", "ID": "6012e1c4-8993-4a5e-ad3c-0f0cf9deeb75", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "43% (6/14)", "ParentId": "15cde2c2-cc23-4aef-9175-6474477d2067"}, {"Element": "<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span></p>\n</td>", "ID": "0dc61743-1754-48d7-9d14-4e7816a6876e", "Styles": "width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d270d4a4-9cf0-4d8f-a3dd-486a8f35829f"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span></p>", "ID": "5aad13cd-343a-419f-b560-6049fed9ec65", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "0dc61743-1754-48d7-9d14-4e7816a6876e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>15% (2<sup>b</sup>/13)</span>", "ID": "70a84ff8-621f-417e-ab67-0bcc3e13de44", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "15% (2/13)", "ParentId": "5aad13cd-343a-419f-b560-6049fed9ec65"}, {"Element": "<sup>b</sup>", "ID": "cb2837ae-33e3-4f77-8ad5-2717807ce65a", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "70a84ff8-621f-417e-ab67-0bcc3e13de44"}, {"Element": "<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span></p>\n</td>", "ID": "9ce120cd-12c6-4b8e-ab90-5ffddd80ceea", "Styles": "width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d270d4a4-9cf0-4d8f-a3dd-486a8f35829f"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span></p>", "ID": "65785c8b-891b-4f04-973a-8b874887fbe6", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "9ce120cd-12c6-4b8e-ab90-5ffddd80ceea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>42% (5<sup>c</sup>/12)</span>", "ID": "c03ccd84-f02b-43e4-b331-dc77ba86a3e0", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "42% (5/12)", "ParentId": "65785c8b-891b-4f04-973a-8b874887fbe6"}, {"Element": "<sup>c</sup>", "ID": "37f5f71e-6fc0-4fa5-91ea-264a3d889218", "Styles": "None", "Classes": "None", "Text": "c", "ParentId": "c03ccd84-f02b-43e4-b331-dc77ba86a3e0"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b></p>\n</td>\n<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span></p>\n</td>\n<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span></p>\n</td>\n<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span></p>\n</td>\n</tr>", "ID": "7730d98f-4c46-4628-8af4-4b2efba7c378", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "2f090ea5-8dbc-4dd9-9200-35a8cd97593a"}, {"Element": "<td style=\"width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"106\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b></p>\n</td>", "ID": "4b97d6e4-4a56-46ac-883b-de840979c7a2", "Styles": "width:1.1in;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7730d98f-4c46-4628-8af4-4b2efba7c378"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b></p>", "ID": "339a561a-433c-4c05-a0fe-c74a7d5c1c1b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4b97d6e4-4a56-46ac-883b-de840979c7a2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span></b>", "ID": "985de025-1fd0-4fd0-9754-d8c686e2d3a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "339a561a-433c-4c05-a0fe-c74a7d5c1c1b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>d</sup></span>", "ID": "4299600a-2cf5-4a1f-800e-b9cfd3b43585", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other", "ParentId": "985de025-1fd0-4fd0-9754-d8c686e2d3a1"}, {"Element": "<sup>d</sup>", "ID": "1bd836a5-b2e0-4a26-ae64-4203fa61a13d", "Styles": "None", "Classes": "None", "Text": "d", "ParentId": "4299600a-2cf5-4a1f-800e-b9cfd3b43585"}, {"Element": "<td style=\"width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"138\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span></p>\n</td>", "ID": "18c9aefb-1cf5-4a01-8402-e14fb7192265", "Styles": "width:103.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7730d98f-4c46-4628-8af4-4b2efba7c378"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span></p>", "ID": "3e3cd5b2-9649-43c6-adce-1cdba4a3070e", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "18c9aefb-1cf5-4a01-8402-e14fb7192265"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/82)</span>", "ID": "b9f95cfc-dd66-4da8-9e49-37daaad263a6", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "5% (4/82)", "ParentId": "3e3cd5b2-9649-43c6-adce-1cdba4a3070e"}, {"Element": "<td style=\"width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"208\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span></p>\n</td>", "ID": "8b94fe2a-2bf1-41ff-932b-290c55f3f2e4", "Styles": "width:155.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7730d98f-4c46-4628-8af4-4b2efba7c378"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span></p>", "ID": "b72a5356-af01-4d8a-b4fd-906b9eb72969", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "8b94fe2a-2bf1-41ff-932b-290c55f3f2e4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>2% (2/81)</span>", "ID": "65701791-452e-4084-a578-bbec00e484a5", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "2% (2/81)", "ParentId": "b72a5356-af01-4d8a-b4fd-906b9eb72969"}, {"Element": "<td style=\"width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"170\">\n<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span></p>\n</td>", "ID": "aae72c23-8580-483b-a526-90807d0d2aa8", "Styles": "width:127.55pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7730d98f-4c46-4628-8af4-4b2efba7c378"}, {"Element": "<p class=\"Table-Text\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span></p>", "ID": "92d54d98-4738-41e4-acf5-8f5bd869e7b5", "Styles": "margin:0in", "Classes": "['Table-Text']", "Text": "", "ParentId": "aae72c23-8580-483b-a526-90807d0d2aa8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>5% (4/83)</span>", "ID": "e9022e88-0a3a-4d69-bbd3-6ef7268d5da0", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "5% (4/83)", "ParentId": "92d54d98-4738-41e4-acf5-8f5bd869e7b5"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 No\npatients with genotype\u00a01 HCV had on-treatment virologic failure.</span></p>", "ID": "6a2cc268-1954-4ddd-961b-bb41b419e928", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 No\npatients with genotype\u00a01 HCV had on-treatment virologic failure.</span>", "ID": "2561d78c-6d64-4b3f-a206-85838ebd94a8", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 No patients with genotype\u00a01 HCV had on-treatment virologic failure.", "ParentId": "6a2cc268-1954-4ddd-961b-bb41b419e928"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure; pharmacokinetic data from this\npatient was consistent with non-adherence to treatment.</span></p>", "ID": "26a67bf7-b945-4295-bcc1-f16967942185", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure; pharmacokinetic data from this\npatient was consistent with non-adherence to treatment.</span>", "ID": "433c46ca-33cf-4ac3-b157-37bccbb5e26c", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 One patient had on-treatment virologic failure; pharmacokinetic data from this patient was consistent with non-adherence to treatment.", "ParentId": "26a67bf7-b945-4295-bcc1-f16967942185"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">c\u00a0\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure.</span></p>", "ID": "e063dd8e-d355-4892-8cd9-037823d42466", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">c\u00a0\u00a0\u00a0\u00a0 One\npatient had on-treatment virologic failure.</span>", "ID": "a3f9deb7-68a5-479e-9022-c241df803377", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "c\u00a0\u00a0\u00a0\u00a0 One patient had on-treatment virologic failure.", "ParentId": "e063dd8e-d355-4892-8cd9-037823d42466"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">d\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>", "ID": "058e3aa3-9cbb-4c03-8b82-56c1fead0aeb", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">d\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span>", "ID": "7dc936ff-418f-4e8a-a88f-b361e4a81956", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "d\u00a0\u00a0\u00a0 Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.", "ParentId": "058e3aa3-9cbb-4c03-8b82-56c1fead0aeb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6949744b-3780-4326-9245-3d12268d6250", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "361bd4c9-0e12-4a35-ae17-8cd117cae96e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6949744b-3780-4326-9245-3d12268d6250"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Changes in the\nparameters found in the CPT score system in patients achieving SVR12 in ASTRAL\u20114\n(all 3 regimens) are shown in Table\u00a016.</span></p>", "ID": "ce52eb57-9833-4df0-a2d1-075af455115b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Changes in the\nparameters found in the CPT score system in patients achieving SVR12 in ASTRAL\u20114\n(all 3 regimens) are shown in Table\u00a016.</span>", "ID": "802aa9f7-c7fa-4100-a781-8e423f150357", "Styles": "None", "Classes": "None", "Text": "Changes in the parameters found in the CPT score system in patients achieving SVR12 in ASTRAL\u20114 (all 3 regimens) are shown in Table\u00a016.", "ParentId": "ce52eb57-9833-4df0-a2d1-075af455115b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "84542afd-a871-4249-82f1-ea655bb67ac9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d831a369-3020-4d08-adb0-08746dbc1273", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "84542afd-a871-4249-82f1-ea655bb67ac9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a016: Changes in CPT score parameters from baseline to week\u00a012\nand 24 post\u2011treatment in patients achieving SVR12, ASTRAL\u20114</span></b></p>", "ID": "e867505e-2c14-419f-89f3-c7a5b057907f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a016: Changes in CPT score parameters from baseline to week\u00a012\nand 24 post\u2011treatment in patients achieving SVR12, ASTRAL\u20114</span></b>", "ID": "405fddf8-f935-4efb-afa3-58760b59921e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e867505e-2c14-419f-89f3-c7a5b057907f"}, {"Element": "<span lang=\"EN-GB\">Table\u00a016: Changes in CPT score parameters from baseline to week\u00a012\nand 24 post\u2011treatment in patients achieving SVR12, ASTRAL\u20114</span>", "ID": "d19b5cb8-b6e4-491c-978e-7044a5ec2ee8", "Styles": "None", "Classes": "None", "Text": "Table\u00a016: Changes in CPT score parameters from baseline to week\u00a012 and 24 post\u2011treatment in patients achieving SVR12, ASTRAL\u20114", "ParentId": "405fddf8-f935-4efb-afa3-58760b59921e"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>\n</td>\n<td style=\"width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;\n  border-left:solid windowtext 1.0pt;border-bottom:solid black 1.0pt;\n  border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:\n  solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n</tr>\n</table>", "ID": "6b71fa40-0f4d-4581-947f-cc110de59005", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "            ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>\n</td>\n<td style=\"width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>\n</td>\n</tr>\n</thead>", "ID": "be6d1702-ec02-4b7f-bf6f-2010dc50e505", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>\n</td>\n<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>\n</td>\n<td style=\"width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>\n</td>\n<td style=\"width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>\n</td>\n</tr>", "ID": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "be6d1702-ec02-4b7f-bf6f-2010dc50e505"}, {"Element": "<td style=\"width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>\n</td>", "ID": "09770120-34a6-410a-b146-e9c60fe547cc", "Styles": "width:115.9pt;border-top:windowtext;\n   border-left:windowtext;border-bottom:black;border-right:black;border-style:\n   solid;border-width:1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></p>", "ID": "11b6e68f-8462-4461-9e34-506d9662c03d", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "09770120-34a6-410a-b146-e9c60fe547cc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "b535a42c-79b6-4f6b-9225-c37e9fa8bcab", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "11b6e68f-8462-4461-9e34-506d9662c03d"}, {"Element": "<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>\n</td>", "ID": "8eb71346-6100-4df9-b581-34726548b7e7", "Styles": "width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b></p>", "ID": "97a9e96e-1115-47f5-a251-ff3ab135a487", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8eb71346-6100-4df9-b581-34726548b7e7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span></b>", "ID": "df263968-b32f-444e-ac2f-39c92b88e787", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "97a9e96e-1115-47f5-a251-ff3ab135a487"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">lb</span><span style=\"letter-spacing:.1pt\">u</span><span style=\"letter-spacing:-.15pt\">m</span><span style=\"letter-spacing:.1pt\">i</span>n</span>", "ID": "83434f4b-6483-4dbe-adaa-df492722acd8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "An", "ParentId": "df263968-b32f-444e-ac2f-39c92b88e787"}, {"Element": "<span style=\"letter-spacing:-.05pt\">lb</span>", "ID": "6887f556-b448-46b4-9ba6-77a15db97247", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "lb", "ParentId": "83434f4b-6483-4dbe-adaa-df492722acd8"}, {"Element": "<span style=\"letter-spacing:.1pt\">u</span>", "ID": "86378335-057a-439d-8d02-32879b5b1a9b", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "u", "ParentId": "83434f4b-6483-4dbe-adaa-df492722acd8"}, {"Element": "<span style=\"letter-spacing:-.15pt\">m</span>", "ID": "fb7e72b8-7dc6-44fe-8ce2-637705902809", "Styles": "letter-spacing:-.15pt", "Classes": "None", "Text": "m", "ParentId": "83434f4b-6483-4dbe-adaa-df492722acd8"}, {"Element": "<span style=\"letter-spacing:.1pt\">i</span>", "ID": "d64697f9-547b-4ee2-ae94-bf0356527073", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "i", "ParentId": "83434f4b-6483-4dbe-adaa-df492722acd8"}, {"Element": "<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>\n</td>", "ID": "28f0b219-6ae3-4c2f-8ac5-48da6218c341", "Styles": "width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b></p>", "ID": "343e9813-e79c-4623-8f45-7f60c69a67c4", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "28f0b219-6ae3-4c2f-8ac5-48da6218c341"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span></b>", "ID": "32205332-d1fc-4bd7-88b0-aa2f7ca598df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "343e9813-e79c-4623-8f45-7f60c69a67c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">B</span>", "ID": "aace3715-39f0-4577-a483-5d630fe62303", "Styles": "font-size:10.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "B", "ParentId": "32205332-d1fc-4bd7-88b0-aa2f7ca598df"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span></b>", "ID": "a73b2d43-9b4b-4c50-bf5f-9f122433bde8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "343e9813-e79c-4623-8f45-7f60c69a67c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">ili</span>", "ID": "886acb9a-8af6-406d-97dc-38528a66b4e2", "Styles": "font-size:10.0pt;letter-spacing:-.05pt", "Classes": "None", "Text": "ili", "ParentId": "a73b2d43-9b4b-4c50-bf5f-9f122433bde8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span></b>", "ID": "9da149b9-2f36-418c-ad17-021911d94b34", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "343e9813-e79c-4623-8f45-7f60c69a67c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">r<span style=\"letter-spacing:-.05pt\">ubi</span>n</span>", "ID": "42483193-9e6b-43f6-9387-cdccafb5fa81", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "rn", "ParentId": "9da149b9-2f36-418c-ad17-021911d94b34"}, {"Element": "<span style=\"letter-spacing:-.05pt\">ubi</span>", "ID": "89f27b80-cd12-41b7-9854-878df232878f", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "ubi", "ParentId": "42483193-9e6b-43f6-9387-cdccafb5fa81"}, {"Element": "<td style=\"width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>\n</td>", "ID": "810e04f1-1189-492d-b8a2-e25c7e0d59b0", "Styles": "width:69.65pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b></p>", "ID": "2e038f6c-ed1b-4a15-b0a6-8a15e2e754dd", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "810e04f1-1189-492d-b8a2-e25c7e0d59b0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span></b>", "ID": "c5dbbb6d-9010-412f-94e9-d72185a5fcff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2e038f6c-ed1b-4a15-b0a6-8a15e2e754dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">I</span>", "ID": "07ac4309-eb88-4e19-ba3e-4d97388d21a7", "Styles": "font-size:10.0pt;letter-spacing:-.05pt", "Classes": "None", "Text": "I", "ParentId": "c5dbbb6d-9010-412f-94e9-d72185a5fcff"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span></b>", "ID": "e4785561-d74f-491e-b466-c0420620cd37", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2e038f6c-ed1b-4a15-b0a6-8a15e2e754dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">NR</span>", "ID": "b0e4cfa3-2a44-441d-bd5c-88c0e8ad5a34", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "NR", "ParentId": "e4785561-d74f-491e-b466-c0420620cd37"}, {"Element": "<td style=\"width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>\n</td>", "ID": "e24fc36e-c106-4f16-a37c-f141c57f9d4a", "Styles": "width:56.2pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b></p>", "ID": "9f6bcfab-80e8-4790-8c67-031d3b3d3789", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e24fc36e-c106-4f16-a37c-f141c57f9d4a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span></b>", "ID": "8b576019-c5d6-4a03-80f7-1626c5cdf70e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9f6bcfab-80e8-4790-8c67-031d3b3d3789"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">A<span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:-.05pt\">i</span>tes</span>", "ID": "8948ece9-5244-4152-8b44-022229204119", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Actes", "ParentId": "8b576019-c5d6-4a03-80f7-1626c5cdf70e"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "d3d6e6de-b9aa-496b-8bbf-ae0d101f02f8", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "8948ece9-5244-4152-8b44-022229204119"}, {"Element": "<span style=\"letter-spacing:-.05pt\">i</span>", "ID": "0583e658-80d2-4c0d-9c16-f54f9b730cde", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "i", "ParentId": "8948ece9-5244-4152-8b44-022229204119"}, {"Element": "<td style=\"width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>\n</td>", "ID": "3336f7b3-385b-4833-8716-50b74aa35706", "Styles": "width:85.05pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d65bade-0bd6-4ede-87c0-4f4c42662ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b></p>", "ID": "6cd4f488-a2e8-4ca0-a1db-882e5f8bb7e9", "Styles": "line-height:normal;page-break-after:avoid;\n   punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3336f7b3-385b-4833-8716-50b74aa35706"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span></b>", "ID": "50eb379e-9aaf-4c61-9363-f59007d717d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6cd4f488-a2e8-4ca0-a1db-882e5f8bb7e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">En</span>", "ID": "fb7a66d0-e16c-4b2c-a68c-7c37ef033e19", "Styles": "font-size:10.0pt;letter-spacing:-.05pt", "Classes": "None", "Text": "En", "ParentId": "50eb379e-9aaf-4c61-9363-f59007d717d0"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span></b>", "ID": "a77b9fe8-168b-48ff-8cca-372738296082", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6cd4f488-a2e8-4ca0-a1db-882e5f8bb7e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ce<span style=\"letter-spacing:.1pt\">p</span><span style=\"letter-spacing:-.05pt\">h</span><span style=\"letter-spacing:.05pt\">a</span><span style=\"letter-spacing:-.05pt\">l</span><span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.05pt\">p</span><span style=\"letter-spacing:.05pt\">a</span>t<span style=\"letter-spacing:-.05pt\">hy</span></span>", "ID": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "cet", "ParentId": "a77b9fe8-168b-48ff-8cca-372738296082"}, {"Element": "<span style=\"letter-spacing:.1pt\">p</span>", "ID": "e2d56b8a-bcbe-4e1c-8177-bbd0e394fb69", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "p", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:-.05pt\">h</span>", "ID": "c261066b-3e53-43e1-91e5-70818d0d2001", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "h", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:.05pt\">a</span>", "ID": "7bd4b322-e0da-43ed-a295-958723de8d73", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "a", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:-.05pt\">l</span>", "ID": "eddb8c5f-4683-4860-8025-d81b0e71eaf2", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "l", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "17e69ad6-b141-47ba-bac3-0d01c41a407b", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:-.05pt\">p</span>", "ID": "08e77dae-d8e4-4b08-85ef-3c0d189d56c3", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "p", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:.05pt\">a</span>", "ID": "c10bc5e5-1560-4a0a-a7da-fb90b9f988a8", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "a", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<span style=\"letter-spacing:-.05pt\">hy</span>", "ID": "cbcf41d2-24d1-4528-a0b7-69f669ee9740", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "hy", "ParentId": "40f53f9f-23a3-41c2-9255-f2c10f58fe5b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b></p>\n</td>\n</tr>", "ID": "82c8e7e2-85ed-46f7-86da-7e87bac5a8ed", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td colspan=\"6\" style=\"width:466.1pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b></p>\n</td>", "ID": "feaa9fe9-d3ae-4806-9407-7e8d5d5b6ab7", "Styles": "width:466.1pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "82c8e7e2-85ed-46f7-86da-7e87bac5a8ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b></p>", "ID": "bc145598-5a04-4859-bdb7-ff9a62091399", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "feaa9fe9-d3ae-4806-9407-7e8d5d5b6ab7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b>", "ID": "ef53ae07-0c9e-44c6-a55a-77307ef2b9d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc145598-5a04-4859-bdb7-ff9a62091399"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span>", "ID": "d8e2161f-ae73-40ac-a080-a0c3b79e6282", "Styles": "font-size:10.0pt;letter-spacing:.1pt", "Classes": "None", "Text": "P", "ParentId": "ef53ae07-0c9e-44c6-a55a-77307ef2b9d2"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b>", "ID": "8f43aab6-acf5-4c08-b4f0-1749824a8a12", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc145598-5a04-4859-bdb7-ff9a62091399"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span>", "ID": "686de9b7-086c-4b27-ba72-240319e5199d", "Styles": "font-size:10.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "8f43aab6-acf5-4c08-b4f0-1749824a8a12"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b>", "ID": "41964b41-c5fe-4172-90de-4d22639d35b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc145598-5a04-4859-bdb7-ff9a62091399"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span>", "ID": "2c7c3eb4-5b39-42c5-9436-4e204fef9440", "Styles": "font-size:10.0pt;letter-spacing:-.05pt", "Classes": "None", "Text": "st\u2011t", "ParentId": "41964b41-c5fe-4172-90de-4d22639d35b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span></b>", "ID": "8a79680e-282b-455b-905b-aa307182f817", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc145598-5a04-4859-bdb7-ff9a62091399"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">1</span>2<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.05pt\">\n  %</span><span style=\"letter-spacing:-.3pt\"> (</span><span style=\"letter-spacing:\n  -.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)<span style=\"letter-spacing:-.3pt\"> </span></span>", "ID": "8458e5d4-8f4f-488d-866b-474c9f603385", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "reateek2(N\u00a0=\u00a0),N)", "ParentId": "8a79680e-282b-455b-905b-aa307182f817"}, {"Element": "<span style=\"letter-spacing:-.05pt\">t</span>", "ID": "c2989175-4929-407b-95c1-20c94564da20", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "t", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.25pt\">m</span>", "ID": "4ca7a10b-c230-4e9c-a489-eca58dcb0325", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": "m", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "306862f8-f011-4ef3-957f-f98119a757c4", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "2b1fb910-2fd6-4aa6-aeb9-e28149c01b82", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "6fb27e9a-8fde-4611-9db0-9691b1af754c", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:.05pt\">W</span>", "ID": "a6672b5e-1f1c-4b51-893a-d66b0a96cf5e", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "W", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.35pt\">\u00a0</span>", "ID": "3a4581e7-5c4b-4313-bfc5-1c41b73e343c", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": "\u00a0", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "2286fbb0-5fcf-4259-8f71-a7291f45d609", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "d076fc1f-7ede-4aed-b8cf-9ea57578b61f", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:.05pt\">236</span>", "ID": "82d1ffc6-4608-4af5-bd15-c6cdf1329a7c", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "236", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.05pt\">\n  %</span>", "ID": "6076befb-3148-497b-815b-fe6a3ab3c793", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "   %", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> (</span>", "ID": "e2f1f4ab-cf2f-4774-beee-d246bfd5c948", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " (", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:\n  -.1pt\">n</span>", "ID": "de8a437d-1ba6-494a-a8b7-9b94b4dcce30", "Styles": "letter-spacing:\n  -.1pt", "Classes": "None", "Text": "n", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.05pt\">/</span>", "ID": "a834430d-01f7-4b3a-a75a-59ac2c344ba0", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "/", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "9483510c-a0d2-45a7-a880-52da9d83f320", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8458e5d4-8f4f-488d-866b-474c9f603385"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n</tr>", "ID": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>", "ID": "75b1d453-0802-4df7-bbbb-1cfe221c5f2b", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>", "ID": "d40b9608-f942-46d3-b650-3d9d27d6aaa4", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75b1d453-0802-4df7-bbbb-1cfe221c5f2b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span>", "ID": "197e2465-055e-4c23-b383-86d1237714a7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Decreaedcre (Ir)", "ParentId": "d40b9608-f942-46d3-b650-3d9d27d6aaa4"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "bbc25077-a815-447c-b7f3-a3286deeecbc", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.6pt\"> </span>", "ID": "0daf1007-ac6c-4c0b-bc95-9797da47cb84", "Styles": "letter-spacing:-.6pt", "Classes": "None", "Text": " ", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "c5bbddc0-2c07-4016-aef3-2221d6f9f74d", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "79d99f16-ac2c-4429-9d60-58959f94e46d", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.25pt\">m</span>", "ID": "692811ac-9c42-45b1-8cb5-745a234a70f1", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": "m", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:.05pt\">p</span>", "ID": "23accf4a-960a-4182-9c97-c7a6235ab7e3", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "p", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "ff03055d-25a7-462c-b1e2-de4b86bd4309", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">v</span>", "ID": "c4ec6cb9-8321-4005-9b72-569fea0ee2d4", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "v", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "bab26901-874c-4a16-8bc5-015bfee74a25", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">m</span>", "ID": "62bbc22d-600c-4a0a-8323-ba479b9555e0", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "m", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "04a96543-054e-4c65-84b4-9e28a3481442", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "68cb2e94-5bd4-46e4-b55a-885413f1f495", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<span style=\"letter-spacing:-.05pt\">t</span>", "ID": "c3486d21-1176-4387-8bb1-e73c58107d65", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "t", "ParentId": "197e2465-055e-4c23-b383-86d1237714a7"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "1e030f93-68ad-47fa-ae72-9a590cc4d414", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "8a37e0ff-e588-49dd-a7df-243306f96053", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e030f93-68ad-47fa-ae72-9a590cc4d414"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">34</span>", "ID": "48bbbacf-d99b-4936-bac9-f762f876c1cb", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "34", "ParentId": "8a37e0ff-e588-49dd-a7df-243306f96053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "56fe2de3-d335-49f9-9124-b975f3307543", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "8a37e0ff-e588-49dd-a7df-243306f96053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span>", "ID": "0b5547f3-8e9e-4465-9032-9270601bd877", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "8a37e0ff-e588-49dd-a7df-243306f96053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "bc8636c7-a633-4b21-a8c7-6551fb86726f", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "8a37e0ff-e588-49dd-a7df-243306f96053"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">79</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "c825dc15-2f0e-4bf0-8265-c2619dbb3804", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (9)", "ParentId": "8a37e0ff-e588-49dd-a7df-243306f96053"}, {"Element": "<span style=\"letter-spacing:.05pt\">79</span>", "ID": "eaa94fbe-10a8-439e-8ad1-31b77aa6a5d7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "79", "ParentId": "c825dc15-2f0e-4bf0-8265-c2619dbb3804"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "9ef080a1-98df-46c0-8117-ec85cb21d757", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "c825dc15-2f0e-4bf0-8265-c2619dbb3804"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "7661cdf1-adc6-4aa3-9d2d-a21d2a411a90", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "c825dc15-2f0e-4bf0-8265-c2619dbb3804"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "cad96bd7-d249-46b7-a350-cd2978a0ad13", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "c825dc15-2f0e-4bf0-8265-c2619dbb3804"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "138d4dc5-c53d-4b33-97a0-31a0e66af602", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "6bbf772a-161f-46e7-b535-e947f017efeb", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "138d4dc5-c53d-4b33-97a0-31a0e66af602"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">17</span>", "ID": "157f4c1e-c7b7-4f98-9322-e690359dcccb", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "17", "ParentId": "6bbf772a-161f-46e7-b535-e947f017efeb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "cb9209c2-7c5e-41e6-acf3-885e8205f90e", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "6bbf772a-161f-46e7-b535-e947f017efeb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span>", "ID": "42993124-7d11-4931-9ed8-c3823b5e5bed", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "9", "ParentId": "6bbf772a-161f-46e7-b535-e947f017efeb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "ac6bd506-2623-4679-b382-77a9fd34d04e", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "6bbf772a-161f-46e7-b535-e947f017efeb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">41</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "cc27aa8d-4b37-4306-b2ae-efa7a5dd430e", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (9)", "ParentId": "6bbf772a-161f-46e7-b535-e947f017efeb"}, {"Element": "<span style=\"letter-spacing:.05pt\">41</span>", "ID": "08fe45c2-f944-40db-b474-365f422ee3b9", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "41", "ParentId": "cc27aa8d-4b37-4306-b2ae-efa7a5dd430e"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "1b4bf502-96ae-4850-9705-a7d06cd1913d", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "cc27aa8d-4b37-4306-b2ae-efa7a5dd430e"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "3f3b02be-b263-4166-b6c7-3036e1ba830c", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "cc27aa8d-4b37-4306-b2ae-efa7a5dd430e"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "1c02ee6d-ea66-48f3-9d3f-524906e4d160", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "cc27aa8d-4b37-4306-b2ae-efa7a5dd430e"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "394af5c3-6605-4a26-bfa7-a9f0e9889388", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "5720cbd7-0388-4e8a-a011-3d8a7706ed47", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "394af5c3-6605-4a26-bfa7-a9f0e9889388"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "1a8a6f8d-2c61-47eb-9905-29965abe9676", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "5720cbd7-0388-4e8a-a011-3d8a7706ed47"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "1211505b-e51a-4228-8e66-d7b48324d99d", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "5720cbd7-0388-4e8a-a011-3d8a7706ed47"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "4be78cf1-28bc-45fb-bc69-59a5cf5304b7", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "5720cbd7-0388-4e8a-a011-3d8a7706ed47"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "5e52cc5a-fde4-44ab-a32b-32c8c7bbb085", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "5720cbd7-0388-4e8a-a011-3d8a7706ed47"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "e5fa2672-bf99-4bd9-b08b-eaf3b6cf0776", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/9)", "ParentId": "5720cbd7-0388-4e8a-a011-3d8a7706ed47"}, {"Element": "<span style=\"letter-spacing:.05pt\">5</span>", "ID": "d6fe6e23-ef15-49f7-84c9-d6ac69afe289", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "e5fa2672-bf99-4bd9-b08b-eaf3b6cf0776"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "e2de47e3-d5dd-4008-a66b-490aaf96c3bc", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "e5fa2672-bf99-4bd9-b08b-eaf3b6cf0776"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "0deb3669-5371-4beb-8027-415a24a007fd", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "e5fa2672-bf99-4bd9-b08b-eaf3b6cf0776"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "583e2ec4-80ec-43dd-b53b-1ff34d425cbc", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "851aa0f4-651b-4b60-9644-1daf07032a57", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "583e2ec4-80ec-43dd-b53b-1ff34d425cbc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">7</span>", "ID": "7dffebc1-5cf3-48c4-90aa-c9a4a2f30d1c", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "7", "ParentId": "851aa0f4-651b-4b60-9644-1daf07032a57"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">9</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (9)", "ParentId": "851aa0f4-651b-4b60-9644-1daf07032a57"}, {"Element": "<span style=\"letter-spacing:.05pt\">9</span>", "ID": "8ff7420d-37ae-4248-a9e1-6abece9a5175", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "9", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "74fc6c0e-7aa3-4e6c-8d4a-91b3c347f005", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<span style=\"letter-spacing:.05pt\">18</span>", "ID": "df911d41-c79e-4201-9dbd-90f0be4486b7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "18", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "4cd1ea24-9a75-4802-b13f-14115b4aa9ed", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "0def770f-3588-4195-b828-636bd4ec2ff7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "a5ceff17-fd3c-47d5-9d0c-2580b4f029fa", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "84f969c8-3f81-4f50-9c1a-dfd632b8dae6"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "fa1e76e7-28f6-4316-9e44-5c6b504dcd5f", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6208c72-89fd-4515-8ee7-a27e4d70f3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "5e6e5017-0df7-461a-b7ed-ee6ec9ab62e9", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa1e76e7-28f6-4316-9e44-5c6b504dcd5f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span>", "ID": "9ddc2a15-3f79-4174-8f06-e6d90369fcba", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "5e6e5017-0df7-461a-b7ed-ee6ec9ab62e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "088738ee-d654-4f13-8377-9db089990cb7", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (9)", "ParentId": "5e6e5017-0df7-461a-b7ed-ee6ec9ab62e9"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "508e0d5c-1005-42df-bfe3-dd3593f0fb29", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "91568086-307f-4484-a798-059b006bae0b", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<span style=\"letter-spacing:.05pt\">12</span>", "ID": "c43f8dd3-48ec-48c6-b6c9-1f96f6a307f0", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "12", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "0d2d300c-d76f-41c5-b82e-c4ff2ff4a308", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "e9fbcdf8-bebb-41bb-8cd6-d6a81183dfa6", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "33c954b4-5c3e-4add-a6ee-e3179210d178", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "088738ee-d654-4f13-8377-9db089990cb7"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>", "ID": "70203587-98fa-46a8-90b8-b48dbd8542a2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>", "ID": "136db79d-2c67-4a6a-93ac-7cb6b6296dfd", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>", "ID": "935c9af6-8126-44e5-ad9c-424bbbf58680", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "136db79d-2c67-4a6a-93ac-7cb6b6296dfd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span>", "ID": "590a33d6-80aa-434a-abb2-168e47cfde3c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Noca", "ParentId": "935c9af6-8126-44e5-ad9c-424bbbf58680"}, {"Element": "<span style=\"letter-spacing:-.4pt\"> </span>", "ID": "27db1de3-4995-40c9-8099-6380ae3089c6", "Styles": "letter-spacing:-.4pt", "Classes": "None", "Text": " ", "ParentId": "590a33d6-80aa-434a-abb2-168e47cfde3c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">h</span>", "ID": "7d6d565e-0c4f-45c2-8a0a-41376d299e3d", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "h", "ParentId": "590a33d6-80aa-434a-abb2-168e47cfde3c"}, {"Element": "<span style=\"letter-spacing:.05pt\">n</span>", "ID": "1ad6d95d-d709-4a2f-b605-d3ef0573b415", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "n", "ParentId": "590a33d6-80aa-434a-abb2-168e47cfde3c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">ge</span>", "ID": "9e6e3c03-1e06-47fe-b2d0-2de4ba679918", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "ge", "ParentId": "590a33d6-80aa-434a-abb2-168e47cfde3c"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "506696ff-951c-4099-b581-9ad87ed4c690", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "04e59c1d-2152-4824-97b1-35805e92ca76", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "506696ff-951c-4099-b581-9ad87ed4c690"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">6</span>", "ID": "4f33ad45-8700-4810-8341-4d474ae43978", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "6", "ParentId": "04e59c1d-2152-4824-97b1-35805e92ca76"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span>", "ID": "1a6f1ce0-869f-4382-bd9c-0bed39ea1167", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "0", "ParentId": "04e59c1d-2152-4824-97b1-35805e92ca76"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/9)", "ParentId": "04e59c1d-2152-4824-97b1-35805e92ca76"}, {"Element": "<span style=\"letter-spacing:.05pt\">3</span>", "ID": "376c41b9-b97c-471d-8b33-4006cf35c904", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "711493f9-08e1-4b55-9866-b10ede1839f2", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<span style=\"letter-spacing:.05pt\">13</span>", "ID": "3d854d30-66d4-4828-a35c-38cc95775843", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "13", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">8</span>", "ID": "a13e45fc-e84b-45c6-8212-c388f43820ef", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "805d5fcd-fe88-415b-ad99-8bfe6f165d08", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "7e9319e4-a369-4462-b5f3-0c6066c97b91", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "11ec7fb2-dbf8-49eb-a758-5c081b696fe5"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "2dc9f600-9e31-4c02-b127-4330c2df4790", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "7a91121d-a7fe-4446-8f85-253f8c276d65", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2dc9f600-9e31-4c02-b127-4330c2df4790"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">7</span>", "ID": "c6c781c3-1d8a-4909-978c-b295699780e1", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "7", "ParentId": "7a91121d-a7fe-4446-8f85-253f8c276d65"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span>", "ID": "f032f1f3-dbdd-440b-95ee-90559b66ec7c", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "7a91121d-a7fe-4446-8f85-253f8c276d65"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/9)", "ParentId": "7a91121d-a7fe-4446-8f85-253f8c276d65"}, {"Element": "<span style=\"letter-spacing:.05pt\">4</span>", "ID": "f3fb8b7a-256b-487a-92ee-575d52433732", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "e5ed79d4-e611-4708-8be3-0b0a48649a52", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<span style=\"letter-spacing:.05pt\">17</span>", "ID": "0a8fc2f4-736a-4eb7-8ff6-66f190f2887b", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "17", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<span style=\"letter-spacing:-.1pt\">5</span>", "ID": "10fd31f1-4964-484e-99c9-19900a76998b", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "5", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "e7e32077-4420-46ca-9763-e8726300c09a", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "63b95c3e-943f-4d5b-b8f0-ff3f45bfb529", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "363a1d10-b2a6-4fc6-ada7-9594a30e59e9"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "01dbef57-4ae1-4d68-9994-b4c888921ce3", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "af7d06b4-cbaf-4d78-b20b-ce522446083f", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "01dbef57-4ae1-4d68-9994-b4c888921ce3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span>", "ID": "785b1bc8-b68d-4a6f-bf9b-4cff366510f2", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "9", "ParentId": "af7d06b4-cbaf-4d78-b20b-ce522446083f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span>", "ID": "9cfa618b-3d48-485e-99b0-9cb382a572d8", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "af7d06b4-cbaf-4d78-b20b-ce522446083f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">5</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">22</span><span style=\"letter-spacing:-.1pt\">1</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "de7366d0-8dea-47e1-8b16-485b89352f9c", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/9)", "ParentId": "af7d06b4-cbaf-4d78-b20b-ce522446083f"}, {"Element": "<span style=\"letter-spacing:.05pt\">5</span>", "ID": "856fe1b2-4e07-415d-b08d-4c0b583ed42d", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "0768bb0e-4ce0-47ba-a0bf-7fe7e1689a28", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<span style=\"letter-spacing:.05pt\">22</span>", "ID": "e36f951e-93da-4e4d-a713-68e06e5f1d92", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "22", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "25a08541-a6be-4201-9317-e5d5074af4e2", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "dcb3af15-60dd-4f64-860c-513efb504acd", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "1b79f8e4-6c24-4814-a7ba-0534d9c18020", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "de7366d0-8dea-47e1-8b16-485b89352f9c"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "151b872a-53fa-4673-94f9-9800d4a5cf30", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "724663da-4523-4cf9-ac12-062a5b40102d", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "151b872a-53fa-4673-94f9-9800d4a5cf30"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span>", "ID": "0e974dd2-2116-4281-80db-da8a51859e6a", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "724663da-4523-4cf9-ac12-062a5b40102d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span>", "ID": "d6f15406-842d-4309-9611-378a8be8d565", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "9", "ParentId": "724663da-4523-4cf9-ac12-062a5b40102d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">1</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">4</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "94593323-9559-4dc9-a204-47e02509e75b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/9)", "ParentId": "724663da-4523-4cf9-ac12-062a5b40102d"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "261d0be4-2464-4926-b9ce-4b796267d419", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "8aa0efd1-d916-47a1-90e5-93ea9992ed3d", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<span style=\"letter-spacing:.05pt\">20</span>", "ID": "a55ae95a-7f78-4e3f-86ef-7ad690088a97", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "20", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">4</span>", "ID": "625a4f30-8655-4620-bd05-3a45070aae3a", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "4", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "cb249ba9-5310-4e8c-a2b4-12c146e1114e", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "bd173a63-77d5-4195-9ae3-1cced52e69d4", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "94593323-9559-4dc9-a204-47e02509e75b"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "b61eada9-6d92-4349-9cfb-d1666fc06ffd", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "70203587-98fa-46a8-90b8-b48dbd8542a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "28e0944f-5306-42e5-9574-27d5b3f44418", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b61eada9-6d92-4349-9cfb-d1666fc06ffd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span>", "ID": "609e43a1-e5aa-4fd8-bbc2-b169084fcca8", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "9", "ParentId": "28e0944f-5306-42e5-9574-27d5b3f44418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span>", "ID": "f5417370-2a11-4de5-baca-1eae6f5e833d", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "28e0944f-5306-42e5-9574-27d5b3f44418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">9</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "05335458-7c6f-4b82-84b0-fe353527a5c8", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/9)", "ParentId": "28e0944f-5306-42e5-9574-27d5b3f44418"}, {"Element": "<span style=\"letter-spacing:.05pt\">3</span>", "ID": "71cc7761-627d-4824-9adc-09776a490ddb", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "24ab82f5-fb4c-43f0-9f59-c5b2a8039b62", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<span style=\"letter-spacing:.05pt\">20</span>", "ID": "8980de43-d044-4075-98bb-2da762ac6959", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "20", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<span style=\"letter-spacing:-.1pt\">9</span>", "ID": "13883303-11e0-410e-b44e-bc289f27718f", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "9", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "b4501f3c-fbc3-4a91-9275-ec0a9e2693f0", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "a87fa1a1-e942-41d8-abfc-333272199366", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "05335458-7c6f-4b82-84b0-fe353527a5c8"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>\n</tr>", "ID": "d5ded81c-7315-4ff4-877b-110787c57f00", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>", "ID": "9060c20d-a0ea-4e95-9f95-3a1a251da274", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>", "ID": "727b62a1-0c75-4e04-a5d8-0fe4a8d6297d", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9060c20d-a0ea-4e95-9f95-3a1a251da274"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span>", "ID": "72aa07f5-5875-40f4-81d5-ea393d129cf6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Icreaedcre   (re", "ParentId": "727b62a1-0c75-4e04-a5d8-0fe4a8d6297d"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "0b4b1069-95ed-499a-8f56-e1374fc40bb7", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "115f1bac-6105-4fc0-84d2-1d720c522e05", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.55pt\"> </span>", "ID": "e1540ea4-b882-45b6-ade4-eb6f917f4a7f", "Styles": "letter-spacing:-.55pt", "Classes": "None", "Text": " ", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "ad139229-07a3-4cff-8087-8e83042a72ad", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "2e300ba1-6afa-4e68-8b4c-42c0ea2013df", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:.05pt\">Wo</span>", "ID": "65105600-e5a5-4588-a724-504052012506", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "Wo", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:\n  -.05pt\">s</span>", "ID": "26496b17-40b2-47a8-889f-98e2867ae926", "Styles": "letter-spacing:\n  -.05pt", "Classes": "None", "Text": "s", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "65a4142b-22d8-4694-9682-4f1d911d1760", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.05pt\">i</span>", "ID": "509cdcc0-5b5c-45f5-bafd-dd71f179114d", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "i", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<span style=\"letter-spacing:-.1pt\">ng)</span>", "ID": "3a0dedea-4e7d-47d8-b920-c9907ee49ae9", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "ng)", "ParentId": "72aa07f5-5875-40f4-81d5-ea393d129cf6"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "d695c133-5318-4245-b1f7-c651f8c94e8f", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "49ed0681-a40c-4fb2-8110-3095190611b7", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d695c133-5318-4245-b1f7-c651f8c94e8f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span>", "ID": "902620f5-4fca-409c-8567-e5d73b57a8d3", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "49ed0681-a40c-4fb2-8110-3095190611b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">12</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "b9032502-1620-4dfc-a0ad-b0384343122b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (9)", "ParentId": "49ed0681-a40c-4fb2-8110-3095190611b7"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "9d78b07f-c4c3-4a0c-9fc5-dfb004005834", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "0277b435-83a1-4673-9f4e-e793079af0dc", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<span style=\"letter-spacing:.05pt\">12</span>", "ID": "a2917b22-a93a-46f0-a827-d0ee6d406ab3", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "12", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "731ef93d-06ee-4644-848a-443653fdb37d", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "797b7a4a-a46c-494a-b208-05c786ffee87", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "c2eaf31f-2ac2-4e47-bed8-f5bbbe141d7a", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "b9032502-1620-4dfc-a0ad-b0384343122b"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>\n</td>", "ID": "fb7f1802-75f2-4939-b8f7-65f5fb5cb50f", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span></p>", "ID": "22cd0a9b-6b49-467e-9494-6a1423cc8ce7", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb7f1802-75f2-4939-b8f7-65f5fb5cb50f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span>", "ID": "3b5d87fd-6cb7-4236-8487-27cd4b0fd7ab", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "22cd0a9b-6b49-467e-9494-6a1423cc8ce7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">7</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">13</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">2</span>9)</span>", "ID": "54096bf3-63b0-4d7a-aa6f-f917dae5934f", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (9)", "ParentId": "22cd0a9b-6b49-467e-9494-6a1423cc8ce7"}, {"Element": "<span style=\"letter-spacing:.05pt\">7</span>", "ID": "681ac76f-35e2-4eb5-9f56-fc00ea02fb4a", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "7", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "c890eff8-a1d8-4897-96e3-cadf7303fa5b", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<span style=\"letter-spacing:.05pt\">13</span>", "ID": "dd6e2269-6261-4185-9d85-65dbb2759ea0", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "13", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "1c0e83a6-559f-4cc0-aa6c-71cab8d6014d", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "3cde4757-e956-4514-8ab9-f252db737991", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "6fdffd5c-4d2f-40e4-9186-7a9865eba3af", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "54096bf3-63b0-4d7a-aa6f-f917dae5934f"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "d79f499c-7f4a-4521-88ae-526781651902", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "79ac1138-6397-4ef9-a3a8-a60a8c16eade", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d79f499c-7f4a-4521-88ae-526781651902"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span>", "ID": "b034d6f3-d64c-417d-8071-50778d7728cc", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "79ac1138-6397-4ef9-a3a8-a60a8c16eade"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "4f6bd1e7-ce65-43be-9a30-97ca5ce27ed5", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "79ac1138-6397-4ef9-a3a8-a60a8c16eade"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "3b1c7488-1e58-41a4-83f8-b9555fbfba7d", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "79ac1138-6397-4ef9-a3a8-a60a8c16eade"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "d2fd5db3-c92d-4257-b18f-74d7bb3752c0", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "79ac1138-6397-4ef9-a3a8-a60a8c16eade"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "b95f3fb4-66be-4f98-827e-d972669302b1", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/9)", "ParentId": "79ac1138-6397-4ef9-a3a8-a60a8c16eade"}, {"Element": "<span style=\"letter-spacing:.05pt\">3</span>", "ID": "a83c6aca-c8ec-4dba-9c3d-96340f452bb2", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "b95f3fb4-66be-4f98-827e-d972669302b1"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "6541b3f4-1b43-4f4c-b7d5-1f75f9b647f2", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "b95f3fb4-66be-4f98-827e-d972669302b1"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "8bd6258a-e4fb-42e3-bef5-813ba1569a7d", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "b95f3fb4-66be-4f98-827e-d972669302b1"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "3a2ac1dd-dfdd-4210-8ab5-7e6ee33d6a90", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "389e8575-7025-48da-9d13-c15c6712cbe5", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a2ac1dd-dfdd-4210-8ab5-7e6ee33d6a90"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "a5385ce8-8844-46be-b560-347e7b2bda8c", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "389e8575-7025-48da-9d13-c15c6712cbe5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "733873d2-2d67-4d31-8e67-b30a9ec90d32", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "389e8575-7025-48da-9d13-c15c6712cbe5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span>", "ID": "8b557a58-6256-42db-a82f-b49ab5b33d21", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "389e8575-7025-48da-9d13-c15c6712cbe5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "f20f3314-9f61-46a7-8913-efd8fd8634e0", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "389e8575-7025-48da-9d13-c15c6712cbe5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">7</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "e501918d-d932-4069-a34c-92b3503fc082", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/9)", "ParentId": "389e8575-7025-48da-9d13-c15c6712cbe5"}, {"Element": "<span style=\"letter-spacing:.05pt\">7</span>", "ID": "f1965b48-e84c-4016-884e-037d5cc1b15b", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "7", "ParentId": "e501918d-d932-4069-a34c-92b3503fc082"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "c7ed32c8-d15d-4a40-99a2-f8a4504b3290", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "e501918d-d932-4069-a34c-92b3503fc082"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "c07282e2-9191-4616-bd78-f52c2ac9d28e", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "e501918d-d932-4069-a34c-92b3503fc082"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>\n</td>", "ID": "82e2d721-a17e-414d-9133-d2e0a8ca7c38", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d5ded81c-7315-4ff4-877b-110787c57f00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span></p>", "ID": "9781e405-8cf8-462e-a8e5-ab37f46bda0d", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82e2d721-a17e-414d-9133-d2e0a8ca7c38"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "64860621-2b81-4940-bd44-5fb8da1b06cc", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "9781e405-8cf8-462e-a8e5-ab37f46bda0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "ed725a01-c84a-4e72-81ba-4c65194b29e1", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "9781e405-8cf8-462e-a8e5-ab37f46bda0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">5</span>", "ID": "b876106f-2ac8-41f3-b26f-282610d943c9", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "9781e405-8cf8-462e-a8e5-ab37f46bda0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "87f60aa4-9f37-4e73-bb28-d832949538e3", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "9781e405-8cf8-462e-a8e5-ab37f46bda0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">2</span>9)</span>", "ID": "4937da7b-675e-4501-8d02-758ad0b2ad2b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/9)", "ParentId": "9781e405-8cf8-462e-a8e5-ab37f46bda0d"}, {"Element": "<span style=\"letter-spacing:.05pt\">8</span>", "ID": "5166ee10-3b35-4290-82cb-011a4c56f7e9", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "4937da7b-675e-4501-8d02-758ad0b2ad2b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "47386f36-ac0c-45fe-8079-491184b167a8", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "4937da7b-675e-4501-8d02-758ad0b2ad2b"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "9564860c-2c87-4724-aad6-5bf574b9ef67", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "4937da7b-675e-4501-8d02-758ad0b2ad2b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>\n</tr>", "ID": "47e1104f-99c0-43ba-8aed-46715eb3c902", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>", "ID": "ec19ceb9-6609-4394-bbe0-2d0f012bfbe2", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>", "ID": "3d6a6fae-8e2b-404c-8e6c-9dba933f958e", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec19ceb9-6609-4394-bbe0-2d0f012bfbe2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span>", "ID": "c9239e4e-c712-4c43-83ee-4372b56d47b0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Noaet", "ParentId": "3d6a6fae-8e2b-404c-8e6c-9dba933f958e"}, {"Element": "<span style=\"letter-spacing:-.55pt\"> </span>", "ID": "c8d8bfed-407a-4680-83bf-1dde4c317419", "Styles": "letter-spacing:-.55pt", "Classes": "None", "Text": " ", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:-.05pt\">ss</span>", "ID": "72afbe89-3c77-4a2b-9fe9-6e7ae8321c72", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "ss", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "024d1116-7a4d-4aeb-9037-6acb9b639f61", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:.05pt\">s</span>", "ID": "1a0f9ffa-267e-4f32-a95a-2dd86d8739d8", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "s", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:-.1pt\">m</span>", "ID": "7ee6e517-eb88-4b4f-a146-ec3ddd0bc9f0", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "m", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "1998eda4-c36c-4c25-bbe1-1dd7e1f57a78", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "03b8326c-e81d-412b-add4-c10b73f2dc7e", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "c9239e4e-c712-4c43-83ee-4372b56d47b0"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>", "ID": "a2119da3-274b-47c0-8b75-e9714d1649a4", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>", "ID": "4e3ed6f6-8b36-4106-afb3-7de8d3082441", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2119da3-274b-47c0-8b75-e9714d1649a4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span>", "ID": "4885a574-18cf-421c-9d84-4799b5cdca2d", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "7", "ParentId": "4e3ed6f6-8b36-4106-afb3-7de8d3082441"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>", "ID": "1c6f2133-0559-4210-8743-52487ceab51b", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>", "ID": "930fbc4f-2490-46c4-8e74-9c8e2a452edf", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1c6f2133-0559-4210-8743-52487ceab51b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span>", "ID": "efe16edc-2699-4ddf-ac88-4aaab4c05a1f", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "7", "ParentId": "930fbc4f-2490-46c4-8e74-9c8e2a452edf"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>", "ID": "1a8907ae-9555-4553-bb1c-d3df128db899", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>", "ID": "846ac9f3-1a14-4edc-a03e-5ddac678c02c", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1a8907ae-9555-4553-bb1c-d3df128db899"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span>", "ID": "0dd922dd-caf0-47d1-948f-b8b3ed56ee7f", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "7", "ParentId": "846ac9f3-1a14-4edc-a03e-5ddac678c02c"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>", "ID": "36e7a573-34e4-41f4-822d-6da83a02c44f", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>", "ID": "81e3316a-f9de-4e0d-becc-57d7a9a91078", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "36e7a573-34e4-41f4-822d-6da83a02c44f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span>", "ID": "1addca93-7289-4cb7-a1b3-f58d79276f2e", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "7", "ParentId": "81e3316a-f9de-4e0d-becc-57d7a9a91078"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>\n</td>", "ID": "c0d3b505-e834-498d-b075-6076933440b5", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47e1104f-99c0-43ba-8aed-46715eb3c902"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span></p>", "ID": "a83fecb2-5307-40e7-9c69-7c7a048accf5", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c0d3b505-e834-498d-b075-6076933440b5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">7</span>", "ID": "636a3a7e-c525-43f0-b7b7-487a02e92c0a", "Styles": "font-size:9.0pt", "Classes": "None", "Text": "7", "ParentId": "a83fecb2-5307-40e7-9c69-7c7a048accf5"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"6\" style=\"width:466.1pt;border-top:none;\n  border-left:solid windowtext 1.0pt;border-bottom:solid black 1.0pt;\n  border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b></p>\n</td>\n</tr>", "ID": "709fda27-6de6-49d9-83f5-c7a745f7da09", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td colspan=\"6\" style=\"width:466.1pt;border-top:none;\n  border-left:solid windowtext 1.0pt;border-bottom:solid black 1.0pt;\n  border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b></p>\n</td>", "ID": "79eb82df-26c3-4834-bd40-2c80462e660a", "Styles": "width:466.1pt;border-top:none;\n  border-left:solid windowtext 1.0pt;border-bottom:solid black 1.0pt;\n  border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "709fda27-6de6-49d9-83f5-c7a745f7da09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b></p>", "ID": "65d71117-4476-4d98-8d93-534683100418", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "79eb82df-26c3-4834-bd40-2c80462e660a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span></b>", "ID": "65f223af-376f-4215-b84d-1a5f750e8eef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65d71117-4476-4d98-8d93-534683100418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.1pt\">P</span>", "ID": "2e3068fd-aa96-4e1b-9a18-34767882eeba", "Styles": "font-size:10.0pt;letter-spacing:.1pt", "Classes": "None", "Text": "P", "ParentId": "65f223af-376f-4215-b84d-1a5f750e8eef"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span></b>", "ID": "953932ac-a4c9-4a34-8fbe-2a3edfc3e6f9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65d71117-4476-4d98-8d93-534683100418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:.05pt\">o</span>", "ID": "f6e811c5-6e04-4bad-9cce-eff82f63831d", "Styles": "font-size:10.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "953932ac-a4c9-4a34-8fbe-2a3edfc3e6f9"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span></b>", "ID": "65c67b90-b32b-4c9d-815c-bb6a68bc8a12", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65d71117-4476-4d98-8d93-534683100418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;letter-spacing:-.05pt\">st\u2011t</span>", "ID": "1714ce76-8d63-4ba0-ba56-472df2cf2517", "Styles": "font-size:10.0pt;letter-spacing:-.05pt", "Classes": "None", "Text": "st\u2011t", "ParentId": "65c67b90-b32b-4c9d-815c-bb6a68bc8a12"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span></b>", "ID": "0b3c2922-bb02-4066-b8d0-56061aaaa3ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65d71117-4476-4d98-8d93-534683100418"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">rea<span style=\"letter-spacing:-.05pt\">t</span><span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">W</span>eek<span style=\"letter-spacing:-.35pt\">\u00a0</span><span style=\"letter-spacing:.05pt\">2</span>4<span style=\"letter-spacing:-.25pt\"> </span>(N\u00a0=\u00a0<span style=\"letter-spacing:.05pt\">236</span>),<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:-.05pt\">%</span> (<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">/</span>N)</span>", "ID": "fe3502f6-620e-46f3-bc08-0eb0458eaf32", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "reateek4(N\u00a0=\u00a0), (N)", "ParentId": "0b3c2922-bb02-4066-b8d0-56061aaaa3ff"}, {"Element": "<span style=\"letter-spacing:-.05pt\">t</span>", "ID": "7d0ba6f8-3c63-46fb-9f61-064de4c022b1", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "t", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.25pt\">m</span>", "ID": "8b187ed0-b184-439a-8ad4-bb6775cc1411", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": "m", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "f7371517-9ddc-43fb-8d4e-a4e10cf08a9a", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "eca55190-ab9a-4f3d-a39a-197dcfeac836", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "ac276790-31e4-4434-bde7-576c2ddc4585", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:.05pt\">W</span>", "ID": "8d1bebc1-71c0-4d60-80fe-7a13be6f0105", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "W", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.35pt\">\u00a0</span>", "ID": "26b6f811-0173-404f-99ac-865ec24ec440", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": "\u00a0", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "18551880-71fc-48d2-bbf3-63f5090a7f88", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "a8756b7e-97a6-4665-b367-cf546e095567", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:.05pt\">236</span>", "ID": "dce6d76d-12f9-4e2c-97d3-5a268d988d9a", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "236", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "abebe7c6-377a-43fb-86b2-1ec1d58b5715", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.05pt\">%</span>", "ID": "d49a94c6-dc61-40a4-9aa5-3239b62fd151", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "%", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "a8b5f769-82bb-4d7e-9a6a-109fe62961ff", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<span style=\"letter-spacing:-.05pt\">/</span>", "ID": "2ed0cfa8-01b5-4b16-8bc5-d0381bbe11a1", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "/", "ParentId": "fe3502f6-620e-46f3-bc08-0eb0458eaf32"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n</tr>", "ID": "3fbb6f2f-20de-4dc1-87a4-08e15183b903", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>\n</td>", "ID": "282cbaee-ec18-442b-8fe9-f781bbc974a0", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span></p>", "ID": "d78346ed-3a38-4efc-beb3-466f4ff3844b", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "282cbaee-ec18-442b-8fe9-f781bbc974a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Decrea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.6pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re (I<span style=\"letter-spacing:-.25pt\">m</span><span style=\"letter-spacing:.05pt\">p</span>r<span style=\"letter-spacing:.05pt\">o</span><span style=\"letter-spacing:-.1pt\">v</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">t</span>)</span>", "ID": "921a962c-fb7a-4051-8700-9e0261ec991d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Decreaedcre (Ir)", "ParentId": "d78346ed-3a38-4efc-beb3-466f4ff3844b"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "b4de958b-6fc2-4fa9-a283-60a544f826c3", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.6pt\"> </span>", "ID": "0de0d372-2d3a-47b1-bc2b-57e138a08ca5", "Styles": "letter-spacing:-.6pt", "Classes": "None", "Text": " ", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "721dfea3-e61f-45a0-a2b5-7d01e3cc624b", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "960267c9-2a95-4562-a2eb-d6422d0c1c94", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.25pt\">m</span>", "ID": "1be2fb74-2c95-4ee5-befc-8d3dec5e0f13", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": "m", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:.05pt\">p</span>", "ID": "864cf38f-5e2f-4f52-bd39-6de175b496d5", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "p", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "f431aa49-58d7-4a49-b2d4-c84f97bae667", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.1pt\">v</span>", "ID": "d71efb8f-a3a4-46f0-b51a-50046024ba54", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "v", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "42f93599-e9cd-4bad-982c-c7bb33a20791", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.1pt\">m</span>", "ID": "d3fcbf63-af41-4afa-9b93-9c547563e293", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "m", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "5111b6b1-f5d9-446a-8a8a-c8fd13523136", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "0fa2964f-002f-47ff-b083-7dde4dbda010", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<span style=\"letter-spacing:-.05pt\">t</span>", "ID": "81526bc4-fea0-41c2-ad66-476d1deb052d", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "t", "ParentId": "921a962c-fb7a-4051-8700-9e0261ec991d"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>", "ID": "b34c6895-8daa-41d8-b948-9dde76987aa5", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>", "ID": "66ee9c07-6a25-4df9-bd00-16fd38b00b31", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b34c6895-8daa-41d8-b948-9dde76987aa5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">39</span>", "ID": "e3e46b20-075e-41c2-a22a-b8e25d72d01d", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "39", "ParentId": "66ee9c07-6a25-4df9-bd00-16fd38b00b31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "75984ada-1cd6-47ea-a0c8-6422f61040ed", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "66ee9c07-6a25-4df9-bd00-16fd38b00b31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span>", "ID": "b44dc736-eda4-4ba7-9234-3e375f6a20f8", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "66ee9c07-6a25-4df9-bd00-16fd38b00b31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "f539e411-ef64-4a5a-8bcb-111ee1ce74e7", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "66ee9c07-6a25-4df9-bd00-16fd38b00b31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">84</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span>", "ID": "2405aa13-86a3-454d-9b2c-c053c05f0030", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (3)", "ParentId": "66ee9c07-6a25-4df9-bd00-16fd38b00b31"}, {"Element": "<span style=\"letter-spacing:.05pt\">84</span>", "ID": "92bea136-2152-492a-871d-ae6d40c1eae0", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "84", "ParentId": "2405aa13-86a3-454d-9b2c-c053c05f0030"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "c91767bd-2bc4-473f-8747-57f73c0800dc", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "2405aa13-86a3-454d-9b2c-c053c05f0030"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "420abb14-cb1d-4560-8fd7-523ce19568ba", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "2405aa13-86a3-454d-9b2c-c053c05f0030"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "2e0193e8-43cb-4be8-844c-eea9703aad4c", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "2405aa13-86a3-454d-9b2c-c053c05f0030"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>", "ID": "ba0dede5-8ff8-4443-be58-986617ba70e8", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>", "ID": "99dbf2af-0ce9-4838-9871-d217b9361002", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba0dede5-8ff8-4443-be58-986617ba70e8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">16</span>", "ID": "becc9998-8a76-4270-b3ca-5155f9f226ba", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "16", "ParentId": "99dbf2af-0ce9-4838-9871-d217b9361002"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "01f1aa5d-3a67-498b-8651-e08c48c8db1d", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "99dbf2af-0ce9-4838-9871-d217b9361002"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span>", "ID": "48cbe2c7-0dd8-4a6a-9e68-5cc111bff2d3", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "99dbf2af-0ce9-4838-9871-d217b9361002"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "7fca0026-ac6c-45f5-915e-f6816434e59d", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "99dbf2af-0ce9-4838-9871-d217b9361002"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">35</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span>", "ID": "cff87dcd-db0f-4bf7-9003-91afc275d268", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (3)", "ParentId": "99dbf2af-0ce9-4838-9871-d217b9361002"}, {"Element": "<span style=\"letter-spacing:.05pt\">35</span>", "ID": "90e7b49f-cf72-445a-a317-c4404f4df756", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "35", "ParentId": "cff87dcd-db0f-4bf7-9003-91afc275d268"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "3a7de2a9-f80c-4073-8249-4f3b058b0e94", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "cff87dcd-db0f-4bf7-9003-91afc275d268"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "7768eab9-f357-4662-a2d9-a58c4df228b8", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "cff87dcd-db0f-4bf7-9003-91afc275d268"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "6c804086-d1e3-4eda-8ba0-bd0742c93096", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "cff87dcd-db0f-4bf7-9003-91afc275d268"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "b074b545-ba36-4f90-8a02-db37dac2f92d", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "11040fe5-fd1c-4540-9b73-543eef0bd761", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b074b545-ba36-4f90-8a02-db37dac2f92d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "cfa2c490-3389-4617-8e9f-90de7253f143", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "11040fe5-fd1c-4540-9b73-543eef0bd761"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "70d1324b-ed20-4b34-ad87-059007fc24f0", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "11040fe5-fd1c-4540-9b73-543eef0bd761"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "750db64c-50b5-4e77-a060-f767ce29d5e8", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "11040fe5-fd1c-4540-9b73-543eef0bd761"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "45bc58c8-c697-4754-98bd-72eec3257a01", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "11040fe5-fd1c-4540-9b73-543eef0bd761"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "7b23730d-5bd6-4053-a762-8d9870862be0", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/3)", "ParentId": "11040fe5-fd1c-4540-9b73-543eef0bd761"}, {"Element": "<span style=\"letter-spacing:.05pt\">5</span>", "ID": "ee77446b-f4a1-4480-ba1e-bb7f4805b5c0", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "7b23730d-5bd6-4053-a762-8d9870862be0"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "10c59c22-64f8-4426-ab23-e34635755619", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "7b23730d-5bd6-4053-a762-8d9870862be0"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "757cc5d6-f75b-4627-8179-e38094612eee", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "7b23730d-5bd6-4053-a762-8d9870862be0"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>", "ID": "71912c3c-5ea1-45d4-a4e9-1579a1128dbf", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>", "ID": "122f1f51-612f-4ebf-9216-a0972470fbb5", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71912c3c-5ea1-45d4-a4e9-1579a1128dbf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">15</span>", "ID": "67ff074c-842d-4636-b8b6-7c8dfbc6ca3e", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "15", "ParentId": "122f1f51-612f-4ebf-9216-a0972470fbb5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "ca079255-3155-4651-9ab3-00fc624642dc", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "122f1f51-612f-4ebf-9216-a0972470fbb5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span>", "ID": "2bb070b9-caa7-4fdf-a332-d75bff5faced", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "0", "ParentId": "122f1f51-612f-4ebf-9216-a0972470fbb5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "8e34ade6-1f7b-4e4a-ba12-4b689079f0f1", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "122f1f51-612f-4ebf-9216-a0972470fbb5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">32</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span>", "ID": "21296481-51ef-47a6-ae76-7107fc7bac4c", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (3)", "ParentId": "122f1f51-612f-4ebf-9216-a0972470fbb5"}, {"Element": "<span style=\"letter-spacing:.05pt\">32</span>", "ID": "c4bc6f58-71ad-45a0-a565-7d7354a371e6", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "32", "ParentId": "21296481-51ef-47a6-ae76-7107fc7bac4c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "136208e6-696d-46d5-aa24-3b3d49d0add7", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "21296481-51ef-47a6-ae76-7107fc7bac4c"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "8344bc45-5abf-44a7-a974-feeaf7219275", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "21296481-51ef-47a6-ae76-7107fc7bac4c"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "835833ba-6888-49e8-832b-6c4db766ad46", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "21296481-51ef-47a6-ae76-7107fc7bac4c"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>", "ID": "20a18b67-8b31-47fa-b31b-71f30571eba2", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3fbb6f2f-20de-4dc1-87a4-08e15183b903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>", "ID": "173538a6-0398-4d69-a453-85d01b2fa383", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "20a18b67-8b31-47fa-b31b-71f30571eba2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">9</span>", "ID": "e8b4a345-2a65-4ebe-aea1-7f4dc6151857", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "9", "ParentId": "173538a6-0398-4d69-a453-85d01b2fa383"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">4</span><span style=\"letter-spacing:-.1pt\">% (</span><span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span>", "ID": "7717b629-f8cc-43ed-ab54-ba48e41bac99", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ".3)", "ParentId": "173538a6-0398-4d69-a453-85d01b2fa383"}, {"Element": "<span style=\"letter-spacing:.05pt\">4</span>", "ID": "ff685b5c-6c7d-4e9d-9f92-2f92915ddcd7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<span style=\"letter-spacing:-.1pt\">% (</span>", "ID": "e58d051b-8ea5-4236-b130-9f35170b6acd", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "% (", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<span style=\"letter-spacing:.05pt\">20</span>", "ID": "9921b1e3-e144-432f-8c54-adae9ccb54df", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "20", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "b7c5fe73-28e0-4e9c-9183-6d9732e1917c", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "95c22e67-8b10-4463-8b27-f2f70ee29b52", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "9734e584-3309-4736-a911-8527d9150043", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "7717b629-f8cc-43ed-ab54-ba48e41bac99"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>", "ID": "87ef7058-5579-44af-893a-3b5a3a4eeed3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>\n</td>", "ID": "6de4fab2-0446-48a3-bf6b-38fe7be9d035", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span></p>", "ID": "c15cf8f3-170f-4126-8104-82a42a70ec89", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de4fab2-0446-48a3-bf6b-38fe7be9d035"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.4pt\"> </span>c<span style=\"letter-spacing:-.1pt\">h</span>a<span style=\"letter-spacing:.05pt\">n</span><span style=\"letter-spacing:-.1pt\">ge</span></span>", "ID": "587a20ed-0ac2-470f-b39a-007450846c3e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Noca", "ParentId": "c15cf8f3-170f-4126-8104-82a42a70ec89"}, {"Element": "<span style=\"letter-spacing:-.4pt\"> </span>", "ID": "d21f49bd-3c6b-42d5-9910-a5b0a93a40a5", "Styles": "letter-spacing:-.4pt", "Classes": "None", "Text": " ", "ParentId": "587a20ed-0ac2-470f-b39a-007450846c3e"}, {"Element": "<span style=\"letter-spacing:-.1pt\">h</span>", "ID": "93b0619c-7596-4634-ab68-a6bb41c499e7", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "h", "ParentId": "587a20ed-0ac2-470f-b39a-007450846c3e"}, {"Element": "<span style=\"letter-spacing:.05pt\">n</span>", "ID": "dbf09b62-074d-4841-abba-98ff0f0184c4", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "n", "ParentId": "587a20ed-0ac2-470f-b39a-007450846c3e"}, {"Element": "<span style=\"letter-spacing:-.1pt\">ge</span>", "ID": "a15fda9b-78c8-40ea-a4ec-407bde19cfaf", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "ge", "ParentId": "587a20ed-0ac2-470f-b39a-007450846c3e"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "2ccb4757-7cff-430e-a350-b81463ceeb3d", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "1f71447a-65c0-40f6-8316-1e36194e09c4", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ccb4757-7cff-430e-a350-b81463ceeb3d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">5</span>", "ID": "bde142fe-f0d9-488a-9a6f-c5fa24b68c0b", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "5", "ParentId": "1f71447a-65c0-40f6-8316-1e36194e09c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span>", "ID": "d66fc42a-ac02-4a49-9d62-89b5aaedd6b4", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "1f71447a-65c0-40f6-8316-1e36194e09c4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">0</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">11</span><span style=\"letter-spacing:-.1pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "575f9114-f219-403f-8c3c-60f56a9097dc", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/3)", "ParentId": "1f71447a-65c0-40f6-8316-1e36194e09c4"}, {"Element": "<span style=\"letter-spacing:.05pt\">0</span>", "ID": "c1f57da8-d901-45c4-af57-603c9e8ea34e", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "0", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "8c2a9735-2ec5-417a-ab03-11677923da34", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<span style=\"letter-spacing:.05pt\">11</span>", "ID": "d71c3122-eee8-48d2-b85a-a09a9473ca05", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "11", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">5</span>", "ID": "c5aa8aeb-5f20-45cd-87a0-c1a9a317a3e2", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "5", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "e7c3ae61-e6ed-4ada-af34-30c169b31ebc", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "00fc3c83-7f11-4a1a-b390-e1f07b3754f5", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "575f9114-f219-403f-8c3c-60f56a9097dc"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "732f657f-a29c-4ba3-848a-10a295379dd9", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "7e665a62-b1aa-45e8-9445-009441eb7e6a", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "732f657f-a29c-4ba3-848a-10a295379dd9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span>", "ID": "cda08720-7291-4ad2-a4f0-edc47e7ab96e", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "7e665a62-b1aa-45e8-9445-009441eb7e6a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">0</span>", "ID": "afa02ab4-e77c-4d0d-a1e4-fa548ec33f14", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "0", "ParentId": "7e665a62-b1aa-45e8-9445-009441eb7e6a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/3)", "ParentId": "7e665a62-b1aa-45e8-9445-009441eb7e6a"}, {"Element": "<span style=\"letter-spacing:.05pt\">8</span>", "ID": "16b0d77f-7e91-467c-bb4a-7b44783f4ef7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "d37804f8-ea5c-4ef2-a1fc-a1fef1484442", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<span style=\"letter-spacing:.05pt\">17</span>", "ID": "694e96aa-7d2a-4020-8f73-3b7b685efa2c", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "17", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "4c4d4596-595b-479f-be4f-48541e5d8488", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "ced67806-4d7d-458c-a68d-958178275ff5", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "de13cf9e-88e3-4d42-98bf-72ba11a8bc52", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "f5e1a2c8-936b-4a8f-ae9f-940e3629a6cd"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "5e35960e-498b-4c49-bb07-7b2f380049fb", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "470c5449-ce10-46d6-ba05-3a65ce188433", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e35960e-498b-4c49-bb07-7b2f380049fb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">9</span>", "ID": "dbd1f8c1-d055-468f-83ab-ed0bef93f070", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "9", "ParentId": "470c5449-ce10-46d6-ba05-3a65ce188433"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">4</span>", "ID": "12303162-1b81-4b1c-851b-e26897db8116", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "4", "ParentId": "470c5449-ce10-46d6-ba05-3a65ce188433"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">8</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">20</span><span style=\"letter-spacing:-.1pt\">2</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/3)", "ParentId": "470c5449-ce10-46d6-ba05-3a65ce188433"}, {"Element": "<span style=\"letter-spacing:.05pt\">8</span>", "ID": "38f6ddb6-8223-4ef9-983e-2c2d95625654", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "a805ae85-7cef-4b34-80fa-1165f7fdbacc", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<span style=\"letter-spacing:.05pt\">20</span>", "ID": "ba19c414-d20a-4450-975f-090afdd865e3", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "20", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "96da6a26-05f7-4a5e-a1d6-47969dcb21b5", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "c50b32d8-6cde-4b1f-8a1f-072183a1245c", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "44b4894c-c2c6-4bd7-9e64-6fd13517ce33", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "68695e3b-fcaa-4bcf-9c69-2094acb67b6b"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "16daf9c7-6762-463b-abd0-3bd00dbef37e", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "53b44f98-434e-45c9-8bc9-618eca50a9a3", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16daf9c7-6762-463b-abd0-3bd00dbef37e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span>", "ID": "36706975-80a9-4c52-982f-2d2001f98f4e", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "53b44f98-434e-45c9-8bc9-618eca50a9a3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">1</span>", "ID": "7cd35386-68ca-4b80-ae14-cb866eae662a", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "53b44f98-434e-45c9-8bc9-618eca50a9a3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">17</span><span style=\"letter-spacing:-.1pt\">3</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "cbc88231-6250-49c5-af6e-b1448fa887c5", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/3)", "ParentId": "53b44f98-434e-45c9-8bc9-618eca50a9a3"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "f4ebc9c9-d38e-4cd1-a147-8e844ad1ab1b", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "164ef520-0c89-415a-a401-4cde5084e194", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<span style=\"letter-spacing:.05pt\">17</span>", "ID": "3b77f120-48e2-4b4e-8273-19090eb19c59", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "17", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">3</span>", "ID": "3cd3602a-e913-4930-a70c-31d4c26a7b84", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "3", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "77e25684-09ed-49fd-b40c-e926ef658a87", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "5351ef68-3ec6-4b38-afbd-dbc0cc84c06e", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "cbc88231-6250-49c5-af6e-b1448fa887c5"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "b5eaf26c-9eab-4710-8357-244fc466fbe7", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "87ef7058-5579-44af-893a-3b5a3a4eeed3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "a8c38bb6-3232-467d-8af9-2fbfbb905a84", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5eaf26c-9eab-4710-8357-244fc466fbe7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">8</span>", "ID": "1b5227f4-0539-4082-bb45-a9dadc594bf0", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "a8c38bb6-3232-467d-8af9-2fbfbb905a84"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span>", "ID": "94c6a351-4029-4cbf-bed5-7118fd86a313", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "a8c38bb6-3232-467d-8af9-2fbfbb905a84"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">3</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">18</span><span style=\"letter-spacing:-.1pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "558d8f60-6791-4c28-808a-269391893cbc", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (/3)", "ParentId": "a8c38bb6-3232-467d-8af9-2fbfbb905a84"}, {"Element": "<span style=\"letter-spacing:.05pt\">3</span>", "ID": "14be6775-7abc-4740-9156-ae8f625ccb51", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "7ee59233-c3a0-4c27-a242-50af364dde8b", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<span style=\"letter-spacing:.05pt\">18</span>", "ID": "ebf0da67-33d0-4ed9-a9f8-072021518b1c", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "18", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">8</span>", "ID": "1333e8b2-071e-471b-907f-b5b1cd6d6cb4", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "8", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "b18ee591-cef5-4f2a-863c-7710034ca406", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "1b2faccd-343f-4574-bcf6-575444cd7cc5", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "558d8f60-6791-4c28-808a-269391893cbc"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>\n</tr>", "ID": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>\n</td>", "ID": "6b0258f6-4386-4467-b91c-36909ab9847a", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span></p>", "ID": "b3a74aa1-e9ae-4b5f-972d-7bcac2e2d343", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b0258f6-4386-4467-b91c-36909ab9847a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">I<span style=\"letter-spacing:-.1pt\">n</span>crea<span style=\"letter-spacing:-.05pt\">s</span>ed<span style=\"letter-spacing:-.55pt\"> </span><span style=\"letter-spacing:-.05pt\">s</span>c<span style=\"letter-spacing:.05pt\">o</span>re\n  (<span style=\"letter-spacing:.05pt\">Wo</span>r<span style=\"letter-spacing:\n  -.05pt\">s</span>e<span style=\"letter-spacing:-.1pt\">n</span><span style=\"letter-spacing:-.05pt\">i</span><span style=\"letter-spacing:-.1pt\">ng)</span></span>", "ID": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Icreaedcre   (re", "ParentId": "b3a74aa1-e9ae-4b5f-972d-7bcac2e2d343"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "e8ec4354-d476-4960-b22b-b984849c92a9", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "54c64997-9a58-437a-9995-78849eba70b5", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.55pt\"> </span>", "ID": "ceb5e2a0-e83a-42f6-9529-38bcfed8313f", "Styles": "letter-spacing:-.55pt", "Classes": "None", "Text": " ", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "15f19894-649c-4e35-820e-9ed4b03648ef", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:.05pt\">o</span>", "ID": "901545e9-b297-4a3c-9f4d-3d9e5bf3f5f9", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "o", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:.05pt\">Wo</span>", "ID": "0bc154ec-6a49-45ef-833c-97c55999c5ff", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "Wo", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:\n  -.05pt\">s</span>", "ID": "bf0784e4-9bd0-409e-ae0a-2928b0803648", "Styles": "letter-spacing:\n  -.05pt", "Classes": "None", "Text": "s", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "82eddb7d-2bad-4694-91bd-3b70642ee552", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.05pt\">i</span>", "ID": "d113c57d-270a-48ae-ac79-e8bd840ba0f2", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "i", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<span style=\"letter-spacing:-.1pt\">ng)</span>", "ID": "58434ab8-23a6-45b8-9132-cd309824d472", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "ng)", "ParentId": "0b34ff96-0dd4-4ab5-bec2-a93f671f1b14"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>\n</td>", "ID": "132321c0-0184-486a-a43c-0378b73e1246", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span></p>", "ID": "dd668725-7914-4e35-97a8-8da7b39681d8", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "132321c0-0184-486a-a43c-0378b73e1246"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">6</span>", "ID": "5247a2c1-a396-41f7-929d-9cc9e0a405fd", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "dd668725-7914-4e35-97a8-8da7b39681d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\">.<span style=\"letter-spacing:.05pt\">6</span><span style=\"letter-spacing:-.1pt\">%</span> (<span style=\"letter-spacing:.05pt\">14</span><span style=\"letter-spacing:-.1pt\">/</span><span style=\"letter-spacing:.05pt\">2</span><span style=\"letter-spacing:-.1pt\">1</span>3)</span>", "ID": "1eb1252b-7c00-4505-89b6-d49e94bff2c7", "Styles": "font-size:9.0pt", "Classes": "None", "Text": ". (3)", "ParentId": "dd668725-7914-4e35-97a8-8da7b39681d8"}, {"Element": "<span style=\"letter-spacing:.05pt\">6</span>", "ID": "6224bc74-4b65-4092-b68f-8bd5acbbe5f1", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">%</span>", "ID": "66ec282d-f180-4e05-a464-bcac28b6df5e", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<span style=\"letter-spacing:.05pt\">14</span>", "ID": "a3c6b870-d69e-4050-85a6-9400795b831f", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "14", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">/</span>", "ID": "f8386456-83a6-451e-8e06-56fc72c3c4b6", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "/", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<span style=\"letter-spacing:.05pt\">2</span>", "ID": "52de18f3-bc0f-47f5-9e13-e746525db99f", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">1</span>", "ID": "9c7aa7d0-82de-4ea9-aa16-8dd65e03a311", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "1", "ParentId": "1eb1252b-7c00-4505-89b6-d49e94bff2c7"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "6c0cb5e7-5720-4224-a453-829dc46f46dd", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "4c47c995-60b4-44ca-879f-a9078e07109d", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c0cb5e7-5720-4224-a453-829dc46f46dd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "0f7b712f-f2e8-4e47-8d44-de88a635842d", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "4c47c995-60b4-44ca-879f-a9078e07109d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "bb2a7aed-55b0-4e1c-b19d-977cf65c0c48", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "4c47c995-60b4-44ca-879f-a9078e07109d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span>", "ID": "5f9d4e04-990e-4036-9086-f0f0cedd061f", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "4c47c995-60b4-44ca-879f-a9078e07109d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "63613d56-9aad-420b-a8a4-d2ff705b7572", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "4c47c995-60b4-44ca-879f-a9078e07109d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "d5dca6c1-c5bb-4712-96b3-22df5776256b", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/3)", "ParentId": "4c47c995-60b4-44ca-879f-a9078e07109d"}, {"Element": "<span style=\"letter-spacing:.05pt\">6</span>", "ID": "b6491a81-c23f-4ab9-aa3a-baab654eac34", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "d5dca6c1-c5bb-4712-96b3-22df5776256b"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "ea2b78be-3166-4a31-bd36-c7a0b72627a6", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "d5dca6c1-c5bb-4712-96b3-22df5776256b"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "90a1e826-2e2c-49c0-9d0a-1bbb093423d1", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "d5dca6c1-c5bb-4712-96b3-22df5776256b"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"93\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "2c7b927c-68b9-44d4-b524-cbdf73e39980", "Styles": "width:69.65pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "27f896c8-f193-4df4-8a13-f3a45751d8ea", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2c7b927c-68b9-44d4-b524-cbdf73e39980"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "845bb6ba-da26-4176-bbee-39b1dc7070c4", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "27f896c8-f193-4df4-8a13-f3a45751d8ea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "162d5ee6-cca7-4591-9d15-7cbe23082a75", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "27f896c8-f193-4df4-8a13-f3a45751d8ea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span>", "ID": "b0bb507d-e913-4c3d-b800-a36c0a852bb0", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "27f896c8-f193-4df4-8a13-f3a45751d8ea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "06877d10-6b24-468a-b848-46d4b067369e", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "27f896c8-f193-4df4-8a13-f3a45751d8ea"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">6</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "c5693e74-637c-414b-a294-1103c00649d4", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/3)", "ParentId": "27f896c8-f193-4df4-8a13-f3a45751d8ea"}, {"Element": "<span style=\"letter-spacing:.05pt\">6</span>", "ID": "6d180161-df62-4fbb-9527-7ce4cbd795d4", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "6", "ParentId": "c5693e74-637c-414b-a294-1103c00649d4"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "b113a547-b137-4e99-be85-bad8586bb3b0", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "c5693e74-637c-414b-a294-1103c00649d4"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "67389337-8ad4-4946-9a52-0e5479aa8ec9", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "c5693e74-637c-414b-a294-1103c00649d4"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"75\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "92c21778-823c-47fa-acae-27f40cff1276", "Styles": "width:56.2pt;border-top:none;border-left:none;border-bottom:\n  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "d338e7b8-9405-4585-95b1-6f88574b5e91", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92c21778-823c-47fa-acae-27f40cff1276"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "d84870e8-e119-4f1a-bc10-f56a46bc94ec", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "d338e7b8-9405-4585-95b1-6f88574b5e91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "1c4b073d-613f-4fad-b746-99701c87a5d1", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "d338e7b8-9405-4585-95b1-6f88574b5e91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">8</span>", "ID": "875c7dc0-f512-48c5-9055-d1b9d3a9708c", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "d338e7b8-9405-4585-95b1-6f88574b5e91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "079e0955-194c-4e6d-a3b8-a46aeabc6c53", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "d338e7b8-9405-4585-95b1-6f88574b5e91"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">8</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "961d1c28-cfc5-4917-b4bc-c8caceb7b1c4", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/3)", "ParentId": "d338e7b8-9405-4585-95b1-6f88574b5e91"}, {"Element": "<span style=\"letter-spacing:.05pt\">8</span>", "ID": "4224c763-bd28-4977-87a6-91de6345cea4", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "8", "ParentId": "961d1c28-cfc5-4917-b4bc-c8caceb7b1c4"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "650e2991-e283-4af8-9f8b-c5f127fae08e", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "961d1c28-cfc5-4917-b4bc-c8caceb7b1c4"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "5d0bed28-55d8-4490-bcf3-4ba168e7523c", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "961d1c28-cfc5-4917-b4bc-c8caceb7b1c4"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"113\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>\n</td>", "ID": "50459b67-842b-41e5-8d89-726041e875ce", "Styles": "width:85.05pt;border-top:none;border-left:none;\n  border-bottom:solid black 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8beee7db-3e3d-4f0b-bcba-fd0c64e9d07c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span></p>", "ID": "18632712-277b-4065-a7fa-98ae5b8fe34b", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50459b67-842b-41e5-8d89-726041e875ce"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">2</span>", "ID": "702aa859-c631-4d2b-ab65-650af07e2f4f", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "2", "ParentId": "18632712-277b-4065-a7fa-98ae5b8fe34b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">.</span>", "ID": "c81d0279-30b9-42d6-9188-41542b2aeeb7", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": ".", "ParentId": "18632712-277b-4065-a7fa-98ae5b8fe34b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">3</span>", "ID": "cd94b276-684d-4d3b-a6f7-83c2702d96e7", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "3", "ParentId": "18632712-277b-4065-a7fa-98ae5b8fe34b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:-.1pt\">%</span>", "ID": "edf30a3b-d55e-4e3e-9ff3-044ec9c0cee4", "Styles": "font-size:9.0pt;letter-spacing:-.1pt", "Classes": "None", "Text": "%", "ParentId": "18632712-277b-4065-a7fa-98ae5b8fe34b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt\"> (<span style=\"letter-spacing:.05pt\">5</span>/<span style=\"letter-spacing:-.1pt\">2</span><span style=\"letter-spacing:.05pt\">1</span>3)</span>", "ID": "29ab47d3-00b7-4d45-ab39-87b1be963b02", "Styles": "font-size:9.0pt", "Classes": "None", "Text": " (/3)", "ParentId": "18632712-277b-4065-a7fa-98ae5b8fe34b"}, {"Element": "<span style=\"letter-spacing:.05pt\">5</span>", "ID": "328f5c99-3ff7-4971-b1cd-276677e5309d", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "5", "ParentId": "29ab47d3-00b7-4d45-ab39-87b1be963b02"}, {"Element": "<span style=\"letter-spacing:-.1pt\">2</span>", "ID": "066264d0-42a6-4dd8-b26d-d94c15e87ad3", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "2", "ParentId": "29ab47d3-00b7-4d45-ab39-87b1be963b02"}, {"Element": "<span style=\"letter-spacing:.05pt\">1</span>", "ID": "85b1adb3-181c-481e-b0ce-7ff0ce47f17f", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "1", "ParentId": "29ab47d3-00b7-4d45-ab39-87b1be963b02"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:\n  solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:56.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>\n</tr>", "ID": "3cfb5db8-7c53-4afe-8223-d04355107959", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "       ", "ParentId": "6b71fa40-0f4d-4581-947f-cc110de59005"}, {"Element": "<td style=\"width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:\n  solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>\n</td>", "ID": "650a7e3a-7074-453a-a443-4c0112bc149b", "Styles": "width:115.9pt;border-top:none;border-left:\n  solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right:\n  solid black 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span></p>", "ID": "8031a157-d57c-4872-bfd6-46c13a888fba", "Styles": "line-height:normal;page-break-after:avoid;\n  punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "650a7e3a-7074-453a-a443-4c0112bc149b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">No<span style=\"letter-spacing:-.55pt\"> </span>a<span style=\"letter-spacing:-.05pt\">ss</span>e<span style=\"letter-spacing:-.05pt\">s</span><span style=\"letter-spacing:.05pt\">s</span><span style=\"letter-spacing:-.1pt\">m</span><span style=\"letter-spacing:.1pt\">e</span><span style=\"letter-spacing:-.1pt\">n</span>t</span>", "ID": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Noaet", "ParentId": "8031a157-d57c-4872-bfd6-46c13a888fba"}, {"Element": "<span style=\"letter-spacing:-.55pt\"> </span>", "ID": "50c32b60-7ea9-4344-909e-41ce3737c603", "Styles": "letter-spacing:-.55pt", "Classes": "None", "Text": " ", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:-.05pt\">ss</span>", "ID": "1f8375ac-6c76-4d18-bd60-d76e33b70195", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "ss", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:-.05pt\">s</span>", "ID": "e28d9e5a-635e-4eba-8217-8833a7d7bbe0", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "s", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:.05pt\">s</span>", "ID": "aa74e8c8-5542-4572-9ca0-a8d15ea0ca14", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "s", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">m</span>", "ID": "bdb44180-d491-4521-9103-083a0e230c22", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "m", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:.1pt\">e</span>", "ID": "691538c4-08b0-448a-b87e-534f3d987622", "Styles": "letter-spacing:.1pt", "Classes": "None", "Text": "e", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<span style=\"letter-spacing:-.1pt\">n</span>", "ID": "c5bd3a75-0fc9-4b1a-909e-ac0df4ffe6d4", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "n", "ParentId": "02a97bd7-4caf-4b7e-a360-f37e07dbd4c7"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>", "ID": "696ff56e-7754-47c4-944c-c61334244093", "Styles": "width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>", "ID": "5bf73294-c5ab-4fe7-8bc6-4630ef13fd07", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "696ff56e-7754-47c4-944c-c61334244093"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span>", "ID": "b283fd42-f950-4eca-844f-3ff8fd84f349", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "23", "ParentId": "5bf73294-c5ab-4fe7-8bc6-4630ef13fd07"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>", "ID": "2ac3611d-b7f8-4937-8849-cfa4b86d57e0", "Styles": "width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>", "ID": "417fb9f7-7b8d-4772-a4e4-91d70e2fb160", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ac3611d-b7f8-4937-8849-cfa4b86d57e0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span>", "ID": "473c3e39-4ecc-46e3-93ec-f6ac3983bd27", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "23", "ParentId": "417fb9f7-7b8d-4772-a4e4-91d70e2fb160"}, {"Element": "<td style=\"width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"93\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>", "ID": "655d1d37-68f6-4a41-a549-f6b37aa6a914", "Styles": "width:69.65pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>", "ID": "b033f9dd-8cb8-40e7-bb2e-a60b59c81b3b", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "655d1d37-68f6-4a41-a549-f6b37aa6a914"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span>", "ID": "566eb120-c696-42d9-ae66-6feb73140aa5", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "23", "ParentId": "b033f9dd-8cb8-40e7-bb2e-a60b59c81b3b"}, {"Element": "<td style=\"width:56.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"75\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>", "ID": "d607fcfd-6727-4aa1-8df0-217b6687c790", "Styles": "width:56.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>", "ID": "fa0cc7bb-a8ba-45be-bba8-267a56c0e1c2", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d607fcfd-6727-4aa1-8df0-217b6687c790"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span>", "ID": "0453de63-1a53-474a-9ab9-0038e540fd85", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "23", "ParentId": "fa0cc7bb-a8ba-45be-bba8-267a56c0e1c2"}, {"Element": "<td style=\"width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"113\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>\n</td>", "ID": "1b74bb7b-752e-4823-997b-190c4c80d12d", "Styles": "width:85.05pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3cfb5db8-7c53-4afe-8223-d04355107959"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span></p>", "ID": "05a7488c-4ad4-4501-87c1-499284a11a8c", "Styles": "text-align:center;line-height:normal;\n  page-break-after:avoid;punctuation-wrap:simple;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b74bb7b-752e-4823-997b-190c4c80d12d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;letter-spacing:.05pt\">23</span>", "ID": "f64fbc00-f3d0-49e0-b67e-2903383d3c7b", "Styles": "font-size:9.0pt;letter-spacing:.05pt", "Classes": "None", "Text": "23", "ParentId": "05a7488c-4ad4-4501-87c1-499284a11a8c"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">Note:\u00a0\u00a0\u00a0 Baseline\nfrequency of ascites was: 20% none, 77% mild/moderate, 3% severe</span></p>", "ID": "9b365421-273b-4045-8eda-4d3895d2c913", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">Note:\u00a0\u00a0\u00a0 Baseline\nfrequency of ascites was: 20% none, 77% mild/moderate, 3% severe</span>", "ID": "68f504d5-9124-4062-bd4b-41eaf748b13a", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "Note:\u00a0\u00a0\u00a0 Baseline frequency of ascites was: 20% none, 77% mild/moderate, 3% severe", "ParentId": "9b365421-273b-4045-8eda-4d3895d2c913"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Baseline\nfrequency of encephalopathy was: 38% none, 62% grade\u00a01\u20112.</span></p>", "ID": "d44e265b-da83-4f51-8006-884f28da596f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Baseline\nfrequency of encephalopathy was: 38% none, 62% grade\u00a01\u20112.</span>", "ID": "21fe4ed1-11e4-46f8-897e-58d3e44f9fdc", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Baseline frequency of encephalopathy was: 38% none, 62% grade\u00a01\u20112.", "ParentId": "d44e265b-da83-4f51-8006-884f28da596f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "743daf5e-8981-4cea-983e-bcaa9350472f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27322832-f2d8-40e4-b0d8-be1764f11eed", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "743daf5e-8981-4cea-983e-bcaa9350472f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Clinical studies in patients with HCV/HIV\u20111 Co-infection <b>\u2013</b>\nASTRAL\u20115 (study\u00a01202)</span></i></p>", "ID": "810cf5dd-1e13-4ca4-abf8-103648fa444d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Clinical studies in patients with HCV/HIV\u20111 Co-infection <b>\u2013</b>\nASTRAL\u20115 (study\u00a01202)</span></i>", "ID": "d8bec3ee-e6ad-494e-bf0f-301bccff4e6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "810cf5dd-1e13-4ca4-abf8-103648fa444d"}, {"Element": "<span lang=\"EN-GB\">Clinical studies in patients with HCV/HIV\u20111 Co-infection <b>\u2013</b>\nASTRAL\u20115 (study\u00a01202)</span>", "ID": "619344d8-57b7-46a9-9d37-7ea23f39b03e", "Styles": "None", "Classes": "None", "Text": "Clinical studies in patients with HCV/HIV\u20111 Co-infection  ASTRAL\u20115 (study\u00a01202)", "ParentId": "d8bec3ee-e6ad-494e-bf0f-301bccff4e6d"}, {"Element": "<b>\u2013</b>", "ID": "bbdd0e66-1b92-4bde-a046-5b8db122f83f", "Styles": "None", "Classes": "None", "Text": "\u2013", "ParentId": "619344d8-57b7-46a9-9d37-7ea23f39b03e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ASTRAL\u20115\nevaluated 12\u00a0weeks of treatment with Epclusa in patients with genotype\u00a01,\n2, 3, or 4 HCV infection who were co-infected with HIV\u20111 (HCV genotype\u00a05\nand 6 allowed, but no such patients were included).\u00a0 Patients were on a\nstable HIV\u20111 antiretroviral therapy that included emtricitabine/tenofovir\ndisoproxil fumarate or abacavir/lamivudine administered with a ritonavir boosted\nprotease inhibitor (atazanavir, darunavir, or lopinavir), rilpivirine,\nraltegravir or emtricitabine/tenofovir disoproxil fumarate /elvitegravir/cobicistat.</span></p>", "ID": "4501d32d-b485-4770-a648-422cb04a5ca1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">ASTRAL\u20115\nevaluated 12\u00a0weeks of treatment with Epclusa in patients with genotype\u00a01,\n2, 3, or 4 HCV infection who were co-infected with HIV\u20111 (HCV genotype\u00a05\nand 6 allowed, but no such patients were included).\u00a0 Patients were on a\nstable HIV\u20111 antiretroviral therapy that included emtricitabine/tenofovir\ndisoproxil fumarate or abacavir/lamivudine administered with a ritonavir boosted\nprotease inhibitor (atazanavir, darunavir, or lopinavir), rilpivirine,\nraltegravir or emtricitabine/tenofovir disoproxil fumarate /elvitegravir/cobicistat.</span>", "ID": "53c6698f-8ba0-4429-909a-d275ef755376", "Styles": "None", "Classes": "None", "Text": "ASTRAL\u20115 evaluated 12\u00a0weeks of treatment with Epclusa in patients with genotype\u00a01, 2, 3, or 4 HCV infection who were co-infected with HIV\u20111 (HCV genotype\u00a05 and 6 allowed, but no such patients were included).\u00a0 Patients were on a stable HIV\u20111 antiretroviral therapy that included emtricitabine/tenofovir disoproxil fumarate or abacavir/lamivudine administered with a ritonavir boosted protease inhibitor (atazanavir, darunavir, or lopinavir), rilpivirine, raltegravir or emtricitabine/tenofovir disoproxil fumarate /elvitegravir/cobicistat.", "ParentId": "4501d32d-b485-4770-a648-422cb04a5ca1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cdfed4ad-aec0-41be-83ff-a79b701d5191", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25293149-45d6-4f9e-b357-9fcfbe77e4c7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cdfed4ad-aec0-41be-83ff-a79b701d5191"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Of the 106\ntreated patients, the median age was 57\u00a0years (range: 25 to 72); 86% of\nthe patients were male; 51% were white; 45% were black; 22% had a baseline body\nmass index \u2265\u00a030\u00a0kg/m<sup>2</sup>; 19 patients (18%) had\ncompensated cirrhosis; and 29% were treatment experienced.\u00a0 The overall\nmean CD4+ count was 598\u00a0cells/\u00b5L (range: 183\u22121513\u00a0cells/\u00b5L).</span></p>", "ID": "9ebccad1-cf93-4e1b-979d-610417048466", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Of the 106\ntreated patients, the median age was 57\u00a0years (range: 25 to 72); 86% of\nthe patients were male; 51% were white; 45% were black; 22% had a baseline body\nmass index \u2265\u00a030\u00a0kg/m<sup>2</sup>; 19 patients (18%) had\ncompensated cirrhosis; and 29% were treatment experienced.\u00a0 The overall\nmean CD4+ count was 598\u00a0cells/\u00b5L (range: 183\u22121513\u00a0cells/\u00b5L).</span>", "ID": "22952ff4-b614-4e9c-b357-373259f73f8c", "Styles": "None", "Classes": "None", "Text": "Of the 106 treated patients, the median age was 57\u00a0years (range: 25 to 72); 86% of the patients were male; 51% were white; 45% were black; 22% had a baseline body mass index \u2265\u00a030\u00a0kg/m; 19 patients (18%) had compensated cirrhosis; and 29% were treatment experienced.\u00a0 The overall mean CD4+ count was 598\u00a0cells/\u00b5L (range: 183\u22121513\u00a0cells/\u00b5L).", "ParentId": "9ebccad1-cf93-4e1b-979d-610417048466"}, {"Element": "<sup>2</sup>", "ID": "f3d6482f-caaf-4eee-90f1-232820dc0b25", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "22952ff4-b614-4e9c-b357-373259f73f8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3259ca2-7de0-46ec-851c-a1bd5073901b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a860ab6e-e8ba-43b8-99c3-2e27c168afc9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3259ca2-7de0-46ec-851c-a1bd5073901b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Table\u00a017\npresents the SVR12 for the ASTRAL\u20115 study by HCV genotype.</span></p>", "ID": "cd3ccb27-0e07-4f63-ab2a-b198435cd798", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Table\u00a017\npresents the SVR12 for the ASTRAL\u20115 study by HCV genotype.</span>", "ID": "1f515583-b718-452d-beb7-bc3dd6110d7a", "Styles": "None", "Classes": "None", "Text": "Table\u00a017 presents the SVR12 for the ASTRAL\u20115 study by HCV genotype.", "ParentId": "cd3ccb27-0e07-4f63-ab2a-b198435cd798"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be59689c-0a85-4696-8b2e-e2d7a6276657", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1107586a-a33d-4f18-abfe-ccc9be237a07", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be59689c-0a85-4696-8b2e-e2d7a6276657"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a017: SVR12 in study ASTRAL\u20115 by HCV genotype</span></b></p>", "ID": "6db70e01-67b4-4062-a400-f5fc8383dc8f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a017: SVR12 in study ASTRAL\u20115 by HCV genotype</span></b>", "ID": "d76e4bc6-6fbb-4952-891b-e82faf332bee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6db70e01-67b4-4062-a400-f5fc8383dc8f"}, {"Element": "<span lang=\"EN-GB\">Table\u00a017: SVR12 in study ASTRAL\u20115 by HCV genotype</span>", "ID": "77494aa2-4841-4d54-ab70-c49216adb9c6", "Styles": "None", "Classes": "None", "Text": "Table\u00a017: SVR12 in study ASTRAL\u20115 by HCV genotype", "ParentId": "d76e4bc6-6fbb-4952-891b-e82faf332bee"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"631\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"7\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"246\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"8\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>\n</table>", "ID": "59bff665-9b2f-4ea3-9903-7901014074f2", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"7\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"246\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "59ed00f9-f370-4be5-a8f1-4a4b1bc270a9", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>\n<td colspan=\"7\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n</tr>", "ID": "8c2304e1-5940-4805-bebd-84dace4de38b", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "59ed00f9-f370-4be5-a8f1-4a4b1bc270a9"}, {"Element": "<td rowspan=\"3\" style=\"width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>\n</td>", "ID": "c52fa92b-9cb9-4f85-8333-f0cf21d12064", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8c2304e1-5940-4805-bebd-84dace4de38b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b></p>", "ID": "44a34dd3-a18b-45e0-bfc5-8c8670992420", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c52fa92b-9cb9-4f85-8333-f0cf21d12064"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span></b>", "ID": "e4c0b9bd-5162-4430-ab2e-cc06bfe49439", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "44a34dd3-a18b-45e0-bfc5-8c8670992420"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a0</span>", "ID": "f92e7ba8-7b0d-488d-9fbf-4b7ffcb395bd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "e4c0b9bd-5162-4430-ab2e-cc06bfe49439"}, {"Element": "<td colspan=\"7\" style=\"width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"558\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>", "ID": "62ad459a-d714-4bb1-aa70-2ed73ca15326", "Styles": "width:418.5pt;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "8c2304e1-5940-4805-bebd-84dace4de38b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b></p>", "ID": "00d162a9-e53d-40fe-9e5f-42a9e4a207cb", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "62ad459a-d714-4bb1-aa70-2ed73ca15326"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span></b>", "ID": "3d690ac8-594c-4d31-b751-b9b96b83f464", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00d162a9-e53d-40fe-9e5f-42a9e4a207cb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Epclusa\n   12\u00a0weeks</span>", "ID": "6a370520-fb55-44df-8906-a8e66a3283f8", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Epclusa    12\u00a0weeks", "ParentId": "3d690ac8-594c-4d31-b751-b9b96b83f464"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>", "ID": "53dcc4ab-fc98-48e9-a787-e4dda38a0ab1", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "62ad459a-d714-4bb1-aa70-2ed73ca15326"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b>", "ID": "ecf8b2ef-1113-4f25-bea8-f8295288fe12", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53dcc4ab-fc98-48e9-a787-e4dda38a0ab1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span>", "ID": "d50d8f30-574d-433f-8df1-c15ff34169e7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0106)", "ParentId": "ecf8b2ef-1113-4f25-bea8-f8295288fe12"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"246\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>\n</td>\n</tr>", "ID": "9045bbe0-cd87-448d-b987-67195f3ab995", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "      ", "ParentId": "59ed00f9-f370-4be5-a8f1-4a4b1bc270a9"}, {"Element": "<td rowspan=\"2\" style=\"width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>\n</td>", "ID": "2b4799ad-35cc-45bd-ba0c-efdcc5c5bedc", "Styles": "width:71.2pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "9045bbe0-cd87-448d-b987-67195f3ab995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "8db47cf3-f9c1-4dd7-82ff-d6abb48b5bf9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b4799ad-35cc-45bd-ba0c-efdcc5c5bedc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "671839bc-7d62-4fe1-a52b-87d1cbaa0f09", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8db47cf3-f9c1-4dd7-82ff-d6abb48b5bf9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "9926657c-c247-42d6-b5e3-d89d31f880c3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "671839bc-7d62-4fe1-a52b-87d1cbaa0f09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b></p>", "ID": "588fa5ea-e4c1-4ab2-b67f-6b6315fb1e82", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b4799ad-35cc-45bd-ba0c-efdcc5c5bedc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span></b>", "ID": "b8ced81c-9158-429e-9593-149d5eee8441", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "588fa5ea-e4c1-4ab2-b67f-6b6315fb1e82"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(all GTs)</span>", "ID": "70caa6f1-464d-4719-ad14-93543818f130", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(all GTs)", "ParentId": "b8ced81c-9158-429e-9593-149d5eee8441"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b></p>", "ID": "6feff680-54c6-4a29-a958-90684d714be4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b4799ad-35cc-45bd-ba0c-efdcc5c5bedc"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span></b>", "ID": "33864c42-ab77-4e36-96df-6ea6f200f319", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6feff680-54c6-4a29-a958-90684d714be4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a0106)</span>", "ID": "b71294a2-ac91-4122-a494-3c51d34fa320", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a0106)", "ParentId": "33864c42-ab77-4e36-96df-6ea6f200f319"}, {"Element": "<td colspan=\"3\" style=\"width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"246\">\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>\n</td>", "ID": "97fba7b2-b7fd-417d-b09f-e094c073db2f", "Styles": "width:184.3pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9045bbe0-cd87-448d-b987-67195f3ab995"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\n   page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b></p>", "ID": "73dcc44a-713c-470e-9684-b9382e15e078", "Styles": "text-align:center;line-height:normal;\n   page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97fba7b2-b7fd-417d-b09f-e094c073db2f"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span></b>", "ID": "31e8b9c2-fbee-4160-b991-e46052fb22a6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "73dcc44a-713c-470e-9684-b9382e15e078"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111</span>", "ID": "9320280f-2b05-4cc6-9c3f-281e45b790d1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111", "ParentId": "31e8b9c2-fbee-4160-b991-e46052fb22a6"}, {"Element": "<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>\n</td>", "ID": "0eccfd7b-8f42-4efb-910a-6ef7d7589467", "Styles": "width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "9045bbe0-cd87-448d-b987-67195f3ab995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b></p>", "ID": "47da52cf-1d66-4d90-8fc4-c3c6724abaf6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0eccfd7b-8f42-4efb-910a-6ef7d7589467"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span></b>", "ID": "4033a9ef-eef0-4c1e-a09d-e1f0bca973c4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "47da52cf-1d66-4d90-8fc4-c3c6724abaf6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20112</span>", "ID": "f418dcd1-fafb-48fd-bd9a-7f9cf15afd9a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20112", "ParentId": "4033a9ef-eef0-4c1e-a09d-e1f0bca973c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b></p>", "ID": "cd1afe07-6a7f-4751-9f53-f4bb84c80173", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0eccfd7b-8f42-4efb-910a-6ef7d7589467"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span></b>", "ID": "0525575c-03ce-43b8-abd7-ce67fcc4c56d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd1afe07-6a7f-4751-9f53-f4bb84c80173"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a011)</span>", "ID": "8a7123d2-1af4-4193-9a60-2ee674f00e66", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a011)", "ParentId": "0525575c-03ce-43b8-abd7-ce67fcc4c56d"}, {"Element": "<td rowspan=\"2\" style=\"width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>", "ID": "56f00f00-a7e8-4830-98d3-6635680324ba", "Styles": "width:56.7pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "9045bbe0-cd87-448d-b987-67195f3ab995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b></p>", "ID": "279606e0-010b-46fc-ab3e-e3e994291f37", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "56f00f00-a7e8-4830-98d3-6635680324ba"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span></b>", "ID": "8cc9ab06-d6f0-4bb0-b80d-47b5f0d7f770", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "279606e0-010b-46fc-ab3e-e3e994291f37"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20113</span>", "ID": "ec4f89bf-f530-4367-9d83-b51aa72b55f1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20113", "ParentId": "8cc9ab06-d6f0-4bb0-b80d-47b5f0d7f770"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>", "ID": "50f32003-28a2-4b6e-b50c-f6821ec23da7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "56f00f00-a7e8-4830-98d3-6635680324ba"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b>", "ID": "6c7cd202-84c5-4f6a-8657-3bd7891a5c03", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50f32003-28a2-4b6e-b50c-f6821ec23da7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span>", "ID": "3639d023-7594-4252-82d2-5a7a8d8c1d6e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a012)", "ParentId": "6c7cd202-84c5-4f6a-8657-3bd7891a5c03"}, {"Element": "<td rowspan=\"2\" style=\"width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>\n</td>", "ID": "13e904e6-49a4-4fc2-a9ac-21747ca9fff9", "Styles": "width:49.6pt;border-top:none;\n   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "9045bbe0-cd87-448d-b987-67195f3ab995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b></p>", "ID": "45b33fdf-d423-4420-9f93-d81168b06b23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "13e904e6-49a4-4fc2-a9ac-21747ca9fff9"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span></b>", "ID": "a3eebf7f-f22c-43a7-adbf-5065306234ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45b33fdf-d423-4420-9f93-d81168b06b23"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20114</span>", "ID": "8fee3f42-13d9-45c4-826b-efb00edaa1a9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20114", "ParentId": "a3eebf7f-f22c-43a7-adbf-5065306234ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b></p>", "ID": "25f88e77-975e-4ce0-a36a-8d422dc9dec0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "13e904e6-49a4-4fc2-a9ac-21747ca9fff9"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span></b>", "ID": "faa7ae1a-8640-488a-840f-7a6066277e4f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25f88e77-975e-4ce0-a36a-8d422dc9dec0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a05)</span>", "ID": "e511078b-4d3d-4362-a937-2f972fe36688", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a05)", "ParentId": "faa7ae1a-8640-488a-840f-7a6066277e4f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>\n</td>\n</tr>", "ID": "97930396-1c98-4f41-9cbd-38682ec19fbd", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "59ed00f9-f370-4be5-a8f1-4a4b1bc270a9"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>\n</td>", "ID": "044e1807-3a8c-49de-aa3d-8f62cc1de507", "Styles": "width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "97930396-1c98-4f41-9cbd-38682ec19fbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b></p>", "ID": "12e79826-d193-4ae1-b38f-10dbb67bfaca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "044e1807-3a8c-49de-aa3d-8f62cc1de507"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span></b>", "ID": "33840d4b-06cd-4911-939f-4891f4226629", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "12e79826-d193-4ae1-b38f-10dbb67bfaca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111a</span>", "ID": "bfdbc05f-9cca-419d-a271-3e055ab95932", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111a", "ParentId": "33840d4b-06cd-4911-939f-4891f4226629"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b></p>", "ID": "92ba73b6-1cd0-4c0a-8e2f-683f7a42c65a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "044e1807-3a8c-49de-aa3d-8f62cc1de507"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span></b>", "ID": "37b5fc2b-5c51-4fc4-833a-8c9df58eb7e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92ba73b6-1cd0-4c0a-8e2f-683f7a42c65a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a066)</span>", "ID": "3a063cdd-31f0-4a4d-b5fe-0ffffc508ce7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a066)", "ParentId": "37b5fc2b-5c51-4fc4-833a-8c9df58eb7e9"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>\n</td>", "ID": "c6ae4920-3a3b-4b3b-b3df-a8513fd15a01", "Styles": "width:63.8pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "97930396-1c98-4f41-9cbd-38682ec19fbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b></p>", "ID": "b8e46959-89c2-4bb1-ad2e-31f5f5c9eadb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6ae4920-3a3b-4b3b-b3df-a8513fd15a01"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span></b>", "ID": "c6bc57e5-ac22-4935-bc88-3e0e825912f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8e46959-89c2-4bb1-ad2e-31f5f5c9eadb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">GT\u20111b</span>", "ID": "4e1c4ebb-574c-4f6c-8cd9-b3c67c4bd24c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "GT\u20111b", "ParentId": "c6bc57e5-ac22-4935-bc88-3e0e825912f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b></p>", "ID": "6c3e2caa-4e7a-4e11-b191-5238270ecaa8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6ae4920-3a3b-4b3b-b3df-a8513fd15a01"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span></b>", "ID": "cc682562-568d-438b-913b-cece5b7378db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c3e2caa-4e7a-4e11-b191-5238270ecaa8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a012)</span>", "ID": "67b2a88f-3b0c-46bc-97c7-4034c3175d20", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a012)", "ParentId": "cc682562-568d-438b-913b-cece5b7378db"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>\n</td>", "ID": "135f7149-cb95-4289-a0b7-8b423ddec04a", "Styles": "width:56.7pt;border-top:none;border-left:\n   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "97930396-1c98-4f41-9cbd-38682ec19fbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b></p>", "ID": "dab899b6-5a83-48d3-8177-735131f3a3d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "135f7149-cb95-4289-a0b7-8b423ddec04a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span></b>", "ID": "90d6bae7-a102-4bac-9689-0cf1a29d15f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dab899b6-5a83-48d3-8177-735131f3a3d8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Total</span>", "ID": "61b1bb39-b506-4218-b8ad-0ac794a8feb7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Total", "ParentId": "90d6bae7-a102-4bac-9689-0cf1a29d15f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b></p>", "ID": "2a467f18-d501-41a3-a9e7-341c99a11497", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "135f7149-cb95-4289-a0b7-8b423ddec04a"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span></b>", "ID": "e3171231-ea81-4df7-bdb0-1b4d23944444", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2a467f18-d501-41a3-a9e7-341c99a11497"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(n\u00a0=\u00a078)</span>", "ID": "e9f72b96-934c-4484-9110-fbd64428d34c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(n\u00a0=\u00a078)", "ParentId": "e3171231-ea81-4df7-bdb0-1b4d23944444"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span></p>\n</td>\n</tr>", "ID": "0b267298-da32-42d2-9ad5-b88524e8b163", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "         ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>\n</td>", "ID": "6e1c0f5e-c65a-428a-8579-4d3418d1b2b1", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span></p>", "ID": "02fbb0f0-e1f9-4ae8-8b19-874f760a957c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6e1c0f5e-c65a-428a-8579-4d3418d1b2b1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">SVR12</span>", "ID": "120e0168-78e6-4527-bd40-d082afa5fd5f", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "SVR12", "ParentId": "02fbb0f0-e1f9-4ae8-8b19-874f760a957c"}, {"Element": "<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span></p>\n</td>", "ID": "b7050673-83e2-40d8-8291-d74b3ff61a8e", "Styles": "width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>", "ID": "07e129c4-98e4-4191-9a86-1b05801e2e20", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7050673-83e2-40d8-8291-d74b3ff61a8e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span>", "ID": "63cca31b-81ef-413b-825b-6600a63b595c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%", "ParentId": "07e129c4-98e4-4191-9a86-1b05801e2e20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span></p>", "ID": "509093b7-131f-4561-a66c-1fa3374269fb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7050673-83e2-40d8-8291-d74b3ff61a8e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(101/106)</span>", "ID": "eafefd16-69ca-4222-9bf8-d58bf1c555f5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(101/106)", "ParentId": "509093b7-131f-4561-a66c-1fa3374269fb"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span></p>\n</td>", "ID": "af137e99-a714-471b-b65b-8f353c81cbc2", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>", "ID": "02908af4-b6ac-4ebd-b912-5aa73c89f07e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af137e99-a714-471b-b65b-8f353c81cbc2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span>", "ID": "27946e54-4254-4ac5-b676-0a4065457341", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%", "ParentId": "02908af4-b6ac-4ebd-b912-5aa73c89f07e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span></p>", "ID": "b3348faf-d2e8-4650-8c42-d03bd7daa6f8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af137e99-a714-471b-b65b-8f353c81cbc2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(63/66)</span>", "ID": "b08935fd-cba6-4255-8a27-7598a546168e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(63/66)", "ParentId": "b3348faf-d2e8-4650-8c42-d03bd7daa6f8"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>", "ID": "73b00f40-2563-4038-921d-ed9852143f43", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>", "ID": "bfbfba08-12e2-4914-a66d-bc8bc2db818d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73b00f40-2563-4038-921d-ed9852143f43"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span>", "ID": "55fd1d5d-c33d-4d9f-af23-f91ef6c1441b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "92%", "ParentId": "bfbfba08-12e2-4914-a66d-bc8bc2db818d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>", "ID": "c49a08cc-817f-417d-ac47-f734d7fc15c7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73b00f40-2563-4038-921d-ed9852143f43"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span>", "ID": "71dcf4f0-3275-43f1-98e9-de2ab7c60e74", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(11/12)", "ParentId": "c49a08cc-817f-417d-ac47-f734d7fc15c7"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span></p>\n</td>", "ID": "3c814eaa-a546-4f0e-8a4d-d3389efc3d54", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span></p>", "ID": "36cba0d0-2b19-4d23-a9e0-a5350e79d98c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c814eaa-a546-4f0e-8a4d-d3389efc3d54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">95%</span>", "ID": "bdd62754-5634-442e-985c-ef851117393d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "95%", "ParentId": "36cba0d0-2b19-4d23-a9e0-a5350e79d98c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span></p>", "ID": "8d3c279a-d1dd-4931-9a11-af0c35ea6dfe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c814eaa-a546-4f0e-8a4d-d3389efc3d54"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(74/78)</span>", "ID": "c842cd95-56ba-47e3-9310-3a0ce17da9c0", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(74/78)", "ParentId": "8d3c279a-d1dd-4931-9a11-af0c35ea6dfe"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span></p>\n</td>", "ID": "cd2d0941-18e0-487d-82cd-a8e20a3867bb", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>", "ID": "7886580c-6cc5-4b8c-bf2e-a4edf767e882", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd2d0941-18e0-487d-82cd-a8e20a3867bb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span>", "ID": "3ffff2ed-de25-44c6-b4dd-d8812fcd63ea", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%", "ParentId": "7886580c-6cc5-4b8c-bf2e-a4edf767e882"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span></p>", "ID": "d0151f87-8bd9-40cc-a938-a10d3c9a6a83", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd2d0941-18e0-487d-82cd-a8e20a3867bb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/11)</span>", "ID": "b65b4448-27ee-499f-bf5c-9e1a33c2d488", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(11/11)", "ParentId": "d0151f87-8bd9-40cc-a938-a10d3c9a6a83"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>\n</td>", "ID": "f2fccadb-68d0-4cfb-9297-dca74744029b", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span></p>", "ID": "34b4c9c0-481d-4269-bd6e-8c585b53970b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f2fccadb-68d0-4cfb-9297-dca74744029b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">92%</span>", "ID": "441a8375-be67-4175-813a-b0a680ee74a4", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "92%", "ParentId": "34b4c9c0-481d-4269-bd6e-8c585b53970b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span></p>", "ID": "8c007bdc-e717-4b9a-a688-c6a99201986c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f2fccadb-68d0-4cfb-9297-dca74744029b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(11/12)</span>", "ID": "3fba48e8-8693-440e-8ca0-e02776bdbe10", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(11/12)", "ParentId": "8c007bdc-e717-4b9a-a688-c6a99201986c"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span></p>\n</td>", "ID": "691c8e82-2447-43a6-92ad-adabac8fcb20", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "0b267298-da32-42d2-9ad5-b88524e8b163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span></p>", "ID": "bea7cf9f-b98c-4f44-afb7-1e5181916e29", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "691c8e82-2447-43a6-92ad-adabac8fcb20"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">100%</span>", "ID": "015817a3-d7ee-4e3d-a871-2889ac7ee82b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "100%", "ParentId": "bea7cf9f-b98c-4f44-afb7-1e5181916e29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span></p>", "ID": "217f337c-218f-4f1f-85bd-ac10c1140aa9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "691c8e82-2447-43a6-92ad-adabac8fcb20"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(5/5)</span>", "ID": "53aa95ee-6042-4e6b-8806-3a05816fe994", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(5/5)", "ParentId": "217f337c-218f-4f1f-85bd-ac10c1140aa9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"8\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span></p>\n</td>\n</tr>", "ID": "d084f384-893f-4c4c-b901-97c0769f8b2c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<td colspan=\"8\" style=\"width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" width=\"631\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span></p>\n</td>", "ID": "d85bb93c-aeb1-47d0-ba52-0c8554c019fe", "Styles": "width:473.2pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d084f384-893f-4c4c-b901-97c0769f8b2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span></p>", "ID": "844fdcc8-25a2-47d5-b250-5579dd3636eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d85bb93c-aeb1-47d0-ba52-0c8554c019fe"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Outcome for patients without SVR</span>", "ID": "c1f727b9-7b83-490d-9035-e7a2c0b5042b", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Outcome for patients without SVR", "ParentId": "844fdcc8-25a2-47d5-b250-5579dd3636eb"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>", "ID": "24863f95-6982-4bb7-b839-91d6ddaee838", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "         ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>\n</td>", "ID": "74d9272a-92ca-49fd-96bd-2b1eb7fdb021", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span></p>", "ID": "40c207fe-10c2-41f8-8ba2-a69c313cb445", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "74d9272a-92ca-49fd-96bd-2b1eb7fdb021"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">On-treatment virologic failure</span>", "ID": "b5dad5da-8370-4aba-b425-b695f0acbc5a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "On-treatment virologic failure", "ParentId": "40c207fe-10c2-41f8-8ba2-a69c313cb445"}, {"Element": "<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span></p>\n</td>", "ID": "73104568-e8fe-43df-8a8c-b5ef256078cf", "Styles": "width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span></p>", "ID": "fb63585b-aba9-4ffa-9bd1-60c71a2162c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73104568-e8fe-43df-8a8c-b5ef256078cf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/106</span>", "ID": "3625eb70-8d5a-4110-b8bc-159add10bc4a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/106", "ParentId": "fb63585b-aba9-4ffa-9bd1-60c71a2162c4"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span></p>\n</td>", "ID": "09b1fefe-d012-4d0b-9483-fa2c0420a679", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span></p>", "ID": "65b1b299-1ac3-4dbd-aff4-815468620621", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "09b1fefe-d012-4d0b-9483-fa2c0420a679"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/66</span>", "ID": "210d108d-56bb-4cc7-97f7-ef5be2e0ed14", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/66", "ParentId": "65b1b299-1ac3-4dbd-aff4-815468620621"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>", "ID": "5bd49330-2c97-4170-9da3-690f51593bfa", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>", "ID": "73c4ea48-9eec-48dd-a808-c098d9163b3c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5bd49330-2c97-4170-9da3-690f51593bfa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span>", "ID": "59a06756-a6a3-4acc-b825-943ba20a66b3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/12", "ParentId": "73c4ea48-9eec-48dd-a808-c098d9163b3c"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span></p>\n</td>", "ID": "e195d7a0-bf1e-41d9-bded-9fd7dd961260", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span></p>", "ID": "de2ef13f-59b1-45ed-bd9e-df337dc2d455", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e195d7a0-bf1e-41d9-bded-9fd7dd961260"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/78</span>", "ID": "c0016613-3d9c-47c4-aee3-38e0f0ebbee9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/78", "ParentId": "de2ef13f-59b1-45ed-bd9e-df337dc2d455"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>", "ID": "67783ea4-bc6d-4dc0-9290-27adc2a098b8", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>", "ID": "c4931709-142c-497a-8b88-a116715a0458", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "67783ea4-bc6d-4dc0-9290-27adc2a098b8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span>", "ID": "32347777-1f96-4bd3-91da-c64a578915a6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/11", "ParentId": "c4931709-142c-497a-8b88-a116715a0458"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>\n</td>", "ID": "2e6c7ceb-9383-48bc-96ad-daa4613ca3e9", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span></p>", "ID": "9f43e528-28fe-46c9-909a-0160795e9661", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e6c7ceb-9383-48bc-96ad-daa4613ca3e9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/12</span>", "ID": "88a23d0c-e8e8-43ce-a2d5-bfedce0dbaf5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/12", "ParentId": "9f43e528-28fe-46c9-909a-0160795e9661"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>", "ID": "f4554735-cab3-48f8-8c3c-6ea39677f9b4", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "24863f95-6982-4bb7-b839-91d6ddaee838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>", "ID": "c03ffb47-3e24-4945-8541-a20014608a32", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f4554735-cab3-48f8-8c3c-6ea39677f9b4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span>", "ID": "e24052b4-54e6-4b1e-a2b3-d81741dea2c6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/5", "ParentId": "c03ffb47-3e24-4945-8541-a20014608a32"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>", "ID": "7c767d3f-0a88-41fc-9921-8fda9053f79a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "         ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>\n</td>", "ID": "d45d09bc-6de3-49dd-b29f-74bae78cac20", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span></p>", "ID": "c4ec3548-7749-436c-b9b3-2d45c1059771", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d45d09bc-6de3-49dd-b29f-74bae78cac20"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Relapse<sup>a</sup></span>", "ID": "e7c78eca-7c82-4210-9000-c65cc4579aea", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Relapse", "ParentId": "c4ec3548-7749-436c-b9b3-2d45c1059771"}, {"Element": "<sup>a</sup>", "ID": "7cfd7ad5-05fe-4235-81aa-8a9a2ef7d579", "Styles": "None", "Classes": "None", "Text": "a", "ParentId": "e7c78eca-7c82-4210-9000-c65cc4579aea"}, {"Element": "<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span></p>\n</td>", "ID": "71959b79-30dd-4b98-930f-f6db18ea2f20", "Styles": "width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>", "ID": "aac0e888-61aa-4e53-8e27-0f1ba54da710", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71959b79-30dd-4b98-930f-f6db18ea2f20"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span>", "ID": "af0e6536-c3b2-484d-8c48-e0fa559eb820", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2%", "ParentId": "aac0e888-61aa-4e53-8e27-0f1ba54da710"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span></p>", "ID": "76f159f5-83c7-43cf-946c-b7b4f0b151ce", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71959b79-30dd-4b98-930f-f6db18ea2f20"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/103)</span>", "ID": "58df2634-7d0b-49a4-856c-d4474cebf611", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/103)", "ParentId": "76f159f5-83c7-43cf-946c-b7b4f0b151ce"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span></p>\n</td>", "ID": "ba02c3c4-01bf-4eef-b828-37f328d2e86e", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>", "ID": "44cd2bb1-b411-4c03-ad8a-c272c28baccd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba02c3c4-01bf-4eef-b828-37f328d2e86e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span>", "ID": "2a96bdc5-0c9c-44f6-965c-fc6ca23f611e", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3%", "ParentId": "44cd2bb1-b411-4c03-ad8a-c272c28baccd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span></p>", "ID": "2f049b50-dc6c-484b-a6f6-88d40dd80ed5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba02c3c4-01bf-4eef-b828-37f328d2e86e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/65)</span>", "ID": "aaff35c7-cdb8-4afe-a08a-25e26ab40a91", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/65)", "ParentId": "2f049b50-dc6c-484b-a6f6-88d40dd80ed5"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>", "ID": "39eef24f-3891-43be-996e-327a2747560a", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>", "ID": "e5ffbb3d-cc89-4c27-8a1c-da4a7944a719", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39eef24f-3891-43be-996e-327a2747560a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span>", "ID": "0ca7e12a-428a-40e1-85a8-c92c1bf40084", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/11", "ParentId": "e5ffbb3d-cc89-4c27-8a1c-da4a7944a719"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span></p>\n</td>", "ID": "cb0fe712-60f2-4d6a-a043-08f6122534d2", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>", "ID": "2fdc0599-b6ed-4b5a-ac32-5531f2a90c3e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb0fe712-60f2-4d6a-a043-08f6122534d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span>", "ID": "ec0c534f-6c84-4d50-9697-d7afe149a0cd", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3%", "ParentId": "2fdc0599-b6ed-4b5a-ac32-5531f2a90c3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span></p>", "ID": "75e1535e-1b3f-4014-8a2b-e6a832e56a62", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb0fe712-60f2-4d6a-a043-08f6122534d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/76)</span>", "ID": "2a5f6f7c-b92c-4a20-a501-95008a8e2908", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/76)", "ParentId": "75e1535e-1b3f-4014-8a2b-e6a832e56a62"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>", "ID": "85481386-919b-40b7-84f3-3957bbbb0231", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>", "ID": "98cf7746-293a-431a-8f6a-6eb620ec7f9f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "85481386-919b-40b7-84f3-3957bbbb0231"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span>", "ID": "990ba116-05a4-4a5b-a085-bf4de514af4a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/11", "ParentId": "98cf7746-293a-431a-8f6a-6eb620ec7f9f"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>", "ID": "39c2145e-c796-4e75-a066-53dfea227a35", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>", "ID": "7f25d5cc-1823-4265-8f44-a43d9c2045db", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "39c2145e-c796-4e75-a066-53dfea227a35"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span>", "ID": "87d056f5-056c-401c-840a-5e917be40f66", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/11", "ParentId": "7f25d5cc-1823-4265-8f44-a43d9c2045db"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>", "ID": "2d824b2c-4076-43fa-aed3-59a6a795e1f7", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7c767d3f-0a88-41fc-9921-8fda9053f79a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>", "ID": "8d15cb1b-9055-46a2-9325-396d07cb9029", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d824b2c-4076-43fa-aed3-59a6a795e1f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span>", "ID": "49578371-64bc-4fe3-8ba0-94f6ee228412", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/5", "ParentId": "8d15cb1b-9055-46a2-9325-396d07cb9029"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>\n<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span></p>\n</td>\n<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>\n<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>\n<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>\n</tr>", "ID": "f220833e-b97d-4259-a934-99ca3695ab57", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "         ", "ParentId": "59bff665-9b2f-4ea3-9903-7901014074f2"}, {"Element": "<td style=\"width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"73\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>\n</td>", "ID": "4ee46ab5-c45c-48e7-b567-7ba6b78f8ccc", "Styles": "width:54.7pt;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span></p>", "ID": "112cc98a-e672-4580-8fdb-f448944eb352", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4ee46ab5-c45c-48e7-b567-7ba6b78f8ccc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Other<sup>b</sup></span>", "ID": "ccf7847e-e4bb-4d76-a2c7-95533c4852db", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Other", "ParentId": "112cc98a-e672-4580-8fdb-f448944eb352"}, {"Element": "<sup>b</sup>", "ID": "4ffbb146-566f-4c66-a28f-66e4ddcc056b", "Styles": "None", "Classes": "None", "Text": "b", "ParentId": "ccf7847e-e4bb-4d76-a2c7-95533c4852db"}, {"Element": "<td style=\"width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"95\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span></p>\n</td>", "ID": "b4b15b7f-ec93-4303-a9d7-588d64e88ccb", "Styles": "width:71.2pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>", "ID": "70a3155a-f2e1-4ab1-b574-05b19878a257", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b4b15b7f-ec93-4303-a9d7-588d64e88ccb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span>", "ID": "67ef239f-877e-4908-8ff7-537b24e059e5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3%", "ParentId": "70a3155a-f2e1-4ab1-b574-05b19878a257"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span></p>", "ID": "5488c6fa-2f53-46e8-8ce5-6ad979469a9b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b4b15b7f-ec93-4303-a9d7-588d64e88ccb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(3/106)</span>", "ID": "fb2172df-c0f7-46f3-bc25-0d8578f301a6", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(3/106)", "ParentId": "5488c6fa-2f53-46e8-8ce5-6ad979469a9b"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span></p>\n</td>", "ID": "8d540c67-e09f-438f-9097-5d1b4d4f66eb", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span></p>", "ID": "fcf9d800-1526-43ad-b51c-01f60e3d56b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d540c67-e09f-438f-9097-5d1b4d4f66eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">2%</span>", "ID": "5494f308-94b7-4692-acd9-025bd130178d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "2%", "ParentId": "fcf9d800-1526-43ad-b51c-01f60e3d56b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span></p>", "ID": "5acd398d-bffe-4794-b30b-aae9c1742586", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d540c67-e09f-438f-9097-5d1b4d4f66eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/66)</span>", "ID": "ddcc8a9b-32fe-45d6-8835-a35f15ebae49", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/66)", "ParentId": "5acd398d-bffe-4794-b30b-aae9c1742586"}, {"Element": "<td style=\"width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>", "ID": "b488d10b-39e9-449c-9dfe-04449cb0107f", "Styles": "width:63.8pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>", "ID": "8a55fbf3-5c77-4af2-9fd0-d31e3a2505ce", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b488d10b-39e9-449c-9dfe-04449cb0107f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span>", "ID": "b714b385-eb64-4654-8495-1dca3749beed", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "8%", "ParentId": "8a55fbf3-5c77-4af2-9fd0-d31e3a2505ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>", "ID": "a61f6c05-0607-4922-be39-10c9d0c90c74", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b488d10b-39e9-449c-9dfe-04449cb0107f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span>", "ID": "114db437-621c-4b7b-9e3a-8a03f0ca5a40", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/12)", "ParentId": "a61f6c05-0607-4922-be39-10c9d0c90c74"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span></p>\n</td>", "ID": "263a2835-9cc4-4461-b5a4-1d303000d5eb", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span></p>", "ID": "f5da1f18-5a0c-4b7c-8002-83a794c42ebc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "263a2835-9cc4-4461-b5a4-1d303000d5eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">3%</span>", "ID": "bcf82091-5521-4d9d-813b-47c13fc12df5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "3%", "ParentId": "f5da1f18-5a0c-4b7c-8002-83a794c42ebc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span></p>", "ID": "d6a1a1cf-50a8-4f30-89ef-96ef2cc740d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "263a2835-9cc4-4461-b5a4-1d303000d5eb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(2/78)</span>", "ID": "5669e9b5-149c-48ea-9784-ffcf8930e47d", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(2/78)", "ParentId": "d6a1a1cf-50a8-4f30-89ef-96ef2cc740d8"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>\n</td>", "ID": "7d47e9ff-1ec0-4bef-9a10-4024b7d5415d", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span></p>", "ID": "87c94d67-6d4b-4e7f-a54c-1d0d338f8c93", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d47e9ff-1ec0-4bef-9a10-4024b7d5415d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/11</span>", "ID": "5e703fbb-0813-4486-8574-6ba9e1c66af3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/11", "ParentId": "87c94d67-6d4b-4e7f-a54c-1d0d338f8c93"}, {"Element": "<td style=\"width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"76\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>\n</td>", "ID": "bdd91789-ff11-4700-9f1f-d24e2371b89d", "Styles": "width:56.7pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span></p>", "ID": "239f90c5-0815-4c32-bf5f-049f8bf7c34f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bdd91789-ff11-4700-9f1f-d24e2371b89d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">8%</span>", "ID": "82e622fd-b881-46a5-b7e8-890560355ee5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "8%", "ParentId": "239f90c5-0815-4c32-bf5f-049f8bf7c34f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span></p>", "ID": "f1e8a3d6-73ba-4587-a61d-c9577633d455", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bdd91789-ff11-4700-9f1f-d24e2371b89d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">(1/12)</span>", "ID": "9c7943c0-046f-4438-87cb-0cd6d1d8f4a5", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "(1/12)", "ParentId": "f1e8a3d6-73ba-4587-a61d-c9577633d455"}, {"Element": "<td style=\"width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"66\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>\n</td>", "ID": "4953e4a1-02b9-4a46-ac2f-05728ab5f829", "Styles": "width:49.6pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f220833e-b97d-4259-a934-99ca3695ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span></p>", "ID": "dfd9a56a-e0b8-4d64-ba29-eb32a9e0b371", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4953e4a1-02b9-4a46-ac2f-05728ab5f829"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">0/5</span>", "ID": "206de139-9055-4dd6-8441-9ec3b0ee8def", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "0/5", "ParentId": "dfd9a56a-e0b8-4d64-ba29-eb32a9e0b371"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">GT\u00a0=\u00a0genotype</span></p>", "ID": "e37b3f55-cd8d-494c-abf4-e9a7ae1c558b", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">GT\u00a0=\u00a0genotype</span>", "ID": "6a36a18c-51ea-44df-ac87-c6d8c2e6d279", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "GT\u00a0=\u00a0genotype", "ParentId": "e37b3f55-cd8d-494c-abf4-e9a7ae1c558b"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA\n&lt;\u00a0LLOQ at their last on-treatment assessment.</span></p>", "ID": "fdd40b46-31d7-46f7-a5eb-ee90f7a98074", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;page-break-after:\navoid", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">a\u00a0\u00a0\u00a0\u00a0 The\ndenominator for relapse is the number of patients with HCV\u00a0RNA\n&lt;\u00a0LLOQ at their last on-treatment assessment.</span>", "ID": "cd8ea77f-1eff-4015-a5ba-923c3e771c32", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "a\u00a0\u00a0\u00a0\u00a0 The denominator for relapse is the number of patients with HCV\u00a0RNA <\u00a0LLOQ at their last on-treatment assessment.", "ParentId": "fdd40b46-31d7-46f7-a5eb-ee90f7a98074"}, {"Element": "<p class=\"Default\" style=\"margin-left:14.2pt;text-indent:-14.2pt\"><span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span></p>", "ID": "2044576f-98d5-46cf-a9e2-4d9d1452f291", "Styles": "margin-left:14.2pt;text-indent:-14.2pt", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:9.0pt;color:windowtext\">b\u00a0\u00a0\u00a0 Other\nincludes patients who did not achieve SVR12 and did not meet virologic failure\ncriteria.</span>", "ID": "48495de4-6b3d-4b2a-82e5-80e972ea37a2", "Styles": "font-size:9.0pt;color:windowtext", "Classes": "None", "Text": "b\u00a0\u00a0\u00a0 Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.", "ParentId": "2044576f-98d5-46cf-a9e2-4d9d1452f291"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bccb8356-6542-470d-b82a-b9e16d6c0523", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b13e699c-14e2-4af6-9350-75f3083dc67f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bccb8356-6542-470d-b82a-b9e16d6c0523"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SVR12 was achieved\nby 19/19 patients with cirrhosis. \u00a0No patient had HIV\u20111 rebound\nduring the study, and CD4+ counts were stable during treatment.</span></p>", "ID": "b2e363de-fbab-4858-8066-0fc637cee3ed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">SVR12 was achieved\nby 19/19 patients with cirrhosis. \u00a0No patient had HIV\u20111 rebound\nduring the study, and CD4+ counts were stable during treatment.</span>", "ID": "aa489308-62d9-470a-9ad6-7a1e3d157e8e", "Styles": "None", "Classes": "None", "Text": "SVR12 was achieved by 19/19 patients with cirrhosis. \u00a0No patient had HIV\u20111 rebound during the study, and CD4+ counts were stable during treatment.", "ParentId": "b2e363de-fbab-4858-8066-0fc637cee3ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f10c9b25-35ae-4c88-aa55-987ffa4a423a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61af2fc6-f506-46a1-871b-5f2fc781e744", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f10c9b25-35ae-4c88-aa55-987ffa4a423a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>", "ID": "1ab5beee-a9c8-4964-8077-052cbac7b148", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Paediatric population</span></i>", "ID": "b931baf9-53cf-4e9a-8c90-bae1fe2afb75", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ab5beee-a9c8-4964-8077-052cbac7b148"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "f68c1534-2340-45d1-b467-aa11df1949e8", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "b931baf9-53cf-4e9a-8c90-bae1fe2afb75"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Epclusa in one or more subsets of the paediatric population in the\ntreatment of chronic hepatitis\u00a0C (see section\u00a04.2 for information on\npaediatric use).</span></p>", "ID": "baaa70d2-945d-42ca-ba02-caaa87a1a492", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Epclusa in one or more subsets of the paediatric population in the\ntreatment of chronic hepatitis\u00a0C (see section\u00a04.2 for information on\npaediatric use).</span>", "ID": "5baf8fe3-fa03-40f9-a609-459b3d3d2ddb", "Styles": "None", "Classes": "None", "Text": "The European Medicines Agency has deferred the obligation to submit the results of studies with Epclusa in one or more subsets of the paediatric population in the treatment of chronic hepatitis\u00a0C (see section\u00a04.2 for information on paediatric use).", "ParentId": "baaa70d2-945d-42ca-ba02-caaa87a1a492"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b2fd43e5-89be-4820-834b-551b7a54cc21", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4b980db6-6a26-4f8c-8cb2-7aa7912cf370", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b2fd43e5-89be-4820-834b-551b7a54cc21"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>", "ID": "41c89bf8-9616-4e3e-9852-deefc6d29435", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Elderly</span></i>", "ID": "7eb554e5-5363-4252-9313-ff1afe42dd4b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "41c89bf8-9616-4e3e-9852-deefc6d29435"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "a9e4c73c-d45c-48e5-a01d-cbf8b0b074cb", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "7eb554e5-5363-4252-9313-ff1afe42dd4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clinical studies\nof Epclusa included 156\u00a0patients aged\u00a065 and over (12% of total number\nof patients in the Phase\u00a03 clinical studies).\u00a0 The response rates\nobserved for patients \u2265\u00a065\u00a0years of age were similar to that of\npatients &lt;\u00a065\u00a0years of age, across treatment groups.</span></p>", "ID": "0d911eb7-ea71-4779-b7c6-dc82375a4a69", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Clinical studies\nof Epclusa included 156\u00a0patients aged\u00a065 and over (12% of total number\nof patients in the Phase\u00a03 clinical studies).\u00a0 The response rates\nobserved for patients \u2265\u00a065\u00a0years of age were similar to that of\npatients &lt;\u00a065\u00a0years of age, across treatment groups.</span>", "ID": "463f1e5b-2350-46c6-bd71-1019104f9028", "Styles": "None", "Classes": "None", "Text": "Clinical studies of Epclusa included 156\u00a0patients aged\u00a065 and over (12% of total number of patients in the Phase\u00a03 clinical studies).\u00a0 The response rates observed for patients \u2265\u00a065\u00a0years of age were similar to that of patients <\u00a065\u00a0years of age, across treatment groups.", "ParentId": "0d911eb7-ea71-4779-b7c6-dc82375a4a69"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "97053170-4f7a-4754-9dd5-de688fec9dea", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5b52e41-d5c6-48d6-9d60-9d0179a654a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "97053170-4f7a-4754-9dd5-de688fec9dea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>", "ID": "6c44ca44-5c9c-43bc-978a-c210a248c949", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b>", "ID": "7c223c6c-7fba-4cd3-bf30-39ca504cb151", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c44ca44-5c9c-43bc-978a-c210a248c949"}, {"Element": "<span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span>", "ID": "c4652715-b4ee-4b88-b8e7-eaf2e5847a57", "Styles": "None", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "7c223c6c-7fba-4cd3-bf30-39ca504cb151"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4dbb9fb4-ff81-488b-beac-7f52164c78b7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4cf3361e-d351-4c2c-9dcb-c9e664ac00d2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dbb9fb4-ff81-488b-beac-7f52164c78b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>", "ID": "5492e1f7-bb27-4de1-9c97-2b68f1af3590", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Absorption</span></u>", "ID": "9a1c6efa-5835-470a-8e57-950bee803386", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5492e1f7-bb27-4de1-9c97-2b68f1af3590"}, {"Element": "<span lang=\"EN-GB\">Absorption</span>", "ID": "4ced9c93-5fb8-4b37-9824-bca9de2238c3", "Styles": "None", "Classes": "None", "Text": "Absorption", "ParentId": "9a1c6efa-5835-470a-8e57-950bee803386"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetic properties of sofosbuvir, GS\u2011331007 and velpatasvir have\nbeen evaluated in healthy adult subjects and in patients with chronic\nhepatitis\u00a0C.\u00a0 Following oral administration of Epclusa, sofosbuvir\nwas absorbed quickly and the peak median plasma concentration was observed\n1\u00a0hour post\u2011dose.\u00a0 Median peak plasma concentration of GS\u2011331007\nwas observed 3\u00a0hours post\u2011dose.\u00a0 Velpatasvir median peak\nconcentrations were observed at 3\u00a0hours post\u2011dose.</span></p>", "ID": "44f33ef6-a549-4725-8fa9-1e285ecaa676", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The\npharmacokinetic properties of sofosbuvir, GS\u2011331007 and velpatasvir have\nbeen evaluated in healthy adult subjects and in patients with chronic\nhepatitis\u00a0C.\u00a0 Following oral administration of Epclusa, sofosbuvir\nwas absorbed quickly and the peak median plasma concentration was observed\n1\u00a0hour post\u2011dose.\u00a0 Median peak plasma concentration of GS\u2011331007\nwas observed 3\u00a0hours post\u2011dose.\u00a0 Velpatasvir median peak\nconcentrations were observed at 3\u00a0hours post\u2011dose.</span>", "ID": "8b3b2a80-e184-4f88-a0ff-c6b9aff3057b", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetic properties of sofosbuvir, GS\u2011331007 and velpatasvir have been evaluated in healthy adult subjects and in patients with chronic hepatitis\u00a0C.\u00a0 Following oral administration of Epclusa, sofosbuvir was absorbed quickly and the peak median plasma concentration was observed 1\u00a0hour post\u2011dose.\u00a0 Median peak plasma concentration of GS\u2011331007 was observed 3\u00a0hours post\u2011dose.\u00a0 Velpatasvir median peak concentrations were observed at 3\u00a0hours post\u2011dose.", "ParentId": "44f33ef6-a549-4725-8fa9-1e285ecaa676"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4737b8dd-5bf6-4080-81f2-d5ad50e8749d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cddec659-a978-4a19-bd2f-e15c58194c4a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4737b8dd-5bf6-4080-81f2-d5ad50e8749d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the\npopulation pharmacokinetic analysis in HCV\u2011infected patients, mean steady\u2011state\nAUC<sub>0\u201124</sub> for sofosbuvir (n\u00a0=\u00a0982), GS\u2011331007 (n\u00a0=\u00a01,428)\nand velpatasvir (n\u00a0=\u00a01,425) were 1,260, 13,970 and 2,970\u00a0ng\u2022h/mL,\nrespectively.\u00a0 Steady-state C<sub>max</sub> for sofosbuvir, GS\u2011331007\nand velpatasvir were 566, 868 and 259\u00a0ng/mL, respectively.\u00a0\nSofosbuvir and GS\u2011331007 AUC<sub>0\u201124</sub> and C<sub>max</sub>\nwere similar in healthy adult subjects and patients with HCV infection.\u00a0\nRelative to healthy subjects (n\u00a0=\u00a0331), velpatasvir AUC<sub>0\u201124</sub>\nand C<sub>max</sub> were 37% lower and 41% lower, respectively in HCV\u2011infected\npatients.</span></p>", "ID": "cd3d74b7-af12-4358-9fa6-555c5a5625c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Based on the\npopulation pharmacokinetic analysis in HCV\u2011infected patients, mean steady\u2011state\nAUC<sub>0\u201124</sub> for sofosbuvir (n\u00a0=\u00a0982), GS\u2011331007 (n\u00a0=\u00a01,428)\nand velpatasvir (n\u00a0=\u00a01,425) were 1,260, 13,970 and 2,970\u00a0ng\u2022h/mL,\nrespectively.\u00a0 Steady-state C<sub>max</sub> for sofosbuvir, GS\u2011331007\nand velpatasvir were 566, 868 and 259\u00a0ng/mL, respectively.\u00a0\nSofosbuvir and GS\u2011331007 AUC<sub>0\u201124</sub> and C<sub>max</sub>\nwere similar in healthy adult subjects and patients with HCV infection.\u00a0\nRelative to healthy subjects (n\u00a0=\u00a0331), velpatasvir AUC<sub>0\u201124</sub>\nand C<sub>max</sub> were 37% lower and 41% lower, respectively in HCV\u2011infected\npatients.</span>", "ID": "306e0f76-c6d6-4a6f-8949-d300264a59dd", "Styles": "None", "Classes": "None", "Text": "Based on the population pharmacokinetic analysis in HCV\u2011infected patients, mean steady\u2011state AUC for sofosbuvir (n\u00a0=\u00a0982), GS\u2011331007 (n\u00a0=\u00a01,428) and velpatasvir (n\u00a0=\u00a01,425) were 1,260, 13,970 and 2,970\u00a0ng\u2022h/mL, respectively.\u00a0 Steady-state C for sofosbuvir, GS\u2011331007 and velpatasvir were 566, 868 and 259\u00a0ng/mL, respectively.\u00a0 Sofosbuvir and GS\u2011331007 AUC and C were similar in healthy adult subjects and patients with HCV infection.\u00a0 Relative to healthy subjects (n\u00a0=\u00a0331), velpatasvir AUC and C were 37% lower and 41% lower, respectively in HCV\u2011infected patients.", "ParentId": "cd3d74b7-af12-4358-9fa6-555c5a5625c1"}, {"Element": "<sub>0\u201124</sub>", "ID": "d653b3f1-2fd0-4120-924c-a5b26ae8550d", "Styles": "None", "Classes": "None", "Text": "0\u201124", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<sub>max</sub>", "ID": "4a10a7d3-d4da-45a6-ae17-9195da8a2748", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<sub>0\u201124</sub>", "ID": "e0783dfc-8f32-45ca-8fae-60325f47d4f3", "Styles": "None", "Classes": "None", "Text": "0\u201124", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<sub>max</sub>", "ID": "a1fe97ff-941c-4d7d-9b6a-cd60eb074a30", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<sub>0\u201124</sub>", "ID": "280fd27a-1a52-46b1-9c99-d713c9ff2247", "Styles": "None", "Classes": "None", "Text": "0\u201124", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<sub>max</sub>", "ID": "8e82e1e9-b4e0-4294-81ec-1805b8fdb075", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "306e0f76-c6d6-4a6f-8949-d300264a59dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "56f32988-b60b-49ca-a2c7-3b42fe3592c4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bb256b72-186e-468f-b69a-39fd9383235d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "56f32988-b60b-49ca-a2c7-3b42fe3592c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Effects of food</span></i></p>", "ID": "d3211700-3e57-4059-afb4-9d2224c3be0c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Effects of food</span></i>", "ID": "08d9a89f-0155-499f-b974-b287ead89f5c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d3211700-3e57-4059-afb4-9d2224c3be0c"}, {"Element": "<span lang=\"EN-GB\">Effects of food</span>", "ID": "c2558aae-4a8c-42f7-a3f7-10de74ea7b21", "Styles": "None", "Classes": "None", "Text": "Effects of food", "ParentId": "08d9a89f-0155-499f-b974-b287ead89f5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Relative to\nfasting conditions, the administration of a single dose of Epclusa with a\nmoderate fat (~600\u00a0kcal, 30% fat) or high fat (~800\u00a0kcal, 50% fat)\nmeal resulted in a 34% and 21% increase in velpatasvir AUC<sub>0\u2011inf</sub>,\nrespectively, and a 31% and 5% increase in velpatasvir C<sub>max</sub>, respectively.\u00a0\nThe moderate or high fat meal increased sofosbuvir AUC<sub>0\u2011inf</sub> by\n60% and 78%, respectively, but did not substantially affect the sofosbuvir C<sub>max</sub>.\n\u00a0The moderate or high fat meal did not alter GS\u2011331007 AUC<sub>0\u2011inf</sub>,\nbut resulted in a 25% and 37% decrease in its C<sub>max</sub>, respectively. \u00a0The\nresponse rates in Phase\u00a03 studies were similar in HCV\u2011infected patients\nwho received Epclusa with food or without food. \u00a0Epclusa can be\nadministered without regard to food.</span></p>", "ID": "fb64f2e2-1101-48e4-af70-53aaf2e1026a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Relative to\nfasting conditions, the administration of a single dose of Epclusa with a\nmoderate fat (~600\u00a0kcal, 30% fat) or high fat (~800\u00a0kcal, 50% fat)\nmeal resulted in a 34% and 21% increase in velpatasvir AUC<sub>0\u2011inf</sub>,\nrespectively, and a 31% and 5% increase in velpatasvir C<sub>max</sub>, respectively.\u00a0\nThe moderate or high fat meal increased sofosbuvir AUC<sub>0\u2011inf</sub> by\n60% and 78%, respectively, but did not substantially affect the sofosbuvir C<sub>max</sub>.\n\u00a0The moderate or high fat meal did not alter GS\u2011331007 AUC<sub>0\u2011inf</sub>,\nbut resulted in a 25% and 37% decrease in its C<sub>max</sub>, respectively. \u00a0The\nresponse rates in Phase\u00a03 studies were similar in HCV\u2011infected patients\nwho received Epclusa with food or without food. \u00a0Epclusa can be\nadministered without regard to food.</span>", "ID": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158", "Styles": "None", "Classes": "None", "Text": "Relative to fasting conditions, the administration of a single dose of Epclusa with a moderate fat (~600\u00a0kcal, 30% fat) or high fat (~800\u00a0kcal, 50% fat) meal resulted in a 34% and 21% increase in velpatasvir AUC, respectively, and a 31% and 5% increase in velpatasvir C, respectively.\u00a0 The moderate or high fat meal increased sofosbuvir AUC by 60% and 78%, respectively, but did not substantially affect the sofosbuvir C. \u00a0The moderate or high fat meal did not alter GS\u2011331007 AUC, but resulted in a 25% and 37% decrease in its C, respectively. \u00a0The response rates in Phase\u00a03 studies were similar in HCV\u2011infected patients who received Epclusa with food or without food. \u00a0Epclusa can be administered without regard to food.", "ParentId": "fb64f2e2-1101-48e4-af70-53aaf2e1026a"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "6b1271b8-5229-40dd-b1c0-7a045c333c9b", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<sub>max</sub>", "ID": "9ff26e88-2296-4bda-b2ee-8ed3309ca51b", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "866e38d1-88f7-483f-9b09-4c0a6b7a1567", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<sub>max</sub>", "ID": "1a4ce2c8-09ee-40bf-9113-8019286f960f", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "c38c3f55-90b9-4370-9213-e3d790137b84", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<sub>max</sub>", "ID": "e456c08d-48c7-48b8-b17c-3886196e5f73", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "8135cf85-8d2a-4563-ab11-cf7ee6fa4158"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9c5789a-c152-46e8-bc66-bee27a6871da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "11b7c0d1-52bd-4fd0-96b6-64af8fefd7d9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9c5789a-c152-46e8-bc66-bee27a6871da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>", "ID": "9f4ccb6a-295e-463d-9318-b81a12939477", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Distribution</span></u>", "ID": "06c9455d-489a-4edc-ad23-bc13352c69e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9f4ccb6a-295e-463d-9318-b81a12939477"}, {"Element": "<span lang=\"EN-GB\">Distribution</span>", "ID": "3829ddab-2dc3-45c3-9a64-2d672f6b991b", "Styles": "None", "Classes": "None", "Text": "Distribution", "ParentId": "06c9455d-489a-4edc-ad23-bc13352c69e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is\napproximately 61\u201165% bound to human plasma proteins and the binding is\nindependent of drug concentration over the range of 1\u00a0\u00b5g/mL to\n20\u00a0\u00b5g/mL.\u00a0 Protein binding of GS\u2011331007 was minimal in\nhuman plasma.\u00a0 After a single 400\u00a0mg dose of [<sup>14</sup>C]\u2011sofosbuvir\nin healthy subjects, the blood to plasma ratio of [<sup>14</sup>C]\u2011radioactivity\nwas approximately 0.7.</span></p>", "ID": "0c2316af-67ce-4475-89cc-02f2442f9a9a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir is\napproximately 61\u201165% bound to human plasma proteins and the binding is\nindependent of drug concentration over the range of 1\u00a0\u00b5g/mL to\n20\u00a0\u00b5g/mL.\u00a0 Protein binding of GS\u2011331007 was minimal in\nhuman plasma.\u00a0 After a single 400\u00a0mg dose of [<sup>14</sup>C]\u2011sofosbuvir\nin healthy subjects, the blood to plasma ratio of [<sup>14</sup>C]\u2011radioactivity\nwas approximately 0.7.</span>", "ID": "61f4b0d4-b8f3-459c-b3d7-7614376b8f22", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir is approximately 61\u201165% bound to human plasma proteins and the binding is independent of drug concentration over the range of 1\u00a0\u00b5g/mL to 20\u00a0\u00b5g/mL.\u00a0 Protein binding of GS\u2011331007 was minimal in human plasma.\u00a0 After a single 400\u00a0mg dose of [C]\u2011sofosbuvir in healthy subjects, the blood to plasma ratio of [C]\u2011radioactivity was approximately 0.7.", "ParentId": "0c2316af-67ce-4475-89cc-02f2442f9a9a"}, {"Element": "<sup>14</sup>", "ID": "7667caac-616b-46bc-82b0-83f898d2d5f9", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "61f4b0d4-b8f3-459c-b3d7-7614376b8f22"}, {"Element": "<sup>14</sup>", "ID": "c2ef1743-ffb5-4f16-ae29-77eb32560148", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "61f4b0d4-b8f3-459c-b3d7-7614376b8f22"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45b09519-6bd1-459b-9f37-039993b54335", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b045fae-ab6c-4639-b76a-0b70c7cf7396", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45b09519-6bd1-459b-9f37-039993b54335"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nis &gt;\u00a099.5% bound to human plasma proteins and binding is independent of\ndrug concentration over the range of 0.09</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">to 1.8</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. \u00a0After a single 100\u00a0mg\ndose of [<sup>14</sup>C]\u2011velpatasvir in healthy subjects, the blood to\nplasma ratio of [<sup>14</sup>C]\u2011radioactivity ranged between 0.52 and\n0.67.</span></p>", "ID": "d16b1a4c-d491-49fb-be56-30c268757654", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nis &gt;\u00a099.5% bound to human plasma proteins and binding is independent of\ndrug concentration over the range of 0.09</span>", "ID": "9e6bbd52-b9e0-4d91-ab6e-b1dbf10f11ee", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Velpatasvir is >\u00a099.5% bound to human plasma proteins and binding is independent of drug concentration over the range of 0.09", "ParentId": "d16b1a4c-d491-49fb-be56-30c268757654"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL </span>", "ID": "34869476-25a0-451d-82aa-a12d04801e7e", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0\u00b5g/mL ", "ParentId": "d16b1a4c-d491-49fb-be56-30c268757654"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">to 1.8</span>", "ID": "df8c4014-80ef-45ac-9aba-eacc1befb989", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "to 1.8", "ParentId": "d16b1a4c-d491-49fb-be56-30c268757654"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0\u00b5g/mL</span>", "ID": "648a1608-af4f-4c7e-bfa7-bbec0896ad05", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0\u00b5g/mL", "ParentId": "d16b1a4c-d491-49fb-be56-30c268757654"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. \u00a0After a single 100\u00a0mg\ndose of [<sup>14</sup>C]\u2011velpatasvir in healthy subjects, the blood to\nplasma ratio of [<sup>14</sup>C]\u2011radioactivity ranged between 0.52 and\n0.67.</span>", "ID": "2b550771-409e-44a4-9985-f6a7b0d5f5b2", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ". \u00a0After a single 100\u00a0mg dose of [C]\u2011velpatasvir in healthy subjects, the blood to plasma ratio of [C]\u2011radioactivity ranged between 0.52 and 0.67.", "ParentId": "d16b1a4c-d491-49fb-be56-30c268757654"}, {"Element": "<sup>14</sup>", "ID": "c838f530-b811-4071-aa60-aad17267f64d", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "2b550771-409e-44a4-9985-f6a7b0d5f5b2"}, {"Element": "<sup>14</sup>", "ID": "e690f1cb-381e-4a78-a321-dacad97387d9", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "2b550771-409e-44a4-9985-f6a7b0d5f5b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "23bc81b1-dae9-4176-a91b-5662ba877fbf", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce67fd32-7e30-4af9-93b8-540d4299e78e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "23bc81b1-dae9-4176-a91b-5662ba877fbf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>", "ID": "b263bde9-cc9f-47ab-9c16-08c7d4a3a11c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Biotransformation</span></u>", "ID": "21f71433-c929-48dd-9934-36342448f2f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b263bde9-cc9f-47ab-9c16-08c7d4a3a11c"}, {"Element": "<span lang=\"EN-GB\">Biotransformation</span>", "ID": "ff831662-8036-41af-98be-35a574e65fd1", "Styles": "None", "Classes": "None", "Text": "Biotransformation", "ParentId": "21f71433-c929-48dd-9934-36342448f2f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir is\nextensively metabolised in the liver to form the pharmacologically active\nnucleoside analog triphosphate GS\u2011461203. \u00a0The metabolic activation\npathway involves sequential hydrolysis of the carboxyl ester moiety catalysed\nby human cathepsin\u00a0A (CatA) or carboxylesterase\u00a01 (CES1) and\nphosphoramidate cleavage by histidine triad nucleotide-binding protein\u00a01\n(HINT1) followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.\u00a0\nDephosphorylation results in the formation of nucleoside metabolite GS\u2011331007\nthat cannot be efficiently rephosphorylated and lacks anti-HCV activity <i>in\u00a0vitro.</i>\n\u00a0Sofosbuvir and GS\u2011331007 are not substrates or inhibitors of UGT1A1\nor CYP3A4, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 enzymes.\u00a0 After\na single 400\u00a0mg oral dose of [<sup>14</sup>C]-sofosbuvir, GS\u2011331007\naccounted for approximately &gt;\u00a090% of total systemic exposure.</span></p>", "ID": "692def89-9f66-47d8-adca-b0432f474ab4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir is\nextensively metabolised in the liver to form the pharmacologically active\nnucleoside analog triphosphate GS\u2011461203. \u00a0The metabolic activation\npathway involves sequential hydrolysis of the carboxyl ester moiety catalysed\nby human cathepsin\u00a0A (CatA) or carboxylesterase\u00a01 (CES1) and\nphosphoramidate cleavage by histidine triad nucleotide-binding protein\u00a01\n(HINT1) followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.\u00a0\nDephosphorylation results in the formation of nucleoside metabolite GS\u2011331007\nthat cannot be efficiently rephosphorylated and lacks anti-HCV activity <i>in\u00a0vitro.</i>\n\u00a0Sofosbuvir and GS\u2011331007 are not substrates or inhibitors of UGT1A1\nor CYP3A4, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 enzymes.\u00a0 After\na single 400\u00a0mg oral dose of [<sup>14</sup>C]-sofosbuvir, GS\u2011331007\naccounted for approximately &gt;\u00a090% of total systemic exposure.</span>", "ID": "8feb9401-948f-48f0-a880-0f54679a2d18", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir is extensively metabolised in the liver to form the pharmacologically active nucleoside analog triphosphate GS\u2011461203. \u00a0The metabolic activation pathway involves sequential hydrolysis of the carboxyl ester moiety catalysed by human cathepsin\u00a0A (CatA) or carboxylesterase\u00a01 (CES1) and phosphoramidate cleavage by histidine triad nucleotide-binding protein\u00a01 (HINT1) followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.\u00a0 Dephosphorylation results in the formation of nucleoside metabolite GS\u2011331007 that cannot be efficiently rephosphorylated and lacks anti-HCV activity  \u00a0Sofosbuvir and GS\u2011331007 are not substrates or inhibitors of UGT1A1 or CYP3A4, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 enzymes.\u00a0 After a single 400\u00a0mg oral dose of [C]-sofosbuvir, GS\u2011331007 accounted for approximately >\u00a090% of total systemic exposure.", "ParentId": "692def89-9f66-47d8-adca-b0432f474ab4"}, {"Element": "<i>in\u00a0vitro.</i>", "ID": "9cb3b22b-16c4-4cff-bef3-06e9b499ddcd", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro.", "ParentId": "8feb9401-948f-48f0-a880-0f54679a2d18"}, {"Element": "<sup>14</sup>", "ID": "1906696d-6e52-4fce-808e-4aca57f04c5b", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "8feb9401-948f-48f0-a880-0f54679a2d18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f3306710-b2f1-4dfb-a769-29a38692be1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2b1a7358-f226-4db1-a991-0a10cf439c29", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f3306710-b2f1-4dfb-a769-29a38692be1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir is a\nsubstrate of CYP2B6, CYP2C8, and CYP3A4 with slow turnover. \u00a0Following a\nsingle dose of 100\u00a0mg [<sup>14</sup>C]\u2011velpatasvir, the majority\n(&gt;\u00a098%) of radioactivity in plasma was parent drug.\u00a0 The\nmonohydroxylated and desmethylated velpatasvir were the metabolites identified\nin human plasma.\u00a0 Unchanged velpatasvir is the major species present in\nfaeces.</span></p>", "ID": "094b54fe-a821-4afd-964c-51a5817c198e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir is a\nsubstrate of CYP2B6, CYP2C8, and CYP3A4 with slow turnover. \u00a0Following a\nsingle dose of 100\u00a0mg [<sup>14</sup>C]\u2011velpatasvir, the majority\n(&gt;\u00a098%) of radioactivity in plasma was parent drug.\u00a0 The\nmonohydroxylated and desmethylated velpatasvir were the metabolites identified\nin human plasma.\u00a0 Unchanged velpatasvir is the major species present in\nfaeces.</span>", "ID": "2a6f5d6a-802d-4a79-b594-f76d20cce63c", "Styles": "None", "Classes": "None", "Text": "Velpatasvir is a substrate of CYP2B6, CYP2C8, and CYP3A4 with slow turnover. \u00a0Following a single dose of 100\u00a0mg [C]\u2011velpatasvir, the majority (>\u00a098%) of radioactivity in plasma was parent drug.\u00a0 The monohydroxylated and desmethylated velpatasvir were the metabolites identified in human plasma.\u00a0 Unchanged velpatasvir is the major species present in faeces.", "ParentId": "094b54fe-a821-4afd-964c-51a5817c198e"}, {"Element": "<sup>14</sup>", "ID": "71712977-1ab8-494a-8a2d-8c27b84608be", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "2a6f5d6a-802d-4a79-b594-f76d20cce63c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "132eeb18-6a20-4068-a312-69386d9b85de", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d9fcacf-6eca-47f1-a961-ee89f869cb11", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "132eeb18-6a20-4068-a312-69386d9b85de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>", "ID": "0e736898-2d87-42f0-aa2d-ee23f177d08c", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Elimination</span></u>", "ID": "234af0d1-224c-4b91-babb-0fc87ba97c13", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e736898-2d87-42f0-aa2d-ee23f177d08c"}, {"Element": "<span lang=\"EN-GB\">Elimination</span>", "ID": "7effb54b-4433-4ab0-bfe1-fde1fb3eecbc", "Styles": "None", "Classes": "None", "Text": "Elimination", "ParentId": "234af0d1-224c-4b91-babb-0fc87ba97c13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following a\nsingle 400\u00a0mg oral dose of [<sup>14</sup>C]\u2011sofosbuvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was greater than 92%,\nconsisting of approximately 80%, 14%, and 2.5% recovered in urine, faeces, and\nexpired air, respectively.\u00a0 The majority of the sofosbuvir dose recovered\nin urine was GS\u2011331007 (78%) while 3.5% was recovered as\nsofosbuvir.\u00a0 These data indicate that renal clearance is the major\nelimination pathway for GS\u2011331007.\u00a0 The median terminal half\u2011lives\nof sofosbuvir and GS\u2011331007 following administration of Epclusa were 0.5\nand 25\u00a0hours, respectively.</span></p>", "ID": "6b8fd554-17a5-4616-bb54-0be2c80274d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Following a\nsingle 400\u00a0mg oral dose of [<sup>14</sup>C]\u2011sofosbuvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was greater than 92%,\nconsisting of approximately 80%, 14%, and 2.5% recovered in urine, faeces, and\nexpired air, respectively.\u00a0 The majority of the sofosbuvir dose recovered\nin urine was GS\u2011331007 (78%) while 3.5% was recovered as\nsofosbuvir.\u00a0 These data indicate that renal clearance is the major\nelimination pathway for GS\u2011331007.\u00a0 The median terminal half\u2011lives\nof sofosbuvir and GS\u2011331007 following administration of Epclusa were 0.5\nand 25\u00a0hours, respectively.</span>", "ID": "8f528fbc-166a-45ef-aaf2-64bb9a416baa", "Styles": "None", "Classes": "None", "Text": "Following a single 400\u00a0mg oral dose of [C]\u2011sofosbuvir, mean total recovery of the [C]\u2011radioactivity was greater than 92%, consisting of approximately 80%, 14%, and 2.5% recovered in urine, faeces, and expired air, respectively.\u00a0 The majority of the sofosbuvir dose recovered in urine was GS\u2011331007 (78%) while 3.5% was recovered as sofosbuvir.\u00a0 These data indicate that renal clearance is the major elimination pathway for GS\u2011331007.\u00a0 The median terminal half\u2011lives of sofosbuvir and GS\u2011331007 following administration of Epclusa were 0.5 and 25\u00a0hours, respectively.", "ParentId": "6b8fd554-17a5-4616-bb54-0be2c80274d5"}, {"Element": "<sup>14</sup>", "ID": "e4e61045-0f4a-4a2e-baa9-e6e2adc09aee", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "8f528fbc-166a-45ef-aaf2-64bb9a416baa"}, {"Element": "<sup>14</sup>", "ID": "7bf60f68-d50e-4615-83bd-7e5a76cbea5f", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "8f528fbc-166a-45ef-aaf2-64bb9a416baa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b3624a13-96a8-48ac-b535-36f50e1460fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dbb7b8a5-db86-45a0-81c1-d3daf0df5d1c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b3624a13-96a8-48ac-b535-36f50e1460fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following a\nsingle 100\u00a0mg oral dose of [<sup>14</sup>C]\u2011velpatasvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was 95%, consisting of\napproximately 94% and 0.4% recovered from the faeces and urine,\nrespectively.\u00a0 Unchanged velpatasvir was the major species in faeces\naccounting for a mean of 77% of the administered dose, followed by\nmonohydroxylated velpatasvir (5.9%) and desmethylated velpatasvir (3.0%).\u00a0\nThese data indicate that biliary excretion of parent drug was a major route of\nelimination for velpatasvir. \u00a0The median terminal half-life of velpatasvir\nfollowing administration of Epclusa was approximately 15\u00a0hours.</span></p>", "ID": "19600cf7-432f-478a-8d55-40b03e0c09dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Following a\nsingle 100\u00a0mg oral dose of [<sup>14</sup>C]\u2011velpatasvir, mean total\nrecovery of the [<sup>14</sup>C]\u2011radioactivity was 95%, consisting of\napproximately 94% and 0.4% recovered from the faeces and urine,\nrespectively.\u00a0 Unchanged velpatasvir was the major species in faeces\naccounting for a mean of 77% of the administered dose, followed by\nmonohydroxylated velpatasvir (5.9%) and desmethylated velpatasvir (3.0%).\u00a0\nThese data indicate that biliary excretion of parent drug was a major route of\nelimination for velpatasvir. \u00a0The median terminal half-life of velpatasvir\nfollowing administration of Epclusa was approximately 15\u00a0hours.</span>", "ID": "a83377df-a7e0-4547-a303-c079cce3c308", "Styles": "None", "Classes": "None", "Text": "Following a single 100\u00a0mg oral dose of [C]\u2011velpatasvir, mean total recovery of the [C]\u2011radioactivity was 95%, consisting of approximately 94% and 0.4% recovered from the faeces and urine, respectively.\u00a0 Unchanged velpatasvir was the major species in faeces accounting for a mean of 77% of the administered dose, followed by monohydroxylated velpatasvir (5.9%) and desmethylated velpatasvir (3.0%).\u00a0 These data indicate that biliary excretion of parent drug was a major route of elimination for velpatasvir. \u00a0The median terminal half-life of velpatasvir following administration of Epclusa was approximately 15\u00a0hours.", "ParentId": "19600cf7-432f-478a-8d55-40b03e0c09dc"}, {"Element": "<sup>14</sup>", "ID": "5851c35f-2437-408a-80a1-61baaaf38f47", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "a83377df-a7e0-4547-a303-c079cce3c308"}, {"Element": "<sup>14</sup>", "ID": "b3cb840b-7f5e-46ff-a89b-c4b18b08418e", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "a83377df-a7e0-4547-a303-c079cce3c308"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc97839e-cbd3-41ab-af30-2408f378bcb9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4dda9d4b-a62b-4883-b568-05a7d086b08d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc97839e-cbd3-41ab-af30-2408f378bcb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non-linearity</span></u></p>", "ID": "a3d154ad-a8b3-4b9c-b200-26da1fd641ca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Linearity/non-linearity</span></u>", "ID": "629e4f42-eb0b-4a19-a9a7-a8887b2eff66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3d154ad-a8b3-4b9c-b200-26da1fd641ca"}, {"Element": "<span lang=\"EN-GB\">Linearity/non-linearity</span>", "ID": "7049a845-bb42-4f17-a00e-6459700c5d35", "Styles": "None", "Classes": "None", "Text": "Linearity/non-linearity", "ParentId": "629e4f42-eb0b-4a19-a9a7-a8887b2eff66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir AUC\nincreases in a nearly dose proportional manner over the dose range of\n25\u00a0mg to 150\u00a0mg.\u00a0 Sofosbuvir and GS\u2011331007 AUCs are near\ndose\u2011proportional over the dose range of 200\u00a0mg to 1,200\u00a0mg.</span></p>", "ID": "51f44e6c-f1f7-4011-abe5-f77efa5d6ed0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir AUC\nincreases in a nearly dose proportional manner over the dose range of\n25\u00a0mg to 150\u00a0mg.\u00a0 Sofosbuvir and GS\u2011331007 AUCs are near\ndose\u2011proportional over the dose range of 200\u00a0mg to 1,200\u00a0mg.</span>", "ID": "23c961ee-e417-40a9-9080-80a7671c227d", "Styles": "None", "Classes": "None", "Text": "Velpatasvir AUC increases in a nearly dose proportional manner over the dose range of 25\u00a0mg to 150\u00a0mg.\u00a0 Sofosbuvir and GS\u2011331007 AUCs are near dose\u2011proportional over the dose range of 200\u00a0mg to 1,200\u00a0mg.", "ParentId": "51f44e6c-f1f7-4011-abe5-f77efa5d6ed0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9fb2488d-0e0e-4a53-b487-b499697453dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "20eb5d66-2d9c-4fa2-a4d6-ca221366970d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9fb2488d-0e0e-4a53-b487-b499697453dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">In\u00a0vitro</span></u></i><u><span lang=\"EN-GB\"> potential for\nsofosbuvir/velpatasvir drug-drug interactions</span></u></p>", "ID": "ed3d57c1-0f88-4071-b322-27d311e6aec9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><u><span lang=\"EN-GB\">In\u00a0vitro</span></u></i>", "ID": "6ef1e8b3-5cd9-4e93-89c7-066135db9d2e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed3d57c1-0f88-4071-b322-27d311e6aec9"}, {"Element": "<u><span lang=\"EN-GB\">In\u00a0vitro</span></u>", "ID": "3f9b7f47-e81f-4802-bb8e-f4e244ca1b04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ef1e8b3-5cd9-4e93-89c7-066135db9d2e"}, {"Element": "<span lang=\"EN-GB\">In\u00a0vitro</span>", "ID": "565834c4-b5c7-4438-b76c-4824b5fcc4aa", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro", "ParentId": "3f9b7f47-e81f-4802-bb8e-f4e244ca1b04"}, {"Element": "<u><span lang=\"EN-GB\"> potential for\nsofosbuvir/velpatasvir drug-drug interactions</span></u>", "ID": "f2721513-6e74-4eee-b67a-6171811d77b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed3d57c1-0f88-4071-b322-27d311e6aec9"}, {"Element": "<span lang=\"EN-GB\"> potential for\nsofosbuvir/velpatasvir drug-drug interactions</span>", "ID": "c82c535a-f04a-4bb8-a570-22010eabd731", "Styles": "None", "Classes": "None", "Text": " potential for sofosbuvir/velpatasvir drug-drug interactions", "ParentId": "f2721513-6e74-4eee-b67a-6171811d77b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP while GS\u2011331007\nis not.\u00a0 Velpatasvir is also a substrate of OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8, and CYP3A4 was\nobserved.</span></p>", "ID": "8b3ebafa-01dc-4dfd-9e8e-24f9e0b0c19d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir and\nvelpatasvir are substrates of drug transporters P\u2011gp and BCRP while GS\u2011331007\nis not.\u00a0 Velpatasvir is also a substrate of OATP1B.\u00a0 <i>In\u00a0vitro,</i>\nslow metabolic turnover of velpatasvir by CYP2B6, CYP2C8, and CYP3A4 was\nobserved.</span>", "ID": "9ecac23d-4b7c-42f6-a25a-aaf2717889ca", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir and velpatasvir are substrates of drug transporters P\u2011gp and BCRP while GS\u2011331007 is not.\u00a0 Velpatasvir is also a substrate of OATP1B.\u00a0  slow metabolic turnover of velpatasvir by CYP2B6, CYP2C8, and CYP3A4 was observed.", "ParentId": "8b3ebafa-01dc-4dfd-9e8e-24f9e0b0c19d"}, {"Element": "<i>In\u00a0vitro,</i>", "ID": "74c10580-34d7-4d07-9b26-4cbb3089afc1", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro,", "ParentId": "9ecac23d-4b7c-42f6-a25a-aaf2717889ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "541f2e43-e9bf-46d7-99a7-77f76d6aaff9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "03bfee24-e742-43d9-905e-80d128880bea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "541f2e43-e9bf-46d7-99a7-77f76d6aaff9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir is\nan inhibitor of drug transporter P\u2011gp, BCRP, OATP1B1 and OATP1B3 and its\ninvolvement in drug interactions with these transporters is primarily limited\nto the process of absorption.\u00a0 At clinically relevant plasma concentration,\nvelpatasvir is not an inhibitor of hepatic transporters bile salt export pump\n(BSEP), sodium taurocholate cotransporter protein (NTCP), OATP2B1, OATP1A2 or organic\ncation transporter (OCT)\u00a01, renal transporters OCT2, OAT1, OAT3, multidrug\nresistance-associated protein\u00a02 (MRP2) or multidrug and toxin extrusion\nprotein (MATE)\u00a01, or CYP or uridine glucuronosyltransferase (UGT)\u00a01A1\nenzymes.</span></p>", "ID": "57232a6a-9164-4fef-a074-378325f33f79", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir is\nan inhibitor of drug transporter P\u2011gp, BCRP, OATP1B1 and OATP1B3 and its\ninvolvement in drug interactions with these transporters is primarily limited\nto the process of absorption.\u00a0 At clinically relevant plasma concentration,\nvelpatasvir is not an inhibitor of hepatic transporters bile salt export pump\n(BSEP), sodium taurocholate cotransporter protein (NTCP), OATP2B1, OATP1A2 or organic\ncation transporter (OCT)\u00a01, renal transporters OCT2, OAT1, OAT3, multidrug\nresistance-associated protein\u00a02 (MRP2) or multidrug and toxin extrusion\nprotein (MATE)\u00a01, or CYP or uridine glucuronosyltransferase (UGT)\u00a01A1\nenzymes.</span>", "ID": "48e9a407-f658-4aa0-991a-5d14864ebe3c", "Styles": "None", "Classes": "None", "Text": "Velpatasvir is an inhibitor of drug transporter P\u2011gp, BCRP, OATP1B1 and OATP1B3 and its involvement in drug interactions with these transporters is primarily limited to the process of absorption.\u00a0 At clinically relevant plasma concentration, velpatasvir is not an inhibitor of hepatic transporters bile salt export pump (BSEP), sodium taurocholate cotransporter protein (NTCP), OATP2B1, OATP1A2 or organic cation transporter (OCT)\u00a01, renal transporters OCT2, OAT1, OAT3, multidrug resistance-associated protein\u00a02 (MRP2) or multidrug and toxin extrusion protein (MATE)\u00a01, or CYP or uridine glucuronosyltransferase (UGT)\u00a01A1 enzymes.", "ParentId": "57232a6a-9164-4fef-a074-378325f33f79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e602063-fe1f-4995-8c47-1d68b776c814", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d58b530-e4a3-4d84-b13c-a5a5cace258b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e602063-fe1f-4995-8c47-1d68b776c814"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sofosbuvir and\nGS\u2011331007 are not inhibitors of drug transporters P\u2011gp, BCRP, MRP2,\nBSEP, OATP1B1, OATP1B3 and OCT1. \u00a0GS\u2011331007 is not an inhibitor of\nOAT1, OCT2, and MATE1.</span></p>", "ID": "ca76b055-3c9e-4d9b-baa0-ec22b3211e23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir and\nGS\u2011331007 are not inhibitors of drug transporters P\u2011gp, BCRP, MRP2,\nBSEP, OATP1B1, OATP1B3 and OCT1. \u00a0GS\u2011331007 is not an inhibitor of\nOAT1, OCT2, and MATE1.</span>", "ID": "3ce703e8-a21a-42e1-ab6e-e6eec46aeb4c", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir and GS\u2011331007 are not inhibitors of drug transporters P\u2011gp, BCRP, MRP2, BSEP, OATP1B1, OATP1B3 and OCT1. \u00a0GS\u2011331007 is not an inhibitor of OAT1, OCT2, and MATE1.", "ParentId": "ca76b055-3c9e-4d9b-baa0-ec22b3211e23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "972bad0b-67e0-485a-8178-e791d5b870d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "08e4c199-15af-4d8b-b874-042d8b9baa6f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "972bad0b-67e0-485a-8178-e791d5b870d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pharmacokinetics in special populations</span></u></p>", "ID": "f00a7fa6-03de-47fe-9808-6cc59737daa6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Pharmacokinetics in special populations</span></u>", "ID": "ccbf0690-156a-45a3-9ea7-a643ccd1b326", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f00a7fa6-03de-47fe-9808-6cc59737daa6"}, {"Element": "<span lang=\"EN-GB\">Pharmacokinetics in special populations</span>", "ID": "ad4a28b9-96f6-48eb-81f0-9848fb307e7f", "Styles": "None", "Classes": "None", "Text": "Pharmacokinetics in special populations", "ParentId": "ccbf0690-156a-45a3-9ea7-a643ccd1b326"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Race and gender</span></i></p>", "ID": "d677b318-9b41-4d44-a389-a4233355bc19", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Race and gender</span></i>", "ID": "47522310-2f6e-4253-a075-5d933d3b8500", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d677b318-9b41-4d44-a389-a4233355bc19"}, {"Element": "<span lang=\"EN-GB\">Race and gender</span>", "ID": "ca298d43-b3da-48ee-ae9a-a12eee744212", "Styles": "None", "Classes": "None", "Text": "Race and gender", "ParentId": "47522310-2f6e-4253-a075-5d933d3b8500"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No clinically\nrelevant pharmacokinetic differences due to race or gender have been identified\nfor sofosbuvir, GS\u2011331007 or velpatasvir.</span></p>", "ID": "ddcc8c07-21a8-4ec3-a445-ad638766fb87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">No clinically\nrelevant pharmacokinetic differences due to race or gender have been identified\nfor sofosbuvir, GS\u2011331007 or velpatasvir.</span>", "ID": "6430bd34-a8bf-4441-993e-80c0e6c19335", "Styles": "None", "Classes": "None", "Text": "No clinically relevant pharmacokinetic differences due to race or gender have been identified for sofosbuvir, GS\u2011331007 or velpatasvir.", "ParentId": "ddcc8c07-21a8-4ec3-a445-ad638766fb87"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "024faf01-4334-43af-a18e-fec7f332f81e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d3332a5-491f-4a5a-87f2-f7be7ba70824", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "024faf01-4334-43af-a18e-fec7f332f81e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>", "ID": "dcca1914-cec2-4c97-a9f0-cb5087bfc39f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Elderly</span></i>", "ID": "21ace7d3-26a2-4606-b7c1-fb20079232b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dcca1914-cec2-4c97-a9f0-cb5087bfc39f"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "d35adfbd-17c2-4c43-a490-f88b16eb2885", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "21ace7d3-26a2-4606-b7c1-fb20079232b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Population\npharmacokinetic analysis in HCV\u2011infected patients showed that within the\nage range (18 to 82\u00a0years) analysed, age did not have a clinically\nrelevant effect on the exposure to sofosbuvir, GS\u2011331007, or velpatasvir.</span></p>", "ID": "2431cf74-4895-4af4-acb4-277d877c6d94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Population\npharmacokinetic analysis in HCV\u2011infected patients showed that within the\nage range (18 to 82\u00a0years) analysed, age did not have a clinically\nrelevant effect on the exposure to sofosbuvir, GS\u2011331007, or velpatasvir.</span>", "ID": "9df78ed4-8b0c-42fa-b021-6f8061b0b4bd", "Styles": "None", "Classes": "None", "Text": "Population pharmacokinetic analysis in HCV\u2011infected patients showed that within the age range (18 to 82\u00a0years) analysed, age did not have a clinically relevant effect on the exposure to sofosbuvir, GS\u2011331007, or velpatasvir.", "ParentId": "2431cf74-4895-4af4-acb4-277d877c6d94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f973e14-760c-4657-8975-69f033022f42", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da13f399-1ceb-4940-8de2-7272204b7099", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f973e14-760c-4657-8975-69f033022f42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>", "ID": "de073365-e951-4276-833a-2c32b76fb668", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Renal impairment</span></i>", "ID": "515ec7f9-c8ac-4f6d-ac71-32947666e10d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de073365-e951-4276-833a-2c32b76fb668"}, {"Element": "<span lang=\"EN-GB\">Renal impairment</span>", "ID": "04bbd695-d3b3-4805-8c5c-444f47d2bf1c", "Styles": "None", "Classes": "None", "Text": "Renal impairment", "ParentId": "515ec7f9-c8ac-4f6d-ac71-32947666e10d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied in HCV negative patients with mild\n(eGFR \u2265\u00a050 and &lt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nmoderate (eGFR \u2265\u00a030 and &lt;\u00a050\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nsevere renal impairment (eGFR &lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nand patients with ESRD requiring haemodialysis following a single 400\u00a0mg\ndose of sofosbuvir.\u00a0 Relative to patients with normal renal function (eGFR\n&gt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>), the sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 61%, 107% and 171% higher in mild, moderate and severe renal impairment,\nwhile the GS\u2011331007 AUC<sub>0\u2011inf</sub> was 55%, 88% and 451%\nhigher, respectively.\u00a0 In patients with ESRD, sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 28% higher when sofosbuvir was dosed 1\u00a0hour before haemodialysis\ncompared with 60% higher when dosed 1\u00a0hour after haemodialysis,\nrespectively.\u00a0 The AUC<sub>0\u2011inf</sub> of GS\u2011331007 in\npatients with ESRD administered with sofosbuvir 1\u00a0hour before or\n1\u00a0hour after haemodialysis was at least 10\u2011fold and 20\u2011fold\nhigher, respectively.\u00a0 GS\u2011331007 is efficiently removed by haemodialysis\nwith an extraction coefficient of approximately 53%.\u00a0 Following a single\n400\u00a0mg dose of sofosbuvir, a 4\u00a0hour haemodialysis removed 18% of\nadministered dose (see section\u00a04.2).</span></p>", "ID": "12fde8a8-aeb5-4148-834c-3196666765f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied in HCV negative patients with mild\n(eGFR \u2265\u00a050 and &lt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nmoderate (eGFR \u2265\u00a030 and &lt;\u00a050\u00a0mL/min/1.73\u00a0m<sup>2</sup>),\nsevere renal impairment (eGFR &lt;\u00a030\u00a0mL/min/1.73\u00a0m<sup>2</sup>)\nand patients with ESRD requiring haemodialysis following a single 400\u00a0mg\ndose of sofosbuvir.\u00a0 Relative to patients with normal renal function (eGFR\n&gt;\u00a080\u00a0mL/min/1.73\u00a0m<sup>2</sup>), the sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 61%, 107% and 171% higher in mild, moderate and severe renal impairment,\nwhile the GS\u2011331007 AUC<sub>0\u2011inf</sub> was 55%, 88% and 451%\nhigher, respectively.\u00a0 In patients with ESRD, sofosbuvir AUC<sub>0\u2011inf</sub>\nwas 28% higher when sofosbuvir was dosed 1\u00a0hour before haemodialysis\ncompared with 60% higher when dosed 1\u00a0hour after haemodialysis,\nrespectively.\u00a0 The AUC<sub>0\u2011inf</sub> of GS\u2011331007 in\npatients with ESRD administered with sofosbuvir 1\u00a0hour before or\n1\u00a0hour after haemodialysis was at least 10\u2011fold and 20\u2011fold\nhigher, respectively.\u00a0 GS\u2011331007 is efficiently removed by haemodialysis\nwith an extraction coefficient of approximately 53%.\u00a0 Following a single\n400\u00a0mg dose of sofosbuvir, a 4\u00a0hour haemodialysis removed 18% of\nadministered dose (see section\u00a04.2).</span>", "ID": "4ac04308-9119-40e6-8310-2a166f661a0d", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of sofosbuvir was studied in HCV negative patients with mild (eGFR \u2265\u00a050 and <\u00a080\u00a0mL/min/1.73\u00a0m), moderate (eGFR \u2265\u00a030 and <\u00a050\u00a0mL/min/1.73\u00a0m), severe renal impairment (eGFR <\u00a030\u00a0mL/min/1.73\u00a0m) and patients with ESRD requiring haemodialysis following a single 400\u00a0mg dose of sofosbuvir.\u00a0 Relative to patients with normal renal function (eGFR >\u00a080\u00a0mL/min/1.73\u00a0m), the sofosbuvir AUC was 61%, 107% and 171% higher in mild, moderate and severe renal impairment, while the GS\u2011331007 AUC was 55%, 88% and 451% higher, respectively.\u00a0 In patients with ESRD, sofosbuvir AUC was 28% higher when sofosbuvir was dosed 1\u00a0hour before haemodialysis compared with 60% higher when dosed 1\u00a0hour after haemodialysis, respectively.\u00a0 The AUC of GS\u2011331007 in patients with ESRD administered with sofosbuvir 1\u00a0hour before or 1\u00a0hour after haemodialysis was at least 10\u2011fold and 20\u2011fold higher, respectively.\u00a0 GS\u2011331007 is efficiently removed by haemodialysis with an extraction coefficient of approximately 53%.\u00a0 Following a single 400\u00a0mg dose of sofosbuvir, a 4\u00a0hour haemodialysis removed 18% of administered dose (see section\u00a04.2).", "ParentId": "12fde8a8-aeb5-4148-834c-3196666765f2"}, {"Element": "<sup>2</sup>", "ID": "c0ce2725-5c8d-43d8-9e1b-5cb9060d65a7", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sup>2</sup>", "ID": "2af2163f-af3a-49f2-9e82-b8be8f1d1cb1", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sup>2</sup>", "ID": "259d5069-99a7-4425-a32b-e793fe06675e", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sup>2</sup>", "ID": "1977f1b8-df4b-4c68-98b5-7db7a679b3bd", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "b6ee33ed-1e15-4ef8-ba33-89d107aafe1f", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "97d53e28-0f0f-446b-a6b4-767ab245e939", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "7e0cb423-308b-4215-8448-c9391a73899e", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<sub>0\u2011inf</sub>", "ID": "1307f59f-530a-4853-8ad2-50aa3df66c45", "Styles": "None", "Classes": "None", "Text": "0\u2011inf", "ParentId": "4ac04308-9119-40e6-8310-2a166f661a0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ece7fc80-a90d-4ead-b294-7bc778e5d083", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d67d5207-0614-422f-9efc-840f2adcc1f5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ece7fc80-a90d-4ead-b294-7bc778e5d083"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with severe renal impairment (eGFR\n&lt;\u00a030\u00a0mL/min by Cockcroft-Gault).\u00a0 Relative to subjects with\nnormal renal function, velpatasvir AUC<sub>inf</sub> was 50% higher in subjects\nwith severe renal impairment (see section\u00a04.2).</span></p>", "ID": "067c8a09-5e13-42ec-9a6c-0533819e63a5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with severe renal impairment (eGFR\n&lt;\u00a030\u00a0mL/min by Cockcroft-Gault).\u00a0 Relative to subjects with\nnormal renal function, velpatasvir AUC<sub>inf</sub> was 50% higher in subjects\nwith severe renal impairment (see section\u00a04.2).</span>", "ID": "7080974a-e85f-42bd-8854-fdd6fa81b43f", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg velpatasvir in HCV negative patients with severe renal impairment (eGFR <\u00a030\u00a0mL/min by Cockcroft-Gault).\u00a0 Relative to subjects with normal renal function, velpatasvir AUC was 50% higher in subjects with severe renal impairment (see section\u00a04.2).", "ParentId": "067c8a09-5e13-42ec-9a6c-0533819e63a5"}, {"Element": "<sub>inf</sub>", "ID": "68a21837-4a02-4fb0-bca7-b4848f54febd", "Styles": "None", "Classes": "None", "Text": "inf", "ParentId": "7080974a-e85f-42bd-8854-fdd6fa81b43f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "14ab77a8-332f-41fe-8a0b-0c238b628d98", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7fe6bbbb-c85b-44cd-8eb2-e454a0105391", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14ab77a8-332f-41fe-8a0b-0c238b628d98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>", "ID": "26adacfb-6cb2-44b3-95cb-3e0c03ec9481", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Hepatic impairment</span></i>", "ID": "0cdaccca-2579-44f8-8250-90c662e50b77", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26adacfb-6cb2-44b3-95cb-3e0c03ec9481"}, {"Element": "<span lang=\"EN-GB\">Hepatic impairment</span>", "ID": "3aac0fbf-e2fd-407f-bfd0-c45fcb229a29", "Styles": "None", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "0cdaccca-2579-44f8-8250-90c662e50b77"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied following 7\u2011day dosing of\n400\u00a0mg sofosbuvir in HCV\u2011infected patients with moderate and severe\nhepatic impairment (CPT Class\u00a0B and C).\u00a0 Relative to patients with\nnormal hepatic function, the sofosbuvir AUC<sub>0\u201124</sub> was 126% and\n143% higher in moderate and severe hepatic impairment, while the GS\u2011331007\nAUC<sub>0\u201124</sub> was 18% and 9% higher, respectively.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to sofosbuvir and GS\u2011331007.</span></p>", "ID": "78c545c1-08b2-4880-88e0-0373760d7c06", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The\npharmacokinetics of sofosbuvir was studied following 7\u2011day dosing of\n400\u00a0mg sofosbuvir in HCV\u2011infected patients with moderate and severe\nhepatic impairment (CPT Class\u00a0B and C).\u00a0 Relative to patients with\nnormal hepatic function, the sofosbuvir AUC<sub>0\u201124</sub> was 126% and\n143% higher in moderate and severe hepatic impairment, while the GS\u2011331007\nAUC<sub>0\u201124</sub> was 18% and 9% higher, respectively.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to sofosbuvir and GS\u2011331007.</span>", "ID": "5b4d70a5-3c10-46dd-81aa-9407c1255fdc", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of sofosbuvir was studied following 7\u2011day dosing of 400\u00a0mg sofosbuvir in HCV\u2011infected patients with moderate and severe hepatic impairment (CPT Class\u00a0B and C).\u00a0 Relative to patients with normal hepatic function, the sofosbuvir AUC was 126% and 143% higher in moderate and severe hepatic impairment, while the GS\u2011331007 AUC was 18% and 9% higher, respectively.\u00a0 Population pharmacokinetics analysis in HCV\u2011infected patients indicated that cirrhosis (including decompensated cirrhosis) had no clinically relevant effect on the exposure to sofosbuvir and GS\u2011331007.", "ParentId": "78c545c1-08b2-4880-88e0-0373760d7c06"}, {"Element": "<sub>0\u201124</sub>", "ID": "ac65d465-fb6d-4810-b7df-cd7b5126bc93", "Styles": "None", "Classes": "None", "Text": "0\u201124", "ParentId": "5b4d70a5-3c10-46dd-81aa-9407c1255fdc"}, {"Element": "<sub>0\u201124</sub>", "ID": "926631ae-bcfa-49e1-8b31-4455d12543e4", "Styles": "None", "Classes": "None", "Text": "0\u201124", "ParentId": "5b4d70a5-3c10-46dd-81aa-9407c1255fdc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "61c03621-46c7-42e6-9382-4060027c5a8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a1edd182-1c61-4217-8b2f-f7683f90b171", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "61c03621-46c7-42e6-9382-4060027c5a8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with moderate and severe hepatic\nimpairment (CPT Class\u00a0B and C).\u00a0 Compared to subjects with normal\nhepatic function velpatasvir total plasma exposure (AUC<sub>inf</sub>) was\nsimilar in patients with moderate or severe hepatic impairment.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to velpatasvir (see section\u00a04.2). </span></p>", "ID": "70ed11d0-a8e6-449d-b4ae-bcef3403438e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The\npharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg\nvelpatasvir in HCV negative patients with moderate and severe hepatic\nimpairment (CPT Class\u00a0B and C).\u00a0 Compared to subjects with normal\nhepatic function velpatasvir total plasma exposure (AUC<sub>inf</sub>) was\nsimilar in patients with moderate or severe hepatic impairment.\u00a0 Population\npharmacokinetics analysis in HCV\u2011infected patients indicated that\ncirrhosis (including decompensated cirrhosis) had no clinically relevant effect\non the exposure to velpatasvir (see section\u00a04.2). </span>", "ID": "99db1717-23bd-4790-9230-7cc5823a09bf", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of velpatasvir was studied with a single dose of 100\u00a0mg velpatasvir in HCV negative patients with moderate and severe hepatic impairment (CPT Class\u00a0B and C).\u00a0 Compared to subjects with normal hepatic function velpatasvir total plasma exposure (AUC) was similar in patients with moderate or severe hepatic impairment.\u00a0 Population pharmacokinetics analysis in HCV\u2011infected patients indicated that cirrhosis (including decompensated cirrhosis) had no clinically relevant effect on the exposure to velpatasvir (see section\u00a04.2). ", "ParentId": "70ed11d0-a8e6-449d-b4ae-bcef3403438e"}, {"Element": "<sub>inf</sub>", "ID": "8db66eab-7d97-4208-a37b-10197a191ee6", "Styles": "None", "Classes": "None", "Text": "inf", "ParentId": "99db1717-23bd-4790-9230-7cc5823a09bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8216ec49-e31f-4fab-bddc-42593114830f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c519d72-afad-443e-acd7-0ad38d2bbc37", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8216ec49-e31f-4fab-bddc-42593114830f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Body weight</span></i></p>", "ID": "c63a1446-f14a-4919-b935-f435f392bb21", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Body weight</span></i>", "ID": "8527e75b-cbdd-40d6-a0ee-0ae323c42ef3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c63a1446-f14a-4919-b935-f435f392bb21"}, {"Element": "<span lang=\"EN-GB\">Body weight</span>", "ID": "25df6c66-b133-4e14-b8b0-2f9d33c8acdd", "Styles": "None", "Classes": "None", "Text": "Body weight", "ParentId": "8527e75b-cbdd-40d6-a0ee-0ae323c42ef3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Body weight did\nnot have a clinically significant effect on sofosbuvir or velpatasvir exposure\naccording to a population pharmacokinetic analysis.</span></p>", "ID": "ea8953ff-3de8-423a-a4a4-17aa1956ff4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Body weight did\nnot have a clinically significant effect on sofosbuvir or velpatasvir exposure\naccording to a population pharmacokinetic analysis.</span>", "ID": "1b7c90f1-e038-4b20-acac-50e78a715dea", "Styles": "None", "Classes": "None", "Text": "Body weight did not have a clinically significant effect on sofosbuvir or velpatasvir exposure according to a population pharmacokinetic analysis.", "ParentId": "ea8953ff-3de8-423a-a4a4-17aa1956ff4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7a23f718-6f2c-4323-b475-2d991751b06e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f57d21af-c640-4dad-b746-7a39430848a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7a23f718-6f2c-4323-b475-2d991751b06e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>", "ID": "c164dff7-9875-4f1c-a638-f7f39480f9dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Paediatric population</span></i>", "ID": "e80f3ee8-d8fc-41a7-af3c-3c8070a01e01", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c164dff7-9875-4f1c-a638-f7f39480f9dd"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "f04eef81-db57-4a13-931c-9412a7a40d8c", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "e80f3ee8-d8fc-41a7-af3c-3c8070a01e01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The pharmacokinetics of sofosbuvir, GS\u2011331007 and velpatasvir\nin paediatric patients have not been established </span><span lang=\"EN-GB\">(see\nsection\u00a04.2).</span></p>", "ID": "d481006d-14ad-4391-89d5-ddd990ac66d9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The pharmacokinetics of sofosbuvir, GS\u2011331007 and velpatasvir\nin paediatric patients have not been established </span>", "ID": "97bdcca5-a0a6-4b1e-a3fc-1cdf5793d220", "Styles": "None", "Classes": "None", "Text": "The pharmacokinetics of sofosbuvir, GS\u2011331007 and velpatasvir in paediatric patients have not been established ", "ParentId": "d481006d-14ad-4391-89d5-ddd990ac66d9"}, {"Element": "<span lang=\"EN-GB\">(see\nsection\u00a04.2).</span>", "ID": "ac66c89a-b621-429b-a8e0-4f95cb381d4f", "Styles": "None", "Classes": "None", "Text": "(see section\u00a04.2).", "ParentId": "d481006d-14ad-4391-89d5-ddd990ac66d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e04e436-1e08-4b0a-8201-f6e94e11d9ac", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "106b5910-9925-4870-922a-0ef9a448e7ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e04e436-1e08-4b0a-8201-f6e94e11d9ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical\nsafety data</span></b></p>", "ID": "94d0ff56-da58-4281-8259-ad526de5542d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical\nsafety data</span></b>", "ID": "014b736e-8039-4434-ab54-2a4a7c002fe4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "94d0ff56-da58-4281-8259-ad526de5542d"}, {"Element": "<span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical\nsafety data</span>", "ID": "64a5be8f-a78c-4843-9b72-ea87a8f5a059", "Styles": "None", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "014b736e-8039-4434-ab54-2a4a7c002fe4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eceffba8-9afa-4f6e-92d0-e8819ec30c44", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64e56ecc-4f3f-432b-a03b-2a228ccf6041", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eceffba8-9afa-4f6e-92d0-e8819ec30c44"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Sofosbuvir</span></u></p>", "ID": "3a9df82d-d612-4c83-803f-58cb1c67b55c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Sofosbuvir</span></u>", "ID": "cdc5b5a1-bffb-4f26-a101-019f29eaac56", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a9df82d-d612-4c83-803f-58cb1c67b55c"}, {"Element": "<span lang=\"EN-GB\">Sofosbuvir</span>", "ID": "584c4169-e952-4f8a-824a-8ef97c6012b0", "Styles": "None", "Classes": "None", "Text": "Sofosbuvir", "ParentId": "cdc5b5a1-bffb-4f26-a101-019f29eaac56"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Exposure\nto sofosbuvir in rodent studies could not be detected likely due to high\nesterase activity and exposure to the major metabolite GS\u2011331007 was\ninstead used to estimate exposure margins.</span></p>", "ID": "2b1104f2-ae59-4db0-ba40-dbcf637ae20d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Exposure\nto sofosbuvir in rodent studies could not be detected likely due to high\nesterase activity and exposure to the major metabolite GS\u2011331007 was\ninstead used to estimate exposure margins.</span>", "ID": "ead302bf-5634-43bd-b327-45b56198946a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Exposure to sofosbuvir in rodent studies could not be detected likely due to high esterase activity and exposure to the major metabolite GS\u2011331007 was instead used to estimate exposure margins.", "ParentId": "2b1104f2-ae59-4db0-ba40-dbcf637ae20d"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "968ace3d-a3ad-48e8-b33a-e8757d7d8a80", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "4f85cc30-08d4-41b0-b235-af4bfab66fa4", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "968ace3d-a3ad-48e8-b33a-e8757d7d8a80"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> mouse micronucleus\nassays.\u00a0 No teratogenic effects were observed in the rat and rabbit\ndevelopmental toxicity studies with sofosbuvir.\u00a0 Sofosbuvir had no adverse\neffects on behaviour, reproduction, or development of the offspring in the rat pre\u2011\nand post\u2011natal development study.</span></p>", "ID": "d456c2d9-9a78-46c6-8964-928d6cd16554", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> mouse micronucleus\nassays.\u00a0 No teratogenic effects were observed in the rat and rabbit\ndevelopmental toxicity studies with sofosbuvir.\u00a0 Sofosbuvir had no adverse\neffects on behaviour, reproduction, or development of the offspring in the rat pre\u2011\nand post\u2011natal development study.</span>", "ID": "37f35c6b-ed95-4d30-897f-25ea0147b8f1", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Sofosbuvir was not genotoxic in a battery of  or  assays, including bacterial mutagenicity, chromosome aberration using human peripheral blood lymphocytes and  mouse micronucleus assays.\u00a0 No teratogenic effects were observed in the rat and rabbit developmental toxicity studies with sofosbuvir.\u00a0 Sofosbuvir had no adverse effects on behaviour, reproduction, or development of the offspring in the rat pre\u2011 and post\u2011natal development study.", "ParentId": "d456c2d9-9a78-46c6-8964-928d6cd16554"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "2b5ddcf1-a62d-48a3-ac1e-214b465ea2cc", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "37f35c6b-ed95-4d30-897f-25ea0147b8f1"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "559ea862-cf9b-478d-afe7-e15990893e31", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "37f35c6b-ed95-4d30-897f-25ea0147b8f1"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "d3366174-7f1b-441f-abd1-5c321fe9c4a6", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "37f35c6b-ed95-4d30-897f-25ea0147b8f1"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "e0833765-9b37-435e-a8ec-d9f68a3094d9", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "1c0bd719-88e6-4cb6-b05b-9f417ee575e3", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "e0833765-9b37-435e-a8ec-d9f68a3094d9"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not a carcinogen in the 2\u2011year mouse and rat carcinogenicity studies\nat GS\u2011331007 exposures up to 15 and 9\u00a0times, respectively, higher\nthan human exposure.</span></p>", "ID": "91150b37-2aa0-4991-932e-afca76200664", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Sofosbuvir\nwas not a carcinogen in the 2\u2011year mouse and rat carcinogenicity studies\nat GS\u2011331007 exposures up to 15 and 9\u00a0times, respectively, higher\nthan human exposure.</span>", "ID": "e1eabb02-2437-4463-8b9b-7fb4bee2c7e0", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Sofosbuvir was not a carcinogen in the 2\u2011year mouse and rat carcinogenicity studies at GS\u2011331007 exposures up to 15 and 9\u00a0times, respectively, higher than human exposure.", "ParentId": "91150b37-2aa0-4991-932e-afca76200664"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "1df25db9-7445-4773-b8c5-58c16dc1d282", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "a2c7fc37-f2b6-4c1c-a5eb-6beeeb20bfdd", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "1df25db9-7445-4773-b8c5-58c16dc1d282"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Velpatasvir</span></u></p>", "ID": "b02a8e5a-7125-43fb-8c3a-210833bebaa9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Velpatasvir</span></u>", "ID": "ff1cc1fa-94b6-40ba-b011-479fc95debfb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b02a8e5a-7125-43fb-8c3a-210833bebaa9"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir</span>", "ID": "76188f77-ca97-4192-9aa0-1c517ca5b96f", "Styles": "None", "Classes": "None", "Text": "Velpatasvir", "ParentId": "ff1cc1fa-94b6-40ba-b011-479fc95debfb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir was\nnot genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> rat micronucleus assays.</span></p>", "ID": "30689dad-b867-43eb-a7df-833aa27549be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir was\nnot genotoxic in a battery of <i>in\u00a0vitro</i> or <i>in\u00a0vivo</i>\nassays, including bacterial mutagenicity, chromosome aberration using human\nperipheral blood lymphocytes and <i>in\u00a0vivo</i> rat micronucleus assays.</span>", "ID": "94b054f5-7de0-41d4-950c-6af11881fce0", "Styles": "None", "Classes": "None", "Text": "Velpatasvir was not genotoxic in a battery of  or  assays, including bacterial mutagenicity, chromosome aberration using human peripheral blood lymphocytes and  rat micronucleus assays.", "ParentId": "30689dad-b867-43eb-a7df-833aa27549be"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "cd8a3944-ccc2-4cf6-ac96-1aafd5887a3a", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "94b054f5-7de0-41d4-950c-6af11881fce0"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "30199b98-0fdc-4a51-b5b2-1f6e6ca987e4", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "94b054f5-7de0-41d4-950c-6af11881fce0"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "78d0733e-186c-4d7d-80de-56adff089805", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "94b054f5-7de0-41d4-950c-6af11881fce0"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "d09de232-d27d-4b94-a95b-3e38f1ec470f", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "7888022b-4d6c-4567-93e5-2aca6983147a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "d09de232-d27d-4b94-a95b-3e38f1ec470f"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nwas not carcinogenic in the 6\u2011month rasH2 transgenic mouse and 2\u2011year\nrat carcinogenicity studies at exposures at least 50-times and 5-times higher\nthan human exposure, respectively.</span></p>", "ID": "0852b214-5b8e-44f1-b05b-390c0770426a", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Velpatasvir\nwas not carcinogenic in the 6\u2011month rasH2 transgenic mouse and 2\u2011year\nrat carcinogenicity studies at exposures at least 50-times and 5-times higher\nthan human exposure, respectively.</span>", "ID": "96905230-14c4-48e9-854a-f7e2018292a2", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Velpatasvir was not carcinogenic in the 6\u2011month rasH2 transgenic mouse and 2\u2011year rat carcinogenicity studies at exposures at least 50-times and 5-times higher than human exposure, respectively.", "ParentId": "0852b214-5b8e-44f1-b05b-390c0770426a"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "3bad9b31-580d-4420-b1f0-3a3d3ccfc51c", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "ce804937-88dc-49f3-91e3-b036e8456cc2", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "3bad9b31-580d-4420-b1f0-3a3d3ccfc51c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Velpatasvir had\nno adverse effects on mating and fertility.\u00a0 </span><span lang=\"EN-GB\">No\nteratogenic effects were observed in the mouse and rat developmental toxicity\nstudies with velpatasvir at AUC exposures approximately 31\u2011 and 6\u2011fold\nhigher, respectively, than the human exposure at the recommended clinical\ndose.\u00a0 However, a possible teratogenic effect was indicated in rabbits\nwhere an increase in total visceral malformations was seen in exposed animals\nat AUC exposures up to 0.7 fold the human exposure at recommended clinical\ndose.\u00a0 The human relevance of this finding is not known.</span><span lang=\"EN-GB\">\u00a0 Velpatasvir had no adverse effects on behaviour,\nreproduction, or development of the offspring in the rat pre\u2011 and post\u2011natal\ndevelopment study at AUC exposures approximately 5\u2011fold higher than the\nhuman exposure at the recommended clinical dose.</span></p>", "ID": "f4d25c82-6e63-4110-b673-4bfa39a2a041", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Velpatasvir had\nno adverse effects on mating and fertility.\u00a0 </span>", "ID": "c1353bb8-fc47-4a05-b807-b3db61d59dd9", "Styles": "None", "Classes": "None", "Text": "Velpatasvir had no adverse effects on mating and fertility.\u00a0 ", "ParentId": "f4d25c82-6e63-4110-b673-4bfa39a2a041"}, {"Element": "<span lang=\"EN-GB\">No\nteratogenic effects were observed in the mouse and rat developmental toxicity\nstudies with velpatasvir at AUC exposures approximately 31\u2011 and 6\u2011fold\nhigher, respectively, than the human exposure at the recommended clinical\ndose.\u00a0 However, a possible teratogenic effect was indicated in rabbits\nwhere an increase in total visceral malformations was seen in exposed animals\nat AUC exposures up to 0.7 fold the human exposure at recommended clinical\ndose.\u00a0 The human relevance of this finding is not known.</span>", "ID": "ead9f99b-f23b-4b07-ba8e-96bb461f3224", "Styles": "None", "Classes": "None", "Text": "No teratogenic effects were observed in the mouse and rat developmental toxicity studies with velpatasvir at AUC exposures approximately 31\u2011 and 6\u2011fold higher, respectively, than the human exposure at the recommended clinical dose.\u00a0 However, a possible teratogenic effect was indicated in rabbits where an increase in total visceral malformations was seen in exposed animals at AUC exposures up to 0.7 fold the human exposure at recommended clinical dose.\u00a0 The human relevance of this finding is not known.", "ParentId": "f4d25c82-6e63-4110-b673-4bfa39a2a041"}, {"Element": "<span lang=\"EN-GB\">\u00a0 Velpatasvir had no adverse effects on behaviour,\nreproduction, or development of the offspring in the rat pre\u2011 and post\u2011natal\ndevelopment study at AUC exposures approximately 5\u2011fold higher than the\nhuman exposure at the recommended clinical dose.</span>", "ID": "0b5335a7-f4fd-4553-8b3c-838e58fdfd3b", "Styles": "None", "Classes": "None", "Text": "\u00a0 Velpatasvir had no adverse effects on behaviour, reproduction, or development of the offspring in the rat pre\u2011 and post\u2011natal development study at AUC exposures approximately 5\u2011fold higher than the human exposure at the recommended clinical dose.", "ParentId": "f4d25c82-6e63-4110-b673-4bfa39a2a041"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0c130541-5f5f-4539-8994-7f2490210cd6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4848859b-8abc-4469-80ce-c978e078d2ba", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0c130541-5f5f-4539-8994-7f2490210cd6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1638178-c549-4822-bdda-2ec6cacde9fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a4921c82-b81d-408b-9d2d-c8a9803f47e7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1638178-c549-4822-bdda-2ec6cacde9fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>", "ID": "71fb97e6-2cca-4808-bbb3-fc01f0f68858", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b>", "ID": "01f950aa-6bd8-4f35-b9f3-c071a83edf30", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71fb97e6-2cca-4808-bbb3-fc01f0f68858"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span>", "ID": "5a588dcc-1533-4fcf-8db7-3b186a715da4", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "01f950aa-6bd8-4f35-b9f3-c071a83edf30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "556418d2-9c4d-4b67-9d47-f629ce562dc4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9592343e-a78c-4393-8d64-6b012be0f571", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "556418d2-9c4d-4b67-9d47-f629ce562dc4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List\nof excipients</span></b></p>", "ID": "b5f9c55c-da2b-4085-9eb8-466eb16b78aa", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List\nof excipients</span></b>", "ID": "1d110f47-b0d4-4c7d-ad55-5761efe953de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5f9c55c-da2b-4085-9eb8-466eb16b78aa"}, {"Element": "<span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List\nof excipients</span>", "ID": "897ca07b-d694-4a99-8c38-b1c859b618b6", "Styles": "None", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "1d110f47-b0d4-4c7d-ad55-5761efe953de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dd3d33f2-eaf0-4c16-8178-57531c0d319a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8cbae821-ad8a-4bfa-90b4-b4c6102e9392", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dd3d33f2-eaf0-4c16-8178-57531c0d319a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Tablet core</span></u></p>", "ID": "cb3a36df-8132-419b-8b8d-361084e1ed67", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Tablet core</span></u>", "ID": "ad56b9e8-dbd2-49c0-977b-7467cff14bf7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb3a36df-8132-419b-8b8d-361084e1ed67"}, {"Element": "<span lang=\"EN-GB\">Tablet core</span>", "ID": "e625cb68-c971-4551-869c-b4df4467cc2b", "Styles": "None", "Classes": "None", "Text": "Tablet core", "ParentId": "ad56b9e8-dbd2-49c0-977b-7467cff14bf7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Copovidone</span></p>", "ID": "8bce5b19-e17e-4f6e-b9e7-a0e2da6d32de", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Copovidone</span>", "ID": "d46d1d9f-fd5b-4879-8566-41eabf640c63", "Styles": "None", "Classes": "None", "Text": "Copovidone", "ParentId": "8bce5b19-e17e-4f6e-b9e7-a0e2da6d32de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>", "ID": "1c223065-f9ce-4ff8-8d5a-e345d6711c28", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Microcrystalline cellulose</span>", "ID": "2756e864-22df-4c03-9a46-6fa3d9f57095", "Styles": "None", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "1c223065-f9ce-4ff8-8d5a-e345d6711c28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Croscarmellose sodium</span></p>", "ID": "222be1e4-00dc-4fbf-a766-06cfd2c9cf3b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Croscarmellose sodium</span>", "ID": "8e6d91a2-8801-463f-ad99-e6d0bafcdd56", "Styles": "None", "Classes": "None", "Text": "Croscarmellose sodium", "ParentId": "222be1e4-00dc-4fbf-a766-06cfd2c9cf3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Magnesium\nstearate</span></p>", "ID": "37f786cf-0432-4391-9edd-f3f02ecdd198", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Magnesium\nstearate</span>", "ID": "e8b930d7-d4cf-4c9b-b234-a3824647c8af", "Styles": "None", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "37f786cf-0432-4391-9edd-f3f02ecdd198"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1d6f0a67-599a-47b3-a446-d69d31332357", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "83c8c9c1-5cc9-49a0-902c-b639b552282e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1d6f0a67-599a-47b3-a446-d69d31332357"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Film\u2011coating</span></u></p>", "ID": "9593c88e-0b79-4dc8-a01f-031782ded46a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Film\u2011coating</span></u>", "ID": "40ef76f9-8dfd-4a29-8466-849ca9e4459a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9593c88e-0b79-4dc8-a01f-031782ded46a"}, {"Element": "<span lang=\"EN-GB\">Film\u2011coating</span>", "ID": "cb4ec549-236f-4399-8a7b-7ed6a1ee1d7b", "Styles": "None", "Classes": "None", "Text": "Film\u2011coating", "ParentId": "40ef76f9-8dfd-4a29-8466-849ca9e4459a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polyvinyl alcohol</span></p>", "ID": "75f21bc7-11e2-4d75-9d79-6301d1547407", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Polyvinyl alcohol</span>", "ID": "81286945-7584-4f78-b5ac-5655394d2872", "Styles": "None", "Classes": "None", "Text": "Polyvinyl alcohol", "ParentId": "75f21bc7-11e2-4d75-9d79-6301d1547407"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Titanium dioxide</span></p>", "ID": "a9488113-7c6d-421f-9872-495622abd8d3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Titanium dioxide</span>", "ID": "3001bbf3-1163-4c14-ab2d-d6344f1744bf", "Styles": "None", "Classes": "None", "Text": "Titanium dioxide", "ParentId": "a9488113-7c6d-421f-9872-495622abd8d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polyethylene glycol</span></p>", "ID": "f509983f-dca2-45c8-bbe7-23595faa5b6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Polyethylene glycol</span>", "ID": "f1aede9e-fd66-4843-8f7c-ceb6a11cd064", "Styles": "None", "Classes": "None", "Text": "Polyethylene glycol", "ParentId": "f509983f-dca2-45c8-bbe7-23595faa5b6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talc</span></p>", "ID": "76758794-87c3-4c61-9a53-49ba2c97aa83", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Talc</span>", "ID": "bfade426-0a29-4238-96a3-1bba2f1b0c54", "Styles": "None", "Classes": "None", "Text": "Talc", "ParentId": "76758794-87c3-4c61-9a53-49ba2c97aa83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Iron oxide red</span></p>", "ID": "f9f67e44-198b-4d60-b5a6-649e6ebe6325", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Iron oxide red</span>", "ID": "3008923c-734a-4746-a32b-f5eefb9ee00c", "Styles": "None", "Classes": "None", "Text": "Iron oxide red", "ParentId": "f9f67e44-198b-4d60-b5a6-649e6ebe6325"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89c0f079-8d3c-4d35-9880-0e05418ec2c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79a83a8c-972f-461f-b0b3-88d71beeb2cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89c0f079-8d3c-4d35-9880-0e05418ec2c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>", "ID": "bd900561-b2af-4a6d-8c66-bbb425dc82c6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b>", "ID": "cffe780e-0b38-4e73-803c-28f9c3da7ee7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd900561-b2af-4a6d-8c66-bbb425dc82c6"}, {"Element": "<span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "0641f5d9-8565-4253-a2a4-efc34da52732", "Styles": "None", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "cffe780e-0b38-4e73-803c-28f9c3da7ee7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc2c2874-5dd2-4738-afb6-c80f6d94e7d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4321a612-cd35-4cfa-a4e7-aeebe2fbfc36", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc2c2874-5dd2-4738-afb6-c80f6d94e7d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>", "ID": "ba54b2ec-1588-44bf-98aa-08e8d3f0defc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Not applicable.</span>", "ID": "4dd6d6ac-15fd-4490-b1de-76716da76683", "Styles": "None", "Classes": "None", "Text": "Not applicable.", "ParentId": "ba54b2ec-1588-44bf-98aa-08e8d3f0defc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "22f63d3b-db02-4c02-abe5-08f72c41749a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f201ec76-f4b2-450c-80a9-21f5abcd586a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22f63d3b-db02-4c02-abe5-08f72c41749a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf\nlife</span></b></p>", "ID": "c53b9219-ddba-4235-9388-1014665dd762", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf\nlife</span></b>", "ID": "591419ef-158d-4499-98e3-145a1e8f2093", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c53b9219-ddba-4235-9388-1014665dd762"}, {"Element": "<span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf\nlife</span>", "ID": "e78444e3-e107-4f32-8f80-e09230e7bed3", "Styles": "None", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "591419ef-158d-4499-98e3-145a1e8f2093"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e5249013-7fe3-4693-908b-548cc42a00dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "781f5e20-cd1c-4018-b61b-30ecdb82b7fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e5249013-7fe3-4693-908b-548cc42a00dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4\u00a0years.</span></p>", "ID": "28793da9-fa2f-4198-85cd-6896a04296ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">4\u00a0years.</span>", "ID": "fd3b7049-8d21-471b-a4e6-be8775770011", "Styles": "None", "Classes": "None", "Text": "4\u00a0years.", "ParentId": "28793da9-fa2f-4198-85cd-6896a04296ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98cc9f61-4591-41c4-86a7-3fab9b959fb8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "95d6499f-0d92-449b-afe0-c1b5b05af1d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98cc9f61-4591-41c4-86a7-3fab9b959fb8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for storage</span></b></p>", "ID": "cc011c7f-54da-44fc-97b5-fe61a7be875f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for storage</span></b>", "ID": "61566ce2-a14a-4240-8d61-93b821e4e2a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cc011c7f-54da-44fc-97b5-fe61a7be875f"}, {"Element": "<span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for storage</span>", "ID": "57ab3cc5-3ab7-43de-8074-80355243cb6b", "Styles": "None", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "61566ce2-a14a-4240-8d61-93b821e4e2a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9bfd7092-70fe-45d9-b96e-ea40fb48cbb5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9a60895-952d-4b16-a6b7-7045ac588c62", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9bfd7092-70fe-45d9-b96e-ea40fb48cbb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span></p>", "ID": "0978db52-72de-4c5b-8036-e69d3fe5a5d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">This medicinal\nproduct does not require any special storage conditions.</span>", "ID": "b1afaab3-6f4f-4ae0-800a-dc43f00e96b4", "Styles": "None", "Classes": "None", "Text": "This medicinal product does not require any special storage conditions.", "ParentId": "0978db52-72de-4c5b-8036-e69d3fe5a5d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b13da3e5-7643-4f20-a429-136247342f62", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c78b41a4-3849-44ad-ade0-60a32e8cd6ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b13da3e5-7643-4f20-a429-136247342f62"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container</span></b></p>", "ID": "c236425b-a3a2-446c-af5c-3bcb1b2480bb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container</span></b>", "ID": "398c3271-baee-4763-b359-ec0da89fa625", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c236425b-a3a2-446c-af5c-3bcb1b2480bb"}, {"Element": "<span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container</span>", "ID": "ab83bc2e-a6e6-4ddb-b3fe-0b9808272ae4", "Styles": "None", "Classes": "None", "Text": "6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container", "ParentId": "398c3271-baee-4763-b359-ec0da89fa625"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b21fe3e3-99fc-4307-b1de-2abe2b9bfdf2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c1c77c8-fa41-444d-aab2-c0b1ebdb6d25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b21fe3e3-99fc-4307-b1de-2abe2b9bfdf2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa tablets\nare supplied in high density polyethylene (HDPE) bottle with a polypropylene\nchild\u2011resistant closure containing 28\u00a0film\u2011coated tablets with\npolyester coil.</span></p>", "ID": "7f8ad6a9-efb9-47bb-91b8-135d32de7cdb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa tablets\nare supplied in high density polyethylene (HDPE) bottle with a polypropylene\nchild\u2011resistant closure containing 28\u00a0film\u2011coated tablets with\npolyester coil.</span>", "ID": "ea5f675d-d173-4b63-80c0-d76265f59a43", "Styles": "None", "Classes": "None", "Text": "Epclusa tablets are supplied in high density polyethylene (HDPE) bottle with a polypropylene child\u2011resistant closure containing 28\u00a0film\u2011coated tablets with polyester coil.", "ParentId": "7f8ad6a9-efb9-47bb-91b8-135d32de7cdb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be630f98-63a6-4f4b-bd6a-ccdb31c02636", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "383ee9f3-24cc-4c6b-8e81-527f4dae36af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be630f98-63a6-4f4b-bd6a-ccdb31c02636"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The following\npack sizes are available: outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets.</span></p>", "ID": "ef4496ce-3a89-4422-9c41-c8b516b7d87f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The following\npack sizes are available: outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets.</span>", "ID": "a3a0026e-5427-4305-aa77-3d779c6b5d9d", "Styles": "None", "Classes": "None", "Text": "The following pack sizes are available: outer cartons containing 1\u00a0bottle of 28\u00a0film\u2011coated tablets.", "ParentId": "ef4496ce-3a89-4422-9c41-c8b516b7d87f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "93b7830d-de01-4c22-a351-824cb20aa1a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "285882bb-3cae-44a5-b1be-4784ee871364", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "93b7830d-de01-4c22-a351-824cb20aa1a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal</span></b></a></p>", "ID": "ed4fd9a7-1822-4112-b5e2-723a12f7cae6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal</span></b></a>", "ID": "f75a0122-853a-4046-a13e-77af2400a58e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed4fd9a7-1822-4112-b5e2-723a12f7cae6"}, {"Element": "<b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal</span></b>", "ID": "d5a012fb-71f6-47a3-9772-8d4dece9145d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f75a0122-853a-4046-a13e-77af2400a58e"}, {"Element": "<span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal</span>", "ID": "2aeee590-3136-4bbe-88e3-bc2a8a34db62", "Styles": "None", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal", "ParentId": "d5a012fb-71f6-47a3-9772-8d4dece9145d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b6682d99-9511-4f99-938a-f5e5fdc18e39", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "03510bd6-8ec7-45f9-ae54-d03f46c4106b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b6682d99-9511-4f99-938a-f5e5fdc18e39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span></p>", "ID": "33af9e7a-4bf9-4a89-a0c2-cc24fdc639e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span>", "ID": "f92f0be0-b850-480e-8226-001b90593392", "Styles": "None", "Classes": "None", "Text": "Any unused medicinal product or waste material should be disposed of in accordance with local requirements.", "ParentId": "33af9e7a-4bf9-4a89-a0c2-cc24fdc639e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bb024b90-f8f2-469f-88ca-6e6eb474f176", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb9a3ccf-5959-4967-bdf0-3f584817ec5f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb024b90-f8f2-469f-88ca-6e6eb474f176"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9a04056-bc37-447f-b6c8-2c45d89e30c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "784dfb78-be8f-4a14-821b-dc158f635c34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9a04056-bc37-447f-b6c8-2c45d89e30c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "1ef1c932-402f-41c3-b1f0-ef171ea18d5d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "f63dfb2b-b34d-4d1e-a0b5-b7a201556bd2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ef1c932-402f-41c3-b1f0-ef171ea18d5d"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span>", "ID": "3548a42d-c07d-42a7-87c3-1099cc4d0de9", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "f63dfb2b-b34d-4d1e-a0b5-b7a201556bd2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e1d7f02-64d7-4c0b-80a0-d5f5ff1556dd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61649164-9460-4eb9-9f4f-ec46b064377a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e1d7f02-64d7-4c0b-80a0-d5f5ff1556dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>", "ID": "9aa16dab-f29e-43bf-9764-c288ec4034d6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Ireland UC</span>", "ID": "20d419d7-31e5-40ac-9fa3-fffc0bd3ce8c", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Ireland UC", "ParentId": "9aa16dab-f29e-43bf-9764-c288ec4034d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>", "ID": "5c2a961b-697a-49d4-bda7-b0ecc045a0ff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Carrigtohill</span>", "ID": "c6cfd104-3044-4588-91c0-3e6167bf466a", "Styles": "None", "Classes": "None", "Text": "Carrigtohill", "ParentId": "5c2a961b-697a-49d4-bda7-b0ecc045a0ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>", "ID": "47064343-f71d-4105-96b6-fa402741082c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">County Cork, T45 DP77</span>", "ID": "3713b56e-9313-4ec0-80c1-b4bd72112c89", "Styles": "None", "Classes": "None", "Text": "County Cork, T45 DP77", "ParentId": "47064343-f71d-4105-96b6-fa402741082c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "67a9d1f3-6319-4bab-bbb0-9c5d21d90659", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "41755c4c-09d9-4ee6-a6bd-77517bb43b10", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "67a9d1f3-6319-4bab-bbb0-9c5d21d90659"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5334ed78-4043-4915-86f7-4f2a7f513f5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73a788a5-726f-42c3-a246-ae1f3f0736e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5334ed78-4043-4915-86f7-4f2a7f513f5b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e06e431-0a97-437a-a598-d8347c9bb6e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "36613c85-2c65-4b1c-8f67-1d1448400f04", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e06e431-0a97-437a-a598-d8347c9bb6e5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>", "ID": "6fe49bf4-31b5-4914-a2e2-bdea8c8703ff", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b>", "ID": "28eab9cc-9682-457b-b572-e6c9c7caa658", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6fe49bf4-31b5-4914-a2e2-bdea8c8703ff"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span>", "ID": "2e1cf859-7607-452e-8ed0-df8c01613f80", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "28eab9cc-9682-457b-b572-e6c9c7caa658"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67e35bd0-c239-4001-bba4-cfc32fe88b19", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4795b42a-59da-46dd-b314-1769b7c702bd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67e35bd0-c239-4001-bba4-cfc32fe88b19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1116/001</span></p>", "ID": "fb65da73-ef87-4af2-9847-cd227dbc9896", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">EU/1/16/1116/001</span>", "ID": "4026e288-440f-44f2-83ca-7444f3cf07e2", "Styles": "None", "Classes": "None", "Text": "EU/1/16/1116/001", "ParentId": "fb65da73-ef87-4af2-9847-cd227dbc9896"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f3c4838c-a636-49b9-aed8-d2629c7ffedb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9bd14cea-37a0-40fe-87cb-e25370c6d7a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f3c4838c-a636-49b9-aed8-d2629c7ffedb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a4c16232-5e0b-484d-ae98-c96cb375e2c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10fc1b91-76b3-4639-b76d-42f16ca09572", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a4c16232-5e0b-484d-ae98-c96cb375e2c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE\nOF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>", "ID": "00a7c2f2-7472-41d7-8dbc-208a6b9bb342", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE\nOF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b>", "ID": "62eadc8f-8cf7-4dc2-b078-2b37579b6bf8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00a7c2f2-7472-41d7-8dbc-208a6b9bb342"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE\nOF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "0f7cad78-faf5-41cf-a1cf-9db6151f87b5", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "62eadc8f-8cf7-4dc2-b078-2b37579b6bf8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc22a02c-03aa-4a06-ad99-4c96a7cec179", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "40a77031-8058-41ac-a607-78487ee0e75e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc22a02c-03aa-4a06-ad99-4c96a7cec179"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of first authorisation:\n06 July 2016</span></p>", "ID": "fe3c1d9c-0968-445d-bfa4-da2152334e8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Date of first authorisation:\n06 July 2016</span>", "ID": "cf905b79-5f23-47cf-961e-19552f6874b9", "Styles": "None", "Classes": "None", "Text": "Date of first authorisation: 06 July 2016", "ParentId": "fe3c1d9c-0968-445d-bfa4-da2152334e8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed0f2f03-4334-47a1-9c35-0a1c4cfed616", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed356245-8d63-4ed1-b48f-adee6bce7694", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed0f2f03-4334-47a1-9c35-0a1c4cfed616"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de6bee70-b817-456b-9db4-6711142bdadf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7641db41-7701-4b92-9da0-e5cd9baec049", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de6bee70-b817-456b-9db4-6711142bdadf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE\nOF REVISION OF THE TEXT</span></b></p>", "ID": "d9098c83-579b-4eaa-a7f1-1bffc48223a0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE\nOF REVISION OF THE TEXT</span></b>", "ID": "6c43861d-a057-48a3-a83a-55d5a978d8ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d9098c83-579b-4eaa-a7f1-1bffc48223a0"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE\nOF REVISION OF THE TEXT</span>", "ID": "5c748918-b3f2-4031-a34b-7ca5da596443", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "6c43861d-a057-48a3-a83a-55d5a978d8ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2d1e83bf-76f4-4f13-88ff-890a8dcc674b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "933aca96-fae6-4ee1-84e2-ec1779157fd4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2d1e83bf-76f4-4f13-88ff-890a8dcc674b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8fa3075d-d9fa-4892-863c-a4a75193742d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efb3e2b4-38e0-4f3a-8929-ccf47cc20a46", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8fa3075d-d9fa-4892-863c-a4a75193742d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f49a91f-60ca-4be8-ac0b-804d2255a063", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b444db54-8501-4082-aa74-fbe817fffaba", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f49a91f-60ca-4be8-ac0b-804d2255a063"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency http://www.ema.europa.eu.</span></p>", "ID": "2d01e68f-a7f5-450e-9b08-a71a5d7f5426", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Detailed\ninformation on this medicinal product is available on the website of the\nEuropean Medicines Agency http://www.ema.europa.eu.</span>", "ID": "161b5899-5649-418a-85d5-0a21af0d8c93", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.", "ParentId": "2d01e68f-a7f5-450e-9b08-a71a5d7f5426"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "1b598d64-51d1-47b8-9f4f-8bc10e1251b7", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "8d02d3d7-e250-485b-8725-b75bc769b701", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "1b598d64-51d1-47b8-9f4f-8bc10e1251b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5a005319-db42-41e0-915e-5b2de8642e89", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e3f5501e-d304-46a6-83a3-fd647c571237", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a005319-db42-41e0-915e-5b2de8642e89"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6c05fa3b-a952-406f-9279-805ff067f86e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "545e84aa-31d8-48a2-9462-da762f2c1c5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6c05fa3b-a952-406f-9279-805ff067f86e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ace8b3f8-d1d6-4b07-be42-dc555efa326c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ea42e9f6-50af-4f5b-b344-71a355d9c08f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ace8b3f8-d1d6-4b07-be42-dc555efa326c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3828bb97-3d01-496a-aeab-d2e6e2a82f4a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8e6778cb-c770-4c07-90fe-3c6b8619f002", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3828bb97-3d01-496a-aeab-d2e6e2a82f4a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "796f7170-a2fc-4eca-9d75-47ebe483b778", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5e36a486-e39f-4160-8db7-25e14a3aa278", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "796f7170-a2fc-4eca-9d75-47ebe483b778"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4fa4e8cf-ace4-4bdc-822a-54e749fb67ba", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd66b015-8ff8-459f-a732-56ef37b13a60", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4fa4e8cf-ace4-4bdc-822a-54e749fb67ba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b9dcd294-648c-484c-8edf-0d09bfe92a69", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "51279fa9-c20d-47e4-ad0e-9fef4211d4f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9dcd294-648c-484c-8edf-0d09bfe92a69"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c6bab00d-7f0d-467e-8301-8f40c8f6a3a4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6312d2d4-c0cb-4e5d-aedf-17729bcf2f25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c6bab00d-7f0d-467e-8301-8f40c8f6a3a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "938f5d7a-313e-4b08-be38-f99637bcdcd2", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5225aecb-7703-4927-a3ad-7ca7f61a9581", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "938f5d7a-313e-4b08-be38-f99637bcdcd2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3bb61878-e178-44f6-899c-fd4bb337ff3f", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb2c505c-92eb-4611-a319-318fc0f2602d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3bb61878-e178-44f6-899c-fd4bb337ff3f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b03f4185-44b8-46be-aee0-1dcdbb7ef9f5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "043d520c-7a9c-4bfa-992f-da1aa8c90a0a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b03f4185-44b8-46be-aee0-1dcdbb7ef9f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7bb5a890-102f-4232-b03c-5459745df631", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84c92c80-a48a-4ccf-adeb-9f7e6b2c2e77", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7bb5a890-102f-4232-b03c-5459745df631"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "633aa070-6dbf-4e2e-987f-ee6b31df26e9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5d58f492-f736-4812-ad37-3bc11caac9af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "633aa070-6dbf-4e2e-987f-ee6b31df26e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d0fa3774-382c-4c1f-b493-c888185327c2", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e74a6c1d-ed6c-46df-a98b-2912725e4e05", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d0fa3774-382c-4c1f-b493-c888185327c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "461d4047-1189-442f-a44e-ed75bec2c591", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5a2306e-3736-42d6-a425-a40ac2b28dab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "461d4047-1189-442f-a44e-ed75bec2c591"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "855e34d8-2b8e-426d-bcdf-1118d92d01f7", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c51aead1-9212-48fb-9e1a-c1543f0bc559", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "855e34d8-2b8e-426d-bcdf-1118d92d01f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc12ab3a-851d-4dc7-9572-f8bd98e8c882", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2207ddfb-baac-4eae-b960-f1be7b924af0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc12ab3a-851d-4dc7-9572-f8bd98e8c882"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0077c81e-4919-4467-9fb7-2e152eca02f4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6483233-b419-4d08-a3b7-57e4a9fa5744", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0077c81e-4919-4467-9fb7-2e152eca02f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f67a9d6a-f189-49fc-9e29-d3e7aa8df825", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "1a0a5a8e-5980-4254-bd90-b931a6e44d6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f67a9d6a-f189-49fc-9e29-d3e7aa8df825"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "027628c3-cda3-45b6-a583-668b647bea9c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1a0a5a8e-5980-4254-bd90-b931a6e44d6f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "bb7bbebd-d3f7-4a26-a8c8-788d2e1f872b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "741acd1b-1795-4029-b822-565e8654a9b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bb7bbebd-d3f7-4a26-a8c8-788d2e1f872b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b4cff69-e2b7-44c9-bd5d-0304ea46c635", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "741acd1b-1795-4029-b822-565e8654a9b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "65489f25-98fa-4263-ad01-02cde822ae96", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "fd3bf545-ace4-4bd7-99a9-0577b4b914a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65489f25-98fa-4263-ad01-02cde822ae96"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "95492c62-2f57-4487-bb16-6a83a705162b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fd3bf545-ace4-4bd7-99a9-0577b4b914a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c366e680-a7ea-410e-85bd-bcd255a21e5a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9a5b8c5a-56e0-460f-b587-fede3b0d5a01", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c366e680-a7ea-410e-85bd-bcd255a21e5a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b3e30fe7-93e1-4bba-b151-125268163a1b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a5b8c5a-56e0-460f-b587-fede3b0d5a01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "93de2d29-276d-4fc8-9b8d-1a14ad009180", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9f109f6b-a961-4fda-9aaf-4ee9b07ed49e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "93de2d29-276d-4fc8-9b8d-1a14ad009180"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75ca4b01-e61e-4d1f-a96e-2a59ba4aee6d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f109f6b-a961-4fda-9aaf-4ee9b07ed49e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-right:-.1pt;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>", "ID": "ead7f2f9-4d90-4ff2-b89f-4c3a6d977dde", "Styles": "margin-right:-.1pt;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX II</span></b>", "ID": "ba1ea24a-a3fa-4e28-a0d6-8d25fc7d7b2d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ead7f2f9-4d90-4ff2-b89f-4c3a6d977dde"}, {"Element": "<span lang=\"EN-GB\">ANNEX II</span>", "ID": "3cb9e9a4-087e-497a-b16d-474e9712d767", "Styles": "None", "Classes": "None", "Text": "ANNEX II", "ParentId": "ba1ea24a-a3fa-4e28-a0d6-8d25fc7d7b2d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7804e245-a97d-4678-826f-a3095faaef4c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e0cdce5d-a208-4ef8-810e-07c5b01aad86", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7804e245-a97d-4678-826f-a3095faaef4c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4e93c1a4-e4c7-4fbf-b21a-af11ab3e7d86", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0cdce5d-a208-4ef8-810e-07c5b01aad86"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE\nFOR BATCH RELEASE</span></b></p>", "ID": "4a19c4e3-9088-4aca-9202-e2e895e528f1", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE\nFOR BATCH RELEASE</span></b>", "ID": "f789ab11-317c-4836-94e7-bfa012087a1d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4a19c4e3-9088-4aca-9202-e2e895e528f1"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE\nFOR BATCH RELEASE</span>", "ID": "ab019458-4e9a-4b24-98d7-ca0096008703", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE FOR BATCH RELEASE", "ParentId": "f789ab11-317c-4836-94e7-bfa012087a1d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "15e7682b-a7cf-4281-95b9-894a7ba558c4", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "25e57f8f-22a9-4398-9df0-ab4e6792575a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15e7682b-a7cf-4281-95b9-894a7ba558c4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2c0b4c0a-37fb-4e72-b369-c1c8e5605620", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25e57f8f-22a9-4398-9df0-ab4e6792575a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>", "ID": "8b65b43a-dd28-41ce-a9c3-56dedbcdac7e", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b>", "ID": "336a8617-c779-43b4-b3c7-b45caa967095", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b65b43a-dd28-41ce-a9c3-56dedbcdac7e"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "351dbce7-91c9-4b82-80c0-826788a6962b", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "336a8617-c779-43b4-b3c7-b45caa967095"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9251dc8b-6ed8-473f-98b0-0bb8d533bca6", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "090101f1-0917-40c8-bb78-9aac86ebbfac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9251dc8b-6ed8-473f-98b0-0bb8d533bca6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a821161-5785-4cb2-b2b8-479e85d752d2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "090101f1-0917-40c8-bb78-9aac86ebbfac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>", "ID": "2e0127b0-b608-436d-b612-e3e1790763ed", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b>", "ID": "98486ff9-99af-489b-8a61-479bc3e364f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2e0127b0-b608-436d-b612-e3e1790763ed"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span>", "ID": "f7bf97e3-d207-4bca-80a6-8b59ba3ab226", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "98486ff9-99af-489b-8a61-479bc3e364f3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "38e910f3-5722-4b74-b4ef-93ca761e7c64", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "aae65285-8d62-4722-836a-3842230e7024", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "38e910f3-5722-4b74-b4ef-93ca761e7c64"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f78a6de1-fa4c-4727-8e8d-969393c0101f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aae65285-8d62-4722-836a-3842230e7024"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "eebf404d-81fd-4c6d-a8af-0e1a04f3ca41", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b>", "ID": "bb1169de-baec-442d-918c-e0e054f78734", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eebf404d-81fd-4c6d-a8af-0e1a04f3ca41"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span>", "ID": "e6de33ca-a20b-438d-8017-d11ee7e6c887", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "bb1169de-baec-442d-918c-e0e054f78734"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "775d912a-d7ea-4dd9-9670-8a0c48634b89", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "870d33b7-919b-474b-b947-37b0bd46a3c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "775d912a-d7ea-4dd9-9670-8a0c48634b89"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c31274ea-10ba-4789-805b-b04781355ad1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "870d33b7-919b-474b-b947-37b0bd46a3c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c84ccc5b-04bb-423d-9c50-055df865fdab", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61d82a15-1a16-4817-951b-d4b8862586d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c84ccc5b-04bb-423d-9c50-055df865fdab"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "c36bed1e-ab87-4d13-a9a0-21b58a1a2004", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "5ff2c76c-22d4-44f9-9ea7-b2e8e98380ba", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "c36bed1e-ab87-4d13-a9a0-21b58a1a2004"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "9e0d4db7-ae9b-465a-b3bf-7b51b4dd4368", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "5ff2c76c-22d4-44f9-9ea7-b2e8e98380ba"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span></p>", "ID": "82cc0bd9-4961-49cb-bbe5-fa26b069925a", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "273ca1ba-dcc8-470e-8886-036cb89a9991", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE FOR BATCH RELEASE", "ParentId": "82cc0bd9-4961-49cb-bbe5-fa26b069925a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "044bc1bb-4d53-4a51-b7c5-e9c7abd0e1a5", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d824032f-7ef0-42d9-9669-8488ceddf429", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "044bc1bb-4d53-4a51-b7c5-e9c7abd0e1a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Name and address of the manufacturer responsible for\nbatch release</span></u></p>", "ID": "5da90399-b207-4314-bee8-47b49627edef", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<u><span lang=\"EN-GB\">Name and address of the manufacturer responsible for\nbatch release</span></u>", "ID": "e823c10c-eb1d-4f47-b4c6-42f884d1691e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5da90399-b207-4314-bee8-47b49627edef"}, {"Element": "<span lang=\"EN-GB\">Name and address of the manufacturer responsible for\nbatch release</span>", "ID": "57f557d1-446a-4e64-a82f-d379c831cefc", "Styles": "None", "Classes": "None", "Text": "Name and address of the manufacturer responsible for batch release", "ParentId": "e823c10c-eb1d-4f47-b4c6-42f884d1691e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "01c38be1-452e-4114-b2fa-f73827f3b7f1", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9a4e5f71-3bd4-43b4-8d8a-f8347144a56c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "01c38be1-452e-4114-b2fa-f73827f3b7f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>", "ID": "58dc6a45-9568-4c72-a167-5c0ade2a591a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Ireland UC</span>", "ID": "f7c76663-70cf-4ef7-83c8-f1c09507841d", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Ireland UC", "ParentId": "58dc6a45-9568-4c72-a167-5c0ade2a591a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">IDA Business &amp; Technology Park</span></p>", "ID": "1c2113bc-6865-4ba8-8abb-c44d4543dbc4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">IDA Business &amp; Technology Park</span>", "ID": "fff4721a-7e7a-49fc-b278-026392450a6e", "Styles": "None", "Classes": "None", "Text": "IDA Business & Technology Park", "ParentId": "1c2113bc-6865-4ba8-8abb-c44d4543dbc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Carrigtohill</span></p>", "ID": "9864d7bb-9021-4dd0-9b17-fe9158110be2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Carrigtohill</span>", "ID": "46eedd75-6fb4-4375-965e-3e7c407bbfe0", "Styles": "None", "Classes": "None", "Text": "Carrigtohill", "ParentId": "9864d7bb-9021-4dd0-9b17-fe9158110be2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">County Cork</span></p>", "ID": "c6301438-e332-4927-9bdb-f28654c3ed2e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">County Cork</span>", "ID": "96d2c00f-3412-4196-9f97-ee2df2789d65", "Styles": "None", "Classes": "None", "Text": "County Cork", "ParentId": "c6301438-e332-4927-9bdb-f28654c3ed2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">IRELAND</span></p>", "ID": "38d2d7a8-cf23-40c7-aba6-0bd7cc4c80b3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">IRELAND</span>", "ID": "233063cc-4306-43a0-9ec0-1cadcaf44beb", "Styles": "None", "Classes": "None", "Text": "IRELAND", "ParentId": "38d2d7a8-cf23-40c7-aba6-0bd7cc4c80b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "03696f13-c28e-4c14-b562-0546a567f692", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b00e60af-4b99-4302-978e-9efccf15319c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03696f13-c28e-4c14-b562-0546a567f692"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c33628bd-aff8-437b-99cb-ed1ac1356427", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe9c3af6-82f6-4e4e-91a6-a8d18838d104", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c33628bd-aff8-437b-99cb-ed1ac1356427"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></p>", "ID": "57c69c5c-cd5b-4492-ba1d-d4f8e39e4c06", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "235cd768-8ae0-47ce-a352-3b77e0bee267", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "57c69c5c-cd5b-4492-ba1d-d4f8e39e4c06"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89a1f8bc-c676-4da5-a648-b92a816bbe1c", "Styles": "margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1fc9ae20-dcf4-4219-b6fb-99d4107f9dc6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89a1f8bc-c676-4da5-a648-b92a816bbe1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex\u00a0I: Summary\nof Product Characteristics, section\u00a04.2).</span></p>", "ID": "00921911-07e3-4c03-90f3-5e2834b4d77f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex\u00a0I: Summary\nof Product Characteristics, section\u00a04.2).</span>", "ID": "146806e6-02e7-491d-8733-14ec65cedcd9", "Styles": "None", "Classes": "None", "Text": "Medicinal product subject to restricted medical prescription (see Annex\u00a0I: Summary of Product Characteristics, section\u00a04.2).", "ParentId": "00921911-07e3-4c03-90f3-5e2834b4d77f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f237670-1f52-47fd-8e08-330a1fb1ea48", "Styles": "margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bbb99e4c-0ea8-407a-8fed-e2bac6e148fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f237670-1f52-47fd-8e08-330a1fb1ea48"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26ca9117-98aa-4ba9-8905-1d05de55e4dc", "Styles": "margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "245f413e-4ad0-443e-92d2-7bc36303ac75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26ca9117-98aa-4ba9-8905-1d05de55e4dc"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></p>", "ID": "459426ae-23ea-4f4d-a309-b99583f74c86", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span>", "ID": "646755b7-250d-4276-8a72-6e5806416b7c", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "459426ae-23ea-4f4d-a309-b99583f74c86"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2be9ed7b-2de4-4eea-9d63-dfc071cb2a7d", "Styles": "margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23561533-e034-44e5-a5c1-e54ac104e392", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2be9ed7b-2de4-4eea-9d63-dfc071cb2a7d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports</span></b></p>", "ID": "4c4cdbb1-b124-48c2-a70b-203f4a34e684", "Styles": "margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "914aad0b-3b64-4eeb-a236-bc3c9a7bcc86", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "4c4cdbb1-b124-48c2-a70b-203f4a34e684"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8cbc8f2d-5359-47fb-a713-b9ed5dbe3bea", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "914aad0b-3b64-4eeb-a236-bc3c9a7bcc86"}, {"Element": "<b><span lang=\"EN-GB\">Periodic safety update reports</span></b>", "ID": "f3a5e458-b2f7-4964-b800-50ce63a15e17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c4cdbb1-b124-48c2-a70b-203f4a34e684"}, {"Element": "<span lang=\"EN-GB\">Periodic safety update reports</span>", "ID": "dd50199e-33eb-4a73-9df5-137d7a605d05", "Styles": "None", "Classes": "None", "Text": "Periodic safety update reports", "ParentId": "f3a5e458-b2f7-4964-b800-50ce63a15e17"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "866b40ed-67b1-4072-ac95-f6db28371a9b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f90224e7-8f84-4f32-94a5-e7a72ff65eeb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "866b40ed-67b1-4072-ac95-f6db28371a9b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The requirements\nfor submission of periodic safety update reports for this medicinal product are\nset out in the list of Union reference dates (EURD list) provided for under\nArticle\u00a0107c(7) of Directive\u00a02001/83/EC and any subsequent updates\npublished on the European medicines web-portal.</span></p>", "ID": "0c9e64ca-2757-4e76-afef-0e8c5fff8581", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The requirements\nfor submission of periodic safety update reports for this medicinal product are\nset out in the list of Union reference dates (EURD list) provided for under\nArticle\u00a0107c(7) of Directive\u00a02001/83/EC and any subsequent updates\npublished on the European medicines web-portal.</span>", "ID": "2f0090e3-dfd0-40fe-ab37-f88aa0031a76", "Styles": "None", "Classes": "None", "Text": "The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article\u00a0107c(7) of Directive\u00a02001/83/EC and any subsequent updates published on the European medicines web-portal.", "ParentId": "0c9e64ca-2757-4e76-afef-0e8c5fff8581"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "77956568-4583-4bf5-89bd-2f23035ceb0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d260118c-b5df-4398-aff3-c706ff639b59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "77956568-4583-4bf5-89bd-2f23035ceb0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder shall submit the first periodic safety update report for\nthis product within 6\u00a0months following authorisation.</span></p>", "ID": "9aa50942-dc93-4899-9ebc-217d9e09db17", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The marketing\nauthorisation holder shall submit the first periodic safety update report for\nthis product within 6\u00a0months following authorisation.</span>", "ID": "3a3079de-5552-4632-9a6f-51ecc22932a2", "Styles": "None", "Classes": "None", "Text": "The marketing authorisation holder shall submit the first periodic safety update report for this product within 6\u00a0months following authorisation.", "ParentId": "9aa50942-dc93-4899-9ebc-217d9e09db17"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bfc2c949-e8dd-442a-b397-f31b0607e5cc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1593d083-ade9-4c1d-9ca8-97f4baa84ece", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bfc2c949-e8dd-442a-b397-f31b0607e5cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f9f70b73-bdce-429b-974c-decf34868051", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d189093-0dbd-464f-bd8c-d8ba2fe54389", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f9f70b73-bdce-429b-974c-decf34868051"}, {"Element": "<p class=\"TitleB\"><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></p>", "ID": "bcaf3345-5028-4bd5-9702-6f12296cbe2e", "Styles": "None", "Classes": "['TitleB']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span>", "ID": "e57099e9-fb2c-4608-aad8-0e3dd358ff2f", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "bcaf3345-5028-4bd5-9702-6f12296cbe2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5151855c-d283-45c9-bd4d-6cbd1b9ec08d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f644239b-e987-47fe-b197-b601c1c394ae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5151855c-d283-45c9-bd4d-6cbd1b9ec08d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b></p>", "ID": "8166c4b4-ed3d-4ea9-a290-3acfd62509c7", "Styles": "margin-left:23.4pt;text-indent:-23.4pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "55fdc2cc-9d9f-4e0a-ad87-aa864efff8bf", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8166c4b4-ed3d-4ea9-a290-3acfd62509c7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7f625e94-728f-46f0-a00e-c19a36a82d75", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "55fdc2cc-9d9f-4e0a-ad87-aa864efff8bf"}, {"Element": "<b><span lang=\"EN-GB\">Risk Management Plan (RMP)</span></b>", "ID": "ade0c294-645a-48f1-9d71-1fd4b51a2531", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8166c4b4-ed3d-4ea9-a290-3acfd62509c7"}, {"Element": "<span lang=\"EN-GB\">Risk Management Plan (RMP)</span>", "ID": "5af53461-2f45-4427-bc40-565e4f8283e2", "Styles": "None", "Classes": "None", "Text": "Risk Management Plan (RMP)", "ParentId": "ade0c294-645a-48f1-9d71-1fd4b51a2531"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e14bcd66-95de-45d7-90fd-5fc531a426b4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8138e7e6-4934-41fc-b24b-590f92d499a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e14bcd66-95de-45d7-90fd-5fc531a426b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The MAH shall\nperform the required pharmacovigilance activities and interventions detailed in\nthe agreed RMP presented in Module\u00a01.8.2 of the marketing authorisation\nand any agreed subsequent updates of the RMP.</span></p>", "ID": "8bb67e37-5fbb-41bd-959f-b2a9abd6d1a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The MAH shall\nperform the required pharmacovigilance activities and interventions detailed in\nthe agreed RMP presented in Module\u00a01.8.2 of the marketing authorisation\nand any agreed subsequent updates of the RMP.</span>", "ID": "13cd92b5-0e9d-4ed8-9514-3bb969f4e11e", "Styles": "None", "Classes": "None", "Text": "The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module\u00a01.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.", "ParentId": "8bb67e37-5fbb-41bd-959f-b2a9abd6d1a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ed4ee7e-0c26-43c1-99d6-91f90cd0c167", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3bad151b-f662-48fc-802a-7f7286c30bb0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ed4ee7e-0c26-43c1-99d6-91f90cd0c167"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p>", "ID": "8823df38-880e-46ab-8b23-21efa12ea151", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">An updated RMP should be submitted:</span>", "ID": "8cd504f6-a22e-4a2f-bb4b-c92e50b76d22", "Styles": "None", "Classes": "None", "Text": "An updated RMP should be submitted:", "ParentId": "8823df38-880e-46ab-8b23-21efa12ea151"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e143eefd-3132-4164-b7c9-e33b9eb0a8e4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f858db6b-33bf-4550-931c-e837125bb1f5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e143eefd-3132-4164-b7c9-e33b9eb0a8e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>", "ID": "d55cea6f-9677-4f56-be8c-fdff94bb373e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a2382ba5-c273-42ba-b3d2-55f5be80cdec", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d55cea6f-9677-4f56-be8c-fdff94bb373e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2f66fa9c-9a3f-4cd6-b778-d43fc1892801", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a2382ba5-c273-42ba-b3d2-55f5be80cdec"}, {"Element": "<span lang=\"EN-GB\">At the request of the European Medicines Agency;</span>", "ID": "d41ffce0-2649-4f6e-8b80-c1d4ff1b07ae", "Styles": "None", "Classes": "None", "Text": "At the request of the European Medicines Agency;", "ParentId": "d55cea6f-9677-4f56-be8c-fdff94bb373e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span></p>", "ID": "f3dd45c6-c315-4814-ac7b-21118cbd3708", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1c24986a-e2f6-4fe3-a0d5-684942369d7e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f3dd45c6-c315-4814-ac7b-21118cbd3708"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c486b7cc-1abb-4c8d-a55d-261c780862d7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1c24986a-e2f6-4fe3-a0d5-684942369d7e"}, {"Element": "<span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span>", "ID": "7e838a79-4f80-4501-a531-2dbd957595a0", "Styles": "None", "Classes": "None", "Text": "Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.", "ParentId": "f3dd45c6-c315-4814-ac7b-21118cbd3708"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d61c49fa-b43e-44f8-8827-1bb0f9170b99", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85506a62-1183-49e2-8d9a-45ee880e6511", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d61c49fa-b43e-44f8-8827-1bb0f9170b99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post-authorisation\nmeasures</span></b></p>", "ID": "6314c37a-2e00-4cdc-b404-003fc6d21938", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2f876630-a233-4d2f-bff5-1e3390c7a043", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6314c37a-2e00-4cdc-b404-003fc6d21938"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "396479c0-1f3c-4ff3-abfb-8bf39080cc08", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2f876630-a233-4d2f-bff5-1e3390c7a043"}, {"Element": "<b><span lang=\"EN-GB\">Obligation to conduct post-authorisation\nmeasures</span></b>", "ID": "e5fb3be4-40b4-445b-91e2-031623e12709", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6314c37a-2e00-4cdc-b404-003fc6d21938"}, {"Element": "<span lang=\"EN-GB\">Obligation to conduct post-authorisation\nmeasures</span>", "ID": "b12e4218-7b8b-441c-ba99-1453e6a4ce8e", "Styles": "None", "Classes": "None", "Text": "Obligation to conduct post-authorisation measures", "ParentId": "e5fb3be4-40b4-445b-91e2-031623e12709"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "026f8391-910d-427f-9d20-2faf2a3f14ce", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a11fc66-9db7-47e5-86d6-863ee5c8d11e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "026f8391-910d-427f-9d20-2faf2a3f14ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span></p>", "ID": "c077ec30-9b21-4535-90d7-eef31fb703b3", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span>", "ID": "d6fb01e2-c2e8-4a89-a21b-3c25ad9e51e0", "Styles": "None", "Classes": "None", "Text": "The MAH shall complete, within the stated timeframe, the below measures:", "ParentId": "c077ec30-9b21-4535-90d7-eef31fb703b3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "450e9583-409d-4d34-8e8c-a0abc1d3e26e", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a03ad067-c89c-407c-96c1-a7ddf4958c89", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "450e9583-409d-4d34-8e8c-a0abc1d3e26e"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.0%;border-collapse:collapse;border:none\" width=\"98%\">\n<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span></p>\n</td>\n<td style=\"width:16.38%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Q2 2021</span></p>\n</td>\n</tr>\n</table>", "ID": "fd8502f5-1791-4dcb-9c02-ee212dcec269", "Styles": "width:98.0%;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "   ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<thead>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "fc8e6458-8d3e-47bf-a1c4-c845c44a7fa4", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "fd8502f5-1791-4dcb-9c02-ee212dcec269"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>", "ID": "3004b107-3c4e-400e-beab-15bef6bee381", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "fc8e6458-8d3e-47bf-a1c4-c845c44a7fa4"}, {"Element": "<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>", "ID": "b2110ac6-45e4-4975-8524-dea4cb9f448e", "Styles": "width:83.62%;border:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3004b107-3c4e-400e-beab-15bef6bee381"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>", "ID": "0deecfeb-019f-4b14-aae6-1c3f02c0dbf1", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2110ac6-45e4-4975-8524-dea4cb9f448e"}, {"Element": "<b><span lang=\"EN-GB\">Description</span></b>", "ID": "d684ca81-5dfc-4f84-bdaf-763737b2f7ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0deecfeb-019f-4b14-aae6-1c3f02c0dbf1"}, {"Element": "<span lang=\"EN-GB\">Description</span>", "ID": "ae05bae3-8330-4b42-a843-672203688679", "Styles": "None", "Classes": "None", "Text": "Description", "ParentId": "d684ca81-5dfc-4f84-bdaf-763737b2f7ca"}, {"Element": "<td style=\"width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>", "ID": "3fd94f29-f4e0-43d6-9afa-b7b9050fc484", "Styles": "width:16.38%;border:solid windowtext 1.0pt;\n   border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3004b107-3c4e-400e-beab-15bef6bee381"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>", "ID": "c982d416-d850-496c-9edd-ece7dbcd465a", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n   avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fd94f29-f4e0-43d6-9afa-b7b9050fc484"}, {"Element": "<b><span lang=\"EN-GB\">Due date</span></b>", "ID": "9961dd33-8030-4d0e-a14e-a3142abd531e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c982d416-d850-496c-9edd-ece7dbcd465a"}, {"Element": "<span lang=\"EN-GB\">Due date</span>", "ID": "b702d66e-6bcc-48bb-b8ae-72f8156dcf65", "Styles": "None", "Classes": "None", "Text": "Due date", "ParentId": "9961dd33-8030-4d0e-a14e-a3142abd531e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span></p>\n</td>\n<td style=\"width:16.38%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Q2 2021</span></p>\n</td>\n</tr>", "ID": "5be87244-34e7-4227-996c-f4b09d79f0ad", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "fd8502f5-1791-4dcb-9c02-ee212dcec269"}, {"Element": "<td style=\"width:83.62%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"83%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span></p>\n</td>", "ID": "643b83d6-38c0-4d1f-b495-d5b612853dc2", "Styles": "width:83.62%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5be87244-34e7-4227-996c-f4b09d79f0ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span></p>", "ID": "1107ce32-aa5a-4625-86eb-e4095afddedf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "643b83d6-38c0-4d1f-b495-d5b612853dc2"}, {"Element": "<span lang=\"EN-GB\">In order to\n  evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,\n  the MAH shall conduct and submit the results of a prospective safety study\n  using data deriving from a cohort of a well-defined group of patients, based\n  on an agreed protocol.\u00a0 The final study report shall be submitted by:</span>", "ID": "6d3a3357-68ec-4b93-a0ec-8b96291ab64a", "Styles": "None", "Classes": "None", "Text": "In order to   evaluate the recurrence of hepatocellular carcinoma associated with Epclusa,   the MAH shall conduct and submit the results of a prospective safety study   using data deriving from a cohort of a well-defined group of patients, based   on an agreed protocol.\u00a0 The final study report shall be submitted by:", "ParentId": "1107ce32-aa5a-4625-86eb-e4095afddedf"}, {"Element": "<td style=\"width:16.38%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"16%\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Q2 2021</span></p>\n</td>", "ID": "357d5920-2576-425a-90cf-de4362def325", "Styles": "width:16.38%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5be87244-34e7-4227-996c-f4b09d79f0ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Q2 2021</span></p>", "ID": "cf5a9a37-fb18-42f7-a9dd-27aa516f87fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "357d5920-2576-425a-90cf-de4362def325"}, {"Element": "<span lang=\"EN-GB\">Q2 2021</span>", "ID": "650eb0c8-030c-477f-bd23-9625b948b1a0", "Styles": "None", "Classes": "None", "Text": "Q2 2021", "ParentId": "cf5a9a37-fb18-42f7-a9dd-27aa516f87fd"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "e8297658-3587-49e5-be1d-12ced43f1e7b", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "a378e424-fc5b-4592-9bfd-3260d2060590", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "e8297658-3587-49e5-be1d-12ced43f1e7b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6f82602a-7f22-450c-bc6c-6576cc0be05e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "322016f5-cc51-433f-a88e-4643e0a39223", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6f82602a-7f22-450c-bc6c-6576cc0be05e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8fb369c-e3d0-463e-a8f1-4bae72d504bf", "Styles": "margin-right:28.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59e31ca7-cbf0-426a-8aa1-538aabe0515c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8fb369c-e3d0-463e-a8f1-4bae72d504bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba5b79e2-bcf4-41df-9969-4b75973a14a6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c12fc81c-420f-428f-9dfa-2e1e0e74a9e1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba5b79e2-bcf4-41df-9969-4b75973a14a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fcb005ed-9e64-4c37-a63d-07c09757181a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ddd1e79-0177-438a-9b20-3dfe18ac61f8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fcb005ed-9e64-4c37-a63d-07c09757181a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1d67eb2-b53b-45ee-a8be-2947825c2daf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "989abd3a-e481-45d6-acbe-3008dac3e826", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1d67eb2-b53b-45ee-a8be-2947825c2daf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8012cd44-0367-4a12-afa9-fd752e80c263", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f4fb553-e216-4ca8-839c-fd08efcd2da1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8012cd44-0367-4a12-afa9-fd752e80c263"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "38c52675-3c4b-4504-a5a3-db173e4e1632", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b376b31f-a446-4c22-a634-db434cda9546", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38c52675-3c4b-4504-a5a3-db173e4e1632"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2fc321f8-5b8b-472f-85f9-835bb6e60a24", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "18d9bba7-9576-4a05-91be-6718b54c7c54", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2fc321f8-5b8b-472f-85f9-835bb6e60a24"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cb1485b3-8cf9-4a0c-b6a5-06526e618c12", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6346e791-fb6c-4dc5-a0af-b99c31676c5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cb1485b3-8cf9-4a0c-b6a5-06526e618c12"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "12cd0020-90fe-44bf-b193-0ff9a8072d5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "621b434a-de87-4fa7-9e58-5a2930c3a247", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "12cd0020-90fe-44bf-b193-0ff9a8072d5b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "68f7aef8-baa2-4291-ad83-78fb670e751f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e074b34-bba2-40b9-aea3-3bada5c87dc9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "68f7aef8-baa2-4291-ad83-78fb670e751f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "29f8628e-2f0a-42dc-b63f-9c91c14d6136", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f6f4a27-5b9d-4825-8a70-35e868033b8c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "29f8628e-2f0a-42dc-b63f-9c91c14d6136"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19a9d8da-4f60-4543-9751-22c2fb9a0a57", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c8ce4b9-72cc-4527-850b-45a0707e522f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19a9d8da-4f60-4543-9751-22c2fb9a0a57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e3c6287f-0442-4515-bebd-bedb7e02dca8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1eb22992-e6cf-453a-be49-a695f0806d8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e3c6287f-0442-4515-bebd-bedb7e02dca8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7b50955d-aec5-4593-b497-f0294c013880", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d28fa365-7276-455c-872e-2dbc202c641b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7b50955d-aec5-4593-b497-f0294c013880"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19107862-69c5-4aa7-a525-06d6854b4531", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75f1470a-da37-426e-a488-0fdad97e3b53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19107862-69c5-4aa7-a525-06d6854b4531"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ea06baf-d88d-4554-8b34-6a1097b1bafc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3da4d6c5-3c5f-4b5e-8057-ff9226697cc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ea06baf-d88d-4554-8b34-6a1097b1bafc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ed810d2-ba4e-45f0-8414-fa74516f0eef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "76b6d7c5-0e65-4952-8650-5c6dc0d1646a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ed810d2-ba4e-45f0-8414-fa74516f0eef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42e8c030-4d3c-429f-83ff-14d9c24f4c40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "00931d3c-7ce8-4279-be87-170b9728715d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42e8c030-4d3c-429f-83ff-14d9c24f4c40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "586c93d4-eef2-4f7d-b7d9-1f29dfe7e288", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9ff1fe88-7475-4f73-a577-17d7885aa2e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "586c93d4-eef2-4f7d-b7d9-1f29dfe7e288"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eaac91b8-4dd5-4537-a84b-738d77c446d2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2f385c32-9b64-46af-8fc7-5f41b1d9369b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eaac91b8-4dd5-4537-a84b-738d77c446d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0adb121f-6bbe-49d4-88dc-eb889bd4b0e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0f29bae-d42d-4916-af88-03236c84b428", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0adb121f-6bbe-49d4-88dc-eb889bd4b0e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3a24f73e-f0fb-4e6e-ba68-b9f7699cff7a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fc6d1644-7c53-42e5-bbb9-0f844a32b6fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3a24f73e-f0fb-4e6e-ba68-b9f7699cff7a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>", "ID": "9221524f-45b1-4d44-aeba-e6193889dd08", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX III</span></b>", "ID": "773dad96-642b-488a-8ecd-87bf96b4680a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9221524f-45b1-4d44-aeba-e6193889dd08"}, {"Element": "<span lang=\"EN-GB\">ANNEX III</span>", "ID": "09f94228-85fc-4885-96f4-1d84be7dd3ea", "Styles": "None", "Classes": "None", "Text": "ANNEX III", "ParentId": "773dad96-642b-488a-8ecd-87bf96b4680a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "56c0ee54-b138-420e-b283-f0966ddff377", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8bbd3934-b88d-47e9-b605-93b992c74be9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56c0ee54-b138-420e-b283-f0966ddff377"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "633367cd-b43f-4623-be23-8f07803c783b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8bbd3934-b88d-47e9-b605-93b992c74be9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>", "ID": "8d719c49-f380-4246-906a-448c610c4f7d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b>", "ID": "5e916c6b-87d9-4d40-9022-b5cd82557eb3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d719c49-f380-4246-906a-448c610c4f7d"}, {"Element": "<span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span>", "ID": "85143a56-b46e-4088-8add-2ca65038d4ca", "Styles": "None", "Classes": "None", "Text": "LABELLING AND PACKAGE LEAFLET", "ParentId": "5e916c6b-87d9-4d40-9022-b5cd82557eb3"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "d104c271-1991-446e-acd7-3c92d8c8c90a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "9435ca30-e5b9-46d3-ac21-c475a091c093", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "d104c271-1991-446e-acd7-3c92d8c8c90a"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "a64735c0-f9fe-4904-96e3-4a4412f7bdf8", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "9435ca30-e5b9-46d3-ac21-c475a091c093"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7d74b395-c271-4830-a005-db45da1de424", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "351bafd9-a4c7-4a81-a7c6-1f70fbb84686", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7d74b395-c271-4830-a005-db45da1de424"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de386d43-363a-4913-af2f-0e177903c771", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56c44f3f-79a6-4b7b-9d86-992f557a0540", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de386d43-363a-4913-af2f-0e177903c771"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3dec75e2-058a-4047-91dc-38902453dadf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "347e0afa-136f-47e4-8754-e912dfe5bad4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3dec75e2-058a-4047-91dc-38902453dadf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f2d304da-c173-4ca2-b6ec-3f6b0ca25fc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "960dbe38-0cd6-4394-89e8-d96089fca4bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2d304da-c173-4ca2-b6ec-3f6b0ca25fc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ad7b0c6c-d243-41e5-acf4-e197f59a4cfe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10560f71-8c3a-4fb3-ab1f-da727a680730", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ad7b0c6c-d243-41e5-acf4-e197f59a4cfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "15566667-b6bd-4342-9224-85a9b20878d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6f208d72-f0b4-4c73-88a2-ab4ba2c8345e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15566667-b6bd-4342-9224-85a9b20878d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ef35ac44-7c28-4841-adaa-7b650c361379", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9a236b92-5238-46ae-ada7-b4185b7f1198", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ef35ac44-7c28-4841-adaa-7b650c361379"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1b40a256-7353-47df-9b98-33dd6710da44", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "187a6a26-7158-4e68-88fe-9babc6cfcb1c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1b40a256-7353-47df-9b98-33dd6710da44"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e7308930-8cb1-43d6-bad2-82575aea1e97", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2c304d34-15b9-4e44-be4a-ad6677e62fec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e7308930-8cb1-43d6-bad2-82575aea1e97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1992d674-c0e0-463d-b98d-485583006169", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc56f1e0-1a72-4fe5-81d4-5bf8dfe703ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1992d674-c0e0-463d-b98d-485583006169"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b8ad6b76-9e23-4314-aaff-659f39c8f674", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c8c53c81-c377-409d-bf4f-1f8940af7786", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8ad6b76-9e23-4314-aaff-659f39c8f674"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9cab372b-e2be-4d33-b46c-25a1f736392d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7706aee-cb77-4d06-bdae-f5680f46a3f3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9cab372b-e2be-4d33-b46c-25a1f736392d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "244374c6-fbc3-4552-bae6-72a6c15bb1dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fa42224f-ea97-4a78-a6b0-fb4ac544fe9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "244374c6-fbc3-4552-bae6-72a6c15bb1dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "481f1675-2934-415b-97b3-c0f2cca91743", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ad2f44ad-a24d-4b22-8af4-8a03114fc100", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "481f1675-2934-415b-97b3-c0f2cca91743"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b5ffd028-dee7-4583-86e5-4cf7a2da404a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64aef4bf-7710-4891-882d-b3b8b3c4ce8f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b5ffd028-dee7-4583-86e5-4cf7a2da404a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "99746d9b-e459-4255-972e-db7008066f3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2fa85d30-1ea5-4fa9-bfa6-219494bd371f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "99746d9b-e459-4255-972e-db7008066f3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6671d485-991d-4c04-9791-eeda2713db7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f415da45-0aea-40cd-9d5b-b2fabbf9ffbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6671d485-991d-4c04-9791-eeda2713db7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4eef98e5-24e6-43e5-b806-e3b456aa1934", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e87c1ceb-40e1-4b7a-b2ed-bd5c58876f67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4eef98e5-24e6-43e5-b806-e3b456aa1934"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "86d4e934-96d5-4f6a-8e48-4bd41c416670", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d26f811-94a2-4800-90cc-88d57d5f7ac3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "86d4e934-96d5-4f6a-8e48-4bd41c416670"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d61f402c-f1c6-4309-b1e3-32d90ec2200a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5881b795-e62a-4f0f-9669-15c06a4dade5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d61f402c-f1c6-4309-b1e3-32d90ec2200a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f6c61329-f88d-4ea3-b3be-aabba348f33e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65d0cd71-5eff-4546-971b-76cd61db60da", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f6c61329-f88d-4ea3-b3be-aabba348f33e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "39ceb575-a7f5-4abc-b9c0-d8cec7602296", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cca5f33a-a8c2-4e88-82d1-27a5ca4e3898", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "39ceb575-a7f5-4abc-b9c0-d8cec7602296"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1ea873fe-e0ca-4936-bc9f-4ab69b57c394", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9faaa884-8605-4d95-8ce1-017928904fa8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1ea873fe-e0ca-4936-bc9f-4ab69b57c394"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>", "ID": "bfffd90e-4062-49ed-97e1-ec6a68343878", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">A. LABELLING</span>", "ID": "a35d5ab0-4234-4e87-ac47-dcdc6dbdce8e", "Styles": "None", "Classes": "None", "Text": "A. LABELLING", "ParentId": "bfffd90e-4062-49ed-97e1-ec6a68343878"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "a5842af8-668e-4cbe-873c-1af9f44dcd44", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "56cc45f0-72af-4a07-8cd3-d9cf02e59f02", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "a5842af8-668e-4cbe-873c-1af9f44dcd44"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE\nPACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BOTTLE AND CARTON LABELLING</span></b></p>\n</div>", "ID": "f762639c-f1bb-48ce-9bb0-ddb4f49afb15", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE\nPACKAGING</span></b></p>", "ID": "17bed7f1-a4b9-408b-9b35-71bd806c07f8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f762639c-f1bb-48ce-9bb0-ddb4f49afb15"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE\nPACKAGING</span></b>", "ID": "53005c73-ffd9-47bc-a9f9-a552d0334b7b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17bed7f1-a4b9-408b-9b35-71bd806c07f8"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE\nPACKAGING</span>", "ID": "d4562cef-b597-4eda-b1fb-55b829d266c0", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING", "ParentId": "53005c73-ffd9-47bc-a9f9-a552d0334b7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4abb7920-6e70-4184-b480-c40c9aac033e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f762639c-f1bb-48ce-9bb0-ddb4f49afb15"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b93eacac-bae4-4fc1-9418-4601be3bc409", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4abb7920-6e70-4184-b480-c40c9aac033e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BOTTLE AND CARTON LABELLING</span></b></p>", "ID": "70c4674b-d9af-47bd-89d1-4f4986e27a3c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f762639c-f1bb-48ce-9bb0-ddb4f49afb15"}, {"Element": "<b><span lang=\"EN-GB\">BOTTLE AND CARTON LABELLING</span></b>", "ID": "d3b7a8c6-cba4-427e-8bb9-2063d16b5903", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "70c4674b-d9af-47bd-89d1-4f4986e27a3c"}, {"Element": "<span lang=\"EN-GB\">BOTTLE AND CARTON LABELLING</span>", "ID": "5fc38c8d-50bc-4524-8ed4-411b4628f38e", "Styles": "None", "Classes": "None", "Text": "BOTTLE AND CARTON LABELLING", "ParentId": "d3b7a8c6-cba4-427e-8bb9-2063d16b5903"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e22e197f-e90d-41bb-8e91-2df65a00118a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5453ba6a-b376-497e-844b-60ec706cbafc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e22e197f-e90d-41bb-8e91-2df65a00118a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b061e299-9f03-4b9c-9595-834b0f28c377", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8ad3c18d-a238-479c-a0c5-cedc1c791203", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b061e299-9f03-4b9c-9595-834b0f28c377"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "89871eb3-21e3-4a88-a0d1-9e3d7a1b09fb", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "32407c0d-7bd9-4358-96f5-20fa22266833", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89871eb3-21e3-4a88-a0d1-9e3d7a1b09fb"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "cb262889-c30e-48e1-9222-691c0cb2c50d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "32407c0d-7bd9-4358-96f5-20fa22266833"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "1bb94fea-21ed-4df9-a06b-5398f6b1e45e", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "cb262889-c30e-48e1-9222-691c0cb2c50d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "70c2a8e5-5db1-4240-822a-a388bd2ea163", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7ebd6a38-eaf8-4244-92c6-3c4ceb1c5365", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "70c2a8e5-5db1-4240-822a-a388bd2ea163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Epclusa 400\u00a0mg/100\u00a0mg film\u2011coated tablets</span></p>", "ID": "38db65b5-ce3b-4cb4-84b5-a88b5529772d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa 400\u00a0mg/100\u00a0mg film\u2011coated tablets</span>", "ID": "7cac23ba-b3bd-4391-96d8-2cdb8d7c554e", "Styles": "None", "Classes": "None", "Text": "Epclusa 400\u00a0mg/100\u00a0mg film\u2011coated tablets", "ParentId": "38db65b5-ce3b-4cb4-84b5-a88b5529772d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">sofosbuvir/</span><span lang=\"EN-GB\">velpatasvir</span></p>", "ID": "804af19c-1740-47af-92cf-e9edd976aead", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">sofosbuvir/</span>", "ID": "1ede8d07-c051-47fd-ac02-7845ae98c469", "Styles": "None", "Classes": "None", "Text": "sofosbuvir/", "ParentId": "804af19c-1740-47af-92cf-e9edd976aead"}, {"Element": "<span lang=\"EN-GB\">velpatasvir</span>", "ID": "004370c8-d456-43b5-ab8f-94ce42d310a7", "Styles": "None", "Classes": "None", "Text": "velpatasvir", "ParentId": "804af19c-1740-47af-92cf-e9edd976aead"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cd399f7a-57ff-48b8-a1c9-58654813b073", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c049ff04-7530-43fb-bd14-fabb0621e412", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cd399f7a-57ff-48b8-a1c9-58654813b073"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b0b8c991-7bd5-4acf-bcf3-6899b9761597", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4c8862ec-b943-4d84-8d9a-6a1ceceef296", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b0b8c991-7bd5-4acf-bcf3-6899b9761597"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>\n</div>", "ID": "a0e4350b-be05-4c22-840c-13891438984f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b></p>", "ID": "ca9a7e26-4582-4ef2-9550-5cec37ba759c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0e4350b-be05-4c22-840c-13891438984f"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span></b>", "ID": "c5a2b716-12b6-40b4-a007-9ddc2c3ab545", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca9a7e26-4582-4ef2-9550-5cec37ba759c"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE(S)</span>", "ID": "ca761dfe-b797-42e8-a9e8-494e0dd29ad4", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "c5a2b716-12b6-40b4-a007-9ddc2c3ab545"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa2ce48d-1205-431f-a48c-981548f1cbe4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de660bd4-2609-4b4f-b089-70a2dd0e44c1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa2ce48d-1205-431f-a48c-981548f1cbe4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg </span><span lang=\"EN-GB\">velpatasvir</span><span lang=\"EN-GB\">.</span></p>", "ID": "1ba7ec94-90c7-4944-85bd-70c2bea57c11", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Each film\u2011coated\ntablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg </span>", "ID": "8d166747-a912-4393-8fb8-e6c525059918", "Styles": "None", "Classes": "None", "Text": "Each film\u2011coated tablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg ", "ParentId": "1ba7ec94-90c7-4944-85bd-70c2bea57c11"}, {"Element": "<span lang=\"EN-GB\">velpatasvir</span>", "ID": "ad09427d-b8f0-40d7-a59e-904309c48f08", "Styles": "None", "Classes": "None", "Text": "velpatasvir", "ParentId": "1ba7ec94-90c7-4944-85bd-70c2bea57c11"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "cf350bea-d6db-4691-9536-8e579fc968f3", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "1ba7ec94-90c7-4944-85bd-70c2bea57c11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "97bcf5b0-885e-4614-9578-0b561088cc59", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d669c868-ee71-4b7c-ab53-6c26d053e513", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "97bcf5b0-885e-4614-9578-0b561088cc59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b83bf301-df52-47c7-8fb0-53398dade86e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5cff1be-1c56-4c11-a5fe-a9eea59be4b9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b83bf301-df52-47c7-8fb0-53398dade86e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "90228e33-13f3-4303-85c7-1c2419708329", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "dd18e6b5-e39f-4fca-9020-06e735006d42", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "90228e33-13f3-4303-85c7-1c2419708329"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "b57610da-0a11-4582-9df1-9b735bacac0a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd18e6b5-e39f-4fca-9020-06e735006d42"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "819fc170-6843-4935-93ff-ad4347f6a8ae", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "b57610da-0a11-4582-9df1-9b735bacac0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "40684f11-8d66-48f4-a736-bd25cdf69a78", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84f9bad8-218c-4a2d-b315-6460e716ab08", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40684f11-8d66-48f4-a736-bd25cdf69a78"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "648bb277-117a-4ec2-9a3a-d1059e17882d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c6f20002-5e6e-4573-8039-54e62d2ff6d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "648bb277-117a-4ec2-9a3a-d1059e17882d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "69a49b1c-6090-48e2-8eed-d81ff9062448", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "406bfe42-aa67-4501-aa9b-60b5ebacc07e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "69a49b1c-6090-48e2-8eed-d81ff9062448"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "bb2f9443-3425-436c-b791-7a86f46c2e6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "406bfe42-aa67-4501-aa9b-60b5ebacc07e"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "7cff4e20-f105-4682-a83d-e089f8bddcf5", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "bb2f9443-3425-436c-b791-7a86f46c2e6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2e0b8cc7-8c3e-4b21-856a-776b45be17b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c680269c-7fc0-4f79-bd83-0dd57296d44f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2e0b8cc7-8c3e-4b21-856a-776b45be17b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">28\u00a0film\u2011coated\ntablets</span></p>", "ID": "e22dc758-56b2-4157-8b7d-490c260af874", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">28\u00a0film\u2011coated\ntablets</span>", "ID": "af01fa74-499a-4f6f-b2fe-3406cd467426", "Styles": "None", "Classes": "None", "Text": "28\u00a0film\u2011coated tablets", "ParentId": "e22dc758-56b2-4157-8b7d-490c260af874"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "23f0dee1-a6ef-4011-b96d-16459c1c16fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ea8d985-88ed-42d1-b800-8e47aaa5c8b2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "23f0dee1-a6ef-4011-b96d-16459c1c16fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eb79f7f7-456d-4e18-a6e8-0df8efc16b18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d86c43e2-c777-46ce-9036-efc7f682c417", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eb79f7f7-456d-4e18-a6e8-0df8efc16b18"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "f2f90b8e-5c73-4804-a394-b1d1741f5dbd", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "f1961015-865c-45ec-aadb-baab64a20b6c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f2f90b8e-5c73-4804-a394-b1d1741f5dbd"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "9b67e26e-fc71-4b42-90ba-f2a2fb4e0af9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1961015-865c-45ec-aadb-baab64a20b6c"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "95316a9e-0ec4-40ea-860e-a8a8add8f103", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "9b67e26e-fc71-4b42-90ba-f2a2fb4e0af9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df157ec3-ec99-4337-9d7c-a73fba6e0495", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0777ee50-91f6-42de-abb1-feb12d6f67aa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df157ec3-ec99-4337-9d7c-a73fba6e0495"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Read the package leaflet before use.</span></p>", "ID": "cf9f10ae-78f7-48dc-bd98-fffe26d26a39", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Read the package leaflet before use.</span>", "ID": "5ecd0b9d-82b9-4805-8f6e-861c96420c2c", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "cf9f10ae-78f7-48dc-bd98-fffe26d26a39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9d7f6f0f-5171-4149-bff8-18b99fa9d9e6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17ce98a6-7d11-4595-b893-9269d7cb2aa4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9d7f6f0f-5171-4149-bff8-18b99fa9d9e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use.</span></p>", "ID": "431cc0d4-8a92-4f33-a93c-4552ab5aa1fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Oral use.</span>", "ID": "67d85dba-8667-4180-9f0e-8ddfdeef2a6f", "Styles": "None", "Classes": "None", "Text": "Oral use.", "ParentId": "431cc0d4-8a92-4f33-a93c-4552ab5aa1fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8388004d-24e2-45fb-a340-ad58809d0325", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d20cec20-094f-44d4-848f-4e27fa2bcf43", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8388004d-24e2-45fb-a340-ad58809d0325"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "94bb789f-c0b1-4b92-87ae-c29a511a9ee4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d276687-c835-439c-a6cc-9f2326df2e9d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "94bb789f-c0b1-4b92-87ae-c29a511a9ee4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "80ed0db6-885d-417b-b203-53be13b07cc8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "947565a6-d8e8-4e0b-a7f6-490b569596c0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "80ed0db6-885d-417b-b203-53be13b07cc8"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "674e2043-d7b0-4af5-a5d8-a9ca9723e4a5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "947565a6-d8e8-4e0b-a7f6-490b569596c0"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "d24d4908-ef9d-4844-a1aa-8043ef4c3b36", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "674e2043-d7b0-4af5-a5d8-a9ca9723e4a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7cd494e3-3aa6-4792-b717-64a1baa7ac41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "218d458c-0d9d-4be8-ad53-d7025718e246", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7cd494e3-3aa6-4792-b717-64a1baa7ac41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children.</span></p>", "ID": "adf9d227-c917-43c6-9528-eaf1518fdd3d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children.</span>", "ID": "0319f29d-dc3a-4209-9442-34dcee358aa0", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "adf9d227-c917-43c6-9528-eaf1518fdd3d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "881528c2-62e7-444b-b6c2-624842557242", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "95a51498-5bd0-4751-b2b9-313adeecba26", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "881528c2-62e7-444b-b6c2-624842557242"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "865e2447-88ec-41a1-a663-5de6b26af98d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d3ef289a-f255-4ac0-bf91-c6bb6946c5c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "865e2447-88ec-41a1-a663-5de6b26af98d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "bc62ab7a-b769-4b72-92f4-10a50fa26ba7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "5960b2cf-aad0-48de-a071-5bd7fa936b06", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc62ab7a-b769-4b72-92f4-10a50fa26ba7"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "eaa30b36-e411-4d4c-b109-5f9894c47956", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5960b2cf-aad0-48de-a071-5bd7fa936b06"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "1d024bf6-9348-4332-afb7-ff706a86b6dd", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "eaa30b36-e411-4d4c-b109-5f9894c47956"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "15176bff-27e8-42c4-a0a9-d4dd02c25de1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3eb7ddd-2476-4124-ae2b-2f105a0381cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15176bff-27e8-42c4-a0a9-d4dd02c25de1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f3b0573-5d35-47f7-baca-45da28f3ef1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ec32c09a-2aae-4a46-a8b4-45a267c8c498", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f3b0573-5d35-47f7-baca-45da28f3ef1a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "d7aa8811-db0e-4488-977f-4cbec20af96c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "be759978-6032-44ee-92ea-bc4d516ef60f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7aa8811-db0e-4488-977f-4cbec20af96c"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "98d33e3a-3999-4d29-929e-a981804c1e66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be759978-6032-44ee-92ea-bc4d516ef60f"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "9abbd521-ceee-4590-b89c-b6ae9b710419", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "98d33e3a-3999-4d29-929e-a981804c1e66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "715fef3d-1750-4712-8d5b-584188440a8d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e8c142e-f301-4cf2-a828-4ca503dea1c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "715fef3d-1750-4712-8d5b-584188440a8d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "13f9d804-6347-4217-84c9-068abdb31046", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "6ad41a62-2217-4363-a79e-627fdf9d6a28", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "13f9d804-6347-4217-84c9-068abdb31046"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "406719a6-bcd7-4b47-b909-9583b24e9be3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05eb61dc-2e27-4cd9-a6cc-6b69dacf4012", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "406719a6-bcd7-4b47-b909-9583b24e9be3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e050c041-c5c2-4048-800b-569caa564a26", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "14c32b67-3e40-4bd9-907d-d48b13c76218", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e050c041-c5c2-4048-800b-569caa564a26"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "383cd477-030e-4705-a945-cd543c8f23fa", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "e249b3d9-7bb2-443c-bba2-9cc70580448e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "383cd477-030e-4705-a945-cd543c8f23fa"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "1ce00c9e-7dd3-49bf-85b1-30fa36d04544", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e249b3d9-7bb2-443c-bba2-9cc70580448e"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "32fcc2d7-82df-40fe-aaf9-ca859dd26f1d", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "1ce00c9e-7dd3-49bf-85b1-30fa36d04544"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "41ddd85b-6d6a-4a67-99f4-66fe4ffa51ba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73943208-e63f-4b96-9ca6-cbd2e48aa6b0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41ddd85b-6d6a-4a67-99f4-66fe4ffa51ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "00675863-8430-4049-bfac-4ec7b25e9d63", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60417f45-76ef-4698-bf23-31eeaa106ba5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00675863-8430-4049-bfac-4ec7b25e9d63"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "ae430a85-fb90-4970-9627-e1407464599f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "5d112b98-0985-4947-8635-a021c586f9f1", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae430a85-fb90-4970-9627-e1407464599f"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "6619eb73-3bce-4c26-9f7d-e98bfc513b71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d112b98-0985-4947-8635-a021c586f9f1"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "d1f2d7db-c767-4b16-ba15-76dd688339e9", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "6619eb73-3bce-4c26-9f7d-e98bfc513b71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "79ef5cdb-abd7-4d6f-bdd0-8c02cbff3954", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6a085983-db35-44db-bf40-2457fa7fa698", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "79ef5cdb-abd7-4d6f-bdd0-8c02cbff3954"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d76ea35f-f98e-4dd7-ab4e-5f7e37d725a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5b044aa9-d29f-447b-9142-bd1c6030131e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d76ea35f-f98e-4dd7-ab4e-5f7e37d725a3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "785b7cca-ebe9-4ab7-85cc-3ade355170dd", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "6f047eab-1692-4408-9390-1ae8ffaa0c01", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "785b7cca-ebe9-4ab7-85cc-3ade355170dd"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "1d214d50-f5b3-4bfc-8d67-a7f73ae9dde7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6f047eab-1692-4408-9390-1ae8ffaa0c01"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "c0dfa2d2-e2e1-4bea-8bd1-f594e6be5542", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "1d214d50-f5b3-4bfc-8d67-a7f73ae9dde7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a81e5cb4-86fb-49b9-99ad-baa69a5a6d34", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f84e52b-5433-4e13-ad78-5376d72d86ec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a81e5cb4-86fb-49b9-99ad-baa69a5a6d34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>", "ID": "b0b269ba-2c58-45d4-b0ee-196627ffcda1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Ireland UC</span>", "ID": "a32d7358-c82b-4154-b75d-0fdc637e639b", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Ireland UC", "ParentId": "b0b269ba-2c58-45d4-b0ee-196627ffcda1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>", "ID": "1cc58410-2bf1-4e28-ac66-37ae1dbdfe6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Carrigtohill</span>", "ID": "1d5575c2-284f-4f50-9b00-6921343b9383", "Styles": "None", "Classes": "None", "Text": "Carrigtohill", "ParentId": "1cc58410-2bf1-4e28-ac66-37ae1dbdfe6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>", "ID": "2bb76446-85a8-48bb-b665-26d5ad72c495", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">County Cork, T45 DP77</span>", "ID": "c3801fef-e447-47c8-8b30-942234b04080", "Styles": "None", "Classes": "None", "Text": "County Cork, T45 DP77", "ParentId": "2bb76446-85a8-48bb-b665-26d5ad72c495"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "abcd9671-caac-4f14-9e34-6a7ae631bc9d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "466dfa84-5eb9-45fe-85d5-4ece68c19870", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "abcd9671-caac-4f14-9e34-6a7ae631bc9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b0fc5d1-8da1-4bbe-b10a-3f6418b40624", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5e4a3b5-2291-4ce1-b8e0-9a4c39a48cac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b0fc5d1-8da1-4bbe-b10a-3f6418b40624"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e0e9f30-48cd-4b89-83bb-4b966e84c4ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df7df6f5-a7cb-4e9e-817c-50e72bcab90a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e0e9f30-48cd-4b89-83bb-4b966e84c4ca"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n</div>", "ID": "2f95fd13-089d-4e80-b212-19a251296ce2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>", "ID": "09e270cb-6273-426b-ba70-4709984922e0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2f95fd13-089d-4e80-b212-19a251296ce2"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b>", "ID": "e62738d1-8a5b-45f6-90bc-c898ec09e415", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "09e270cb-6273-426b-ba70-4709984922e0"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span>", "ID": "24fe0f5d-a362-453f-9349-00cc53f5d589", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "e62738d1-8a5b-45f6-90bc-c898ec09e415"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ee6cc39-effd-4e18-a893-5433d42ce295", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f4ba682-e25f-4cce-bb4e-1fcb990b463b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ee6cc39-effd-4e18-a893-5433d42ce295"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1116/001</span></p>", "ID": "703960a9-c7d8-46aa-8cbe-2c866c906ee8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">EU/1/16/1116/001</span>", "ID": "1c4f0f40-821a-4697-a2b3-6886c7802e29", "Styles": "None", "Classes": "None", "Text": "EU/1/16/1116/001", "ParentId": "703960a9-c7d8-46aa-8cbe-2c866c906ee8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "483f1cbd-5573-4f57-8084-a7d24d688e38", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "50fbadc6-6674-49a5-afd2-a7ad368a16ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "483f1cbd-5573-4f57-8084-a7d24d688e38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fae6d1bf-373f-455f-aa6c-4c185d7db5b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92a7751a-7d07-44b1-afd9-0459a1791dc1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fae6d1bf-373f-455f-aa6c-4c185d7db5b3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "28388c7a-8b71-4159-9cff-2530a372df59", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "8097e222-3d83-4fb2-bdad-328aaa47509a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "28388c7a-8b71-4159-9cff-2530a372df59"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "b5194fa6-37af-4073-afd1-0fe94fe5e542", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8097e222-3d83-4fb2-bdad-328aaa47509a"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "afb093f7-4411-463b-8f41-3ad52bfa22e9", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "b5194fa6-37af-4073-afd1-0fe94fe5e542"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b55fc341-1d2e-4b01-b5cb-0ee92839831d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "43cee9d4-7337-4e0c-ac4d-0e3b78d03aaa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b55fc341-1d2e-4b01-b5cb-0ee92839831d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "48c078a3-754b-4cdc-80b0-e73624958da5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "0de29a80-e5f3-46a4-8a44-430504ffe5a7", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "48c078a3-754b-4cdc-80b0-e73624958da5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6519ada1-6825-43aa-a507-49bddedd6142", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70959588-e5ba-4aa9-a9da-20d2166899a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6519ada1-6825-43aa-a507-49bddedd6142"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e913d01a-4ff8-454b-86da-461d7f62b1de", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "804669c5-f9a5-4eb7-ba57-d1d7fd219754", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e913d01a-4ff8-454b-86da-461d7f62b1de"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "ca3895c7-7104-40c3-a32f-82fc15178008", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "f0a6239b-cd7d-4e43-b43d-6954984e47fc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ca3895c7-7104-40c3-a32f-82fc15178008"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "4c746ab7-8187-4338-af08-224a3f74eaa5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f0a6239b-cd7d-4e43-b43d-6954984e47fc"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "f723777c-1291-489a-bfc2-7d4e7a7af0d5", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "4c746ab7-8187-4338-af08-224a3f74eaa5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25a5aafd-2363-42cb-ae99-883af1412548", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bec1a041-aea3-4ed9-86c9-8b7314f5cd03", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25a5aafd-2363-42cb-ae99-883af1412548"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "63678dd8-2ff5-435c-a16c-d0bd441087dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a27b4c6d-2634-4f47-8721-f91f34484564", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "63678dd8-2ff5-435c-a16c-d0bd441087dc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "bcdab280-5298-4396-ac57-1ca9fff3ff15", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "28a2c83f-e08f-4f07-bcf7-419407ece9f7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bcdab280-5298-4396-ac57-1ca9fff3ff15"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "2dc3cbc7-8592-4409-96d4-64bd3d9a5dec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28a2c83f-e08f-4f07-bcf7-419407ece9f7"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "2b517cc3-0429-4b71-aa4c-98a2b4d04a65", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "2dc3cbc7-8592-4409-96d4-64bd3d9a5dec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b5d8c72-0b55-4ead-a8b9-3d918fc9363a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e07b3e58-9147-4431-bc5c-88d8818cc778", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b5d8c72-0b55-4ead-a8b9-3d918fc9363a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3abb7294-20f9-4dbf-bbb6-1fe40999f2c4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8063eaec-30d1-4714-bc16-23e11cf9af6c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3abb7294-20f9-4dbf-bbb6-1fe40999f2c4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "464fc638-d711-40c5-8211-d86cdb027e98", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "330db22e-dabf-4e03-8db3-393289d875ca", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "464fc638-d711-40c5-8211-d86cdb027e98"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "174c6c77-d3f5-4618-b104-f209c658eb45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "330db22e-dabf-4e03-8db3-393289d875ca"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "da3e4c04-4908-4a25-94e1-49e9a31b0833", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "174c6c77-d3f5-4618-b104-f209c658eb45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2e6b8650-3c97-4c17-b262-ebd30935087e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "668fb778-4d25-4126-90b2-c110a0a10d20", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2e6b8650-3c97-4c17-b262-ebd30935087e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa <span style=\"color:black;background:#BFBFBF\">[Outer packaging only]</span></span></p>", "ID": "9b7d5750-7271-4884-a1da-103d6c206d4f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa <span style=\"color:black;background:#BFBFBF\">[Outer packaging only]</span></span>", "ID": "14cd0c8a-98e4-4b35-9bc4-f58f32137468", "Styles": "None", "Classes": "None", "Text": "Epclusa ", "ParentId": "9b7d5750-7271-4884-a1da-103d6c206d4f"}, {"Element": "<span style=\"color:black;background:#BFBFBF\">[Outer packaging only]</span>", "ID": "2ca02ff6-3711-4b30-acbe-c878bce36d5d", "Styles": "color:black;background:#BFBFBF", "Classes": "None", "Text": "[Outer packaging only]", "ParentId": "14cd0c8a-98e4-4b35-9bc4-f58f32137468"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3d5207f0-1f88-40a3-9783-c11f9cbb56de", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a7dd52b-85d3-4441-bdab-3ebc56bf4829", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3d5207f0-1f88-40a3-9783-c11f9cbb56de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "09f7c84d-228c-4a70-9602-2cf4419d758d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5344c125-c2b7-479e-8f9c-3feef374d0e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "09f7c84d-228c-4a70-9602-2cf4419d758d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "685619de-2db9-4efb-8565-bbd29288c28d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "9a00493d-4eee-4995-a80c-fa506c634b73", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "685619de-2db9-4efb-8565-bbd29288c28d"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "0f70cf13-909f-49b2-adb3-2e6bc71c4537", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a00493d-4eee-4995-a80c-fa506c634b73"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "b6a2e8b5-e313-440b-bdf5-2fc6009484ca", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "0f70cf13-909f-49b2-adb3-2e6bc71c4537"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b64d9178-9219-49d2-bcbe-2fc5fe1fbe80", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7f80af97-e752-428f-94a6-52865beff30c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b64d9178-9219-49d2-bcbe-2fc5fe1fbe80"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">2D barcode carrying the unique\nidentifier included.</span></p>", "ID": "7ab56d3c-a5a3-4ac6-ad09-fb6bbdd31ac6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">2D barcode carrying the unique\nidentifier included.</span>", "ID": "7ba40d99-f598-4b6c-906d-b05265689dc5", "Styles": "color:black;background:#BFBFBF", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "7ab56d3c-a5a3-4ac6-ad09-fb6bbdd31ac6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "95ec1baf-d1a7-4cce-ace8-514a2c9792c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "61f89790-c9ef-4ecd-b351-df87eadfe003", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "95ec1baf-d1a7-4cce-ace8-514a2c9792c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "91462b4a-bf32-4d5a-8c54-95c6845a63fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d56fac0-6dda-45c9-93aa-41b26e046b82", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "91462b4a-bf32-4d5a-8c54-95c6845a63fb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "a460dab2-c7f1-45eb-9a68-6d63d3e0da00", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "0dff0db6-7748-498e-bcc3-e206c7ce6775", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a460dab2-c7f1-45eb-9a68-6d63d3e0da00"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "892ed163-4b37-4d95-a4ad-47cb766995ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0dff0db6-7748-498e-bcc3-e206c7ce6775"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER - HUMAN READABLE DATA</span>", "ID": "9afd9f7d-5103-4b9f-88bf-59ce6c88d066", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "892ed163-4b37-4d95-a4ad-47cb766995ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "573924cb-be3f-4d68-a359-a45ea9ca338b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae3f627b-4cc9-4496-8fb0-f1778a60a955", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "573924cb-be3f-4d68-a359-a45ea9ca338b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">PC: </span></p>", "ID": "e1a40631-3781-4c4e-b845-37f804f129eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">PC: </span>", "ID": "b77931e1-5f5d-4471-8862-56631de1ab15", "Styles": "None", "Classes": "None", "Text": "PC: ", "ParentId": "e1a40631-3781-4c4e-b845-37f804f129eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">SN: </span></p>", "ID": "09924b47-9518-4632-a770-5408c680e672", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">SN: </span>", "ID": "6ad1a216-9278-4ec6-b8ae-f6f4c4e351c6", "Styles": "None", "Classes": "None", "Text": "SN: ", "ParentId": "09924b47-9518-4632-a770-5408c680e672"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN: </span></p>", "ID": "eec187ab-fd56-4d7a-9e34-6bceaa772a04", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">NN: </span>", "ID": "60516ef8-bdb5-4427-889a-7aaa74495a68", "Styles": "None", "Classes": "None", "Text": "NN: ", "ParentId": "eec187ab-fd56-4d7a-9e34-6bceaa772a04"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "d5827390-49a9-4594-a7e4-da3382e01997", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "32820e2b-bd24-426b-a8bc-e6ad77ea2c22", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "d5827390-49a9-4594-a7e4-da3382e01997"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca8db290-76ff-4497-ba56-474a1ac7a9f4", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f133d9ae-bba8-4da7-9eef-66897664e5a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca8db290-76ff-4497-ba56-474a1ac7a9f4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "783f7378-177a-4fa9-81d5-58d653f76f1d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d4aa9b7-9132-4c3a-9fc5-2f8d4ac20757", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "783f7378-177a-4fa9-81d5-58d653f76f1d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1f2d031-f9e8-4635-aedc-8a0884a679f6", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6fdf9453-d748-40ac-ad87-1abdba61f1de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1f2d031-f9e8-4635-aedc-8a0884a679f6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4edd1ee4-a045-4649-bf5f-f50a43b5889b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e56895b6-8829-4725-a629-7e7d2778aced", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4edd1ee4-a045-4649-bf5f-f50a43b5889b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d26fb04d-7d7b-49e2-99de-5b4089c45b3c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fdaccb92-5983-4294-8cc6-120a60efb5ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d26fb04d-7d7b-49e2-99de-5b4089c45b3c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "72e3c3e8-784a-49e7-9bde-0ee33f2fee8f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2cd810d-1db8-4af3-912d-8562c51a910d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "72e3c3e8-784a-49e7-9bde-0ee33f2fee8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f003db65-eb4e-4603-859d-12124fbb6255", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a28ce615-d8a3-43a4-942a-b2a5c804ef17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f003db65-eb4e-4603-859d-12124fbb6255"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cece59f2-ee1d-407c-93df-f6ae195914a3", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06635491-3b58-4162-aad3-ce037776af91", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cece59f2-ee1d-407c-93df-f6ae195914a3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "233bd85c-6d45-4a8e-94e7-1f934b439a47", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5cd18cd9-95e5-4cb5-a5a8-67d1bd4868e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "233bd85c-6d45-4a8e-94e7-1f934b439a47"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e7ac476-9a18-4146-9cc9-1e1e671611c7", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba496556-fc6f-4c2f-be2a-3afcd9787946", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e7ac476-9a18-4146-9cc9-1e1e671611c7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5f48ee18-2d95-4a29-a3c0-375374a1df0c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "42da49c5-09bf-4ce0-9f48-23e249e87885", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5f48ee18-2d95-4a29-a3c0-375374a1df0c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1666051d-f92d-42e3-92de-de00484dbe31", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6de29b02-6f22-4d5e-aaa6-d78d1e022358", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1666051d-f92d-42e3-92de-de00484dbe31"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8071d21-1349-4e24-a7e4-ec6064b061e0", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a746f298-96e8-478c-a340-c35f825436b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8071d21-1349-4e24-a7e4-ec6064b061e0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8c969934-30e4-469e-b3b8-101abb32da1d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45aeb445-f4d8-4b0c-a2f7-14dec0de8aad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8c969934-30e4-469e-b3b8-101abb32da1d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "db1de963-80cc-4510-ac2a-9a5253149224", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "09d6f9a4-9d9e-4b57-a9ff-9f97db87e4c9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "db1de963-80cc-4510-ac2a-9a5253149224"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98ab4dbb-51d3-429d-96d2-6052986a0c67", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf369b51-db05-48d0-a907-bfef8c35eeba", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98ab4dbb-51d3-429d-96d2-6052986a0c67"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b2f58a8f-e43d-4e42-bded-4ecba4d719e3", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4da694f-8f2a-4350-8c16-d63d7fe59433", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b2f58a8f-e43d-4e42-bded-4ecba4d719e3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89cce4be-3219-4527-a383-0b8ed2931441", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cde3a2f6-aa7e-481b-b585-e2e2f31a1c90", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89cce4be-3219-4527-a383-0b8ed2931441"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2c1a74f9-d597-417e-b51a-6888dce9a9dd", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac6f3a96-9784-47cd-9a80-2009609f1a5b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2c1a74f9-d597-417e-b51a-6888dce9a9dd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "341640ce-c1e5-44e4-84d4-5c42f40d58c2", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f8180ba4-8dd5-4698-ae59-4d889c5fdcf2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "341640ce-c1e5-44e4-84d4-5c42f40d58c2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4057da2-dc27-4b48-a3f2-1d6f835beebb", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0265a669-3c47-4fe8-b117-af67f1e28b6e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4057da2-dc27-4b48-a3f2-1d6f835beebb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ff32402-57d7-4273-a771-fce6e34ef824", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "43d774d8-b7d6-4cf4-872c-aae92607e783", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ff32402-57d7-4273-a771-fce6e34ef824"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d1e88a40-8938-4f2c-b837-7d8d2136a05a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bfaf891e-9be4-4286-a72f-0cae20eb6bfd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d1e88a40-8938-4f2c-b837-7d8d2136a05a"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>", "ID": "3742b281-e463-48ca-aa74-3998534769c9", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">B. PACKAGE LEAFLET</span>", "ID": "522bd53a-17ab-41e9-b7b7-ad4de0c53b7f", "Styles": "None", "Classes": "None", "Text": "B. PACKAGE LEAFLET", "ParentId": "3742b281-e463-48ca-aa74-3998534769c9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6fdfe993-dd44-4b59-9152-aa3b19c3edfa", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba62350c-547a-4522-bf5c-0a78203186f4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6fdfe993-dd44-4b59-9152-aa3b19c3edfa"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "f1ab81b7-7245-4c55-9afa-c1f23f644ebb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "a57a0d84-7dc1-425d-aaa4-f1ee99cad226", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "f1ab81b7-7245-4c55-9afa-c1f23f644ebb"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "ef00728b-0548-44a4-ae14-3aeb1702b198", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "a57a0d84-7dc1-425d-aaa4-f1ee99cad226"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the user</span></b></p>", "ID": "fd7f9660-6358-44ce-8beb-5a3f51427c67", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Package leaflet: Information for the user</span></b>", "ID": "7e3c5125-b003-4037-a93c-3cce1d0ce3ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fd7f9660-6358-44ce-8beb-5a3f51427c67"}, {"Element": "<span lang=\"EN-GB\">Package leaflet: Information for the user</span>", "ID": "1b2f5761-f551-44f7-b1d6-a478591f2188", "Styles": "None", "Classes": "None", "Text": "Package leaflet: Information for the user", "ParentId": "7e3c5125-b003-4037-a93c-3cce1d0ce3ca"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9c8d63c9-3053-43b4-94a5-ff3e6b3ea65e", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d57cdaf-78e4-4223-b248-a42e54ccca47", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9c8d63c9-3053-43b4-94a5-ff3e6b3ea65e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Epclusa</span></b><b><span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated\ntablets</span></b></p>", "ID": "7648729b-5f14-4328-911b-f6fa52f4047a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Epclusa</span></b>", "ID": "eda7f3e2-74ed-464e-a6f0-fc79b916d803", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7648729b-5f14-4328-911b-f6fa52f4047a"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "94db1033-a2d5-4120-90a5-b812ed560e0d", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "eda7f3e2-74ed-464e-a6f0-fc79b916d803"}, {"Element": "<b><span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated\ntablets</span></b>", "ID": "c0aab560-c7e9-467f-ae84-52a65ab41e6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7648729b-5f14-4328-911b-f6fa52f4047a"}, {"Element": "<span lang=\"EN-GB\"> 400\u00a0mg/100\u00a0mg film\u2011coated\ntablets</span>", "ID": "4e47b83b-7548-4708-963a-fc024dfa7cff", "Styles": "None", "Classes": "None", "Text": " 400\u00a0mg/100\u00a0mg film\u2011coated tablets", "ParentId": "c0aab560-c7e9-467f-ae84-52a65ab41e6f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">sofosbuvir/velpatasvir</span></p>", "ID": "6eccf774-ae8b-406e-b3d0-398ebbdf5b3c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">sofosbuvir/velpatasvir</span>", "ID": "26bca1ca-b5b9-40dc-a8b1-ef77a92b484e", "Styles": "None", "Classes": "None", "Text": "sofosbuvir/velpatasvir", "ParentId": "6eccf774-ae8b-406e-b3d0-398ebbdf5b3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34c60911-2c43-4a9e-9b46-43b193912f34", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0db2758f-d9be-49ab-a2ad-f106d33bf9e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34c60911-2c43-4a9e-9b46-43b193912f34"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"><img border=\"0\" height=\"17\" id=\"Picture 2\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicine\nis subject to additional monitoring.\u00a0 This will allow quick identification\nof new safety information.\u00a0 You can help by reporting any side effects you\nmay get.\u00a0 See the end of section\u00a04 for how to report side effects.</span></p>", "ID": "ad94c019-c194-4d83-b30b-516448482ab4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\"><img border=\"0\" height=\"17\" id=\"Picture 2\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/></span>", "ID": "18e3533e-bd28-48ad-99f0-d26c017dc33d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad94c019-c194-4d83-b30b-516448482ab4"}, {"Element": "<img border=\"0\" height=\"17\" id=\"Picture 2\" src=\"Epclusa-h-4210-e_files/image001.gif\" width=\"21\"/>", "ID": "d8f268f6-6988-4068-8941-6f6ed1559719", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18e3533e-bd28-48ad-99f0-d26c017dc33d"}, {"Element": "<span lang=\"EN-GB\">This medicine\nis subject to additional monitoring.\u00a0 This will allow quick identification\nof new safety information.\u00a0 You can help by reporting any side effects you\nmay get.\u00a0 See the end of section\u00a04 for how to report side effects.</span>", "ID": "9f05d0cb-341a-4325-95b8-7b328af79d49", "Styles": "None", "Classes": "None", "Text": "This medicine is subject to additional monitoring.\u00a0 This will allow quick identification of new safety information.\u00a0 You can help by reporting any side effects you may get.\u00a0 See the end of section\u00a04 for how to report side effects.", "ParentId": "ad94c019-c194-4d83-b30b-516448482ab4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d70539b0-ceb1-4d25-832a-360ec332321a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "13422e9c-6285-414d-881d-4c8f19580b2f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d70539b0-ceb1-4d25-832a-360ec332321a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains important information for you.</span></b></p>", "ID": "71b405fa-72fc-4d3e-babe-1276bdf0b300", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains important information for you.</span></b>", "ID": "86e5839c-e936-4797-8cec-de0f4326e992", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71b405fa-72fc-4d3e-babe-1276bdf0b300"}, {"Element": "<span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains important information for you.</span>", "ID": "bf51a787-9f27-41fc-81b7-a54d4d68ccd1", "Styles": "None", "Classes": "None", "Text": "Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.", "ParentId": "86e5839c-e936-4797-8cec-de0f4326e992"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Keep this\nleaflet.\u00a0 You may need to read it again.</span></p>", "ID": "3292e69a-7dfb-4577-b41e-4dba79d2ad67", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Keep this\nleaflet.\u00a0 You may need to read it again.</span>", "ID": "337c170c-c388-42a4-a4d2-d51c896ad422", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Keep this leaflet.\u00a0 You may need to read it again.", "ParentId": "3292e69a-7dfb-4577-b41e-4dba79d2ad67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you\nhave any further questions, ask your doctor or pharmacist.</span></p>", "ID": "3671db64-d210-4391-a6ab-89aeb87987da", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you\nhave any further questions, ask your doctor or pharmacist.</span>", "ID": "93daebe1-371b-46dd-9b88-a719ae6d4981", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you have any further questions, ask your doctor or pharmacist.", "ParentId": "3671db64-d210-4391-a6ab-89aeb87987da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only.\u00a0 Do not pass it on to\nothers.\u00a0 It may harm them, even if their signs of illness are the same as\nyours.</span></p>", "ID": "de0db9f7-f6bc-443d-84b3-f26cf0e62644", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only.\u00a0 Do not pass it on to\nothers.\u00a0 It may harm them, even if their signs of illness are the same as\nyours.</span>", "ID": "673c1fe3-324a-43c6-b294-cc8696afa202", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This medicine has been prescribed for you only.\u00a0 Do not pass it on to others.\u00a0 It may harm them, even if their signs of illness are the same as yours.", "ParentId": "de0db9f7-f6bc-443d-84b3-f26cf0e62644"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you get\nany side effects talk to your doctor or pharmacist.\u00a0 This includes any\npossible side effects not listed in this leaflet.\u00a0 See section\u00a04.</span></p>", "ID": "e800289b-92d9-499b-a119-8d75dbacc84f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you get\nany side effects talk to your doctor or pharmacist.\u00a0 This includes any\npossible side effects not listed in this leaflet.\u00a0 See section\u00a04.</span>", "ID": "38c641ae-15a3-4ab1-8aa5-92bdc55e2662", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you get any side effects talk to your doctor or pharmacist.\u00a0 This includes any possible side effects not listed in this leaflet.\u00a0 See section\u00a04.", "ParentId": "e800289b-92d9-499b-a119-8d75dbacc84f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "15e4eb43-0438-46a5-8195-6bdf5dc3f24d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d091a90-305d-4c4b-bf85-71da363b32a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15e4eb43-0438-46a5-8195-6bdf5dc3f24d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>", "ID": "4ced59bc-494b-45fd-a9fa-eaed82df417a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">What is in this leaflet</span></b>", "ID": "1c75a321-783e-4e8e-868d-789419d6c2a8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ced59bc-494b-45fd-a9fa-eaed82df417a"}, {"Element": "<span lang=\"EN-GB\">What is in this leaflet</span>", "ID": "5d8b84aa-1361-4063-b86b-3b3a51d4ecf7", "Styles": "None", "Classes": "None", "Text": "What is in this leaflet", "ParentId": "1c75a321-783e-4e8e-868d-789419d6c2a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Epclusa is\nand what it is used for</span></p>", "ID": "a92047c3-262f-4327-972d-0a01a1e88f79", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Epclusa is\nand what it is used for</span>", "ID": "4946e52e-3291-45c0-b12e-9c77d16d4f04", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Epclusa is and what it is used for", "ParentId": "a92047c3-262f-4327-972d-0a01a1e88f79"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Epclusa</span></p>", "ID": "d1dd90b9-4835-4fd9-aa7c-cc518e21ead7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Epclusa</span>", "ID": "e1bdd0c2-500a-4b93-a695-d1910fbd7f32", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you take Epclusa", "ParentId": "d1dd90b9-4835-4fd9-aa7c-cc518e21ead7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Epclusa</span></p>", "ID": "31c545ce-5a59-4521-8438-9de97a177cfc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Epclusa</span>", "ID": "6b57fb50-622b-4f00-8c84-a7ddf543cfca", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Epclusa", "ParentId": "31c545ce-5a59-4521-8438-9de97a177cfc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></p>", "ID": "a36703b4-9886-4a2c-a178-a06905e3cd0a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span>", "ID": "e4bbd0d9-3014-4b7b-9cdc-cc8248de104b", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "a36703b4-9886-4a2c-a178-a06905e3cd0a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Epclusa</span></p>", "ID": "53bee5c4-c6ac-457e-92ae-ccb5e159d0e1", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Epclusa</span>", "ID": "58207ade-14fc-4be6-a586-81172ea63dff", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Epclusa", "ParentId": "53bee5c4-c6ac-457e-92ae-ccb5e159d0e1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span></p>", "ID": "1b415c7d-9545-45da-9dc1-aed71001509d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span>", "ID": "e1d9404a-aa7b-460a-b2ec-fd63328be1dd", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "1b415c7d-9545-45da-9dc1-aed71001509d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64567c7e-4f9d-4310-915f-c16a425d280c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d17707de-ef2e-43dc-b439-5a053c471817", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64567c7e-4f9d-4310-915f-c16a425d280c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c801b149-b316-488e-b217-a928dd3a9ad1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5469819-380c-4efc-b691-972b44179edf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c801b149-b316-488e-b217-a928dd3a9ad1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nEpclusa is and what it is used for</span></b></p>", "ID": "3ce763bb-f079-4ce1-983c-73bba52b70f5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nEpclusa is and what it is used for</span></b>", "ID": "dc3cf95d-39fd-4074-9b9a-84a637ea0d4a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ce763bb-f079-4ce1-983c-73bba52b70f5"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nEpclusa is and what it is used for</span>", "ID": "3bda0661-86f4-47d2-ba36-61c6c0d90bcf", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Epclusa is and what it is used for", "ParentId": "dc3cf95d-39fd-4074-9b9a-84a637ea0d4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bde27bdf-5eb5-4817-9f5a-55eb4f3fc85a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a1e7fe1a-258f-4fe6-a35a-244cef2011e0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bde27bdf-5eb5-4817-9f5a-55eb4f3fc85a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">is a medicine that contains the active substances sofosbuvir and\nvelpatasvir in a single tablet.\u00a0 It is given to treat a chronic\n(long-term) viral infection of the liver called hepatitis\u00a0C in adults of\n18\u00a0years and older.</span></p>", "ID": "b1a40dd1-2e31-4696-a071-afefc2d853ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa </span>", "ID": "dbf7fcda-2d2c-49e5-8179-e9344fe5381c", "Styles": "None", "Classes": "None", "Text": "Epclusa ", "ParentId": "b1a40dd1-2e31-4696-a071-afefc2d853ce"}, {"Element": "<span lang=\"EN-GB\">is a medicine that contains the active substances sofosbuvir and\nvelpatasvir in a single tablet.\u00a0 It is given to treat a chronic\n(long-term) viral infection of the liver called hepatitis\u00a0C in adults of\n18\u00a0years and older.</span>", "ID": "cd498ccb-6d3d-475e-83ca-3341d2965431", "Styles": "None", "Classes": "None", "Text": "is a medicine that contains the active substances sofosbuvir and velpatasvir in a single tablet.\u00a0 It is given to treat a chronic (long-term) viral infection of the liver called hepatitis\u00a0C in adults of 18\u00a0years and older.", "ParentId": "b1a40dd1-2e31-4696-a071-afefc2d853ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e41bea7-8f5e-4ba4-94ae-a2cc10850680", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "77066336-8e71-4c69-a759-8904a3980b12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e41bea7-8f5e-4ba4-94ae-a2cc10850680"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The active\nsubstances in this medicine work together by blocking two different proteins\nthat the virus needs to grow and reproduce itself, allowing the infection to be\npermanently eliminated from the body.</span></p>", "ID": "50f9619e-a696-4253-ad0d-580f2e73ea22", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The active\nsubstances in this medicine work together by blocking two different proteins\nthat the virus needs to grow and reproduce itself, allowing the infection to be\npermanently eliminated from the body.</span>", "ID": "c87eb75d-a515-4646-a5a7-571cb098284e", "Styles": "None", "Classes": "None", "Text": "The active substances in this medicine work together by blocking two different proteins that the virus needs to grow and reproduce itself, allowing the infection to be permanently eliminated from the body.", "ParentId": "50f9619e-a696-4253-ad0d-580f2e73ea22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "894105f3-651b-479d-98dc-03c6729506e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "270a6ee3-a039-4284-b262-6372b0722ab5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "894105f3-651b-479d-98dc-03c6729506e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">is sometimes taken with another medicine, ribavirin.</span></p>", "ID": "11324a90-47d5-44ce-8e53-61795f6cd486", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa </span>", "ID": "39b90e6c-7486-481f-bb59-6c28a5f0b34c", "Styles": "None", "Classes": "None", "Text": "Epclusa ", "ParentId": "11324a90-47d5-44ce-8e53-61795f6cd486"}, {"Element": "<span lang=\"EN-GB\">is sometimes taken with another medicine, ribavirin.</span>", "ID": "11de6fc3-d31f-475a-a7b5-af36354c0ac8", "Styles": "None", "Classes": "None", "Text": "is sometimes taken with another medicine, ribavirin.", "ParentId": "11324a90-47d5-44ce-8e53-61795f6cd486"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "22be242f-5fc8-414b-93cc-562a86949e38", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "804e30f8-d8fb-4dec-9457-d07431b99cf0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22be242f-5fc8-414b-93cc-562a86949e38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is very\nimportant that you also read the leaflets for the other medicines that you will\nbe taking with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.\u00a0\nIf you have any questions about your medicines, please ask your doctor or\npharmacist.</span></p>", "ID": "d88c35e7-0953-435c-b4d0-d4c7fb889e25", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">It is very\nimportant that you also read the leaflets for the other medicines that you will\nbe taking with </span>", "ID": "eae4b6a7-c595-4954-a538-d0e800807256", "Styles": "None", "Classes": "None", "Text": "It is very important that you also read the leaflets for the other medicines that you will be taking with ", "ParentId": "d88c35e7-0953-435c-b4d0-d4c7fb889e25"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "01d0dafe-d134-4e28-aaea-626cf345e649", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "d88c35e7-0953-435c-b4d0-d4c7fb889e25"}, {"Element": "<span lang=\"EN-GB\">.\u00a0\nIf you have any questions about your medicines, please ask your doctor or\npharmacist.</span>", "ID": "5b5508ec-8455-4fac-8185-9f9ef67e939e", "Styles": "None", "Classes": "None", "Text": ".\u00a0 If you have any questions about your medicines, please ask your doctor or pharmacist.", "ParentId": "d88c35e7-0953-435c-b4d0-d4c7fb889e25"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58232cd4-f111-4d5a-b1fb-49aa26f1b475", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aaec867c-0a4c-42ab-b368-caffc2bf1c17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58232cd4-f111-4d5a-b1fb-49aa26f1b475"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4561fb68-3c04-4035-a275-71c55b871eaa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e82ab677-8fb8-4d84-9053-6dc81a32e960", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4561fb68-3c04-4035-a275-71c55b871eaa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nyou need to know before you take Epclusa</span></b></p>", "ID": "49c0c54b-a13f-4192-8b8d-7d76901ea098", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nyou need to know before you take Epclusa</span></b>", "ID": "299b76e8-76b9-4df9-96c2-deddbf4fd686", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "49c0c54b-a13f-4192-8b8d-7d76901ea098"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What\nyou need to know before you take Epclusa</span>", "ID": "c84dc26d-62ca-4371-8a23-a859b7b7cd86", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you take Epclusa", "ParentId": "299b76e8-76b9-4df9-96c2-deddbf4fd686"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2e8001db-aa46-4e70-9f8a-24eabb11ce79", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56d2c37a-dde0-43cd-83c6-26e0db5a1117", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2e8001db-aa46-4e70-9f8a-24eabb11ce79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not take Epclusa</span></b></p>", "ID": "2337fcab-8756-428a-b2d8-7a047e24234d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Do not take Epclusa</span></b>", "ID": "3e372768-1f41-49b3-879c-9d1eba68be81", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2337fcab-8756-428a-b2d8-7a047e24234d"}, {"Element": "<span lang=\"EN-GB\">Do not take Epclusa</span>", "ID": "e5fdab59-0d29-464f-96a9-aa8341550899", "Styles": "None", "Classes": "None", "Text": "Do not take Epclusa", "ParentId": "3e372768-1f41-49b3-879c-9d1eba68be81"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK2\"></a><a name=\"OLE_LINK3\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you are allergic</span></b><span lang=\"EN-GB\"> to sofosbuvir, velpatasvir or any of the other ingredients of this\nmedicine (listed in section\u00a06 of this leaflet).</span></a></p>", "ID": "9e17ed33-d20d-4bd5-b038-75d920359635", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<a name=\"OLE_LINK2\"></a>", "ID": "b81b5c02-4ce7-4d3b-9580-2f59c5d1ae61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e17ed33-d20d-4bd5-b038-75d920359635"}, {"Element": "<a name=\"OLE_LINK3\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you are allergic</span></b><span lang=\"EN-GB\"> to sofosbuvir, velpatasvir or any of the other ingredients of this\nmedicine (listed in section\u00a06 of this leaflet).</span></a>", "ID": "59db304a-7118-42c0-b7f1-4ded515d1be8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e17ed33-d20d-4bd5-b038-75d920359635"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "089c22a4-f40a-4e66-a079-d591fc66aa9e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "59db304a-7118-42c0-b7f1-4ded515d1be8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e022ba36-e533-4047-8bad-15ac28284d09", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "089c22a4-f40a-4e66-a079-d591fc66aa9e"}, {"Element": "<b><span lang=\"EN-GB\">If you are allergic</span></b>", "ID": "6dd5b6fb-f381-4a9f-94fa-a905259d7fbb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "59db304a-7118-42c0-b7f1-4ded515d1be8"}, {"Element": "<span lang=\"EN-GB\">If you are allergic</span>", "ID": "2c7266fb-1381-4e5f-8d34-5a88d8c263ed", "Styles": "None", "Classes": "None", "Text": "If you are allergic", "ParentId": "6dd5b6fb-f381-4a9f-94fa-a905259d7fbb"}, {"Element": "<span lang=\"EN-GB\"> to sofosbuvir, velpatasvir or any of the other ingredients of this\nmedicine (listed in section\u00a06 of this leaflet).</span>", "ID": "57e51db8-e91c-4093-bf33-17b364e8dad5", "Styles": "None", "Classes": "None", "Text": " to sofosbuvir, velpatasvir or any of the other ingredients of this medicine (listed in section\u00a06 of this leaflet).", "ParentId": "59db304a-7118-42c0-b7f1-4ded515d1be8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "47f5174e-1147-4cc8-88cc-e4455d4e13a0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0c2aea09-2be2-4100-8e27-5403c79e0220", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47f5174e-1147-4cc8-88cc-e4455d4e13a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span><span lang=\"EN-GB\"> </span></b><span lang=\"EN-GB\">If this applies to you, <b>do not take Epclusa\nand tell your doctor immediately.</b></span></p>", "ID": "d8125991-868d-4dfa-8253-ab2304538a6a", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span><span lang=\"EN-GB\"> </span></b>", "ID": "516cdce3-1695-42f4-9280-5836ddeb9a57", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d8125991-868d-4dfa-8253-ab2304538a6a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span>", "ID": "283431f5-e983-4ce1-a8d3-40c5b48d83d3", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e0", "ParentId": "516cdce3-1695-42f4-9280-5836ddeb9a57"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "f2761b2b-dd1f-4ada-875a-a4636fc6e8de", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "516cdce3-1695-42f4-9280-5836ddeb9a57"}, {"Element": "<span lang=\"EN-GB\">If this applies to you, <b>do not take Epclusa\nand tell your doctor immediately.</b></span>", "ID": "9402f568-4eab-4679-a5f4-6e79f3a9101c", "Styles": "None", "Classes": "None", "Text": "If this applies to you, ", "ParentId": "d8125991-868d-4dfa-8253-ab2304538a6a"}, {"Element": "<b>do not take Epclusa\nand tell your doctor immediately.</b>", "ID": "1b283139-0fc9-4d4a-a9c7-5058d6ac3299", "Styles": "None", "Classes": "None", "Text": "do not take Epclusa and tell your doctor immediately.", "ParentId": "9402f568-4eab-4679-a5f4-6e79f3a9101c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3cd869bb-620b-4a11-b5fa-263f300ade58", "Styles": "margin-left:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bac570fe-458a-4918-bc46-e04b6f9ed309", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3cd869bb-620b-4a11-b5fa-263f300ade58"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you are currently taking any of the\nfollowing medicines:</span></b></p>", "ID": "e4838089-8a9f-4a30-b67a-a96d919b1692", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ebbc78c5-d8db-46df-af1a-27e2c6df9ed6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e4838089-8a9f-4a30-b67a-a96d919b1692"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b1999e5d-1617-4bb3-838e-41f712308995", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ebbc78c5-d8db-46df-af1a-27e2c6df9ed6"}, {"Element": "<b><span lang=\"EN-GB\">If you are currently taking any of the\nfollowing medicines:</span></b>", "ID": "72a7c4ba-8365-4da9-9221-52bcb3440380", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4838089-8a9f-4a30-b67a-a96d919b1692"}, {"Element": "<span lang=\"EN-GB\">If you are currently taking any of the\nfollowing medicines:</span>", "ID": "59699a1d-7029-4c09-9cf7-f28c4a4f582c", "Styles": "None", "Classes": "None", "Text": "If you are currently taking any of the following medicines:", "ParentId": "72a7c4ba-8365-4da9-9221-52bcb3440380"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rifampicin</span></b><span lang=\"EN-GB\"> and <b>rifabutin</b>\n(antibiotics used to treat infections, including tuberculosis);</span></p>", "ID": "9383f25a-e9fd-409b-b2c4-42e4e1ddb3b4", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "95d9589b-3819-417c-89f0-47cf7e9f3f24", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9383f25a-e9fd-409b-b2c4-42e4e1ddb3b4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eccbf113-ea3b-472f-902e-e1b55437f9e1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "95d9589b-3819-417c-89f0-47cf7e9f3f24"}, {"Element": "<b><span lang=\"EN-GB\">rifampicin</span></b>", "ID": "483488fc-1b04-4c80-a54b-526206d73a04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9383f25a-e9fd-409b-b2c4-42e4e1ddb3b4"}, {"Element": "<span lang=\"EN-GB\">rifampicin</span>", "ID": "4e7fd87a-f3da-45cb-88ab-336971ea8e0b", "Styles": "None", "Classes": "None", "Text": "rifampicin", "ParentId": "483488fc-1b04-4c80-a54b-526206d73a04"}, {"Element": "<span lang=\"EN-GB\"> and <b>rifabutin</b>\n(antibiotics used to treat infections, including tuberculosis);</span>", "ID": "715ca24a-9c92-4ebc-96c3-befabc0635b2", "Styles": "None", "Classes": "None", "Text": " and  (antibiotics used to treat infections, including tuberculosis);", "ParentId": "9383f25a-e9fd-409b-b2c4-42e4e1ddb3b4"}, {"Element": "<b>rifabutin</b>", "ID": "3efdc287-6b0b-40ee-8114-b33a5bb10911", "Styles": "None", "Classes": "None", "Text": "rifabutin", "ParentId": "715ca24a-9c92-4ebc-96c3-befabc0635b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">St.\u00a0John\u2019s wort</span></b><span lang=\"EN-GB\"> (<i>Hypericum perforatum</i> \u2013 herbal medicine used to treat\ndepression);</span></p>", "ID": "5ba39f45-4864-4111-bb87-d286579da3e6", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bbfc5c84-0850-4cad-b00c-c9c1153a80d2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5ba39f45-4864-4111-bb87-d286579da3e6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b067c3bb-70e4-44cf-81c5-7cfd520938cd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bbfc5c84-0850-4cad-b00c-c9c1153a80d2"}, {"Element": "<b><span lang=\"EN-GB\">St.\u00a0John\u2019s wort</span></b>", "ID": "e6b3ef31-680a-4037-bce0-54bf7b062aa8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ba39f45-4864-4111-bb87-d286579da3e6"}, {"Element": "<span lang=\"EN-GB\">St.\u00a0John\u2019s wort</span>", "ID": "6fe3285c-f94d-406f-bcb1-ebbeeec55f2a", "Styles": "None", "Classes": "None", "Text": "St.\u00a0John\u2019s wort", "ParentId": "e6b3ef31-680a-4037-bce0-54bf7b062aa8"}, {"Element": "<span lang=\"EN-GB\"> (<i>Hypericum perforatum</i> \u2013 herbal medicine used to treat\ndepression);</span>", "ID": "a0ae9c85-7f14-4ace-b7fa-1482f116a105", "Styles": "None", "Classes": "None", "Text": " ( \u2013 herbal medicine used to treat depression);", "ParentId": "5ba39f45-4864-4111-bb87-d286579da3e6"}, {"Element": "<i>Hypericum perforatum</i>", "ID": "3ba3330f-d934-4f9a-b475-00bc389164e9", "Styles": "None", "Classes": "None", "Text": "Hypericum perforatum", "ParentId": "a0ae9c85-7f14-4ace-b7fa-1482f116a105"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">carbamazepine, phenobarbital</span></b><span lang=\"EN-GB\"> and <b>phenytoin</b> (medicines used to treat epilepsy and prevent\nseizures);</span></p>", "ID": "3b9ba7d9-f63d-4ae4-bd55-f40d17d07f07", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "425cfa04-ce5b-4c2d-9845-478a502e785a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3b9ba7d9-f63d-4ae4-bd55-f40d17d07f07"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b9a92eef-9b06-4d57-9ac5-c168fb686b79", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "425cfa04-ce5b-4c2d-9845-478a502e785a"}, {"Element": "<b><span lang=\"EN-GB\">carbamazepine, phenobarbital</span></b>", "ID": "9cc15422-9379-43f2-b896-294a7dd215f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b9ba7d9-f63d-4ae4-bd55-f40d17d07f07"}, {"Element": "<span lang=\"EN-GB\">carbamazepine, phenobarbital</span>", "ID": "a2b66ed8-dc5a-407f-9329-8e906cd38971", "Styles": "None", "Classes": "None", "Text": "carbamazepine, phenobarbital", "ParentId": "9cc15422-9379-43f2-b896-294a7dd215f6"}, {"Element": "<span lang=\"EN-GB\"> and <b>phenytoin</b> (medicines used to treat epilepsy and prevent\nseizures);</span>", "ID": "9340fbce-d482-41b1-b3e3-fb0db7ef1640", "Styles": "None", "Classes": "None", "Text": " and  (medicines used to treat epilepsy and prevent seizures);", "ParentId": "3b9ba7d9-f63d-4ae4-bd55-f40d17d07f07"}, {"Element": "<b>phenytoin</b>", "ID": "95c12d3b-fe65-4006-b165-d0c6a81aa38e", "Styles": "None", "Classes": "None", "Text": "phenytoin", "ParentId": "9340fbce-d482-41b1-b3e3-fb0db7ef1640"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "06c57d75-28c7-4ee2-a7f3-b8906c8df82b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c37a2d7b-6e5c-451c-a369-33204358a673", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "06c57d75-28c7-4ee2-a7f3-b8906c8df82b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>", "ID": "bdde88ff-f9bc-43fd-b77d-d58860e75cfa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Warnings and precautions</span></b>", "ID": "eea4a961-929a-4c10-939e-0e2e5f0120f0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bdde88ff-f9bc-43fd-b77d-d58860e75cfa"}, {"Element": "<span lang=\"EN-GB\">Warnings and precautions</span>", "ID": "6987b854-0e31-44c8-acc3-fcecb66d6d9b", "Styles": "None", "Classes": "None", "Text": "Warnings and precautions", "ParentId": "eea4a961-929a-4c10-939e-0e2e5f0120f0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor if you:</span></p>", "ID": "655f2541-64a7-4409-84aa-c390ec26ae53", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Talk to your doctor if you:</span>", "ID": "5518fd55-d824-452b-aa1d-e7cb24aa45b6", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor if you:", "ParentId": "655f2541-64a7-4409-84aa-c390ec26ae53"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">have liver problems</span></b><span lang=\"EN-GB\"> other than from hepatitis\u00a0C, for instance</span></p>", "ID": "cce300e1-7246-43d8-bef8-21cd03a21bdc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "45576d6d-d4e3-4c5c-8a33-a6c5da436d99", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cce300e1-7246-43d8-bef8-21cd03a21bdc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "23da3e18-1752-48ba-95ba-448047a5a07c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "45576d6d-d4e3-4c5c-8a33-a6c5da436d99"}, {"Element": "<b><span lang=\"EN-GB\">have liver problems</span></b>", "ID": "825f1f5f-4b8a-4cc6-9be8-a1f54c87a98b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cce300e1-7246-43d8-bef8-21cd03a21bdc"}, {"Element": "<span lang=\"EN-GB\">have liver problems</span>", "ID": "a46fdd4c-72b1-4152-aba3-1362413d582c", "Styles": "None", "Classes": "None", "Text": "have liver problems", "ParentId": "825f1f5f-4b8a-4cc6-9be8-a1f54c87a98b"}, {"Element": "<span lang=\"EN-GB\"> other than from hepatitis\u00a0C, for instance</span>", "ID": "ae5e36fd-7555-4840-aaae-82aacf82da99", "Styles": "None", "Classes": "None", "Text": " other than from hepatitis\u00a0C, for instance", "ParentId": "cce300e1-7246-43d8-bef8-21cd03a21bdc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">if you have</span></b><span lang=\"EN-GB\"> a\ncurrent or previous infection with the <b>hepatitis\u00a0B</b> virus</span><span lang=\"EN-GB\">, since your doctor may want to monitor you more closely;</span></p>", "ID": "62ca7d6c-ab5c-4cc9-909e-5d32b1cbe0ff", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "67c15170-f479-4b1b-8389-c308eff9fef3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "62ca7d6c-ab5c-4cc9-909e-5d32b1cbe0ff"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5853f618-42b5-4271-ab8b-e25963462f4e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "67c15170-f479-4b1b-8389-c308eff9fef3"}, {"Element": "<b><span lang=\"EN-GB\">if you have</span></b>", "ID": "4fd82c22-c730-48b3-b152-b6f258281be4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62ca7d6c-ab5c-4cc9-909e-5d32b1cbe0ff"}, {"Element": "<span lang=\"EN-GB\">if you have</span>", "ID": "4764113c-8407-4675-9395-f6ae9057a9b8", "Styles": "None", "Classes": "None", "Text": "if you have", "ParentId": "4fd82c22-c730-48b3-b152-b6f258281be4"}, {"Element": "<span lang=\"EN-GB\"> a\ncurrent or previous infection with the <b>hepatitis\u00a0B</b> virus</span>", "ID": "15388097-b010-467d-b3dd-40f188ea8fb2", "Styles": "None", "Classes": "None", "Text": " a current or previous infection with the  virus", "ParentId": "62ca7d6c-ab5c-4cc9-909e-5d32b1cbe0ff"}, {"Element": "<b>hepatitis\u00a0B</b>", "ID": "15739878-54eb-4cfd-acb7-1e0fcc1c21a8", "Styles": "None", "Classes": "None", "Text": "hepatitis\u00a0B", "ParentId": "15388097-b010-467d-b3dd-40f188ea8fb2"}, {"Element": "<span lang=\"EN-GB\">, since your doctor may want to monitor you more closely;</span>", "ID": "ce4a9c97-d9fc-4d5e-a824-9683ed08818d", "Styles": "None", "Classes": "None", "Text": ", since your doctor may want to monitor you more closely;", "ParentId": "62ca7d6c-ab5c-4cc9-909e-5d32b1cbe0ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">if you have had a liver transplant</span></b></p>", "ID": "2bc18a2c-2968-4471-ba5b-cb395b1ffdb8", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b4501979-963b-4a86-9fb3-22e56f84624a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2bc18a2c-2968-4471-ba5b-cb395b1ffdb8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "806de6ff-c4b6-464e-a120-3fab7fd9231f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b4501979-963b-4a86-9fb3-22e56f84624a"}, {"Element": "<b><span lang=\"EN-GB\">if you have had a liver transplant</span></b>", "ID": "4f8c6a9a-3b1a-4abe-894c-c7159c5dff6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2bc18a2c-2968-4471-ba5b-cb395b1ffdb8"}, {"Element": "<span lang=\"EN-GB\">if you have had a liver transplant</span>", "ID": "009489bd-8938-4922-9920-b904b57e690f", "Styles": "None", "Classes": "None", "Text": "if you have had a liver transplant", "ParentId": "4f8c6a9a-3b1a-4abe-894c-c7159c5dff6d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">have kidney problems,</span></b><span lang=\"EN-GB\"> since </span><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">has\nnot been fully tested in patients with some severe kidney problems;</span></p>", "ID": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b220532f-97a5-4cec-bde2-c0f8aac98599", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0a1dff46-ef1a-46f2-8db0-599e8aa70bcb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b220532f-97a5-4cec-bde2-c0f8aac98599"}, {"Element": "<b><span lang=\"EN-GB\">have kidney problems,</span></b>", "ID": "24c36d75-0db7-4375-95fe-7277932367ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef"}, {"Element": "<span lang=\"EN-GB\">have kidney problems,</span>", "ID": "c91b7e8c-71d7-417b-b15e-a713973f848e", "Styles": "None", "Classes": "None", "Text": "have kidney problems,", "ParentId": "24c36d75-0db7-4375-95fe-7277932367ba"}, {"Element": "<span lang=\"EN-GB\"> since </span>", "ID": "f62c1129-30af-4910-a7c1-3408e21cc646", "Styles": "None", "Classes": "None", "Text": " since ", "ParentId": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef"}, {"Element": "<span lang=\"EN-GB\">Epclusa </span>", "ID": "97d2caf9-921b-40c8-a169-fd7924dad6c1", "Styles": "None", "Classes": "None", "Text": "Epclusa ", "ParentId": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef"}, {"Element": "<span lang=\"EN-GB\">has\nnot been fully tested in patients with some severe kidney problems;</span>", "ID": "e592f194-75c7-4b6e-be5e-eaecff4951da", "Styles": "None", "Classes": "None", "Text": "has not been fully tested in patients with some severe kidney problems;", "ParentId": "a8b28cf0-1085-4ab7-9026-ba8ead7914ef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">are taking treatment for human\nimmunodeficiency virus (HIV) infection,</span></b><span lang=\"EN-GB\"> since your\ndoctor may want to monitor you more closely.</span></p>", "ID": "976cba7d-1eee-45e9-af9a-cdcfe738f597", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ba2ff652-0015-4654-9802-96097263a858", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "976cba7d-1eee-45e9-af9a-cdcfe738f597"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "02359f25-1f09-4d98-a767-031877d53650", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ba2ff652-0015-4654-9802-96097263a858"}, {"Element": "<b><span lang=\"EN-GB\">are taking treatment for human\nimmunodeficiency virus (HIV) infection,</span></b>", "ID": "607f2c20-af59-4129-946d-1285636b4112", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "976cba7d-1eee-45e9-af9a-cdcfe738f597"}, {"Element": "<span lang=\"EN-GB\">are taking treatment for human\nimmunodeficiency virus (HIV) infection,</span>", "ID": "a022bda4-99e4-457b-9260-55334b9e3609", "Styles": "None", "Classes": "None", "Text": "are taking treatment for human immunodeficiency virus (HIV) infection,", "ParentId": "607f2c20-af59-4129-946d-1285636b4112"}, {"Element": "<span lang=\"EN-GB\"> since your\ndoctor may want to monitor you more closely.</span>", "ID": "46d54534-7275-48f0-bd18-cbd443c8cd4c", "Styles": "None", "Classes": "None", "Text": " since your doctor may want to monitor you more closely.", "ParentId": "976cba7d-1eee-45e9-af9a-cdcfe738f597"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd6522b9-924c-4b0f-a705-cefffec236b0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a241ea49-2c8c-4ea0-8dad-d0e827ac5ed1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd6522b9-924c-4b0f-a705-cefffec236b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor or pharmacist before taking </span><span lang=\"EN-GB\">Epclusa </span><span lang=\"EN-GB\">if:</span></p>", "ID": "cb17c3ba-ac6a-4e49-92ea-297947f16a85", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Talk to your doctor or pharmacist before taking </span>", "ID": "4a011fc9-1649-454a-9edf-724fe18e728d", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor or pharmacist before taking ", "ParentId": "cb17c3ba-ac6a-4e49-92ea-297947f16a85"}, {"Element": "<span lang=\"EN-GB\">Epclusa </span>", "ID": "9ad48ecb-2515-414a-b801-2f1d3dd4b37b", "Styles": "None", "Classes": "None", "Text": "Epclusa ", "ParentId": "cb17c3ba-ac6a-4e49-92ea-297947f16a85"}, {"Element": "<span lang=\"EN-GB\">if:</span>", "ID": "c3995763-a099-41be-9a6c-6b7bfbf2b152", "Styles": "None", "Classes": "None", "Text": "if:", "ParentId": "cb17c3ba-ac6a-4e49-92ea-297947f16a85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you currently take, or have taken in the last\nfew months, the medicine amiodarone to treat irregular heartbeats (your doctor\nmay consider alternative treatments if you have taken this medicine).</span></p>", "ID": "c4665842-6774-4504-b9bd-9dfe9b8eac38", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "19f36754-c843-4105-9a02-80ad6a9c48c2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c4665842-6774-4504-b9bd-9dfe9b8eac38"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "89bae88d-8e9f-418e-b604-a7859949c921", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "19f36754-c843-4105-9a02-80ad6a9c48c2"}, {"Element": "<span lang=\"EN-GB\">you currently take, or have taken in the last\nfew months, the medicine amiodarone to treat irregular heartbeats (your doctor\nmay consider alternative treatments if you have taken this medicine).</span>", "ID": "d51a6e32-954c-4bee-af25-712dcee16838", "Styles": "None", "Classes": "None", "Text": "you currently take, or have taken in the last few months, the medicine amiodarone to treat irregular heartbeats (your doctor may consider alternative treatments if you have taken this medicine).", "ParentId": "c4665842-6774-4504-b9bd-9dfe9b8eac38"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have diabetes. You may need closer\nmonitoring of your blood glucose levels and/or adjustment of your diabetes\nmedication after starting Epclusa. Some diabetic patients have experienced low\nsugar levels in the blood (hypoglycaemia) after starting treatment with\nmedicines like Epclusa.</span></p>", "ID": "015c4496-a43c-4c0a-aabd-31c9a48b624d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b5e37beb-0e13-43e4-a1ec-2ffa42362ad6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "015c4496-a43c-4c0a-aabd-31c9a48b624d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "de6dbd99-d471-43eb-8cbb-e39117d56c47", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b5e37beb-0e13-43e4-a1ec-2ffa42362ad6"}, {"Element": "<span lang=\"EN-GB\">you have diabetes. You may need closer\nmonitoring of your blood glucose levels and/or adjustment of your diabetes\nmedication after starting Epclusa. Some diabetic patients have experienced low\nsugar levels in the blood (hypoglycaemia) after starting treatment with\nmedicines like Epclusa.</span>", "ID": "32283e0a-a663-4903-b5a4-44f191f15b69", "Styles": "None", "Classes": "None", "Text": "you have diabetes. You may need closer monitoring of your blood glucose levels and/or adjustment of your diabetes medication after starting Epclusa. Some diabetic patients have experienced low sugar levels in the blood (hypoglycaemia) after starting treatment with medicines like Epclusa.", "ParentId": "015c4496-a43c-4c0a-aabd-31c9a48b624d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd775428-f714-4317-9ce2-76d6d2f5ce4c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7dcb58c1-b2e4-4b00-8898-dffd09bde9bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd775428-f714-4317-9ce2-76d6d2f5ce4c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor immediately</span></b><span lang=\"EN-GB\"> if you are\ntaking any medicines for heart problems and during treatment you experience:</span></p>", "ID": "d5cbfd79-065b-4cdd-b033-22af5be76472", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Tell your doctor immediately</span></b>", "ID": "e7e413ee-9fd2-46e6-b0c2-24f2e0029283", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d5cbfd79-065b-4cdd-b033-22af5be76472"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor immediately</span>", "ID": "55ed7f51-3b8f-4f0b-aa95-6f1bc5246cb5", "Styles": "None", "Classes": "None", "Text": "Tell your doctor immediately", "ParentId": "e7e413ee-9fd2-46e6-b0c2-24f2e0029283"}, {"Element": "<span lang=\"EN-GB\"> if you are\ntaking any medicines for heart problems and during treatment you experience:</span>", "ID": "6211d30d-8ec6-4e0e-a0c3-03e1bdaa9956", "Styles": "None", "Classes": "None", "Text": " if you are taking any medicines for heart problems and during treatment you experience:", "ParentId": "d5cbfd79-065b-4cdd-b033-22af5be76472"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">shortness of breath</span></p>", "ID": "896d98bf-d6bc-4815-b368-55879cbd30c0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "548bd4ec-564a-4931-8521-d4d74e303b0d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "896d98bf-d6bc-4815-b368-55879cbd30c0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "15206536-2a9b-4545-b3c1-254f6d368b10", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "548bd4ec-564a-4931-8521-d4d74e303b0d"}, {"Element": "<span lang=\"EN-GB\">shortness of breath</span>", "ID": "7a2934db-efef-4037-91af-b4f7b5827d98", "Styles": "None", "Classes": "None", "Text": "shortness of breath", "ParentId": "896d98bf-d6bc-4815-b368-55879cbd30c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">light-headedness</span></p>", "ID": "ba09e624-c829-4f07-9378-67e34cc721d5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ffebc853-9cc8-40ec-abc2-f28ab543685e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ba09e624-c829-4f07-9378-67e34cc721d5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ebfbbeef-d606-4bd1-8d23-78c3596f5b11", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ffebc853-9cc8-40ec-abc2-f28ab543685e"}, {"Element": "<span lang=\"EN-GB\">light-headedness</span>", "ID": "1d9fcb1c-916e-4a9a-aac0-1168626572a2", "Styles": "None", "Classes": "None", "Text": "light-headedness", "ParentId": "ba09e624-c829-4f07-9378-67e34cc721d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">palpitations</span></p>", "ID": "17edbed2-6427-44f2-9467-b923c4407023", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b26a7d23-3d53-444f-a523-96559dbe555b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "17edbed2-6427-44f2-9467-b923c4407023"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5926ba6b-087a-4b2c-8a1c-79db3dd06662", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b26a7d23-3d53-444f-a523-96559dbe555b"}, {"Element": "<span lang=\"EN-GB\">palpitations</span>", "ID": "ad37d85c-4d68-4ee6-b81f-571e17c54cae", "Styles": "None", "Classes": "None", "Text": "palpitations", "ParentId": "17edbed2-6427-44f2-9467-b923c4407023"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">fainting</span></p>", "ID": "fd4c5a81-c7cc-4e25-96bc-c6f6cd4ccad6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "72b5a412-475c-4f6a-86e0-f90e0f62c6f1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fd4c5a81-c7cc-4e25-96bc-c6f6cd4ccad6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "bb1ae173-0e4d-4ffc-8453-6e8d9cf52c4c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "72b5a412-475c-4f6a-86e0-f90e0f62c6f1"}, {"Element": "<span lang=\"EN-GB\">fainting</span>", "ID": "294a7ced-3aab-4e0b-a364-3938e56c95bc", "Styles": "None", "Classes": "None", "Text": "fainting", "ParentId": "fd4c5a81-c7cc-4e25-96bc-c6f6cd4ccad6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "77a1e7c1-ce39-4733-b005-fd7ae4b55e01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be5bc1ce-5bad-424f-a68e-bf66050db0b6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "77a1e7c1-ce39-4733-b005-fd7ae4b55e01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood tests</span></b></p>", "ID": "a7e99c3e-8b5b-4986-80b2-691f6357be42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Blood tests</span></b>", "ID": "b2799e87-3cb2-49f4-80a9-a691c0f311d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a7e99c3e-8b5b-4986-80b2-691f6357be42"}, {"Element": "<span lang=\"EN-GB\">Blood tests</span>", "ID": "f0459697-334e-4370-8b68-ca9121a4a19b", "Styles": "None", "Classes": "None", "Text": "Blood tests", "ParentId": "b2799e87-3cb2-49f4-80a9-a691c0f311d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Your doctor will test your blood before, during and after your\ntreatment with </span><span lang=\"EN-GB\">Epclusa</span><span lang=\"EN-GB\">.\u00a0\nThis is so that:</span></p>", "ID": "c207e488-6ea9-4d4d-879d-8e1ae8e0ffdf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Your doctor will test your blood before, during and after your\ntreatment with </span>", "ID": "e6fa1100-6f6f-434a-8a7e-7957530c7db3", "Styles": "None", "Classes": "None", "Text": "Your doctor will test your blood before, during and after your treatment with ", "ParentId": "c207e488-6ea9-4d4d-879d-8e1ae8e0ffdf"}, {"Element": "<span lang=\"EN-GB\">Epclusa</span>", "ID": "b9a4725c-5095-4534-9339-2d99e85b0374", "Styles": "None", "Classes": "None", "Text": "Epclusa", "ParentId": "c207e488-6ea9-4d4d-879d-8e1ae8e0ffdf"}, {"Element": "<span lang=\"EN-GB\">.\u00a0\nThis is so that:</span>", "ID": "0928d063-82fd-40c6-8d19-5eac2ef230cc", "Styles": "None", "Classes": "None", "Text": ".\u00a0 This is so that:", "ParentId": "c207e488-6ea9-4d4d-879d-8e1ae8e0ffdf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor can decide if you should take Epclusa\nand for how long;</span></p>", "ID": "123a2b3d-e825-4e61-850d-f6351d2f4648", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e1c508a9-e21e-4367-9924-ffdaeb54e603", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "123a2b3d-e825-4e61-850d-f6351d2f4648"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ad3efa82-ea48-4a98-9519-6bf207924362", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e1c508a9-e21e-4367-9924-ffdaeb54e603"}, {"Element": "<span lang=\"EN-GB\">Your doctor can decide if you should take Epclusa\nand for how long;</span>", "ID": "77ea21b1-d3c0-46c8-a6b4-809215f3f0e1", "Styles": "None", "Classes": "None", "Text": "Your doctor can decide if you should take Epclusa and for how long;", "ParentId": "123a2b3d-e825-4e61-850d-f6351d2f4648"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor can confirm that your treatment has\nworked and you are free of the hepatitis\u00a0C virus.</span></p>", "ID": "89e4fd14-f199-4b1c-80ac-d0d249a7ef08", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a1a186d5-20ba-4210-8aed-091936eb58d6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "89e4fd14-f199-4b1c-80ac-d0d249a7ef08"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a5d86c50-e862-4435-a476-a94324a39cda", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a1a186d5-20ba-4210-8aed-091936eb58d6"}, {"Element": "<span lang=\"EN-GB\">Your doctor can confirm that your treatment has\nworked and you are free of the hepatitis\u00a0C virus.</span>", "ID": "f3b52852-021b-4adb-82dc-0a8d02b84962", "Styles": "None", "Classes": "None", "Text": "Your doctor can confirm that your treatment has worked and you are free of the hepatitis\u00a0C virus.", "ParentId": "89e4fd14-f199-4b1c-80ac-d0d249a7ef08"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45bc7953-4e4a-4d77-b311-a30954a23c29", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fca4204a-5210-4735-b29d-d239cba6fa9c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45bc7953-4e4a-4d77-b311-a30954a23c29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>", "ID": "e45bb554-a25d-4cd5-8ce5-b74f88a3c869", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Children and adolescents</span></b>", "ID": "b2a42db8-ec3a-4765-a0ec-9fa6678a5d4b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e45bb554-a25d-4cd5-8ce5-b74f88a3c869"}, {"Element": "<span lang=\"EN-GB\">Children and adolescents</span>", "ID": "7ec09130-6938-4411-b870-431f8521059a", "Styles": "None", "Classes": "None", "Text": "Children and adolescents", "ParentId": "b2a42db8-ec3a-4765-a0ec-9fa6678a5d4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not give this\nmedicine to children and adolescents under 18\u00a0years of age.\u00a0 The use\nof Epclusa in children and adolescents has not yet been studied.</span></p>", "ID": "4f077fc3-a997-4074-9d90-e8eaf48d8d90", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Do not give this\nmedicine to children and adolescents under 18\u00a0years of age.\u00a0 The use\nof Epclusa in children and adolescents has not yet been studied.</span>", "ID": "60e979f5-37d2-4773-b792-154b04f2990e", "Styles": "None", "Classes": "None", "Text": "Do not give this medicine to children and adolescents under 18\u00a0years of age.\u00a0 The use of Epclusa in children and adolescents has not yet been studied.", "ParentId": "4f077fc3-a997-4074-9d90-e8eaf48d8d90"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fcfdbb70-4fa4-43bb-a2a9-89a463bbfeed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c325dc1-b6ed-49aa-8345-1a5ccc3a1224", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fcfdbb70-4fa4-43bb-a2a9-89a463bbfeed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and Epclusa</span></b></p>", "ID": "8a7140a2-96f4-4051-a2f8-9167a4180cc8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Other medicines and Epclusa</span></b>", "ID": "62830583-c5d0-45bd-8900-dd66211366cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8a7140a2-96f4-4051-a2f8-9167a4180cc8"}, {"Element": "<span lang=\"EN-GB\">Other medicines and Epclusa</span>", "ID": "de5fcab6-8480-45f3-b268-2c21bcf76907", "Styles": "None", "Classes": "None", "Text": "Other medicines and Epclusa", "ParentId": "62830583-c5d0-45bd-8900-dd66211366cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Tell your\ndoctor or pharmacist</span></b><span lang=\"EN-GB\"> if you are taking, have\nrecently taken or might take any other medicines.</span></p>", "ID": "6ec3efa9-1d0d-4748-8901-eb9ba877799a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Tell your\ndoctor or pharmacist</span></b>", "ID": "c86b3e06-6ac8-40fb-8025-18e3f4ba481d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ec3efa9-1d0d-4748-8901-eb9ba877799a"}, {"Element": "<span lang=\"EN-GB\">Tell your\ndoctor or pharmacist</span>", "ID": "e8d0f78d-0d0e-456c-9d83-4de32e51e77a", "Styles": "None", "Classes": "None", "Text": "Tell your doctor or pharmacist", "ParentId": "c86b3e06-6ac8-40fb-8025-18e3f4ba481d"}, {"Element": "<span lang=\"EN-GB\"> if you are taking, have\nrecently taken or might take any other medicines.</span>", "ID": "d6c35ea9-10d9-44df-87fa-368a639bf907", "Styles": "None", "Classes": "None", "Text": " if you are taking, have recently taken or might take any other medicines.", "ParentId": "6ec3efa9-1d0d-4748-8901-eb9ba877799a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7fcb966e-4143-424a-983c-d414b5974d94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "62d41458-1465-4f97-a382-994ccaaec0fb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7fcb966e-4143-424a-983c-d414b5974d94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Warfarin and\nother similar medicines called vitamin\u00a0K antagonists used to thin the\nblood.\u00a0 Your doctor may need to increase the frequency of your blood tests\nto check how well your blood can clot.</span></p>", "ID": "f78aecf6-99ae-4163-9e89-72a7977d60bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Warfarin and\nother similar medicines called vitamin\u00a0K antagonists used to thin the\nblood.\u00a0 Your doctor may need to increase the frequency of your blood tests\nto check how well your blood can clot.</span>", "ID": "e95e7d72-e508-4755-9963-e35a6e6fadde", "Styles": "None", "Classes": "None", "Text": "Warfarin and other similar medicines called vitamin\u00a0K antagonists used to thin the blood.\u00a0 Your doctor may need to increase the frequency of your blood tests to check how well your blood can clot.", "ParentId": "f78aecf6-99ae-4163-9e89-72a7977d60bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a86637fb-7ea9-4f29-b75f-7c7f4af37c9e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f0d0c5d-e644-438c-97a5-37851c2b8028", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a86637fb-7ea9-4f29-b75f-7c7f4af37c9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are not sure\ntalk to your doctor or pharmacist.</span></p>", "ID": "58fbdfd9-c353-43f4-a701-fe87ec7fe8ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If you are not sure\ntalk to your doctor or pharmacist.</span>", "ID": "7747ad82-965c-443e-8cbe-f80a58c006eb", "Styles": "None", "Classes": "None", "Text": "If you are not sure talk to your doctor or pharmacist.", "ParentId": "58fbdfd9-c353-43f4-a701-fe87ec7fe8ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4156f63a-4355-4039-bc96-858ee583e71d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3792a407-041c-4bd3-a141-ebfcf6325af4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4156f63a-4355-4039-bc96-858ee583e71d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Some medicines should not be taken with Epclusa.</span></b></p>", "ID": "c1d3dfb0-77f8-411e-82b1-4a232f3bab23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Some medicines should not be taken with Epclusa.</span></b>", "ID": "e0f100df-40b6-4de6-a34a-b257a858060c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c1d3dfb0-77f8-411e-82b1-4a232f3bab23"}, {"Element": "<span lang=\"EN-GB\">Some medicines should not be taken with Epclusa.</span>", "ID": "c8b93220-383d-4061-bdf1-8ce1704fe66a", "Styles": "None", "Classes": "None", "Text": "Some medicines should not be taken with Epclusa.", "ParentId": "e0f100df-40b6-4de6-a34a-b257a858060c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cccbdba5-07f6-463b-908e-5a91553aef10", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b442cbc5-c720-44e8-836a-05d70f9684ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cccbdba5-07f6-463b-908e-5a91553aef10"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Do not take any other medicine that contains\nsofosbuvir, one of the active substances in Epclusa.</span></b></p>", "ID": "83af2ba5-d7ae-4fa6-8acb-864f9179e3fb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4146caec-2258-410b-81bf-6ef4ee918f66", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "83af2ba5-d7ae-4fa6-8acb-864f9179e3fb"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d3b8195a-73d4-4477-ac43-0c8ac422d306", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4146caec-2258-410b-81bf-6ef4ee918f66"}, {"Element": "<b><span lang=\"EN-GB\">Do not take any other medicine that contains\nsofosbuvir, one of the active substances in Epclusa.</span></b>", "ID": "23cd3806-857c-4cfe-8243-0b8ae486531d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83af2ba5-d7ae-4fa6-8acb-864f9179e3fb"}, {"Element": "<span lang=\"EN-GB\">Do not take any other medicine that contains\nsofosbuvir, one of the active substances in Epclusa.</span>", "ID": "50ddf917-ed39-42c3-9ee8-3cf90d38e5d0", "Styles": "None", "Classes": "None", "Text": "Do not take any other medicine that contains sofosbuvir, one of the active substances in Epclusa.", "ParentId": "23cd3806-857c-4cfe-8243-0b8ae486531d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4e60f3c-b8f1-4735-ae74-aa27d364ee94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5fe850f1-537c-4693-9002-cf02ebc329f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4e60f3c-b8f1-4735-ae74-aa27d364ee94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or pharmacist</span></b><span lang=\"EN-GB\"> if you\nare taking any of the medicines below:</span></p>", "ID": "6834b519-fb46-496d-a58e-2a565131a6cb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Tell your doctor or pharmacist</span></b>", "ID": "a3f01120-6fbc-48a9-b214-4ed6fe0d104f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6834b519-fb46-496d-a58e-2a565131a6cb"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor or pharmacist</span>", "ID": "f37bd879-b8af-4e0b-bebc-1672de623473", "Styles": "None", "Classes": "None", "Text": "Tell your doctor or pharmacist", "ParentId": "a3f01120-6fbc-48a9-b214-4ed6fe0d104f"}, {"Element": "<span lang=\"EN-GB\"> if you\nare taking any of the medicines below:</span>", "ID": "715c8aa7-df0f-4777-8aa7-c2213f140d7c", "Styles": "None", "Classes": "None", "Text": " if you are taking any of the medicines below:", "ParentId": "6834b519-fb46-496d-a58e-2a565131a6cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6617b92e-35e4-4569-bf9b-2734470aa571", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e5934d91-b809-437e-8b85-3ee8a3c6b4a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6617b92e-35e4-4569-bf9b-2734470aa571"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">amiodarone</span></b><span lang=\"EN-GB\"> used\nto treat irregular heartbeats;</span></p>", "ID": "5fa4361f-fada-4395-9fe0-3c5ebedf9f5d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5871122d-ee70-47a4-b3b7-c284855f0493", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5fa4361f-fada-4395-9fe0-3c5ebedf9f5d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "553ab581-5cfb-4e3e-bad7-7cd2f4f4ea39", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5871122d-ee70-47a4-b3b7-c284855f0493"}, {"Element": "<b><span lang=\"EN-GB\">amiodarone</span></b>", "ID": "b9bf5fe1-1063-4408-8ea7-dab531b568a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5fa4361f-fada-4395-9fe0-3c5ebedf9f5d"}, {"Element": "<span lang=\"EN-GB\">amiodarone</span>", "ID": "791eec14-6c5a-452f-ad50-d7912c5c8eec", "Styles": "None", "Classes": "None", "Text": "amiodarone", "ParentId": "b9bf5fe1-1063-4408-8ea7-dab531b568a1"}, {"Element": "<span lang=\"EN-GB\"> used\nto treat irregular heartbeats;</span>", "ID": "9fc8212c-7cca-4331-a587-c4693ab289b2", "Styles": "None", "Classes": "None", "Text": " used to treat irregular heartbeats;", "ParentId": "5fa4361f-fada-4395-9fe0-3c5ebedf9f5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rifapentine</span></b><span lang=\"EN-GB\">\n(antibiotic used to treat infections, including tuberculosis);</span></p>", "ID": "3ad8dce0-bc25-44e0-81e8-fba2fc6bd96b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4a196d44-0d5b-40e1-ae63-c2ba91c726e2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3ad8dce0-bc25-44e0-81e8-fba2fc6bd96b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "49a26e71-22b2-4ff8-bf95-65cd7ae186a4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4a196d44-0d5b-40e1-ae63-c2ba91c726e2"}, {"Element": "<b><span lang=\"EN-GB\">rifapentine</span></b>", "ID": "892fb3c4-f63d-4dea-9e8e-2f6706f883cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ad8dce0-bc25-44e0-81e8-fba2fc6bd96b"}, {"Element": "<span lang=\"EN-GB\">rifapentine</span>", "ID": "79135f0c-e8ab-4a01-b16d-5c18a354fd75", "Styles": "None", "Classes": "None", "Text": "rifapentine", "ParentId": "892fb3c4-f63d-4dea-9e8e-2f6706f883cf"}, {"Element": "<span lang=\"EN-GB\">\n(antibiotic used to treat infections, including tuberculosis);</span>", "ID": "1e331dca-5539-49a2-b0be-4af5e0a20c25", "Styles": "None", "Classes": "None", "Text": " (antibiotic used to treat infections, including tuberculosis);", "ParentId": "3ad8dce0-bc25-44e0-81e8-fba2fc6bd96b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">oxcarbazepine</span></b><span lang=\"EN-GB\">\n(medicine used to treat epilepsy and prevent seizures)</span></p>", "ID": "77d077dd-36c7-4ba7-8fb9-4154cbf5208d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "deefe6ef-3c52-4a37-a078-b06035486460", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "77d077dd-36c7-4ba7-8fb9-4154cbf5208d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e0ee626c-3005-4c19-aad0-8aa0f997ed27", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "deefe6ef-3c52-4a37-a078-b06035486460"}, {"Element": "<b><span lang=\"EN-GB\">oxcarbazepine</span></b>", "ID": "9fba2bd8-5175-4b07-938d-2c3bf3da36c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "77d077dd-36c7-4ba7-8fb9-4154cbf5208d"}, {"Element": "<span lang=\"EN-GB\">oxcarbazepine</span>", "ID": "d0a3fa2f-424f-47f5-a27c-169e2f60280f", "Styles": "None", "Classes": "None", "Text": "oxcarbazepine", "ParentId": "9fba2bd8-5175-4b07-938d-2c3bf3da36c3"}, {"Element": "<span lang=\"EN-GB\">\n(medicine used to treat epilepsy and prevent seizures)</span>", "ID": "886d8ba9-aefc-47e4-9341-0cace3a725ca", "Styles": "None", "Classes": "None", "Text": " (medicine used to treat epilepsy and prevent seizures)", "ParentId": "77d077dd-36c7-4ba7-8fb9-4154cbf5208d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">tenofovir disoproxil fumarate</span></b><span lang=\"EN-GB\"> or any medicine containing tenofovir disoproxil fumarate, used to\ntreat HIV infection;</span></p>", "ID": "6288ce16-e101-4f39-aaf7-4a42b5347d18", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8c2a48cb-79c8-4772-ba7a-a83c34568ce4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6288ce16-e101-4f39-aaf7-4a42b5347d18"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2f4620ad-e3da-4694-878a-5fdc0ee18f37", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8c2a48cb-79c8-4772-ba7a-a83c34568ce4"}, {"Element": "<b><span lang=\"EN-GB\">tenofovir disoproxil fumarate</span></b>", "ID": "2f900a6e-ca93-4f73-8ac2-19b311b361d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6288ce16-e101-4f39-aaf7-4a42b5347d18"}, {"Element": "<span lang=\"EN-GB\">tenofovir disoproxil fumarate</span>", "ID": "c125d246-837e-4a77-a79e-78a88de7094a", "Styles": "None", "Classes": "None", "Text": "tenofovir disoproxil fumarate", "ParentId": "2f900a6e-ca93-4f73-8ac2-19b311b361d6"}, {"Element": "<span lang=\"EN-GB\"> or any medicine containing tenofovir disoproxil fumarate, used to\ntreat HIV infection;</span>", "ID": "93d23607-5c4e-4c01-bd60-f5e74503f80b", "Styles": "None", "Classes": "None", "Text": " or any medicine containing tenofovir disoproxil fumarate, used to treat HIV infection;", "ParentId": "6288ce16-e101-4f39-aaf7-4a42b5347d18"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">efavirenz</span></b><span lang=\"EN-GB\"> used to\ntreat HIV infection;</span></p>", "ID": "8bd78354-0c57-489e-ba82-08474baa08e4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8ef17cf6-34e5-4054-926a-fff6e4a9b526", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8bd78354-0c57-489e-ba82-08474baa08e4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f18a93ba-3e65-42c5-9f1e-988b462a1044", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8ef17cf6-34e5-4054-926a-fff6e4a9b526"}, {"Element": "<b><span lang=\"EN-GB\">efavirenz</span></b>", "ID": "d9d4c5c2-e5b8-40be-94d9-cc9e15916c83", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8bd78354-0c57-489e-ba82-08474baa08e4"}, {"Element": "<span lang=\"EN-GB\">efavirenz</span>", "ID": "3659d575-2d31-42d0-9257-ca310f655baa", "Styles": "None", "Classes": "None", "Text": "efavirenz", "ParentId": "d9d4c5c2-e5b8-40be-94d9-cc9e15916c83"}, {"Element": "<span lang=\"EN-GB\"> used to\ntreat HIV infection;</span>", "ID": "81266bf5-8b84-453a-a525-ad63e9283fb4", "Styles": "None", "Classes": "None", "Text": " used to treat HIV infection;", "ParentId": "8bd78354-0c57-489e-ba82-08474baa08e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">digoxin</span></b><span lang=\"EN-GB\"> used to\ntreat heart conditions;</span></p>", "ID": "9123eac8-70a4-4404-a139-8d9e05f3752d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1ef1e7d1-3800-4bff-9b84-e1ef0b8715a7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9123eac8-70a4-4404-a139-8d9e05f3752d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "48385690-75a1-4160-bd9d-38b3ccf034bc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1ef1e7d1-3800-4bff-9b84-e1ef0b8715a7"}, {"Element": "<b><span lang=\"EN-GB\">digoxin</span></b>", "ID": "6f9a3aa5-e8d6-4c54-85b0-28df3f208095", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9123eac8-70a4-4404-a139-8d9e05f3752d"}, {"Element": "<span lang=\"EN-GB\">digoxin</span>", "ID": "6f89cb5a-a4a5-4d17-b85f-865581009acd", "Styles": "None", "Classes": "None", "Text": "digoxin", "ParentId": "6f9a3aa5-e8d6-4c54-85b0-28df3f208095"}, {"Element": "<span lang=\"EN-GB\"> used to\ntreat heart conditions;</span>", "ID": "a4e2f45e-5401-42fe-bfda-30df5b587193", "Styles": "None", "Classes": "None", "Text": " used to treat heart conditions;", "ParentId": "9123eac8-70a4-4404-a139-8d9e05f3752d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">dabigatran</span></b><span lang=\"EN-GB\"> used\nto thin the blood;</span></p>", "ID": "20a2ee87-6f2a-4a99-8667-209a2824835e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e82d1c29-c9af-4cae-b7a5-5322d9f90c0e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "20a2ee87-6f2a-4a99-8667-209a2824835e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e1061159-e615-4a27-aa54-038fbeb40977", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e82d1c29-c9af-4cae-b7a5-5322d9f90c0e"}, {"Element": "<b><span lang=\"EN-GB\">dabigatran</span></b>", "ID": "be855820-3d7b-43d0-96eb-34a7e92f6e89", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "20a2ee87-6f2a-4a99-8667-209a2824835e"}, {"Element": "<span lang=\"EN-GB\">dabigatran</span>", "ID": "f95b46a7-d121-4aa2-9aef-0a2665797c6b", "Styles": "None", "Classes": "None", "Text": "dabigatran", "ParentId": "be855820-3d7b-43d0-96eb-34a7e92f6e89"}, {"Element": "<span lang=\"EN-GB\"> used\nto thin the blood;</span>", "ID": "912c5049-92e1-4e34-9b83-8ca7bc18c899", "Styles": "None", "Classes": "None", "Text": " used to thin the blood;", "ParentId": "20a2ee87-6f2a-4a99-8667-209a2824835e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">modafinil</span></b><span lang=\"EN-GB\"> used to\ntreat sleep disorders;</span></p>", "ID": "a3ae9adf-4c87-41fd-b681-cb4b25f44cd9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "9c665ee8-6979-4153-af60-b1065efc8c56", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a3ae9adf-4c87-41fd-b681-cb4b25f44cd9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c06108c8-914b-4a5e-8cbe-43f41de98644", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "9c665ee8-6979-4153-af60-b1065efc8c56"}, {"Element": "<b><span lang=\"EN-GB\">modafinil</span></b>", "ID": "b547f6f5-7bba-4754-abaa-8a83e3e59c22", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3ae9adf-4c87-41fd-b681-cb4b25f44cd9"}, {"Element": "<span lang=\"EN-GB\">modafinil</span>", "ID": "925f928f-a0a7-4dab-9ad4-969a6f4242d7", "Styles": "None", "Classes": "None", "Text": "modafinil", "ParentId": "b547f6f5-7bba-4754-abaa-8a83e3e59c22"}, {"Element": "<span lang=\"EN-GB\"> used to\ntreat sleep disorders;</span>", "ID": "4585c5f1-3964-4794-b6db-80e6dc3b8cfe", "Styles": "None", "Classes": "None", "Text": " used to treat sleep disorders;", "ParentId": "a3ae9adf-4c87-41fd-b681-cb4b25f44cd9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">rosuvastatin</span></b><span lang=\"EN-GB\"> or <b>other\nstatins</b> used to treat high cholesterol.</span></p>", "ID": "9983280e-9694-40b0-8133-67a69ffebb74", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a9c0cba6-28dc-4f4a-ba90-06f941fa2757", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9983280e-9694-40b0-8133-67a69ffebb74"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ee4c50ce-2020-48a4-a79d-e4134aa933bc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a9c0cba6-28dc-4f4a-ba90-06f941fa2757"}, {"Element": "<b><span lang=\"EN-GB\">rosuvastatin</span></b>", "ID": "368eef5e-e81e-4644-8266-f85fc684f881", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9983280e-9694-40b0-8133-67a69ffebb74"}, {"Element": "<span lang=\"EN-GB\">rosuvastatin</span>", "ID": "a585163a-4e77-41c2-945a-998fc88d360c", "Styles": "None", "Classes": "None", "Text": "rosuvastatin", "ParentId": "368eef5e-e81e-4644-8266-f85fc684f881"}, {"Element": "<span lang=\"EN-GB\"> or <b>other\nstatins</b> used to treat high cholesterol.</span>", "ID": "10899fb7-9dc8-4e80-877e-ac26ecde82c3", "Styles": "None", "Classes": "None", "Text": " or  used to treat high cholesterol.", "ParentId": "9983280e-9694-40b0-8133-67a69ffebb74"}, {"Element": "<b>other\nstatins</b>", "ID": "aec4923a-7345-4832-a2ec-05e1b667466b", "Styles": "None", "Classes": "None", "Text": "other statins", "ParentId": "10899fb7-9dc8-4e80-877e-ac26ecde82c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Taking Epclusa with\nany of these may stop your medicines from working properly, or make any side\neffects worse.\u00a0 Your doctor may need to give you a different medicine or\nadjust the dose of medicine you are taking.\u00a0 This change could be to\nEpclusa or another medicine you are taking.</span></p>", "ID": "f4c0363d-e2f4-493b-8093-6ea3cf7af301", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Taking Epclusa with\nany of these may stop your medicines from working properly, or make any side\neffects worse.\u00a0 Your doctor may need to give you a different medicine or\nadjust the dose of medicine you are taking.\u00a0 This change could be to\nEpclusa or another medicine you are taking.</span>", "ID": "fb180b20-bbd7-4030-9885-0d9036e8272d", "Styles": "None", "Classes": "None", "Text": "Taking Epclusa with any of these may stop your medicines from working properly, or make any side effects worse.\u00a0 Your doctor may need to give you a different medicine or adjust the dose of medicine you are taking.\u00a0 This change could be to Epclusa or another medicine you are taking.", "ParentId": "f4c0363d-e2f4-493b-8093-6ea3cf7af301"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1d1cfe3-c197-438d-89f9-d9adf734512e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da04c908-8a5c-45d7-8699-44575235d034", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1d1cfe3-c197-438d-89f9-d9adf734512e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Get advice from a doctor or pharmacist</span></b><span lang=\"EN-GB\"> if you take medicines used to treat <b>stomach ulcers, heartburn or\nacid reflux</b> as they </span><span lang=\"EN-GB\">can decrease the amount of\nvelpatasvir in your blood.\u00a0 These medicines include:</span></p>", "ID": "e7315d0f-9854-4fc8-b17c-be1fb3ad3031", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c1ea4d1d-fe0c-4bb4-bd69-be4fe0d45d42", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e7315d0f-9854-4fc8-b17c-be1fb3ad3031"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f196e7e8-0a7e-4223-8612-172771acf02d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c1ea4d1d-fe0c-4bb4-bd69-be4fe0d45d42"}, {"Element": "<b><span lang=\"EN-GB\">Get advice from a doctor or pharmacist</span></b>", "ID": "f0959d80-a793-4db9-bd7c-0427079afdc8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7315d0f-9854-4fc8-b17c-be1fb3ad3031"}, {"Element": "<span lang=\"EN-GB\">Get advice from a doctor or pharmacist</span>", "ID": "491086ec-4529-4531-a613-2e5550416d03", "Styles": "None", "Classes": "None", "Text": "Get advice from a doctor or pharmacist", "ParentId": "f0959d80-a793-4db9-bd7c-0427079afdc8"}, {"Element": "<span lang=\"EN-GB\"> if you take medicines used to treat <b>stomach ulcers, heartburn or\nacid reflux</b> as they </span>", "ID": "cb8a89ca-b618-4581-b5b5-900475ea9c8a", "Styles": "None", "Classes": "None", "Text": " if you take medicines used to treat  as they ", "ParentId": "e7315d0f-9854-4fc8-b17c-be1fb3ad3031"}, {"Element": "<b>stomach ulcers, heartburn or\nacid reflux</b>", "ID": "3cea0b97-a283-41f4-997f-9b4f365acfa5", "Styles": "None", "Classes": "None", "Text": "stomach ulcers, heartburn or acid reflux", "ParentId": "cb8a89ca-b618-4581-b5b5-900475ea9c8a"}, {"Element": "<span lang=\"EN-GB\">can decrease the amount of\nvelpatasvir in your blood.\u00a0 These medicines include:</span>", "ID": "5db032f4-95ae-4d08-8011-02ffa0583f3b", "Styles": "None", "Classes": "None", "Text": "can decrease the amount of velpatasvir in your blood.\u00a0 These medicines include:", "ParentId": "e7315d0f-9854-4fc8-b17c-be1fb3ad3031"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">antacids (such as aluminium/magnesium hydroxide\nor calcium carbonate).\u00a0 These should be taken at least 4\u00a0hours before\nor 4\u00a0hours after Epclusa;</span></p>", "ID": "09340316-b1bd-4651-b50e-90b48f491eac", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f80c2d7c-f964-43d1-ae53-937d61abf4b8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "09340316-b1bd-4651-b50e-90b48f491eac"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "383509c7-fac8-4965-b1ab-7e6ccca638e5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f80c2d7c-f964-43d1-ae53-937d61abf4b8"}, {"Element": "<span lang=\"EN-GB\">antacids (such as aluminium/magnesium hydroxide\nor calcium carbonate).\u00a0 These should be taken at least 4\u00a0hours before\nor 4\u00a0hours after Epclusa;</span>", "ID": "93d3f38a-a052-4887-98f0-49d2150c0c55", "Styles": "None", "Classes": "None", "Text": "antacids (such as aluminium/magnesium hydroxide or calcium carbonate).\u00a0 These should be taken at least 4\u00a0hours before or 4\u00a0hours after Epclusa;", "ParentId": "09340316-b1bd-4651-b50e-90b48f491eac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">proton pump inhibitors (such as omeprazole,\nlansoprazole, rabeprazole, pantoprazole and esomeprazole).\u00a0 Epclusa should\nbe taken with food 4\u00a0hours before using a proton pump inhibitor.</span></p>", "ID": "49fb9c37-a82b-403f-b30c-2e1d4aa59ce2", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6c919c83-2378-48f7-b5ab-0caa17ccf3f6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "49fb9c37-a82b-403f-b30c-2e1d4aa59ce2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2b74c81e-3e1d-47c2-9114-64318678e325", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6c919c83-2378-48f7-b5ab-0caa17ccf3f6"}, {"Element": "<span lang=\"EN-GB\">proton pump inhibitors (such as omeprazole,\nlansoprazole, rabeprazole, pantoprazole and esomeprazole).\u00a0 Epclusa should\nbe taken with food 4\u00a0hours before using a proton pump inhibitor.</span>", "ID": "4ba845e5-0fc1-41f1-ae8c-6b934a7a80ec", "Styles": "None", "Classes": "None", "Text": "proton pump inhibitors (such as omeprazole, lansoprazole, rabeprazole, pantoprazole and esomeprazole).\u00a0 Epclusa should be taken with food 4\u00a0hours before using a proton pump inhibitor.", "ParentId": "49fb9c37-a82b-403f-b30c-2e1d4aa59ce2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">H<sub>2</sub>\u2011receptor antagonists (such\nas famotidine, cimetidine, nizatidine or ranitidine).\u00a0 If you need high\ndoses of these medicines your doctor may give you a different medicine instead\nor adjust the dose of the medicine you are taking.</span></p>", "ID": "ea075ae4-75a0-4213-8dd1-a2ca853d0dc5", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0e52132a-350a-422a-aeaf-d41fb8074132", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ea075ae4-75a0-4213-8dd1-a2ca853d0dc5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9f49c17a-c42c-49d6-8a85-c0abc83679b7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0e52132a-350a-422a-aeaf-d41fb8074132"}, {"Element": "<span lang=\"EN-GB\">H<sub>2</sub>\u2011receptor antagonists (such\nas famotidine, cimetidine, nizatidine or ranitidine).\u00a0 If you need high\ndoses of these medicines your doctor may give you a different medicine instead\nor adjust the dose of the medicine you are taking.</span>", "ID": "bb5f0f27-ead9-4abe-9669-bf26583dad15", "Styles": "None", "Classes": "None", "Text": "H\u2011receptor antagonists (such as famotidine, cimetidine, nizatidine or ranitidine).\u00a0 If you need high doses of these medicines your doctor may give you a different medicine instead or adjust the dose of the medicine you are taking.", "ParentId": "ea075ae4-75a0-4213-8dd1-a2ca853d0dc5"}, {"Element": "<sub>2</sub>", "ID": "df1e67af-47b5-4a0a-a9d8-de183c5c808d", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "bb5f0f27-ead9-4abe-9669-bf26583dad15"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">These medicines\ncan decrease the amount of velpatasvir in your blood.\u00a0 If you are taking\none of these medicines your doctor will either give you a different medicine\nfor stomach ulcers, heartburn or acid reflux, or recommend how and when you\ntake that medicine.</span></p>", "ID": "71135c74-856f-4cc9-9f39-abce9098c3ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">These medicines\ncan decrease the amount of velpatasvir in your blood.\u00a0 If you are taking\none of these medicines your doctor will either give you a different medicine\nfor stomach ulcers, heartburn or acid reflux, or recommend how and when you\ntake that medicine.</span>", "ID": "74fd20ac-c0b1-41e1-8961-4165952fb5eb", "Styles": "None", "Classes": "None", "Text": "These medicines can decrease the amount of velpatasvir in your blood.\u00a0 If you are taking one of these medicines your doctor will either give you a different medicine for stomach ulcers, heartburn or acid reflux, or recommend how and when you take that medicine.", "ParentId": "71135c74-856f-4cc9-9f39-abce9098c3ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "30ce962c-e99f-4683-b915-d68d7db2e1b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce7b8401-0954-4be1-8599-a11a8aed44eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "30ce962c-e99f-4683-b915-d68d7db2e1b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and contraception</span></b></p>", "ID": "31a4139c-6649-4258-b665-eda64b3b32ed", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Pregnancy and contraception</span></b>", "ID": "a7f7b237-35fd-460a-b763-77146b5c010e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "31a4139c-6649-4258-b665-eda64b3b32ed"}, {"Element": "<span lang=\"EN-GB\">Pregnancy and contraception</span>", "ID": "c4a9f1d2-6304-4c4d-872b-3247e91acc33", "Styles": "None", "Classes": "None", "Text": "Pregnancy and contraception", "ParentId": "a7f7b237-35fd-460a-b763-77146b5c010e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The effects of Epclusa\nduring pregnancy are not known.\u00a0 If you are pregnant, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before taking\nthis medicine.</span></p>", "ID": "78dc966d-ff7a-468e-999a-54a91c17e5fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The effects of Epclusa\nduring pregnancy are not known.\u00a0 If you are pregnant, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before taking\nthis medicine.</span>", "ID": "07c7337b-d7da-4b47-bf48-06e739ffc2c4", "Styles": "None", "Classes": "None", "Text": "The effects of Epclusa during pregnancy are not known.\u00a0 If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.", "ParentId": "78dc966d-ff7a-468e-999a-54a91c17e5fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd76fdc7-8ca1-41bb-a6ec-175e106d3212", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f6762a5-2695-4c20-8c65-e28ef678b9f5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd76fdc7-8ca1-41bb-a6ec-175e106d3212"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa is\nsometimes used together with ribavirin.\u00a0 Ribavirin can harm your unborn\nbaby.\u00a0 It is therefore very important that you (or your partner) do not\nbecome pregnant during this treatment or for a period of time after completing\ntreatment.\u00a0 You must read the \u201cPregnancy\u201d section in the\nribavirin package leaflet very carefully. \u00a0Ask your doctor for effective\ncontraception method suitable for you and your partner.</span></p>", "ID": "0843e9ba-c1c3-447f-9c84-0a67ca5def31", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa is\nsometimes used together with ribavirin.\u00a0 Ribavirin can harm your unborn\nbaby.\u00a0 It is therefore very important that you (or your partner) do not\nbecome pregnant during this treatment or for a period of time after completing\ntreatment.\u00a0 You must read the \u201cPregnancy\u201d section in the\nribavirin package leaflet very carefully. \u00a0Ask your doctor for effective\ncontraception method suitable for you and your partner.</span>", "ID": "9c4b311e-d3ce-4cb0-9209-bdd6972816b3", "Styles": "None", "Classes": "None", "Text": "Epclusa is sometimes used together with ribavirin.\u00a0 Ribavirin can harm your unborn baby.\u00a0 It is therefore very important that you (or your partner) do not become pregnant during this treatment or for a period of time after completing treatment.\u00a0 You must read the \u201cPregnancy\u201d section in the ribavirin package leaflet very carefully. \u00a0Ask your doctor for effective contraception method suitable for you and your partner.", "ParentId": "0843e9ba-c1c3-447f-9c84-0a67ca5def31"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "51bb6563-a1a8-4467-9d73-399e09cb1e58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "848d9b5d-52c0-4c7a-9300-28ed71abfb2a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "51bb6563-a1a8-4467-9d73-399e09cb1e58"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Breast\u2011feeding</span></b></p>", "ID": "cab9f4b7-9293-4031-99f0-7850c670d442", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Breast\u2011feeding</span></b>", "ID": "2c2c2a24-cb1c-4bb3-a768-f14a8afde48f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cab9f4b7-9293-4031-99f0-7850c670d442"}, {"Element": "<span lang=\"EN-GB\">Breast\u2011feeding</span>", "ID": "2318329c-70df-455b-b39c-69aac29b9ba7", "Styles": "None", "Classes": "None", "Text": "Breast\u2011feeding", "ParentId": "2c2c2a24-cb1c-4bb3-a768-f14a8afde48f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Do not breast\u2011feed\nduring treatment with Epclusa.</span></b><span lang=\"EN-GB\">\u00a0 It is not\nknown whether sofosbuvir or velpatasvir, the two active substances of Epclusa,\npass into human breast milk.</span></p>", "ID": "b9c11c21-af4e-4de8-a3b3-383786e467bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Do not breast\u2011feed\nduring treatment with Epclusa.</span></b>", "ID": "1f7f9117-204e-47ef-a67b-4c2af4df64c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9c11c21-af4e-4de8-a3b3-383786e467bf"}, {"Element": "<span lang=\"EN-GB\">Do not breast\u2011feed\nduring treatment with Epclusa.</span>", "ID": "90b12ea2-8fd7-44e2-b771-55855e919032", "Styles": "None", "Classes": "None", "Text": "Do not breast\u2011feed during treatment with Epclusa.", "ParentId": "1f7f9117-204e-47ef-a67b-4c2af4df64c3"}, {"Element": "<span lang=\"EN-GB\">\u00a0 It is not\nknown whether sofosbuvir or velpatasvir, the two active substances of Epclusa,\npass into human breast milk.</span>", "ID": "6f19510d-644f-4f7c-8768-41117c3cba7e", "Styles": "None", "Classes": "None", "Text": "\u00a0 It is not known whether sofosbuvir or velpatasvir, the two active substances of Epclusa, pass into human breast milk.", "ParentId": "b9c11c21-af4e-4de8-a3b3-383786e467bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b716d4d9-aa90-4cce-b10e-4b5625b6979f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e17288dc-bb0b-4533-8989-fdc13d197409", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b716d4d9-aa90-4cce-b10e-4b5625b6979f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>", "ID": "4dc8c357-1182-4c9b-8792-0dfa0f07d5aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Driving and using machines</span></b>", "ID": "f9b3e9a6-cc30-4bee-98c3-c7e4cef758db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4dc8c357-1182-4c9b-8792-0dfa0f07d5aa"}, {"Element": "<span lang=\"EN-GB\">Driving and using machines</span>", "ID": "82a07c5c-b9d9-41e5-9f05-ff69567484d3", "Styles": "None", "Classes": "None", "Text": "Driving and using machines", "ParentId": "f9b3e9a6-cc30-4bee-98c3-c7e4cef758db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Epclusa should\nnot affect your ability to drive or use any tools or machinery.</span></p>", "ID": "97106281-d70c-42cc-bf67-695f49546b66", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Epclusa should\nnot affect your ability to drive or use any tools or machinery.</span>", "ID": "4743621e-a356-447f-9be3-30de4f8ca77c", "Styles": "None", "Classes": "None", "Text": "Epclusa should not affect your ability to drive or use any tools or machinery.", "ParentId": "97106281-d70c-42cc-bf67-695f49546b66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aecc5a8c-740e-44e5-9b37-d743bbfc6798", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84e4544d-be59-4009-93cf-2a0a853a6838", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aecc5a8c-740e-44e5-9b37-d743bbfc6798"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "953d6d4b-3263-4193-b1b0-39f9f2bb14b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2778b419-b9ec-4f36-a1a8-3e53a87f5553", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "953d6d4b-3263-4193-b1b0-39f9f2bb14b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto take Epclusa</span></b></p>", "ID": "e08fdede-1d7b-4d72-b723-385cf0845981", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto take Epclusa</span></b>", "ID": "4a680c53-dc12-4304-b66e-f55953fc0221", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e08fdede-1d7b-4d72-b723-385cf0845981"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto take Epclusa</span>", "ID": "e631ceb8-286a-4eed-b237-b20fe417eaa7", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Epclusa", "ParentId": "4a680c53-dc12-4304-b66e-f55953fc0221"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3258d3ef-5235-4ae1-a339-f142fe91806b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0cc9adf-82f0-4c8c-b423-7517026e22e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3258d3ef-5235-4ae1-a339-f142fe91806b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you.\u00a0\nCheck with your doctor or pharmacist if you are not sure.</span></p>", "ID": "a7f8a172-9f8c-4bd2-a7ed-f303590d7b70", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Always take this medicine exactly as your doctor has told you.\u00a0\nCheck with your doctor or pharmacist if you are not sure.</span>", "ID": "60063b56-2869-4134-8518-7c50551cceb6", "Styles": "None", "Classes": "None", "Text": "Always take this medicine exactly as your doctor has told you.\u00a0 Check with your doctor or pharmacist if you are not sure.", "ParentId": "a7f8a172-9f8c-4bd2-a7ed-f303590d7b70"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ead61643-415b-46ea-b035-c4dee90edce4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "120ba29d-81f7-4dec-8157-4e461832d3f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ead61643-415b-46ea-b035-c4dee90edce4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Recommended dose</span></b></p>", "ID": "63343a01-df15-4599-b922-e1696edf65e9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Recommended dose</span></b>", "ID": "39c91673-cceb-4377-8d9e-5c42a34151d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63343a01-df15-4599-b922-e1696edf65e9"}, {"Element": "<span lang=\"EN-GB\">Recommended dose</span>", "ID": "265d31a6-9c66-4a0f-be8a-160ae846da89", "Styles": "None", "Classes": "None", "Text": "Recommended dose", "ParentId": "39c91673-cceb-4377-8d9e-5c42a34151d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended\ndose is <b>one\u00a0tablet once\u00a0a\u00a0day for 12\u00a0weeks.</b></span></p>", "ID": "083f6b53-6024-4aa0-adc4-f9dca1acf261", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The recommended\ndose is <b>one\u00a0tablet once\u00a0a\u00a0day for 12\u00a0weeks.</b></span>", "ID": "f04b22f1-15e8-478e-be25-b6221fced032", "Styles": "None", "Classes": "None", "Text": "The recommended dose is ", "ParentId": "083f6b53-6024-4aa0-adc4-f9dca1acf261"}, {"Element": "<b>one\u00a0tablet once\u00a0a\u00a0day for 12\u00a0weeks.</b>", "ID": "e49bb8bc-b2b1-4de7-a4c8-6ae4e4931ea7", "Styles": "None", "Classes": "None", "Text": "one\u00a0tablet once\u00a0a\u00a0day for 12\u00a0weeks.", "ParentId": "f04b22f1-15e8-478e-be25-b6221fced032"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ff75922-8775-4f24-b3c5-5bf6d7289520", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ece3ce2c-45b8-47b8-8bc0-4137a52977cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ff75922-8775-4f24-b3c5-5bf6d7289520"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Swallow the\ntablet whole with or without food.\u00a0 Do not chew, crush or split the tablet\nas it has a very bitter taste.</span></p>", "ID": "31f6d70a-8fbe-49e6-95d8-46a8d0ec4098", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Swallow the\ntablet whole with or without food.\u00a0 Do not chew, crush or split the tablet\nas it has a very bitter taste.</span>", "ID": "19342603-1272-4e2b-82d4-eab7eca79842", "Styles": "None", "Classes": "None", "Text": "Swallow the tablet whole with or without food.\u00a0 Do not chew, crush or split the tablet as it has a very bitter taste.", "ParentId": "31f6d70a-8fbe-49e6-95d8-46a8d0ec4098"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "082bf739-38ca-4cc2-8b68-4bbeb0faeddb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3dbb7b17-c2d8-4d9d-8c0e-a8175d7fda1b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "082bf739-38ca-4cc2-8b68-4bbeb0faeddb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you are\ntaking an antacid,</span></b><span lang=\"EN-GB\"> take it at least 4\u00a0hours\nbefore or at least 4\u00a0hours after Epclusa.</span></p>", "ID": "cc073853-8e67-4da1-b85c-a6dd97b6686a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you are\ntaking an antacid,</span></b>", "ID": "372d077b-4b77-4af3-beee-b0e55a36ae1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cc073853-8e67-4da1-b85c-a6dd97b6686a"}, {"Element": "<span lang=\"EN-GB\">If you are\ntaking an antacid,</span>", "ID": "e7a21dc8-0213-436e-bd73-44a16b12d59d", "Styles": "None", "Classes": "None", "Text": "If you are taking an antacid,", "ParentId": "372d077b-4b77-4af3-beee-b0e55a36ae1f"}, {"Element": "<span lang=\"EN-GB\"> take it at least 4\u00a0hours\nbefore or at least 4\u00a0hours after Epclusa.</span>", "ID": "ee9d2aa7-ffc1-415b-8ea8-c5b027c64dbf", "Styles": "None", "Classes": "None", "Text": " take it at least 4\u00a0hours before or at least 4\u00a0hours after Epclusa.", "ParentId": "cc073853-8e67-4da1-b85c-a6dd97b6686a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "179f8a40-d53c-4ef4-a7fa-fc21a6551e3d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0559c5b0-374b-4495-a3a2-b10acb3a2fe0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "179f8a40-d53c-4ef4-a7fa-fc21a6551e3d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you are\ntaking a proton pump inhibitor,</span></b><span lang=\"EN-GB\"> take Epclusa with\nfood 4\u00a0hours before using a proton pump inhibitor.</span></p>", "ID": "b674ba35-7248-4e81-8425-fb4ac40b3876", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you are\ntaking a proton pump inhibitor,</span></b>", "ID": "a35adb4f-03d5-42c4-8971-411bccbf93ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b674ba35-7248-4e81-8425-fb4ac40b3876"}, {"Element": "<span lang=\"EN-GB\">If you are\ntaking a proton pump inhibitor,</span>", "ID": "1ab9d8cb-94b8-436d-84bc-3bb289e5d418", "Styles": "None", "Classes": "None", "Text": "If you are taking a proton pump inhibitor,", "ParentId": "a35adb4f-03d5-42c4-8971-411bccbf93ee"}, {"Element": "<span lang=\"EN-GB\"> take Epclusa with\nfood 4\u00a0hours before using a proton pump inhibitor.</span>", "ID": "36ceccd9-5b25-40ec-a63a-83376540bb8a", "Styles": "None", "Classes": "None", "Text": " take Epclusa with food 4\u00a0hours before using a proton pump inhibitor.", "ParentId": "b674ba35-7248-4e81-8425-fb4ac40b3876"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "73964512-8a60-433c-84cb-f41a330b417e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c5d8e7b9-233e-46eb-a610-4c78034e1d67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "73964512-8a60-433c-84cb-f41a330b417e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you are sick (vomit) after taking Epclusa</span></b><span lang=\"EN-GB\"> it may affect the amount of Epclusa in your blood.\u00a0 This may\nmake Epclusa work less well.</span></p>", "ID": "03ff5bbc-4539-434e-848e-31798faf970a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you are sick (vomit) after taking Epclusa</span></b>", "ID": "943eb3de-4888-49c3-a41f-528fcdf6c297", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03ff5bbc-4539-434e-848e-31798faf970a"}, {"Element": "<span lang=\"EN-GB\">If you are sick (vomit) after taking Epclusa</span>", "ID": "eb1b34d0-11d0-4e51-8b0c-f41c1391613b", "Styles": "None", "Classes": "None", "Text": "If you are sick (vomit) after taking Epclusa", "ParentId": "943eb3de-4888-49c3-a41f-528fcdf6c297"}, {"Element": "<span lang=\"EN-GB\"> it may affect the amount of Epclusa in your blood.\u00a0 This may\nmake Epclusa work less well.</span>", "ID": "e22a8621-bf9a-48cc-a899-d5d5bb7a1b7e", "Styles": "None", "Classes": "None", "Text": " it may affect the amount of Epclusa in your blood.\u00a0 This may make Epclusa work less well.", "ParentId": "03ff5bbc-4539-434e-848e-31798faf970a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you are sick (vomit) <b>less than 3\u00a0hours\nafter</b> taking Epclusa, take another tablet.</span></p>", "ID": "0a6628f5-62e6-4a85-b262-d30016f7c493", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "41e1379e-32ea-4e1e-80d9-b19231bfc7a7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0a6628f5-62e6-4a85-b262-d30016f7c493"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f70bbd19-3532-4b05-8411-492a11e2e957", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "41e1379e-32ea-4e1e-80d9-b19231bfc7a7"}, {"Element": "<span lang=\"EN-GB\">If you are sick (vomit) <b>less than 3\u00a0hours\nafter</b> taking Epclusa, take another tablet.</span>", "ID": "7090001c-60b2-4e1b-b8e2-96df2e69a01f", "Styles": "None", "Classes": "None", "Text": "If you are sick (vomit)  taking Epclusa, take another tablet.", "ParentId": "0a6628f5-62e6-4a85-b262-d30016f7c493"}, {"Element": "<b>less than 3\u00a0hours\nafter</b>", "ID": "05352b4f-f928-4616-8da4-75fbdc3cd5ea", "Styles": "None", "Classes": "None", "Text": "less than 3\u00a0hours after", "ParentId": "7090001c-60b2-4e1b-b8e2-96df2e69a01f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you are sick (vomit) <b>more than 3\u00a0hours\nafter</b> taking Epclusa, you do not need to take another tablet until your\nnext scheduled tablet.</span></p>", "ID": "25ec5c07-29b4-4919-b8e6-6bb4cd8cd89b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0861cd32-d9fe-43c3-b35f-25a292ab27eb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "25ec5c07-29b4-4919-b8e6-6bb4cd8cd89b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c25c1a7e-f8d2-44b5-8ac8-c5666057a0b3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0861cd32-d9fe-43c3-b35f-25a292ab27eb"}, {"Element": "<span lang=\"EN-GB\">If you are sick (vomit) <b>more than 3\u00a0hours\nafter</b> taking Epclusa, you do not need to take another tablet until your\nnext scheduled tablet.</span>", "ID": "b0645b10-d288-4e4a-a9a4-2d73221a67e4", "Styles": "None", "Classes": "None", "Text": "If you are sick (vomit)  taking Epclusa, you do not need to take another tablet until your next scheduled tablet.", "ParentId": "25ec5c07-29b4-4919-b8e6-6bb4cd8cd89b"}, {"Element": "<b>more than 3\u00a0hours\nafter</b>", "ID": "19a4077a-4e82-4b73-8c2e-2ecb4f7386ce", "Styles": "None", "Classes": "None", "Text": "more than 3\u00a0hours after", "ParentId": "b0645b10-d288-4e4a-a9a4-2d73221a67e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca9f2fb6-50e6-4632-a868-717903c2eeee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6753cf0d-55e3-4242-a9c5-0bef56e1ea13", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca9f2fb6-50e6-4632-a868-717903c2eeee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you take more Epclusa than you should</span></b></p>", "ID": "2cb2241e-8914-4a6e-8048-488eb5b68bb9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you take more Epclusa than you should</span></b>", "ID": "4817a32d-862a-4b39-8655-2589e97596b2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2cb2241e-8914-4a6e-8048-488eb5b68bb9"}, {"Element": "<span lang=\"EN-GB\">If you take more Epclusa than you should</span>", "ID": "94a0449d-0c6d-4942-ba6b-c98af1945284", "Styles": "None", "Classes": "None", "Text": "If you take more Epclusa than you should", "ParentId": "4817a32d-862a-4b39-8655-2589e97596b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you\naccidentally take more than the recommended dose you should contact your doctor\nor nearest emergency department immediately for advice.\u00a0 Keep the tablet\nbottle with you so that you can easily describe what you have taken.</span></p>", "ID": "74bd9340-9371-4c6d-a75d-6410497cb896", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If you\naccidentally take more than the recommended dose you should contact your doctor\nor nearest emergency department immediately for advice.\u00a0 Keep the tablet\nbottle with you so that you can easily describe what you have taken.</span>", "ID": "948877ca-aaeb-40cc-a7e6-57b3d6f25219", "Styles": "None", "Classes": "None", "Text": "If you accidentally take more than the recommended dose you should contact your doctor or nearest emergency department immediately for advice.\u00a0 Keep the tablet bottle with you so that you can easily describe what you have taken.", "ParentId": "74bd9340-9371-4c6d-a75d-6410497cb896"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "56fa4cda-a149-4021-bf90-853102554ea6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b5c8ead-b7de-4481-b664-0d31829cf5bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "56fa4cda-a149-4021-bf90-853102554ea6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you forget to take Epclusa</span></b></p>", "ID": "740ddb5e-7d5d-4c6c-bad5-d9dbbda47aba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you forget to take Epclusa</span></b>", "ID": "54eb4212-353b-4981-9ef8-9a42e974acb6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "740ddb5e-7d5d-4c6c-bad5-d9dbbda47aba"}, {"Element": "<span lang=\"EN-GB\">If you forget to take Epclusa</span>", "ID": "a213780d-e257-4ace-8030-4d2b45682c7d", "Styles": "None", "Classes": "None", "Text": "If you forget to take Epclusa", "ParentId": "54eb4212-353b-4981-9ef8-9a42e974acb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is important\nnot to miss a dose of this medicine.</span></p>", "ID": "c7f90111-eba1-4e0a-8d1c-782fb1ca752c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">It is important\nnot to miss a dose of this medicine.</span>", "ID": "9355279d-daa7-424f-96d5-56d2762d1761", "Styles": "None", "Classes": "None", "Text": "It is important not to miss a dose of this medicine.", "ParentId": "c7f90111-eba1-4e0a-8d1c-782fb1ca752c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "40f7a84e-1c83-4018-8e93-0b8c67a929d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "504a2d29-7bce-4799-9fe5-ce19a300761e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40f7a84e-1c83-4018-8e93-0b8c67a929d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If you do miss a dose, work out how long it is since you last took\nyour Epclusa:</span></p>", "ID": "a838fb97-b7c6-410f-b48e-186d906664e3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If you do miss a dose, work out how long it is since you last took\nyour Epclusa:</span>", "ID": "7531b088-dc57-4699-a000-f273c6c018f3", "Styles": "None", "Classes": "None", "Text": "If you do miss a dose, work out how long it is since you last took your Epclusa:", "ParentId": "a838fb97-b7c6-410f-b48e-186d906664e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If you notice within 18\u00a0hours</span></b><span lang=\"EN-GB\"> of the time you usually take Epclusa, you must take the tablet as\nsoon as possible.\u00a0 Then take the next dose at your usual time.</span></p>", "ID": "17d4ef33-4b67-48d1-a09d-7500899bee61", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6e60dee4-54c7-4042-a9b5-41695fa89432", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "17d4ef33-4b67-48d1-a09d-7500899bee61"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9b1e8e82-4642-418c-a3e4-e48bc2c2f147", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6e60dee4-54c7-4042-a9b5-41695fa89432"}, {"Element": "<b><span lang=\"EN-GB\">If you notice within 18\u00a0hours</span></b>", "ID": "201bd78f-08d3-40f9-8327-676954c3cef7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17d4ef33-4b67-48d1-a09d-7500899bee61"}, {"Element": "<span lang=\"EN-GB\">If you notice within 18\u00a0hours</span>", "ID": "a941bf29-6468-4519-bc56-ebcb4be80c4d", "Styles": "None", "Classes": "None", "Text": "If you notice within 18\u00a0hours", "ParentId": "201bd78f-08d3-40f9-8327-676954c3cef7"}, {"Element": "<span lang=\"EN-GB\"> of the time you usually take Epclusa, you must take the tablet as\nsoon as possible.\u00a0 Then take the next dose at your usual time.</span>", "ID": "77e543ab-d0d4-450e-a44a-7c2cd50fd5a2", "Styles": "None", "Classes": "None", "Text": " of the time you usually take Epclusa, you must take the tablet as soon as possible.\u00a0 Then take the next dose at your usual time.", "ParentId": "17d4ef33-4b67-48d1-a09d-7500899bee61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">If it\u2019s 18\u00a0hours or more</span></b><span lang=\"EN-GB\"> after the time you usually take Epclusa, wait and take the next\ndose at your usual time.\u00a0 Do not take a double dose (two doses close\ntogether).</span></p>", "ID": "d2a986fd-2ad8-4c49-9136-437fcff74d65", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f53e8159-f83b-4401-b080-c7f24815cac1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d2a986fd-2ad8-4c49-9136-437fcff74d65"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "21243eb5-efcd-4359-866d-f456d3ae9428", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f53e8159-f83b-4401-b080-c7f24815cac1"}, {"Element": "<b><span lang=\"EN-GB\">If it\u2019s 18\u00a0hours or more</span></b>", "ID": "7f0c46d6-8e0f-46cd-84b2-d9a511a3d142", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2a986fd-2ad8-4c49-9136-437fcff74d65"}, {"Element": "<span lang=\"EN-GB\">If it\u2019s 18\u00a0hours or more</span>", "ID": "06628007-9ae5-4e66-afdf-27525688369f", "Styles": "None", "Classes": "None", "Text": "If it\u2019s 18\u00a0hours or more", "ParentId": "7f0c46d6-8e0f-46cd-84b2-d9a511a3d142"}, {"Element": "<span lang=\"EN-GB\"> after the time you usually take Epclusa, wait and take the next\ndose at your usual time.\u00a0 Do not take a double dose (two doses close\ntogether).</span>", "ID": "f6655851-4a16-453f-b5b2-6d2b06c420f3", "Styles": "None", "Classes": "None", "Text": " after the time you usually take Epclusa, wait and take the next dose at your usual time.\u00a0 Do not take a double dose (two doses close together).", "ParentId": "d2a986fd-2ad8-4c49-9136-437fcff74d65"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8094550b-9959-435d-88d1-586e50ec3c91", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f10fb0a-990e-403b-9ee8-7e35778f4dc2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8094550b-9959-435d-88d1-586e50ec3c91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not stop taking Epclusa</span></b></p>", "ID": "cd7b84ee-102f-4fbd-89f6-3b94f367ac09", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Do not stop taking Epclusa</span></b>", "ID": "61e4aaa5-fc62-4903-80d1-2d671f410f9f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd7b84ee-102f-4fbd-89f6-3b94f367ac09"}, {"Element": "<span lang=\"EN-GB\">Do not stop taking Epclusa</span>", "ID": "a998a419-b5e7-4b54-bd84-20f74b145449", "Styles": "None", "Classes": "None", "Text": "Do not stop taking Epclusa", "ParentId": "61e4aaa5-fc62-4903-80d1-2d671f410f9f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop\ntaking this medicine unless your doctor tells you to.\u00a0 It is very\nimportant that you complete the full course of treatment to give the medicine\nthe best chance to treat your hepatitis\u00a0C virus infection.</span></p>", "ID": "debda237-85aa-4226-add0-e675073de4a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Do not stop\ntaking this medicine unless your doctor tells you to.\u00a0 It is very\nimportant that you complete the full course of treatment to give the medicine\nthe best chance to treat your hepatitis\u00a0C virus infection.</span>", "ID": "7f16a945-bcfc-4f86-80e8-6eb59e1848cc", "Styles": "None", "Classes": "None", "Text": "Do not stop taking this medicine unless your doctor tells you to.\u00a0 It is very important that you complete the full course of treatment to give the medicine the best chance to treat your hepatitis\u00a0C virus infection.", "ParentId": "debda237-85aa-4226-add0-e675073de4a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e81bd52-5728-4740-aceb-ca26efe3008a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "962f462f-aa2c-4ba2-807c-99989a370df4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e81bd52-5728-4740-aceb-ca26efe3008a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any\nfurther questions on the use of this medicine, ask your doctor or pharmacist.</span></p>", "ID": "37d06a4f-d42b-4431-bff6-13ec6f18ceb8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">If you have any\nfurther questions on the use of this medicine, ask your doctor or pharmacist.</span>", "ID": "74407707-716c-47f6-88a4-cea20b04b46e", "Styles": "None", "Classes": "None", "Text": "If you have any further questions on the use of this medicine, ask your doctor or pharmacist.", "ParentId": "37d06a4f-d42b-4431-bff6-13ec6f18ceb8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4e1356b3-83f4-4621-bf08-8853e1da5805", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "773ccae2-1ec1-497a-9658-e3782cfa8e8a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4e1356b3-83f4-4621-bf08-8853e1da5805"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1713cdfe-78d8-472e-b3d8-17559d296feb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "766bbadb-3f61-4a48-a2aa-740cf05a84ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1713cdfe-78d8-472e-b3d8-17559d296feb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b></p>", "ID": "dfe5aade-af55-4f4e-9c81-e1fae2b81088", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span></b>", "ID": "f30ea6eb-bba2-4f26-95f4-7ed0be92e06c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dfe5aade-af55-4f4e-9c81-e1fae2b81088"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible\nside effects</span>", "ID": "70337ad8-fc69-455d-8727-0f45f7f54ffd", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "f30ea6eb-bba2-4f26-95f4-7ed0be92e06c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "37df9e28-c2c1-4ad5-b04e-588d9e4560c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae253cd3-87f9-4c29-9b2c-4c070966829c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "37df9e28-c2c1-4ad5-b04e-588d9e4560c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Like all medicines, this medicine may cause side effects, although\nnot everybody gets them.</span></p>", "ID": "98e576fc-8fec-48f7-bec3-1f52b6fc0470", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Like all medicines, this medicine may cause side effects, although\nnot everybody gets them.</span>", "ID": "0eb72fbd-a2fd-483d-9845-f7f5a86d82a1", "Styles": "None", "Classes": "None", "Text": "Like all medicines, this medicine may cause side effects, although not everybody gets them.", "ParentId": "98e576fc-8fec-48f7-bec3-1f52b6fc0470"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "882409b5-2731-4b74-a8b9-439e1ebd8ef6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5ef80889-6fb0-4a4a-a0c1-712a5f020e3a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "882409b5-2731-4b74-a8b9-439e1ebd8ef6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other effects that may be seen during treatment with sofosbuvir:</span></b></p>", "ID": "6272dea3-88cc-4304-a3ba-6a4ca4250c23", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Other effects that may be seen during treatment with sofosbuvir:</span></b>", "ID": "b8dd2938-7f00-4b99-a202-288274e16724", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6272dea3-88cc-4304-a3ba-6a4ca4250c23"}, {"Element": "<span lang=\"EN-GB\">Other effects that may be seen during treatment with sofosbuvir:</span>", "ID": "b59abc38-f7a2-4c50-81a6-7ba08466a50a", "Styles": "None", "Classes": "None", "Text": "Other effects that may be seen during treatment with sofosbuvir:", "ParentId": "b8dd2938-7f00-4b99-a202-288274e16724"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The frequency of the following side effects is not known (frequency\ncannot be estimated from the available data).</span></p>", "ID": "6a3d1f52-7c7a-4d18-bfd5-b89179092344", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The frequency of the following side effects is not known (frequency\ncannot be estimated from the available data).</span>", "ID": "36c8e61c-4f39-4445-b251-66a032d753ec", "Styles": "None", "Classes": "None", "Text": "The frequency of the following side effects is not known (frequency cannot be estimated from the available data).", "ParentId": "6a3d1f52-7c7a-4d18-bfd5-b89179092344"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a wide\nspread severe rash with peeling skin which may be accompanied by fever, flu\nlike symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson\nsyndrome).</span></p>", "ID": "0ffdd2c0-93a8-447a-af29-d9c80f4980e7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a wide\nspread severe rash with peeling skin which may be accompanied by fever, flu\nlike symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson\nsyndrome).</span>", "ID": "a56af3dd-edcc-4120-960d-a2f3596b0875", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a wide spread severe rash with peeling skin which may be accompanied by fever, flu like symptoms, blisters in the mouth, eyes, and/or genitals (Stevens Johnson syndrome).", "ParentId": "0ffdd2c0-93a8-447a-af29-d9c80f4980e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ab6205ab-f920-4e2d-94db-ca1e16bd588e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b68d7309-0d14-4faf-8a8f-e17ce5aff085", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab6205ab-f920-4e2d-94db-ca1e16bd588e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span></b><b><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">If you get any side effects tell your\ndoctor.</span></b></p>", "ID": "4e209b5c-5b89-4d04-be2f-bee507fe3cae", "Styles": "margin-left:14.2pt;text-indent:-14.2pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span></b>", "ID": "2c03b9a0-76d3-407b-b997-563a0b77e8a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e209b5c-5b89-4d04-be2f-bee507fe3cae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Wingdings\">\u00e0</span>", "ID": "f577e648-2a5d-4093-ab5c-cfba33c896f9", "Styles": "font-family:Wingdings", "Classes": "None", "Text": "\u00e0", "ParentId": "2c03b9a0-76d3-407b-b997-563a0b77e8a9"}, {"Element": "<b><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">If you get any side effects tell your\ndoctor.</span></b>", "ID": "46fcf1ee-64e6-4485-8ee8-e7fe12dc314a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e209b5c-5b89-4d04-be2f-bee507fe3cae"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "81d3097d-ed27-47a4-a14d-47bfc1de8efb", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "46fcf1ee-64e6-4485-8ee8-e7fe12dc314a"}, {"Element": "<span lang=\"EN-GB\">If you get any side effects tell your\ndoctor.</span>", "ID": "e06365c8-8440-4ef9-9c27-530731f80224", "Styles": "None", "Classes": "None", "Text": "If you get any side effects tell your doctor.", "ParentId": "46fcf1ee-64e6-4485-8ee8-e7fe12dc314a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e79a09f8-93c4-45ef-b11a-1bfb3c6b4b5a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f69f4cb5-2242-4f59-9a66-7c7f21f4fc5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e79a09f8-93c4-45ef-b11a-1bfb3c6b4b5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>", "ID": "f1695b3c-116f-47e4-98b7-e160ac39e48b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Reporting of side effects</span></b>", "ID": "b241b57f-a97b-4f93-8f85-e3d4a9543baa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1695b3c-116f-47e4-98b7-e160ac39e48b"}, {"Element": "<span lang=\"EN-GB\">Reporting of side effects</span>", "ID": "94b3e275-5877-40e4-aefe-7792a3ced55a", "Styles": "None", "Classes": "None", "Text": "Reporting of side effects", "ParentId": "b241b57f-a97b-4f93-8f85-e3d4a9543baa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">If you get\nany side effects, talk to your doctor or pharmacist.</span></b><span lang=\"EN-GB\">\u00a0 This includes any possible side effects not listed in this\nleaflet.\u00a0 You can also report side effects directly via </span><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">the national reporting system\nlisted in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span><span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">.</span><span lang=\"EN-GB\">\u00a0\nBy reporting side effects you can help provide more information on the safety\nof this medicine.</span></p>", "ID": "45c219d9-b5ab-4c4c-9e09-642b928f3858", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">If you get\nany side effects, talk to your doctor or pharmacist.</span></b>", "ID": "55a37d6c-2401-4405-82f4-c2acf867995b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<span lang=\"EN-GB\">If you get\nany side effects, talk to your doctor or pharmacist.</span>", "ID": "6c170a94-4d19-4f28-b93c-1eaeeae56f8a", "Styles": "None", "Classes": "None", "Text": "If you get any side effects, talk to your doctor or pharmacist.", "ParentId": "55a37d6c-2401-4405-82f4-c2acf867995b"}, {"Element": "<span lang=\"EN-GB\">\u00a0 This includes any possible side effects not listed in this\nleaflet.\u00a0 You can also report side effects directly via </span>", "ID": "3c32e4f7-bf61-46a0-a922-f5c2972cef2d", "Styles": "None", "Classes": "None", "Text": "\u00a0 This includes any possible side effects not listed in this leaflet.\u00a0 You can also report side effects directly via ", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">the national reporting system\nlisted in </span>", "ID": "e62e6b83-4f82-472d-855b-be7cbd026cd8", "Styles": "color:black;background:#BFBFBF", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a></span>", "ID": "ed838695-29de-44f6-9044-cc86d6920ad1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span></a>", "ID": "374b4c45-b333-414b-92fd-9e8d13998de5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed838695-29de-44f6-9044-cc86d6920ad1"}, {"Element": "<span style=\"color:black;background:#BFBFBF;text-decoration:none\">Appendix\u00a0V</span>", "ID": "c9b16a1a-2465-4f24-9551-8b86c39d3e45", "Styles": "color:black;background:#BFBFBF;text-decoration:none", "Classes": "None", "Text": "Appendix\u00a0V", "ParentId": "374b4c45-b333-414b-92fd-9e8d13998de5"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#BFBFBF\">.</span>", "ID": "2282e2a5-e6dc-43a0-b52b-c0d495b9c629", "Styles": "color:black;background:#BFBFBF", "Classes": "None", "Text": ".", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<span lang=\"EN-GB\">\u00a0\nBy reporting side effects you can help provide more information on the safety\nof this medicine.</span>", "ID": "ef9d5424-0591-4da5-a03d-d56ac19de89a", "Styles": "None", "Classes": "None", "Text": "\u00a0 By reporting side effects you can help provide more information on the safety of this medicine.", "ParentId": "45c219d9-b5ab-4c4c-9e09-642b928f3858"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "87562c5a-9589-4fef-a612-0ff66063bff2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "638ada8e-f164-416f-8c3c-0cbffb260a9e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87562c5a-9589-4fef-a612-0ff66063bff2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6085a3c4-1ead-4830-b391-b01ef6d2dabf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d78d23df-b433-46b5-a927-6dc472e25562", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6085a3c4-1ead-4830-b391-b01ef6d2dabf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto store Epclusa</span></b></p>", "ID": "d23b003e-2d6e-4fea-ad78-1beaf0a30cdb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto store Epclusa</span></b>", "ID": "36161876-c249-4774-8043-3e594e174bdf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d23b003e-2d6e-4fea-ad78-1beaf0a30cdb"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How\nto store Epclusa</span>", "ID": "a19102ba-fee1-4f06-bbd5-06d42652dfd1", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Epclusa", "ParentId": "36161876-c249-4774-8043-3e594e174bdf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "03e8a31e-5017-4606-b04f-5686da4bfd65", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efb370bd-c18a-4353-b92a-7b73afb0d563", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03e8a31e-5017-4606-b04f-5686da4bfd65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span></p>", "ID": "89164e7c-11ad-4a90-bb8e-51eb8204252d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span>", "ID": "f6d3101c-c525-4144-9b6e-e63de792dcd9", "Styles": "None", "Classes": "None", "Text": "Keep this medicine out of the sight and reach of children.", "ParentId": "89164e7c-11ad-4a90-bb8e-51eb8204252d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2f5e76cb-1bdd-423b-9d1e-18ac84bb0405", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8fd0fccc-1fe8-49c4-98d3-ff9ad68bbee1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2f5e76cb-1bdd-423b-9d1e-18ac84bb0405"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the bottle and carton after\n\u201cEXP\u201d.\u00a0 The expiry date refers to the last day of that month.</span></p>", "ID": "903f2ad3-b23d-4db1-8185-aca9bb78214a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the bottle and carton after\n\u201cEXP\u201d.\u00a0 The expiry date refers to the last day of that month.</span>", "ID": "9680d392-4da6-4859-829a-fa17d6be75c4", "Styles": "None", "Classes": "None", "Text": "Do not use this medicine after the expiry date which is stated on the bottle and carton after \u201cEXP\u201d.\u00a0 The expiry date refers to the last day of that month.", "ParentId": "903f2ad3-b23d-4db1-8185-aca9bb78214a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f6bb5b0a-2c91-4e10-bd9b-c1df81596ab6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "db78764f-572d-495b-8df8-519aee287030", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f6bb5b0a-2c91-4e10-bd9b-c1df81596ab6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine\ndoes not require any special storage conditions.</span></p>", "ID": "5cafcd7a-520c-4d16-9964-0585ef937c6e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">This medicine\ndoes not require any special storage conditions.</span>", "ID": "7c24e4c2-832c-455e-9a5b-d62540d9f7f5", "Styles": "None", "Classes": "None", "Text": "This medicine does not require any special storage conditions.", "ParentId": "5cafcd7a-520c-4d16-9964-0585ef937c6e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "14b2f536-2665-43f3-a8c1-504d30c5c7c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e08b9b92-22f5-4c19-8675-07abe2b114ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14b2f536-2665-43f3-a8c1-504d30c5c7c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste.\u00a0 Ask your pharmacist\nhow to throw away medicines you no longer use.\u00a0 These measures will help\nprotect the environment.</span></p>", "ID": "6da3270a-63e3-4e9a-ac16-34c40c3bd3b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste.\u00a0 Ask your pharmacist\nhow to throw away medicines you no longer use.\u00a0 These measures will help\nprotect the environment.</span>", "ID": "ab537368-c94f-45ea-b7f7-489ab59e2515", "Styles": "None", "Classes": "None", "Text": "Do not throw away any medicines via wastewater or household waste.\u00a0 Ask your pharmacist how to throw away medicines you no longer use.\u00a0 These measures will help protect the environment.", "ParentId": "6da3270a-63e3-4e9a-ac16-34c40c3bd3b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b14444a-cc22-4854-8ae8-2eda72ebb79b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5e047ba-6290-4116-9af3-fc18a4b8030e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b14444a-cc22-4854-8ae8-2eda72ebb79b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fbd726f5-ec0c-4152-b101-6549083a6a43", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4be8110b-ea77-4b64-8c74-ebfe0e7bed4d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fbd726f5-ec0c-4152-b101-6549083a6a43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span></b></p>", "ID": "ad99c87e-9e93-4a37-88d7-ff64f3127f93", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span></b>", "ID": "ed8712da-5094-4184-b89e-ff1c330e9948", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad99c87e-9e93-4a37-88d7-ff64f3127f93"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span>", "ID": "faf4bf94-8da4-4c7e-b929-f4e116efb4c9", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "ed8712da-5094-4184-b89e-ff1c330e9948"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b8583cbb-86eb-48a7-8807-60bb11780d9d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f19005f-ea4a-44f4-84e8-1268a6257c97", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8583cbb-86eb-48a7-8807-60bb11780d9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Epclusa contains</span></b></p>", "ID": "fcb57f58-b3b2-4571-b49b-cba0db383a6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">What Epclusa contains</span></b>", "ID": "cc19d3f9-5527-4045-b02c-34a971296bd5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fcb57f58-b3b2-4571-b49b-cba0db383a6d"}, {"Element": "<span lang=\"EN-GB\">What Epclusa contains</span>", "ID": "011abec3-01ed-4da5-962b-126d892edea1", "Styles": "None", "Classes": "None", "Text": "What Epclusa contains", "ParentId": "cc19d3f9-5527-4045-b02c-34a971296bd5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2014091-678e-4282-a77b-62fff6608c11", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85288b52-7d03-4a76-a084-904437ff6144", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2014091-678e-4282-a77b-62fff6608c11"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">The active substances are</span></b><span lang=\"EN-GB\"> sofosbuvir and velpatasvir.\u00a0 Each film\u2011coated tablet\ncontains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir.</span></p>", "ID": "aaa292b3-89cc-4cf8-998c-bd8fc92a4679", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "032c878a-7d3f-4d97-b974-743e221c7448", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "aaa292b3-89cc-4cf8-998c-bd8fc92a4679"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f0edd577-05f2-42a3-9d7d-8c26b700e926", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "032c878a-7d3f-4d97-b974-743e221c7448"}, {"Element": "<b><span lang=\"EN-GB\">The active substances are</span></b>", "ID": "9448c1c7-dc20-46ab-9a22-d3bea5b8631a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aaa292b3-89cc-4cf8-998c-bd8fc92a4679"}, {"Element": "<span lang=\"EN-GB\">The active substances are</span>", "ID": "3df692e0-9284-4c81-8cda-f65f630758fa", "Styles": "None", "Classes": "None", "Text": "The active substances are", "ParentId": "9448c1c7-dc20-46ab-9a22-d3bea5b8631a"}, {"Element": "<span lang=\"EN-GB\"> sofosbuvir and velpatasvir.\u00a0 Each film\u2011coated tablet\ncontains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir.</span>", "ID": "d1f5b9ae-010c-4d8d-befa-5ee38ec08cbe", "Styles": "None", "Classes": "None", "Text": " sofosbuvir and velpatasvir.\u00a0 Each film\u2011coated tablet contains 400\u00a0mg sofosbuvir and 100\u00a0mg velpatasvir.", "ParentId": "aaa292b3-89cc-4cf8-998c-bd8fc92a4679"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a9f96bf3-7eef-477a-98ac-815da18ca6a2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79237c1d-780e-474e-855f-ecdb951a4828", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a9f96bf3-7eef-477a-98ac-815da18ca6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">The other ingredients are</span></b></p>", "ID": "17788b05-889b-4bcb-89bd-c50def7a29b9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "eef97d0a-1299-4336-871a-2fb1f831d7d0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "17788b05-889b-4bcb-89bd-c50def7a29b9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "01be4bdf-fdff-4277-a524-9810f14c2b50", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "eef97d0a-1299-4336-871a-2fb1f831d7d0"}, {"Element": "<b><span lang=\"EN-GB\">The other ingredients are</span></b>", "ID": "d3dcbaca-663c-4034-8eb4-d90a6440839f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17788b05-889b-4bcb-89bd-c50def7a29b9"}, {"Element": "<span lang=\"EN-GB\">The other ingredients are</span>", "ID": "473f80fa-d05a-451b-817f-6994ebb2dc4f", "Styles": "None", "Classes": "None", "Text": "The other ingredients are", "ParentId": "d3dcbaca-663c-4034-8eb4-d90a6440839f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:\navoid\"><i><span lang=\"EN-GB\">Tablet core:</span></i></p>", "ID": "6b11c423-2d68-4df4-a244-322368fedc04", "Styles": "margin-left:28.35pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Tablet core:</span></i>", "ID": "19580dee-f923-4c44-8889-ec6dc78563ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b11c423-2d68-4df4-a244-322368fedc04"}, {"Element": "<span lang=\"EN-GB\">Tablet core:</span>", "ID": "a25f6945-1bc3-4b08-931f-a6b55a09b6cd", "Styles": "None", "Classes": "None", "Text": "Tablet core:", "ParentId": "19580dee-f923-4c44-8889-ec6dc78563ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">Copovidone, microcrystalline cellulose, croscarmellose sodium,\nmagnesium stearate</span></p>", "ID": "31d33f59-fb65-4232-bfc8-b6c9d3286b4d", "Styles": "margin-left:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Copovidone, microcrystalline cellulose, croscarmellose sodium,\nmagnesium stearate</span>", "ID": "97d6b259-6ca4-424c-8021-2089f644974e", "Styles": "None", "Classes": "None", "Text": "Copovidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate", "ParentId": "31d33f59-fb65-4232-bfc8-b6c9d3286b4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1340c380-956b-4aa1-9119-6cef928c3635", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ae1ba94-474a-4f3d-a1b9-b94f05404e38", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1340c380-956b-4aa1-9119-6cef928c3635"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:\navoid\"><i><span lang=\"EN-GB\">Film\u2011coating:</span></i></p>", "ID": "a0375165-8984-44e7-ba70-c39968eee5d3", "Styles": "margin-left:28.35pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<i><span lang=\"EN-GB\">Film\u2011coating:</span></i>", "ID": "5d4088e0-4cc0-410f-9035-cf6ba70b72e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0375165-8984-44e7-ba70-c39968eee5d3"}, {"Element": "<span lang=\"EN-GB\">Film\u2011coating:</span>", "ID": "33400f41-cc23-4dc6-80db-aac51dd26333", "Styles": "None", "Classes": "None", "Text": "Film\u2011coating:", "ParentId": "5d4088e0-4cc0-410f-9035-cf6ba70b72e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal\"><span lang=\"EN-GB\">Polyvinyl alcohol, titanium dioxide, p</span><span lang=\"EN-GB\">olyethylene\nglycol, talc, iron oxide red</span></p>", "ID": "250e0826-1820-4ff9-ba1d-560bbc78a935", "Styles": "margin-left:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Polyvinyl alcohol, titanium dioxide, p</span>", "ID": "561c65f6-3f9e-4629-a50f-29467647ea00", "Styles": "None", "Classes": "None", "Text": "Polyvinyl alcohol, titanium dioxide, p", "ParentId": "250e0826-1820-4ff9-ba1d-560bbc78a935"}, {"Element": "<span lang=\"EN-GB\">olyethylene\nglycol, talc, iron oxide red</span>", "ID": "97881cb2-b28b-4fbd-ae36-c668f328a0fb", "Styles": "None", "Classes": "None", "Text": "olyethylene glycol, talc, iron oxide red", "ParentId": "250e0826-1820-4ff9-ba1d-560bbc78a935"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eb8db12f-d6c5-47fa-8f7b-e5b1b1a13380", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9f625673-6361-4c81-9837-fc36bab46f80", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eb8db12f-d6c5-47fa-8f7b-e5b1b1a13380"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Epclusa looks like and contents of the pack</span></b></p>", "ID": "aff5f8f8-11f5-4e23-ac23-d53791850e1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">What Epclusa looks like and contents of the pack</span></b>", "ID": "2005cac0-7795-433d-9468-a5c99536a2fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aff5f8f8-11f5-4e23-ac23-d53791850e1c"}, {"Element": "<span lang=\"EN-GB\">What Epclusa looks like and contents of the pack</span>", "ID": "850bb081-2584-4aa7-80de-8fce4897d2b6", "Styles": "None", "Classes": "None", "Text": "What Epclusa looks like and contents of the pack", "ParentId": "2005cac0-7795-433d-9468-a5c99536a2fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The film\u2011coated\ntablets are pink, diamond\u2011shaped tablets debossed with \u201cGSI\u201d\non one side and \u201c7916\u201d on the other side.\u00a0 The tablet is 20\u00a0mm\nlong and 10\u00a0mm wide.</span></p>", "ID": "8c043ca0-aa7d-4de3-b743-e3569cb9aa0b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The film\u2011coated\ntablets are pink, diamond\u2011shaped tablets debossed with \u201cGSI\u201d\non one side and \u201c7916\u201d on the other side.\u00a0 The tablet is 20\u00a0mm\nlong and 10\u00a0mm wide.</span>", "ID": "94ed7f58-825a-41e5-a3c7-ef150886989a", "Styles": "None", "Classes": "None", "Text": "The film\u2011coated tablets are pink, diamond\u2011shaped tablets debossed with \u201cGSI\u201d on one side and \u201c7916\u201d on the other side.\u00a0 The tablet is 20\u00a0mm long and 10\u00a0mm wide.", "ParentId": "8c043ca0-aa7d-4de3-b743-e3569cb9aa0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3dd794b5-a7a7-42b2-8121-706e24249399", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9f6e095c-da6e-4cbb-a21a-3b29390c0b71", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3dd794b5-a7a7-42b2-8121-706e24249399"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The following pack sizes are available:</span></p>", "ID": "195d9a28-cef6-42ba-a3a1-8349363e43d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">The following pack sizes are available:</span>", "ID": "36d12d4a-d69e-4b2e-9a10-ae8b498073c7", "Styles": "None", "Classes": "None", "Text": "The following pack sizes are available:", "ParentId": "195d9a28-cef6-42ba-a3a1-8349363e43d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets</span></p>", "ID": "fe5b876b-f959-4782-ad6f-164a0f8092dd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5674b483-7fd2-4431-968c-b789e8812445", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fe5b876b-f959-4782-ad6f-164a0f8092dd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "518828a3-1b9e-45e5-946d-28236cb04975", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5674b483-7fd2-4431-968c-b789e8812445"}, {"Element": "<span lang=\"EN-GB\">outer cartons containing 1\u00a0bottle of\n28\u00a0film\u2011coated tablets</span>", "ID": "c5618ae7-468d-47e6-811a-f6ee788b2ea6", "Styles": "None", "Classes": "None", "Text": "outer cartons containing 1\u00a0bottle of 28\u00a0film\u2011coated tablets", "ParentId": "fe5b876b-f959-4782-ad6f-164a0f8092dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9808e4fc-f336-4f61-bb1c-d003f9c1172f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d659947-8786-447e-b144-8c83653fc664", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9808e4fc-f336-4f61-bb1c-d003f9c1172f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>", "ID": "2974772c-9482-4267-92fb-08afa49bf139", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b>", "ID": "42ba888b-76f3-4236-82a0-f4c88f7c66c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2974772c-9482-4267-92fb-08afa49bf139"}, {"Element": "<span lang=\"EN-GB\">Marketing Authorisation Holder</span>", "ID": "d3e2188a-5421-408f-a928-6fbfff272e1f", "Styles": "None", "Classes": "None", "Text": "Marketing Authorisation Holder", "ParentId": "42ba888b-76f3-4236-82a0-f4c88f7c66c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>", "ID": "d38da0d4-e3e1-4a88-8a09-5553630f7df7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Ireland UC</span>", "ID": "99e26884-0d73-4693-816b-542cbd026185", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Ireland UC", "ParentId": "d38da0d4-e3e1-4a88-8a09-5553630f7df7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>", "ID": "254495b8-7335-4127-84fb-6e96720ce954", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Carrigtohill</span>", "ID": "d90a428b-dda1-420c-8966-6a3e26c64076", "Styles": "None", "Classes": "None", "Text": "Carrigtohill", "ParentId": "254495b8-7335-4127-84fb-6e96720ce954"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork, T45 DP77</span></p>", "ID": "43f3327a-b562-4851-9537-cbd772a0cba7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">County Cork, T45 DP77</span>", "ID": "8ddaaf97-e913-4cb6-97e5-4b3a9b6e9618", "Styles": "None", "Classes": "None", "Text": "County Cork, T45 DP77", "ParentId": "43f3327a-b562-4851-9537-cbd772a0cba7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "397df87b-b746-44ff-bf18-c8ab67c59053", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "a4b85ac8-be92-4b4d-ac6b-9b58fe4ee7c5", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "397df87b-b746-44ff-bf18-c8ab67c59053"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3257ab5d-ff5b-4a71-ace3-5a24f311982e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be40e9ae-1db6-4c07-be1d-12e61daa566b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3257ab5d-ff5b-4a71-ace3-5a24f311982e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>", "ID": "104e7599-b74e-45b3-b77b-aaa9dae68ca8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">Manufacturer</span></b>", "ID": "e16467d7-9586-4dd9-817c-bfaae81666da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "104e7599-b74e-45b3-b77b-aaa9dae68ca8"}, {"Element": "<span lang=\"EN-GB\">Manufacturer</span>", "ID": "b91cedc3-23f9-491a-afd9-d8b01757d761", "Styles": "None", "Classes": "None", "Text": "Manufacturer", "ParentId": "e16467d7-9586-4dd9-817c-bfaae81666da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Gilead Sciences Ireland UC</span></p>", "ID": "65a69153-8862-45a2-988b-0c2d8ef951e6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Ireland UC</span>", "ID": "66614c56-95bb-4256-96f2-27cd9734c2d1", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Ireland UC", "ParentId": "65a69153-8862-45a2-988b-0c2d8ef951e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">IDA Business &amp; Technology Park</span></p>", "ID": "a6250876-5362-4f22-8b0a-cba5ddd13849", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">IDA Business &amp; Technology Park</span>", "ID": "3847416a-27e1-4714-aae8-e7f87f4c6e9a", "Styles": "None", "Classes": "None", "Text": "IDA Business & Technology Park", "ParentId": "a6250876-5362-4f22-8b0a-cba5ddd13849"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carrigtohill</span></p>", "ID": "2627b752-92f2-4c86-a4e3-0706522ca9a1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Carrigtohill</span>", "ID": "b43468c8-6c8d-4e0f-872e-b2ab91f5388d", "Styles": "None", "Classes": "None", "Text": "Carrigtohill", "ParentId": "2627b752-92f2-4c86-a4e3-0706522ca9a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">County Cork</span></p>", "ID": "e565623a-81fb-45a8-b1b3-c5298bb9d7f3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">County Cork</span>", "ID": "1e3b0e22-82d8-46e0-9926-8856d8ecc162", "Styles": "None", "Classes": "None", "Text": "County Cork", "ParentId": "e565623a-81fb-45a8-b1b3-c5298bb9d7f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "10f8a489-2ff6-415d-8959-c5dfcb7012be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "5de9e09b-d30d-4d7b-a77a-a27dde51e567", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "10f8a489-2ff6-415d-8959-c5dfcb7012be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "43fe3305-2c09-43ac-a76e-7292de330773", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f5a0202-d4d7-4316-9ae9-eb28dee79625", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "43fe3305-2c09-43ac-a76e-7292de330773"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder:</span></p>", "ID": "1b754b0f-c5e5-4cd9-8885-9999d7cbe522", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">For any information about this medicine, please contact the local\nrepresentative of the Marketing Authorisation Holder:</span>", "ID": "aedfe7d9-7283-4128-b611-6c86af564bd1", "Styles": "None", "Classes": "None", "Text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "ParentId": "1b754b0f-c5e5-4cd9-8885-9999d7cbe522"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca995fa8-79a6-43a4-b364-fe6139bf47e6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "62492820-dbeb-4457-9dc6-b1cc9095bd04", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca995fa8-79a6-43a4-b364-fe6139bf47e6"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 39 02\n  439201</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n</table>", "ID": "73256d47-2f3c-4ad4-9da4-8050cf77b735", "Styles": "margin-left:-1.7pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                ", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "4e723214-83e9-4836-8f7b-dc8effc7e462", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "6d808111-17b5-4ed1-8611-318bfd5e3286", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "4e723214-83e9-4836-8f7b-dc8effc7e462"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>", "ID": "9ce62d05-923a-41c5-954c-9176a4602b0a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d808111-17b5-4ed1-8611-318bfd5e3286"}, {"Element": "<b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b>", "ID": "b0aa49e3-0564-458f-9c07-3b5895e80413", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9ce62d05-923a-41c5-954c-9176a4602b0a"}, {"Element": "<span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span>", "ID": "f053214e-4315-4cf0-8802-7adf7002d395", "Styles": "None", "Classes": "None", "Text": "Belgi\u00eb/Belgique/Belgien", "ParentId": "b0aa49e3-0564-458f-9c07-3b5895e80413"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>", "ID": "1928d032-75b7-490a-bf3e-d59e9724a2da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d808111-17b5-4ed1-8611-318bfd5e3286"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span>", "ID": "b3e1defe-5f27-4351-94c2-700ed992dc5e", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Belgium SPRL-BVBA", "ParentId": "1928d032-75b7-490a-bf3e-d59e9724a2da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>", "ID": "62e27ac4-9bf2-4b34-b348-d083b1cb5378", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d808111-17b5-4ed1-8611-318bfd5e3286"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span>", "ID": "25ee9273-c455-4e68-af58-4738a33b18d7", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel:   + 32 (0) 24 01 35 50", "ParentId": "62e27ac4-9bf2-4b34-b348-d083b1cb5378"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "226b0091-456d-4ec5-8441-1445e5afb47c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d808111-17b5-4ed1-8611-318bfd5e3286"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "add16162-5c5e-4991-a407-d27562601bac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "226b0091-456d-4ec5-8441-1445e5afb47c"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "381fb6dd-5bcf-4e22-97ce-eaa4389d117b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "4e723214-83e9-4836-8f7b-dc8effc7e462"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>", "ID": "b7d35047-c142-4182-95f1-c9d6bb55a6e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "381fb6dd-5bcf-4e22-97ce-eaa4389d117b"}, {"Element": "<b><span lang=\"EN-GB\">Lietuva</span></b>", "ID": "151c895c-a39f-4d1a-91a3-ecc2319c875d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7d35047-c142-4182-95f1-c9d6bb55a6e9"}, {"Element": "<span lang=\"EN-GB\">Lietuva</span>", "ID": "c440f8a1-00b9-442a-ae85-9c807de3fdf0", "Styles": "None", "Classes": "None", "Text": "Lietuva", "ParentId": "151c895c-a39f-4d1a-91a3-ecc2319c875d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>", "ID": "702b8689-22fb-4fee-8af6-514abe6ad25d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "381fb6dd-5bcf-4e22-97ce-eaa4389d117b"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span>", "ID": "d9dc44f8-a116-4be0-b073-1d2d5fc4a9cc", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Poland Sp. z o.o.", "ParentId": "702b8689-22fb-4fee-8af6-514abe6ad25d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>", "ID": "dc484c4a-71c2-4bf3-8442-37f1040d9fad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "381fb6dd-5bcf-4e22-97ce-eaa4389d117b"}, {"Element": "<span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span>", "ID": "91592cc4-e7c8-4b12-ac0f-ad6adbe6ed2e", "Styles": "None", "Classes": "None", "Text": "Tel: + 48 22   262 8702", "ParentId": "dc484c4a-71c2-4bf3-8442-37f1040d9fad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5a4dbca1-59c9-44c1-bd19-58d7a435966c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "381fb6dd-5bcf-4e22-97ce-eaa4389d117b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17c15416-bd09-46d1-9afb-a752f7a0b33c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a4dbca1-59c9-44c1-bd19-58d7a435966c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "077ec2d6-751b-480d-8424-36c9a982d182", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "2d965199-d78f-4c64-ac16-c895579a9518", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "077ec2d6-751b-480d-8424-36c9a982d182"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>", "ID": "a2ee130d-cdb2-48d8-aaa8-87ff9eebc969", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d965199-d78f-4c64-ac16-c895579a9518"}, {"Element": "<b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b>", "ID": "588b60c9-c373-4659-aaa2-48674feab473", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a2ee130d-cdb2-48d8-aaa8-87ff9eebc969"}, {"Element": "<span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span>", "ID": "2e07a355-2047-4244-8eed-7ac69745da8c", "Styles": "None", "Classes": "None", "Text": "\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f", "ParentId": "588b60c9-c373-4659-aaa2-48674feab473"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "318264e5-ade7-4fca-835d-0feb87805f15", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d965199-d78f-4c64-ac16-c895579a9518"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "1087ef7a-994a-4dc7-a984-20fbb7a20352", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "318264e5-ade7-4fca-835d-0feb87805f15"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span></p>", "ID": "486103ad-3166-441e-b5c3-6eb0a3a8bc48", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d965199-d78f-4c64-ac16-c895579a9518"}, {"Element": "<span lang=\"EN-GB\">\u0422\u0435\u043b.:\n  + 353 (0) 1 686 1888</span>", "ID": "b0ec33b7-9c0d-4c6b-a5f1-ec817764839e", "Styles": "None", "Classes": "None", "Text": "\u0422\u0435\u043b.:   + 353 (0) 1 686 1888", "ParentId": "486103ad-3166-441e-b5c3-6eb0a3a8bc48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "727c14a3-6612-48af-bd00-657b06051b54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d965199-d78f-4c64-ac16-c895579a9518"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "15cb74b2-06e0-4553-8c1c-82ddeba8221b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "727c14a3-6612-48af-bd00-657b06051b54"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "372cfc81-eb50-4477-a891-011a19f6756d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15cb74b2-06e0-4553-8c1c-82ddeba8221b"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "082053ae-4715-4c7b-973e-ddda39f48540", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "077ec2d6-751b-480d-8424-36c9a982d182"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>", "ID": "3c985357-4261-49b1-9c7e-78d72183e4a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082053ae-4715-4c7b-973e-ddda39f48540"}, {"Element": "<b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b>", "ID": "c6cd0777-e23c-499a-a38b-40b43475b998", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c985357-4261-49b1-9c7e-78d72183e4a7"}, {"Element": "<span lang=\"EN-GB\">Luxembourg/Luxemburg</span>", "ID": "e1f12a52-c3b4-4a9c-b4ff-414ca645739e", "Styles": "None", "Classes": "None", "Text": "Luxembourg/Luxemburg", "ParentId": "c6cd0777-e23c-499a-a38b-40b43475b998"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span></p>", "ID": "f952f64b-99ce-49a9-a85d-989304481757", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082053ae-4715-4c7b-973e-ddda39f48540"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Belgium SPRL-BVBA</span>", "ID": "482d3414-594e-4a82-8bcf-1ac25106dc26", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Belgium SPRL-BVBA", "ParentId": "f952f64b-99ce-49a9-a85d-989304481757"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span></p>", "ID": "30c24b62-1e1b-487b-ac16-bf117862de98", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082053ae-4715-4c7b-973e-ddda39f48540"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l/Tel:\n  + 32 (0) 24 01 35 50</span>", "ID": "53395c88-4d06-4d59-bd53-41969cc06662", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel:   + 32 (0) 24 01 35 50", "ParentId": "30c24b62-1e1b-487b-ac16-bf117862de98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d3ea4cd-49d7-454e-9543-3920f561da36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082053ae-4715-4c7b-973e-ddda39f48540"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a3daa95-0841-4a01-83ee-e9c424b34f27", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d3ea4cd-49d7-454e-9543-3920f561da36"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "e8093f7c-c7ca-469e-b07a-73529e946775", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "a4f5da43-5f69-4c4f-b0a5-212cf86d0057", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "e8093f7c-c7ca-469e-b07a-73529e946775"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>", "ID": "0cd06e29-27d3-4bd0-b955-c1c86ade6b5e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4f5da43-5f69-4c4f-b0a5-212cf86d0057"}, {"Element": "<b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b>", "ID": "fb626b09-4e3c-416f-a462-12473e8c78cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0cd06e29-27d3-4bd0-b955-c1c86ade6b5e"}, {"Element": "<span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span>", "ID": "7235e500-fc5c-482f-9983-3ff5d6cc54de", "Styles": "None", "Classes": "None", "Text": "\u010cesk\u00e1   republika", "ParentId": "fb626b09-4e3c-416f-a462-12473e8c78cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span></p>", "ID": "732df64b-4be1-46a2-a1ec-dadfe7fdb1e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4f5da43-5f69-4c4f-b0a5-212cf86d0057"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences s.r.o.</span>", "ID": "b9d374b9-def0-4d87-84d6-88dea0c7252d", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences s.r.o.", "ParentId": "732df64b-4be1-46a2-a1ec-dadfe7fdb1e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span></p>", "ID": "a969e82b-e8b0-4214-805d-c74d649b7b4d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4f5da43-5f69-4c4f-b0a5-212cf86d0057"}, {"Element": "<span lang=\"EN-GB\">Tel: + 420 910\n  871 986</span>", "ID": "4537c8c9-ee65-4e98-a1db-af8170b84da3", "Styles": "None", "Classes": "None", "Text": "Tel: + 420 910   871 986", "ParentId": "a969e82b-e8b0-4214-805d-c74d649b7b4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0cc95de1-f047-460e-a4ae-4a66eea12d87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4f5da43-5f69-4c4f-b0a5-212cf86d0057"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a52411e6-ee9e-413c-b48b-447ea745d51b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0cc95de1-f047-460e-a4ae-4a66eea12d87"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "a5eb3eac-c034-4e88-a047-e800af194f96", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "e8093f7c-c7ca-469e-b07a-73529e946775"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>", "ID": "9a42495e-782f-4567-b24f-19d896872bce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5eb3eac-c034-4e88-a047-e800af194f96"}, {"Element": "<b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b>", "ID": "e7827137-7729-48bb-92c5-a0f9a70ece45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a42495e-782f-4567-b24f-19d896872bce"}, {"Element": "<span lang=\"EN-GB\">Magyarorsz\u00e1g</span>", "ID": "dc8b7840-ba9a-4142-b016-db235881a29d", "Styles": "None", "Classes": "None", "Text": "Magyarorsz\u00e1g", "ParentId": "e7827137-7729-48bb-92c5-a0f9a70ece45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "261fdf31-6ff4-4474-90cf-01dbf47fb28a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5eb3eac-c034-4e88-a047-e800af194f96"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "3d8ac3fc-aa24-4bbc-b41d-32556e78d956", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "261fdf31-6ff4-4474-90cf-01dbf47fb28a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>", "ID": "5dc4a471-6a75-4530-b2f3-7bc4433fe255", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5eb3eac-c034-4e88-a047-e800af194f96"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span>", "ID": "9c487d73-7ea8-4a22-83f3-6b03db1dc8f7", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   1 686 1888", "ParentId": "5dc4a471-6a75-4530-b2f3-7bc4433fe255"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "dd89608e-f4b9-4f48-89be-afc8f5dcf251", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5eb3eac-c034-4e88-a047-e800af194f96"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "6b9bfb36-ebae-4654-b216-7541be3c3fcc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd89608e-f4b9-4f48-89be-afc8f5dcf251"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cbf4c795-8047-4025-81c8-b5b1e766a360", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b9bfb36-ebae-4654-b216-7541be3c3fcc"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "11e10e8d-761c-4977-8b06-ba021ff4e01a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "4e51a7e8-8a69-41e6-a8fb-af6d41b103ef", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "11e10e8d-761c-4977-8b06-ba021ff4e01a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>", "ID": "f2994cbd-39ca-4bbc-b6f2-369955b90615", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e51a7e8-8a69-41e6-a8fb-af6d41b103ef"}, {"Element": "<b><span lang=\"EN-GB\">Danmark</span></b>", "ID": "f3fe7a0e-7ca8-478e-b3b4-d4f14059e400", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2994cbd-39ca-4bbc-b6f2-369955b90615"}, {"Element": "<span lang=\"EN-GB\">Danmark</span>", "ID": "4ab318ab-79fd-4f5f-9651-ebc49de94f47", "Styles": "None", "Classes": "None", "Text": "Danmark", "ParentId": "f3fe7a0e-7ca8-478e-b3b4-d4f14059e400"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>", "ID": "cd3cd93e-8d6c-4434-8541-b15af86fd5e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e51a7e8-8a69-41e6-a8fb-af6d41b103ef"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span>", "ID": "a5f59f90-2267-4004-a00e-89be1791e805", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Sweden AB", "ParentId": "cd3cd93e-8d6c-4434-8541-b15af86fd5e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>", "ID": "260876ee-26de-4052-bef8-d7093dc50088", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e51a7e8-8a69-41e6-a8fb-af6d41b103ef"}, {"Element": "<span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span>", "ID": "81b5f203-3793-4d4f-9e7f-9022d6f999a8", "Styles": "None", "Classes": "None", "Text": "Tlf: + 46 (0)   8 5057 1849", "ParentId": "260876ee-26de-4052-bef8-d7093dc50088"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "10a8ccf9-e40d-416e-9ef7-120aa10079e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e51a7e8-8a69-41e6-a8fb-af6d41b103ef"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1f7a198c-f3b2-4ac4-9661-396d96c33f0b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "10a8ccf9-e40d-416e-9ef7-120aa10079e8"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "18ae04f3-35fb-46fd-b13a-b2fb25220ba6", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "11e10e8d-761c-4977-8b06-ba021ff4e01a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Malta</span></b></p>", "ID": "5528d836-1d00-4fef-aa9c-2cc5d6636c42", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18ae04f3-35fb-46fd-b13a-b2fb25220ba6"}, {"Element": "<b><span lang=\"EN-GB\">Malta</span></b>", "ID": "983d2f48-4781-4bb1-b4ce-c6902d0e1682", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5528d836-1d00-4fef-aa9c-2cc5d6636c42"}, {"Element": "<span lang=\"EN-GB\">Malta</span>", "ID": "06bfd034-ab00-4c85-81f6-9f181746a37c", "Styles": "None", "Classes": "None", "Text": "Malta", "ParentId": "983d2f48-4781-4bb1-b4ce-c6902d0e1682"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "8f50db15-7070-492f-8b9d-0a0d3b7f4ff7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18ae04f3-35fb-46fd-b13a-b2fb25220ba6"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "2995fdb1-b461-40b3-b8b1-5fe7a6c4c5ab", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "8f50db15-7070-492f-8b9d-0a0d3b7f4ff7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>", "ID": "e4982287-e287-4249-b82b-15320a529a38", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18ae04f3-35fb-46fd-b13a-b2fb25220ba6"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span>", "ID": "b54f233e-24b4-4c76-8e31-3a40c6a9d475", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   1 686 1888", "ParentId": "e4982287-e287-4249-b82b-15320a529a38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ab69c33c-39d8-43f9-a0ce-6302469502b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18ae04f3-35fb-46fd-b13a-b2fb25220ba6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a2e3def5-5f71-4dd7-8cc6-30836fdd8daf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab69c33c-39d8-43f9-a0ce-6302469502b5"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "fa3c649d-b4b3-4905-aad7-d3316666bd2f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "84ab6997-2db5-4c52-aad8-cb87a1f351c2", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "fa3c649d-b4b3-4905-aad7-d3316666bd2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>", "ID": "49116d48-c70d-4392-b678-3645fc52efdf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84ab6997-2db5-4c52-aad8-cb87a1f351c2"}, {"Element": "<b><span lang=\"EN-GB\">Deutschland</span></b>", "ID": "3c334d50-a811-4264-b58b-22f9eb38183a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "49116d48-c70d-4392-b678-3645fc52efdf"}, {"Element": "<span lang=\"EN-GB\">Deutschland</span>", "ID": "f23036cf-733b-4b10-9d67-4a605f5baa0b", "Styles": "None", "Classes": "None", "Text": "Deutschland", "ParentId": "3c334d50-a811-4264-b58b-22f9eb38183a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span></p>", "ID": "6bcffc5f-1425-468e-9ba4-e8f66a56ed1e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84ab6997-2db5-4c52-aad8-cb87a1f351c2"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences GmbH</span>", "ID": "92fe7c09-5815-49f5-9776-8e41b00c35c2", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences GmbH", "ParentId": "6bcffc5f-1425-468e-9ba4-e8f66a56ed1e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span></p>", "ID": "ab1c366a-782d-4e1d-9dec-73aa0d507db2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84ab6997-2db5-4c52-aad8-cb87a1f351c2"}, {"Element": "<span lang=\"EN-GB\">Tel: + 49 (0)\n  89 899890-0</span>", "ID": "ddb55f04-d7d2-4539-bdbe-4b2baf499cc4", "Styles": "None", "Classes": "None", "Text": "Tel: + 49 (0)   89 899890-0", "ParentId": "ab1c366a-782d-4e1d-9dec-73aa0d507db2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cdd5c0c9-676e-49ab-8675-857a72db5265", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84ab6997-2db5-4c52-aad8-cb87a1f351c2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4133d046-1fc5-4ffe-9a2c-3ba58ef27141", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cdd5c0c9-676e-49ab-8675-857a72db5265"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8a9c5d48-15ed-4af4-9a41-0ee10fbcfb8c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "fa3c649d-b4b3-4905-aad7-d3316666bd2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nederland</span></b></p>", "ID": "81d456ba-a38c-4b24-8a86-5b871474bb06", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a9c5d48-15ed-4af4-9a41-0ee10fbcfb8c"}, {"Element": "<b><span lang=\"EN-GB\">Nederland</span></b>", "ID": "117ac37b-2150-4a00-aae1-cbec261408b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81d456ba-a38c-4b24-8a86-5b871474bb06"}, {"Element": "<span lang=\"EN-GB\">Nederland</span>", "ID": "6fb13fef-689f-449f-a61b-125eedd3cd91", "Styles": "None", "Classes": "None", "Text": "Nederland", "ParentId": "117ac37b-2150-4a00-aae1-cbec261408b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span></p>", "ID": "37faff2b-c2bb-4bd0-a560-896028e4d6f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a9c5d48-15ed-4af4-9a41-0ee10fbcfb8c"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Netherlands B.V.</span>", "ID": "532d6cb2-8ab1-4adf-9ce6-754e037c7aa1", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Netherlands B.V.", "ParentId": "37faff2b-c2bb-4bd0-a560-896028e4d6f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span></p>", "ID": "a1e75ad1-c689-45ec-b313-6001420aa8a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a9c5d48-15ed-4af4-9a41-0ee10fbcfb8c"}, {"Element": "<span lang=\"EN-GB\">Tel: + 31 (0)\n  20 718 36 98</span>", "ID": "e9b39603-edfe-425b-ba65-b10aeb6a8c84", "Styles": "None", "Classes": "None", "Text": "Tel: + 31 (0)   20 718 36 98", "ParentId": "a1e75ad1-c689-45ec-b313-6001420aa8a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "754c06d2-4e26-4e3a-8877-6ab971d88b5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a9c5d48-15ed-4af4-9a41-0ee10fbcfb8c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "715938c6-9b66-42cd-b25b-1e84aee8e85a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "754c06d2-4e26-4e3a-8877-6ab971d88b5b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "56aec893-3278-4db2-bc01-660add6336a4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ccc276a7-df86-43ab-b516-b596cb4916b4", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "56aec893-3278-4db2-bc01-660add6336a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eesti</span></b></p>", "ID": "696ec297-f033-44e8-a52e-efb262d634dd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccc276a7-df86-43ab-b516-b596cb4916b4"}, {"Element": "<b><span lang=\"EN-GB\">Eesti</span></b>", "ID": "61478e7c-5405-4f25-8050-c29919a1a352", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "696ec297-f033-44e8-a52e-efb262d634dd"}, {"Element": "<span lang=\"EN-GB\">Eesti</span>", "ID": "e7609b1e-666d-40b7-b8a8-74ec7801a5be", "Styles": "None", "Classes": "None", "Text": "Eesti", "ParentId": "61478e7c-5405-4f25-8050-c29919a1a352"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>", "ID": "7c4f575c-16d4-4688-b1a6-6cc97899485f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccc276a7-df86-43ab-b516-b596cb4916b4"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span>", "ID": "c9eb4530-17a4-47aa-8e20-06223b1150a3", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Poland Sp. z o.o.", "ParentId": "7c4f575c-16d4-4688-b1a6-6cc97899485f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>", "ID": "89f59f46-e018-4d99-9d59-95315d1f7272", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccc276a7-df86-43ab-b516-b596cb4916b4"}, {"Element": "<span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span>", "ID": "a6980521-c25a-4de9-bfc7-06992a3acbb8", "Styles": "None", "Classes": "None", "Text": "Tel: + 48 22   262 8702", "ParentId": "89f59f46-e018-4d99-9d59-95315d1f7272"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0a9b806-cd1a-420b-9f7e-19ae60449fcf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccc276a7-df86-43ab-b516-b596cb4916b4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "90564487-d6eb-4ab4-8bed-034f606707e6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0a9b806-cd1a-420b-9f7e-19ae60449fcf"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "eb0886a4-65fa-4d5b-965a-17f9d89a642e", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "56aec893-3278-4db2-bc01-660add6336a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Norge</span></b></p>", "ID": "55cc7da6-b639-44fb-a16e-57209083b516", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb0886a4-65fa-4d5b-965a-17f9d89a642e"}, {"Element": "<b><span lang=\"EN-GB\">Norge</span></b>", "ID": "7a203b14-0575-49c7-8460-5c1eaae199b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "55cc7da6-b639-44fb-a16e-57209083b516"}, {"Element": "<span lang=\"EN-GB\">Norge</span>", "ID": "f75e19da-e2a9-432b-82c7-8209c0d88f8b", "Styles": "None", "Classes": "None", "Text": "Norge", "ParentId": "7a203b14-0575-49c7-8460-5c1eaae199b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>", "ID": "ad1eceaf-d2ff-44d8-ae70-05ef5f5b1fac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb0886a4-65fa-4d5b-965a-17f9d89a642e"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span>", "ID": "f712b223-ff47-40f1-90cc-674a9b7e4087", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Sweden AB", "ParentId": "ad1eceaf-d2ff-44d8-ae70-05ef5f5b1fac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span></p>", "ID": "8071a177-802d-4cd6-adaa-8b61e5411272", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb0886a4-65fa-4d5b-965a-17f9d89a642e"}, {"Element": "<span lang=\"EN-GB\">Tlf: + 46 (0)\n  8 5057 1849</span>", "ID": "fda23dcd-d7ee-4ef2-a846-7b3226b49e7b", "Styles": "None", "Classes": "None", "Text": "Tlf: + 46 (0)   8 5057 1849", "ParentId": "8071a177-802d-4cd6-adaa-8b61e5411272"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f40645e2-5985-47d8-a9fa-d304b0aaf84a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb0886a4-65fa-4d5b-965a-17f9d89a642e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45dfbbce-8bf8-47f0-88ab-7ec5c38cb833", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f40645e2-5985-47d8-a9fa-d304b0aaf84a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "7796beda-35f4-434b-8755-ebac97164cad", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8227a18a-521a-4be4-a1b0-99bea06a60fc", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "7796beda-35f4-434b-8755-ebac97164cad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>", "ID": "0dcb7069-d21f-4766-b4e8-cec90914d2ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8227a18a-521a-4be4-a1b0-99bea06a60fc"}, {"Element": "<b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b>", "ID": "89af47ee-cbce-4156-8fd6-e44eaa2549e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0dcb7069-d21f-4766-b4e8-cec90914d2ce"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span>", "ID": "730e204b-5d44-4032-a658-99434c649e43", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1", "ParentId": "89af47ee-cbce-4156-8fd6-e44eaa2549e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>", "ID": "3ec4320e-c8f1-4bd4-a84c-70f2d04ba20b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8227a18a-521a-4be4-a1b0-99bea06a60fc"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span>", "ID": "86b218ef-1b9c-455e-a311-105ff94c2d4e", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.", "ParentId": "3ec4320e-c8f1-4bd4-a84c-70f2d04ba20b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>", "ID": "27cc986f-5a10-4ce8-b2a3-7a49f97e5d85", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8227a18a-521a-4be4-a1b0-99bea06a60fc"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span>", "ID": "b293be9b-ae2a-4854-987a-5a44bca91644", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   + 30 210 8930 100", "ParentId": "27cc986f-5a10-4ce8-b2a3-7a49f97e5d85"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa9a495d-17fb-4938-b788-4712533362a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8227a18a-521a-4be4-a1b0-99bea06a60fc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7efd8b9-9144-4baf-90de-0f597782e3c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa9a495d-17fb-4938-b788-4712533362a9"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "c74b3765-c1ee-438c-b2d2-14db10d5655d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "7796beda-35f4-434b-8755-ebac97164cad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>", "ID": "8e5b953b-bbbb-44b5-ba55-54bbbff05101", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c74b3765-c1ee-438c-b2d2-14db10d5655d"}, {"Element": "<b><span lang=\"EN-GB\">\u00d6sterreich</span></b>", "ID": "4856d1fa-738b-481c-8e3f-69510e44bb33", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8e5b953b-bbbb-44b5-ba55-54bbbff05101"}, {"Element": "<span lang=\"EN-GB\">\u00d6sterreich</span>", "ID": "cdfd6b29-501d-47ea-b302-30eb37c9c75b", "Styles": "None", "Classes": "None", "Text": "\u00d6sterreich", "ParentId": "4856d1fa-738b-481c-8e3f-69510e44bb33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span></p>", "ID": "dd42a1c3-730e-44b2-bcde-e98ad8e465f3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c74b3765-c1ee-438c-b2d2-14db10d5655d"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences GesmbH</span>", "ID": "493098ab-76ea-4567-ab17-307a4cbd4f09", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences GesmbH", "ParentId": "dd42a1c3-730e-44b2-bcde-e98ad8e465f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span></p>", "ID": "5f4c479c-7eeb-49a4-bec2-b72b99f3bd43", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c74b3765-c1ee-438c-b2d2-14db10d5655d"}, {"Element": "<span lang=\"EN-GB\">Tel: + 43 1\n  260 830</span>", "ID": "a9499512-1db6-4a33-8d8e-cfd4e8bc4db1", "Styles": "None", "Classes": "None", "Text": "Tel: + 43 1   260 830", "ParentId": "5f4c479c-7eeb-49a4-bec2-b72b99f3bd43"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fef54d94-ab4f-43dc-9e82-8d8503ffb816", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c74b3765-c1ee-438c-b2d2-14db10d5655d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ed4d5ba-2c95-46f3-afe0-cb7110f64358", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fef54d94-ab4f-43dc-9e82-8d8503ffb816"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "d8322e30-5d83-49de-b4a0-3fb6b937b577", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "cd200930-bacc-4505-b3b8-2d2e1e40e754", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "d8322e30-5d83-49de-b4a0-3fb6b937b577"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>", "ID": "c828c5e8-7298-4f3a-956a-dc15a1030137", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd200930-bacc-4505-b3b8-2d2e1e40e754"}, {"Element": "<b><span lang=\"EN-GB\">Espa\u00f1a</span></b>", "ID": "feacc300-882a-4064-b422-9b4251fe20ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c828c5e8-7298-4f3a-956a-dc15a1030137"}, {"Element": "<span lang=\"EN-GB\">Espa\u00f1a</span>", "ID": "86120ce9-33e5-4e37-ab30-6fb849ea11e8", "Styles": "None", "Classes": "None", "Text": "Espa\u00f1a", "ParentId": "feacc300-882a-4064-b422-9b4251fe20ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span></p>", "ID": "19e2abc2-a7a0-4cc1-a1ea-573a2cdb81c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd200930-bacc-4505-b3b8-2d2e1e40e754"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences, S.L.</span>", "ID": "086e0919-d78c-4da1-8cdf-fbe1bc98a4b0", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences, S.L.", "ParentId": "19e2abc2-a7a0-4cc1-a1ea-573a2cdb81c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span></p>", "ID": "b546c149-3c17-4be0-b318-fc5374f2cc74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd200930-bacc-4505-b3b8-2d2e1e40e754"}, {"Element": "<span lang=\"EN-GB\">Tel: + 34 91\n  378 98 30</span>", "ID": "7f41729e-0cb7-45d1-90b1-0d3dae959189", "Styles": "None", "Classes": "None", "Text": "Tel: + 34 91   378 98 30", "ParentId": "b546c149-3c17-4be0-b318-fc5374f2cc74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3390cd87-3d84-4df6-98c5-896e6a3e9c61", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd200930-bacc-4505-b3b8-2d2e1e40e754"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "144a2f27-dc1a-4b4d-ad21-c9274854164d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3390cd87-3d84-4df6-98c5-896e6a3e9c61"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "a9734096-3f2d-4d66-9e05-b9ec17111f3c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "d8322e30-5d83-49de-b4a0-3fb6b937b577"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Polska</span></b></p>", "ID": "91767f4a-18ae-4597-982f-f1f6f32a3d06", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9734096-3f2d-4d66-9e05-b9ec17111f3c"}, {"Element": "<b><span lang=\"EN-GB\">Polska</span></b>", "ID": "b6c9ca4b-2a45-4299-bcea-e561383fe9d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "91767f4a-18ae-4597-982f-f1f6f32a3d06"}, {"Element": "<span lang=\"EN-GB\">Polska</span>", "ID": "d627297e-51a2-4224-a075-c853a958938b", "Styles": "None", "Classes": "None", "Text": "Polska", "ParentId": "b6c9ca4b-2a45-4299-bcea-e561383fe9d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>", "ID": "942405be-eed6-41b0-b866-d743101940d1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9734096-3f2d-4d66-9e05-b9ec17111f3c"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span>", "ID": "9909f7d8-cf94-4aef-bd27-5bc199beac73", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Poland Sp. z o.o.", "ParentId": "942405be-eed6-41b0-b866-d743101940d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>", "ID": "6e5b2953-d864-402c-a0cf-3a825f390576", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9734096-3f2d-4d66-9e05-b9ec17111f3c"}, {"Element": "<span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span>", "ID": "de0c3272-2d86-45ca-a084-13ca9bfaf661", "Styles": "None", "Classes": "None", "Text": "Tel: + 48 22   262 8702", "ParentId": "6e5b2953-d864-402c-a0cf-3a825f390576"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5c0ca550-fa60-4bd0-86b1-e9ba307f2bfe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9734096-3f2d-4d66-9e05-b9ec17111f3c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e3bdf13-ef76-424a-b4ef-c101c8254b17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5c0ca550-fa60-4bd0-86b1-e9ba307f2bfe"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c13dda64-f95a-49a1-a8d4-7f35b7d01dc6", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "db7aa4ab-f28a-49f5-838a-6f675a25131b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c13dda64-f95a-49a1-a8d4-7f35b7d01dc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">France</span></b></p>", "ID": "ea6d1a3a-8a91-4787-8ab4-a3385cbe8097", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db7aa4ab-f28a-49f5-838a-6f675a25131b"}, {"Element": "<b><span lang=\"EN-GB\">France</span></b>", "ID": "44d69b55-6966-4f33-8ef7-bab80a098ec8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea6d1a3a-8a91-4787-8ab4-a3385cbe8097"}, {"Element": "<span lang=\"EN-GB\">France</span>", "ID": "04f802cf-1412-43c5-82ff-584134a4d394", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "44d69b55-6966-4f33-8ef7-bab80a098ec8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences</span></p>", "ID": "34e40fd9-a675-45ca-bc96-587fba5bfdd9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db7aa4ab-f28a-49f5-838a-6f675a25131b"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences</span>", "ID": "0f2c38e5-0b53-4268-9f2a-90697513eda7", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences", "ParentId": "34e40fd9-a675-45ca-bc96-587fba5bfdd9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span></p>", "ID": "b29d8717-67ff-435b-b5f6-295ef7464b63", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db7aa4ab-f28a-49f5-838a-6f675a25131b"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l: +\n  33 (0) 1 46 09 41 00</span>", "ID": "39d645ff-3a6e-4333-9d7b-ecb4318e5db9", "Styles": "None", "Classes": "None", "Text": "T\u00e9l: +   33 (0) 1 46 09 41 00", "ParentId": "b29d8717-67ff-435b-b5f6-295ef7464b63"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cf66edd6-564c-4d7d-ab8c-189f4564db54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db7aa4ab-f28a-49f5-838a-6f675a25131b"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "570bf1c6-bc01-467d-92e6-5f9afe4bc240", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf66edd6-564c-4d7d-ab8c-189f4564db54"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc4a11d6-480c-4f44-8600-00c7d7fa24c9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "570bf1c6-bc01-467d-92e6-5f9afe4bc240"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b0f26f70-7d65-4856-87c7-41367689d923", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c13dda64-f95a-49a1-a8d4-7f35b7d01dc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Portugal</span></b></p>", "ID": "b410028e-9246-45ef-a573-2b0d1f0df96f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0f26f70-7d65-4856-87c7-41367689d923"}, {"Element": "<b><span lang=\"EN-GB\">Portugal</span></b>", "ID": "604ebc4c-c266-4c6c-a362-187e8c3577a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b410028e-9246-45ef-a573-2b0d1f0df96f"}, {"Element": "<span lang=\"EN-GB\">Portugal</span>", "ID": "08f6a76c-54de-402f-86ac-b4b78622073c", "Styles": "None", "Classes": "None", "Text": "Portugal", "ParentId": "604ebc4c-c266-4c6c-a362-187e8c3577a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span></p>", "ID": "140973bc-8f7c-49b5-b3cd-785f7ec1272d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0f26f70-7d65-4856-87c7-41367689d923"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences, Lda.</span>", "ID": "4eaf6b77-b2e3-4af8-9613-75311b33903e", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences, Lda.", "ParentId": "140973bc-8f7c-49b5-b3cd-785f7ec1272d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span></p>", "ID": "11173c9d-62fc-4909-8621-9d1994b0044e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0f26f70-7d65-4856-87c7-41367689d923"}, {"Element": "<span lang=\"EN-GB\">Tel: + 351 21\n  7928790</span>", "ID": "2b2928c7-2b0e-468a-b80a-16aed67a2828", "Styles": "None", "Classes": "None", "Text": "Tel: + 351 21   7928790", "ParentId": "11173c9d-62fc-4909-8621-9d1994b0044e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f325e121-2ee6-4698-b7e6-06a5176580ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0f26f70-7d65-4856-87c7-41367689d923"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df28984a-506b-4b51-b67d-0fa37e343783", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f325e121-2ee6-4698-b7e6-06a5176580ab"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "6b08680a-54e8-440f-9684-cc8bd602a645", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "b5b17ca4-6927-43cf-84c7-73468093188d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "6b08680a-54e8-440f-9684-cc8bd602a645"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>", "ID": "1da210a1-fe12-4eb7-a642-c94e94de60eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5b17ca4-6927-43cf-84c7-73468093188d"}, {"Element": "<b><span lang=\"EN-GB\">Hrvatska</span></b>", "ID": "28437b47-3b27-442e-bf6c-667943e2d34b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1da210a1-fe12-4eb7-a642-c94e94de60eb"}, {"Element": "<span lang=\"EN-GB\">Hrvatska</span>", "ID": "d0689acc-eb75-473f-89f7-9f9add72f37e", "Styles": "None", "Classes": "None", "Text": "Hrvatska", "ParentId": "28437b47-3b27-442e-bf6c-667943e2d34b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "18390350-1d9a-4118-873f-c51b9b6cb1ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5b17ca4-6927-43cf-84c7-73468093188d"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "d52c6aee-d3cd-453f-9f67-e5c2c7078dc7", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "18390350-1d9a-4118-873f-c51b9b6cb1ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>", "ID": "f296021b-f210-4c2f-ae8d-1362452f942d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5b17ca4-6927-43cf-84c7-73468093188d"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span>", "ID": "f2c1237a-33c1-428d-b625-79bcdaa26301", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   1 686 1888", "ParentId": "f296021b-f210-4c2f-ae8d-1362452f942d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "1a8a7b74-5611-4d72-9cb3-c4a4c034060c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5b17ca4-6927-43cf-84c7-73468093188d"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9021639c-70d9-4b9d-b54c-b488cbb7d8d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a8a7b74-5611-4d72-9cb3-c4a4c034060c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "543715c8-2e91-4d4d-8e1d-3ba4c9edbb1c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9021639c-70d9-4b9d-b54c-b488cbb7d8d9"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ae519870-cca8-4513-89c2-0a9b6bf26891", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "6b08680a-54e8-440f-9684-cc8bd602a645"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>", "ID": "c600eb60-04dd-4ebe-a632-86224e50921d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae519870-cca8-4513-89c2-0a9b6bf26891"}, {"Element": "<b><span lang=\"EN-GB\">Rom\u00e2nia</span></b>", "ID": "489e6be5-b0e2-48e7-90cb-fea6a8e2408a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c600eb60-04dd-4ebe-a632-86224e50921d"}, {"Element": "<span lang=\"EN-GB\">Rom\u00e2nia</span>", "ID": "6903a2ab-5eb5-4417-92cb-109a2767f5d4", "Styles": "None", "Classes": "None", "Text": "Rom\u00e2nia", "ParentId": "489e6be5-b0e2-48e7-90cb-fea6a8e2408a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "af96a46b-624c-4770-a434-8015c691541a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae519870-cca8-4513-89c2-0a9b6bf26891"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "e2734c4a-9e81-4348-bab8-d342aab7768d", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "af96a46b-624c-4770-a434-8015c691541a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>", "ID": "19e666f4-d68f-4692-8a8e-a7a59f5833eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae519870-cca8-4513-89c2-0a9b6bf26891"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span>", "ID": "96c4c1b5-ee78-42e2-a645-ecd1bcdc020c", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   1 686 1888", "ParentId": "19e666f4-d68f-4692-8a8e-a7a59f5833eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "219bbd44-14fc-4a5a-8751-6f2d867a2614", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ae519870-cca8-4513-89c2-0a9b6bf26891"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0b78de78-173d-41f5-bde5-fe9ec20e7ebc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "219bbd44-14fc-4a5a-8751-6f2d867a2614"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c2638ea9-a7cf-490a-a4c3-62c95308b973", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "cf3ee406-266c-4033-9462-1b61c8c1e5f1", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c2638ea9-a7cf-490a-a4c3-62c95308b973"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>", "ID": "26a21843-06e0-443d-a1ab-e1d121ddd2ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf3ee406-266c-4033-9462-1b61c8c1e5f1"}, {"Element": "<b><span lang=\"EN-GB\">Ireland</span></b>", "ID": "d97b9cde-65c0-484c-9b9c-cf643c9ee8f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26a21843-06e0-443d-a1ab-e1d121ddd2ae"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "dd31c4e4-91d3-45dd-9a4e-5f626499ccea", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "d97b9cde-65c0-484c-9b9c-cf643c9ee8f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "36234763-cae7-4124-a114-700e1e0dcfc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf3ee406-266c-4033-9462-1b61c8c1e5f1"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "db94f4d3-90a1-4dba-a0f6-e32ac339a8a4", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "36234763-cae7-4124-a114-700e1e0dcfc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span></p>", "ID": "0991d75f-f3bd-46ce-ae36-8bd09f496e39", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf3ee406-266c-4033-9462-1b61c8c1e5f1"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  214 825 999</span>", "ID": "84bef1d4-2314-4f28-8f12-2350a2ff6695", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   214 825 999", "ParentId": "0991d75f-f3bd-46ce-ae36-8bd09f496e39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cb0b9f09-50d6-460d-8392-ee8d44d75748", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf3ee406-266c-4033-9462-1b61c8c1e5f1"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "903f9b5b-4ccd-4267-b987-39eac5f60c5f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb0b9f09-50d6-460d-8392-ee8d44d75748"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a402c073-7da1-4f2c-9d8c-5ef27383e46b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "903f9b5b-4ccd-4267-b987-39eac5f60c5f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "94ccab6c-ad84-4dfa-af89-9f6198b5b739", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c2638ea9-a7cf-490a-a4c3-62c95308b973"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>", "ID": "6be62ece-0c31-4b11-8af0-4f6f0ffdba15", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94ccab6c-ad84-4dfa-af89-9f6198b5b739"}, {"Element": "<b><span lang=\"EN-GB\">Slovenija</span></b>", "ID": "69e08be4-eb7f-40a6-affb-c13d07e84cc1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6be62ece-0c31-4b11-8af0-4f6f0ffdba15"}, {"Element": "<span lang=\"EN-GB\">Slovenija</span>", "ID": "d9d4ffdb-193d-44d2-b1bd-12597954b4c3", "Styles": "None", "Classes": "None", "Text": "Slovenija", "ParentId": "69e08be4-eb7f-40a6-affb-c13d07e84cc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span></p>", "ID": "eb16d6bb-8ad9-48b0-8d6c-14c4aa878204", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94ccab6c-ad84-4dfa-af89-9f6198b5b739"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ireland UC</span>", "ID": "228d0626-ab17-4550-bf1d-490edabf1c73", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ireland UC", "ParentId": "eb16d6bb-8ad9-48b0-8d6c-14c4aa878204"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span></p>", "ID": "2e6210a0-88d7-4860-9647-7637b8122d3e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94ccab6c-ad84-4dfa-af89-9f6198b5b739"}, {"Element": "<span lang=\"EN-GB\">Tel: + 353 (0)\n  1 686 1888</span>", "ID": "f3410aec-56aa-4d38-a628-b0ad0d5eae40", "Styles": "None", "Classes": "None", "Text": "Tel: + 353 (0)   1 686 1888", "ParentId": "2e6210a0-88d7-4860-9647-7637b8122d3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "89cbf577-5cc2-4e35-ab75-b85f42dddf2b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94ccab6c-ad84-4dfa-af89-9f6198b5b739"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "37c8a15a-a916-4e05-94b2-106a219de7cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89cbf577-5cc2-4e35-ab75-b85f42dddf2b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d030e37e-7854-4596-b78a-c9bb97e3df03", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "37c8a15a-a916-4e05-94b2-106a219de7cf"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "a5ca5f16-7671-4acb-99e3-657bfe8d35e8", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "a4b126d5-304f-480a-995f-84611d130d5d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a5ca5f16-7671-4acb-99e3-657bfe8d35e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>", "ID": "c6067cb1-1ace-49a1-81cf-c706d5f8a790", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4b126d5-304f-480a-995f-84611d130d5d"}, {"Element": "<b><span lang=\"EN-GB\">\u00cdsland</span></b>", "ID": "eaad7061-7a52-4818-933f-45047bab4e03", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6067cb1-1ace-49a1-81cf-c706d5f8a790"}, {"Element": "<span lang=\"EN-GB\">\u00cdsland</span>", "ID": "a9b1be26-18e6-4464-88de-3ab3c439d306", "Styles": "None", "Classes": "None", "Text": "\u00cdsland", "ParentId": "eaad7061-7a52-4818-933f-45047bab4e03"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>", "ID": "edbf443d-bbae-49c8-8e5a-8a5207a4c750", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4b126d5-304f-480a-995f-84611d130d5d"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span>", "ID": "2050248d-8b6d-4c95-b6a2-a3fd9cfe0e9c", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Sweden AB", "ParentId": "edbf443d-bbae-49c8-8e5a-8a5207a4c750"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span></p>", "ID": "afb3f837-49e5-4ff6-a1b5-13203b3749ee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4b126d5-304f-480a-995f-84611d130d5d"}, {"Element": "<span lang=\"EN-GB\">S\u00edmi: +\n  46 (0) 8 5057 1849</span>", "ID": "4126e7bc-b299-4820-bcfc-c41cb8569508", "Styles": "None", "Classes": "None", "Text": "S\u00edmi: +   46 (0) 8 5057 1849", "ParentId": "afb3f837-49e5-4ff6-a1b5-13203b3749ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9db2371d-0734-4bc3-98fe-23efac6d7dea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4b126d5-304f-480a-995f-84611d130d5d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "611d44eb-6be4-476c-9656-5cad825573f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9db2371d-0734-4bc3-98fe-23efac6d7dea"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "93ca6052-71e6-4b4c-b64a-a3dd35fdd246", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a5ca5f16-7671-4acb-99e3-657bfe8d35e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>", "ID": "a9a380c7-0a95-4377-a00c-9d6fc3a1038d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93ca6052-71e6-4b4c-b64a-a3dd35fdd246"}, {"Element": "<b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b>", "ID": "b7716093-1b26-4065-868e-b67a4971ffca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9a380c7-0a95-4377-a00c-9d6fc3a1038d"}, {"Element": "<span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span>", "ID": "953eaa24-8829-48a9-9bac-4df78126d061", "Styles": "None", "Classes": "None", "Text": "Slovensk\u00e1   republika", "ParentId": "b7716093-1b26-4065-868e-b67a4971ffca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span></p>", "ID": "e59300c6-2bbe-449f-ab09-7571aa934bb4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93ca6052-71e6-4b4c-b64a-a3dd35fdd246"}, {"Element": "<span lang=\"EN-GB\">Gilead Sciences Slovakia s.r.o.</span>", "ID": "5daf1fd4-91d3-4e0d-99f9-29b1ab227116", "Styles": "None", "Classes": "None", "Text": "Gilead Sciences Slovakia s.r.o.", "ParentId": "e59300c6-2bbe-449f-ab09-7571aa934bb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span></p>", "ID": "a3829bf8-7fe4-46d5-b85c-d183b1fd93c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93ca6052-71e6-4b4c-b64a-a3dd35fdd246"}, {"Element": "<span lang=\"EN-GB\">Tel: + 421 232\n  121 210</span>", "ID": "645c18ce-3b90-4942-8ff2-87aba25b5bab", "Styles": "None", "Classes": "None", "Text": "Tel: + 421 232   121 210", "ParentId": "a3829bf8-7fe4-46d5-b85c-d183b1fd93c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ff51c6a6-6e3f-4df5-86dc-0ae99aad6b9a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93ca6052-71e6-4b4c-b64a-a3dd35fdd246"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a76054bc-3156-4617-8178-65788d6cac8f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ff51c6a6-6e3f-4df5-86dc-0ae99aad6b9a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 39 02\n  439201</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "a1895627-d6f9-4087-a4e6-4c7502c6d982", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 39 02\n  439201</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "33e5327d-83df-4f93-9532-729aa755ef95", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a1895627-d6f9-4087-a4e6-4c7502c6d982"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Italia</span></b></p>", "ID": "e1d43f83-6772-4bcd-9f76-7fc68de00b66", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33e5327d-83df-4f93-9532-729aa755ef95"}, {"Element": "<b><span lang=\"EN-GB\">Italia</span></b>", "ID": "8c77c929-05dc-4a6d-955b-102bf6ab9310", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e1d43f83-6772-4bcd-9f76-7fc68de00b66"}, {"Element": "<span lang=\"EN-GB\">Italia</span>", "ID": "56a2ece6-2562-4efa-9df3-ed58aba21530", "Styles": "None", "Classes": "None", "Text": "Italia", "ParentId": "8c77c929-05dc-4a6d-955b-102bf6ab9310"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span></p>", "ID": "9a3a4bbb-0097-48ee-aa1e-6e58304cb018", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33e5327d-83df-4f93-9532-729aa755ef95"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences S.r.l.</span>", "ID": "7c05eb9e-041f-4190-bceb-3e88d72b7915", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences S.r.l.", "ParentId": "9a3a4bbb-0097-48ee-aa1e-6e58304cb018"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 39 02\n  439201</span></p>", "ID": "94a6f523-030c-49c7-a274-1a75ede98d94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33e5327d-83df-4f93-9532-729aa755ef95"}, {"Element": "<span lang=\"EN-GB\">Tel: + 39 02\n  439201</span>", "ID": "65d252e7-2819-43d2-87c9-5b8051081e79", "Styles": "None", "Classes": "None", "Text": "Tel: + 39 02   439201", "ParentId": "94a6f523-030c-49c7-a274-1a75ede98d94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0dadf5da-ba51-442e-a410-912024167ffd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33e5327d-83df-4f93-9532-729aa755ef95"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "975728b7-960c-4bb9-aa39-a0065c95411f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0dadf5da-ba51-442e-a410-912024167ffd"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0eec4a9e-7ba6-49fb-9d96-e186334a176b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "975728b7-960c-4bb9-aa39-a0065c95411f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "71b67405-62a3-43af-b742-536c9cd792a8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a1895627-d6f9-4087-a4e6-4c7502c6d982"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>", "ID": "10f897e2-cf7c-47f6-9420-26d57fedcae0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71b67405-62a3-43af-b742-536c9cd792a8"}, {"Element": "<b><span lang=\"EN-GB\">Suomi/Finland</span></b>", "ID": "2e334404-41ef-4e0e-a690-a06a113c5b73", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10f897e2-cf7c-47f6-9420-26d57fedcae0"}, {"Element": "<span lang=\"EN-GB\">Suomi/Finland</span>", "ID": "fbe6d05c-8de7-4075-81fb-4f34d9c9a201", "Styles": "None", "Classes": "None", "Text": "Suomi/Finland", "ParentId": "2e334404-41ef-4e0e-a690-a06a113c5b73"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>", "ID": "98aab43c-538a-483d-883c-db3d155a3aa4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71b67405-62a3-43af-b742-536c9cd792a8"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span>", "ID": "e36b02e8-00d4-4657-9f61-7e49bb4fb1f8", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Sweden AB", "ParentId": "98aab43c-538a-483d-883c-db3d155a3aa4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span></p>", "ID": "d676a33f-eb15-4c63-8786-5b7c19b57a4d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71b67405-62a3-43af-b742-536c9cd792a8"}, {"Element": "<span lang=\"EN-GB\">Puh/Tel: + 46\n  (0) 8 5057 1849</span>", "ID": "efd14cb2-7d34-4f85-9233-eb0ea0288acb", "Styles": "None", "Classes": "None", "Text": "Puh/Tel: + 46   (0) 8 5057 1849", "ParentId": "d676a33f-eb15-4c63-8786-5b7c19b57a4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "be1c7107-56ef-45c7-963e-2c4126a3ee9d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71b67405-62a3-43af-b742-536c9cd792a8"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c6ee998d-efc2-43ed-a962-3d78b3347ee3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be1c7107-56ef-45c7-963e-2c4126a3ee9d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "146feb86-6091-4b88-8265-b2cf1b2cbe53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c6ee998d-efc2-43ed-a962-3d78b3347ee3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c01eee14-ea66-420d-97ce-94284d55b2b7", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "48912cde-7c66-46bf-883d-908979d656cf", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c01eee14-ea66-420d-97ce-94284d55b2b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>", "ID": "49566ed4-0cd2-4755-947f-b9639a267cd5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48912cde-7c66-46bf-883d-908979d656cf"}, {"Element": "<b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b>", "ID": "e5a8a38f-7519-4238-a6e2-5d2846208ecb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "49566ed4-0cd2-4755-947f-b9639a267cd5"}, {"Element": "<span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span>", "ID": "af6de52a-cd8e-48e5-bcb2-0324819fa883", "Styles": "None", "Classes": "None", "Text": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2", "ParentId": "e5a8a38f-7519-4238-a6e2-5d2846208ecb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span></p>", "ID": "62dabe81-730f-4599-aa26-a0b0193653f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48912cde-7c66-46bf-883d-908979d656cf"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.</span>", "ID": "c2e2281d-8f70-4524-bddd-4b2745ced8e6", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences \u0395\u03bb\u03bb\u03ac\u03c2 \u039c.\u0395\u03a0\u0395.", "ParentId": "62dabe81-730f-4599-aa26-a0b0193653f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span></p>", "ID": "31cc6b21-623f-42af-a37b-8a614353cb6c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48912cde-7c66-46bf-883d-908979d656cf"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 30 210 8930 100</span>", "ID": "bd11206b-d2af-49d1-a7c0-13880d3121d6", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   + 30 210 8930 100", "ParentId": "31cc6b21-623f-42af-a37b-8a614353cb6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a7d30f89-58bd-42c0-9390-9fd0497061b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48912cde-7c66-46bf-883d-908979d656cf"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8ae18f1a-5285-4b5d-b64d-1052a0850927", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a7d30f89-58bd-42c0-9390-9fd0497061b3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3e5daa06-2685-415b-b428-50f6b9d4b44a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8ae18f1a-5285-4b5d-b64d-1052a0850927"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "84c0da1a-b3d2-4a6d-a6f9-c3812b13054c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c01eee14-ea66-420d-97ce-94284d55b2b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Sverige</span></b></p>", "ID": "623826d1-b70d-4208-aee9-c6566e75f69b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84c0da1a-b3d2-4a6d-a6f9-c3812b13054c"}, {"Element": "<b><span lang=\"EN-GB\">Sverige</span></b>", "ID": "9463e905-2027-49b7-9509-488dcadcc41d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "623826d1-b70d-4208-aee9-c6566e75f69b"}, {"Element": "<span lang=\"EN-GB\">Sverige</span>", "ID": "a1818b4d-1bc8-4d6e-9aac-49949bac17f6", "Styles": "None", "Classes": "None", "Text": "Sverige", "ParentId": "9463e905-2027-49b7-9509-488dcadcc41d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span></p>", "ID": "9d35b47d-3a6a-43ae-b1b3-fd57697064d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84c0da1a-b3d2-4a6d-a6f9-c3812b13054c"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Sweden AB</span>", "ID": "7a3d10ec-24ba-49e3-b1c7-a5936766f836", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Sweden AB", "ParentId": "9d35b47d-3a6a-43ae-b1b3-fd57697064d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span></p>", "ID": "38e78cb4-9712-447b-9d54-2a2cc500f438", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84c0da1a-b3d2-4a6d-a6f9-c3812b13054c"}, {"Element": "<span lang=\"EN-GB\">Tel: + 46 (0)\n  8 5057 1849</span>", "ID": "89cab7a2-75ae-4c37-935f-22111bc7cafe", "Styles": "None", "Classes": "None", "Text": "Tel: + 46 (0)   8 5057 1849", "ParentId": "38e78cb4-9712-447b-9d54-2a2cc500f438"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0054d7cf-aeec-414b-aeca-b46b22e76d12", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84c0da1a-b3d2-4a6d-a6f9-c3812b13054c"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b9ce094e-11ec-4d3c-a3af-a949888c1227", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0054d7cf-aeec-414b-aeca-b46b22e76d12"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d286fce8-e08b-4e78-ba6c-e0453e7e18c6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9ce094e-11ec-4d3c-a3af-a949888c1227"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "a0316a2f-b567-4c22-bef3-9cfb5e56ea32", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "73256d47-2f3c-4ad4-9da4-8050cf77b735"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "409e6f95-587e-4b60-850e-30b011eb99f5", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a0316a2f-b567-4c22-bef3-9cfb5e56ea32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Latvija</span></b></p>", "ID": "124b1520-8ff6-463f-8e0d-fe75fdd16796", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409e6f95-587e-4b60-850e-30b011eb99f5"}, {"Element": "<b><span lang=\"EN-GB\">Latvija</span></b>", "ID": "a9a1bc04-403a-49e4-8d0b-9b56a3e1cf8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "124b1520-8ff6-463f-8e0d-fe75fdd16796"}, {"Element": "<span lang=\"EN-GB\">Latvija</span>", "ID": "e77b0d66-770d-4995-860b-8d99bd030b0a", "Styles": "None", "Classes": "None", "Text": "Latvija", "ParentId": "a9a1bc04-403a-49e4-8d0b-9b56a3e1cf8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span></p>", "ID": "7a51e5c9-be63-423f-9784-db21bda207e1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409e6f95-587e-4b60-850e-30b011eb99f5"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Poland Sp. z o.o.</span>", "ID": "f8335a57-25d7-4172-a329-432263fefb6f", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Poland Sp. z o.o.", "ParentId": "7a51e5c9-be63-423f-9784-db21bda207e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span></p>", "ID": "53588db8-f02e-4aee-853e-bad112a9b2db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409e6f95-587e-4b60-850e-30b011eb99f5"}, {"Element": "<span lang=\"EN-GB\">Tel: + 48 22\n  262 8702</span>", "ID": "4f6ecf30-e86a-4c46-8a22-35b05c6b5940", "Styles": "None", "Classes": "None", "Text": "Tel: + 48 22   262 8702", "ParentId": "53588db8-f02e-4aee-853e-bad112a9b2db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b2101954-2580-46f2-ac17-1e9ba0ae72f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409e6f95-587e-4b60-850e-30b011eb99f5"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4748baa2-6ddf-4d62-9670-81e5724871ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b2101954-2580-46f2-ac17-1e9ba0ae72f6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f203ac63-7820-4f45-8388-796420840c08", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4748baa2-6ddf-4d62-9670-81e5724871ed"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "a50c4004-952e-46c6-9070-104d9b9fd85c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "a0316a2f-b567-4c22-bef3-9cfb5e56ea32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>", "ID": "04d4a033-76bc-41cb-8a48-fba5a2695658", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a50c4004-952e-46c6-9070-104d9b9fd85c"}, {"Element": "<b><span lang=\"EN-GB\">United\n  Kingdom</span></b>", "ID": "d70a3b27-6703-4dac-8497-e120e5b71a5f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04d4a033-76bc-41cb-8a48-fba5a2695658"}, {"Element": "<span lang=\"EN-GB\">United\n  Kingdom</span>", "ID": "c85bdad9-af37-414c-b6ee-f63851d1a923", "Styles": "None", "Classes": "None", "Text": "United   Kingdom", "ParentId": "d70a3b27-6703-4dac-8497-e120e5b71a5f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span></p>", "ID": "e32b0e64-eef0-4803-8298-63ae31530c65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a50c4004-952e-46c6-9070-104d9b9fd85c"}, {"Element": "<span lang=\"EN-GB\">Gilead\n  Sciences Ltd.</span>", "ID": "29189564-e5be-4b76-8464-05880f26e4e0", "Styles": "None", "Classes": "None", "Text": "Gilead   Sciences Ltd.", "ParentId": "e32b0e64-eef0-4803-8298-63ae31530c65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span></p>", "ID": "bf0412dc-6bdc-49ba-affa-dff42889ec36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a50c4004-952e-46c6-9070-104d9b9fd85c"}, {"Element": "<span lang=\"EN-GB\">Tel: + 44 (0)\n  8000 113700</span>", "ID": "6ba5b4db-4f2a-4d63-b976-5c5131bc2681", "Styles": "None", "Classes": "None", "Text": "Tel: + 44 (0)   8000 113700", "ParentId": "bf0412dc-6bdc-49ba-affa-dff42889ec36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4e3e5e98-1934-43c2-9dcf-a73147e5663f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a50c4004-952e-46c6-9070-104d9b9fd85c"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3b7c45f2-93ec-4dc2-8de5-22aea487626e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e3e5e98-1934-43c2-9dcf-a73147e5663f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d374b78-7ce7-4018-b6b8-a7014789b7ec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b7c45f2-93ec-4dc2-8de5-22aea487626e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6e37dc0a-95d9-4261-8b4c-cb2781fedbe6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d5aed16-e177-40a5-8b26-6188a553198d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6e37dc0a-95d9-4261-8b4c-cb2781fedbe6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b></p>", "ID": "ac3ea0cd-558b-4b65-91a5-b9644690d981", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<b><span lang=\"EN-GB\">This leaflet was last revised in </span></b>", "ID": "11085442-3eef-4819-84f3-683f8d413338", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac3ea0cd-558b-4b65-91a5-b9644690d981"}, {"Element": "<span lang=\"EN-GB\">This leaflet was last revised in </span>", "ID": "e7707388-1557-412e-835c-836e8c1c8897", "Styles": "None", "Classes": "None", "Text": "This leaflet was last revised in ", "ParentId": "11085442-3eef-4819-84f3-683f8d413338"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "656b59fe-65c6-47f2-a30e-3d69e14bb49a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f468d99-61ba-4166-bc1f-730f7e8ee89b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "656b59fe-65c6-47f2-a30e-3d69e14bb49a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\"><span style=\"color:windowtext;\ntext-decoration:none\">http://www.ema.europa.eu</span></a>.</span></p>", "ID": "d8d4baad-6e11-496c-9f3c-4d640e014074", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebce45a2-df8a-4783-898d-96fb3461993e"}, {"Element": "<span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\"><span style=\"color:windowtext;\ntext-decoration:none\">http://www.ema.europa.eu</span></a>.</span>", "ID": "4983cf8e-418b-4548-923c-3696b25cffdf", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicine is available on the European Medicines Agency web site: .", "ParentId": "d8d4baad-6e11-496c-9f3c-4d640e014074"}, {"Element": "<a href=\"http://www.ema.europa.eu/\"><span style=\"color:windowtext;\ntext-decoration:none\">http://www.ema.europa.eu</span></a>", "ID": "c6c5e9d8-7134-41a8-a77f-0074506192e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4983cf8e-418b-4548-923c-3696b25cffdf"}, {"Element": "<span style=\"color:windowtext;\ntext-decoration:none\">http://www.ema.europa.eu</span>", "ID": "fbf0d996-a49c-4e2d-b15a-a13fa4a8b34c", "Styles": "color:windowtext;\ntext-decoration:none", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "c6c5e9d8-7134-41a8-a77f-0074506192e4"}]}